CAS No. | Saflık | Ürün Adı | BOSTON KODU |
---|---|---|---|
Cas.: 22276-99-9 | Purity: 95% | 5-Bromo-1H-pyrrolo[2,3-d]pyrimidin-4-amine | ESD-843500-50MG |
Cas.: 22276-99-9 | Purity: 95% | 5-Bromo-1H-pyrrolo[2,3-d]pyrimidin-4-amine | ESD-843500-250MG |
Cas.: 479353-63-4 | Purity: 97% | 1-Boc-4-(4-Carboxybenzyl)piperazine | ESD-843501-250MG |
Cas.: 479353-63-4 | Purity: 97% | 1-Boc-4-(4-Carboxybenzyl)piperazine | ESD-843501-1G |
Cas.: 131774-72-6 | Purity: 98% | 3-Hydrazinylbenzenesulfonamide | ESD-843502-50MG |
Cas.: 131774-72-6 | Purity: 98% | 3-Hydrazinylbenzenesulfonamide | ESD-843502-250MG |
Cas.: 7147-14-0 | Purity: 97% | 5-Nitro-1H-indole-3-carbonitrile | ESD-843503-250MG |
Cas.: 7147-14-0 | Purity: 97% | 5-Nitro-1H-indole-3-carbonitrile | ESD-843503-1G |
Cas.: 162364-72-9 | Purity: 98% | 7-(Benzyloxy)-4-chloro-6-methoxyquinazoline | ESD-843504-250MG |
Cas.: 162364-72-9 | Purity: 98% | 7-(Benzyloxy)-4-chloro-6-methoxyquinazoline | ESD-843504-1G |
Cas.: 23244-87-3 | Purity: 97% | Pyridine-2,4,5-triamine | ESD-843505-25MG |
Cas.: 23244-87-3 | Purity: 97% | Pyridine-2,4,5-triamine | ESD-843505-100MG |
Cas.: 207742-88-9 | Purity: 95% | 3,4,5-Trihydroxybenzaldehyde hydrate | ESD-843506-250MG |
Cas.: 207742-88-9 | Purity: 95% | 3,4,5-Trihydroxybenzaldehyde hydrate | ESD-843506-1G |
Cas.: 89937-26-8 | Purity: 97% | 1-(6-Chloropyridazin-3-yl)piperidin-4-ol | ESD-843507-250MG |
Cas.: 89937-26-8 | Purity: 97% | 1-(6-Chloropyridazin-3-yl)piperidin-4-ol | ESD-843507-1G |
Cas.: 76045-71-1 | Purity: 98% | 3-Amino-5-hydroxybenzoic acid | ESD-843509-50MG |
Cas.: 76045-71-1 | Purity: 98% | 3-Amino-5-hydroxybenzoic acid | ESD-843509-250MG |
Cas.: 957198-30-0 | Purity: 97% | 4-(5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl)morpholine | ESD-843510-250MG |
Cas.: 957198-30-0 | Purity: 97% | 4-(5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl)morpholine | ESD-843510-1G |
Cas.: 1665-48-1 | Purity: 98% | Metaxalone | ESD-843511-10MG |
Cas.: 121660-37-5 | Purity: 95% | 2-Cyclopropyl-4-(4-fluorophenyl)quinoline-3-carbaldehyde | ESD-843512-250MG |
Cas.: 121660-37-5 | Purity: 95% | 2-Cyclopropyl-4-(4-fluorophenyl)quinoline-3-carbaldehyde | ESD-843512-1G |
Cas.: 284493-65-8 | Purity: 97% | 3-((tert-Butoxycarbonyl)amino)-3-(4-chlorophenyl)propanoic acid | ESD-843513-250MG |
Cas.: 284493-65-8 | Purity: 97% | 3-((tert-Butoxycarbonyl)amino)-3-(4-chlorophenyl)propanoic acid | ESD-843513-1G |
Cas.: 479064-93-2 | Purity: 98% | (R)-3-((tert-Butoxycarbonyl)amino)-3-(4-chlorophenyl)propanoic acid | ESD-843514-250MG |
Cas.: 479064-93-2 | Purity: 98% | (R)-3-((tert-Butoxycarbonyl)amino)-3-(4-chlorophenyl)propanoic acid | ESD-843514-1G |
Cas.: 1207370-28-2 | Purity: 97% | 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)quinolin-2(1H)-one | ESD-843515-50MG |
Cas.: 1207370-28-2 | Purity: 97% | 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)quinolin-2(1H)-one | ESD-843515-250MG |
Cas.: 5334-31-6 | Purity: 98% | 3-Amino-1H-pyrazole-4-carboxamide | ESD-843516-250MG |
Cas.: 5334-31-6 | Purity: 98% | 3-Amino-1H-pyrazole-4-carboxamide | ESD-843516-1G |
Cas.: 701917-03-5 | Purity: 98% | 4-Nitro-1-phenyl-1H-pyrazole-3-carboxylic acid | ESD-843517-25MG |
Cas.: 701917-03-5 | Purity: 98% | 4-Nitro-1-phenyl-1H-pyrazole-3-carboxylic acid | ESD-843517-100MG |
Cas.: 2770-01-6 | Purity: 97% | 4-Chloro-1H-imidazo[4,5-c]pyridine | ESD-843518-250MG |
Cas.: 2770-01-6 | Purity: 97% | 4-Chloro-1H-imidazo[4,5-c]pyridine | ESD-843518-1G |
Cas.: 73942-87-7 | Purity: 95% | 7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one | ESD-843519-250MG |
Cas.: 73942-87-7 | Purity: 95% | 7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one | ESD-843519-1G |
Cas.: 112725-89-0 | Purity: 97% | 3,5-Diamino-2-hydroxybenzoic acid | ESD-843520-50MG |
Cas.: 112725-89-0 | Purity: 97% | 3,5-Diamino-2-hydroxybenzoic acid | ESD-843520-250MG |
Cas.: 16017-76-8 | Purity: 98% | 2-Chloro-7-methyl-7H-purin-6-ol | ESD-843521-25MG |
Cas.: 16017-76-8 | Purity: 98% | 2-Chloro-7-methyl-7H-purin-6-ol | ESD-843521-100MG |
Cas.: 128502-56-7 | Purity: 97% | (S)-7-Hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | ESD-843522-50MG |
Cas.: 128502-56-7 | Purity: 97% | (S)-7-Hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | ESD-843522-250MG |
Cas.: 223127-49-9 | Purity: 95% | 4-(5-Nitropyridin-2-yl)benzoic acid | ESD-843523-250MG |
Cas.: 223127-49-9 | Purity: 95% | 4-(5-Nitropyridin-2-yl)benzoic acid | ESD-843523-1G |
Cas.: 182618-86-6 | Purity: 98% | 1-Boc-4-(4-Nitrophenyl)piperazine | ESD-843524-250MG |
Cas.: 182618-86-6 | Purity: 98% | 1-Boc-4-(4-Nitrophenyl)piperazine | ESD-843524-1G |
Cas.: 4414-87-3 | Purity: 97% | 2-(1H-Pyrrolo[2,3-b]pyridin-3-yl)acetonitrile | ESD-843525-50MG |
Cas.: 4414-87-3 | Purity: 97% | 2-(1H-Pyrrolo[2,3-b]pyridin-3-yl)acetonitrile | ESD-843525-250MG |
Cas.: 96799-04-1 | Purity: 98% | 5-(3-Methoxyphenyl)-2H-pyrazol-3-ylamine | ESD-843526-250MG |
Cas.: 96799-04-1 | Purity: 98% | 5-(3-Methoxyphenyl)-2H-pyrazol-3-ylamine | ESD-843526-1G |
Cas.: 119434-75-2 | Purity: 98% | (S)-2-((tert-Butoxycarbonyl)amino)-3-(thiazol-4-yl)propanoic acid | ESD-843527-250MG |
Cas.: 119434-75-2 | Purity: 98% | (S)-2-((tert-Butoxycarbonyl)amino)-3-(thiazol-4-yl)propanoic acid | ESD-843527-1G |
Cas.: 84434-11-7 | Purity: 97% | Ethyl phenyl(2,4,6-trimethylbenzoyl)phosphinate | ESD-843528-1G |
Cas.: 84434-11-7 | Purity: 97% | Ethyl phenyl(2,4,6-trimethylbenzoyl)phosphinate | ESD-843528-5G |
Cas.: 79868-79-4 | Purity: 95% | (R)-2-Amino-1,1,2-triphenylethanol | ESD-843529-25MG |
Cas.: 79868-79-4 | Purity: 95% | (R)-2-Amino-1,1,2-triphenylethanol | ESD-843529-100MG |
Cas.: 73200-73-4 | Purity: 97% | 3-Phenylpyrazin-2-ol | ESD-843530-50MG |
Cas.: 73200-73-4 | Purity: 97% | 3-Phenylpyrazin-2-ol | ESD-843530-250MG |
Cas.: 505-54-4 | Purity: 98% | Hexadecanedioic acid | ESD-843531-250MG |
Cas.: 505-54-4 | Purity: 98% | Hexadecanedioic acid | ESD-843531-1G |
Cas.: 34113-69-4 | Purity: 98% | 4-Chloro-3-hydroxybenzoic acid | ESD-843532-250MG |
Cas.: 34113-69-4 | Purity: 98% | 4-Chloro-3-hydroxybenzoic acid | ESD-843532-1G |
Cas.: 66270-97-1 | Purity: 95% | 2-Oxo-2-phenylethyl 2-(4-(bromomethyl)phenyl)acetate | ESD-843533-250MG |
Cas.: 66270-97-1 | Purity: 95% | 2-Oxo-2-phenylethyl 2-(4-(bromomethyl)phenyl)acetate | ESD-843533-1G |
Cas.: 1256359-21-3 | Purity: 96% | Methyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-6-carboxylate | ESD-843534-25MG |
Cas.: 1256359-21-3 | Purity: 96% | Methyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-6-carboxylate | ESD-843534-100MG |
Cas.: 39150-45-3 | Purity: 95% | 4-Amino-3,5-dibromobenzenesulfonamide | ESD-843535-250MG |
Cas.: 39150-45-3 | Purity: 95% | 4-Amino-3,5-dibromobenzenesulfonamide | ESD-843535-1G |
Cas.: 122536-75-8 | Purity: 97% | (R)-1-Cbz-3-Boc-Aminopyrrolidine | ESD-843536-50MG |
Cas.: 122536-75-8 | Purity: 97% | (R)-1-Cbz-3-Boc-Aminopyrrolidine | ESD-843536-250MG |
Cas.: 444582-90-5 | Purity: 95% | 2-(4-(tert-Butoxycarbonyl)piperazin-1-yl)benzoic acid | ESD-843538-250MG |
Cas.: 444582-90-5 | Purity: 95% | 2-(4-(tert-Butoxycarbonyl)piperazin-1-yl)benzoic acid | ESD-843538-1G |
Cas.: 70315-70-7 | Purity: 97% | 3-Iodo-6-nitro-1H-indazole | ESD-843539-50MG |
Cas.: 70315-70-7 | Purity: 97% | 3-Iodo-6-nitro-1H-indazole | ESD-843539-250MG |
Cas.: 1260811-27-5 | Purity: 98% | Bis((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)methyl)amine | ESD-843540-250MG |
Cas.: 1260811-27-5 | Purity: 98% | Bis((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)methyl)amine | ESD-843540-1G |
Cas.: 112811-71-9 | Purity: 98% | Ethyl 1-cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylate | ESD-843541-250MG |
Cas.: 112811-71-9 | Purity: 98% | Ethyl 1-cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylate | ESD-843541-1G |
Cas.: 132335-47-8 | Purity: 95% | (S)-N,N-Dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine oxalate | ESD-843542-250MG |
Cas.: 132335-47-8 | Purity: 95% | (S)-N,N-Dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine oxalate | ESD-843542-1G |
Cas.: 138564-60-0 | Purity: 95% | 2-Methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-amine hydrochloride | ESD-843543-250MG |
Cas.: 138564-60-0 | Purity: 95% | 2-Methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-amine hydrochloride | ESD-843543-1G |
Cas.: 143527-70-2 | Purity: 95% | (4S,5R)-3-(tert-Butoxycarbonyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid | ESD-843544-250MG |
Cas.: 143527-70-2 | Purity: 95% | (4S,5R)-3-(tert-Butoxycarbonyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid | ESD-843544-1G |
Cas.: 118452-02-1 | Purity: 97% | 2-Aminothiazole-4-carboxamide | ESD-843545-250MG |
Cas.: 118452-02-1 | Purity: 97% | 2-Aminothiazole-4-carboxamide | ESD-843545-1G |
Cas.: 54-05-7 | Purity: 97% | Chloroquine | ESD-843546-50MG |
Cas.: 54-05-7 | Purity: 97% | Chloroquine | ESD-843546-250MG |
Cas.: 59820-43-8 | Purity: 98% | 2-((2-(2-Hydroxyethoxy)-4-nitrophenyl)amino)ethanol | ESD-843547-10G |
Cas.: 170147-29-2 | Purity: 95% | tert-Butyl 5-(benzyloxy)-1H-indole-1-carboxylate | ESD-843548-50MG |
Cas.: 170147-29-2 | Purity: 95% | tert-Butyl 5-(benzyloxy)-1H-indole-1-carboxylate | ESD-843548-250MG |
Cas.: 7145-71-3 | Purity: 98% | N-(1H-Indol-5-yl)acetamide | ESD-843549-25MG |
Cas.: 7145-71-3 | Purity: 98% | N-(1H-Indol-5-yl)acetamide | ESD-843549-100MG |
Cas.: 80307-12-6 | Purity: 98% | 2,5-Dioxopyrrolidin-1-yl 4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)butanoate | ESD-843550-50MG |
Cas.: 80307-12-6 | Purity: 98% | 2,5-Dioxopyrrolidin-1-yl 4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)butanoate | ESD-843550-250MG |
Cas.: 16155-08-1 | Purity: 98% | 1-Benzyl-4-(4-nitrophenyl)piperazine | ESD-843551-250MG |
Cas.: 16155-08-1 | Purity: 98% | 1-Benzyl-4-(4-nitrophenyl)piperazine | ESD-843551-1G |
Cas.: 22276-97-7 | Purity: 95% | 5-Bromo-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one | ESD-843552-50MG |
Cas.: 22276-97-7 | Purity: 95% | 5-Bromo-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one | ESD-843552-250MG |
Cas.: 852633-82-0 | Purity: 95% | 4-Morpholinophenylglyoxal hydrate | ESD-843553-250MG |
Cas.: 852633-82-0 | Purity: 95% | 4-Morpholinophenylglyoxal hydrate | ESD-843553-1G |
Cas.: 677702-36-2 | Purity: 98% | 5-Nitro-1H-indazole-3-carbaldehyde | ESD-843554-50MG |
Cas.: 677702-36-2 | Purity: 98% | 5-Nitro-1H-indazole-3-carbaldehyde | ESD-843554-250MG |
Cas.: 1601-18-9 | Purity: 98% | Methyl 2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetate | ESD-843555-50MG |
Cas.: 1601-18-9 | Purity: 98% | Methyl 2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetate | ESD-843555-250MG |
Cas.: 172648-19-0 | Purity: 95% | (6-Bromo-3H-imidazo[4,5-b]pyridin-2-yl)methanol | ESD-843556-50MG |
Cas.: 172648-19-0 | Purity: 95% | (6-Bromo-3H-imidazo[4,5-b]pyridin-2-yl)methanol | ESD-843556-250MG |
Cas.: 149330-25-6 | Purity: 95% | 2,2′-((2-Methyl-1,3-phenylene)bis(azanediyl))diethanol | ESD-843557-1G |
Cas.: 149330-25-6 | Purity: 95% | 2,2′-((2-Methyl-1,3-phenylene)bis(azanediyl))diethanol | ESD-843557-10G |
Cas.: 115905-43-6 | Purity: 98% | 2-Bromo-1-methyl-1H-imidazole-4,5-dicarbonitrile | ESD-843558-250MG |
Cas.: 115905-43-6 | Purity: 98% | 2-Bromo-1-methyl-1H-imidazole-4,5-dicarbonitrile | ESD-843558-1G |
Cas.: 139058-18-7 | Purity: 98% | 3-Bromo-4-pivalamidobenzoic acid | ESD-843559-50MG |
Cas.: 139058-18-7 | Purity: 98% | 3-Bromo-4-pivalamidobenzoic acid | ESD-843559-250MG |
Cas.: 33662-26-9 | Purity: 98% | Boc-Thr-OBzl | ESD-843560-1G |
Cas.: 33662-26-9 | Purity: 98% | Boc-Thr-OBzl | ESD-843560-5G |
Cas.: 92952-81-3 | Purity: 95% | 4-((3-Hydroxypropyl)amino)-3-nitrophenol | ESD-843561-1G |
Cas.: 92952-81-3 | Purity: 95% | 4-((3-Hydroxypropyl)amino)-3-nitrophenol | ESD-843561-5G |
Cas.: 64172-98-1 | Purity: 95% | 4-((Benzyloxy)carbonyl)piperazine-2-carboxylic acid | ESD-843562-250MG |
Cas.: 64172-98-1 | Purity: 95% | 4-((Benzyloxy)carbonyl)piperazine-2-carboxylic acid | ESD-843562-1G |
Cas.: 43229-01-2 | Purity: 98% | 1-(4-(Benzyloxy)-3-nitrophenyl)-2-bromoethanone | ESD-843563-250MG |
Cas.: 43229-01-2 | Purity: 98% | 1-(4-(Benzyloxy)-3-nitrophenyl)-2-bromoethanone | ESD-843563-1G |
Cas.: 58349-77-2 | Purity: 97% | 9-(2-Nitrovinyl)anthracene | ESD-843564-25MG |
Cas.: 58349-77-2 | Purity: 97% | 9-(2-Nitrovinyl)anthracene | ESD-843564-100MG |
Cas.: 914347-48-1 | Purity: 95% | 2-[4-(6-Amino-2-methylpyrimidin-4-yl)piperazin-1-yl]ethanol | ESD-843565-50MG |
Cas.: 914347-48-1 | Purity: 95% | 2-[4-(6-Amino-2-methylpyrimidin-4-yl)piperazin-1-yl]ethanol | ESD-843565-250MG |
Cas.: 426219-35-4 | Purity: 98% | 6-Bromo-N-methyl-2-naphthamide | ESD-843566-50MG |
Cas.: 426219-35-4 | Purity: 98% | 6-Bromo-N-methyl-2-naphthamide | ESD-843566-250MG |
Cas.: 143141-23-5 | Purity: 95% | 1-(Phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine | ESD-843567-250MG |
Cas.: 143141-23-5 | Purity: 95% | 1-(Phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine | ESD-843567-1G |
Cas.: 40432-84-6 | Purity: 98% | 2-(5-Bromo-1H-indol-3-yl)acetic acid | ESD-843568-250MG |
Cas.: 40432-84-6 | Purity: 98% | 2-(5-Bromo-1H-indol-3-yl)acetic acid | ESD-843568-1G |
Cas.: 34800-90-3 | Purity: 97% | 2-(Naphthalen-1-yl)acetohydrazide | ESD-843569-250MG |
Cas.: 34800-90-3 | Purity: 97% | 2-(Naphthalen-1-yl)acetohydrazide | ESD-843569-1G |
Cas.: 1004294-80-7 | Purity: 95% | 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)isoindolin-1-one | ESD-843570-25MG |
Cas.: 1004294-80-7 | Purity: 95% | 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)isoindolin-1-one | ESD-843570-100MG |
Cas.: 20503-40-6 | Purity: 97% | 6-Aminobenzo[b]thiophene 1,1-dioxide | ESD-843571-50MG |
Cas.: 20503-40-6 | Purity: 97% | 6-Aminobenzo[b]thiophene 1,1-dioxide | ESD-843571-250MG |
Cas.: 104504-45-2 | Purity: 98% | H-Bpa-OH H-Phe(4-Bz)-OH | ESD-843572-250MG |
Cas.: 104504-45-2 | Purity: 98% | H-Bpa-OH H-Phe(4-Bz)-OH | ESD-843572-1G |
Cas.: 100643-71-8 | Purity: 98% | Desloratadine | ESD-843573-250MG |
Cas.: 100643-71-8 | Purity: 98% | Desloratadine | ESD-843573-1G |
Cas.: 39205-87-3 | Purity: 95% | 3-Nitro-1H-pyrazole-4-carbonitrile | ESD-843574-25MG |
Cas.: 39205-87-3 | Purity: 95% | 3-Nitro-1H-pyrazole-4-carbonitrile | ESD-843574-100MG |
Cas.: 851784-82-2 | Purity: 98% | 2-(tert-Butoxycarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid | ESD-843575-250MG |
Cas.: 851784-82-2 | Purity: 98% | 2-(tert-Butoxycarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid | ESD-843575-1G |
Cas.: 40262-73-5 | Purity: 95% | 6-(4-Morpholinyl)pyrazine-2-carboxylic acid | ESD-843576-50MG |
Cas.: 40262-73-5 | Purity: 95% | 6-(4-Morpholinyl)pyrazine-2-carboxylic acid | ESD-843576-250MG |
Cas.: 3605-01-4 | Purity: 98% | 2-(4-(Benzo[d][1,3]dioxol-5-ylmethyl)piperazin-1-yl)pyrimidine | ESD-843577-250MG |
Cas.: 3605-01-4 | Purity: 98% | 2-(4-(Benzo[d][1,3]dioxol-5-ylmethyl)piperazin-1-yl)pyrimidine | ESD-843577-1G |
Cas.: 5978-22-3 | Purity: 97% | H-Lys(Z)-OtBu.HCl | ESD-843578-250MG |
Cas.: 5978-22-3 | Purity: 97% | H-Lys(Z)-OtBu.HCl | ESD-843578-1G |
Cas.: 447463-65-2 | Purity: 97% | 1,2,4,5-Tetrakis(tert-butylthio)benzene | ESD-843579-250MG |
Cas.: 447463-65-2 | Purity: 97% | 1,2,4,5-Tetrakis(tert-butylthio)benzene | ESD-843579-1G |
Cas.: 63845-33-0 | Purity: 95% | 3-(1-((Benzyloxy)carbonyl)piperidin-4-yl)propanoic acid | ESD-843580-250MG |
Cas.: 63845-33-0 | Purity: 95% | 3-(1-((Benzyloxy)carbonyl)piperidin-4-yl)propanoic acid | ESD-843580-1G |
Cas.: 51276-85-8 | Purity: 95% | 2-Amino-1H-benzo[d]imidazol-5-ol | ESD-843581-50MG |
Cas.: 51276-85-8 | Purity: 95% | 2-Amino-1H-benzo[d]imidazol-5-ol | ESD-843581-250MG |
Cas.: 119285-07-3 | Purity: 97% | tert-Butyl 4-(5-aminopyridin-2-yl)piperazine-1-carboxylate | ESD-843582-250MG |
Cas.: 119285-07-3 | Purity: 97% | tert-Butyl 4-(5-aminopyridin-2-yl)piperazine-1-carboxylate | ESD-843582-1G |
Cas.: 101774-27-0 | Purity: 98% | 6-Bromo-1H-indole-3-carboxylic acid | ESD-843583-250MG |
Cas.: 101774-27-0 | Purity: 98% | 6-Bromo-1H-indole-3-carboxylic acid | ESD-843583-1G |
Cas.: 16732-71-1 | Purity: 98% | 7-Bromo-1H-indole-2-carboxylic acid | ESD-843584-250MG |
Cas.: 16732-71-1 | Purity: 98% | 7-Bromo-1H-indole-2-carboxylic acid | ESD-843584-1G |
Cas.: 16732-64-2 | Purity: 95% | 4-Bromo-1H-indole-2-carboxylic acid | ESD-843585-250MG |
Cas.: 16732-64-2 | Purity: 95% | 4-Bromo-1H-indole-2-carboxylic acid | ESD-843585-1G |
Cas.: 196603-96-0 | Purity: 95% | 4-((4-Bromo-2-fluorophenyl)amino)-6-methoxyquinazolin-7-ol | ESD-843586-250MG |
Cas.: 196603-96-0 | Purity: 95% | 4-((4-Bromo-2-fluorophenyl)amino)-6-methoxyquinazolin-7-ol | ESD-843586-1G |
Cas.: 218608-96-9 | Purity: 97% | (R)-3-((tert-Butoxycarbonyl)amino)-4-(4-chlorophenyl)butanoic acid | ESD-843587-50MG |
Cas.: 218608-96-9 | Purity: 97% | (R)-3-((tert-Butoxycarbonyl)amino)-4-(4-chlorophenyl)butanoic acid | ESD-843587-250MG |
Cas.: 30364-60-4 | Purity: 97% | Bis(2,5-dioxopyrrolidin-1-yl) succinate | ESD-843588-50MG |
Cas.: 30364-60-4 | Purity: 97% | Bis(2,5-dioxopyrrolidin-1-yl) succinate | ESD-843588-250MG |
Cas.: 1220-78-6 | Purity: 98% | 4,4′-(Propane-2,2-diyl)bis(2-aminophenol) | ESD-843589-5G |
Cas.: 153436-54-5 | Purity: 98% | PD153035 | ESD-843590-50MG |
Cas.: 153436-54-5 | Purity: 98% | PD153035 | ESD-843590-250MG |
Cas.: 67085-11-4 | Purity: 98% | 4-(4-Chlorophenyl)-1-(1H-imidazol-1-yl)butan-2-ol | ESD-843591-250MG |
Cas.: 67085-11-4 | Purity: 98% | 4-(4-Chlorophenyl)-1-(1H-imidazol-1-yl)butan-2-ol | ESD-843591-1G |
Cas.: 51123-09-2 | Purity: 97% | 5-Amino-N-ethyl-2-methyl-N-phenylbenzenesulfonamide | ESD-843592-250MG |
Cas.: 51123-09-2 | Purity: 97% | 5-Amino-N-ethyl-2-methyl-N-phenylbenzenesulfonamide | ESD-843592-1G |
Cas.: 492431-11-5 | Purity: 98% | 1-Boc-4-(6-Chloropyridazin-3-yl)piperazine | ESD-843593-250MG |
Cas.: 492431-11-5 | Purity: 98% | 1-Boc-4-(6-Chloropyridazin-3-yl)piperazine | ESD-843593-1G |
Cas.: 76757-92-1 | Purity: 98% | Boc-D-Tyr(Et)-OH | ESD-843594-250MG |
Cas.: 76757-92-1 | Purity: 98% | Boc-D-Tyr(Et)-OH | ESD-843594-1G |
Cas.: 76757-91-0 | Purity: 97% | (S)-2-((tert-Butoxycarbonyl)amino)-3-(4-ethoxyphenyl)propanoic acid | ESD-843595-250MG |
Cas.: 76757-91-0 | Purity: 97% | (S)-2-((tert-Butoxycarbonyl)amino)-3-(4-ethoxyphenyl)propanoic acid | ESD-843595-1G |
Cas.: 134521-16-7 | Purity: 97% | 4,4′-Dicyanobenzhydrol | ESD-843596-250MG |
Cas.: 134521-16-7 | Purity: 97% | 4,4′-Dicyanobenzhydrol | ESD-843596-1G |
Cas.: 21161-11-5 | Purity: 98% | 2-Nitroisophthalic acid | ESD-843597-250MG |
Cas.: 21161-11-5 | Purity: 98% | 2-Nitroisophthalic acid | ESD-843597-1G |
Cas.: 609781-33-1 | Purity: 97% | tert-Butyl 4-(4-carbamoylphenoxy)piperidine-1-carboxylate | ESD-843598-50MG |
Cas.: 609781-33-1 | Purity: 97% | tert-Butyl 4-(4-carbamoylphenoxy)piperidine-1-carboxylate | ESD-843598-250MG |
Cas.: 92855-64-6 | Purity: 98% | 6-Benzyloxyindole-3-carbaldehyde | ESD-843599-250MG |
Cas.: 92855-64-6 | Purity: 98% | 6-Benzyloxyindole-3-carbaldehyde | ESD-843599-1G |
Cas.: 38092-89-6 | Purity: 95% | 8-Chloroazatadine | ESD-843600-250MG |
Cas.: 38092-89-6 | Purity: 95% | 8-Chloroazatadine | ESD-843600-1G |
Cas.: 851484-94-1 | Purity: 95% | 1-(tert-Butoxycarbonyl)-4-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid | ESD-843601-25MG |
Cas.: 851484-94-1 | Purity: 95% | 1-(tert-Butoxycarbonyl)-4-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid | ESD-843601-100MG |
Cas.: 3167-50-8 | Purity: 98% | 2-Aminopyrimidine-5-carboxylic acid | ESD-843602-250MG |
Cas.: 3167-50-8 | Purity: 98% | 2-Aminopyrimidine-5-carboxylic acid | ESD-843602-1G |
Cas.: 4793-22-0 | Purity: 98% | 4-Chloro-2-fluoro-5-sulfamoylbenzoic acid | ESD-843603-250MG |
Cas.: 4793-22-0 | Purity: 98% | 4-Chloro-2-fluoro-5-sulfamoylbenzoic acid | ESD-843603-1G |
Cas.: 82278-73-7 | Purity: 98% | Boc-Phe(3-Br)-OH | ESD-843604-250MG |
Cas.: 82278-73-7 | Purity: 98% | Boc-Phe(3-Br)-OH | ESD-843604-1G |
Cas.: 144163-97-3 | Purity: 99% | 4-Nitrophenyl (thiazol-5-ylmethyl) carbonate | ESD-843605-1G |
Cas.: 144163-97-3 | Purity: 99% | 4-Nitrophenyl (thiazol-5-ylmethyl) carbonate | ESD-843605-5G |
Cas.: 252882-60-3 | Purity: 95% | 1′-Boc-1,2-dihydro-2-oxo-spiro[3H-indole-3,4′-piperidine] | ESD-843606-50MG |
Cas.: 252882-60-3 | Purity: 95% | 1′-Boc-1,2-dihydro-2-oxo-spiro[3H-indole-3,4′-piperidine] | ESD-843606-250MG |
Cas.: 53786-45-1 | Purity: 98% | Ethyl 4-((2-amino-4-chlorophenyl)amino)piperidine-1-carboxylate | ESD-843607-50MG |
Cas.: 53786-45-1 | Purity: 98% | Ethyl 4-((2-amino-4-chlorophenyl)amino)piperidine-1-carboxylate | ESD-843607-250MG |
Cas.: 99429-68-2 | Purity: 97% | Ethyl 4-hydroxy-6-oxo-6,7-dihydrothieno[2,3-b]pyridine-5-carboxylate | ESD-843608-25MG |
Cas.: 99429-68-2 | Purity: 97% | Ethyl 4-hydroxy-6-oxo-6,7-dihydrothieno[2,3-b]pyridine-5-carboxylate | ESD-843608-100MG |
Cas.: 1457-58-5 | Purity: 97% | 2-Methyl-1H-imidazole-5-carboxylic acid | ESD-843610-50MG |
Cas.: 1457-58-5 | Purity: 97% | 2-Methyl-1H-imidazole-5-carboxylic acid | ESD-843610-250MG |
Cas.: 116855-08-4 | Purity: 97% | 1H-Pyrazolo[3,4-b]pyridine-3-carboxylic acid | ESD-843612-50MG |
Cas.: 116855-08-4 | Purity: 97% | 1H-Pyrazolo[3,4-b]pyridine-3-carboxylic acid | ESD-843612-250MG |
Cas.: 18938-60-8 | Purity: 97% | Boc-Tyr-OtBu | ESD-843613-1G |
Cas.: 636-76-0 | Purity: 95% | 3-Sulfamoylbenzoic acid | ESD-843614-250MG |
Cas.: 636-76-0 | Purity: 95% | 3-Sulfamoylbenzoic acid | ESD-843614-1G |
Cas.: 205264-33-1 | Purity: 95% | 1-Boc-4-Isoquinolin-1-yl-piperazine | ESD-843615-250MG |
Cas.: 205264-33-1 | Purity: 95% | 1-Boc-4-Isoquinolin-1-yl-piperazine | ESD-843615-1G |
Cas.: 500-98-1 | Purity: 97% | 2-(2-Phenylacetamido)acetic acid | ESD-843616-250MG |
Cas.: 500-98-1 | Purity: 97% | 2-(2-Phenylacetamido)acetic acid | ESD-843616-1G |
Cas.: 33468-35-8 | Purity: 98% | (S)-2-Amino-3-(6-chloro-1H-indol-3-yl)propanoic acid | ESD-843617-50MG |
Cas.: 33468-35-8 | Purity: 98% | (S)-2-Amino-3-(6-chloro-1H-indol-3-yl)propanoic acid | ESD-843617-250MG |
Cas.: 4331-29-7 | Purity: 98% | 1H-Benzo[d]imidazol-7-amine | ESD-843618-50MG |
Cas.: 4331-29-7 | Purity: 98% | 1H-Benzo[d]imidazol-7-amine | ESD-843618-250MG |
Cas.: 864075-95-6 | Purity: 95% | 3-(5-Nitropyridin-2-yl)benzoic acid | ESD-843619-250MG |
Cas.: 864075-95-6 | Purity: 95% | 3-(5-Nitropyridin-2-yl)benzoic acid | ESD-843619-1G |
Cas.: 147636-36-0 | Purity: 95% | 1-Tosylpiperidine-4-carboxylic acid | ESD-843620-250MG |
Cas.: 147636-36-0 | Purity: 95% | 1-Tosylpiperidine-4-carboxylic acid | ESD-843620-1G |
Cas.: 339071-18-0 | Purity: 97% | N-(3-Chloro-4-morpholinophenyl)-N’-hydroxyformimidamide | ESD-843621-50MG |
Cas.: 339071-18-0 | Purity: 97% | N-(3-Chloro-4-morpholinophenyl)-N’-hydroxyformimidamide | ESD-843621-250MG |
Cas.: 161233-97-2 | Purity: 97% | 2-Cyanoisonicotinic acid | ESD-843622-250MG |
Cas.: 161233-97-2 | Purity: 97% | 2-Cyanoisonicotinic acid | ESD-843622-1G |
Cas.: 6232-92-4 | Purity: 97% | 6-Nitro-1H-benzo[d]imidazol-2-amine | ESD-843623-50MG |
Cas.: 6232-92-4 | Purity: 97% | 6-Nitro-1H-benzo[d]imidazol-2-amine | ESD-843623-250MG |
Cas.: 184475-71-6 | Purity: 98% | FAAH-IN-2 | ESD-843624-1G |
Cas.: 184475-71-6 | Purity: 98% | FAAH-IN-2 | ESD-843624-5G |
Cas.: 735-06-8 | Purity: 95% | (2-Fluorophenyl)(2-(methylamino)-5-nitrophenyl)methanone | ESD-843625-250MG |
Cas.: 735-06-8 | Purity: 95% | (2-Fluorophenyl)(2-(methylamino)-5-nitrophenyl)methanone | ESD-843625-1G |
Cas.: 76275-14-4 | Purity: 95% | 9,10-Dibutoxyanthracene | ESD-843626-50MG |
Cas.: 76275-14-4 | Purity: 95% | 9,10-Dibutoxyanthracene | ESD-843626-250MG |
Cas.: 61337-89-1 | Purity: 95% | 1-(3-Hydroxymethylpyridyl-2)-2-phenyl-4-methylpyperazine | ESD-843627-250MG |
Cas.: 61337-89-1 | Purity: 95% | 1-(3-Hydroxymethylpyridyl-2)-2-phenyl-4-methylpyperazine | ESD-843627-1G |
Cas.: 120013-39-0 | Purity: 95% | 5,6-Dimethoxy-2-(4-piperidinylmethyl)-1-indanone hydrochloride | ESD-843628-1G |
Cas.: 120013-39-0 | Purity: 95% | 5,6-Dimethoxy-2-(4-piperidinylmethyl)-1-indanone hydrochloride | ESD-843628-5G |
Cas.: 28491-52-3 | Purity: 98% | 5-Amino-1H-pyrazol-3(2H)-one | ESD-843629-1G |
Cas.: 28491-52-3 | Purity: 98% | 5-Amino-1H-pyrazol-3(2H)-one | ESD-843629-5G |
Cas.: 133865-88-0 | Purity: 95% | (S)-2-((4-((2-Fluorobenzyl)oxy)benzyl)amino)propanamide | ESD-843630-25MG |
Cas.: 133865-88-0 | Purity: 95% | (S)-2-((4-((2-Fluorobenzyl)oxy)benzyl)amino)propanamide | ESD-843630-100MG |
Cas.: 668983-97-9 | Purity: 97% | Dibenzo[b,d]thiophen-2-ylboronic acid | ESD-843631-1G |
Cas.: 668983-97-9 | Purity: 97% | Dibenzo[b,d]thiophen-2-ylboronic acid | ESD-843631-5G |
Cas.: 267875-45-6 | Purity: 97% | 5,6-Diaminonicotinic acid | ESD-843632-50MG |
Cas.: 267875-45-6 | Purity: 97% | 5,6-Diaminonicotinic acid | ESD-843632-250MG |
Cas.: 59408-74-1 | Purity: 98% | Boc-HomoSer(Bzl)-OH | ESD-843633-250MG |
Cas.: 59408-74-1 | Purity: 98% | Boc-HomoSer(Bzl)-OH | ESD-843633-1G |
Cas.: 168828-90-8 | Purity: 98% | (S)-5-(Aminomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one | ESD-843634-25MG |
Cas.: 168828-90-8 | Purity: 98% | (S)-5-(Aminomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one | ESD-843634-100MG |
Cas.: 1194-78-1 | Purity: 97% | 6-Chloropyrimidine-2,4,5-triamine | ESD-843635-50MG |
Cas.: 1194-78-1 | Purity: 97% | 6-Chloropyrimidine-2,4,5-triamine | ESD-843635-250MG |
Cas.: 365996-87-8 | Purity: 97% | tert-Butyl 2-(methylsulfonyl)-5H-pyrrolo[3,4-d]pyrimidine-6(7H)-carboxylate | ESD-843636-25MG |
Cas.: 365996-87-8 | Purity: 97% | tert-Butyl 2-(methylsulfonyl)-5H-pyrrolo[3,4-d]pyrimidine-6(7H)-carboxylate | ESD-843636-100MG |
Cas.: 13280-60-9 | Purity: 95% | 5-Amino-2-nitrobenzoic acid | ESD-843637-250MG |
Cas.: 13280-60-9 | Purity: 95% | 5-Amino-2-nitrobenzoic acid | ESD-843637-1G |
Cas.: 17518-98-8 | Purity: 97% | 7-Bromo-6-chloroquinazolin-4(3H)-one | ESD-843638-1G |
Cas.: 17518-98-8 | Purity: 97% | 7-Bromo-6-chloroquinazolin-4(3H)-one | ESD-843638-5G |
Cas.: 651734-52-0 | Purity: 95% | 4-(Benzylamino)-3,5-difluoro-2,6-dimethoxybenzoic acid | ESD-843639-25MG |
Cas.: 651734-52-0 | Purity: 95% | 4-(Benzylamino)-3,5-difluoro-2,6-dimethoxybenzoic acid | ESD-843639-100MG |
Cas.: 74440-02-1 | Purity: 98% | (Z)-2-(2-Aminothiazol-4-yl)-2-(tert-Butoxycarbonylmethoxyimino)acetic acid | ESD-843640-250MG |
Cas.: 74440-02-1 | Purity: 98% | (Z)-2-(2-Aminothiazol-4-yl)-2-(tert-Butoxycarbonylmethoxyimino)acetic acid | ESD-843640-1G |
Cas.: 26723-60-4 | Purity: 95% | 3-Chloro-6,11-dihydro-5,5-dioxo-11-hydroxy-6-methyldibenzo[c,f][1,2]thiazepine | ESD-843641-250MG |
Cas.: 26723-60-4 | Purity: 95% | 3-Chloro-6,11-dihydro-5,5-dioxo-11-hydroxy-6-methyldibenzo[c,f][1,2]thiazepine | ESD-843641-1G |
Cas.: 26171-23-3 | Purity: 95% | 1-Methyl-5-p-toluoylpyrrole-2-acetic acid | ESD-843642-250MG |
Cas.: 26171-23-3 | Purity: 95% | 1-Methyl-5-p-toluoylpyrrole-2-acetic acid | ESD-843642-1G |
Cas.: 799283-92-4 | Purity: 95% | 1-(5-Bromopyrimidin-2-yl)piperidine-4-carboxylic acid | ESD-843643-250MG |
Cas.: 799283-92-4 | Purity: 95% | 1-(5-Bromopyrimidin-2-yl)piperidine-4-carboxylic acid | ESD-843643-1G |
Cas.: 312746-74-0 | Purity: 95% | 1H-Indazole-7-carboxamide | ESD-843644-50MG |
Cas.: 312746-74-0 | Purity: 95% | 1H-Indazole-7-carboxamide | ESD-843644-250MG |
Cas.: 3786-46-7 | Purity: 98% | 3,6-Dihydroxyphthalic acid | ESD-843645-50MG |
Cas.: 3786-46-7 | Purity: 98% | 3,6-Dihydroxyphthalic acid | ESD-843645-250MG |
Cas.: 28782-78-7 | Purity: 95% | (S)-2-(2-((tert-Butoxycarbonyl)amino)propanamido)acetic acid | ESD-843646-250MG |
Cas.: 28782-78-7 | Purity: 95% | (S)-2-(2-((tert-Butoxycarbonyl)amino)propanamido)acetic acid | ESD-843646-1G |
Cas.: 870521-33-8 | Purity: 97% | 2-Morpholinopyrimidin-5-ylboronic acid | ESD-843649-50MG |
Cas.: 870521-33-8 | Purity: 97% | 2-Morpholinopyrimidin-5-ylboronic acid | ESD-843649-250MG |
Cas.: 5098-14-6 | Purity: 97% | 2-Aminoomalononitrile 4-methylbenzenesulfonate | ESD-843650-250MG |
Cas.: 5098-14-6 | Purity: 97% | 2-Aminoomalononitrile 4-methylbenzenesulfonate | ESD-843650-1G |
Cas.: 67449-23-4 | Purity: 97% | 8-Methylquinazoline-2,4(1H,3H)-dione | ESD-843651-250MG |
Cas.: 67449-23-4 | Purity: 97% | 8-Methylquinazoline-2,4(1H,3H)-dione | ESD-843651-1G |
Cas.: 16965-06-3 | Purity: 95% | Boc-Lys(Tfa)-OH | ESD-843652-250MG |
Cas.: 16965-06-3 | Purity: 95% | Boc-Lys(Tfa)-OH | ESD-843652-1G |
Cas.: 100361-18-0 | Purity: 95% | 1-Cyclopropyl-6-fluoro-7-chloro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid | ESD-843653-1G |
Cas.: 104206-65-7 | Purity: 98% | Nitisinone | ESD-843654-250MG |
Cas.: 104206-65-7 | Purity: 98% | Nitisinone | ESD-843654-1G |
Cas.: 1032452-86-0 | Purity: 98% | 3-(2-Chloropyrimidin-4-yl)-1-methyl-1H-indole | ESD-843655-1G |
Cas.: 1032452-86-0 | Purity: 98% | 3-(2-Chloropyrimidin-4-yl)-1-methyl-1H-indole | ESD-843655-5G |
Cas.: 77472-70-9 | Purity: 98% | Phenylpiracetam | ESD-843656-250MG |
Cas.: 77472-70-9 | Purity: 98% | Phenylpiracetam | ESD-843656-1G |
Cas.: 42017-89-0 | Purity: 98% | Fenofibric acid | ESD-843657-5G |
Cas.: 42017-89-0 | Purity: 98% | Fenofibric acid | ESD-843657-25G |
Cas.: 62871-28-7 | Purity: 97% | 2-(1H-Benzo[d]imidazol-2-yl)-4-bromophenol | ESD-843658-250MG |
Cas.: 62871-28-7 | Purity: 97% | 2-(1H-Benzo[d]imidazol-2-yl)-4-bromophenol | ESD-843658-1G |
Cas.: 5361-54-6 | Purity: 95% | 4-(Phenylsulfonyl)benzoic acid | ESD-843659-50MG |
Cas.: 5361-54-6 | Purity: 95% | 4-(Phenylsulfonyl)benzoic acid | ESD-843659-250MG |
Cas.: 150435-81-7 | Purity: 97% | 1-Benzyl-4-(Boc-amino)piperidine-4-carboxylic acid | ESD-843660-250MG |
Cas.: 150435-81-7 | Purity: 97% | 1-Benzyl-4-(Boc-amino)piperidine-4-carboxylic acid | ESD-843660-1G |
Cas.: 169205-78-1 | Purity: 95% | N4-(3-Bromophenyl)quinazoline-4,6-diamine | ESD-843661-50MG |
Cas.: 169205-78-1 | Purity: 95% | N4-(3-Bromophenyl)quinazoline-4,6-diamine | ESD-843661-250MG |
Cas.: 162135-93-5 | Purity: 95% | 3-Phenylquinoxaline-5-carboxylic acid | ESD-843662-50MG |
Cas.: 162135-93-5 | Purity: 95% | 3-Phenylquinoxaline-5-carboxylic acid | ESD-843662-250MG |
Cas.: 819867-24-8 | Purity: 97% | (2′,6′-Dimethoxy-[1,1′-biphenyl]-2-yl)diphenylphosphine | ESD-843663-250MG |
Cas.: 819867-24-8 | Purity: 97% | (2′,6′-Dimethoxy-[1,1′-biphenyl]-2-yl)diphenylphosphine | ESD-843663-1G |
Cas.: 34206-49-0 | Purity: 95% | 5-Bromopyridine-2,3-diol | ESD-843664-250MG |
Cas.: 34206-49-0 | Purity: 95% | 5-Bromopyridine-2,3-diol | ESD-843664-1G |
Cas.: 54-91-1 | Purity: 98% | Pipobroman | ESD-843665-250MG |
Cas.: 54-91-1 | Purity: 98% | Pipobroman | ESD-843665-1G |
Cas.: 87219-22-5 | Purity: 95% | 2-(2-Oxoimidazolidin-1-yl)acetic acid | ESD-843666-25MG |
Cas.: 87219-22-5 | Purity: 95% | 2-(2-Oxoimidazolidin-1-yl)acetic acid | ESD-843666-100MG |
Cas.: 5397-34-2 | Purity: 98% | 2-((4-Hydroxyphenyl)sulfonyl)phenol | ESD-843667-1G |
Cas.: 332099-36-2 | Purity: 98% | 3-Bromo-4H-thieno[3,2-b]pyrrole-5-carboxylic acid | ESD-843668-250MG |
Cas.: 332099-36-2 | Purity: 98% | 3-Bromo-4H-thieno[3,2-b]pyrrole-5-carboxylic acid | ESD-843668-1G |
Cas.: 110568-64-4 | Purity: 95% | 6-Nitroisoindolin-1-one | ESD-843669-50MG |
Cas.: 110568-64-4 | Purity: 95% | 6-Nitroisoindolin-1-one | ESD-843669-250MG |
Cas.: 15308-01-7 | Purity: 97% | 2-Chloro-N-(2,6-dichlorophenyl)-N-phenylacetamide | ESD-843670-250MG |
Cas.: 15308-01-7 | Purity: 97% | 2-Chloro-N-(2,6-dichlorophenyl)-N-phenylacetamide | ESD-843670-1G |
Cas.: 2450-27-3 | Purity: 97% | 4-(Benzyloxy)-3-methoxy-2-nitrobenzaldehyde | ESD-843671-25MG |
Cas.: 2450-27-3 | Purity: 97% | 4-(Benzyloxy)-3-methoxy-2-nitrobenzaldehyde | ESD-843671-100MG |
Cas.: 86299-47-0 | Purity: 98% | (Z)-2-(2-Aminothiazol-4-yl)-2-(((1-(tert-butoxy)-2-methyl-1-oxopropan-2-yl)oxy)imino)acetic acid | ESD-843672-250MG |
Cas.: 86299-47-0 | Purity: 98% | (Z)-2-(2-Aminothiazol-4-yl)-2-(((1-(tert-butoxy)-2-methyl-1-oxopropan-2-yl)oxy)imino)acetic acid | ESD-843672-1G |
Cas.: 15362-40-0 | Purity: 97% | 1-(2,6-Dichlorophenyl)-2-indolinone | ESD-843673-5G |
Cas.: 15362-40-0 | Purity: 97% | 1-(2,6-Dichlorophenyl)-2-indolinone | ESD-843673-25G |
Cas.: 366452-97-3 | Purity: 95% | 4-Nitroisoindolin-1-one | ESD-843674-50MG |
Cas.: 366452-97-3 | Purity: 95% | 4-Nitroisoindolin-1-one | ESD-843674-250MG |
Cas.: 31972-52-8 | Purity: 95% | Boc-Gly-Gly-OH | ESD-843675-1G |
Cas.: 31972-52-8 | Purity: 95% | Boc-Gly-Gly-OH | ESD-843675-5G |
Cas.: 153559-46-7 | Purity: 97% | 4-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalene-2-carbonyl)benzoic acid | ESD-843676-25MG |
Cas.: 153559-46-7 | Purity: 97% | 4-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalene-2-carbonyl)benzoic acid | ESD-843676-100MG |
Cas.: 41354-03-4 | Purity: 98% | 1-Benzyl-1H-indazole-3-carboxylic acid | ESD-843677-50MG |
Cas.: 41354-03-4 | Purity: 98% | 1-Benzyl-1H-indazole-3-carboxylic acid | ESD-843677-250MG |
Cas.: 157255-72-6 | Purity: 97% | 4-Iodo-2-methyl-1-trityl-1H-imidazole | ESD-843678-50MG |
Cas.: 157255-72-6 | Purity: 97% | 4-Iodo-2-methyl-1-trityl-1H-imidazole | ESD-843678-250MG |
Cas.: 69901-75-3 | Purity: 97% | Z-Chg-OH | ESD-843679-1G |
Cas.: 202865-57-4 | Purity: 98% | 1-Bromo-2,5-dichloro-3-fluorobenzene | ESD-843680-1G |
Cas.: 202865-57-4 | Purity: 98% | 1-Bromo-2,5-dichloro-3-fluorobenzene | ESD-843680-5G |
Cas.: 877399-74-1 | Purity: 98% | tert-Butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate | ESD-843681-250MG |
Cas.: 877399-74-1 | Purity: 98% | tert-Butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate | ESD-843681-1G |
Cas.: 4315-09-7 | Purity: 98% | 4-Nitroisophthalic acid | ESD-843682-250MG |
Cas.: 4315-09-7 | Purity: 98% | 4-Nitroisophthalic acid | ESD-843682-1G |
Cas.: 23478-25-3 | Purity: 97% | N-(3-Hydroxyphenyl)cinnamamide | ESD-843683-25MG |
Cas.: 23478-25-3 | Purity: 97% | N-(3-Hydroxyphenyl)cinnamamide | ESD-843683-100MG |
Cas.: 58446-52-9 | Purity: 95% | 1-Phenylicosane-1,3-dione | ESD-843684-250MG |
Cas.: 58446-52-9 | Purity: 95% | 1-Phenylicosane-1,3-dione | ESD-843684-1G |
Cas.: 1077-94-7 | Purity: 95% | 5-Bromo-1H-indazole-3-carboxylic acid | ESD-843685-250MG |
Cas.: 1077-94-7 | Purity: 95% | 5-Bromo-1H-indazole-3-carboxylic acid | ESD-843685-1G |
Cas.: 154992-24-2 | Purity: 98% | RU 58841 | ESD-843686-250MG |
Cas.: 154992-24-2 | Purity: 98% | RU 58841 | ESD-843686-1G |
Cas.: 37842-58-3 | Purity: ≥95% | Ethyl 2-amino-2-cyanoacetate 4-methylbenzenesulfonate | ESD-843687-50MG |
Cas.: 37842-58-3 | Purity: ≥95% | Ethyl 2-amino-2-cyanoacetate 4-methylbenzenesulfonate | ESD-843687-250MG |
Cas.: 26638-53-9 | Purity: 95% | 3-Chloro-6,11-dihydro-6-methyl-5,5,11-trioxodibenzo[c,f][1,2]thiazepine | ESD-843688-250MG |
Cas.: 26638-53-9 | Purity: 95% | 3-Chloro-6,11-dihydro-6-methyl-5,5,11-trioxodibenzo[c,f][1,2]thiazepine | ESD-843688-1G |
Cas.: 2538-68-3 | Purity: 98% | Phenazine-1-carboxylic acid | ESD-843689-25MG |
Cas.: 2538-68-3 | Purity: 98% | Phenazine-1-carboxylic acid | ESD-843689-100MG |
Cas.: 103577-40-8 | Purity: 97% | 2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole | ESD-843690-250MG |
Cas.: 103577-40-8 | Purity: 97% | 2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole | ESD-843690-1G |
Cas.: 77471-42-2 | Purity: 98% | 2-Amino-N-(4-methyl-2-oxo-2H-chromen-7-yl)acetamide | ESD-843691-50MG |
Cas.: 77471-42-2 | Purity: 98% | 2-Amino-N-(4-methyl-2-oxo-2H-chromen-7-yl)acetamide | ESD-843691-250MG |
Cas.: 16494-24-9 | Purity: 97% | 4-Ethoxyphenyl 4-((butoxycarbonyl)oxy)benzoate | ESD-843692-50MG |
Cas.: 16494-24-9 | Purity: 97% | 4-Ethoxyphenyl 4-((butoxycarbonyl)oxy)benzoate | ESD-843692-250MG |
Cas.: 4029-41-8 | Purity: 95% | N-(3-Chloroquinoxalin-2-yl)-4-methylbenzenesulfonamide | ESD-843693-50MG |
Cas.: 4029-41-8 | Purity: 95% | N-(3-Chloroquinoxalin-2-yl)-4-methylbenzenesulfonamide | ESD-843693-250MG |
Cas.: 85098-64-2 | Purity: 97% | 1-Benzyl-4-(phenylamino)piperidine-4-carboxylic acid | ESD-843694-50MG |
Cas.: 85098-64-2 | Purity: 97% | 1-Benzyl-4-(phenylamino)piperidine-4-carboxylic acid | ESD-843694-250MG |
Cas.: 259809-79-5 | Purity: 98% | tert-Butyl 7,8-dihydro-2-(methylsulfonyl)pyrido[4,3-d]pyrimidine-6(5H)-carboxylate | ESD-843695-25MG |
Cas.: 259809-79-5 | Purity: 98% | tert-Butyl 7,8-dihydro-2-(methylsulfonyl)pyrido[4,3-d]pyrimidine-6(5H)-carboxylate | ESD-843695-100MG |
Cas.: 24867-26-3 | Purity: 98% | 2,4-Diamino-6-piperidinopyrimidine | ESD-843696-250MG |
Cas.: 24867-26-3 | Purity: 98% | 2,4-Diamino-6-piperidinopyrimidine | ESD-843696-1G |
Cas.: 161798-03-4 | Purity: 98% | Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate | ESD-843697-250MG |
Cas.: 161798-03-4 | Purity: 98% | Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate | ESD-843697-1G |
Cas.: 3584-32-5 | Purity: 95% | 4-(Benzyloxy)-3-methoxy-2-nitrobenzoic acid | ESD-843698-25MG |
Cas.: 3584-32-5 | Purity: 95% | 4-(Benzyloxy)-3-methoxy-2-nitrobenzoic acid | ESD-843698-100MG |
Cas.: 1229000-10-5 | Purity: 95% | 2-(N-Boc-piperidin-3-yl)-1H-benzoimidazole | ESD-843699-250MG |
Cas.: 1229000-10-5 | Purity: 95% | 2-(N-Boc-piperidin-3-yl)-1H-benzoimidazole | ESD-843699-1G |
Cas.: 51035-17-7 | Purity: 95% | 9H-Carbazole-3-carboxylic acid | ESD-843700-25MG |
Cas.: 51035-17-7 | Purity: 95% | 9H-Carbazole-3-carboxylic acid | ESD-843700-100MG |
Cas.: 16490-02-1 | Purity: 95% | Pyrimidine-4,6-dicarboxylic acid | ESD-843701-250MG |
Cas.: 16490-02-1 | Purity: 95% | Pyrimidine-4,6-dicarboxylic acid | ESD-843701-1G |
Cas.: 6975-44-6 | Purity: 98% | Ethyl 4,6-dihydroxynicotinate | ESD-843702-250MG |
Cas.: 6975-44-6 | Purity: 98% | Ethyl 4,6-dihydroxynicotinate | ESD-843702-1G |
Cas.: 80883-54-1 | Purity: 98% | 2-(7-(Dimethylamino)-2-oxo-2H-chromen-4-yl)acetic acid | ESD-843703-25MG |
Cas.: 80883-54-1 | Purity: 98% | 2-(7-(Dimethylamino)-2-oxo-2H-chromen-4-yl)acetic acid | ESD-843703-100MG |
Cas.: 1233200-57-1 | Purity: 97% | 3-Bromo-5′-phenyl-1,1′:3′,1”-terphenyl | ESD-843704-250MG |
Cas.: 1233200-57-1 | Purity: 97% | 3-Bromo-5′-phenyl-1,1′:3′,1”-terphenyl | ESD-843704-1G |
Cas.: 110964-79-9 | Purity: 98% | 4-(Methylsulfonyl)-2-nitrobenzoic acid | ESD-843705-5G |
Cas.: 821785-76-6 | Purity: 98% | 6-Boc-1,4,5,7-tetrahydropyrazolo[3,4-c]pyridine-3-carboxylic acid | ESD-843706-250MG |
Cas.: 821785-76-6 | Purity: 98% | 6-Boc-1,4,5,7-tetrahydropyrazolo[3,4-c]pyridine-3-carboxylic acid | ESD-843706-1G |
Cas.: 141761-83-3 | Purity: 98% | Methyl 6-chloro-4-methyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-8-carboxylate | ESD-843707-250MG |
Cas.: 141761-83-3 | Purity: 98% | Methyl 6-chloro-4-methyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-8-carboxylate | ESD-843707-1G |
Cas.: 4784-02-5 | Purity: 97% | 6,7-Dimethoxyquinoxaline-2,3(1H,4H)-dione | ESD-843708-50MG |
Cas.: 4784-02-5 | Purity: 97% | 6,7-Dimethoxyquinoxaline-2,3(1H,4H)-dione | ESD-843708-250MG |
Cas.: 13827-62-8 | Purity: 97% | Naphthalene-2,6-disulfonyl dichloride | ESD-843709-50MG |
Cas.: 13827-62-8 | Purity: 97% | Naphthalene-2,6-disulfonyl dichloride | ESD-843709-250MG |
Cas.: 110-25-8 | Purity: 95% | 2-(N-Methyloleamido)acetic acid | ESD-843710-1G |
Cas.: 110-25-8 | Purity: 95% | 2-(N-Methyloleamido)acetic acid | ESD-843710-10G |
Cas.: 309947-86-2 | Purity: 97% | tert-Butyl N-tert-butoxycarbonyl-N-(7H-purin-6-yl)carbamate | ESD-843711-250MG |
Cas.: 309947-86-2 | Purity: 97% | tert-Butyl N-tert-butoxycarbonyl-N-(7H-purin-6-yl)carbamate | ESD-843711-1G |
Cas.: 74711-43-6 | Purity: 98% | Zaltoprofen | ESD-843712-250MG |
Cas.: 74711-43-6 | Purity: 98% | Zaltoprofen | ESD-843712-1G |
Cas.: 903899-13-8 | Purity: 98% | (6-Hydroxypyridin-3-yl)boronic acid | ESD-843713-50MG |
Cas.: 903899-13-8 | Purity: 98% | (6-Hydroxypyridin-3-yl)boronic acid | ESD-843713-250MG |
Cas.: 147539-23-9 | Purity: 95% | 1-Boc-4-(6-Chloro-5-nitro-4-pyrimidinyl)piperazine | ESD-843714-50MG |
Cas.: 147539-23-9 | Purity: 95% | 1-Boc-4-(6-Chloro-5-nitro-4-pyrimidinyl)piperazine | ESD-843714-250MG |
Cas.: 775304-57-9 | Purity: 98% | PTC124 | ESD-843715-250MG |
Cas.: 775304-57-9 | Purity: 98% | PTC124 | ESD-843715-1G |
Cas.: 22483-40-5 | Purity: 96% | 1-(2-Methoxyethoxy)-4-nitrobenzene | ESD-843716-250MG |
Cas.: 22483-40-5 | Purity: 96% | 1-(2-Methoxyethoxy)-4-nitrobenzene | ESD-843716-1G |
Cas.: 84405-44-7 | Purity: 97% | 2,7-Dibromophenanthrene-9,10-dione | ESD-843717-250MG |
Cas.: 84405-44-7 | Purity: 97% | 2,7-Dibromophenanthrene-9,10-dione | ESD-843717-1G |
Cas.: 578-76-7 | Purity: 98% | 2-Amino-7-methyl-1H-purin-6(7H)-one | ESD-843718-50MG |
Cas.: 578-76-7 | Purity: 98% | 2-Amino-7-methyl-1H-purin-6(7H)-one | ESD-843718-250MG |
Cas.: 22245-98-3 | Purity: 98% | 6-Hydroxy-3,4-dihydroisoquinolin-1(2H)-one | ESD-843719-50MG |
Cas.: 22245-98-3 | Purity: 98% | 6-Hydroxy-3,4-dihydroisoquinolin-1(2H)-one | ESD-843719-250MG |
Cas.: 60547-92-4 | Purity: 98% | 4-(Benzyloxy)-5-methoxy-2-nitrobenzoic acid | ESD-843720-250MG |
Cas.: 60547-92-4 | Purity: 98% | 4-(Benzyloxy)-5-methoxy-2-nitrobenzoic acid | ESD-843720-1G |
Cas.: 174891-10-2 | Purity: 97% | 5-Amino-1H-pyrazole-3-acetic acid | ESD-843721-50MG |
Cas.: 174891-10-2 | Purity: 97% | 5-Amino-1H-pyrazole-3-acetic acid | ESD-843721-250MG |
Cas.: 255835-82-6 | Purity: 97% | Dicyclohexyl(2′-methoxy-[1,1′-biphenyl]-2-yl)phosphine | ESD-843722-250MG |
Cas.: 255835-82-6 | Purity: 97% | Dicyclohexyl(2′-methoxy-[1,1′-biphenyl]-2-yl)phosphine | ESD-843722-1G |
Cas.: 209736-59-4 | Purity: 98% | ((1S,3S,4S)-3-Bromo-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid hydrate | ESD-843723-250MG |
Cas.: 209736-59-4 | Purity: 98% | ((1S,3S,4S)-3-Bromo-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid hydrate | ESD-843723-1G |
Cas.: 242478-38-2 | Purity: 98% | Solifenacin succinate | ESD-843724-250MG |
Cas.: 242478-38-2 | Purity: 98% | Solifenacin succinate | ESD-843724-1G |
Cas.: 33900-28-6 | Purity: 98% | Boc-Trp-OMe | ESD-843725-1G |
Cas.: 33900-28-6 | Purity: 98% | Boc-Trp-OMe | ESD-843725-5G |
Cas.: 343239-58-7 | Purity: 97% | 5′-Phenyl-[1,1′:3′,1”-terphenyl]-4-amine | ESD-843726-250MG |
Cas.: 343239-58-7 | Purity: 97% | 5′-Phenyl-[1,1′:3′,1”-terphenyl]-4-amine | ESD-843726-1G |
Cas.: 252061-78-2 | Purity: 98% | 6-Hydroxyisoquinolin-1(2H)-one | ESD-843727-25MG |
Cas.: 2732-18-5 | Purity: 98% | 5,7-Dihydroxy-2H-chromen-2-one | ESD-843728-250MG |
Cas.: 2732-18-5 | Purity: 98% | 5,7-Dihydroxy-2H-chromen-2-one | ESD-843728-1G |
Cas.: 106973-37-9 | Purity: 97% | (S)-4-Benzyl-5-oxomorpholine-3-carboxylic acid | ESD-843729-250MG |
Cas.: 106973-37-9 | Purity: 97% | (S)-4-Benzyl-5-oxomorpholine-3-carboxylic acid | ESD-843729-1G |
Cas.: 1242336-80-6 | Purity: 97% | 5-Amino-2-bromoisonicotinic acid | ESD-843730-50MG |
Cas.: 1242336-80-6 | Purity: 97% | 5-Amino-2-bromoisonicotinic acid | ESD-843730-250MG |
Cas.: 187949-86-6 | Purity: 95% | 3-Amino-5-(4-chlorophenyl)thiophene-2-carboxylic acid | ESD-843731-250MG |
Cas.: 187949-86-6 | Purity: 95% | 3-Amino-5-(4-chlorophenyl)thiophene-2-carboxylic acid | ESD-843731-1G |
Cas.: 462-10-2 | Purity: 95% | 4,4′-Disulfanediylbis(2-aminobutanoic acid) | ESD-843732-1G |
Cas.: 462-10-2 | Purity: 95% | 4,4′-Disulfanediylbis(2-aminobutanoic acid) | ESD-843732-10G |
Cas.: 85726-29-0 | Purity: 98% | 2-((4-Methoxyphenyl)amino)isonicotinic acid | ESD-843733-25MG |
Cas.: 85726-29-0 | Purity: 98% | 2-((4-Methoxyphenyl)amino)isonicotinic acid | ESD-843733-100MG |
Cas.: 205873-28-5 | Purity: 98% | Methyl 5-(methylsulfonyl)-1H-indole-2-carboxylate | ESD-843734-250MG |
Cas.: 205873-28-5 | Purity: 98% | Methyl 5-(methylsulfonyl)-1H-indole-2-carboxylate | ESD-843734-1G |
Cas.: 202826-52-6 | Purity: 95% | 1’H-Spiro[piperidine-4,2′-quinazolin]-4′(3’H)-one | ESD-843735-50MG |
Cas.: 202826-52-6 | Purity: 95% | 1’H-Spiro[piperidine-4,2′-quinazolin]-4′(3’H)-one | ESD-843735-250MG |
Cas.: 101-67-7 | Purity: 98% | Bis(4-octylphenyl)amine | ESD-843736-250MG |
Cas.: 101-67-7 | Purity: 98% | Bis(4-octylphenyl)amine | ESD-843736-1G |
Cas.: 137553-43-6 | Purity: 95% | 7-Bromoquinazoline-2,4-diamine | ESD-843737-50MG |
Cas.: 137553-43-6 | Purity: 95% | 7-Bromoquinazoline-2,4-diamine | ESD-843737-250MG |
Cas.: 2624-43-3 | Purity: 98% | (Cyclohexylidenemethylene)bis(4,1-phenylene) diacetate | ESD-843738-25MG |
Cas.: 2624-43-3 | Purity: 98% | (Cyclohexylidenemethylene)bis(4,1-phenylene) diacetate | ESD-843738-100MG |
Cas.: 1466-82-6 | Purity: 95% | 2-Acetoxybenzoic anhydride | ESD-843739-25MG |
Cas.: 1466-82-6 | Purity: 95% | 2-Acetoxybenzoic anhydride | ESD-843739-100MG |
Cas.: 30484-77-6 | Purity: 98% | Flunarizine dihydrochloride | ESD-843740-5G |
Cas.: 30484-77-6 | Purity: 98% | Flunarizine dihydrochloride | ESD-843740-25G |
Cas.: 880769-95-9 | Purity: 95% | 3-Bromo-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine | ESD-843741-250MG |
Cas.: 880769-95-9 | Purity: 95% | 3-Bromo-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine | ESD-843741-1G |
Cas.: 914348-98-4 | Purity: 95% | tert-Butyl 5-(benzyloxy)-3-formyl-1H-indole-1-carboxylate | ESD-843742-250MG |
Cas.: 914348-98-4 | Purity: 95% | tert-Butyl 5-(benzyloxy)-3-formyl-1H-indole-1-carboxylate | ESD-843742-1G |
Cas.: 404888-01-3 | Purity: 95% | 1-Boc-4-Benzyloxy-3-formylindole | ESD-843743-250MG |
Cas.: 404888-01-3 | Purity: 95% | 1-Boc-4-Benzyloxy-3-formylindole | ESD-843743-1G |
Cas.: 752234-64-3 | Purity: 98% | tert-Butyl 5-methoxy-2-oxospiro[indoline-3,4′-piperidine]-1′-carboxylate | ESD-843744-50MG |
Cas.: 752234-64-3 | Purity: 98% | tert-Butyl 5-methoxy-2-oxospiro[indoline-3,4′-piperidine]-1′-carboxylate | ESD-843744-250MG |
Cas.: 85-57-4 | Purity: 98% | 2-(4-Hydroxybenzoyl)benzoic acid | ESD-843745-1G |
Cas.: 85-57-4 | Purity: 98% | 2-(4-Hydroxybenzoyl)benzoic acid | ESD-843745-10G |
Cas.: 84041-77-0 | Purity: 97% | 2,2′-((2-Nitro-1,4-phenylene)bis(azanediyl))diethanol | ESD-843746-250MG |
Cas.: 84041-77-0 | Purity: 97% | 2,2′-((2-Nitro-1,4-phenylene)bis(azanediyl))diethanol | ESD-843746-1G |
Cas.: 212651-47-3 | Purity: 98% | 2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)acetic acid hydrate | ESD-843747-1G |
Cas.: 212651-47-3 | Purity: 98% | 2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)acetic acid hydrate | ESD-843747-5G |
Cas.: 755037-03-7 | Purity: 98% | Regorafenib | ESD-843748-10MG |
Cas.: 98105-79-4 | Purity: 98% | 7-Chloro-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | ESD-843749-50MG |
Cas.: 98105-79-4 | Purity: 98% | 7-Chloro-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | ESD-843749-250MG |
Cas.: 54006-63-2 | Purity: 95% | 5-(4-Chlorophenyl)-1H-pyrazole-3-carboxylic acid | ESD-843750-250MG |
Cas.: 54006-63-2 | Purity: 95% | 5-(4-Chlorophenyl)-1H-pyrazole-3-carboxylic acid | ESD-843750-1G |
Cas.: 496786-98-2 | Purity: 97% | tert-Butyl 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)piperazine-1-carboxylate | ESD-843751-250MG |
Cas.: 496786-98-2 | Purity: 97% | tert-Butyl 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)piperazine-1-carboxylate | ESD-843751-1G |
Cas.: 55453-89-9 | Purity: 98% | 2-((4-(Carboxymethyl)phenoxy)methyl)benzoic acid | ESD-843752-250MG |
Cas.: 55453-89-9 | Purity: 98% | 2-((4-(Carboxymethyl)phenoxy)methyl)benzoic acid | ESD-843752-1G |
Cas.: 747-36-4 | Purity: 98% | Hydroxychloroquine sulfate | ESD-843753-250MG |
Cas.: 747-36-4 | Purity: 98% | Hydroxychloroquine sulfate | ESD-843753-1G |
Cas.: 446292-04-2 | Purity: 98% | 4-(4-Nitrophenyl)morpholin-3-one | ESD-843754-250MG |
Cas.: 446292-04-2 | Purity: 98% | 4-(4-Nitrophenyl)morpholin-3-one | ESD-843754-1G |
Cas.: 914349-61-4 | Purity: 95% | (2-(4-(Bis(4-fluorophenyl)methyl)piperazin-1-yl)phenyl)methanol | ESD-843755-250MG |
Cas.: 914349-61-4 | Purity: 95% | (2-(4-(Bis(4-fluorophenyl)methyl)piperazin-1-yl)phenyl)methanol | ESD-843755-1G |
Cas.: 914349-58-9 | Purity: 97% | 4-(4-(Bis(4-fluorophenyl)methyl)piperazin-1-yl)benzaldehyde | ESD-843756-250MG |
Cas.: 914349-58-9 | Purity: 97% | 4-(4-(Bis(4-fluorophenyl)methyl)piperazin-1-yl)benzaldehyde | ESD-843756-1G |
Cas.: 1640-60-4 | Purity: 95% | 6-Chloroquinazoline-2,4(1H,3H)-dione | ESD-843757-250MG |
Cas.: 1640-60-4 | Purity: 95% | 6-Chloroquinazoline-2,4(1H,3H)-dione | ESD-843757-1G |
Cas.: 42864-78-8 | Purity: 98% | 1-((3,4-Dimethoxyphenethyl)amino)-3-(m-tolyloxy)propan-2-ol hydrochloride | ESD-843758-250MG |
Cas.: 129287-26-9 | Purity: 95% | 3-(6-Chloropyridazin-3-yl)-1H-indole | ESD-843759-250MG |
Cas.: 129287-26-9 | Purity: 95% | 3-(6-Chloropyridazin-3-yl)-1H-indole | ESD-843759-1G |
Cas.: 4330-21-6 | Purity: 90% | Hoffer’s chlorosugar | ESD-843760-250MG |
Cas.: 4330-21-6 | Purity: 90% | Hoffer’s chlorosugar | ESD-843760-1G |
Cas.: 954388-33-1 | Purity: 97% | (R)-1-((Benzyloxy)carbonyl)-4-(tert-butoxycarbonyl)piperazine-2-carboxylic acid | ESD-843761-50MG |
Cas.: 954388-33-1 | Purity: 97% | (R)-1-((Benzyloxy)carbonyl)-4-(tert-butoxycarbonyl)piperazine-2-carboxylic acid | ESD-843761-250MG |
Cas.: 150407-69-5 | Purity: 98% | (S)-1-((Benzyloxy)carbonyl)-4-(tert-butoxycarbonyl)piperazine-2-carboxylic acid | ESD-843762-50MG |
Cas.: 150407-69-5 | Purity: 98% | (S)-1-((Benzyloxy)carbonyl)-4-(tert-butoxycarbonyl)piperazine-2-carboxylic acid | ESD-843762-250MG |
Cas.: 149057-19-2 | Purity: 95% | 4-((Benzyloxy)carbonyl)-1-(tert-butoxycarbonyl)piperazine-2-carboxylic acid | ESD-843763-250MG |
Cas.: 149057-19-2 | Purity: 95% | 4-((Benzyloxy)carbonyl)-1-(tert-butoxycarbonyl)piperazine-2-carboxylic acid | ESD-843763-1G |
Cas.: 147126-75-8 | Purity: 95% | (2S,5R)-(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 5-(4-amino-5-fluoro-2-oxopyrimdin-1(2H)-yl)-1,3-oxathiolane- 2-carboxylate | ESD-843764-1G |
Cas.: 252061-66-8 | Purity: 98% | 5-Hydroxyisoindolin-1-one | ESD-843765-50MG |
Cas.: 252061-66-8 | Purity: 98% | 5-Hydroxyisoindolin-1-one | ESD-843765-250MG |
Cas.: 175137-09-4 | Purity: 95% | 6-(4-Chlorophenyl)pyrimidine-2,4-diamine | ESD-843766-250MG |
Cas.: 175137-09-4 | Purity: 95% | 6-(4-Chlorophenyl)pyrimidine-2,4-diamine | ESD-843766-1G |
Cas.: 16730-20-4 | Purity: 97% | 5-Nitro-1H-indole-2-carboxylic acid | ESD-843767-250MG |
Cas.: 16730-20-4 | Purity: 97% | 5-Nitro-1H-indole-2-carboxylic acid | ESD-843767-1G |
Cas.: 6958-37-8 | Purity: 97% | 5-Nitro-1H-indole-3-carboxylic acid | ESD-843768-250MG |
Cas.: 6958-37-8 | Purity: 97% | 5-Nitro-1H-indole-3-carboxylic acid | ESD-843768-1G |
Cas.: 222036-66-0 | Purity: 98% | 5-Aminoisoindolin-1-one | ESD-843769-250MG |
Cas.: 222036-66-0 | Purity: 98% | 5-Aminoisoindolin-1-one | ESD-843769-1G |
Cas.: 885519-98-2 | Purity: 97% | 3-Formyl-1H-indazole-5-carboxylic acid | ESD-843770-25MG |
Cas.: 885519-98-2 | Purity: 97% | 3-Formyl-1H-indazole-5-carboxylic acid | ESD-843770-100MG |
Cas.: 34562-97-5 | Purity: 98% | 4-(Nicotinamido)butanoic acid | ESD-843771-250MG |
Cas.: 34562-97-5 | Purity: 98% | 4-(Nicotinamido)butanoic acid | ESD-843771-1G |
Cas.: 118247-88-4 | Purity: 98% | (S)-3-(((Benzyloxy)carbonyl)amino)-5-(tert-butoxy)-5-oxopentanoic acid | ESD-843772-50MG |
Cas.: 118247-88-4 | Purity: 98% | (S)-3-(((Benzyloxy)carbonyl)amino)-5-(tert-butoxy)-5-oxopentanoic acid | ESD-843772-250MG |
Cas.: 23503-68-6 | Purity: 98% | 2-(Methylsulfonyl)-10H-phenothiazine | ESD-843773-250MG |
Cas.: 23503-68-6 | Purity: 98% | 2-(Methylsulfonyl)-10H-phenothiazine | ESD-843773-1G |
Cas.: 215306-02-8 | Purity: 98% | 2-Chloropyridine-3,4-dicarboxylic acid | ESD-843774-25MG |
Cas.: 215306-02-8 | Purity: 98% | 2-Chloropyridine-3,4-dicarboxylic acid | ESD-843774-100MG |
Cas.: 25840-82-8 | Purity: 97% | HD-Cys(Trt)-OH | ESD-843775-250MG |
Cas.: 25840-82-8 | Purity: 97% | HD-Cys(Trt)-OH | ESD-843775-1G |
Cas.: 4425-56-3 | Purity: 98% | 2,4-Dioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile | ESD-843776-250MG |
Cas.: 4425-56-3 | Purity: 98% | 2,4-Dioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile | ESD-843776-1G |
Cas.: 13368-14-4 | Purity: 95% | 2-Chloro-1H-purin-6(7H)-one | ESD-843777-25MG |
Cas.: 13368-14-4 | Purity: 95% | 2-Chloro-1H-purin-6(7H)-one | ESD-843777-100MG |
Cas.: 883984-95-0 | Purity: 95% | Benzyl 7′-chloro-2′-oxo-1′,2′-dihydrospiro[piperidine-4,4′-pyrido[2,3-d][1,3]oxazine]-1-carboxylate | ESD-843778-50MG |
Cas.: 883984-95-0 | Purity: 95% | Benzyl 7′-chloro-2′-oxo-1′,2′-dihydrospiro[piperidine-4,4′-pyrido[2,3-d][1,3]oxazine]-1-carboxylate | ESD-843778-250MG |
Cas.: 136584-14-0 | Purity: 95% | 2-(3-Oxo-1,2,3,4-tetrahydroquinoxalin-2-yl)acetic acid | ESD-843779-250MG |
Cas.: 136584-14-0 | Purity: 95% | 2-(3-Oxo-1,2,3,4-tetrahydroquinoxalin-2-yl)acetic acid | ESD-843779-1G |
Cas.: 888041-37-0 | Purity: 97% | 2,7-Dibromotriphenylene | ESD-843780-250MG |
Cas.: 888041-37-0 | Purity: 97% | 2,7-Dibromotriphenylene | ESD-843780-1G |
Cas.: 222987-21-5 | Purity: 98% | 4-(2-Aminopyrimidin-5-yl)benzoic acid | ESD-843781-250MG |
Cas.: 222987-21-5 | Purity: 98% | 4-(2-Aminopyrimidin-5-yl)benzoic acid | ESD-843781-1G |
Cas.: 63897-10-9 | Purity: 95% | 4-Nitropyridine-2,6-dicarboxylic acid | ESD-843782-25MG |
Cas.: 63897-10-9 | Purity: 95% | 4-Nitropyridine-2,6-dicarboxylic acid | ESD-843782-100MG |
Cas.: 39824-26-5 | Purity: 96% | 6-Chloro-9-[2,3-O-(1-methylethylidene)-beta-D-ribofuranosyl]-9H-Purine | ESD-843783-250MG |
Cas.: 39824-26-5 | Purity: 96% | 6-Chloro-9-[2,3-O-(1-methylethylidene)-beta-D-ribofuranosyl]-9H-Purine | ESD-843783-1G |
Cas.: 128779-47-5 | Purity: 95% | (R)-3-([1,1′-Biphenyl]-4-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid | ESD-843784-250MG |
Cas.: 128779-47-5 | Purity: 95% | (R)-3-([1,1′-Biphenyl]-4-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid | ESD-843784-1G |
Cas.: 130798-48-0 | Purity: 95% | (R)-Di-2-Naphthylprolinol | ESD-843785-250MG |
Cas.: 130798-48-0 | Purity: 95% | (R)-Di-2-Naphthylprolinol | ESD-843785-1G |
Cas.: 71675-87-1 | Purity: 98% | 4-Amino-5-(ethylsulfonyl)-2-methoxybenzoic acid | ESD-843786-1G |
Cas.: 50847-09-1 | Purity: 97% | 2-Bromo-1H-imidazole-4,5-dicarbonitrile | ESD-843787-50MG |
Cas.: 50847-09-1 | Purity: 97% | 2-Bromo-1H-imidazole-4,5-dicarbonitrile | ESD-843787-250MG |
Cas.: 42959-40-0 | Purity: 95% | 2-Chloro-5-hydroxynicotinic acid | ESD-843788-25MG |
Cas.: 42959-40-0 | Purity: 95% | 2-Chloro-5-hydroxynicotinic acid | ESD-843788-100MG |
Cas.: 76375-60-5 | Purity: 98% | (3R,4R,5R,6R)-3-Acetamido-6-(acetoxymethyl)tetrahydro-2H-pyran-2,4,5-triyl triacetate | ESD-843789-250MG |
Cas.: 76375-60-5 | Purity: 98% | (3R,4R,5R,6R)-3-Acetamido-6-(acetoxymethyl)tetrahydro-2H-pyran-2,4,5-triyl triacetate | ESD-843789-1G |
Cas.: 24584-09-6 | Purity: 98% | Dexrazoxane | ESD-843790-50MG |
Cas.: 24584-09-6 | Purity: 98% | Dexrazoxane | ESD-843790-250MG |
Cas.: 41662-92-4 | Purity: 97% | 1,3-Bis(dodecyloxy)benzene | ESD-843791-250MG |
Cas.: 41662-92-4 | Purity: 97% | 1,3-Bis(dodecyloxy)benzene | ESD-843791-1G |
Cas.: 154212-61-0 | Purity: 95% | N-[2-Isopropylthiazol-4-ylmethyl(methyl)carbamoyl]-L-valine | ESD-843792-1G |
Cas.: 154212-61-0 | Purity: 95% | N-[2-Isopropylthiazol-4-ylmethyl(methyl)carbamoyl]-L-valine | ESD-843792-5G |
Cas.: 5629-98-1 | Purity: 98% | 2,4-Dibromobenzaldehyde | ESD-843793-250MG |
Cas.: 5629-98-1 | Purity: 98% | 2,4-Dibromobenzaldehyde | ESD-843793-1G |
Cas.: 546141-08-6 | Purity: 98% | URB-597 | ESD-843794-250MG |
Cas.: 546141-08-6 | Purity: 98% | URB-597 | ESD-843794-1G |
Cas.: 21209-51-8 | Purity: 98% | Z-Ser-Obzl | ESD-843795-1G |
Cas.: 144060-53-7 | Purity: 98% | Febuxostat | ESD-843796-250MG |
Cas.: 144060-53-7 | Purity: 98% | Febuxostat | ESD-843796-1G |
Cas.: 58457-37-7 | Purity: 97% | 1H-Pyrrolo[3,2-h]quinoline-2-carboxylic acid | ESD-843797-25MG |
Cas.: 58457-37-7 | Purity: 97% | 1H-Pyrrolo[3,2-h]quinoline-2-carboxylic acid | ESD-843797-100MG |
Cas.: 20806-43-3 | Purity: 95% | Z-Ser(Bzl)-OH | ESD-843798-250MG |
Cas.: 20806-43-3 | Purity: 95% | Z-Ser(Bzl)-OH | ESD-843798-1G |
Cas.: 310454-53-6 | Purity: 96% | 1-Benzyl 3-ethyl piperidine-1,3-dicarboxylate | ESD-843799-1G |
Cas.: 1060804-57-0 | Purity: 97% | 2-Chloro-5-hydroxyisonicotinic acid | ESD-843800-25MG |
Cas.: 1060804-57-0 | Purity: 97% | 2-Chloro-5-hydroxyisonicotinic acid | ESD-843800-100MG |
Cas.: 118-04-7 | Purity: 97% | 2-(3-Amino-4-chlorobenzoyl)benzoic acid | ESD-843801-1G |
Cas.: 118-04-7 | Purity: 97% | 2-(3-Amino-4-chlorobenzoyl)benzoic acid | ESD-843801-10G |
Cas.: 43029-19-2 | Purity: 98% | 3-Aminopyrazin-2(1H)-one | ESD-843802-250MG |
Cas.: 43029-19-2 | Purity: 98% | 3-Aminopyrazin-2(1H)-one | ESD-843802-1G |
Cas.: 69863-36-1 | Purity: 97% | Z-Thr(Bzl)-OH | ESD-843803-250MG |
Cas.: 69863-36-1 | Purity: 97% | Z-Thr(Bzl)-OH | ESD-843803-1G |
Cas.: 66338-96-3 | Purity: 95% | (Z)-2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)acetic acid | ESD-843804-250MG |
Cas.: 66338-96-3 | Purity: 95% | (Z)-2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)acetic acid | ESD-843804-1G |
Cas.: 179087-93-5 | Purity: 98% | 2-(4-((2,4-Dioxothiazolidin-5-yl)methyl)phenoxy)acetic acid | ESD-843805-25MG |
Cas.: 179087-93-5 | Purity: 98% | 2-(4-((2,4-Dioxothiazolidin-5-yl)methyl)phenoxy)acetic acid | ESD-843805-100MG |
Cas.: 548-61-8 | Purity: 95% | 4,4′,4”-Methanetriyltrianiline | ESD-843806-50MG |
Cas.: 548-61-8 | Purity: 95% | 4,4′,4”-Methanetriyltrianiline | ESD-843806-250MG |
Cas.: 136310-64-0 | Purity: 96% | Scopine di(2-thienyl)glycolate | ESD-843807-25MG |
Cas.: 136310-64-0 | Purity: 96% | Scopine di(2-thienyl)glycolate | ESD-843807-100MG |
Cas.: 374791-02-3 | Purity: 96% | (R)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)azetidine-2-carboxylic acid | ESD-843808-50MG |
Cas.: 374791-02-3 | Purity: 96% | (R)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)azetidine-2-carboxylic acid | ESD-843808-250MG |
Cas.: 1096-84-0 | Purity: 95% | 1,1′-Methylenebis(naphthalen-2-ol) | ESD-843809-250MG |
Cas.: 1096-84-0 | Purity: 95% | 1,1′-Methylenebis(naphthalen-2-ol) | ESD-843809-1G |
Cas.: 865887-11-2 | Purity: 97% | 6-Benzyloxy-1H-indazole-3-carboxylic acid | ESD-843810-50MG |
Cas.: 865887-11-2 | Purity: 97% | 6-Benzyloxy-1H-indazole-3-carboxylic acid | ESD-843810-250MG |
Cas.: 117977-21-6 | Purity: 98% | 2-[[[4-(3-Methoxypropoxy)-3-methylpyridine-2-yl ]methyl]thio]-1H-benzimidazole | ESD-843811-1G |
Cas.: 3807-81-6 | Purity: 95% | 5-Nitrobenzene-1,2,3-tricarboxylic acid | ESD-843812-1G |
Cas.: 3807-81-6 | Purity: 95% | 5-Nitrobenzene-1,2,3-tricarboxylic acid | ESD-843812-5G |
Cas.: 152460-09-8 | Purity: 95% | N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine | ESD-843813-1G |
Cas.: 152460-09-8 | Purity: 95% | N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine | ESD-843813-10G |
Cas.: 27019-47-2 | Purity: 98% | H-β-Ala-Obzl.TosOH | ESD-843814-1G |
Cas.: 185422-96-2 | Purity: 98% | 2,6-Dichloro-3-hydroxyisonicotinic acid | ESD-843815-25MG |
Cas.: 185422-96-2 | Purity: 98% | 2,6-Dichloro-3-hydroxyisonicotinic acid | ESD-843815-100MG |
Cas.: 5175-14-4 | Purity: 95% | 2-Oxo-1,2-dihydro-1,8-naphthyridine-3-carboxylic acid | ESD-843816-50MG |
Cas.: 5175-14-4 | Purity: 95% | 2-Oxo-1,2-dihydro-1,8-naphthyridine-3-carboxylic acid | ESD-843816-250MG |
Cas.: 112885-41-3 | Purity: 98% | Mosapride | ESD-843817-250MG |
Cas.: 112885-41-3 | Purity: 98% | Mosapride | ESD-843817-1G |
Cas.: 5635-98-3 | Purity: 98% | 2-(Methoxymethyl)phenol | ESD-843818-250MG |
Cas.: 5635-98-3 | Purity: 98% | 2-(Methoxymethyl)phenol | ESD-843818-1G |
Cas.: 229639-48-9 | Purity: 95% | (S)-3-((tert-Butoxycarbonyl)amino)-4-(1H-indol-3-yl)butanoic acid | ESD-843819-50MG |
Cas.: 229639-48-9 | Purity: 95% | (S)-3-((tert-Butoxycarbonyl)amino)-4-(1H-indol-3-yl)butanoic acid | ESD-843819-250MG |
Cas.: 170642-27-0 | Purity: 97% | Fmoc-D-Abu-OH | ESD-843820-1G |
Cas.: 170642-27-0 | Purity: 97% | Fmoc-D-Abu-OH | ESD-843820-5G |
Cas.: 96187-53-0 | Purity: 95% | 6-Fluoro-2-(2′-fluoro-[1,1′-biphenyl]-4-yl)-3-methylquinoline-4-carboxylic acid | ESD-843821-25MG |
Cas.: 1089687-05-7 | Purity: 97% | 2,6-Dibromo-4,4-bis(2-ethylhexyl)-4H-silolo[3,2-b:4,5-b’]dithiophene | ESD-843822-25MG |
Cas.: 1089687-05-7 | Purity: 97% | 2,6-Dibromo-4,4-bis(2-ethylhexyl)-4H-silolo[3,2-b:4,5-b’]dithiophene | ESD-843822-100MG |
Cas.: 86404-04-8 | Purity: 95% | 3-O-Ethyl-L-ascorbic acid | ESD-843823-250MG |
Cas.: 86404-04-8 | Purity: 95% | 3-O-Ethyl-L-ascorbic acid | ESD-843823-1G |
Cas.: 171752-68-4 | Purity: 98% | (1R,3R)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3- carboxylate hydrochloride | ESD-843824-1G |
Cas.: 171752-68-4 | Purity: 98% | (1R,3R)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3- carboxylate hydrochloride | ESD-843824-5G |
Cas.: 519032-08-7 | Purity: 97% | Methyl 2-(2-(((benzyloxy)carbonyl)amino)propan-2-yl)-5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxylate | ESD-843825-250MG |
Cas.: 519032-08-7 | Purity: 97% | Methyl 2-(2-(((benzyloxy)carbonyl)amino)propan-2-yl)-5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxylate | ESD-843825-1G |
Cas.: 914349-45-4 | Purity: 95% | 3-(2-Aminopyrimidin-5-yl)benzoic acid | ESD-843826-250MG |
Cas.: 914349-45-4 | Purity: 95% | 3-(2-Aminopyrimidin-5-yl)benzoic acid | ESD-843826-1G |
Cas.: 36894-69-6 | Purity: 98% | 2-Hydroxy-5-(1-hydroxy-2-((4-phenylbutan-2-yl)amino)ethyl)benzamide | ESD-843827-25MG |
Cas.: 36894-69-6 | Purity: 98% | 2-Hydroxy-5-(1-hydroxy-2-((4-phenylbutan-2-yl)amino)ethyl)benzamide | ESD-843827-100MG |
Cas.: 92623-83-1 | Purity: 95% | (4-Methoxyphenyl)(2-methyl-1-(2-morpholinoethyl)-1H-indol-3-yl)methanone | ESD-843828-50MG |
Cas.: 92623-83-1 | Purity: 95% | (4-Methoxyphenyl)(2-methyl-1-(2-morpholinoethyl)-1H-indol-3-yl)methanone | ESD-843828-250MG |
Cas.: 106368-32-5 | Purity: 98% | 5-Amino-1-(4-(methylsulfonyl)phenyl)-1H-pyrazole-4-carbonitrile | ESD-843829-50MG |
Cas.: 106368-32-5 | Purity: 98% | 5-Amino-1-(4-(methylsulfonyl)phenyl)-1H-pyrazole-4-carbonitrile | ESD-843829-250MG |
Cas.: 5274-71-5 | Purity: 98% | 2-Bromo-4-nitrobenzaldehyde | ESD-843830-50MG |
Cas.: 5274-71-5 | Purity: 98% | 2-Bromo-4-nitrobenzaldehyde | ESD-843830-250MG |
Cas.: 96034-64-9 | Purity: 95% | (2S,4S)-4-Nitrobenzyl 2-(dimethylcarbamoyl)-4-mercaptopyrrolidine-1-carboxylate | ESD-843831-250MG |
Cas.: 96034-64-9 | Purity: 95% | (2S,4S)-4-Nitrobenzyl 2-(dimethylcarbamoyl)-4-mercaptopyrrolidine-1-carboxylate | ESD-843831-1G |
Cas.: 288154-16-5 | Purity: 97% | 4-(((Benzyloxy)carbonyl)amino)-1-(tert-butoxycarbonyl)piperidine-4-carboxylic acid | ESD-843832-250MG |
Cas.: 288154-16-5 | Purity: 97% | 4-(((Benzyloxy)carbonyl)amino)-1-(tert-butoxycarbonyl)piperidine-4-carboxylic acid | ESD-843832-1G |
Cas.: 19311-37-6 | Purity: 96% | 3-Bromotetrahydrofuran | ESD-843833-250MG |
Cas.: 19311-37-6 | Purity: 96% | 3-Bromotetrahydrofuran | ESD-843833-1G |
Cas.: 15781-70-1 | Purity: 98% | Bis(2,4,6-trichlorophenyl) malonate | ESD-843834-250MG |
Cas.: 15781-70-1 | Purity: 98% | Bis(2,4,6-trichlorophenyl) malonate | ESD-843834-1G |
Cas.: 118904-37-3 | Purity: 98% | Fmoc-D-Allo-Ile-OH | ESD-843835-250MG |
Cas.: 118904-37-3 | Purity: 98% | Fmoc-D-Allo-Ile-OH | ESD-843835-1G |
Cas.: 808758-81-8 | Purity: 96% | 4-(Bis(4-iodophenyl)amino)benzaldehyde | ESD-843836-50MG |
Cas.: 808758-81-8 | Purity: 96% | 4-(Bis(4-iodophenyl)amino)benzaldehyde | ESD-843836-250MG |
Cas.: 331711-99-0 | Purity: 98% | Naphthalene-1,8-diyl dibenzoate | ESD-843837-250MG |
Cas.: 331711-99-0 | Purity: 98% | Naphthalene-1,8-diyl dibenzoate | ESD-843837-1G |
Cas.: 91714-94-2 | Purity: 97% | 2-(2-Amino-3-(4-bromobenzoyl)phenyl)acetic acid | ESD-843838-250MG |
Cas.: 91714-94-2 | Purity: 97% | 2-(2-Amino-3-(4-bromobenzoyl)phenyl)acetic acid | ESD-843838-1G |
Cas.: 1820587-57-2 | Purity: 95% | (Z)-Methyl 2-(1-(2-chlorophenyl)-4-((3-(dimethylamino)phenyl)(methylamino)methylene)-5-oxo-4,5-dihydro-1H-pyrazol-3-yl )acetate | ESD-843839-25MG |
Cas.: 3641-13-2 | Purity: 95% | 5-Amino-4H-1,2,4-triazole-3-carboxylic acid | ESD-843840-5G |
Cas.: 459789-99-2 | Purity: 98% | INT-747 | ESD-843841-50MG |
Cas.: 459789-99-2 | Purity: 98% | INT-747 | ESD-843841-250MG |
Cas.: 288617-71-0 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpent-4-enoic acid | ESD-843842-25MG |
Cas.: 288617-71-0 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpent-4-enoic acid | ESD-843842-100MG |
Cas.: 981-34-0 | Purity: 97% | (4aS,4bS,5aS,6aS,7R,8S,9aS,9bS)-7-Hydroxy-7-(2-hydroxyacetyl)-4a,6a,8-trimethyl-5a,6,6a,7,8,9, 9a,9b,10,11-decahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-2(4aH)-one | ESD-843843-250MG |
Cas.: 981-34-0 | Purity: 97% | (4aS,4bS,5aS,6aS,7R,8S,9aS,9bS)-7-Hydroxy-7-(2-hydroxyacetyl)-4a,6a,8-trimethyl-5a,6,6a,7,8,9, 9a,9b,10,11-decahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-2(4aH)-one | ESD-843843-1G |
Cas.: 87321-20-8 | Purity: 95% | (S)-Octan-2-yl 4-((4-(hexyloxy)benzoyl)oxy)benzoate | ESD-843844-250MG |
Cas.: 87321-20-8 | Purity: 95% | (S)-Octan-2-yl 4-((4-(hexyloxy)benzoyl)oxy)benzoate | ESD-843844-1G |
Cas.: 5472-70-8 | Purity: 97% | 2-Amino-3-(m-tolyl)propanoic acid | ESD-843845-1G |
Cas.: 5472-70-8 | Purity: 97% | 2-Amino-3-(m-tolyl)propanoic acid | ESD-843845-5G |
Cas.: 74431-23-5 | Purity: 98% | (5R,6S)-3-((2-Formimidamidoethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid hydrate | ESD-843846-50MG |
Cas.: 74431-23-5 | Purity: 98% | (5R,6S)-3-((2-Formimidamidoethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid hydrate | ESD-843846-250MG |
Cas.: 456-12-2 | Purity: 95% | N-(2-Hydroxy-2-(4-methoxyphenyl)ethyl)cinnamamide | ESD-843847-250MG |
Cas.: 456-12-2 | Purity: 95% | N-(2-Hydroxy-2-(4-methoxyphenyl)ethyl)cinnamamide | ESD-843847-1G |
Cas.: 1133058-06-6 | Purity: 95% | 6,9-Diphenyl-9H-carbazol-3-yl-3-boronic acid | ESD-843848-250MG |
Cas.: 1133058-06-6 | Purity: 95% | 6,9-Diphenyl-9H-carbazol-3-yl-3-boronic acid | ESD-843848-1G |
Cas.: 6044-30-0 | Purity: 95% | 2-Naphthyl bD-glucopyranoside | ESD-843849-250MG |
Cas.: 6044-30-0 | Purity: 95% | 2-Naphthyl bD-glucopyranoside | ESD-843849-1G |
Cas.: 155760-02-4 | Purity: 97% | (S)-3-([1,1′-Biphenyl]-4-yl)-2-aminopropanoic acid | ESD-843850-250MG |
Cas.: 155760-02-4 | Purity: 97% | (S)-3-([1,1′-Biphenyl]-4-yl)-2-aminopropanoic acid | ESD-843850-1G |
Cas.: 15097-38-8 | Purity: 97% | Benzyl 2-(triphenylphosphoranylidene)acetate | ESD-843851-1G |
Cas.: 13001-40-6 | Purity: 97% | 4,4′-(1,4-Phenylenebis(ethene-2,1-diyl))dibenzonitrile | ESD-843852-1G |
Cas.: 13001-40-6 | Purity: 97% | 4,4′-(1,4-Phenylenebis(ethene-2,1-diyl))dibenzonitrile | ESD-843852-10G |
Cas.: 6237-96-3 | Purity: 97% | 4,6-Dichloro-2-ethylpyrimidin-5-amine | ESD-843853-50MG |
Cas.: 6237-96-3 | Purity: 97% | 4,6-Dichloro-2-ethylpyrimidin-5-amine | ESD-843853-250MG |
Cas.: 696-23-1 | Purity: 97% | 2-Methyl-5-nitro-1H-imidazole | ESD-843854-5G |
Cas.: 696-23-1 | Purity: 97% | 2-Methyl-5-nitro-1H-imidazole | ESD-843854-25G |
Cas.: 1516887-33-4 | Purity: 95% | (R)-4-((3R,5R,8S,9S,10R,13R,14S,17R,E)-6-Ethylidene-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a ]phenanthren-17-yl)pentanoic acid | ESD-843855-50MG |
Cas.: 1516887-33-4 | Purity: 95% | (R)-4-((3R,5R,8S,9S,10R,13R,14S,17R,E)-6-Ethylidene-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a ]phenanthren-17-yl)pentanoic acid | ESD-843855-250MG |
Cas.: 851909-08-5 | Purity: 98% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)hex-5-enoic acid | ESD-843856-25MG |
Cas.: 851909-08-5 | Purity: 98% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)hex-5-enoic acid | ESD-843856-100MG |
Cas.: 196404-55-4 | Purity: 95% | (4S,5R)-3-(tert-Butoxycarbonyl)-2-(4-methoxyphenyl)-4-phenyloxazolidine-5-carboxylic acid | ESD-843857-250MG |
Cas.: 196404-55-4 | Purity: 95% | (4S,5R)-3-(tert-Butoxycarbonyl)-2-(4-methoxyphenyl)-4-phenyloxazolidine-5-carboxylic acid | ESD-843857-1G |
Cas.: 114457-94-2 | Purity: 98% | (S)-3-Phenyl-2-(pyrazine-2-carboxamido)propanoic acid | ESD-843858-250MG |
Cas.: 114457-94-2 | Purity: 98% | (S)-3-Phenyl-2-(pyrazine-2-carboxamido)propanoic acid | ESD-843858-1G |
Cas.: 494-08-6 | Purity: 95% | Vanillin 4-ObD-Glucoside | ESD-843859-50MG |
Cas.: 494-08-6 | Purity: 95% | Vanillin 4-ObD-Glucoside | ESD-843859-250MG |
Cas.: 316833-32-6 | Purity: 97% | 2-(Pyridin-4-yl)-1H-benzo[d]imidazole-6-carboxylic acid | ESD-843860-50MG |
Cas.: 316833-32-6 | Purity: 97% | 2-(Pyridin-4-yl)-1H-benzo[d]imidazole-6-carboxylic acid | ESD-843860-250MG |
Cas.: 56973-26-3 | Purity: 98% | 5-Hydroxy-1H-imidazole-4-carboxamide | ESD-843861-50MG |
Cas.: 56973-26-3 | Purity: 98% | 5-Hydroxy-1H-imidazole-4-carboxamide | ESD-843861-250MG |
Cas.: 255064-08-5 | Purity: 98% | 6-Bromo-1H-benzo[d]imidazole-4-carboxylic acid | ESD-843862-25MG |
Cas.: 255064-08-5 | Purity: 98% | 6-Bromo-1H-benzo[d]imidazole-4-carboxylic acid | ESD-843862-100MG |
Cas.: 51-49-0 | Purity: 95% | (R)-2-Amino-3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoic acid | ESD-843863-25MG |
Cas.: 51-49-0 | Purity: 95% | (R)-2-Amino-3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoic acid | ESD-843863-100MG |
Cas.: 146346-82-9 | Purity: 97% | Fmoc-Thr(TBDMS)-OH | ESD-843864-250MG |
Cas.: 146346-82-9 | Purity: 97% | Fmoc-Thr(TBDMS)-OH | ESD-843864-1G |
Cas.: 676273-39-5 | Purity: 98% | 3-Iodo-1-tosyl-1H-indole-5-carbonitrile | ESD-843865-250MG |
Cas.: 676273-39-5 | Purity: 98% | 3-Iodo-1-tosyl-1H-indole-5-carbonitrile | ESD-843865-1G |
Cas.: 4779-31-1 | Purity: 97% | Z-Asp-OBzl | ESD-843866-250MG |
Cas.: 4779-31-1 | Purity: 97% | Z-Asp-OBzl | ESD-843866-1G |
Cas.: 317318-70-0 | Purity: 98% | GW 501516 | ESD-843867-50MG |
Cas.: 317318-70-0 | Purity: 98% | GW 501516 | ESD-843867-250MG |
Cas.: 116568-17-3 | Purity: 95% | 1H-Benzo[d]imidazole-6-carboxamide | ESD-843868-50MG |
Cas.: 116568-17-3 | Purity: 95% | 1H-Benzo[d]imidazole-6-carboxamide | ESD-843868-250MG |
Cas.: 35146-32-8 | Purity: 97% | H-His(Trt)-OH | ESD-843869-250MG |
Cas.: 35146-32-8 | Purity: 97% | H-His(Trt)-OH | ESD-843869-1G |
Cas.: 220497-66-5 | Purity: 95% | (1S,3R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)cyclopentanecarboxylic acid | ESD-843870-50MG |
Cas.: 220497-66-5 | Purity: 95% | (1S,3R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)cyclopentanecarboxylic acid | ESD-843870-250MG |
Cas.: 26040-51-7 | Purity: 95% | Bis(2-ethylhexyl) 3,4,5,6-tetrabromophthalate | ESD-843871-50MG |
Cas.: 26040-51-7 | Purity: 95% | Bis(2-ethylhexyl) 3,4,5,6-tetrabromophthalate | ESD-843871-250MG |
Cas.: 863238-73-7 | Purity: 97% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-trityl-1H-pyrazole | ESD-843872-250MG |
Cas.: 863238-73-7 | Purity: 97% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-trityl-1H-pyrazole | ESD-843872-1G |
Cas.: 641569-94-0 | Purity: 95% | 4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoic acid | ESD-843873-250MG |
Cas.: 641569-94-0 | Purity: 95% | 4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoic acid | ESD-843873-1G |
Cas.: 778571-57-6 | Purity: 95% | Magnesium (2R,3S)-2,3,4-trihydroxybutanoate | ESD-843874-1G |
Cas.: 778571-57-6 | Purity: 95% | Magnesium (2R,3S)-2,3,4-trihydroxybutanoate | ESD-843874-5G |
Cas.: 29876-14-0 | Purity: 95% | N-(2-(1H-Indol-3-yl)ethyl)nicotinamide | ESD-843875-50MG |
Cas.: 29876-14-0 | Purity: 95% | N-(2-(1H-Indol-3-yl)ethyl)nicotinamide | ESD-843875-250MG |
Cas.: 356068-93-4 | Purity: 97% | (Z)-5-((5-Fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid | ESD-843876-25MG |
Cas.: 356068-93-4 | Purity: 97% | (Z)-5-((5-Fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid | ESD-843876-100MG |
Cas.: 57808-65-8 | Purity: 98% | Closantel | ESD-843877-250MG |
Cas.: 57808-65-8 | Purity: 98% | Closantel | ESD-843877-1G |
Cas.: 881302-73-4 | Purity: 97% | 5-Boronoisophthalic acid | ESD-843878-250MG |
Cas.: 881302-73-4 | Purity: 97% | 5-Boronoisophthalic acid | ESD-843878-1G |
Cas.: 288617-77-6 | Purity: 98% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methylhept-6-enoic acid | ESD-843879-25MG |
Cas.: 288617-77-6 | Purity: 98% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methylhept-6-enoic acid | ESD-843879-100MG |
Cas.: 1217512-55-4 | Purity: 95% | (2R)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)octahydro-1H-indole-2-carboxylic acid | ESD-843880-25MG |
Cas.: 1217512-55-4 | Purity: 95% | (2R)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)octahydro-1H-indole-2-carboxylic acid | ESD-843880-100MG |
Cas.: 86401-80-1 | Purity: 97% | 16alpha-Hydroxyprednisonlone acetate | ESD-843881-25MG |
Cas.: 86401-80-1 | Purity: 97% | 16alpha-Hydroxyprednisonlone acetate | ESD-843881-100MG |
Cas.: 1046864-83-8 | Purity: 95% | Di-tert-butyl 1,4-dioxo-3,6-di(thiophen-2-yl)pyrrolo[3,4-c]pyrrole-2,5(1H,4H)-dicarboxylate | ESD-843882-25MG |
Cas.: 1046864-83-8 | Purity: 95% | Di-tert-butyl 1,4-dioxo-3,6-di(thiophen-2-yl)pyrrolo[3,4-c]pyrrole-2,5(1H,4H)-dicarboxylate | ESD-843882-100MG |
Cas.: 161420-87-7 | Purity: 98% | Fmoc-Dab-OH | ESD-843883-250MG |
Cas.: 161420-87-7 | Purity: 98% | Fmoc-Dab-OH | ESD-843883-1G |
Cas.: 7387-57-7 | Purity: 98% | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(6-amino-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate | ESD-843884-50MG |
Cas.: 7387-57-7 | Purity: 98% | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(6-amino-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate | ESD-843884-250MG |
Cas.: 1421252-90-5 | Purity: 97% | 3,5-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1H-indazole | ESD-843885-25MG |
Cas.: 1421252-90-5 | Purity: 97% | 3,5-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1H-indazole | ESD-843885-100MG |
Cas.: 77128-73-5 | Purity: 97% | Fmoc-N-Me-Phe-OH | ESD-843887-250MG |
Cas.: 77128-73-5 | Purity: 97% | Fmoc-N-Me-Phe-OH | ESD-843887-1G |
Cas.: 882562-39-2 | Purity: 97% | (1-Tosyl-1H-pyrrolo[2,3-b]pyridin-3-yl)boronic acid | ESD-843888-25MG |
Cas.: 882562-39-2 | Purity: 97% | (1-Tosyl-1H-pyrrolo[2,3-b]pyridin-3-yl)boronic acid | ESD-843888-100MG |
Cas.: 7545-50-8 | Purity: 95% | 3,3′-Diamino-4,4′-dihydroxydiphenyl sulfone | ESD-843889-250MG |
Cas.: 7545-50-8 | Purity: 95% | 3,3′-Diamino-4,4′-dihydroxydiphenyl sulfone | ESD-843889-1G |
Cas.: 68377-92-4 | Purity: 95% | 5-(2-((3-(tert-Butylamino)-2-hydroxypropyl)thio)thiazol-4-yl)thiophene-2-carboxamide | ESD-843890-50MG |
Cas.: 89544-83-2 | Purity: 97% | Ethyl 1-bromocyclopropanecarboxylate | ESD-843891-25MG |
Cas.: 89544-83-2 | Purity: 97% | Ethyl 1-bromocyclopropanecarboxylate | ESD-843891-100MG |
Cas.: 82034-46-6 | Purity: 98% | Loteprednol etabonate | ESD-843892-250MG |
Cas.: 82034-46-6 | Purity: 98% | Loteprednol etabonate | ESD-843892-1G |
Cas.: 83763-48-8 | Purity: 95% | 5-(2-Hydroxyethylamino)-2-methoxylaniline sulfate | ESD-843893-250MG |
Cas.: 83763-48-8 | Purity: 95% | 5-(2-Hydroxyethylamino)-2-methoxylaniline sulfate | ESD-843893-1G |
Cas.: 161796-78-7 | Purity: 98% | Esomeprazole sodium | ESD-843894-250MG |
Cas.: 161796-78-7 | Purity: 98% | Esomeprazole sodium | ESD-843894-1G |
Cas.: 77449-43-5 | Purity: 95% | 4-Nitrobenzyl 6-(1-hydroxyethyl)-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate | ESD-843895-250MG |
Cas.: 77449-43-5 | Purity: 95% | 4-Nitrobenzyl 6-(1-hydroxyethyl)-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate | ESD-843895-1G |
Cas.: 60129-59-1 | Purity: 98% | 7-Deaza-2′-dA | ESD-843896-25MG |
Cas.: 60129-59-1 | Purity: 98% | 7-Deaza-2′-dA | ESD-843896-100MG |
Cas.: 161321-36-4 | Purity: 97% | Fmoc-Chg-OH | ESD-843897-250MG |
Cas.: 161321-36-4 | Purity: 97% | Fmoc-Chg-OH | ESD-843897-1G |
Cas.: 6790-09-6 | Purity: 95% | 3,6,9,12,15,18,21,24,27,30,33-Undecaoxapentatriacontane-1,35-diol | ESD-843898-50MG |
Cas.: 6790-09-6 | Purity: 95% | 3,6,9,12,15,18,21,24,27,30,33-Undecaoxapentatriacontane-1,35-diol | ESD-843898-250MG |
Cas.: 73536-69-3 | Purity: 98% | Dimethyl 7,7′-dimethoxy-[4,4′-bibenzo[d][1,3]dioxole]-5,5′-dicarboxylate | ESD-843899-250MG |
Cas.: 73536-69-3 | Purity: 98% | Dimethyl 7,7′-dimethoxy-[4,4′-bibenzo[d][1,3]dioxole]-5,5′-dicarboxylate | ESD-843899-1G |
Cas.: 75844-69-8 | Purity: 98% | 1-Boc-Piperidine | ESD-843900-1G |
Cas.: 75844-69-8 | Purity: 98% | 1-Boc-Piperidine | ESD-843900-5G |
Cas.: 65996-50-1 | Purity: 97% | 1H-Pyrrolo[3,2-d]pyrimidine-2,4(3H,5H)-dione | ESD-843901-250MG |
Cas.: 65996-50-1 | Purity: 97% | 1H-Pyrrolo[3,2-d]pyrimidine-2,4(3H,5H)-dione | ESD-843901-1G |
Cas.: 16294-75-0 | Purity: 95% | 14H-Anthra[2,1,9-mna]thioxanthen-14-one | ESD-843902-250MG |
Cas.: 16294-75-0 | Purity: 95% | 14H-Anthra[2,1,9-mna]thioxanthen-14-one | ESD-843902-1G |
Cas.: 180200-66-2 | Purity: 95% | 1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid sesquihydrate | ESD-843903-250MG |
Cas.: 180200-66-2 | Purity: 95% | 1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid sesquihydrate | ESD-843903-1G |
Cas.: 137281-39-1 | Purity: 98% | 4-(2-(2-Amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoic acid | ESD-843904-250MG |
Cas.: 137281-39-1 | Purity: 98% | 4-(2-(2-Amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoic acid | ESD-843904-1G |
Cas.: 167940-02-5 | Purity: 95% | 2,2′-(Oxybis(2,1-ethanediylsulfinyl))bisethanol | ESD-843905-50MG |
Cas.: 167940-02-5 | Purity: 95% | 2,2′-(Oxybis(2,1-ethanediylsulfinyl))bisethanol | ESD-843905-250MG |
Cas.: 145038-53-5 | Purity: 98% | Fmoc-Asp(OMe)-OH | ESD-843906-250MG |
Cas.: 145038-53-5 | Purity: 98% | Fmoc-Asp(OMe)-OH | ESD-843906-1G |
Cas.: 303180-11-2 | Purity: 95% | 1H-Pyrazole-3,5-dicarboxylic acid hydrate | ESD-843907-1G |
Cas.: 303180-11-2 | Purity: 95% | 1H-Pyrazole-3,5-dicarboxylic acid hydrate | ESD-843907-5G |
Cas.: 40356-52-3 | Purity: 95% | (S)-1-Benzyl 2-(4-nitrophenyl) 5-oxopyrrolidine-1,2-dicarboxylate | ESD-843908-250MG |
Cas.: 40356-52-3 | Purity: 95% | (S)-1-Benzyl 2-(4-nitrophenyl) 5-oxopyrrolidine-1,2-dicarboxylate | ESD-843908-1G |
Cas.: 1397683-79-2 | Purity: 95% | 1H-Pyrazole-3,5-dicarboxamide | ESD-843909-50MG |
Cas.: 1397683-79-2 | Purity: 95% | 1H-Pyrazole-3,5-dicarboxamide | ESD-843909-250MG |
Cas.: 6758-40-3 | Purity: 97% | (S)-2-(4-Nitrobenzamido)pentanedioic acid | ESD-843910-250MG |
Cas.: 6758-40-3 | Purity: 97% | (S)-2-(4-Nitrobenzamido)pentanedioic acid | ESD-843910-1G |
Cas.: 700874-72-2 | Purity: 98% | LY2157299 | ESD-843911-10MG |
Cas.: 122111-11-9 | Purity: 98% | ((2R,3R)-3-(Benzoyloxy)-4,4-difluoro-5-((methylsulfonyl)oxy)tetrahydrofuran-2-yl)methyl benzoate | ESD-843912-250MG |
Cas.: 122111-11-9 | Purity: 98% | ((2R,3R)-3-(Benzoyloxy)-4,4-difluoro-5-((methylsulfonyl)oxy)tetrahydrofuran-2-yl)methyl benzoate | ESD-843912-1G |
Cas.: 89604-92-2 | Purity: 97% | (Z)-tert-Butyl 2-(((1-(2-aminothiazol-4-yl)-2-(benzo[d]thiazol-2-ylthio)-2-oxoethylidene)amino)oxy)-2-methylpropanoate | ESD-843913-1G |
Cas.: 99591-74-9 | Purity: 98% | 1,5,2,4-Dioxadithiane 2,2,4,4-tetraoxide | ESD-843914-250MG |
Cas.: 99591-74-9 | Purity: 98% | 1,5,2,4-Dioxadithiane 2,2,4,4-tetraoxide | ESD-843914-1G |
Cas.: 5395-50-6 | Purity: 98% | 1,3,4,6-Tetrakis(hydroxymethyl)tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione | ESD-843915-5G |
Cas.: 5395-50-6 | Purity: 98% | 1,3,4,6-Tetrakis(hydroxymethyl)tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione | ESD-843915-25G |
Cas.: 145038-50-2 | Purity: 97% | Fmoc-Glu(OMe)-OH | ESD-843916-1G |
Cas.: 164470-64-8 | Purity: 97% | Fmoc-4-Amb-OH | ESD-843917-1G |
Cas.: 119478-56-7 | Purity: 98% | Meropenem trihydrate | ESD-843918-250MG |
Cas.: 119478-56-7 | Purity: 98% | Meropenem trihydrate | ESD-843918-1G |
Cas.: 7484-34-6 | Purity: 95% | 2,2′-(Ethane-1,2-diyldisulfonyl)diethanol | ESD-843919-25MG |
Cas.: 7484-34-6 | Purity: 95% | 2,2′-(Ethane-1,2-diyldisulfonyl)diethanol | ESD-843919-100MG |
Cas.: 135944-09-1 | Purity: 97% | Fmoc-D-HoPhe-OH | ESD-843920-250MG |
Cas.: 135944-09-1 | Purity: 97% | Fmoc-D-HoPhe-OH | ESD-843920-1G |
Cas.: 108466-89-3 | Purity: 97% | 2,2-Dimethyl-4-oxo-3,8,11-trioxa-5-azatridecan-13-oic acid | ESD-843921-50MG |
Cas.: 108466-89-3 | Purity: 97% | 2,2-Dimethyl-4-oxo-3,8,11-trioxa-5-azatridecan-13-oic acid | ESD-843921-250MG |
Cas.: 139481-44-0 | Purity: 98% | Methyl 1-((2′-cyano-[1,1′-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate | ESD-843922-250MG |
Cas.: 139481-44-0 | Purity: 98% | Methyl 1-((2′-cyano-[1,1′-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate | ESD-843922-1G |
Cas.: 29914-81-6 | Purity: 95% | 1,3-Bis(1H-benzo[d]imidazol-2-yl)benzene | ESD-843923-50MG |
Cas.: 29914-81-6 | Purity: 95% | 1,3-Bis(1H-benzo[d]imidazol-2-yl)benzene | ESD-843923-250MG |
Cas.: 30363-03-2 | Purity: 97% | 2,4,6-Tris(4-bromophenyl)-1,3,5-triazine | ESD-843924-250MG |
Cas.: 30363-03-2 | Purity: 97% | 2,4,6-Tris(4-bromophenyl)-1,3,5-triazine | ESD-843924-1G |
Cas.: 128-80-3 | Purity: 97% | 1,4-Bis(p-tolylamino)anthracene-9,10-dione | ESD-843925-1G |
Cas.: 128-80-3 | Purity: 97% | 1,4-Bis(p-tolylamino)anthracene-9,10-dione | ESD-843925-10G |
Cas.: 918504-27-5 | Purity: 98% | N-(3-(5-Bromo-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide | ESD-843926-50MG |
Cas.: 918504-27-5 | Purity: 98% | N-(3-(5-Bromo-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide | ESD-843926-250MG |
Cas.: 15811-32-2 | Purity: 98% | 2′,3′,5′-Tri-O-acetyl-2-fluoroadenosine | ESD-843927-250MG |
Cas.: 15811-32-2 | Purity: 98% | 2′,3′,5′-Tri-O-acetyl-2-fluoroadenosine | ESD-843927-1G |
Cas.: 16966-07-7 | Purity: 97% | Z-Thr(tBu)-OH.DCHA | ESD-843928-250MG |
Cas.: 16966-07-7 | Purity: 97% | Z-Thr(tBu)-OH.DCHA | ESD-843928-1G |
Cas.: 151096-09-2 | Purity: 98% | Moxifloxacin | ESD-843929-250MG |
Cas.: 151096-09-2 | Purity: 98% | Moxifloxacin | ESD-843929-1G |
Cas.: 2382-79-8 | Purity: 98% | (S)-2-Acetamido-3-(1H-indol-3-yl)propanamide | ESD-843930-250MG |
Cas.: 2382-79-8 | Purity: 98% | (S)-2-Acetamido-3-(1H-indol-3-yl)propanamide | ESD-843930-1G |
Cas.: 142569-70-8 | Purity: 97% | (S)-1-(3-(2-(7-Chloroquinolin-2-yl)vinyl)phenyl)-3-(2-(2-hydroxypropan-2-yl)phenyl)propan-1-ol | ESD-843931-1G |
Cas.: 142569-70-8 | Purity: 97% | (S)-1-(3-(2-(7-Chloroquinolin-2-yl)vinyl)phenyl)-3-(2-(2-hydroxypropan-2-yl)phenyl)propan-1-ol | ESD-843931-5G |
Cas.: 200116-81-0 | Purity: 96% | HD-Arg(Pbf)-OH | ESD-843932-250MG |
Cas.: 200116-81-0 | Purity: 96% | HD-Arg(Pbf)-OH | ESD-843932-1G |
Cas.: 200115-86-2 | Purity: 95% | H-Arg(Pbf)-OH | ESD-843933-250MG |
Cas.: 200115-86-2 | Purity: 95% | H-Arg(Pbf)-OH | ESD-843933-1G |
Cas.: 139481-41-7 | Purity: 95% | Ethyl 1-((2′-cyano-[1,1′-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate | ESD-843934-1G |
Cas.: 1246651-90-0 | Purity: 97% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(tert-butoxy)-5-oxopentanoic acid | ESD-843935-50MG |
Cas.: 1246651-90-0 | Purity: 97% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(tert-butoxy)-5-oxopentanoic acid | ESD-843935-250MG |
Cas.: 5312-97-0 | Purity: 98% | 2,5-Dimethoxybenzonitrile | ESD-843936-250MG |
Cas.: 5312-97-0 | Purity: 98% | 2,5-Dimethoxybenzonitrile | ESD-843936-1G |
Cas.: 200192-49-0 | Purity: 97% | HD-Asn(Trt)-OH | ESD-843937-250MG |
Cas.: 200192-49-0 | Purity: 97% | HD-Asn(Trt)-OH | ESD-843937-1G |
Cas.: 13115-71-4 | Purity: 97% | (S)-5-Amino-2-(2-aminoacetamido)-5-oxopentanoic acid | ESD-843938-1G |
Cas.: 13115-71-4 | Purity: 97% | (S)-5-Amino-2-(2-aminoacetamido)-5-oxopentanoic acid | ESD-843938-5G |
Cas.: 7360-09-0 | Purity: 97% | (S)-2-(2-Amino-3-(1H-indol-3-yl)propanamido)acetic acid | ESD-843939-50MG |
Cas.: 7360-09-0 | Purity: 97% | (S)-2-(2-Amino-3-(1H-indol-3-yl)propanamido)acetic acid | ESD-843939-250MG |
Cas.: 20749-68-2 | Purity: 95% | 8,9,10,11-Tetrachloro-12H-isoindolo[2,1-a]perimidin-12-one | ESD-843940-250MG |
Cas.: 20749-68-2 | Purity: 95% | 8,9,10,11-Tetrachloro-12H-isoindolo[2,1-a]perimidin-12-one | ESD-843940-1G |
Cas.: 7724-76-7 | Purity: 98% | N6-(3-Methyl-2-butenyl)adenosine | ESD-843941-50MG |
Cas.: 7724-76-7 | Purity: 98% | N6-(3-Methyl-2-butenyl)adenosine | ESD-843941-250MG |
Cas.: 77128-72-4 | Purity: 95% | Fmoc-Tyr(Me)-OH | ESD-843942-250MG |
Cas.: 77128-72-4 | Purity: 95% | Fmoc-Tyr(Me)-OH | ESD-843942-1G |
Cas.: 288617-75-4 | Purity: 95% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methyldec-9-enoic acid | ESD-843943-50MG |
Cas.: 288617-75-4 | Purity: 95% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methyldec-9-enoic acid | ESD-843943-250MG |
Cas.: 30203-11-3 | Purity: 98% | 3,3′-((Sulfonylbis(4,1-phenylene))bis(oxy))dianiline | ESD-843944-1G |
Cas.: 30203-11-3 | Purity: 98% | 3,3′-((Sulfonylbis(4,1-phenylene))bis(oxy))dianiline | ESD-843944-10G |
Cas.: 1867-73-8 | Purity: 98% | N6-Methyladenosine | ESD-843945-250MG |
Cas.: 1867-73-8 | Purity: 98% | N6-Methyladenosine | ESD-843945-1G |
Cas.: 162502-65-0 | Purity: 97% | Fmoc-D-Tyr(4-Et)-OH | ESD-843946-250MG |
Cas.: 162502-65-0 | Purity: 97% | Fmoc-D-Tyr(4-Et)-OH | ESD-843946-1G |
Cas.: 129722-25-4 | Purity: 97% | 7-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)quinolin-2(1H)-one | ESD-843947-25MG |
Cas.: 129722-25-4 | Purity: 97% | 7-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)quinolin-2(1H)-one | ESD-843947-100MG |
Cas.: 28047-15-6 | Purity: 96% | (S)-5-Amino-5-oxo-2-(2-phenylacetamido)pentanoic acid | ESD-843948-250MG |
Cas.: 28047-15-6 | Purity: 96% | (S)-5-Amino-5-oxo-2-(2-phenylacetamido)pentanoic acid | ESD-843948-1G |
Cas.: 147403-65-4 | Purity: 98% | Methyl 2-ethoxy-1-((2′-(N-hydroxycarbamimidoyl)-[1,1′-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate | ESD-843949-50MG |
Cas.: 147403-65-4 | Purity: 98% | Methyl 2-ethoxy-1-((2′-(N-hydroxycarbamimidoyl)-[1,1′-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate | ESD-843949-250MG |
Cas.: 13122-90-2 | Purity: 97% | Boc-Phe-Phe-OH | ESD-843950-250MG |
Cas.: 13122-90-2 | Purity: 97% | Boc-Phe-Phe-OH | ESD-843950-1G |
Cas.: 10351-75-4 | Purity: 97% | 1H-Benzo[d]imidazole-5,6-dicarboxylic acid | ESD-843951-250MG |
Cas.: 10351-75-4 | Purity: 97% | 1H-Benzo[d]imidazole-5,6-dicarboxylic acid | ESD-843951-1G |
Cas.: 668270-12-0 | Purity: 98% | Linagliptin | ESD-843952-250MG |
Cas.: 668270-12-0 | Purity: 98% | Linagliptin | ESD-843952-1G |
Cas.: 87344-06-7 | Purity: 95% | 2-Methoxyphenyl 2-(2-(1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl)acetamido)acetate | ESD-843953-50MG |
Cas.: 87344-06-7 | Purity: 95% | 2-Methoxyphenyl 2-(2-(1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl)acetamido)acetate | ESD-843953-250MG |
Cas.: 134071-44-6 | Purity: 95% | (cis-2-((1H-Imidazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl 4-methylbenzenesulfonate | ESD-843954-1G |
Cas.: 134071-44-6 | Purity: 95% | (cis-2-((1H-Imidazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl 4-methylbenzenesulfonate | ESD-843954-5G |
Cas.: 55260-24-7 | Purity: 97% | Boc-Gln(Xan)-OH | ESD-843955-1G |
Cas.: 531-18-0 | Purity: 95% | ((1,3,5-Triazine-2,4,6-triyl)tris(azanetriyl))hexamethanol | ESD-843956-1G |
Cas.: 110637-52-0 | Purity: 95% | Dicyclohexylamine (S)-6-(((allyloxy)carbonyl)amino)-2-((tert-butoxycarbonyl)amino)hexanoate | ESD-843957-1G |
Cas.: 991-84-4 | Purity: 95% | 4-((4,6-Bis(octylthio)-1,3,5-triazin-2-yl)amino)-2,6-di-tert-butylphenol | ESD-843958-250MG |
Cas.: 991-84-4 | Purity: 95% | 4-((4,6-Bis(octylthio)-1,3,5-triazin-2-yl)amino)-2,6-di-tert-butylphenol | ESD-843958-1G |
Cas.: 131570-57-5 | Purity: 98% | Boc-D-Dab(Fmoc)-OH | ESD-843959-250MG |
Cas.: 131570-57-5 | Purity: 98% | Boc-D-Dab(Fmoc)-OH | ESD-843959-1G |
Cas.: 173054-11-0 | Purity: 97% | Boc-D-Phe(4-NHFmoc)-OH | ESD-843960-250MG |
Cas.: 173054-11-0 | Purity: 97% | Boc-D-Phe(4-NHFmoc)-OH | ESD-843960-1G |
Cas.: 66905-24-6 | Purity: 95% | (2R,3S,4R,5R)-2,3,4,5,6-Pentahydroxyhexanoic acid hydrate | ESD-843961-1G |
Cas.: 66905-24-6 | Purity: 95% | (2R,3S,4R,5R)-2,3,4,5,6-Pentahydroxyhexanoic acid hydrate | ESD-843961-10G |
Cas.: 87512-31-0 | Purity: 98% | Fmoc-Ala-Ala-OH | ESD-843962-250MG |
Cas.: 87512-31-0 | Purity: 98% | Fmoc-Ala-Ala-OH | ESD-843962-1G |
Cas.: 36443-68-2 | Purity: 98% | Antioxidant 245 | ESD-843963-250MG |
Cas.: 36443-68-2 | Purity: 98% | Antioxidant 245 | ESD-843963-1G |
Cas.: 2212-69-3 | Purity: 95% | Z-Lys(Boc)-ONp | ESD-843964-1G |
Cas.: 2212-69-3 | Purity: 95% | Z-Lys(Boc)-ONp | ESD-843964-5G |
Cas.: 129223-22-9 | Purity: 98% | Fmoc-Pro-Pro-OH | ESD-843965-250MG |
Cas.: 129223-22-9 | Purity: 98% | Fmoc-Pro-Pro-OH | ESD-843965-1G |
Cas.: 124750-53-4 | Purity: 97% | 5-(4′-Methyl-[1,1′-biphenyl]-2-yl)-1-trityl-1H-tetrazole | ESD-843966-25MG |
Cas.: 124750-53-4 | Purity: 97% | 5-(4′-Methyl-[1,1′-biphenyl]-2-yl)-1-trityl-1H-tetrazole | ESD-843966-100MG |
Cas.: 147290-11-7 | Purity: 98% | Fmoc-Orn(Aloc)-OH | ESD-843967-250MG |
Cas.: 147290-11-7 | Purity: 98% | Fmoc-Orn(Aloc)-OH | ESD-843967-1G |
Cas.: 491878-06-9 | Purity: 98% | (2S,4S)-4-Nitrobenzyl 4-(acetylthio)-2-(((tert-butoxycarbonyl)(sulfamoyl)amino)methyl)pyrrolidine-1-carboxylate | ESD-843968-250MG |
Cas.: 491878-06-9 | Purity: 98% | (2S,4S)-4-Nitrobenzyl 4-(acetylthio)-2-(((tert-butoxycarbonyl)(sulfamoyl)amino)methyl)pyrrolidine-1-carboxylate | ESD-843968-1G |
Cas.: 214750-75-1 | Purity: 97% | Fmoc-D-Lys(Aloc)-OH | ESD-843969-250MG |
Cas.: 214750-75-1 | Purity: 97% | Fmoc-D-Lys(Aloc)-OH | ESD-843969-1G |
Cas.: 4378-61-4 | Purity: 95% | 4,10-Dibromonaphtho[7,8,1,2,3-nopqr]tetraphene-6,12-dione | ESD-843970-250MG |
Cas.: 4378-61-4 | Purity: 95% | 4,10-Dibromonaphtho[7,8,1,2,3-nopqr]tetraphene-6,12-dione | ESD-843970-1G |
Cas.: 116470-67-8 | Purity: 97% | 2-(Trifluoromethyl)pyrimidine | ESD-843971-25MG |
Cas.: 116470-67-8 | Purity: 97% | 2-(Trifluoromethyl)pyrimidine | ESD-843971-100MG |
Cas.: 3326-35-0 | Purity: 97% | 4-Nitrofluorescein | ESD-843972-50MG |
Cas.: 3326-35-0 | Purity: 97% | 4-Nitrofluorescein | ESD-843972-250MG |
Cas.: 123447-62-1 | Purity: 98% | Prulifluxacin | ESD-843973-250MG |
Cas.: 123447-62-1 | Purity: 98% | Prulifluxacin | ESD-843973-1G |
Cas.: 355806-00-7 | Purity: 97% | (3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-isopropyl-2-[(methanesulfonyl) methylamino]pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid tert- butyl ester | ESD-843974-250MG |
Cas.: 355806-00-7 | Purity: 97% | (3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-isopropyl-2-[(methanesulfonyl) methylamino]pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid tert- butyl ester | ESD-843974-1G |
Cas.: 88889-14-9 | Purity: 98% | Fosinopril sodium | ESD-843975-250MG |
Cas.: 88889-14-9 | Purity: 98% | Fosinopril sodium | ESD-843975-1G |
Cas.: 14215-97-5 | Purity: 98% | D-Ribofuranose, 1-acetate 2,3,5-tribenzoate | ESD-843976-1G |
Cas.: 14215-97-5 | Purity: 98% | D-Ribofuranose, 1-acetate 2,3,5-tribenzoate | ESD-843976-5G |
Cas.: 116611-64-4 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(1H-imidazol-4-yl)propanoic acid | ESD-843977-250MG |
Cas.: 116611-64-4 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(1H-imidazol-4-yl)propanoic acid | ESD-843977-1G |
Cas.: 190595-65-4 | Purity: 98% | (3R,4S)-4-(4-(Benzyloxy)phenyl)-1-(4-fluorophenyl)-3-(3-(4-fluorophenyl)-3-oxopropyl)azetidin-2-one | ESD-843978-250MG |
Cas.: 190595-65-4 | Purity: 98% | (3R,4S)-4-(4-(Benzyloxy)phenyl)-1-(4-fluorophenyl)-3-(3-(4-fluorophenyl)-3-oxopropyl)azetidin-2-one | ESD-843978-1G |
Cas.: 1111311-65-9 | Purity: 98% | 5-Bromoisoquinoline-1-carboxylic acid | ESD-843979-50MG |
Cas.: 1111311-65-9 | Purity: 98% | 5-Bromoisoquinoline-1-carboxylic acid | ESD-843979-250MG |
Cas.: 89786-04-9 | Purity: 98% | Tazobactam acid | ESD-843980-250MG |
Cas.: 89786-04-9 | Purity: 98% | Tazobactam acid | ESD-843980-1G |
Cas.: 101854-42-6 | Purity: 95% | Boc-D-Dab(Z)-OH.DCHA | ESD-843981-250MG |
Cas.: 101854-42-6 | Purity: 95% | Boc-D-Dab(Z)-OH.DCHA | ESD-843981-1G |
Cas.: 168300-88-7 | Purity: 97% | Fmoc-D-Cys(Acm)-OH | ESD-843982-250MG |
Cas.: 168300-88-7 | Purity: 97% | Fmoc-D-Cys(Acm)-OH | ESD-843982-1G |
Cas.: 90776-59-3 | Purity: 97% | (4R,5R,6S)-4-Nitrobenzyl 3-((diphenoxyphosphoryl)oxy)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept- 2-ene-2-carboxylate | ESD-843984-250MG |
Cas.: 90776-59-3 | Purity: 97% | (4R,5R,6S)-4-Nitrobenzyl 3-((diphenoxyphosphoryl)oxy)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept- 2-ene-2-carboxylate | ESD-843984-1G |
Cas.: 89226-50-6 | Purity: 98% | Manidipine | ESD-843985-50MG |
Cas.: 89226-50-6 | Purity: 98% | Manidipine | ESD-843985-250MG |
Cas.: 174063-87-7 | Purity: 98% | 2-Methyl-1,4-phenylene bis(4-(3-(acryloyloxy)propoxy)benzoate) | ESD-843986-250MG |
Cas.: 174063-87-7 | Purity: 98% | 2-Methyl-1,4-phenylene bis(4-(3-(acryloyloxy)propoxy)benzoate) | ESD-843986-1G |
Cas.: 209216-23-9 | Purity: 98% | Entecavir hydrate | ESD-843987-50MG |
Cas.: 209216-23-9 | Purity: 98% | Entecavir hydrate | ESD-843987-250MG |
Cas.: 156648-40-7 | Purity: 97% | DDE-Lys(Fmoc)-OH | ESD-843988-250MG |
Cas.: 156648-40-7 | Purity: 97% | DDE-Lys(Fmoc)-OH | ESD-843988-1G |
Cas.: 388082-77-7 | Purity: 98% | Lapatinib ditosylate | ESD-843989-250MG |
Cas.: 388082-77-7 | Purity: 98% | Lapatinib ditosylate | ESD-843989-1G |
Cas.: 110990-07-3 | Purity: 97% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-(((benzyloxy)carbonyl)amino)hexanoic acid | ESD-843990-250MG |
Cas.: 110990-07-3 | Purity: 97% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-(((benzyloxy)carbonyl)amino)hexanoic acid | ESD-843990-1G |
Cas.: 1550-50-1 | Purity: 95% | 1,1,2,2-Tetrafluoro-N,N-dimethylethanamine | ESD-843991-1G |
Cas.: 1550-50-1 | Purity: 95% | 1,1,2,2-Tetrafluoro-N,N-dimethylethanamine | ESD-843991-5G |
Cas.: 40422-70-6 | Purity: 96% | 1-Bromo-3-(2-bromoethyl)benzene | ESD-843992-250MG |
Cas.: 40422-70-6 | Purity: 96% | 1-Bromo-3-(2-bromoethyl)benzene | ESD-843992-1G |
Cas.: 16259-78-2 | Purity: 97% | (S)-Benzyl 2,6-diaminohexanoate bis(4-methylbenzenesulfonate) | ESD-843993-250MG |
Cas.: 16259-78-2 | Purity: 97% | (S)-Benzyl 2,6-diaminohexanoate bis(4-methylbenzenesulfonate) | ESD-843993-1G |
Cas.: 13569-65-8 | Purity: 98% | Rhodium(III) chloride trihydrate | ESD-843994-50MG |
Cas.: 13569-65-8 | Purity: 98% | Rhodium(III) chloride trihydrate | ESD-843994-250MG |
Cas.: 103980-44-5 | Purity: 98% | (6R,7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(((furan-2-carbonyl)thio)methyl)-8 -oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrochloride | ESD-843995-1G |
Cas.: 103980-44-5 | Purity: 98% | (6R,7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(((furan-2-carbonyl)thio)methyl)-8 -oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrochloride | ESD-843995-10G |
Cas.: 873-31-4 | Purity: 98% | 1-Chloro-2-ethynylbenzene | ESD-843996-250MG |
Cas.: 873-31-4 | Purity: 98% | 1-Chloro-2-ethynylbenzene | ESD-843996-1G |
Cas.: 926-06-7 | Purity: 97% | Isopropyl methanesulfonate | ESD-843997-250MG |
Cas.: 926-06-7 | Purity: 97% | Isopropyl methanesulfonate | ESD-843997-1G |
Cas.: 49557-75-7 | Purity: 98% | Glycyl-L-Histidyl-L-Lysine | ESD-843998-250MG |
Cas.: 49557-75-7 | Purity: 98% | Glycyl-L-Histidyl-L-Lysine | ESD-843998-1G |
Cas.: 1038866-44-2 | Purity: 97% | Spiro[piperidine-4,4′-pyrido[2,3-d][1,3]oxazin]-2′(1’H)-one hydrochloride | ESD-843999-25MG |
Cas.: 1038866-44-2 | Purity: 97% | Spiro[piperidine-4,4′-pyrido[2,3-d][1,3]oxazin]-2′(1’H)-one hydrochloride | ESD-843999-100MG |
Cas.: 119665-62-2 | Purity: 95% | 6-O-Methyl-2′,4”-bis-O-(trimethylsilyl)-9-[O-(1-ethoxy-1-methylethyl)oxime]-Erythromycin | ESD-844000-1G |
Cas.: 119665-62-2 | Purity: 95% | 6-O-Methyl-2′,4”-bis-O-(trimethylsilyl)-9-[O-(1-ethoxy-1-methylethyl)oxime]-Erythromycin | ESD-844000-10G |
Cas.: 10599-59-4 | Purity: 95% | 2-Isopropylfuran | ESD-844001-25MG |
Cas.: 10599-59-4 | Purity: 95% | 2-Isopropylfuran | ESD-844001-100MG |
Cas.: 145040-37-5 | Purity: 98% | Candesartan cilexetil | ESD-844002-250MG |
Cas.: 145040-37-5 | Purity: 98% | Candesartan cilexetil | ESD-844002-1G |
Cas.: 693-93-6 | Purity: 97% | 4-Methyloxazole | ESD-844003-50MG |
Cas.: 693-93-6 | Purity: 97% | 4-Methyloxazole | ESD-844003-250MG |
Cas.: 3286-46-2 | Purity: 98% | Sulbutiamine | ESD-844004-250MG |
Cas.: 3286-46-2 | Purity: 98% | Sulbutiamine | ESD-844004-1G |
Cas.: 139481-72-4 | Purity: 97% | Trityl candesartan | ESD-844005-50MG |
Cas.: 139481-72-4 | Purity: 97% | Trityl candesartan | ESD-844005-250MG |
Cas.: 14618-78-1 | Purity: 97% | 4,4-Dimethoxybutanenitrile | ESD-844006-1G |
Cas.: 42548-78-7 | Purity: 97% | N-Ethylhydroxylamine hydrochloride | ESD-844007-250MG |
Cas.: 42548-78-7 | Purity: 97% | N-Ethylhydroxylamine hydrochloride | ESD-844007-1G |
Cas.: 1001202-16-9 | Purity: 97% | Fmoc-Gly-Gly-Gly-Gly | ESD-844008-25MG |
Cas.: 1001202-16-9 | Purity: 97% | Fmoc-Gly-Gly-Gly-Gly | ESD-844008-100MG |
Cas.: 104-58-5 | Purity: 97% | 3-(Piperidin-1-yl)propan-1-ol | ESD-844009-250MG |
Cas.: 104-58-5 | Purity: 97% | 3-(Piperidin-1-yl)propan-1-ol | ESD-844009-1G |
Cas.: 31407-74-6 | Purity: 97% | Ethyl carbamimidate hydrochloride | ESD-844010-1G |
Cas.: 31407-74-6 | Purity: 97% | Ethyl carbamimidate hydrochloride | ESD-844010-10G |
Cas.: 26178-14-3 | Purity: 97% | 3-Methyl-1,2,5-oxadiazole | ESD-844011-50MG |
Cas.: 26178-14-3 | Purity: 97% | 3-Methyl-1,2,5-oxadiazole | ESD-844011-250MG |
Cas.: 21635-88-1 | Purity: 98% | 3-Oxetanamine | ESD-844012-250MG |
Cas.: 21635-88-1 | Purity: 98% | 3-Oxetanamine | ESD-844012-1G |
Cas.: 5379-16-8 | Purity: 98% | 1-(3,5-Dimethylphenyl)ethanone | ESD-844013-1G |
Cas.: 21168-72-9 | Purity: 97% | 2-(4-(Aminomethyl)piperidin-1-yl)ethanol | ESD-844014-50MG |
Cas.: 21168-72-9 | Purity: 97% | 2-(4-(Aminomethyl)piperidin-1-yl)ethanol | ESD-844014-250MG |
Cas.: 152513-91-2 | Purity: 95% | 1,2,4-Thiadiazol-5-amine hydrochloride | ESD-844015-250MG |
Cas.: 3685-23-2 | Purity: 97% | cis-4-Aminocyclohexanecarboxylic acid | ESD-844016-250MG |
Cas.: 28314-82-1 | Purity: 97% | 4-Bromo-2,5-difluorobenzoic acid | ESD-844017-250MG |
Cas.: 29124-56-9 | Purity: 98% | 1-(2-Amino-5-bromophenyl)ethanone | ESD-844018-250MG |
Cas.: 824-80-6 | Purity: 95% | Sodium 4-fluorobenzenesulfinate | ESD-844019-1G |
Cas.: 625120-81-2 | Purity: 97% | 3-(Methyl(pentyl)amino)propanoic acid hydrochloride | ESD-844020-1G |
Cas.: 185629-32-7 | Purity: 98% | Methyl 4-amino-3-fluorobenzoate | ESD-844021-1G |
Cas.: 28697-07-6 | Purity: 97% | N-Cbz-2-Piperidinecarboxylic acid | ESD-844022-5G |
Cas.: 71026-66-9 | Purity: 98% | tert-Butyl (4-aminophenyl)carbamate | ESD-844023-1G |
Cas.: 137862-53-4 | Purity: 95% | Valsartan | ESD-844024-5G |
Cas.: 1926-80-3 | Purity: 98% | Methyl 6-aminohexanoate hydrochloride | ESD-844025-1G |
Cas.: 4337-33-1 | Purity: 97% | (2-Carboxyethyl)dimethylsulfonium chloride | ESD-844026-10G |
Cas.: 50846-36-1 | Purity: 95% | 2-Amino-2-methylpropanenitrile hydrochloride | ESD-844028-5G |
Cas.: 7699-00-5 | Purity: 98% | (R)-Ethyl 2-hydroxypropanoate | ESD-844029-1G |
Cas.: 304675-74-9 | Purity: 98% | Sodium 4-vinylbenzenesulfonate hydrate | ESD-844030-10G |
Cas.: 5382-17-2 | Purity: 97% | Piperidin-4-ol hydrochloride | ESD-844031-1G |
Cas.: 578-22-3 | Purity: 98% | 5-Hydroxy-2-methylbenzoic acid | ESD-844032-1G |
Cas.: 14205-46-0 | Purity: 95% | Isopropyl 3-aminobut-2-enoate | ESD-844033-10G |
Cas.: 24476-55-9 | Purity: 95% | 4-Phenyl-1-(p-tolylsulphonyl)piperidine-4-carbonitrile | ESD-844034-1G |
Cas.: 17852-67-4 | Purity: 95% | (4-(Methylsulfonyl)phenyl)hydrazine hydrochloride | ESD-844035-1G |
Cas.: 15028-40-7 | Purity: 98% | H-DL-Phg-Ome.HCl | ESD-844036-1G |
Cas.: 6091-44-7 | Purity: 98% | Piperidine hydrochloride | ESD-844037-10G |
Cas.: 79660-46-1 | Purity: 95% | Ethyl 6,7,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate | ESD-844038-1G |
Cas.: 5321-63-1 | Purity: 97% | 1-Benzylpiperazine dihydrochloride | ESD-844039-10G |
Cas.: 27527-05-5 | Purity: 98% | H-Cha-OH | ESD-844040-1G |
Cas.: 1150271-23-0 | Purity: 97% | tert-Butyl 4-bromo-1H-pyrazole-1-carboxylate | ESD-844041-1G |
Cas.: 56962-04-0 | Purity: 95% | 3-Bromo-5-chlorophenol | ESD-844042-1G |
Cas.: 82560-12-1 | Purity: 97% | 3-Amino-5-tert-butylpyrazole | ESD-844043-5G |
Cas.: 17282-03-0 | Purity: 97% | 3-Bromo-2-chloro-5-methylpyridine | ESD-844044-1G |
Cas.: 34667-88-4 | Purity: 98% | 2-Fluoro-4-nitrobenzonitrile | ESD-844045-1G |
Cas.: 98045-03-5 | Purity: 97% | Boc-Asp-OMe | ESD-844047-1G |
Cas.: 6188-25-6 | Purity: 95% | 6-Chloroimidazo[1,2-a]pyridine | ESD-844048-1G |
Cas.: 6100-74-9 | Purity: 98% | 3′-Hydroxy-4′-methoxyacetophenone | ESD-844049-1G |
Cas.: 94158-14-2 | Purity: 95% | 2-(Benzo[d][1,3]dioxol-5-ylamino)ethanol hydrochloride | ESD-844050-1G |
Cas.: 18342-98-8 | Purity: 95% | Ethyl 2-(pyridin-3-yloxy)acetate | ESD-844051-1G |
Cas.: 7492-55-9 | Purity: 97% | Calcium (2E,4E)-hexa-2,4-dienoate | ESD-844052-10G |
Cas.: 1204396-41-7 | Purity: 95% | 5-Amino-1H-pyrazole-4-carbonitrile | ESD-844053-10G |
Cas.: 89-58-7 | Purity: 97% | 1,4-Dimethyl-2-nitrobenzene | ESD-844054-10G |
Cas.: 58656-98-7 | Purity: 98% | tert-Butyl 4-fluorobenzoate | ESD-844057-1G |
Cas.: 71999-74-1 | Purity: 98% | N-Boc-2-chloroethylamine | ESD-844058-1G |
Cas.: 105258-93-3 | Purity: 97% | Benzyl 3-oxoazetidine-1-carboxylate | ESD-844059-1G |
Cas.: 52234-82-9 | Purity: 95% | 2-(((3-(Aziridin-1-yl)propanoyl)oxy)methyl)-2-ethylpropane-1,3-diyl bis(3-(aziridin-1-yl)propanoate) | ESD-844060-1G |
Cas.: 100342-30-1 | Purity: 95% | N-tert-Butyl-2-thiophenesulfonamide | ESD-844061-1G |
Cas.: 1141-23-7 | Purity: 95% | 5-Amino-3-(4-chlorophenyl)-5-oxopentanoic acid | ESD-844062-1G |
Cas.: 200295-57-4 | Purity: 97% | 4-Nitrobenzene-1,3-diamine sulfate | ESD-844063-1G |
Cas.: 40291-26-7 | Purity: 97% | Z-Pyr-Osu | ESD-844064-1G |
Cas.: 57883-28-0 | Purity: 97% | 1-Ethyl-7-nitro-1,2,3,4-tetrahydroquinoline | ESD-844065-1G |
Cas.: 54571-66-3 | Purity: 97% | Methyl DL-pyroglutamate | ESD-844066-1G |
Cas.: 1588441-34-2 | Purity: 98% | 4-Methylbenzenesulfinic acid hydrate | ESD-844067-1G |
Cas.: 65737-59-9 | Purity: 97% | Pyridin-4-ylmethanol hydrobromide | ESD-844068-1G |
Cas.: 169253-31-0 | Purity: 97% | 2-Hydroxyisonicotinic acid | ESD-844070-1G |
Cas.: 247584-10-7 | Purity: 97% | 4-Amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide hydrochloride | ESD-844071-1G |
Cas.: 57675-44-2 | Purity: 98% | Trimethylolpropane trioleate | ESD-844072-10G |
Cas.: 6636-55-1 | Purity: 98% | Methyl 6-chloropicolinate | ESD-844073-1G |
Cas.: 1588441-01-3 | Purity: 95% | 3-Chloro-6-hydrazinylpyridazine hydrate | ESD-844074-1G |
Cas.: 623-69-8 | Purity: 98% | 1,3-Dimethoxypropan-2-ol | ESD-844075-1G |
Cas.: 473596-07-5 | Purity: 97% | 3,5-Dibromo-2-fluoropyridine | ESD-844076-1G |
Cas.: 71258-18-9 | Purity: 98% | 1-Benzyl-4-phenylpiperidine-4-carbonitrile hydrochloride | ESD-844077-10G |
Cas.: 4561-10-8 | Purity: 97% | H-Glu(OBzl)-OBzl.HCl | ESD-844078-1G |
Cas.: 850140-73-7 | Purity: 98% | Afatinib Dimaleate | ESD-844079-25MG |
Cas.: 1268524-70-4 | Purity: 98% | (+)-JQ-1 | ESD-844080-10MG |
Cas.: 867130-83-4 | Purity: 97% | 4-Amino-6-chloro-2-phenylpyridazin-3(2H)-one | ESD-844081-25MG |
Cas.: 80537-07-1 | Purity: 97% | 2-Phenylpyrazolo[1,5-a]pyridine-3-carboxylic acid | ESD-844082-25MG |
Cas.: 1624262-44-7 | Purity: 95% | 3-(5-Bromo-2-chloropyrimidin-4-yl)-1-(phenylsulfonyl)-1H-indole | ESD-844083-25MG |
Cas.: 3598-37-6 | Purity: 97% | Acepromazine maleate | ESD-844084-25MG |
Cas.: 1260850-75-6 | Purity: 98% | 1-(6-Chloropyrimidin-4-yl)-1H-1,2,4-triazol-3-amine | ESD-844085-25MG |
Cas.: 1432571-98-6 | Purity: 97% | 4,4,5,5-Tetramethyl-2-(4-(1,1,1-trifluoro-2-methylpropan-2-yl)phenyl)-1,3,2-dioxaborolane | ESD-844086-25MG |
Cas.: 1820580-79-7 | Purity: 95% | (2S,5S)-2,5-Dimethylmorpholine hydrochloride | ESD-844087-25MG |
Cas.: 165963-71-3 | Purity: 97% | tert-Butyl (2-(2-(2-bromoethoxy)ethoxy)ethyl)carbamate | ESD-844088-25MG |
Cas.: 946497-94-5 | Purity: 95% | tert-Butyl 4-cyano-2,2-dimethyl-3-oxopyrrolidine-1-carboxylate | ESD-844089-25MG |
Cas.: 494767-29-2 | Purity: 98% | 4-Chloro-2,3-dihydro-1H-pyrrolo[3,2-c]pyridine | ESD-844090-25MG |
Cas.: 886047-13-8 | Purity: 95% | 3-Amino-5-chloro-N-cyclopropyl-6-methoxy-4-methylthieno[2,3-b]pyridine-2-carboxamide | ESD-844091-25MG |
Cas.: 1100243-35-3 | Purity: 97% | 4,9-Dibromo-2,7-bis(2-octyldodecyl)benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetraone | ESD-844092-25MG |
Cas.: 1143502-75-3 | Purity: 97% | 5-Bromo-1,2-difluoro-3-methylbenzene | ESD-844093-25MG |
Cas.: 1086064-46-1 | Purity: 95% | 6-Bromo-1-methyl-1H-pyrrolo[3,2-b]pyridine | ESD-844094-25MG |
Cas.: 178393-14-1 | Purity: 97% | 5-Methoxy-1H-pyrrolo[3,2-b]pyridin-2(3H)-one | ESD-844095-25MG |
Cas.: 1346597-89-4 | Purity: 98% | 2-(4-Cyano-1H-indol-3-yl)acetic acid | ESD-844096-25MG |
Cas.: 1221818-81-0 | Purity: 95% | 7-(tert-Butoxycarbonyl)-7-azabicyclo[2.2.1]heptane-2-carboxylic acid | ESD-844097-25MG |
Cas.: 1665288-66-3 | Purity: 95% | 6-Fluorobenzo[d]thiazol-4-ol | ESD-844098-25MG |
Cas.: 92409-34-2 | Purity: 96% | 1-(4-Hydroxy-3,5-dimethoxyphenyl)-2-(2-methoxyphenoxy)propane-1,3-diol | ESD-844099-25MG |
Cas.: 1260088-72-9 | Purity: 98% | 2,4-Dichloro-7,7-dimethyl-5,7-dihydrofuro[3,4-d]pyrimidine | ESD-844100-25MG |
Cas.: 210345-86-1 | Purity: 97% | (R)-2-(Aminomethyl)-3-methylbutanoic acid | ESD-844101-25MG |
Cas.: 1403766-73-3 | Purity: 95% | 3-Methyl-[1,3′-biazetidin]-3-ol dihydrochloride | ESD-844102-25MG |
Cas.: 1383481-11-5 | Purity: 98% | 7-Chloroimidazo[1,2-b]pyridazine | ESD-844103-25MG |
Cas.: 66999-64-2 | Purity: 98% | 3-Bromo-5-chloro-[1,2,4]triazolo[4,3-a]pyridine | ESD-844104-25MG |
Cas.: 617678-32-7 | Purity: 97% | 5-(Trifluoromethyl)-1H-imidazo[4,5-b]pyridine | ESD-844105-25MG |
Cas.: 1161362-35-1 | Purity: 97% | tert-Butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-benzo[b][1,4]oxazine-4(3H)-carboxylate | ESD-844106-25MG |
Cas.: 90271-39-9 | Purity: 95% | 2-Amino-2-(3-aminophenyl)acetic acid | ESD-844107-25MG |
Cas.: 115063-93-9 | Purity: 95% | Thieno[3,2-b]pyridin-6-ol | ESD-844108-25MG |
Cas.: 672883-63-5 | Purity: 97% | (S)-4-Aminopyrrolidin-2-one hydrochloride | ESD-844109-25MG |
Cas.: 1523571-08-5 | Purity: 95% | tert-Butyl 2,6-diazaspiro[3.5]nonane-2-carboxylate oxalate(2:1) | ESD-844110-25MG |
Cas.: 1256353-14-6 | Purity: 98% | 6-Benzyl-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-2-amine | ESD-844111-25MG |
Cas.: 1131594-78-9 | Purity: 95% | tert-Butyl (1-(pipidin-3-yl)azetidin-3-yl)carbamate | ESD-844112-25MG |
Cas.: 1352709-57-9 | Purity: 95% | (S)-2-(Morpholin-2-yl)acetic acid hydrochloride | ESD-844113-25MG |
Cas.: 1625682-44-1 | Purity: 95% | (1R,3R)-3-Aminocyclopentanecarboxylic acid hydrochloride | ESD-844114-25MG |
Cas.: 377727-87-2 | Purity: 98% | Preladenant | ESD-844115-25MG |
Cas.: 1273562-98-3 | Purity: 95% | 3-(Oxetan-3-yl)azetidine | ESD-844116-25MG |
Cas.: 1292369-18-6 | Purity: 95% | 6-Aminoazepan-2-one hydrochloride | ESD-844117-25MG |
Cas.: 1131594-80-3 | Purity: 95% | tert-Butyl ((1-(pipidin-3-yl)azetidin-3-yl)methyl)carbamate | ESD-844118-25MG |
Cas.: 1207839-91-5 | Purity: 95% | 6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbaldehyde | ESD-844119-25MG |
Cas.: 63155-10-2 | Purity: 95% | Ethyl 2-(4,6-dichloropyrimidin-2-yl)acetate | ESD-844120-25MG |
Cas.: 1588441-29-5 | Purity: 97% | 3-(tert-Butyl)-4-methyl-1H-pyrazole | ESD-844121-25MG |
Cas.: 1312610-07-3 | Purity: 98% | Ethyl 7-bromobenzo[d][1,3]dioxole-4-carboxylate | ESD-844123-25MG |
Cas.: 1523571-18-7 | Purity: 95% | tert-Butyl 3,6-diazabicyclo[3.2.1]octane-6-carboxylate hydrochloride | ESD-844124-25MG |
Cas.: 1283718-31-9 | Purity: 97% | Methyl 2-(trifluoromethyl)-1,2,3,4-tetrahydroquinoline-6-carboxylate | ESD-844125-25MG |
Cas.: 1416437-27-8 | Purity: 97% | 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[1,5-a]pyrimidine | ESD-844126-25MG |
Cas.: 945244-28-0 | Purity: 98% | 3-Bromo-4-(3-methyloxetan-3-yl)aniline | ESD-844127-25MG |
Cas.: 195981-08-9 | Purity: 97% | (R)-1-((1H-Imidazol-4-yl)methyl)-3-benzyl-4-(thiophen-2-ylsulfonyl)-2,3,4,5-tetrahydro-1H-benzo[e][ 1,4]diazepine-7-carbonitrile hydrochloride | ESD-844128-25MG |
Cas.: 1352625-30-9 | Purity: 98% | 3-Bromo-6-fluoropyrazolo[1,5-a]pyridine | ESD-844129-25MG |
Cas.: 1072874-79-3 | Purity: 95% | (5-(4-Chlorophenyl)-3H-[1,2,3]triazolo[4,5-b]pyridin-3-yl)(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)methanone | ESD-844130-25MG |
Cas.: 1802489-63-9 | Purity: 98% | Methyl 6-fluoropyrazolo[1,5-a]pyridine-3-carboxylate | ESD-844131-25MG |
Cas.: 105784-61-0 | Purity: 97% | Temafloxacin hydrochloride | ESD-844132-25MG |
Cas.: 478827-33-7 | Purity: 97% | 5-(Piperazin-1-yl)-1H-indazole | ESD-844133-25MG |
Cas.: 909698-11-9 | Purity: 95% | Dibutyl (2-(trifluoromethyl)cyclopropyl)boronate | ESD-844134-25MG |
Cas.: 1200461-84-2 | Purity: 97% | 7H-Pyrrolo[2,3-d]pyrimidine-5-methanol, 4-chloro-7-[2-deoxy-3,5-bis-O-[(1,1-dimethylethyl)dimethylsilyl]-beta-D- erythro-pentofuranosyl]-2-[[(1,1-dimethylethyl)dimethylsilyl]amino]- | ESD-844135-25MG |
Cas.: 508186-14-9 | Purity: 96% | 1-(2,3-Di(thiophen-2-yl)quinoxalin-6-yl)-3-(2-methoxyethyl)urea | ESD-844136-25MG |
Cas.: 1403864-74-3 | Purity: 97% | 4-Aminobicyclo[2.2.2]octan-1-ol hydrochloride | ESD-844137-25MG |
Cas.: 172922-91-7 | Purity: 98% | FICZ | ESD-844138-25MG |
Cas.: 34381-68-5 | Purity: 98% | Acebutolol hydrochloride | ESD-844139-250MG |
Cas.: 34381-68-5 | Purity: 98% | Acebutolol hydrochloride | ESD-844139-1G |
Cas.: 32780-64-6 | Purity: 98% | Labelalol hydrochloride | ESD-844140-250MG |
Cas.: 32780-64-6 | Purity: 98% | Labelalol hydrochloride | ESD-844140-1G |
Cas.: 914347-91-4 | Purity: 98% | Ethyl 3-fluoro-4-nitrobenzoate | ESD-844141-250MG |
Cas.: 914347-91-4 | Purity: 98% | Ethyl 3-fluoro-4-nitrobenzoate | ESD-844141-1G |
Cas.: 1197193-30-8 | Purity: 98% | Ethyl 5-bromopyrimidine-2-carboxylate | ESD-844142-50MG |
Cas.: 1197193-30-8 | Purity: 98% | Ethyl 5-bromopyrimidine-2-carboxylate | ESD-844142-250MG |
Cas.: 1520-70-3 | Purity: 97% | Ethanesulfonamide | ESD-844143-1G |
Cas.: 1520-70-3 | Purity: 97% | Ethanesulfonamide | ESD-844143-5G |
Cas.: 68104-62-1 | Purity: 97% | 1-(4-Bromophenyl)piperazine hydrochloride | ESD-844144-250MG |
Cas.: 68104-62-1 | Purity: 97% | 1-(4-Bromophenyl)piperazine hydrochloride | ESD-844144-1G |
Cas.: 63857-00-1 | Purity: 95% | N-((2-Chloro-3-((phenylimino)methyl)cyclohex-2-en-1-ylidene)methyl)aniline hydrochloride | ESD-844145-250MG |
Cas.: 63857-00-1 | Purity: 95% | N-((2-Chloro-3-((phenylimino)methyl)cyclohex-2-en-1-ylidene)methyl)aniline hydrochloride | ESD-844145-1G |
Cas.: 487-21-8 | Purity: 98% | 2,4-Pteridinediol | ESD-844146-250MG |
Cas.: 487-21-8 | Purity: 98% | 2,4-Pteridinediol | ESD-844146-1G |
Cas.: 67123-97-1 | Purity: 98% | 1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid | ESD-844147-250MG |
Cas.: 67123-97-1 | Purity: 98% | 1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid | ESD-844147-1G |
Cas.: 18092-54-1 | Purity: 95% | 4-Methoxy-2-nitrobenzenesulfonyl chloride | ESD-844148-250MG |
Cas.: 18092-54-1 | Purity: 95% | 4-Methoxy-2-nitrobenzenesulfonyl chloride | ESD-844148-1G |
Cas.: 73724-40-0 | Purity: 97% | Fmoc-Ala-OSu | ESD-844149-250MG |
Cas.: 73724-40-0 | Purity: 97% | Fmoc-Ala-OSu | ESD-844149-1G |
Cas.: 439290-35-4 | Purity: 95% | (2S,4S)-1-((9H-Fluoren-9-yl)methyl) 2-benzyl 4-hydroxypyrrolidine-1,2-dicarboxylate | ESD-844150-250MG |
Cas.: 439290-35-4 | Purity: 95% | (2S,4S)-1-((9H-Fluoren-9-yl)methyl) 2-benzyl 4-hydroxypyrrolidine-1,2-dicarboxylate | ESD-844150-1G |
Cas.: 784130-66-1 | Purity: 97% | 4-(4-Ethylpiperazin-1-yl)benzoic acid | ESD-844151-250MG |
Cas.: 784130-66-1 | Purity: 97% | 4-(4-Ethylpiperazin-1-yl)benzoic acid | ESD-844151-1G |
Cas.: 65435-04-3 | Purity: 98% | 5-(2-Chloroacetyl)indolin-2-one | ESD-844152-250MG |
Cas.: 65435-04-3 | Purity: 98% | 5-(2-Chloroacetyl)indolin-2-one | ESD-844152-1G |
Cas.: 134002-26-9 | Purity: 97% | (S)-2,2-Diphenyl-2-(pyrrolidin-3-yl)acetamide (2R,3R)-2,3-dihydroxysuccinate | ESD-844153-250MG |
Cas.: 134002-26-9 | Purity: 97% | (S)-2,2-Diphenyl-2-(pyrrolidin-3-yl)acetamide (2R,3R)-2,3-dihydroxysuccinate | ESD-844153-1G |
Cas.: 6525-45-7 | Purity: 95% | Ethyl 2-cyanobenzoate | ESD-844154-250MG |
Cas.: 6525-45-7 | Purity: 95% | Ethyl 2-cyanobenzoate | ESD-844154-1G |
Cas.: 23429-44-9 | Purity: 98% | (Chloro(p-tolyl)methylene)dibenzene | ESD-844155-1G |
Cas.: 23429-44-9 | Purity: 98% | (Chloro(p-tolyl)methylene)dibenzene | ESD-844155-5G |
Cas.: 34381-71-0 | Purity: 97% | (S)-(-)-1-Methyl-2-pyrrolidinemethanol | ESD-844156-1G |
Cas.: 34381-71-0 | Purity: 97% | (S)-(-)-1-Methyl-2-pyrrolidinemethanol | ESD-844156-5G |
Cas.: 864377-33-3 | Purity: 97% | (3-(9H-Carbazol-9-yl)phenyl)boronic acid | ESD-844157-250MG |
Cas.: 864377-33-3 | Purity: 97% | (3-(9H-Carbazol-9-yl)phenyl)boronic acid | ESD-844157-1G |
Cas.: 774-47-0 | Purity: 98% | 5,6-Difluoroindoline-2,3-dione | ESD-844158-250MG |
Cas.: 774-47-0 | Purity: 98% | 5,6-Difluoroindoline-2,3-dione | ESD-844158-1G |
Cas.: 874801-46-4 | Purity: 98% | 4-Bromo-3-chlorobenzene-1-sulfonyl chloride | ESD-844159-250MG |
Cas.: 874801-46-4 | Purity: 98% | 4-Bromo-3-chlorobenzene-1-sulfonyl chloride | ESD-844159-1G |
Cas.: 22952-24-5 | Purity: 97% | 6-Nitrobenzo[d]isothiazol-3(2H)-one 1,1-dioxide | ESD-844160-1G |
Cas.: 22952-24-5 | Purity: 97% | 6-Nitrobenzo[d]isothiazol-3(2H)-one 1,1-dioxide | ESD-844160-5G |
Cas.: 7150-55-2 | Purity: 96% | 4-Chloro-1-(4-hydroxyphenyl)butan-1-one | ESD-844161-250MG |
Cas.: 7150-55-2 | Purity: 96% | 4-Chloro-1-(4-hydroxyphenyl)butan-1-one | ESD-844161-1G |
Cas.: 274-79-3 | Purity: 97% | Imidazo[1,2-a]pyrazine | ESD-844162-250MG |
Cas.: 274-79-3 | Purity: 97% | Imidazo[1,2-a]pyrazine | ESD-844162-1G |
Cas.: 64690-19-3 | Purity: 98% | 4-(Octylamino)pyridine | ESD-844163-250MG |
Cas.: 64690-19-3 | Purity: 98% | 4-(Octylamino)pyridine | ESD-844163-1G |
Cas.: 104-11-0 | Purity: 97% | 1-(4-Chlorophenyl)-N-methylmethanamine | ESD-844164-250MG |
Cas.: 104-11-0 | Purity: 97% | 1-(4-Chlorophenyl)-N-methylmethanamine | ESD-844164-1G |
Cas.: 824-39-5 | Purity: 97% | Sodium 2-nitrophenolate | ESD-844165-5G |
Cas.: 824-39-5 | Purity: 97% | Sodium 2-nitrophenolate | ESD-844165-25G |
Cas.: 65938-77-4 | Purity: 97% | 5-Methyl-2-pyridinesulfonamide | ESD-844167-250MG |
Cas.: 65938-77-4 | Purity: 97% | 5-Methyl-2-pyridinesulfonamide | ESD-844167-1G |
Cas.: 161234-80-6 | Purity: 98% | H-Orn(Z)-OtBu.HCl | ESD-844168-250MG |
Cas.: 161234-80-6 | Purity: 98% | H-Orn(Z)-OtBu.HCl | ESD-844168-1G |
Cas.: 5305-45-3 | Purity: 99% | 4,6-Dichloropyrimidine-5-carbonitrile | ESD-844169-250MG |
Cas.: 5305-45-3 | Purity: 99% | 4,6-Dichloropyrimidine-5-carbonitrile | ESD-844169-1G |
Cas.: 159603-42-6 | Purity: 95% | 1-Benzhydrylazetidin-3-amine hydrochloride | ESD-844170-250MG |
Cas.: 159603-42-6 | Purity: 95% | 1-Benzhydrylazetidin-3-amine hydrochloride | ESD-844170-1G |
Cas.: 37169-36-1 | Purity: 97% | (S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-(3,4-dihydroxyphenyl)propanoate | ESD-844171-250MG |
Cas.: 37169-36-1 | Purity: 97% | (S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-(3,4-dihydroxyphenyl)propanoate | ESD-844171-1G |
Cas.: 20577-27-9 | Purity: 97% | 3-Cyano-2-hydroxypyridine | ESD-844172-1G |
Cas.: 20577-27-9 | Purity: 97% | 3-Cyano-2-hydroxypyridine | ESD-844172-5G |
Cas.: 64700-65-8 | Purity: 97% | (R)-Methyl 5-oxopyrrolidine-2-carboxylate | ESD-844173-250MG |
Cas.: 64700-65-8 | Purity: 97% | (R)-Methyl 5-oxopyrrolidine-2-carboxylate | ESD-844173-1G |
Cas.: 261723-33-5 | Purity: 98% | (2-Bromo-6-fluorophenyl)methanol | ESD-844174-250MG |
Cas.: 261723-33-5 | Purity: 98% | (2-Bromo-6-fluorophenyl)methanol | ESD-844174-1G |
Cas.: 13734-31-1 | Purity: 97% | 2-((tert-Butoxycarbonyl)(methyl)amino)propanoic acid | ESD-844175-250MG |
Cas.: 13734-31-1 | Purity: 97% | 2-((tert-Butoxycarbonyl)(methyl)amino)propanoic acid | ESD-844175-1G |
Cas.: 99-29-6 | Purity: 95% | 2-Bromo-6-chloro-4-nitroaniline | ESD-844176-5G |
Cas.: 99-29-6 | Purity: 95% | 2-Bromo-6-chloro-4-nitroaniline | ESD-844176-25G |
Cas.: 19999-64-5 | Purity: 97% | 1-Methylpiperidine-3-carboxylic acid hydrochloride | ESD-844177-250MG |
Cas.: 19999-64-5 | Purity: 97% | 1-Methylpiperidine-3-carboxylic acid hydrochloride | ESD-844177-1G |
Cas.: 74283-34-4 | Purity: 95% | 2,4-Diaminophenol sulfate | ESD-844178-250MG |
Cas.: 74283-34-4 | Purity: 95% | 2,4-Diaminophenol sulfate | ESD-844178-1G |
Cas.: 71757-14-7 | Purity: 95% | 2,4-Dibromo-6-(trifluoromethyl)aniline | ESD-844179-1G |
Cas.: 71757-14-7 | Purity: 95% | 2,4-Dibromo-6-(trifluoromethyl)aniline | ESD-844179-5G |
Cas.: 2150-42-7 | Purity: 95% | Methyl 2,3-dimethoxybenzoate | ESD-844180-250MG |
Cas.: 2150-42-7 | Purity: 95% | Methyl 2,3-dimethoxybenzoate | ESD-844180-1G |
Cas.: 54322-20-2 | Purity: 97% | Sodium 4-chloro-1-hydroxybutane-1-sulfonate | ESD-844181-250MG |
Cas.: 54322-20-2 | Purity: 97% | Sodium 4-chloro-1-hydroxybutane-1-sulfonate | ESD-844181-1G |
Cas.: 3731-16-6 | Purity: 95% | 3-Carbethoxy-2-piperidone | ESD-844182-250MG |
Cas.: 3731-16-6 | Purity: 95% | 3-Carbethoxy-2-piperidone | ESD-844182-1G |
Cas.: 41295-98-1 | Purity: 99.5%, GC | Sodium 4-amino-2,5-dichlorobenzenesulfonate | ESD-844183-250MG |
Cas.: 41295-98-1 | Purity: 99.5%, GC | Sodium 4-amino-2,5-dichlorobenzenesulfonate | ESD-844183-1G |
Cas.: 55981-09-4 | Purity: 98% | Nitazoxanide | ESD-844184-1G |
Cas.: 55981-09-4 | Purity: 98% | Nitazoxanide | ESD-844184-10G |
Cas.: 137-09-7 | Purity: 98% | 2,4-Diaminophenol dihydrochloride | ESD-844185-1G |
Cas.: 137-09-7 | Purity: 98% | 2,4-Diaminophenol dihydrochloride | ESD-844185-5G |
Cas.: 112641-20-0 | Purity: ≥98% | 2-Fluoro-3-(trifluoromethyl)benzaldehyde | ESD-844186-250MG |
Cas.: 112641-20-0 | Purity: ≥98% | 2-Fluoro-3-(trifluoromethyl)benzaldehyde | ESD-844186-1G |
Cas.: 96-75-3 | Purity: 95% | 2-Amino-5-nitrobenzenesulfonic acid | ESD-844187-1G |
Cas.: 96-75-3 | Purity: 95% | 2-Amino-5-nitrobenzenesulfonic acid | ESD-844187-10G |
Cas.: 161045-79-0 | Purity: 97% | 4-Bromo-2-chloro-6-fluorophenol | ESD-844188-250MG |
Cas.: 161045-79-0 | Purity: 97% | 4-Bromo-2-chloro-6-fluorophenol | ESD-844188-1G |
Cas.: 73792-12-8 | Purity: 97% | Ethyl 4-amino-3-fluorobenzoate | ESD-844189-250MG |
Cas.: 73792-12-8 | Purity: 97% | Ethyl 4-amino-3-fluorobenzoate | ESD-844189-1G |
Cas.: 87808-48-8 | Purity: 95% | Methyl 3-fluoro-4-methylbenzoate | ESD-844190-250MG |
Cas.: 87808-48-8 | Purity: 95% | Methyl 3-fluoro-4-methylbenzoate | ESD-844190-1G |
Cas.: 213475-52-6 | Purity: 95% | H-Chg-OtBu.HCl | ESD-844191-250MG |
Cas.: 213475-52-6 | Purity: 95% | H-Chg-OtBu.HCl | ESD-844191-1G |
Cas.: 89976-27-2 | Purity: 98% | Methyl 4-iodo-3-nitrobenzoate | ESD-844192-250MG |
Cas.: 89976-27-2 | Purity: 98% | Methyl 4-iodo-3-nitrobenzoate | ESD-844192-1G |
Cas.: 1673-47-8 | Purity: 98% | 3-Chlorobenzhydrazide | ESD-844193-250MG |
Cas.: 1673-47-8 | Purity: 98% | 3-Chlorobenzhydrazide | ESD-844193-1G |
Cas.: 219715-62-5 | Purity: 98% | 5,8-Dimethoxy-[1,2,4]triazolo[1,5-c]pyrimidin-2-amine | ESD-844194-250MG |
Cas.: 219715-62-5 | Purity: 98% | 5,8-Dimethoxy-[1,2,4]triazolo[1,5-c]pyrimidin-2-amine | ESD-844194-1G |
Cas.: 27069-16-5 | Purity: 95% | 5-(4-Methoxyphenyl)-1H-pyrazole-3-carboxylic acid | ESD-844195-250MG |
Cas.: 27069-16-5 | Purity: 95% | 5-(4-Methoxyphenyl)-1H-pyrazole-3-carboxylic acid | ESD-844195-1G |
Cas.: 98593-51-2 | Purity: 98% | 4-Methanesulfonylbenzylamine hydrochloride | ESD-844196-250MG |
Cas.: 98593-51-2 | Purity: 98% | 4-Methanesulfonylbenzylamine hydrochloride | ESD-844196-1G |
Cas.: 42365-62-8 | Purity: 95% | (3,5-Bis(trifluoromethyl)phenyl)methanamine hydrochloride | ESD-844197-250MG |
Cas.: 42365-62-8 | Purity: 95% | (3,5-Bis(trifluoromethyl)phenyl)methanamine hydrochloride | ESD-844197-1G |
Cas.: 832-66-6 | Purity: 95% | 1,3,7,8-Tetramethylxanthine | ESD-844198-250MG |
Cas.: 832-66-6 | Purity: 95% | 1,3,7,8-Tetramethylxanthine | ESD-844198-1G |
Cas.: 58640-01-0 | Purity: 98% | H-γ-Abu-OtBu.HCl | ESD-844199-250MG |
Cas.: 58640-01-0 | Purity: 98% | H-γ-Abu-OtBu.HCl | ESD-844199-1G |
Cas.: 201009-98-5 | Purity: 97% | (S)-Methyl 6-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-aminohexanoate hydrochloride | ESD-844200-250MG |
Cas.: 201009-98-5 | Purity: 97% | (S)-Methyl 6-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-aminohexanoate hydrochloride | ESD-844200-1G |
Cas.: 35309-35-4 | Purity: 95% | Methyl 5-oxopyrrolidine-3-carboxylate | ESD-844201-250MG |
Cas.: 35309-35-4 | Purity: 95% | Methyl 5-oxopyrrolidine-3-carboxylate | ESD-844201-1G |
Cas.: 1146954-88-2 | Purity: 95% | (R)-Ethyl 2-((tert-butoxycarbonyl)amino)-3-hydroxypropanoate | ESD-844202-250MG |
Cas.: 1146954-88-2 | Purity: 95% | (R)-Ethyl 2-((tert-butoxycarbonyl)amino)-3-hydroxypropanoate | ESD-844202-1G |
Cas.: 61367-07-5 | Purity: 97% | Methyl trans-4-aminocyclohexanecarboxylate hydrochloride | ESD-844203-250MG |
Cas.: 61367-07-5 | Purity: 97% | Methyl trans-4-aminocyclohexanecarboxylate hydrochloride | ESD-844203-1G |
Cas.: 694499-26-8 | Purity: 98% | 4-((4-Methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)aniline | ESD-844204-250MG |
Cas.: 694499-26-8 | Purity: 98% | 4-((4-Methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)aniline | ESD-844204-1G |
Cas.: 15317-58-5 | Purity: 97% | 1H-Indole-3-carbohydrazide | ESD-844205-250MG |
Cas.: 15317-58-5 | Purity: 97% | 1H-Indole-3-carbohydrazide | ESD-844205-1G |
Cas.: 17193-39-4 | Purity: 97% | (S)-Methyl 2-amino-3-cyclohexylpropanoate hydrochloride | ESD-844206-250MG |
Cas.: 17193-39-4 | Purity: 97% | (S)-Methyl 2-amino-3-cyclohexylpropanoate hydrochloride | ESD-844206-1G |
Cas.: 1174865-69-0 | Purity: 97% | 2-(3,4-Dihydroxyphenyl)-3,7-dihydroxy-4H-chromen-4-one hydrate | ESD-844207-250MG |
Cas.: 1174865-69-0 | Purity: 97% | 2-(3,4-Dihydroxyphenyl)-3,7-dihydroxy-4H-chromen-4-one hydrate | ESD-844207-1G |
Cas.: 200122-49-2 | Purity: 95% | Boc-D-Arg(Mtr)-OH | ESD-844208-250MG |
Cas.: 200122-49-2 | Purity: 95% | Boc-D-Arg(Mtr)-OH | ESD-844208-1G |
Cas.: 145038-49-9 | Purity: 98% | Fmoc-Glu-OMe | ESD-844209-250MG |
Cas.: 145038-49-9 | Purity: 98% | Fmoc-Glu-OMe | ESD-844209-1G |
Cas.: 6952-89-2 | Purity: 97% | (4-Bromophenyl)(cyclopropyl)methanone | ESD-844210-250MG |
Cas.: 6952-89-2 | Purity: 97% | (4-Bromophenyl)(cyclopropyl)methanone | ESD-844210-1G |
Cas.: 66346-85-8 | Purity: 95% | 3-Chloro-6-pyrrolidin-1-yl-pyridazine | ESD-844211-250MG |
Cas.: 66346-85-8 | Purity: 95% | 3-Chloro-6-pyrrolidin-1-yl-pyridazine | ESD-844211-1G |
Cas.: 63837-11-6 | Purity: 97% | 5-Bromo-2-methylbenzothiazole | ESD-844212-250MG |
Cas.: 63837-11-6 | Purity: 97% | 5-Bromo-2-methylbenzothiazole | ESD-844212-1G |
Cas.: 34966-48-8 | Purity: 97% | Ethyl 2-(4-chlorophenyl)-2-oxoacetate | ESD-844213-250MG |
Cas.: 34966-48-8 | Purity: 97% | Ethyl 2-(4-chlorophenyl)-2-oxoacetate | ESD-844213-1G |
Cas.: 71233-25-5 | Purity: 98% | 1-tert-Butyl 4-ethyl 3-oxopiperidine-1,4-dicarboxylate | ESD-844214-250MG |
Cas.: 71233-25-5 | Purity: 98% | 1-tert-Butyl 4-ethyl 3-oxopiperidine-1,4-dicarboxylate | ESD-844214-1G |
Cas.: 69630-50-8 | Purity: 97% | HD-Asp(OMe)-OMe.HCl | ESD-844215-1G |
Cas.: 69630-50-8 | Purity: 97% | HD-Asp(OMe)-OMe.HCl | ESD-844215-5G |
Cas.: 6708-37-8 | Purity: 97% | 3a,4,7,7a-Tetrahydro-4,7-ethanoisobenzofuran-1,3-dione | ESD-844216-250MG |
Cas.: 6708-37-8 | Purity: 97% | 3a,4,7,7a-Tetrahydro-4,7-ethanoisobenzofuran-1,3-dione | ESD-844216-1G |
Cas.: 5391-39-9 | Purity: 97% | 1-Acetylimidazolidin-2-one | ESD-844218-250MG |
Cas.: 5391-39-9 | Purity: 97% | 1-Acetylimidazolidin-2-one | ESD-844218-1G |
Cas.: 70331-94-1 | Purity: 97% | (Oxalylbis(azanediyl))bis(ethane-2,1-diyl)bis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanoate) | ESD-844219-250MG |
Cas.: 70331-94-1 | Purity: 97% | (Oxalylbis(azanediyl))bis(ethane-2,1-diyl)bis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanoate) | ESD-844219-1G |
Cas.: 374564-34-8 | Purity: 98% | potassium (3-bromophenyl)trifluoroborate | ESD-844220-250MG |
Cas.: 374564-34-8 | Purity: 98% | potassium (3-bromophenyl)trifluoroborate | ESD-844220-1G |
Cas.: 25271-35-6 | Purity: 95% | 1-Methylpiperidine-2-carboxylic acid hydrochloride | ESD-844221-250MG |
Cas.: 25271-35-6 | Purity: 95% | 1-Methylpiperidine-2-carboxylic acid hydrochloride | ESD-844221-1G |
Cas.: 161357-89-7 | Purity: 97% | 1-(Methylsulfonyl)piperazine hydrochloride | ESD-844222-250MG |
Cas.: 161357-89-7 | Purity: 97% | 1-(Methylsulfonyl)piperazine hydrochloride | ESD-844222-1G |
Cas.: 55870-50-3 | Purity: 98% | Ammonium ((1S,3R,4R,7S)-3-bromo-1,7-dimethyl-2-oxobicyclo[2.2.1]heptan-7-yl)methanesulfonate | ESD-844223-250MG |
Cas.: 55870-50-3 | Purity: 98% | Ammonium ((1S,3R,4R,7S)-3-bromo-1,7-dimethyl-2-oxobicyclo[2.2.1]heptan-7-yl)methanesulfonate | ESD-844223-1G |
Cas.: 77214-82-5 | Purity: 98% | Iron(III) 4-methylbenzenesulfonate | ESD-844224-1G |
Cas.: 77214-82-5 | Purity: 98% | Iron(III) 4-methylbenzenesulfonate | ESD-844224-5G |
Cas.: 36276-24-1 | Purity: 98% | 3-Bromo-4-methylbenzaldehyde | ESD-844225-250MG |
Cas.: 36276-24-1 | Purity: 98% | 3-Bromo-4-methylbenzaldehyde | ESD-844225-1G |
Cas.: 903550-26-5 | Purity: 97% | 1-(Tetrahydro-2H-pyran-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-844227-1G |
Cas.: 903550-26-5 | Purity: 97% | 1-(Tetrahydro-2H-pyran-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-844227-5G |
Cas.: 3638-04-8 | Purity: 97% | 2,4-Dichloro-6-methoxy-1,3,5-triazine | ESD-844228-250MG |
Cas.: 3638-04-8 | Purity: 97% | 2,4-Dichloro-6-methoxy-1,3,5-triazine | ESD-844228-1G |
Cas.: 1330-80-9 | Purity: 95% | Oleic acid compound with propane-1,2-diol (1:1) | ESD-844229-1G |
Cas.: 1330-80-9 | Purity: 95% | Oleic acid compound with propane-1,2-diol (1:1) | ESD-844229-10G |
Cas.: 460-08-2 | Purity: 95% | 2-Fluoroethanamine hydrochloride | ESD-844230-250MG |
Cas.: 460-08-2 | Purity: 95% | 2-Fluoroethanamine hydrochloride | ESD-844230-1G |
Cas.: 1000339-94-5 | Purity: 98% | 3-Chloro-4-trifluoromethoxyphenol | ESD-844231-250MG |
Cas.: 1000339-94-5 | Purity: 98% | 3-Chloro-4-trifluoromethoxyphenol | ESD-844231-1G |
Cas.: 67367-26-4 | Purity: 97% | Methyl 2-methoxynicotinate | ESD-844232-1G |
Cas.: 67367-26-4 | Purity: 97% | Methyl 2-methoxynicotinate | ESD-844232-10G |
Cas.: 84192-88-1 | Purity: 98% | Ac-Glu(OtBu)-OH | ESD-844233-250MG |
Cas.: 84192-88-1 | Purity: 98% | Ac-Glu(OtBu)-OH | ESD-844233-1G |
Cas.: 86408-72-2 | Purity: 98% | Ecabet sodium | ESD-844234-250MG |
Cas.: 86408-72-2 | Purity: 98% | Ecabet sodium | ESD-844234-1G |
Cas.: 3994-50-1 | Purity: 98% | 1-Methyl-4-nitro-1H-pyrazole | ESD-844235-250MG |
Cas.: 3994-50-1 | Purity: 98% | 1-Methyl-4-nitro-1H-pyrazole | ESD-844235-1G |
Cas.: 119229-74-2 | Purity: 95% | 4-Chloro-3-fluoropyridine hydrochloride | ESD-844236-250MG |
Cas.: 119229-74-2 | Purity: 95% | 4-Chloro-3-fluoropyridine hydrochloride | ESD-844236-1G |
Cas.: 176694-36-3 | Purity: 98% | Methyl 4-fluoro-3-(trifluoromethyl)benzoate | ESD-844237-250MG |
Cas.: 176694-36-3 | Purity: 98% | Methyl 4-fluoro-3-(trifluoromethyl)benzoate | ESD-844237-1G |
Cas.: 75028-24-9 | Purity: 98% | (Z)-2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-(ethoxyimino)acetic acid | ESD-844239-250MG |
Cas.: 75028-24-9 | Purity: 98% | (Z)-2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-(ethoxyimino)acetic acid | ESD-844239-1G |
Cas.: 1613191-73-3 | Purity: 98% | Allyl 3,5-diamino-1H-pyrazole-4-carboxylate | ESD-844240-250MG |
Cas.: 1613191-73-3 | Purity: 98% | Allyl 3,5-diamino-1H-pyrazole-4-carboxylate | ESD-844240-1G |
Cas.: 1508261-86-6 | Purity: 95% | (S)-2-Methylpyrrolidine-2-carboxylic acid hydrochloride | ESD-844241-250MG |
Cas.: 1508261-86-6 | Purity: 95% | (S)-2-Methylpyrrolidine-2-carboxylic acid hydrochloride | ESD-844241-1G |
Cas.: 210471-09-3 | Purity: 95% | (R)-2-(((Benzyloxy)carbonyl)amino)-4-(tert-butoxy)-4-oxobutanoic acid hydrate | ESD-844242-250MG |
Cas.: 210471-09-3 | Purity: 95% | (R)-2-(((Benzyloxy)carbonyl)amino)-4-(tert-butoxy)-4-oxobutanoic acid hydrate | ESD-844242-1G |
Cas.: 70643-20-8 | Purity: 95% | 2-(2,4-Diaminophenoxy)ethanol sulfate | ESD-844243-1G |
Cas.: 70643-20-8 | Purity: 95% | 2-(2,4-Diaminophenoxy)ethanol sulfate | ESD-844243-5G |
Cas.: 62774-90-7 | Purity: 98% | 2,6-Dichloro-4-methylnicotinic acid | ESD-844244-250MG |
Cas.: 62774-90-7 | Purity: 98% | 2,6-Dichloro-4-methylnicotinic acid | ESD-844244-1G |
Cas.: 1074-38-0 | Purity: 98% | 5-Methyl-2-nitropyridine | ESD-844245-250MG |
Cas.: 1074-38-0 | Purity: 98% | 5-Methyl-2-nitropyridine | ESD-844245-1G |
Cas.: 1690-72-8 | Purity: 97% | Methyl 1-methylpiperidine-3-carboxylate | ESD-844247-1G |
Cas.: 1690-72-8 | Purity: 97% | Methyl 1-methylpiperidine-3-carboxylate | ESD-844247-5G |
Cas.: 332134-60-8 | Purity: 95% | 2-Bromo-6-morpholinopyridine | ESD-844248-250MG |
Cas.: 332134-60-8 | Purity: 95% | 2-Bromo-6-morpholinopyridine | ESD-844248-1G |
Cas.: 99-32-1 | Purity: 97% | 4-Oxo-4H-pyran-2,6-dicarboxylic acid | ESD-844249-250MG |
Cas.: 99-32-1 | Purity: 97% | 4-Oxo-4H-pyran-2,6-dicarboxylic acid | ESD-844249-1G |
Cas.: 3190-71-4 | Purity: 97% | (S)-Benzyl 3-(2,5-dioxooxazolidin-4-yl)propanoate | ESD-844250-250MG |
Cas.: 3190-71-4 | Purity: 97% | (S)-Benzyl 3-(2,5-dioxooxazolidin-4-yl)propanoate | ESD-844250-1G |
Cas.: 42933-07-3 | Purity: 97% | Methyl 3-bromo-2-oxo-2H-pyran-5-carboxylate | ESD-844251-50MG |
Cas.: 42933-07-3 | Purity: 97% | Methyl 3-bromo-2-oxo-2H-pyran-5-carboxylate | ESD-844251-250MG |
Cas.: 124623-36-5 | Purity: 95% | N1,N1-Dimethylbenzene-1,3-diamine hydrochloride | ESD-844252-50MG |
Cas.: 124623-36-5 | Purity: 95% | N1,N1-Dimethylbenzene-1,3-diamine hydrochloride | ESD-844252-250MG |
Cas.: 98027-36-2 | Purity: 97% | 3-Amino-5-chloropyridin-2(1H)-one | ESD-844253-250MG |
Cas.: 98027-36-2 | Purity: 97% | 3-Amino-5-chloropyridin-2(1H)-one | ESD-844253-1G |
Cas.: 1184936-21-7 | Purity: 95% | 1-(2-Amino-5-chlorophenyl)-2,2,2-trifluoroethanone hydrochloride hydrate | ESD-844254-5G |
Cas.: 1184936-21-7 | Purity: 95% | 1-(2-Amino-5-chlorophenyl)-2,2,2-trifluoroethanone hydrochloride hydrate | ESD-844254-25G |
Cas.: 172793-31-6 | Purity: 97% | (R)-Di-tert-butyl 2-aminopentanedioate hydrochloride | ESD-844255-250MG |
Cas.: 172793-31-6 | Purity: 97% | (R)-Di-tert-butyl 2-aminopentanedioate hydrochloride | ESD-844255-1G |
Cas.: 41056-90-0 | Purity: 98% | 3-Methylthiophene-2-carbaldehyde oxime | ESD-844256-250MG |
Cas.: 41056-90-0 | Purity: 98% | 3-Methylthiophene-2-carbaldehyde oxime | ESD-844256-1G |
Cas.: 56700-70-0 | Purity: 98% | tert-Butyl pyridin-3-ylcarbamate | ESD-844257-250MG |
Cas.: 56700-70-0 | Purity: 98% | tert-Butyl pyridin-3-ylcarbamate | ESD-844257-1G |
Cas.: 144599-95-1 | Purity: 97% | Boc-Trp(Boc)-OH | ESD-844258-250MG |
Cas.: 144599-95-1 | Purity: 97% | Boc-Trp(Boc)-OH | ESD-844258-1G |
Cas.: 108831-66-9 | Purity: 98% | 6-Methyl-3H-thieno[2,3-d]pyrimidin-4-one | ESD-844259-250MG |
Cas.: 108831-66-9 | Purity: 98% | 6-Methyl-3H-thieno[2,3-d]pyrimidin-4-one | ESD-844259-1G |
Cas.: 4532-25-6 | Purity: 97% | 7-Chloroimidazo[1,2-a]pyridine | ESD-844260-250MG |
Cas.: 4532-25-6 | Purity: 97% | 7-Chloroimidazo[1,2-a]pyridine | ESD-844260-1G |
Cas.: 942060-04-0 | Purity: 95% | 5-Methyl-3-(trifluoromethyl)-1H-pyrazole | ESD-844261-250MG |
Cas.: 942060-04-0 | Purity: 95% | 5-Methyl-3-(trifluoromethyl)-1H-pyrazole | ESD-844261-1G |
Cas.: 324-03-8 | Purity: 95% | 6-Fluoroindoline-2,3-dione | ESD-844262-250MG |
Cas.: 324-03-8 | Purity: 95% | 6-Fluoroindoline-2,3-dione | ESD-844262-1G |
Cas.: 172023-97-1 | Purity: 95% | (3-Bromo-5-(trifluoromethyl)phenyl)methanol | ESD-844263-250MG |
Cas.: 172023-97-1 | Purity: 95% | (3-Bromo-5-(trifluoromethyl)phenyl)methanol | ESD-844263-1G |
Cas.: 21047-89-2 | Purity: 98% | N-(6-Oxo-6,7-dihydro-1H-purin-2-yl)isobutyramide | ESD-844264-250MG |
Cas.: 21047-89-2 | Purity: 98% | N-(6-Oxo-6,7-dihydro-1H-purin-2-yl)isobutyramide | ESD-844264-1G |
Cas.: 32457-23-1 | Purity: 97% | (S)-2,3-Dihydro-1H-inden-1-amine hydrochloride | ESD-844265-250MG |
Cas.: 32457-23-1 | Purity: 97% | (S)-2,3-Dihydro-1H-inden-1-amine hydrochloride | ESD-844265-1G |
Cas.: 1810070-21-3 | Purity: 95% | (4-(4-Methylpiperazin-1-yl)phenyl)methanamine hydrochloride | ESD-844266-250MG |
Cas.: 1810070-21-3 | Purity: 95% | (4-(4-Methylpiperazin-1-yl)phenyl)methanamine hydrochloride | ESD-844266-1G |
Cas.: 198543-96-3 | Purity: 97% | Fmoc-D-Chg-OH | ESD-844267-250MG |
Cas.: 198543-96-3 | Purity: 97% | Fmoc-D-Chg-OH | ESD-844267-1G |
Cas.: 4985-92-6 | Purity: 98% | 5-Methylpicolinaldehyde | ESD-844268-250MG |
Cas.: 4985-92-6 | Purity: 98% | 5-Methylpicolinaldehyde | ESD-844268-1G |
Cas.: 625446-22-2 | Purity: 98% | 1-(4-Bromo-2-fluorophenyl)ethanone | ESD-844269-250MG |
Cas.: 625446-22-2 | Purity: 98% | 1-(4-Bromo-2-fluorophenyl)ethanone | ESD-844269-1G |
Cas.: 16369-21-4 | Purity: 98% | 2-(Propylamino)ethanol | ESD-844270-250MG |
Cas.: 16369-21-4 | Purity: 98% | 2-(Propylamino)ethanol | ESD-844270-1G |
Cas.: 175278-13-4 | Purity: 95% | 1,4-Dibromo-2-(trifluoromethoxy)benzene | ESD-844271-250MG |
Cas.: 175278-13-4 | Purity: 95% | 1,4-Dibromo-2-(trifluoromethoxy)benzene | ESD-844271-1G |
Cas.: 20197-92-6 | Purity: 97% | 6,7-Dimethoxy-1H-benzo[d][1,3]oxazine-2,4-dione | ESD-844272-250MG |
Cas.: 20197-92-6 | Purity: 97% | 6,7-Dimethoxy-1H-benzo[d][1,3]oxazine-2,4-dione | ESD-844272-1G |
Cas.: 240401-22-3 | Purity: 95% | Piperidine-4-carbonitrile hydrochloride | ESD-844273-250MG |
Cas.: 240401-22-3 | Purity: 95% | Piperidine-4-carbonitrile hydrochloride | ESD-844273-1G |
Cas.: 151257-01-1 | Purity: 98% | 2-Butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride | ESD-844274-1G |
Cas.: 151257-01-1 | Purity: 98% | 2-Butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride | ESD-844274-5G |
Cas.: 1214377-09-9 | Purity: 98% | 3,5-Difluoroisonicotinonitrile | ESD-844275-250MG |
Cas.: 1214377-09-9 | Purity: 98% | 3,5-Difluoroisonicotinonitrile | ESD-844275-1G |
Cas.: 1138444-17-3 | Purity: 97% | 6-Bromo-2-chloro-3-iodopyridine | ESD-844276-250MG |
Cas.: 1138444-17-3 | Purity: 97% | 6-Bromo-2-chloro-3-iodopyridine | ESD-844276-1G |
Cas.: 42843-94-7 | Purity: 97% | (3-Ethoxy-3-oxopropyl)triphenylphosphonium bromide | ESD-844277-250MG |
Cas.: 42843-94-7 | Purity: 97% | (3-Ethoxy-3-oxopropyl)triphenylphosphonium bromide | ESD-844277-1G |
Cas.: 850663-54-6 | Purity: 98% | 4-Chloro-5-nitropyridin-2(1H)-one | ESD-844278-50MG |
Cas.: 850663-54-6 | Purity: 98% | 4-Chloro-5-nitropyridin-2(1H)-one | ESD-844278-250MG |
Cas.: 1184-88-9 | Purity: 98% | Sodium pivalate | ESD-844279-250MG |
Cas.: 1184-88-9 | Purity: 98% | Sodium pivalate | ESD-844279-1G |
Cas.: 81245-24-1 | Purity: 97% | Methyl 2-methoxy-4-methylbenzoate | ESD-844280-250MG |
Cas.: 81245-24-1 | Purity: 97% | Methyl 2-methoxy-4-methylbenzoate | ESD-844280-1G |
Cas.: 766557-02-2 | Purity: 98% | 6-Chloro-1H-indole-3-carboxylic acid | ESD-844281-250MG |
Cas.: 766557-02-2 | Purity: 98% | 6-Chloro-1H-indole-3-carboxylic acid | ESD-844281-1G |
Cas.: 74536-43-9 | Purity: 98% | 2-Benzamido-2-phenylacetic acid | ESD-844282-1G |
Cas.: 74536-43-9 | Purity: 98% | 2-Benzamido-2-phenylacetic acid | ESD-844282-10G |
Cas.: 162401-70-9 | Purity: 97% | 3-Methoxy-4-(difluoromethoxy)benzaldehyde | ESD-844283-250MG |
Cas.: 162401-70-9 | Purity: 97% | 3-Methoxy-4-(difluoromethoxy)benzaldehyde | ESD-844283-1G |
Cas.: 17994-94-4 | Purity: 97% | Methyl 7-aminoheptanoate hydrochloride | ESD-844284-250MG |
Cas.: 17994-94-4 | Purity: 97% | Methyl 7-aminoheptanoate hydrochloride | ESD-844284-1G |
Cas.: 3724-16-1 | Purity: 95% | 2-(Pyridin-3-yl)acetamide | ESD-844285-250MG |
Cas.: 3724-16-1 | Purity: 95% | 2-(Pyridin-3-yl)acetamide | ESD-844285-1G |
Cas.: 113402-89-4 | Purity: 95% | 3-Methyl-1H-pyrazol-5-amine | ESD-844286-1G |
Cas.: 113402-89-4 | Purity: 95% | 3-Methyl-1H-pyrazol-5-amine | ESD-844286-5G |
Cas.: 55-57-2 | Purity: 97% | N-Phenylimidodicarbonimidic diamide hydrochloride | ESD-844287-250MG |
Cas.: 55-57-2 | Purity: 97% | N-Phenylimidodicarbonimidic diamide hydrochloride | ESD-844287-1G |
Cas.: 873697-75-7 | Purity: 95% | Methyl piperazine-1-carboxylate hydrochloride | ESD-844288-250MG |
Cas.: 873697-75-7 | Purity: 95% | Methyl piperazine-1-carboxylate hydrochloride | ESD-844288-1G |
Cas.: 133-74-4 | Purity: 95% | 2-Amino-5-chlorobenzenesulfonic acid | ESD-844289-250MG |
Cas.: 133-74-4 | Purity: 95% | 2-Amino-5-chlorobenzenesulfonic acid | ESD-844289-1G |
Cas.: 84719-31-3 | Purity: 98% | Pyridine-2,4-diol | ESD-844290-1G |
Cas.: 84719-31-3 | Purity: 98% | Pyridine-2,4-diol | ESD-844290-5G |
Cas.: 83948-53-2 | Purity: 98% | 3-(Boc-Amino)propylbromide | ESD-844291-250MG |
Cas.: 83948-53-2 | Purity: 98% | 3-(Boc-Amino)propylbromide | ESD-844291-1G |
Cas.: 16932-44-8 | Purity: 97% | 2-Iodo-1,3-dimethoxybenzene | ESD-844292-250MG |
Cas.: 16932-44-8 | Purity: 97% | 2-Iodo-1,3-dimethoxybenzene | ESD-844292-1G |
Cas.: 69954-66-1 | Purity: 97% | 4-(Dimethylamino)butanoic acid hydrochloride | ESD-844293-1G |
Cas.: 69954-66-1 | Purity: 97% | 4-(Dimethylamino)butanoic acid hydrochloride | ESD-844293-5G |
Cas.: 166943-39-1 | Purity: 97% | N-Methyl-2-(4-nitrophenyl)ethanamine hydrochloride | ESD-844294-250MG |
Cas.: 166943-39-1 | Purity: 97% | N-Methyl-2-(4-nitrophenyl)ethanamine hydrochloride | ESD-844294-1G |
Cas.: 67400-25-3 | Purity: 95% | 3-Bromo-5-nitroindazole | ESD-844295-1G |
Cas.: 67400-25-3 | Purity: 95% | 3-Bromo-5-nitroindazole | ESD-844295-5G |
Cas.: 78162-58-0 | Purity: 98% | N,N-Dimethyl-1H-imidazole-1-sulfonamide | ESD-844296-250MG |
Cas.: 78162-58-0 | Purity: 98% | N,N-Dimethyl-1H-imidazole-1-sulfonamide | ESD-844296-1G |
Cas.: 775-00-8 | Purity: 98% | 4-Trifluoromethylphenethylamine | ESD-844297-250MG |
Cas.: 775-00-8 | Purity: 98% | 4-Trifluoromethylphenethylamine | ESD-844297-1G |
Cas.: 52522-49-3 | Purity: 97% | 2,3,5-Tri-o-benzyl-1-o-(4-nitrobenzoyl)-D-arabinofuranose | ESD-844298-250MG |
Cas.: 52522-49-3 | Purity: 97% | 2,3,5-Tri-o-benzyl-1-o-(4-nitrobenzoyl)-D-arabinofuranose | ESD-844298-1G |
Cas.: 4876-14-6 | Purity: 95% | 2-Amino-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid hydrochloride | ESD-844299-250MG |
Cas.: 4876-14-6 | Purity: 95% | 2-Amino-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid hydrochloride | ESD-844299-1G |
Cas.: 15933-07-0 | Purity: 95% | Ethyl 2-oxobutanoate | ESD-844300-250MG |
Cas.: 15933-07-0 | Purity: 95% | Ethyl 2-oxobutanoate | ESD-844300-1G |
Cas.: 1087160-38-0 | Purity: 96% | 5-(Trifluoromethyl)-1H-pyrazole | ESD-844301-1G |
Cas.: 1087160-38-0 | Purity: 96% | 5-(Trifluoromethyl)-1H-pyrazole | ESD-844301-5G |
Cas.: 39156-41-7 | Purity: 97% | 4-Methoxybenzene-1,3-diamine sulfate | ESD-844302-25G |
Cas.: 39156-41-7 | Purity: 97% | 4-Methoxybenzene-1,3-diamine sulfate | ESD-844302-100G |
Cas.: 18740-38-0 | Purity: 97% | Thieno[2,3-d]pyrimidine-2,4-diol | ESD-844303-50MG |
Cas.: 18740-38-0 | Purity: 97% | Thieno[2,3-d]pyrimidine-2,4-diol | ESD-844303-250MG |
Cas.: 944901-07-9 | Purity: 98% | 2-Bromo-4-methoxy-1-(trifluoromethyl)benzene | ESD-844304-50MG |
Cas.: 944901-07-9 | Purity: 98% | 2-Bromo-4-methoxy-1-(trifluoromethyl)benzene | ESD-844304-250MG |
Cas.: 503612-47-3 | Purity: 98% | Apixaban | ESD-844305-10MG |
Cas.: 503612-47-3 | Purity: 98% | Apixaban | ESD-844305-50MG |
Cas.: 445264-60-8 | Purity: 98% | 3-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-844306-250MG |
Cas.: 445264-60-8 | Purity: 98% | 3-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-844306-1G |
Cas.: 55403-34-4 | Purity: 97% | 1-Methyl-4-(5-nitropyridin-2-yl)piperazine | ESD-844307-250MG |
Cas.: 55403-34-4 | Purity: 97% | 1-Methyl-4-(5-nitropyridin-2-yl)piperazine | ESD-844307-1G |
Cas.: 101990-73-2 | Purity: 97% | 2-Chloro-4-(chloromethyl)pyridine | ESD-844308-250MG |
Cas.: 101990-73-2 | Purity: 97% | 2-Chloro-4-(chloromethyl)pyridine | ESD-844308-1G |
Cas.: 571-57-3 | Purity: 98% | 4-Bromonaphthalen-1-ol | ESD-844309-250MG |
Cas.: 571-57-3 | Purity: 98% | 4-Bromonaphthalen-1-ol | ESD-844309-1G |
Cas.: 21881-18-5 | Purity: 95% | Z-Phe-Ala-OH | ESD-844310-250MG |
Cas.: 21881-18-5 | Purity: 95% | Z-Phe-Ala-OH | ESD-844310-1G |
Cas.: 2390-54-7 | Purity: 97% | Thioflavin T | ESD-844311-1G |
Cas.: 2390-54-7 | Purity: 97% | Thioflavin T | ESD-844311-10G |
Cas.: 854391-95-0 | Purity: 97% | Bis(4-methoxybenzyl)amine hydrochloride | ESD-844312-250MG |
Cas.: 854391-95-0 | Purity: 97% | Bis(4-methoxybenzyl)amine hydrochloride | ESD-844312-1G |
Cas.: 58186-27-9 | Purity: 98% | Idebenone | ESD-844313-250MG |
Cas.: 58186-27-9 | Purity: 98% | Idebenone | ESD-844313-1G |
Cas.: 50593-91-4 | Purity: 98% | Methyl 5-bromo-2-(methylthio)pyrimidine-4-carboxylate | ESD-844314-250MG |
Cas.: 50593-91-4 | Purity: 98% | Methyl 5-bromo-2-(methylthio)pyrimidine-4-carboxylate | ESD-844314-1G |
Cas.: 64318-28-1 | Purity: 97% | tert-Butyl 4-hydroxyphenethylcarbamate | ESD-844315-250MG |
Cas.: 64318-28-1 | Purity: 97% | tert-Butyl 4-hydroxyphenethylcarbamate | ESD-844315-1G |
Cas.: 1207-72-3 | Purity: 98% | 10-Methyl-10H-phenothiazine | ESD-844316-250MG |
Cas.: 1207-72-3 | Purity: 98% | 10-Methyl-10H-phenothiazine | ESD-844316-1G |
Cas.: 38261-78-8 | Purity: 95% | (2R,2’R)-Di-tert-butyl 3,3′-disulfanediylbis(2-aminopropanoate) dihydrochloride | ESD-844317-250MG |
Cas.: 38261-78-8 | Purity: 95% | (2R,2’R)-Di-tert-butyl 3,3′-disulfanediylbis(2-aminopropanoate) dihydrochloride | ESD-844317-1G |
Cas.: 2256-76-0 | Purity: 95% | Ac-Ile-OMe | ESD-844318-250MG |
Cas.: 2256-76-0 | Purity: 95% | Ac-Ile-OMe | ESD-844318-1G |
Cas.: 877397-65-4 | Purity: 97% | (S)-1-(2,6-Dichloro-3-fluorophenyl)ethanol | ESD-844319-250MG |
Cas.: 877397-65-4 | Purity: 97% | (S)-1-(2,6-Dichloro-3-fluorophenyl)ethanol | ESD-844319-1G |
Cas.: 63001-30-9 | Purity: 97% | Methyl 6-oxo-1,6-dihydropyridazine-3-carboxylate | ESD-844320-250MG |
Cas.: 63001-30-9 | Purity: 97% | Methyl 6-oxo-1,6-dihydropyridazine-3-carboxylate | ESD-844320-1G |
Cas.: 583823-94-3 | Purity: 95% | 3-Amino-3-methylbutanoic acid hydrochloride | ESD-844321-250MG |
Cas.: 583823-94-3 | Purity: 95% | 3-Amino-3-methylbutanoic acid hydrochloride | ESD-844321-1G |
Cas.: 330794-03-1 | Purity: 98% | 4-Bromo-5-fluoro-2-methoxyaniline | ESD-844322-250MG |
Cas.: 330794-03-1 | Purity: 98% | 4-Bromo-5-fluoro-2-methoxyaniline | ESD-844322-1G |
Cas.: 149861-22-3 | Purity: 95% | 2-Amino-5-ethylphenol hydrochloride | ESD-844323-250MG |
Cas.: 149861-22-3 | Purity: 95% | 2-Amino-5-ethylphenol hydrochloride | ESD-844323-1G |
Cas.: 1450877-56-1 | Purity: 97% | 4-Nitrophenyl 5-chlorothiophene-2-carboxylate | ESD-844324-250MG |
Cas.: 1450877-56-1 | Purity: 97% | 4-Nitrophenyl 5-chlorothiophene-2-carboxylate | ESD-844324-1G |
Cas.: 1628557-03-8 | Purity: 95% | 3-Chloroisonicotinaldehyde hydrate | ESD-844325-250MG |
Cas.: 1628557-03-8 | Purity: 95% | 3-Chloroisonicotinaldehyde hydrate | ESD-844325-1G |
Cas.: 6106-41-8 | Purity: 97% | Sodium pentanoate | ESD-844326-250MG |
Cas.: 6106-41-8 | Purity: 97% | Sodium pentanoate | ESD-844326-1G |
Cas.: 1228957-10-5 | Purity: 95% | 2-Chloroisonicotinaldehyde hydrate (contain dehydrate aldehyde) | ESD-844327-250MG |
Cas.: 1228957-10-5 | Purity: 95% | 2-Chloroisonicotinaldehyde hydrate (contain dehydrate aldehyde) | ESD-844327-1G |
Cas.: 261506-45-0 | Purity: 95% | Sodium 2-((2-amino-6-oxo-1H-purin-9(6H)-yl)methoxy)ethanolate dihydrate | ESD-844328-250MG |
Cas.: 261506-45-0 | Purity: 95% | Sodium 2-((2-amino-6-oxo-1H-purin-9(6H)-yl)methoxy)ethanolate dihydrate | ESD-844328-1G |
Cas.: 186590-04-5 | Purity: 97% | 4-Fluoro-3-hydroxybenzonitrile | ESD-844329-250MG |
Cas.: 186590-04-5 | Purity: 97% | 4-Fluoro-3-hydroxybenzonitrile | ESD-844329-1G |
Cas.: 475102-10-4 | Purity: 98% | tert-Butyl 5-cyano-1H-indole-1-carboxylate | ESD-844330-250MG |
Cas.: 475102-10-4 | Purity: 98% | tert-Butyl 5-cyano-1H-indole-1-carboxylate | ESD-844330-1G |
Cas.: 79397-50-5 | Purity: 98% | H-DL-Pro-OMe.HCl | ESD-844331-1G |
Cas.: 79397-50-5 | Purity: 98% | H-DL-Pro-OMe.HCl | ESD-844331-5G |
Cas.: 54773-19-2 | Purity: 98% | 1,2-Dichloro-3-(trifluoromethyl)benzene | ESD-844332-250MG |
Cas.: 54773-19-2 | Purity: 98% | 1,2-Dichloro-3-(trifluoromethyl)benzene | ESD-844332-1G |
Cas.: 695-95-4 | Purity: 98% | Methyl 3-oxocyclobutanecarboxylate | ESD-844333-1G |
Cas.: 695-95-4 | Purity: 98% | Methyl 3-oxocyclobutanecarboxylate | ESD-844333-5G |
Cas.: 4540-33-4 | Purity: 95% | Piperidin-1-ium acetate | ESD-844334-1G |
Cas.: 4540-33-4 | Purity: 95% | Piperidin-1-ium acetate | ESD-844334-5G |
Cas.: 78-71-7 | Purity: 98% | 3,3-Bis(chloromethyl)oxetane | ESD-844335-250MG |
Cas.: 78-71-7 | Purity: 98% | 3,3-Bis(chloromethyl)oxetane | ESD-844335-1G |
Cas.: 2133-33-7 | Purity: 95% | (S)-Piperidine-2-carboxylic acid hydrochloride | ESD-844336-1G |
Cas.: 2133-33-7 | Purity: 95% | (S)-Piperidine-2-carboxylic acid hydrochloride | ESD-844336-5G |
Cas.: 15666-97-4 | Purity: 98% | Octyl 2-cyanoacetate | ESD-844337-1G |
Cas.: 15666-97-4 | Purity: 98% | Octyl 2-cyanoacetate | ESD-844337-5G |
Cas.: 104055-46-1 | Purity: 97% | HD-Ser-OEt.HCl | ESD-844338-1G |
Cas.: 104055-46-1 | Purity: 97% | HD-Ser-OEt.HCl | ESD-844338-5G |
Cas.: 312693-72-4 | Purity: 97% | 2′-Deoxyguanosine monohydrate | ESD-844339-1G |
Cas.: 312693-72-4 | Purity: 97% | 2′-Deoxyguanosine monohydrate | ESD-844339-5G |
Cas.: 6329-74-4 | Purity: 98% | 5-Bromo-2-hydroxybenzamide | ESD-844340-1G |
Cas.: 6329-74-4 | Purity: 98% | 5-Bromo-2-hydroxybenzamide | ESD-844340-5G |
Cas.: 39608-31-6 | Purity: 95% | Z-Sar-OH | ESD-844341-1G |
Cas.: 39608-31-6 | Purity: 95% | Z-Sar-OH | ESD-844341-10G |
Cas.: 21770-81-0 | Purity: 98% | 1-Methylguanidine hydrochloride | ESD-844342-1G |
Cas.: 21770-81-0 | Purity: 98% | 1-Methylguanidine hydrochloride | ESD-844342-5G |
Cas.: 628-09-1 | Purity: 98% | 3-Chloropropyl acetate | ESD-844343-5G |
Cas.: 628-09-1 | Purity: 98% | 3-Chloropropyl acetate | ESD-844343-25G |
Cas.: 104146-10-3 | Purity: 97% | (6R,7R)-4-Methoxybenzyl 3-(chloromethyl)-8-oxo-7-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | ESD-844344-5G |
Cas.: 104146-10-3 | Purity: 97% | (6R,7R)-4-Methoxybenzyl 3-(chloromethyl)-8-oxo-7-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | ESD-844344-25G |
Cas.: 78473-00-4 | Purity: 97% | 4-Amino-3,5-dichlorobenzonitrile | ESD-844345-1G |
Cas.: 78473-00-4 | Purity: 97% | 4-Amino-3,5-dichlorobenzonitrile | ESD-844345-5G |
Cas.: 6344-05-4 | Purity: 97% | 4-Chloroisatin | ESD-844346-1G |
Cas.: 6344-05-4 | Purity: 97% | 4-Chloroisatin | ESD-844346-5G |
Cas.: 64407-07-4 | Purity: 97% | 3-(Chloromethyl)benzonitrile | ESD-844347-1G |
Cas.: 64407-07-4 | Purity: 97% | 3-(Chloromethyl)benzonitrile | ESD-844347-5G |
Cas.: 6086-21-1 | Purity: 98% | 1-Methyl-1,2,4-triazole | ESD-844348-1G |
Cas.: 6086-21-1 | Purity: 98% | 1-Methyl-1,2,4-triazole | ESD-844348-5G |
Cas.: 42899-11-6 | Purity: 98% | 1,4-Dioxa-8-azaspiro[4.5]decane hydrochloride | ESD-844349-1G |
Cas.: 42899-11-6 | Purity: 98% | 1,4-Dioxa-8-azaspiro[4.5]decane hydrochloride | ESD-844349-5G |
Cas.: 66192-24-3 | Purity: 98% | 1-Bromo-2-(bromomethyl)-4-chlorobenzene | ESD-844350-1G |
Cas.: 66192-24-3 | Purity: 98% | 1-Bromo-2-(bromomethyl)-4-chlorobenzene | ESD-844350-5G |
Cas.: 209959-33-1 | Purity: 98% | 2-[Bis(tert-Butoxycarbonyl)amino]-5-bromopyrimidine | ESD-844351-1G |
Cas.: 209959-33-1 | Purity: 98% | 2-[Bis(tert-Butoxycarbonyl)amino]-5-bromopyrimidine | ESD-844351-5G |
Cas.: 64017-81-8 | Purity: 98% | H-β-Ala-NH2.HCl | ESD-844352-1G |
Cas.: 64017-81-8 | Purity: 98% | H-β-Ala-NH2.HCl | ESD-844352-5G |
Cas.: 6575-08-2 | Purity: 98% | 2-Bromo-6-chlorobenzonitrile | ESD-844353-50MG |
Cas.: 6575-08-2 | Purity: 98% | 2-Bromo-6-chlorobenzonitrile | ESD-844353-250MG |
Cas.: 1010422-92-0 | Purity: 95% | Ethyl 6-(trifluoromethyl)picolinate | ESD-844354-50MG |
Cas.: 1010422-92-0 | Purity: 95% | Ethyl 6-(trifluoromethyl)picolinate | ESD-844354-250MG |
Cas.: 13338-49-3 | Purity: 95% | 2-(Chloromethyl)-4,5-dihydro-1H-imidazole hydrochloride | ESD-844355-1G |
Cas.: 13338-49-3 | Purity: 95% | 2-(Chloromethyl)-4,5-dihydro-1H-imidazole hydrochloride | ESD-844355-5G |
Cas.: 32909-05-0 | Purity: 95% | N4-Acetyl-2′-deoxycytidine | ESD-844356-1G |
Cas.: 32909-05-0 | Purity: 95% | N4-Acetyl-2′-deoxycytidine | ESD-844356-5G |
Cas.: 56296-78-7 | Purity: 98% | Fluoxetine hydrochloride | ESD-844357-1G |
Cas.: 56296-78-7 | Purity: 98% | Fluoxetine hydrochloride | ESD-844357-5G |
Cas.: 97-08-5 | Purity: 97% | 4-Chloro-3-nitrobenzene-1-sulfonyl chloride | ESD-844358-1G |
Cas.: 97-08-5 | Purity: 97% | 4-Chloro-3-nitrobenzene-1-sulfonyl chloride | ESD-844358-5G |
Cas.: 31603-77-7 | Purity: 97% | 2-([1,1′-Biphenyl]-4-yl)acetonitrile | ESD-844359-1G |
Cas.: 31603-77-7 | Purity: 97% | 2-([1,1′-Biphenyl]-4-yl)acetonitrile | ESD-844359-10G |
Cas.: 221352-64-3 | Purity: 97% | Boc-D-Gly(allyl)-OH.DCHA | ESD-844360-250MG |
Cas.: 221352-64-3 | Purity: 97% | Boc-D-Gly(allyl)-OH.DCHA | ESD-844360-1G |
Cas.: 118665-00-2 | Purity: 95% | 1,5-Dichloro-3-methyl-2-nitrobenzene | ESD-844361-250MG |
Cas.: 118665-00-2 | Purity: 95% | 1,5-Dichloro-3-methyl-2-nitrobenzene | ESD-844361-1G |
Cas.: 100911-49-7 | Purity: 95% | 2-(Piperidin-1-yl)ethanamine dihydrochloride | ESD-844362-250MG |
Cas.: 100911-49-7 | Purity: 95% | 2-(Piperidin-1-yl)ethanamine dihydrochloride | ESD-844362-1G |
Cas.: 189819-75-8 | Purity: 95% | tert-Butyl 4-aminopiperidine-1-carboxylate hydrochloride | ESD-844363-250MG |
Cas.: 189819-75-8 | Purity: 95% | tert-Butyl 4-aminopiperidine-1-carboxylate hydrochloride | ESD-844363-1G |
Cas.: 20680-59-5 | Purity: 97% | 3-Methylbenzimidamide hydrochloride | ESD-844364-250MG |
Cas.: 20680-59-5 | Purity: 97% | 3-Methylbenzimidamide hydrochloride | ESD-844364-1G |
Cas.: 51376-06-8 | Purity: 95% | 5-Bromobenzo[c][1,2,5]oxadiazole | ESD-844365-250MG |
Cas.: 51376-06-8 | Purity: 95% | 5-Bromobenzo[c][1,2,5]oxadiazole | ESD-844365-1G |
Cas.: 14140-15-9 | Purity: 98% | 4-(2-Bromoethyl)phenol | ESD-844366-250MG |
Cas.: 14140-15-9 | Purity: 98% | 4-(2-Bromoethyl)phenol | ESD-844366-1G |
Cas.: 104060-23-3 | Purity: 98% | N-Boc-2-(4-Aminophenyl)ethanol | ESD-844367-250MG |
Cas.: 104060-23-3 | Purity: 98% | N-Boc-2-(4-Aminophenyl)ethanol | ESD-844367-1G |
Cas.: 679794-03-7 | Purity: 98% | 6-Bromo-1-(phenylsulfonyl)-1H-indole | ESD-844368-250MG |
Cas.: 679794-03-7 | Purity: 98% | 6-Bromo-1-(phenylsulfonyl)-1H-indole | ESD-844368-1G |
Cas.: 133115-55-6 | Purity: 97% | (3-(Trifluoromethoxy)phenyl)hydrazine hydrochloride | ESD-844369-250MG |
Cas.: 133115-55-6 | Purity: 97% | (3-(Trifluoromethoxy)phenyl)hydrazine hydrochloride | ESD-844369-1G |
Cas.: 146645-63-8 | Purity: 95% | H-Trp(Boc)-OH | ESD-844370-250MG |
Cas.: 146645-63-8 | Purity: 95% | H-Trp(Boc)-OH | ESD-844370-1G |
Cas.: 15115-59-0 | Purity: 97% | 4-Chloro-2,3-dihydroinden-1-one | ESD-844371-250MG |
Cas.: 15115-59-0 | Purity: 97% | 4-Chloro-2,3-dihydroinden-1-one | ESD-844371-1G |
Cas.: 83602-38-4 | Purity: 95% | Ethyl (S)-3-Piperidinecarboxylate D-tartrate | ESD-844372-1G |
Cas.: 83602-38-4 | Purity: 95% | Ethyl (S)-3-Piperidinecarboxylate D-tartrate | ESD-844372-10G |
Cas.: 7425-63-0 | Purity: 90% | Methyl 3-bromo-2-oxopropanoate | ESD-844373-1G |
Cas.: 7425-63-0 | Purity: 90% | Methyl 3-bromo-2-oxopropanoate | ESD-844373-10G |
Cas.: 1882-71-9 | Purity: 98% | 2-Amino-5-methoxybenzamide | ESD-844374-250MG |
Cas.: 1882-71-9 | Purity: 98% | 2-Amino-5-methoxybenzamide | ESD-844374-1G |
Cas.: 54709-94-3 | Purity: 98% | 5-Methylpyridazin-3(2H)-one | ESD-844375-250MG |
Cas.: 54709-94-3 | Purity: 98% | 5-Methylpyridazin-3(2H)-one | ESD-844375-1G |
Cas.: 320-38-7 | Purity: 95% | 4-Nitro-3-(trifluoromethyl)benzoic acid | ESD-844376-250MG |
Cas.: 320-38-7 | Purity: 95% | 4-Nitro-3-(trifluoromethyl)benzoic acid | ESD-844376-1G |
Cas.: 20274-70-8 | Purity: 97% | 4-(Chloromethyl)-1-fluoro-2-nitrobenzene | ESD-844377-250MG |
Cas.: 20274-70-8 | Purity: 97% | 4-(Chloromethyl)-1-fluoro-2-nitrobenzene | ESD-844377-1G |
Cas.: 16233-51-5 | Purity: 95% | 1H-Thieno[3,2-d]pyrimidine-2,4-dione | ESD-844378-250MG |
Cas.: 16233-51-5 | Purity: 95% | 1H-Thieno[3,2-d]pyrimidine-2,4-dione | ESD-844378-1G |
Cas.: 10538-59-7 | Purity: 98% | (R)-Methyl 4-((3R,5S,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17- yl)pentanoate | ESD-844379-250MG |
Cas.: 10538-59-7 | Purity: 98% | (R)-Methyl 4-((3R,5S,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17- yl)pentanoate | ESD-844379-1G |
Cas.: 13020-57-0 | Purity: 98% | (3-Hydroxyphenyl)(phenyl)methanone | ESD-844380-250MG |
Cas.: 13020-57-0 | Purity: 98% | (3-Hydroxyphenyl)(phenyl)methanone | ESD-844380-1G |
Cas.: 25372-03-6 | Purity: 98% | 4-(1H-imidazol-1-yl)benzonitrile | ESD-844381-250MG |
Cas.: 25372-03-6 | Purity: 98% | 4-(1H-imidazol-1-yl)benzonitrile | ESD-844381-1G |
Cas.: 55775-97-8 | Purity: 98% | 2,6-Dichloro-3-nitrobenzoic acid | ESD-844382-250MG |
Cas.: 55775-97-8 | Purity: 98% | 2,6-Dichloro-3-nitrobenzoic acid | ESD-844382-1G |
Cas.: 18202-73-8 | Purity: 97% | Pivalimidamide hydrochloride | ESD-844383-250MG |
Cas.: 18202-73-8 | Purity: 97% | Pivalimidamide hydrochloride | ESD-844383-1G |
Cas.: 19395-40-5 | Purity: 95% | 2-Phenyl-2-(pipidin-2-yl)acetic acid hydrochloride | ESD-844384-250MG |
Cas.: 19395-40-5 | Purity: 95% | 2-Phenyl-2-(pipidin-2-yl)acetic acid hydrochloride | ESD-844384-1G |
Cas.: 147149-84-6 | Purity: 97% | 4-Bromo-5-methylindoline-2,3-dione | ESD-844385-250MG |
Cas.: 147149-84-6 | Purity: 97% | 4-Bromo-5-methylindoline-2,3-dione | ESD-844385-1G |
Cas.: 6587-24-2 | Purity: 96% | Methyl 2-cyanobenzoate | ESD-844386-250MG |
Cas.: 6587-24-2 | Purity: 96% | Methyl 2-cyanobenzoate | ESD-844386-1G |
Cas.: 4926-47-0 | Purity: 97% | 3-Bromoimidazo[1,2-a]pyridine | ESD-844387-250MG |
Cas.: 4926-47-0 | Purity: 97% | 3-Bromoimidazo[1,2-a]pyridine | ESD-844387-1G |
Cas.: 634-91-3 | Purity: 98% | 3,4,5-Trichloroaniline | ESD-844388-250MG |
Cas.: 634-91-3 | Purity: 98% | 3,4,5-Trichloroaniline | ESD-844388-1G |
Cas.: 32996-16-0 | Purity: 98% | Ethyl 1H-indole-5-carboxylate | ESD-844389-250MG |
Cas.: 32996-16-0 | Purity: 98% | Ethyl 1H-indole-5-carboxylate | ESD-844389-1G |
Cas.: 32991-17-6 | Purity: 95% | Boc-Leu-Gly-OH | ESD-844390-250MG |
Cas.: 32991-17-6 | Purity: 95% | Boc-Leu-Gly-OH | ESD-844390-1G |
Cas.: 3681-78-5 | Purity: 97% | Propyl dodecanoate | ESD-844391-250MG |
Cas.: 3681-78-5 | Purity: 97% | Propyl dodecanoate | ESD-844391-1G |
Cas.: 1159826-41-1 | Purity: 97% | Benzyl 4-aminopiperidine-1-carboxylate hydrochloride | ESD-844392-250MG |
Cas.: 1159826-41-1 | Purity: 97% | Benzyl 4-aminopiperidine-1-carboxylate hydrochloride | ESD-844392-1G |
Cas.: 521284-22-0 | Purity: 98% | (R)-2-((4-Aminophenethyl)amino)-1-phenylethanol hydrochloride | ESD-844393-250MG |
Cas.: 521284-22-0 | Purity: 98% | (R)-2-((4-Aminophenethyl)amino)-1-phenylethanol hydrochloride | ESD-844393-1G |
Cas.: 89203-22-5 | Purity: 95% | 3-Aminopyridazine hydrochloride | ESD-844394-250MG |
Cas.: 89203-22-5 | Purity: 95% | 3-Aminopyridazine hydrochloride | ESD-844394-1G |
Cas.: 127582-76-7 | Purity: 98% | Fmoc-7-Ahp-OH | ESD-844395-250MG |
Cas.: 127582-76-7 | Purity: 98% | Fmoc-7-Ahp-OH | ESD-844395-1G |
Cas.: 601-87-6 | Purity: 98% | 3-Methyl-2-nitroaniline | ESD-844396-250MG |
Cas.: 601-87-6 | Purity: 98% | 3-Methyl-2-nitroaniline | ESD-844396-1G |
Cas.: 60856-51-1 | Purity: 98% | H-Thr(Bzl)-OH·HCl | ESD-844397-250MG |
Cas.: 60856-51-1 | Purity: 98% | H-Thr(Bzl)-OH·HCl | ESD-844397-1G |
Cas.: 16636-51-4 | Purity: 95% | cis-3-Aminocyclohexanecarboxylic acid | ESD-844398-250MG |
Cas.: 16636-51-4 | Purity: 95% | cis-3-Aminocyclohexanecarboxylic acid | ESD-844398-1G |
Cas.: 829-02-7 | Purity: 98% | 4-Bromo-N,N-dimethyl-2-nitroaniline | ESD-844399-250MG |
Cas.: 829-02-7 | Purity: 98% | 4-Bromo-N,N-dimethyl-2-nitroaniline | ESD-844399-1G |
Cas.: 99073-88-8 | Purity: 97% | Ethyl 2-bromo-6-benzothiazolecarboxylate | ESD-844400-50MG |
Cas.: 99073-88-8 | Purity: 97% | Ethyl 2-bromo-6-benzothiazolecarboxylate | ESD-844400-250MG |
Cas.: 215798-19-9 | Purity: 98% | 6-Bromo-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-844401-50MG |
Cas.: 215798-19-9 | Purity: 98% | 6-Bromo-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-844401-250MG |
Cas.: 919346-89-7 | Purity: 97% | 5-Bromoisoindoline hydrochloride | ESD-844402-50MG |
Cas.: 919346-89-7 | Purity: 97% | 5-Bromoisoindoline hydrochloride | ESD-844402-250MG |
Cas.: 2013-26-5 | Purity: 98% | Sodium 2-oxobutanoate | ESD-844403-1G |
Cas.: 2013-26-5 | Purity: 98% | Sodium 2-oxobutanoate | ESD-844403-5G |
Cas.: 58-73-1 | Purity: 98% | 2-(Benzhydryloxy)-N,N-dimethylethanamine | ESD-844404-1G |
Cas.: 58-73-1 | Purity: 98% | 2-(Benzhydryloxy)-N,N-dimethylethanamine | ESD-844404-5G |
Cas.: 864685-26-7 | Purity: 98% | tert-Butyl 5-cyano-3-iodo-1H-indole-1-carboxylate | ESD-844405-250MG |
Cas.: 864685-26-7 | Purity: 98% | tert-Butyl 5-cyano-3-iodo-1H-indole-1-carboxylate | ESD-844405-1G |
Cas.: 58539-65-4 | Purity: 97% | 2-Methylnicotinamide | ESD-844406-250MG |
Cas.: 58539-65-4 | Purity: 97% | 2-Methylnicotinamide | ESD-844406-1G |
Cas.: 246232-73-5 | Purity: 97% | 2-(Dibenzylamino)propane-1,3-diol | ESD-844407-250MG |
Cas.: 246232-73-5 | Purity: 97% | 2-(Dibenzylamino)propane-1,3-diol | ESD-844407-1G |
Cas.: 58584-94-4 | Purity: 98% | 2,6-Dichloro-3-methylpyridine | ESD-844408-250MG |
Cas.: 58584-94-4 | Purity: 98% | 2,6-Dichloro-3-methylpyridine | ESD-844408-1G |
Cas.: 50595-15-8 | Purity: 98% | tert-Butyl 2-hydroxyacetate | ESD-844409-250MG |
Cas.: 50595-15-8 | Purity: 98% | tert-Butyl 2-hydroxyacetate | ESD-844409-1G |
Cas.: 7169-95-1 | Purity: 98% | 6-Bromo-2-methyl-[1,2,4]triazolo[1,5-a]pyridine | ESD-844410-50MG |
Cas.: 7169-95-1 | Purity: 98% | 6-Bromo-2-methyl-[1,2,4]triazolo[1,5-a]pyridine | ESD-844410-250MG |
Cas.: 25804-49-3 | Purity: 97% | tert-Butyl 4-hydroxybenzoate | ESD-844411-250MG |
Cas.: 25804-49-3 | Purity: 97% | tert-Butyl 4-hydroxybenzoate | ESD-844411-1G |
Cas.: 4771-49-7 | Purity: 98% | 6-Methylindole-3-carboxyaldehyde | ESD-844412-250MG |
Cas.: 4771-49-7 | Purity: 98% | 6-Methylindole-3-carboxyaldehyde | ESD-844412-1G |
Cas.: 23358-42-1 | Purity: 98% | H-DL-Val-OEt.HCl | ESD-844413-1G |
Cas.: 23358-42-1 | Purity: 98% | H-DL-Val-OEt.HCl | ESD-844413-5G |
Cas.: 3006-60-8 | Purity: 98% | (2S,3R,4R,5R,6R)-3-Acetamido-6-(acetoxymethyl)tetrahydro-2H-pyran-2,4,5-triyl triacetate | ESD-844414-250MG |
Cas.: 3006-60-8 | Purity: 98% | (2S,3R,4R,5R,6R)-3-Acetamido-6-(acetoxymethyl)tetrahydro-2H-pyran-2,4,5-triyl triacetate | ESD-844414-1G |
Cas.: 849061-98-9 | Purity: 97% | (2-Fluoro-3-formylphenyl)boronic acid | ESD-844415-250MG |
Cas.: 849061-98-9 | Purity: 97% | (2-Fluoro-3-formylphenyl)boronic acid | ESD-844415-1G |
Cas.: 97628-92-7 | Purity: 97% | 1-Cbz-Azetidine-3-carboxylic acid | ESD-844416-250MG |
Cas.: 97628-92-7 | Purity: 97% | 1-Cbz-Azetidine-3-carboxylic acid | ESD-844416-1G |
Cas.: 34761-09-6 | Purity: 95% | Ethyl 3-aminobenzo[b]thiophene-2-carboxylate | ESD-844417-250MG |
Cas.: 34761-09-6 | Purity: 95% | Ethyl 3-aminobenzo[b]thiophene-2-carboxylate | ESD-844417-1G |
Cas.: 518336-20-4 | Purity: 98% | (4-(1-Hydroxyethyl)phenyl)boronic acid | ESD-844418-50MG |
Cas.: 518336-20-4 | Purity: 98% | (4-(1-Hydroxyethyl)phenyl)boronic acid | ESD-844418-250MG |
Cas.: 4045-25-4 | Purity: 95% | 4-Methoxypiperidine hydrochloride | ESD-844419-250MG |
Cas.: 4045-25-4 | Purity: 95% | 4-Methoxypiperidine hydrochloride | ESD-844419-1G |
Cas.: 13380-89-7 | Purity: 97% | Octahydro-1H-4,7-methanoinden-5-ol | ESD-844420-250MG |
Cas.: 13380-89-7 | Purity: 97% | Octahydro-1H-4,7-methanoinden-5-ol | ESD-844420-1G |
Cas.: 95740-49-1 | Purity: 98% | 1-Bromo-2-methoxy-4-methylbenzene | ESD-844421-250MG |
Cas.: 95740-49-1 | Purity: 98% | 1-Bromo-2-methoxy-4-methylbenzene | ESD-844421-1G |
Cas.: 18087-76-8 | Purity: 98% | 6-Chloro-3-nitroimidazo[1,2-b]pyridazine | ESD-844422-250MG |
Cas.: 18087-76-8 | Purity: 98% | 6-Chloro-3-nitroimidazo[1,2-b]pyridazine | ESD-844422-1G |
Cas.: 13420-63-8 | Purity: 98% | 2-Chloro-6-iodobenzoic acid | ESD-844423-250MG |
Cas.: 13420-63-8 | Purity: 98% | 2-Chloro-6-iodobenzoic acid | ESD-844423-1G |
Cas.: 66638-22-0 | Purity: 95% | (S)-3-Acetoxy-2-aminopropanoic acid hydrochloride | ESD-844424-250MG |
Cas.: 66638-22-0 | Purity: 95% | (S)-3-Acetoxy-2-aminopropanoic acid hydrochloride | ESD-844424-1G |
Cas.: 83882-67-1 | Purity: 97% | 1-(4-(Difluoromethoxy)phenyl)ethanone | ESD-844425-250MG |
Cas.: 83882-67-1 | Purity: 97% | 1-(4-(Difluoromethoxy)phenyl)ethanone | ESD-844425-1G |
Cas.: 15401-08-8 | Purity: 95% | (S)-1-((S)-1-(tert-Butoxycarbonyl)pyrrolidine-2-carbonyl)pyrrolidine-2-carboxylic acid | ESD-844426-250MG |
Cas.: 15401-08-8 | Purity: 95% | (S)-1-((S)-1-(tert-Butoxycarbonyl)pyrrolidine-2-carbonyl)pyrrolidine-2-carboxylic acid | ESD-844426-1G |
Cas.: 106984-91-2 | Purity: 97% | 6-Oxo-1,6-dihydropyridine-3-carbaldehyde | ESD-844427-250MG |
Cas.: 106984-91-2 | Purity: 97% | 6-Oxo-1,6-dihydropyridine-3-carbaldehyde | ESD-844427-1G |
Cas.: 20099-90-5 | Purity: 97% | 4-(2-Bromoacetyl)benzoic acid | ESD-844428-250MG |
Cas.: 20099-90-5 | Purity: 97% | 4-(2-Bromoacetyl)benzoic acid | ESD-844428-1G |
Cas.: 53786-28-0 | Purity: 95% | 5-Chloro-1-(pipidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one | ESD-844429-250MG |
Cas.: 53786-28-0 | Purity: 95% | 5-Chloro-1-(pipidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one | ESD-844429-1G |
Cas.: 6338-41-6 | Purity: 97% | 5-Hydroxymethyl-2-furancarboxylic acid | ESD-844430-250MG |
Cas.: 6338-41-6 | Purity: 97% | 5-Hydroxymethyl-2-furancarboxylic acid | ESD-844430-1G |
Cas.: 65515-39-1 | Purity: 98% | 2-Methoxy-4,6-dimethylnicotinonitrile | ESD-844431-250MG |
Cas.: 65515-39-1 | Purity: 98% | 2-Methoxy-4,6-dimethylnicotinonitrile | ESD-844431-1G |
Cas.: 3462-95-1 | Purity: 95% | (4-Fluorobenzyl)triphenylphosphonium chloride | ESD-844433-250MG |
Cas.: 3462-95-1 | Purity: 95% | (4-Fluorobenzyl)triphenylphosphonium chloride | ESD-844433-1G |
Cas.: 5324-13-0 | Purity: 98% | 2,6-Dibromo-4-chlorophenol | ESD-844434-250MG |
Cas.: 5324-13-0 | Purity: 98% | 2,6-Dibromo-4-chlorophenol | ESD-844434-1G |
Cas.: 61500-87-6 | Purity: 95% | Methyl 2-amino-4-(trifluoromethyl)benzoate | ESD-844435-250MG |
Cas.: 61500-87-6 | Purity: 95% | Methyl 2-amino-4-(trifluoromethyl)benzoate | ESD-844435-1G |
Cas.: 72696-48-1 | Purity: 97% | Adenosine 5′-diphosphate monopotassium salt dihydrate | ESD-844436-250MG |
Cas.: 72696-48-1 | Purity: 97% | Adenosine 5′-diphosphate monopotassium salt dihydrate | ESD-844436-1G |
Cas.: 786616-54-4 | Purity: 97% | 3-Amino-5-fluorobenzoic acid | ESD-844437-250MG |
Cas.: 786616-54-4 | Purity: 97% | 3-Amino-5-fluorobenzoic acid | ESD-844437-1G |
Cas.: 126674-78-0 | Purity: 98% | 2-Amino-3,5-difluorobenzoic acid | ESD-844438-250MG |
Cas.: 126674-78-0 | Purity: 98% | 2-Amino-3,5-difluorobenzoic acid | ESD-844438-1G |
Cas.: 517920-70-6 | Purity: 98% | 4-Bromo-2-fluoro-6-nitroaniline | ESD-844439-250MG |
Cas.: 517920-70-6 | Purity: 98% | 4-Bromo-2-fluoro-6-nitroaniline | ESD-844439-1G |
Cas.: 1072944-98-9 | Purity: 97% | tert-Butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole-1-carboxylate | ESD-844440-250MG |
Cas.: 1072944-98-9 | Purity: 97% | tert-Butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole-1-carboxylate | ESD-844440-1G |
Cas.: 288148-34-5 | Purity: 98% | 1-Methyl-1H-pyrazole-4-sulfonyl chloride | ESD-844441-250MG |
Cas.: 288148-34-5 | Purity: 98% | 1-Methyl-1H-pyrazole-4-sulfonyl chloride | ESD-844441-1G |
Cas.: 203314-28-7 | Purity: 98% | 2-(2,5-Dibromophenyl)acetic acid | ESD-844442-250MG |
Cas.: 203314-28-7 | Purity: 98% | 2-(2,5-Dibromophenyl)acetic acid | ESD-844442-1G |
Cas.: 143557-91-9 | Purity: 97% | tert-Butyl 3-endo-3-hydroxy-8-azabicyclo[3.2.1]octane-8-carboxylate | ESD-844443-250MG |
Cas.: 143557-91-9 | Purity: 97% | tert-Butyl 3-endo-3-hydroxy-8-azabicyclo[3.2.1]octane-8-carboxylate | ESD-844443-1G |
Cas.: 143254-82-4 | Purity: 97% | 1-Chlorocarbonyl-4-piperidinopiperidine hydrochloride | ESD-844444-250MG |
Cas.: 143254-82-4 | Purity: 97% | 1-Chlorocarbonyl-4-piperidinopiperidine hydrochloride | ESD-844444-1G |
Cas.: 186413-79-6 | Purity: 95% | 3-Amino-2-methoxy-6-picoline | ESD-844445-250MG |
Cas.: 186413-79-6 | Purity: 95% | 3-Amino-2-methoxy-6-picoline | ESD-844445-1G |
Cas.: 817170-70-0 | Purity: 98% | 1-(2-Fluoro-4-(trifluoromethyl)phenyl)piperazine | ESD-844446-250MG |
Cas.: 817170-70-0 | Purity: 98% | 1-(2-Fluoro-4-(trifluoromethyl)phenyl)piperazine | ESD-844446-1G |
Cas.: 909122-50-5 | Purity: 98% | (3-Chloro-4-ethoxy-2-fluorophenyl)boronic acid | ESD-844447-250MG |
Cas.: 909122-50-5 | Purity: 98% | (3-Chloro-4-ethoxy-2-fluorophenyl)boronic acid | ESD-844447-1G |
Cas.: 158580-57-5 | Purity: 98% | Methyl 4-bromo-2-nitrobenzoate | ESD-844448-250MG |
Cas.: 158580-57-5 | Purity: 98% | Methyl 4-bromo-2-nitrobenzoate | ESD-844448-1G |
Cas.: 73831-13-7 | Purity: 98% | 4-Cyano-3-methylbenzoic acid | ESD-844449-250MG |
Cas.: 73831-13-7 | Purity: 98% | 4-Cyano-3-methylbenzoic acid | ESD-844449-1G |
Cas.: 1256945-00-2 | Purity: 95% | 4-Bromo-2-iodo-1-(trifluoromethyl)benzene | ESD-844450-250MG |
Cas.: 1256945-00-2 | Purity: 95% | 4-Bromo-2-iodo-1-(trifluoromethyl)benzene | ESD-844450-1G |
Cas.: 135904-71-1 | Purity: 95% | HD-Asp(OtBu)-OtBu.HCl | ESD-844451-250MG |
Cas.: 135904-71-1 | Purity: 95% | HD-Asp(OtBu)-OtBu.HCl | ESD-844451-1G |
Cas.: 126689-00-7 | Purity: 97% | 4,4,5,5-Tetramethyl-2-(2-methylprop-1-en-1-yl)-1,3,2-dioxaborolane | ESD-844452-250MG |
Cas.: 126689-00-7 | Purity: 97% | 4,4,5,5-Tetramethyl-2-(2-methylprop-1-en-1-yl)-1,3,2-dioxaborolane | ESD-844452-1G |
Cas.: 132210-25-4 | Purity: 97% | 2-Amino-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid dihydrochloride | ESD-844453-250MG |
Cas.: 132210-25-4 | Purity: 97% | 2-Amino-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid dihydrochloride | ESD-844453-1G |
Cas.: 115787-50-3 | Purity: 96% | 5-(2-Bromoacetyl)-2-hydroxybenzaldehyde | ESD-844454-250MG |
Cas.: 115787-50-3 | Purity: 96% | 5-(2-Bromoacetyl)-2-hydroxybenzaldehyde | ESD-844454-1G |
Cas.: 83922-51-4 | Purity: 98% | N-(3-Bromophenyl)methanesulfonamide | ESD-844455-250MG |
Cas.: 83922-51-4 | Purity: 98% | N-(3-Bromophenyl)methanesulfonamide | ESD-844455-1G |
Cas.: 123344-02-5 | Purity: 98% | 2,4-Difluoro-5-nitroaniline | ESD-844457-250MG |
Cas.: 123344-02-5 | Purity: 98% | 2,4-Difluoro-5-nitroaniline | ESD-844457-1G |
Cas.: 170844-49-2 | Purity: 97% | 1-tert-Butyl 3-ethyl pyrrolidine-1,3-dicarboxylate | ESD-844458-250MG |
Cas.: 170844-49-2 | Purity: 97% | 1-tert-Butyl 3-ethyl pyrrolidine-1,3-dicarboxylate | ESD-844458-1G |
Cas.: 4487-56-3 | Purity: 98% | 2,4-Dichloro-5-nitropyridine | ESD-844459-250MG |
Cas.: 4487-56-3 | Purity: 98% | 2,4-Dichloro-5-nitropyridine | ESD-844459-1G |
Cas.: 927676-52-6 | Purity: 97% | tert-Butyl 4-(4-methylpiperazin-1-yl)benzylcarbamate | ESD-844460-250MG |
Cas.: 927676-52-6 | Purity: 97% | tert-Butyl 4-(4-methylpiperazin-1-yl)benzylcarbamate | ESD-844460-1G |
Cas.: 1303968-15-1 | Purity: 97% | 1-Benzyl-4-methylpiperidin-3-one hydrochloride | ESD-844461-250MG |
Cas.: 1303968-15-1 | Purity: 97% | 1-Benzyl-4-methylpiperidin-3-one hydrochloride | ESD-844461-1G |
Cas.: 138647-49-1 | Purity: 97% | tert-Butyl 4-(((trifluoromethyl)sulfonyl)oxy)-5,6-dihydropyridine-1(2H)-carboxylate | ESD-844462-250MG |
Cas.: 138647-49-1 | Purity: 97% | tert-Butyl 4-(((trifluoromethyl)sulfonyl)oxy)-5,6-dihydropyridine-1(2H)-carboxylate | ESD-844462-1G |
Cas.: 153035-62-2 | Purity: 97% | (4′-Ethyl-[1,1′-biphenyl]-4-yl)boronic acid | ESD-844463-250MG |
Cas.: 153035-62-2 | Purity: 97% | (4′-Ethyl-[1,1′-biphenyl]-4-yl)boronic acid | ESD-844463-1G |
Cas.: 2517-04-6 | Purity: 98% | Azetidine-2-carboxylic acid | ESD-844464-250MG |
Cas.: 2517-04-6 | Purity: 98% | Azetidine-2-carboxylic acid | ESD-844464-1G |
Cas.: 321318-42-7 | Purity: 95% | (R)-1-(4-Fluorophenyl)ethanamine hydrochloride | ESD-844465-250MG |
Cas.: 321318-42-7 | Purity: 95% | (R)-1-(4-Fluorophenyl)ethanamine hydrochloride | ESD-844465-1G |
Cas.: 36589-61-4 | Purity: 98% | Sodium butane-1,4-disulfonate | ESD-844466-250MG |
Cas.: 36589-61-4 | Purity: 98% | Sodium butane-1,4-disulfonate | ESD-844466-1G |
Cas.: 20443-99-6 | Purity: 98% | 1-(Bromomethyl)-2,4-dichlorobenzene | ESD-844467-250MG |
Cas.: 20443-99-6 | Purity: 98% | 1-(Bromomethyl)-2,4-dichlorobenzene | ESD-844467-1G |
Cas.: 4956-05-2 | Purity: 97% | 6-Bromo-1,2,4-triazine-3,5(2H,4H)-dione | ESD-844468-250MG |
Cas.: 4956-05-2 | Purity: 97% | 6-Bromo-1,2,4-triazine-3,5(2H,4H)-dione | ESD-844468-1G |
Cas.: 6921-22-8 | Purity: 98% | 2,3-Difluoronitrobenzene | ESD-844469-250MG |
Cas.: 6921-22-8 | Purity: 98% | 2,3-Difluoronitrobenzene | ESD-844469-1G |
Cas.: 115282-41-2 | Purity: 95% | 4-Dimethylaminophenylglyoxal hydrate | ESD-844470-250MG |
Cas.: 115282-41-2 | Purity: 95% | 4-Dimethylaminophenylglyoxal hydrate | ESD-844470-1G |
Cas.: 141302-36-5 | Purity: 95% | 5-Bromo-2-(4-methylpiperazin-1-yl)pyrimidine | ESD-844471-250MG |
Cas.: 141302-36-5 | Purity: 95% | 5-Bromo-2-(4-methylpiperazin-1-yl)pyrimidine | ESD-844471-1G |
Cas.: 182224-71-1 | Purity: 97% | N-Benzyl-2,6-dichloroisonicotinamide | ESD-844472-250MG |
Cas.: 182224-71-1 | Purity: 97% | N-Benzyl-2,6-dichloroisonicotinamide | ESD-844472-1G |
Cas.: 100643-25-2 | Purity: 98% | 2-Aminopyrimidin-4-ol | ESD-844473-1G |
Cas.: 100643-25-2 | Purity: 98% | 2-Aminopyrimidin-4-ol | ESD-844473-5G |
Cas.: 79784-34-2 | Purity: 98% | 3,4-Difluorophenylglyoxal hydrate | ESD-844475-250MG |
Cas.: 79784-34-2 | Purity: 98% | 3,4-Difluorophenylglyoxal hydrate | ESD-844475-1G |
Cas.: 217479-60-2 | Purity: 97% | 2,4,6-Trichlorobenzyl alcohol | ESD-844476-250MG |
Cas.: 217479-60-2 | Purity: 97% | 2,4,6-Trichlorobenzyl alcohol | ESD-844476-1G |
Cas.: 73415-84-6 | Purity: 95% | 2-(Piperidin-4yl)acetic acid hydrochloride | ESD-844477-250MG |
Cas.: 73415-84-6 | Purity: 95% | 2-(Piperidin-4yl)acetic acid hydrochloride | ESD-844477-1G |
Cas.: 889858-12-2 | Purity: 98% | tert-Butyl 4-bromo-2-fluorobenzoate | ESD-844478-250MG |
Cas.: 889858-12-2 | Purity: 98% | tert-Butyl 4-bromo-2-fluorobenzoate | ESD-844478-1G |
Cas.: 914349-13-6 | Purity: 97% | tert-Butyl 3-(hydroxymethyl)-2-methyl-1H-indole-1-carboxylate | ESD-844479-250MG |
Cas.: 914349-13-6 | Purity: 97% | tert-Butyl 3-(hydroxymethyl)-2-methyl-1H-indole-1-carboxylate | ESD-844479-1G |
Cas.: 79370-78-8 | Purity: 97% | 5-Hydroxyisophthalonitrile | ESD-844480-250MG |
Cas.: 79370-78-8 | Purity: 97% | 5-Hydroxyisophthalonitrile | ESD-844480-1G |
Cas.: 673487-32-6 | Purity: 95% | 4-Methyl-1H-benzimidazole-2-carboxylic acid | ESD-844482-250MG |
Cas.: 673487-32-6 | Purity: 95% | 4-Methyl-1H-benzimidazole-2-carboxylic acid | ESD-844482-1G |
Cas.: 58401-43-7 | Purity: 98% | 4-Chloroquinolin-3-amine | ESD-844483-50MG |
Cas.: 58401-43-7 | Purity: 98% | 4-Chloroquinolin-3-amine | ESD-844483-250MG |
Cas.: 34813-49-5 | Purity: 98% | 2-Methylpropane-2-sulfonamide | ESD-844485-250MG |
Cas.: 34813-49-5 | Purity: 98% | 2-Methylpropane-2-sulfonamide | ESD-844485-1G |
Cas.: 768-11-6 | Purity: 98% | 5-Bromobenzothiazole | ESD-844486-250MG |
Cas.: 768-11-6 | Purity: 98% | 5-Bromobenzothiazole | ESD-844486-1G |
Cas.: 35856-62-3 | Purity: 95% | Piperidine-1-sulfonyl chloride | ESD-844487-250MG |
Cas.: 35856-62-3 | Purity: 95% | Piperidine-1-sulfonyl chloride | ESD-844487-1G |
Cas.: 60187-00-0 | Purity: 95% | 3,5-Dimethylpyrazin-2-ol | ESD-844488-50MG |
Cas.: 60187-00-0 | Purity: 95% | 3,5-Dimethylpyrazin-2-ol | ESD-844488-250MG |
Cas.: 90657-55-9 | Purity: 97% | H-Chpro-OH.HCl | ESD-844489-250MG |
Cas.: 90657-55-9 | Purity: 97% | H-Chpro-OH.HCl | ESD-844489-1G |
Cas.: 3476-89-9 | Purity: 97% | 1,2,3,4-Tetrahydroquinoxaline | ESD-844490-250MG |
Cas.: 3476-89-9 | Purity: 97% | 1,2,3,4-Tetrahydroquinoxaline | ESD-844490-1G |
Cas.: 858523-37-2 | Purity: 95% | (4-Bromo-2-methoxyphenyl)acetonitrile | ESD-844491-250MG |
Cas.: 858523-37-2 | Purity: 95% | (4-Bromo-2-methoxyphenyl)acetonitrile | ESD-844491-1G |
Cas.: 61324-97-8 | Purity: 95% | 2-Fluoro-3-nitrobenzotrifluoride | ESD-844492-250MG |
Cas.: 61324-97-8 | Purity: 95% | 2-Fluoro-3-nitrobenzotrifluoride | ESD-844492-1G |
Cas.: 4228-00-6 | Purity: 95% | Phenyl dodecanoate | ESD-844493-1G |
Cas.: 4228-00-6 | Purity: 95% | Phenyl dodecanoate | ESD-844493-5G |
Cas.: 76360-43-5 | Purity: 95% | Methyl 2-bromothiophene-3-carboxylate | ESD-844494-50MG |
Cas.: 76360-43-5 | Purity: 95% | Methyl 2-bromothiophene-3-carboxylate | ESD-844494-250MG |
Cas.: 932373-72-3 | Purity: 98% | 2,3-Difluoro-1-methyl-4-nitrobenzene | ESD-844495-250MG |
Cas.: 932373-72-3 | Purity: 98% | 2,3-Difluoro-1-methyl-4-nitrobenzene | ESD-844495-1G |
Cas.: 160706-62-7 | Purity: 98% | (R)-1-((Benzyloxy)carbonyl)piperidine-3-carboxylic acid | ESD-844496-250MG |
Cas.: 160706-62-7 | Purity: 98% | (R)-1-((Benzyloxy)carbonyl)piperidine-3-carboxylic acid | ESD-844496-1G |
Cas.: 946126-94-9 | Purity: 98% | Methyl 2-fluoro-3-nitrobenzoate | ESD-844497-50MG |
Cas.: 946126-94-9 | Purity: 98% | Methyl 2-fluoro-3-nitrobenzoate | ESD-844497-250MG |
Cas.: 15397-15-6 | Purity: 98% | (2S,3R,4R,5R)-5-((Benzoyloxy)methyl)-3-methyltetrahydrofuran-2,3,4-triyl tribenzoate | ESD-844498-250MG |
Cas.: 15397-15-6 | Purity: 98% | (2S,3R,4R,5R)-5-((Benzoyloxy)methyl)-3-methyltetrahydrofuran-2,3,4-triyl tribenzoate | ESD-844498-1G |
Cas.: 16732-65-3 | Purity: 97% | 6-Bromo-1H-indole-2-carboxylic acid | ESD-844499-250MG |
Cas.: 16732-65-3 | Purity: 97% | 6-Bromo-1H-indole-2-carboxylic acid | ESD-844499-1G |
Cas.: 644-90-6 | Purity: 95% | 2-Aminooctanoic acid | ESD-844500-250MG |
Cas.: 644-90-6 | Purity: 95% | 2-Aminooctanoic acid | ESD-844500-1G |
Cas.: 179617-08-4 | Purity: 95% | 5-Bromo-1,3-difluoro-2-methylbenzene | ESD-844501-250MG |
Cas.: 179617-08-4 | Purity: 95% | 5-Bromo-1,3-difluoro-2-methylbenzene | ESD-844501-1G |
Cas.: 720720-96-7 | Purity: 97% | 5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylic acid hydrochloride | ESD-844502-250MG |
Cas.: 720720-96-7 | Purity: 97% | 5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylic acid hydrochloride | ESD-844502-1G |
Cas.: 402-10-8 | Purity: 95% | 2-Bromo-1-methoxy-4-(trifluoromethyl)benzene | ESD-844503-250MG |
Cas.: 402-10-8 | Purity: 95% | 2-Bromo-1-methoxy-4-(trifluoromethyl)benzene | ESD-844503-1G |
Cas.: 29006-01-7 | Purity: 95% | Methyl 4-methoxybutanoate | ESD-844504-250MG |
Cas.: 29006-01-7 | Purity: 95% | Methyl 4-methoxybutanoate | ESD-844504-1G |
Cas.: 5932-30-9 | Purity: 97% | Ethyl 5-phenyl-1H-pyrazole-3-carboxylate | ESD-844505-250MG |
Cas.: 5932-30-9 | Purity: 97% | Ethyl 5-phenyl-1H-pyrazole-3-carboxylate | ESD-844505-1G |
Cas.: 64113-86-6 | Purity: 95% | 5-Methyl-2-nitrobenzonitrile | ESD-844506-250MG |
Cas.: 64113-86-6 | Purity: 95% | 5-Methyl-2-nitrobenzonitrile | ESD-844506-1G |
Cas.: 70557-99-2 | Purity: 95% | 2-(Iodomethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-844507-250MG |
Cas.: 70557-99-2 | Purity: 95% | 2-(Iodomethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-844507-1G |
Cas.: 106261-48-7 | Purity: 98% | 4-((4-Methylpiperazin-1-yl)methyl)benzoic acid | ESD-844508-250MG |
Cas.: 106261-48-7 | Purity: 98% | 4-((4-Methylpiperazin-1-yl)methyl)benzoic acid | ESD-844508-1G |
Cas.: 78350-50-2 | Purity: 98% | 4-Amino-1,2,5-oxadiazole-3-carboxylic acid | ESD-844509-250MG |
Cas.: 78350-50-2 | Purity: 98% | 4-Amino-1,2,5-oxadiazole-3-carboxylic acid | ESD-844509-1G |
Cas.: 864448-61-3 | Purity: 97% | (R)-Dimethylpyrrolidin-3-yl-amine dihydrochloride | ESD-844510-250MG |
Cas.: 864448-61-3 | Purity: 97% | (R)-Dimethylpyrrolidin-3-yl-amine dihydrochloride | ESD-844510-1G |
Cas.: 153471-67-1 | Purity: 95% | (2-Chlorothiazol-5-yl)methanamine hydrochloride | ESD-844511-250MG |
Cas.: 153471-67-1 | Purity: 95% | (2-Chlorothiazol-5-yl)methanamine hydrochloride | ESD-844511-1G |
Cas.: 89720-77-4 | Purity: 97% | 4-Bromo-1-(bromomethyl)-2-chlorobenzene | ESD-844512-250MG |
Cas.: 89720-77-4 | Purity: 97% | 4-Bromo-1-(bromomethyl)-2-chlorobenzene | ESD-844512-1G |
Cas.: 86984-32-9 | Purity: 98% | 6-Chloro-5-nitroquinoline | ESD-844513-250MG |
Cas.: 86984-32-9 | Purity: 98% | 6-Chloro-5-nitroquinoline | ESD-844513-1G |
Cas.: 175137-21-0 | Purity: 97% | 4-Chloro-7-methylthieno[3,2-d]pyrimidine | ESD-844514-250MG |
Cas.: 175137-21-0 | Purity: 97% | 4-Chloro-7-methylthieno[3,2-d]pyrimidine | ESD-844514-1G |
Cas.: 209529-81-7 | Purity: 95% | 5-Nitropyrimidine-2,4,6(1H,3H,5H)-trione xhydrate | ESD-844516-250MG |
Cas.: 209529-81-7 | Purity: 95% | 5-Nitropyrimidine-2,4,6(1H,3H,5H)-trione xhydrate | ESD-844516-1G |
Cas.: 903895-48-7 | Purity: 97% | tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate | ESD-844517-250MG |
Cas.: 903895-48-7 | Purity: 97% | tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate | ESD-844517-1G |
Cas.: 61929-24-6 | Purity: 98% | 2-Bromo-1,3,4-thiadiazole | ESD-844518-250MG |
Cas.: 61929-24-6 | Purity: 98% | 2-Bromo-1,3,4-thiadiazole | ESD-844518-1G |
Cas.: 85888-81-9 | Purity: 95% | 2-(Chloromethyl)benzoic acid | ESD-844519-250MG |
Cas.: 85888-81-9 | Purity: 95% | 2-(Chloromethyl)benzoic acid | ESD-844519-1G |
Cas.: 220239-68-9 | Purity: 95% | 4-Hydroxy-3-(trifluoromethyl)benzoic acid | ESD-844520-250MG |
Cas.: 220239-68-9 | Purity: 95% | 4-Hydroxy-3-(trifluoromethyl)benzoic acid | ESD-844520-1G |
Cas.: 58419-67-3 | Purity: 98% | Methyl 4-(1H-1,2,4-triazol-1-yl)benzoate | ESD-844521-250MG |
Cas.: 58419-67-3 | Purity: 98% | Methyl 4-(1H-1,2,4-triazol-1-yl)benzoate | ESD-844521-1G |
Cas.: 253605-31-1 | Purity: 95% | N-(tert-Butyl)hydroxylamine acetate | ESD-844523-250MG |
Cas.: 253605-31-1 | Purity: 95% | N-(tert-Butyl)hydroxylamine acetate | ESD-844523-1G |
Cas.: 144163-85-9 | Purity: 95% | tert-Butyl ((2S,4S,5S)-5-amino-4-hydroxy-1,6-diphenylhexan-2-yl)carbamate | ESD-844524-250MG |
Cas.: 144163-85-9 | Purity: 95% | tert-Butyl ((2S,4S,5S)-5-amino-4-hydroxy-1,6-diphenylhexan-2-yl)carbamate | ESD-844524-1G |
Cas.: 13850-91-4 | Purity: 95% | Boc-N-Me-DL-Val-OH | ESD-844525-250MG |
Cas.: 13850-91-4 | Purity: 95% | Boc-N-Me-DL-Val-OH | ESD-844525-1G |
Cas.: 914347-05-0 | Purity: 95% | N-(Hydrazinecarbonothioyl)pivalamide | ESD-844526-250MG |
Cas.: 914347-05-0 | Purity: 95% | N-(Hydrazinecarbonothioyl)pivalamide | ESD-844526-1G |
Cas.: 68886-07-7 | Purity: 95% | 2-Fluoro-4-hydroxyphenylacetic acid | ESD-844528-250MG |
Cas.: 68886-07-7 | Purity: 95% | 2-Fluoro-4-hydroxyphenylacetic acid | ESD-844528-1G |
Cas.: 2885-02-1 | Purity: 97% | (S)-Butyl 2-aminopropanoate | ESD-844529-250MG |
Cas.: 2885-02-1 | Purity: 97% | (S)-Butyl 2-aminopropanoate | ESD-844529-1G |
Cas.: 914349-62-5 | Purity: 97% | (4-(4-(Bis(4-fluorophenyl)methyl)piperazin-1-yl)phenyl)methanol | ESD-844530-250MG |
Cas.: 914349-62-5 | Purity: 97% | (4-(4-(Bis(4-fluorophenyl)methyl)piperazin-1-yl)phenyl)methanol | ESD-844530-1G |
Cas.: 32014-70-3 | Purity: 95% | 5,6-Diaminopyrimidine-2,4-diol sulfate | ESD-844531-250MG |
Cas.: 32014-70-3 | Purity: 95% | 5,6-Diaminopyrimidine-2,4-diol sulfate | ESD-844531-1G |
Cas.: 6926-09-6 | Purity: 95% | tert-Butyl (2-hydrazinyl-2-oxoethyl)carbamate | ESD-844532-250MG |
Cas.: 6926-09-6 | Purity: 95% | tert-Butyl (2-hydrazinyl-2-oxoethyl)carbamate | ESD-844532-1G |
Cas.: 43192-34-3 | Purity: 97% | 4-Bromo-3-methoxybenzaldehyde | ESD-844533-250MG |
Cas.: 43192-34-3 | Purity: 97% | 4-Bromo-3-methoxybenzaldehyde | ESD-844533-1G |
Cas.: 893440-50-1 | Purity: 97% | 2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-amine | ESD-844534-250MG |
Cas.: 893440-50-1 | Purity: 97% | 2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-amine | ESD-844534-1G |
Cas.: 56962-10-8 | Purity: 97% | 2-Chloro-3-hydroxybenzaldehyde | ESD-844535-250MG |
Cas.: 56962-10-8 | Purity: 97% | 2-Chloro-3-hydroxybenzaldehyde | ESD-844535-1G |
Cas.: 60456-92-0 | Purity: 97% | 1H-Pyrazol-3-ol | ESD-844536-250MG |
Cas.: 60456-92-0 | Purity: 97% | 1H-Pyrazol-3-ol | ESD-844536-1G |
Cas.: 403-18-9 | Purity: 97% | 4-Fluoro-3-iodobenzoic acid | ESD-844537-250MG |
Cas.: 403-18-9 | Purity: 97% | 4-Fluoro-3-iodobenzoic acid | ESD-844537-1G |
Cas.: 13301-04-7 | Purity: 97% | Methyl 3,6-dibromopyrazine-2-carboxylate | ESD-844538-250MG |
Cas.: 13301-04-7 | Purity: 97% | Methyl 3,6-dibromopyrazine-2-carboxylate | ESD-844538-1G |
Cas.: 13794-15-5 | Purity: 95% | 2-(4-Methoxyphenoxy)propanoic acid | ESD-844539-250MG |
Cas.: 13794-15-5 | Purity: 95% | 2-(4-Methoxyphenoxy)propanoic acid | ESD-844539-1G |
Cas.: 58677-05-7 | Purity: 95% | Ethyl 2-amino-5-methylbenzoate | ESD-844540-250MG |
Cas.: 58677-05-7 | Purity: 95% | Ethyl 2-amino-5-methylbenzoate | ESD-844540-1G |
Cas.: 201002-47-3 | Purity: 98% | Fmoc-D-Lys-OH.HCl | ESD-844541-250MG |
Cas.: 201002-47-3 | Purity: 98% | Fmoc-D-Lys-OH.HCl | ESD-844541-1G |
Cas.: 170015-99-3 | Purity: 98% | 2-(4-(Trifluoromethoxy)phenyl)ethanamine | ESD-844542-250MG |
Cas.: 170015-99-3 | Purity: 98% | 2-(4-(Trifluoromethoxy)phenyl)ethanamine | ESD-844542-1G |
Cas.: 312613-82-4 | Purity: 98% | Pyrimidine-2-carboximidamide acetate | ESD-844543-250MG |
Cas.: 312613-82-4 | Purity: 98% | Pyrimidine-2-carboximidamide acetate | ESD-844543-1G |
Cas.: 1159680-21-3 | Purity: 97% | Fmoc-HoArg(Pbf)-OH | ESD-844544-250MG |
Cas.: 1159680-21-3 | Purity: 97% | Fmoc-HoArg(Pbf)-OH | ESD-844544-1G |
Cas.: 68015-98-5 | Purity: 97% | 4-Ethoxybenzene-1,3-diamine sulfate | ESD-844545-1G |
Cas.: 68015-98-5 | Purity: 97% | 4-Ethoxybenzene-1,3-diamine sulfate | ESD-844545-5G |
Cas.: 76644-74-1 | Purity: 97% | 1H-Isoindol-3-amine hydrochloride | ESD-844546-250MG |
Cas.: 76644-74-1 | Purity: 97% | 1H-Isoindol-3-amine hydrochloride | ESD-844546-1G |
Cas.: 124072-89-5 | Purity: 97% | Hexahydropyridazine dihydrochloride | ESD-844547-250MG |
Cas.: 124072-89-5 | Purity: 97% | Hexahydropyridazine dihydrochloride | ESD-844547-1G |
Cas.: 768-05-8 | Purity: 97% | Pyrazinoic acid hydrazide | ESD-844548-250MG |
Cas.: 768-05-8 | Purity: 97% | Pyrazinoic acid hydrazide | ESD-844548-1G |
Cas.: 870777-32-5 | Purity: 98% | (4,5-Difluoro-2-methoxyphenyl)boronic acid | ESD-844549-250MG |
Cas.: 870777-32-5 | Purity: 98% | (4,5-Difluoro-2-methoxyphenyl)boronic acid | ESD-844549-1G |
Cas.: 850568-22-8 | Purity: 98% | (4-((2-(Dimethylamino)ethyl)carbamoyl)phenyl)boronic acid hydrochloride | ESD-844550-250MG |
Cas.: 850568-22-8 | Purity: 98% | (4-((2-(Dimethylamino)ethyl)carbamoyl)phenyl)boronic acid hydrochloride | ESD-844550-1G |
Cas.: 57196-62-0 | Purity: 97% | 6-Methoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-844551-250MG |
Cas.: 57196-62-0 | Purity: 97% | 6-Methoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-844551-1G |
Cas.: 4664-00-0 | Purity: 98% | 5H-Pyrrolo[3,4-b]pyridine-5,7(6H)-dione | ESD-844552-250MG |
Cas.: 4664-00-0 | Purity: 98% | 5H-Pyrrolo[3,4-b]pyridine-5,7(6H)-dione | ESD-844552-1G |
Cas.: 14161-11-6 | Purity: 97% | 3,4,5-Trichloropyridazine | ESD-844553-250MG |
Cas.: 14161-11-6 | Purity: 97% | 3,4,5-Trichloropyridazine | ESD-844553-1G |
Cas.: 124072-61-3 | Purity: 97% | 3-((tert-Butoxycarbonyl)(methyl)amino)propanoic acid | ESD-844554-250MG |
Cas.: 124072-61-3 | Purity: 97% | 3-((tert-Butoxycarbonyl)(methyl)amino)propanoic acid | ESD-844554-1G |
Cas.: 80172-04-9 | Purity: 98% | 1,2,3-Trifluoro-5-(trifluoromethyl)benzene | ESD-844555-250MG |
Cas.: 80172-04-9 | Purity: 98% | 1,2,3-Trifluoro-5-(trifluoromethyl)benzene | ESD-844555-1G |
Cas.: 72587-18-9 | Purity: 97% | 2-Chloro-5-(trifluoromethyl)pyridin-3-amine | ESD-844556-250MG |
Cas.: 72587-18-9 | Purity: 97% | 2-Chloro-5-(trifluoromethyl)pyridin-3-amine | ESD-844556-1G |
Cas.: 960283-58-3 | Purity: 95% | (S)-tert-Butyl 2-methylpiperazine-1-carboxylate hydrochloride | ESD-844557-250MG |
Cas.: 960283-58-3 | Purity: 95% | (S)-tert-Butyl 2-methylpiperazine-1-carboxylate hydrochloride | ESD-844557-1G |
Cas.: 791642-68-7 | Purity: 98% | 4-Bromo-1-iodo-2-methoxybenzene | ESD-844558-250MG |
Cas.: 791642-68-7 | Purity: 98% | 4-Bromo-1-iodo-2-methoxybenzene | ESD-844558-1G |
Cas.: 1310278-53-5 | Purity: 95% | tert-Butyl 3-aminopyrrolidine-1-carboxylate 2-hydroxypropane-1,2,3-tricarboxylate | ESD-844559-250MG |
Cas.: 1310278-53-5 | Purity: 95% | tert-Butyl 3-aminopyrrolidine-1-carboxylate 2-hydroxypropane-1,2,3-tricarboxylate | ESD-844559-1G |
Cas.: 62965-10-0 | Purity: 95% | (S)-2-(((Benzyloxy)carbonyl)amino)-3,3-dimethylbutanoic acid | ESD-844560-250MG |
Cas.: 62965-10-0 | Purity: 95% | (S)-2-(((Benzyloxy)carbonyl)amino)-3,3-dimethylbutanoic acid | ESD-844560-1G |
Cas.: 1489-97-0 | Purity: 95% | Ethyl 1,4-dioxaspiro[4.5]decane-8-carboxylate | ESD-844561-250MG |
Cas.: 1489-97-0 | Purity: 95% | Ethyl 1,4-dioxaspiro[4.5]decane-8-carboxylate | ESD-844561-1G |
Cas.: 858855-11-5 | Purity: 98% | 5-Bromo-2-iodophenol | ESD-844562-250MG |
Cas.: 858855-11-5 | Purity: 98% | 5-Bromo-2-iodophenol | ESD-844562-1G |
Cas.: 99329-85-8 | Purity: 97% | 2-Chloro-4-fluoro-5-nitrobenzaldehyde | ESD-844563-250MG |
Cas.: 99329-85-8 | Purity: 97% | 2-Chloro-4-fluoro-5-nitrobenzaldehyde | ESD-844563-1G |
Cas.: 6125-57-1 | Purity: 98% | trans-Methyl 4-hydroxycyclohexanecarboxylate | ESD-844564-250MG |
Cas.: 6125-57-1 | Purity: 98% | trans-Methyl 4-hydroxycyclohexanecarboxylate | ESD-844564-1G |
Cas.: 1092693-73-6 | Purity: 98% | tert-Butyl 2,2-difluoro-3-(methacryloyloxy)pentanoate | ESD-844565-250MG |
Cas.: 1092693-73-6 | Purity: 98% | tert-Butyl 2,2-difluoro-3-(methacryloyloxy)pentanoate | ESD-844565-1G |
Cas.: 1749-68-4 | Purity: 98% | 6-Chloro-2-methylpyrimidin-4-amine | ESD-844566-250MG |
Cas.: 1749-68-4 | Purity: 98% | 6-Chloro-2-methylpyrimidin-4-amine | ESD-844566-1G |
Cas.: 188660-14-2 | Purity: 97% | (2R,3S)-Benzyl 2-amino-3-(benzyloxy)butanoate oxalate | ESD-844567-250MG |
Cas.: 188660-14-2 | Purity: 97% | (2R,3S)-Benzyl 2-amino-3-(benzyloxy)butanoate oxalate | ESD-844567-1G |
Cas.: 26113-44-0 | Purity: 98% | 3-Methoxybenzamidine hydrochloride | ESD-844568-250MG |
Cas.: 26113-44-0 | Purity: 98% | 3-Methoxybenzamidine hydrochloride | ESD-844568-1G |
Cas.: 915095-94-2 | Purity: 97% | (S)-3-(4-(2-Chloro-5-iodobenzyl)phenoxy)tetrahydrofuran | ESD-844569-250MG |
Cas.: 915095-94-2 | Purity: 97% | (S)-3-(4-(2-Chloro-5-iodobenzyl)phenoxy)tetrahydrofuran | ESD-844569-1G |
Cas.: 81246-82-4 | Purity: 95% | 5′-DMT-Bz-rA | ESD-844570-250MG |
Cas.: 81246-82-4 | Purity: 95% | 5′-DMT-Bz-rA | ESD-844570-1G |
Cas.: 7149-03-3 | Purity: 98% | Ethyl 4-amino-3-bromobenzoate | ESD-844572-250MG |
Cas.: 7149-03-3 | Purity: 98% | Ethyl 4-amino-3-bromobenzoate | ESD-844572-1G |
Cas.: 1339903-09-1 | Purity: 97% | 2-(4-Ethylphenoxy)-N,N-dimethylethanamine | ESD-844573-250MG |
Cas.: 1339903-09-1 | Purity: 97% | 2-(4-Ethylphenoxy)-N,N-dimethylethanamine | ESD-844573-1G |
Cas.: 175422-04-5 | Purity: 98% | 2,6-Dibromo-4-nitropyridine | ESD-844574-250MG |
Cas.: 175422-04-5 | Purity: 98% | 2,6-Dibromo-4-nitropyridine | ESD-844574-1G |
Cas.: 657-36-3 | Purity: 98% | 4-Trifluoromethylpiperidine | ESD-844575-250MG |
Cas.: 657-36-3 | Purity: 98% | 4-Trifluoromethylpiperidine | ESD-844575-1G |
Cas.: 827614-69-7 | Purity: 97% | 1-Propyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-844576-250MG |
Cas.: 827614-69-7 | Purity: 97% | 1-Propyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-844576-1G |
Cas.: 133692-16-7 | Purity: 95% | 2-Amino-5-bromo-4-methylthiazole hydrochloride | ESD-844577-250MG |
Cas.: 133692-16-7 | Purity: 95% | 2-Amino-5-bromo-4-methylthiazole hydrochloride | ESD-844577-1G |
Cas.: 920313-27-5 | Purity: 95% | 2-Aminothiazole-5-carbaldehyde hydrochloride | ESD-844578-250MG |
Cas.: 920313-27-5 | Purity: 95% | 2-Aminothiazole-5-carbaldehyde hydrochloride | ESD-844578-1G |
Cas.: 41789-95-1 | Purity: 98% | 1-(3-Methoxyphenyl)-N-methylmethanamine | ESD-844579-250MG |
Cas.: 41789-95-1 | Purity: 98% | 1-(3-Methoxyphenyl)-N-methylmethanamine | ESD-844579-1G |
Cas.: 57248-88-1 | Purity: 98% | Pamidronate Disodium | ESD-844580-50MG |
Cas.: 57248-88-1 | Purity: 98% | Pamidronate Disodium | ESD-844580-250MG |
Cas.: 93102-96-6 | Purity: 95% | 2-Amino-1-(2-fluorophenyl)ethanone hydrochloride | ESD-844581-250MG |
Cas.: 93102-96-6 | Purity: 95% | 2-Amino-1-(2-fluorophenyl)ethanone hydrochloride | ESD-844581-1G |
Cas.: 859040-56-5 | Purity: 95% | 2-(2-Methyl-1H-indol-3-yl)ethanamine oxalate | ESD-844582-250MG |
Cas.: 859040-56-5 | Purity: 95% | 2-(2-Methyl-1H-indol-3-yl)ethanamine oxalate | ESD-844582-1G |
Cas.: 914348-93-9 | Purity: 95% | tert-Butyl 5-cyano-3-formyl-1H-indole-1-carboxylate | ESD-844583-250MG |
Cas.: 914348-93-9 | Purity: 95% | tert-Butyl 5-cyano-3-formyl-1H-indole-1-carboxylate | ESD-844583-1G |
Cas.: 42417-66-3 | Purity: 95% | (2S,3S)-2-(((Benzyloxy)carbonyl)(methyl)amino)-3-methylpentanoic acid | ESD-844584-250MG |
Cas.: 42417-66-3 | Purity: 95% | (2S,3S)-2-(((Benzyloxy)carbonyl)(methyl)amino)-3-methylpentanoic acid | ESD-844584-1G |
Cas.: 7795-95-1 | Purity: 95% | Octane-1-sulfonyl chloride | ESD-844585-5G |
Cas.: 7795-95-1 | Purity: 95% | Octane-1-sulfonyl chloride | ESD-844585-25G |
Cas.: 5308-51-0 | Purity: 97% | 1-Bromobutane-2,3-dione | ESD-844586-250MG |
Cas.: 5308-51-0 | Purity: 97% | 1-Bromobutane-2,3-dione | ESD-844586-1G |
Cas.: 88145-89-5 | Purity: 98% | 6-Bromoquinazoline-2,4(1H,3H)-dione | ESD-844587-250MG |
Cas.: 88145-89-5 | Purity: 98% | 6-Bromoquinazoline-2,4(1H,3H)-dione | ESD-844587-1G |
Cas.: 3921-01-5 | Purity: 97% | 2,4-Dibromopyrimidine | ESD-844588-250MG |
Cas.: 3921-01-5 | Purity: 97% | 2,4-Dibromopyrimidine | ESD-844588-1G |
Cas.: 92333-25-0 | Purity: 95% | 2-(Pyridin-4-yl)acetonitrile hydrochloride | ESD-844590-250MG |
Cas.: 92333-25-0 | Purity: 95% | 2-(Pyridin-4-yl)acetonitrile hydrochloride | ESD-844590-1G |
Cas.: 54413-93-3 | Purity: 97% | 2-Iodo-5-methoxybenzoic acid | ESD-844591-1G |
Cas.: 54413-93-3 | Purity: 97% | 2-Iodo-5-methoxybenzoic acid | ESD-844591-5G |
Cas.: 66358-23-4 | Purity: 98% | Imidazo[1,2-a]pyridin-5-amine | ESD-844592-250MG |
Cas.: 66358-23-4 | Purity: 98% | Imidazo[1,2-a]pyridin-5-amine | ESD-844592-1G |
Cas.: 404827-78-7 | Purity: 98% | 4-Fluoro-1H-indazol-3-amine | ESD-844593-250MG |
Cas.: 404827-78-7 | Purity: 98% | 4-Fluoro-1H-indazol-3-amine | ESD-844593-1G |
Cas.: 220247-73-4 | Purity: 98% | 7-Bromo-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-844594-250MG |
Cas.: 220247-73-4 | Purity: 98% | 7-Bromo-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-844594-1G |
Cas.: 196811-66-2 | Purity: 97% | tert-Butyl 4-carbamothioylpiperazine-1-carboxylate | ESD-844595-250MG |
Cas.: 196811-66-2 | Purity: 97% | tert-Butyl 4-carbamothioylpiperazine-1-carboxylate | ESD-844595-1G |
Cas.: 56026-36-9 | Purity: 98% | Methyl 6-(hydroxymethyl)nicotinate | ESD-844596-250MG |
Cas.: 56026-36-9 | Purity: 98% | Methyl 6-(hydroxymethyl)nicotinate | ESD-844596-1G |
Cas.: 15456-86-7 | Purity: 98% | 4-Bromo-1,2-dihydropyridazine-3,6-dione | ESD-844597-250MG |
Cas.: 15456-86-7 | Purity: 98% | 4-Bromo-1,2-dihydropyridazine-3,6-dione | ESD-844597-1G |
Cas.: 283167-28-2 | Purity: 97% | tert-Butyl (1-acetylpiperidin-4-yl)carbamate | ESD-844598-250MG |
Cas.: 283167-28-2 | Purity: 97% | tert-Butyl (1-acetylpiperidin-4-yl)carbamate | ESD-844598-1G |
Cas.: 64394-45-2 | Purity: 97% | [1,3]Dithiolo[4,5-d][1,3]dithiole-2,5-dione | ESD-844599-250MG |
Cas.: 64394-45-2 | Purity: 97% | [1,3]Dithiolo[4,5-d][1,3]dithiole-2,5-dione | ESD-844599-1G |
Cas.: 503184-35-8 | Purity: 95% | 6-Methoxy-4-methylpyridin-3-ylboronic acid | ESD-844600-50MG |
Cas.: 503184-35-8 | Purity: 95% | 6-Methoxy-4-methylpyridin-3-ylboronic acid | ESD-844600-250MG |
Cas.: 3190-70-3 | Purity: 95% | (S)-4-Isobutyloxazolidine-2,5-dione | ESD-844601-250MG |
Cas.: 3190-70-3 | Purity: 95% | (S)-4-Isobutyloxazolidine-2,5-dione | ESD-844601-1G |
Cas.: 475-11-6 | Purity: 98% | HN-Me-Pro-OH | ESD-844602-250MG |
Cas.: 475-11-6 | Purity: 98% | HN-Me-Pro-OH | ESD-844602-1G |
Cas.: 850793-25-8 | Purity: 95% | 3-Fluoro-5-methoxyphenol | ESD-844603-250MG |
Cas.: 850793-25-8 | Purity: 95% | 3-Fluoro-5-methoxyphenol | ESD-844603-1G |
Cas.: 138199-71-0 | Purity: 98% | Levofloxacin hemihydrate | ESD-844604-250MG |
Cas.: 138199-71-0 | Purity: 98% | Levofloxacin hemihydrate | ESD-844604-1G |
Cas.: 74420-02-3 | Purity: 98% | 4-Hydroxy-7-azindole | ESD-844605-250MG |
Cas.: 74420-02-3 | Purity: 98% | 4-Hydroxy-7-azindole | ESD-844605-1G |
Cas.: 19718-49-1 | Purity: 98% | Methyl 4-amino-3-iodobenzoate | ESD-844608-1G |
Cas.: 19718-49-1 | Purity: 98% | Methyl 4-amino-3-iodobenzoate | ESD-844608-5G |
Cas.: 105603-49-4 | Purity: 98% | Methyl 5-bromo-2,3-dihydroxybenzoate | ESD-844609-50MG |
Cas.: 105603-49-4 | Purity: 98% | Methyl 5-bromo-2,3-dihydroxybenzoate | ESD-844609-250MG |
Cas.: 182181-19-7 | Purity: 98% | 6-Chloroimidazo[1,2-a]pyridine-2-carboxylic acid | ESD-844610-250MG |
Cas.: 182181-19-7 | Purity: 98% | 6-Chloroimidazo[1,2-a]pyridine-2-carboxylic acid | ESD-844610-1G |
Cas.: 305800-60-6 | Purity: 98% | 2-(5-Bromo-2-fluorophenyl)acetonitrile | ESD-844611-250MG |
Cas.: 305800-60-6 | Purity: 98% | 2-(5-Bromo-2-fluorophenyl)acetonitrile | ESD-844611-1G |
Cas.: 2469-99-0 | Purity: 97% | 3-Oxobutanenitrile | ESD-844612-250MG |
Cas.: 2469-99-0 | Purity: 97% | 3-Oxobutanenitrile | ESD-844612-1G |
Cas.: 34570-16-6 | Purity: 95% | Ethyl ethoxyacrylate hydrochloride | ESD-844614-1G |
Cas.: 34570-16-6 | Purity: 95% | Ethyl ethoxyacrylate hydrochloride | ESD-844614-10G |
Cas.: 837364-88-2 | Purity: 98% | 2,4-Difluoro-3-iodopyridine | ESD-844615-50MG |
Cas.: 837364-88-2 | Purity: 98% | 2,4-Difluoro-3-iodopyridine | ESD-844615-250MG |
Cas.: 36242-50-9 | Purity: 95% | Methyl 4-(methylamino)-3-nitrobenzoate | ESD-844616-250MG |
Cas.: 36242-50-9 | Purity: 95% | Methyl 4-(methylamino)-3-nitrobenzoate | ESD-844616-1G |
Cas.: 831203-34-0 | Purity: 97% | tert-Butyl 2-(5-bromopyridin-2-yl)-2-cyanoacetate | ESD-844617-250MG |
Cas.: 831203-34-0 | Purity: 97% | tert-Butyl 2-(5-bromopyridin-2-yl)-2-cyanoacetate | ESD-844617-1G |
Cas.: 185345-46-4 | Purity: 95% | 3-Bromo-5-fluoro-4-hydroxybenzaldehyde | ESD-844618-250MG |
Cas.: 185345-46-4 | Purity: 95% | 3-Bromo-5-fluoro-4-hydroxybenzaldehyde | ESD-844618-1G |
Cas.: 81012-94-4 | Purity: 98% | 2-Chloroadenosine hemihydrate | ESD-844620-250MG |
Cas.: 81012-94-4 | Purity: 98% | 2-Chloroadenosine hemihydrate | ESD-844620-1G |
Cas.: 90-45-9 | Purity: 98% | Acridin-9-amine | ESD-844621-250MG |
Cas.: 90-45-9 | Purity: 98% | Acridin-9-amine | ESD-844621-1G |
Cas.: 862539-91-1 | Purity: 97% | 1-(Bromomethyl)-4-fluoro-2-methylbenzene | ESD-844622-250MG |
Cas.: 862539-91-1 | Purity: 97% | 1-(Bromomethyl)-4-fluoro-2-methylbenzene | ESD-844622-1G |
Cas.: 66207-23-6 | Purity: 98% | Benzyl 5,6-dihydropyridine-1(2H)-carboxylate | ESD-844623-250MG |
Cas.: 66207-23-6 | Purity: 98% | Benzyl 5,6-dihydropyridine-1(2H)-carboxylate | ESD-844623-1G |
Cas.: 1084801-91-1 | Purity: 97% | Methyl 2-fluoro-5-hydroxybenzoate | ESD-844624-250MG |
Cas.: 1084801-91-1 | Purity: 97% | Methyl 2-fluoro-5-hydroxybenzoate | ESD-844624-1G |
Cas.: 37813-30-2 | Purity: 95% | Boc-Hyp-OEt | ESD-844625-250MG |
Cas.: 37813-30-2 | Purity: 95% | Boc-Hyp-OEt | ESD-844625-1G |
Cas.: 876-03-9 | Purity: 97% | 3-(Aminomethyl)benzoic acid hydrochloride | ESD-844626-250MG |
Cas.: 876-03-9 | Purity: 97% | 3-(Aminomethyl)benzoic acid hydrochloride | ESD-844626-1G |
Cas.: 380225-68-3 | Purity: 97% | 1-(2-Bromo-6-methoxyphenyl)ethanone | ESD-844627-250MG |
Cas.: 380225-68-3 | Purity: 97% | 1-(2-Bromo-6-methoxyphenyl)ethanone | ESD-844627-1G |
Cas.: 873107-98-3 | Purity: 98% | 5-Iodo-2-(trifluoromethyl)pyridine | ESD-844628-250MG |
Cas.: 1024583-33-2 | Purity: 97% | Methyl 2-bromobenzo[d]thiazole-6-carboxylate | ESD-844629-50MG |
Cas.: 1024583-33-2 | Purity: 97% | Methyl 2-bromobenzo[d]thiazole-6-carboxylate | ESD-844629-250MG |
Cas.: 81265-93-2 | Purity: 95% | 5′-O-DMT-2′-O-TBDMS-N-Bz-Adenosine | ESD-844630-50MG |
Cas.: 81265-93-2 | Purity: 95% | 5′-O-DMT-2′-O-TBDMS-N-Bz-Adenosine | ESD-844630-250MG |
Cas.: 613-51-4 | Purity: 98% | 7-Nitroquinoline | ESD-844631-250MG |
Cas.: 613-51-4 | Purity: 98% | 7-Nitroquinoline | ESD-844631-1G |
Cas.: 40851-95-4 | Purity: 98% | 6-Chloropyridine-2,3-diamine | ESD-844632-250MG |
Cas.: 40851-95-4 | Purity: 98% | 6-Chloropyridine-2,3-diamine | ESD-844632-1G |
Cas.: 98083-43-3 | Purity: 95% | 1-(5-Chloro-1H-indazol-1-yl)ethanone | ESD-844634-250MG |
Cas.: 98083-43-3 | Purity: 95% | 1-(5-Chloro-1H-indazol-1-yl)ethanone | ESD-844634-1G |
Cas.: 857530-80-4 | Purity: 97% | 3,5-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-844635-250MG |
Cas.: 857530-80-4 | Purity: 97% | 3,5-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-844635-1G |
Cas.: 72080-83-2 | Purity: 97% | Benzyl (2-aminoethyl)carbamate | ESD-844636-250MG |
Cas.: 72080-83-2 | Purity: 97% | Benzyl (2-aminoethyl)carbamate | ESD-844636-1G |
Cas.: 62642-62-0 | Purity: 98% | 4-(Morpholinomethyl)benzoic acid | ESD-844637-250MG |
Cas.: 62642-62-0 | Purity: 98% | 4-(Morpholinomethyl)benzoic acid | ESD-844637-1G |
Cas.: 1049785-94-5 | Purity: 95% | 2-(4-(tert-Butoxycarbonyl)piperazin-1-yl)acetic acid dihydrate | ESD-844638-250MG |
Cas.: 1049785-94-5 | Purity: 95% | 2-(4-(tert-Butoxycarbonyl)piperazin-1-yl)acetic acid dihydrate | ESD-844638-1G |
Cas.: 2967-54-6 | Purity: 96% | 3,5-Difluoro-4-hydroxybenzonitrile | ESD-844639-250MG |
Cas.: 2967-54-6 | Purity: 96% | 3,5-Difluoro-4-hydroxybenzonitrile | ESD-844639-1G |
Cas.: 26156-51-4 | Purity: 95% | Methyl 2-methoxyisonicotinate | ESD-844640-250MG |
Cas.: 26156-51-4 | Purity: 95% | Methyl 2-methoxyisonicotinate | ESD-844640-1G |
Cas.: 22717-56-2 | Purity: 98% | Methyl 4-bromo-2-hydroxybenzoate | ESD-844641-250MG |
Cas.: 22717-56-2 | Purity: 98% | Methyl 4-bromo-2-hydroxybenzoate | ESD-844641-1G |
Cas.: 102292-50-2 | Purity: 98% | 1-(2,6-Dichlorobenzyl)piperazine | ESD-844642-250MG |
Cas.: 102292-50-2 | Purity: 98% | 1-(2,6-Dichlorobenzyl)piperazine | ESD-844642-1G |
Cas.: 24621-70-3 | Purity: 98% | (1H-Indol-2-yl)methanol | ESD-844643-250MG |
Cas.: 24621-70-3 | Purity: 98% | (1H-Indol-2-yl)methanol | ESD-844643-1G |
Cas.: 94838-55-8 | Purity: 98% | 4-(N-Boc-Aminomethyl)aniline | ESD-844644-250MG |
Cas.: 94838-55-8 | Purity: 98% | 4-(N-Boc-Aminomethyl)aniline | ESD-844644-1G |
Cas.: 19128-48-4 | Purity: 98% | 2-Bromo-1-chloro-3-nitrobenzene | ESD-844645-250MG |
Cas.: 19128-48-4 | Purity: 98% | 2-Bromo-1-chloro-3-nitrobenzene | ESD-844645-1G |
Cas.: 72220-50-9 | Purity: 95% | 2-(4-(Trifluoromethoxy)phenoxy)acetic acid | ESD-844646-250MG |
Cas.: 72220-50-9 | Purity: 95% | 2-(4-(Trifluoromethoxy)phenoxy)acetic acid | ESD-844646-1G |
Cas.: 102-05-6 | Purity: 97% | Dibemethine | ESD-844647-250MG |
Cas.: 102-05-6 | Purity: 97% | Dibemethine | ESD-844647-1G |
Cas.: 169458-04-2 | Purity: 97% | Ethyl 2-(pipidin-4-yl)acetate hydrochloride | ESD-844648-250MG |
Cas.: 169458-04-2 | Purity: 97% | Ethyl 2-(pipidin-4-yl)acetate hydrochloride | ESD-844648-1G |
Cas.: 117324-58-0 | Purity: 98% | Methyl 2-amino-5-(trifluoromethyl)benzoate | ESD-844649-250MG |
Cas.: 117324-58-0 | Purity: 98% | Methyl 2-amino-5-(trifluoromethyl)benzoate | ESD-844649-1G |
Cas.: 330808-88-3 | Purity: 98% | Vardenafil hydrochloride trihydrate | ESD-844650-250MG |
Cas.: 330808-88-3 | Purity: 98% | Vardenafil hydrochloride trihydrate | ESD-844650-1G |
Cas.: 916488-42-1 | Purity: 98% | 1-(2-(Methylsulfonyl)phenyl)piperazine hydrochloride | ESD-844651-250MG |
Cas.: 916488-42-1 | Purity: 98% | 1-(2-(Methylsulfonyl)phenyl)piperazine hydrochloride | ESD-844651-1G |
Cas.: 914349-65-8 | Purity: 98% | 4-(4-(Bis(4-fluorophenyl)methyl)piperazin-1-yl)aniline | ESD-844652-250MG |
Cas.: 914349-65-8 | Purity: 98% | 4-(4-(Bis(4-fluorophenyl)methyl)piperazin-1-yl)aniline | ESD-844652-1G |
Cas.: 130636-61-2 | Purity: 98% | 1-Boc-4-(4-Nitrobenzyl)piperazine | ESD-844653-250MG |
Cas.: 130636-61-2 | Purity: 98% | 1-Boc-4-(4-Nitrobenzyl)piperazine | ESD-844653-1G |
Cas.: 74346-19-3 | Purity: 98% | 4-Bromo-2,6-dimethylbenzoic acid | ESD-844654-250MG |
Cas.: 74346-19-3 | Purity: 98% | 4-Bromo-2,6-dimethylbenzoic acid | ESD-844654-1G |
Cas.: 186685-89-2 | Purity: 97% | 2-(4-Formyl-2-methoxyphenoxy)acetamide | ESD-844655-250MG |
Cas.: 186685-89-2 | Purity: 97% | 2-(4-Formyl-2-methoxyphenoxy)acetamide | ESD-844655-1G |
Cas.: 1373253-26-9 | Purity: 95% | 3-Amino-1-benzhydryl-azetidine mesylate | ESD-844656-250MG |
Cas.: 1373253-26-9 | Purity: 95% | 3-Amino-1-benzhydryl-azetidine mesylate | ESD-844656-1G |
Cas.: 551952-55-7 | Purity: 95% | N-(2-(2,4,6-Trichlorophenoxy)ethyl)propan-1-amine hydrochloride | ESD-844657-250MG |
Cas.: 551952-55-7 | Purity: 95% | N-(2-(2,4,6-Trichlorophenoxy)ethyl)propan-1-amine hydrochloride | ESD-844657-1G |
Cas.: 71879-46-4 | Purity: 95% | 1-(4-(Methylamino)piperidin-1-yl)ethanone hydrochloride | ESD-844658-250MG |
Cas.: 71879-46-4 | Purity: 95% | 1-(4-(Methylamino)piperidin-1-yl)ethanone hydrochloride | ESD-844658-1G |
Cas.: 346691-23-4 | Purity: 97% | Methyl 2-amino-6-fluoro-3-nitrobenzoate | ESD-844659-250MG |
Cas.: 346691-23-4 | Purity: 97% | Methyl 2-amino-6-fluoro-3-nitrobenzoate | ESD-844659-1G |
Cas.: 916516-89-7 | Purity: 98% | 2-(4-Bromo-2-chlorophenyl)acetic acid | ESD-844660-250MG |
Cas.: 916516-89-7 | Purity: 98% | 2-(4-Bromo-2-chlorophenyl)acetic acid | ESD-844660-1G |
Cas.: 4925-88-6 | Purity: 98% | 2,5-Dimethoxy-4-methylbenzaldehyde | ESD-844661-250MG |
Cas.: 4925-88-6 | Purity: 98% | 2,5-Dimethoxy-4-methylbenzaldehyde | ESD-844661-1G |
Cas.: 391248-11-6 | Purity: 98% | 4-N-Fmoc-Amino-cyclohexanone | ESD-844662-250MG |
Cas.: 391248-11-6 | Purity: 98% | 4-N-Fmoc-Amino-cyclohexanone | ESD-844662-1G |
Cas.: 6716-98-9 | Purity: 97% | 4-(4-Fluorophenyl)piperidine hydrochloride | ESD-844663-250MG |
Cas.: 6716-98-9 | Purity: 97% | 4-(4-Fluorophenyl)piperidine hydrochloride | ESD-844663-1G |
Cas.: 364727-74-2 | Purity: 97% | 3-Hydrazinylpyridine dihydrochloride | ESD-844664-250MG |
Cas.: 364727-74-2 | Purity: 97% | 3-Hydrazinylpyridine dihydrochloride | ESD-844664-1G |
Cas.: 923565-91-7 | Purity: 95% | N-(3-Fluorophenyl)piperidin-4-amine hydrochloride | ESD-844665-250MG |
Cas.: 923565-91-7 | Purity: 95% | N-(3-Fluorophenyl)piperidin-4-amine hydrochloride | ESD-844665-1G |
Cas.: 623580-01-8 | Purity: 95% | 2,2-Dimethylpyrrolidine hydrochloride | ESD-844666-50MG |
Cas.: 623580-01-8 | Purity: 95% | 2,2-Dimethylpyrrolidine hydrochloride | ESD-844666-250MG |
Cas.: 351426-04-5 | Purity: 96% | 6-Bromo-4-chloro-2-methylquinazoline | ESD-844667-50MG |
Cas.: 351426-04-5 | Purity: 96% | 6-Bromo-4-chloro-2-methylquinazoline | ESD-844667-250MG |
Cas.: 64614-49-9 | Purity: 98% | (6-Chloropyridin-3-yl)(morpholino)methanone | ESD-844668-50MG |
Cas.: 64614-49-9 | Purity: 98% | (6-Chloropyridin-3-yl)(morpholino)methanone | ESD-844668-250MG |
Cas.: 1000801-76-2 | Purity: 95% | 1-(3-Methoxypropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-844669-50MG |
Cas.: 1000801-76-2 | Purity: 95% | 1-(3-Methoxypropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-844669-250MG |
Cas.: 83766-88-5 | Purity: 95% | 2-(tert-Butoxy)pyridine | ESD-844671-50MG |
Cas.: 83766-88-5 | Purity: 95% | 2-(tert-Butoxy)pyridine | ESD-844671-250MG |
Cas.: 1016231-39-2 | Purity: 97% | (2-Fluoro-3-iodophenyl)boronic acid | ESD-844672-250MG |
Cas.: 1016231-39-2 | Purity: 97% | (2-Fluoro-3-iodophenyl)boronic acid | ESD-844672-1G |
Cas.: 20304-86-3 | Purity: 98% | 5-Methylbenzo[c][1,2,5]oxadiazole | ESD-844673-250MG |
Cas.: 20304-86-3 | Purity: 98% | 5-Methylbenzo[c][1,2,5]oxadiazole | ESD-844673-1G |
Cas.: 41877-24-1 | Purity: 98% | 1-(5-Bromo-2-nitrophenyl)ethanone | ESD-844674-50MG |
Cas.: 41877-24-1 | Purity: 98% | 1-(5-Bromo-2-nitrophenyl)ethanone | ESD-844674-250MG |
Cas.: 1060816-67-2 | Purity: 97% | 2-Chloro-7-methyl-7H-pyrrolo[2,3-d]pyrimidine | ESD-844675-50MG |
Cas.: 1060816-67-2 | Purity: 97% | 2-Chloro-7-methyl-7H-pyrrolo[2,3-d]pyrimidine | ESD-844675-250MG |
Cas.: 19878-18-3 | Purity: 98% | trans-Ethyl 4-(aminomethyl)cyclohexanecarboxylate hydrochloride | ESD-844676-50MG |
Cas.: 19878-18-3 | Purity: 98% | trans-Ethyl 4-(aminomethyl)cyclohexanecarboxylate hydrochloride | ESD-844676-250MG |
Cas.: 132308-19-1 | Purity: 98% | Methyl 5-chloropyridine-2-carboxylate | ESD-844677-250MG |
Cas.: 132308-19-1 | Purity: 98% | Methyl 5-chloropyridine-2-carboxylate | ESD-844677-1G |
Cas.: 18711-15-4 | Purity: 98% | 4,6-Dichloroisatin | ESD-844678-250MG |
Cas.: 18711-15-4 | Purity: 98% | 4,6-Dichloroisatin | ESD-844678-1G |
Cas.: 124184-67-4 | Purity: 98% | Boc-D-Asp(OMe)-OH | ESD-844679-250MG |
Cas.: 124184-67-4 | Purity: 98% | Boc-D-Asp(OMe)-OH | ESD-844679-1G |
Cas.: 522-48-5 | Purity: 98% | Tetrahydrozoline hydrochloride | ESD-844680-250MG |
Cas.: 522-48-5 | Purity: 98% | Tetrahydrozoline hydrochloride | ESD-844680-1G |
Cas.: 21950-36-7 | Purity: 98% | 5′-Amino-5′-deoxy-2′,3′-O-(1-methylethylidene)-adenosine | ESD-844681-50MG |
Cas.: 21950-36-7 | Purity: 98% | 5′-Amino-5′-deoxy-2′,3′-O-(1-methylethylidene)-adenosine | ESD-844681-250MG |
Cas.: 100846-24-0 | Purity: 98% | 5-(Trifluoromethyl)indole | ESD-844682-50MG |
Cas.: 100846-24-0 | Purity: 98% | 5-(Trifluoromethyl)indole | ESD-844682-250MG |
Cas.: 56341-38-9 | Purity: 97% | 6-Methylindolin-2-one | ESD-844683-50MG |
Cas.: 56341-38-9 | Purity: 97% | 6-Methylindolin-2-one | ESD-844683-250MG |
Cas.: 77112-52-8 | Purity: 97% | Ethyl imidazo[1,2-a]pyrazine-2-carboxylate | ESD-844684-50MG |
Cas.: 77112-52-8 | Purity: 97% | Ethyl imidazo[1,2-a]pyrazine-2-carboxylate | ESD-844684-250MG |
Cas.: 73799-64-1 | Purity: 98% | 3-Azabicyclo[3.1.0]hexane hydrochloride | ESD-844685-50MG |
Cas.: 73799-64-1 | Purity: 98% | 3-Azabicyclo[3.1.0]hexane hydrochloride | ESD-844685-250MG |
Cas.: 1032231-24-5 | Purity: 97% | 2-Bromo-5-iodobenzaldehyde | ESD-844686-50MG |
Cas.: 1032231-24-5 | Purity: 97% | 2-Bromo-5-iodobenzaldehyde | ESD-844686-250MG |
Cas.: 219921-68-3 | Purity: 98% | 5-Amino-2-(pyrrolidin-1-yl)benzonitrile | ESD-844687-50MG |
Cas.: 219921-68-3 | Purity: 98% | 5-Amino-2-(pyrrolidin-1-yl)benzonitrile | ESD-844687-250MG |
Cas.: 478922-47-3 | Purity: 97% | (3R,5S)-5-(Hydroxymethyl)pyrrolidin-3-ol hydrochloride | ESD-844688-50MG |
Cas.: 478922-47-3 | Purity: 97% | (3R,5S)-5-(Hydroxymethyl)pyrrolidin-3-ol hydrochloride | ESD-844688-250MG |
Cas.: 356560-80-0 | Purity: 98% | 6-Bromo-[1,2,4]triazolo[1,5-a]pyridine | ESD-844689-250MG |
Cas.: 356560-80-0 | Purity: 98% | 6-Bromo-[1,2,4]triazolo[1,5-a]pyridine | ESD-844689-1G |
Cas.: 166176-45-0 | Purity: 97% | 6-Chloroimidazo[1,2-b]pyridazin-3-amine | ESD-844690-250MG |
Cas.: 166176-45-0 | Purity: 97% | 6-Chloroimidazo[1,2-b]pyridazin-3-amine | ESD-844690-1G |
Cas.: 88770-19-8 | Purity: 98% | Methyl 5-bromothiophene-3-carboxylate | ESD-844691-50MG |
Cas.: 88770-19-8 | Purity: 98% | Methyl 5-bromothiophene-3-carboxylate | ESD-844691-250MG |
Cas.: 1498333-87-1 | Purity: 95% | (4-(Pyridin-2-yl)phenyl)methanamine hydrochloride | ESD-844692-50MG |
Cas.: 1498333-87-1 | Purity: 95% | (4-(Pyridin-2-yl)phenyl)methanamine hydrochloride | ESD-844692-250MG |
Cas.: 181955-79-3 | Purity: 97% | 1,4-Di-Boc-piperazine-2-carboxylic acid | ESD-844693-250MG |
Cas.: 181955-79-3 | Purity: 97% | 1,4-Di-Boc-piperazine-2-carboxylic acid | ESD-844693-1G |
Cas.: 42466-67-1 | Purity: 95% | (E)-Ethyl 2-cyano-3-ethoxyacrylate | ESD-844694-250MG |
Cas.: 42466-67-1 | Purity: 95% | (E)-Ethyl 2-cyano-3-ethoxyacrylate | ESD-844694-1G |
Cas.: 1501-04-8 | Purity: 95% | Methyl 5-oxo-5-phenylpentanoate | ESD-844695-250MG |
Cas.: 1501-04-8 | Purity: 95% | Methyl 5-oxo-5-phenylpentanoate | ESD-844695-1G |
Cas.: 699-04-7 | Purity: 97% | N-Methyl-1-(p-tolyl)methanamine | ESD-844696-250MG |
Cas.: 699-04-7 | Purity: 97% | N-Methyl-1-(p-tolyl)methanamine | ESD-844696-1G |
Cas.: 67376-94-7 | Purity: 98% | N-Methylcyclopropanamine hydrochloride | ESD-844697-250MG |
Cas.: 67376-94-7 | Purity: 98% | N-Methylcyclopropanamine hydrochloride | ESD-844697-1G |
Cas.: 1031791-16-8 | Purity: 95% | 3-Cyclopropyl-1H-pyrazol-5-amine hydrochloride | ESD-844698-250MG |
Cas.: 1031791-16-8 | Purity: 95% | 3-Cyclopropyl-1H-pyrazol-5-amine hydrochloride | ESD-844698-1G |
Cas.: 88912-22-5 | Purity: 98% | 5-Chloro-2-methoxyisonicotinic acid | ESD-844699-250MG |
Cas.: 88912-22-5 | Purity: 98% | 5-Chloro-2-methoxyisonicotinic acid | ESD-844699-1G |
Cas.: 115619-00-6 | Purity: 95% | 1-Ethyl-4-(4-nitrophenyl)piperazine | ESD-844700-250MG |
Cas.: 115619-00-6 | Purity: 95% | 1-Ethyl-4-(4-nitrophenyl)piperazine | ESD-844700-1G |
Cas.: 5845-28-3 | Purity: 97% | 1-(2-Bromoethyl)-4-methylpiperazine dihydrobromide | ESD-844701-50MG |
Cas.: 5845-28-3 | Purity: 97% | 1-(2-Bromoethyl)-4-methylpiperazine dihydrobromide | ESD-844701-250MG |
Cas.: 1638487-45-2 | Purity: 97% | Methyl 2-(aminomethyl)-5-bromobenzoate hydrochloride | ESD-844702-50MG |
Cas.: 1638487-45-2 | Purity: 97% | Methyl 2-(aminomethyl)-5-bromobenzoate hydrochloride | ESD-844702-250MG |
Cas.: 6267-02-3 | Purity: 98% | 9,9-Dimethyl-9,10-dihydroacridine | ESD-844703-50MG |
Cas.: 6267-02-3 | Purity: 98% | 9,9-Dimethyl-9,10-dihydroacridine | ESD-844703-250MG |
Cas.: 32136-81-5 | Purity: 98% | 1-(4-Hydroxyphenyl)-2-methoxyethanone | ESD-844704-50MG |
Cas.: 32136-81-5 | Purity: 98% | 1-(4-Hydroxyphenyl)-2-methoxyethanone | ESD-844704-250MG |
Cas.: 287953-38-2 | Purity: 95% | tert-Butyl (1-(methylsulfonyl)piperidin-4-yl)carbamate | ESD-844705-50MG |
Cas.: 287953-38-2 | Purity: 95% | tert-Butyl (1-(methylsulfonyl)piperidin-4-yl)carbamate | ESD-844705-250MG |
Cas.: 58481-14-4 | Purity: 95% | Ethyl 2-cyanoisonicotinate | ESD-844706-50MG |
Cas.: 58481-14-4 | Purity: 95% | Ethyl 2-cyanoisonicotinate | ESD-844706-250MG |
Cas.: 443914-95-2 | Purity: 97% | 2-Bromo-1-(4-fluoro-3-methoxyphenyl)ethanone | ESD-844707-50MG |
Cas.: 443914-95-2 | Purity: 97% | 2-Bromo-1-(4-fluoro-3-methoxyphenyl)ethanone | ESD-844707-250MG |
Cas.: 166438-83-1 | Purity: 97% | (1-(4-Nitrophenyl)piperidin-3-yl)methanol | ESD-844708-50MG |
Cas.: 166438-83-1 | Purity: 97% | (1-(4-Nitrophenyl)piperidin-3-yl)methanol | ESD-844708-250MG |
Cas.: 255882-72-5 | Purity: 95% | Methyl 1-Boc-azetidine-2-carboxylate | ESD-844709-50MG |
Cas.: 255882-72-5 | Purity: 95% | Methyl 1-Boc-azetidine-2-carboxylate | ESD-844709-250MG |
Cas.: 54864-83-4 | Purity: 96% | 6-Chloro-N,N-dimethylnicotinamide | ESD-844710-50MG |
Cas.: 54864-83-4 | Purity: 96% | 6-Chloro-N,N-dimethylnicotinamide | ESD-844710-250MG |
Cas.: 1245647-61-3 | Purity: 95% | Methyl 5-fluoro-6-methylpicolinate | ESD-844711-50MG |
Cas.: 1245647-61-3 | Purity: 95% | Methyl 5-fluoro-6-methylpicolinate | ESD-844711-250MG |
Cas.: 179323-60-5 | Purity: 98% | 1-(Pyrazin-2-yl)ethanamine | ESD-844712-50MG |
Cas.: 179323-60-5 | Purity: 98% | 1-(Pyrazin-2-yl)ethanamine | ESD-844712-250MG |
Cas.: 308386-36-9 | Purity: 95% | 4-(Piperidin-4-yloxy)pyridine dihydrochloride | ESD-844713-50MG |
Cas.: 308386-36-9 | Purity: 95% | 4-(Piperidin-4-yloxy)pyridine dihydrochloride | ESD-844713-250MG |
Cas.: 5094-12-2 | Purity: 98% | 2-Methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole | ESD-844714-50MG |
Cas.: 5094-12-2 | Purity: 98% | 2-Methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole | ESD-844714-250MG |
Cas.: 65515-32-4 | Purity: 98% | Methyl 6-chloro-2-methoxynicotinate | ESD-844715-50MG |
Cas.: 65515-32-4 | Purity: 98% | Methyl 6-chloro-2-methoxynicotinate | ESD-844715-250MG |
Cas.: 3697-68-5 | Purity: 98% | Ethyl 1-(hydroxymethyl)cyclopropanecarboxylate | ESD-844716-50MG |
Cas.: 3697-68-5 | Purity: 98% | Ethyl 1-(hydroxymethyl)cyclopropanecarboxylate | ESD-844716-250MG |
Cas.: 1393440-06-6 | Purity: 95% | (4R,5R)-3-tert-Butyl 4-methyl 2,2,5-trimethyloxazolidine-3,4-dicarboxylate | ESD-844717-50MG |
Cas.: 1393440-06-6 | Purity: 95% | (4R,5R)-3-tert-Butyl 4-methyl 2,2,5-trimethyloxazolidine-3,4-dicarboxylate | ESD-844717-250MG |
Cas.: 1210247-51-0 | Purity: 96% | 6-Fluoro-3,4-dihydro-2H-benzo[b][1,4]oxazine hydrochloride | ESD-844718-50MG |
Cas.: 1210247-51-0 | Purity: 96% | 6-Fluoro-3,4-dihydro-2H-benzo[b][1,4]oxazine hydrochloride | ESD-844718-250MG |
Cas.: 239074-27-2 | Purity: 97% | tert-Butyl (4-(bromomethyl)phenyl)carbamate | ESD-844719-50MG |
Cas.: 239074-27-2 | Purity: 97% | tert-Butyl (4-(bromomethyl)phenyl)carbamate | ESD-844719-250MG |
Cas.: 1227157-98-3 | Purity: 95% | (R)-Pyrrolidin-3-ylmethanol hydrochloride | ESD-844720-50MG |
Cas.: 1227157-98-3 | Purity: 95% | (R)-Pyrrolidin-3-ylmethanol hydrochloride | ESD-844720-250MG |
Cas.: 90110-98-8 | Purity: 98% | 3-Bromo-4-(hydroxymethyl)benzonitrile | ESD-844721-50MG |
Cas.: 90110-98-8 | Purity: 98% | 3-Bromo-4-(hydroxymethyl)benzonitrile | ESD-844721-250MG |
Cas.: 1263285-73-9 | Purity: 97% | 5-Acetyl-2-bromobenzonitrile | ESD-844722-50MG |
Cas.: 1263285-73-9 | Purity: 97% | 5-Acetyl-2-bromobenzonitrile | ESD-844722-250MG |
Cas.: 2939-05-1 | Purity: 95% | 2-(Bromomethyl)-1H-imidazole hydrobromide | ESD-844723-50MG |
Cas.: 2939-05-1 | Purity: 95% | 2-(Bromomethyl)-1H-imidazole hydrobromide | ESD-844723-250MG |
Cas.: 20733-10-2 | Purity: 97% | 4-Hydroxypyridazine | ESD-844724-50MG |
Cas.: 20733-10-2 | Purity: 97% | 4-Hydroxypyridazine | ESD-844724-250MG |
Cas.: 95538-03-7 | Purity: 98% | 2,3-Dibromopyrazine | ESD-844725-50MG |
Cas.: 95538-03-7 | Purity: 98% | 2,3-Dibromopyrazine | ESD-844725-250MG |
Cas.: 80353-94-2 | Purity: 95% | 7-Methylimidazo[1,2-a]pyridine-2-carboxylic acid | ESD-844726-250MG |
Cas.: 80353-94-2 | Purity: 95% | 7-Methylimidazo[1,2-a]pyridine-2-carboxylic acid | ESD-844726-1G |
Cas.: 508233-74-7 | Purity: 98% | Vortioxetine | ESD-844727-50MG |
Cas.: 508233-74-7 | Purity: 98% | Vortioxetine | ESD-844727-250MG |
Cas.: 53581-86-5 | Purity: 97% | 4-Chloro-2-methoxybenzaldehyde | ESD-844728-250MG |
Cas.: 53581-86-5 | Purity: 97% | 4-Chloro-2-methoxybenzaldehyde | ESD-844728-1G |
Cas.: 928715-37-1 | Purity: 98% | 1-(2-Bromo-6-fluorophenyl)ethanone | ESD-844729-250MG |
Cas.: 928715-37-1 | Purity: 98% | 1-(2-Bromo-6-fluorophenyl)ethanone | ESD-844729-1G |
Cas.: 937063-34-8 | Purity: 97% | Methyl morpholine-2-carboxylate hydrochloride | ESD-844730-250MG |
Cas.: 937063-34-8 | Purity: 97% | Methyl morpholine-2-carboxylate hydrochloride | ESD-844730-1G |
Cas.: 71985-81-4 | Purity: 95% | 2-(Piperidin-3-yl)acetic acid hydrochloride | ESD-844731-250MG |
Cas.: 71985-81-4 | Purity: 95% | 2-(Piperidin-3-yl)acetic acid hydrochloride | ESD-844731-1G |
Cas.: 534602-47-6 | Purity: 97% | 1-(tert-Butoxycarbonyl)-3-methylpiperidine-3-carboxylic acid | ESD-844732-250MG |
Cas.: 534602-47-6 | Purity: 97% | 1-(tert-Butoxycarbonyl)-3-methylpiperidine-3-carboxylic acid | ESD-844732-1G |
Cas.: 169468-83-1 | Purity: 98% | 2-Chloro-3,4-difluoronitrobenzene | ESD-844733-250MG |
Cas.: 169468-83-1 | Purity: 98% | 2-Chloro-3,4-difluoronitrobenzene | ESD-844733-1G |
Cas.: 946525-30-0 | Purity: 98% | (2-Bromo-5-iodophenyl)methanol | ESD-844734-1G |
Cas.: 946525-30-0 | Purity: 98% | (2-Bromo-5-iodophenyl)methanol | ESD-844734-5G |
Cas.: 28165-50-6 | Purity: 97% | 2-Amino-6-bromophenol | ESD-844735-1G |
Cas.: 28165-50-6 | Purity: 97% | 2-Amino-6-bromophenol | ESD-844735-5G |
Cas.: 1256826-55-7 | Purity: 98% | Methyl 4-chloro-2-methoxynicotinate | ESD-844736-50MG |
Cas.: 1256826-55-7 | Purity: 98% | Methyl 4-chloro-2-methoxynicotinate | ESD-844736-250MG |
Cas.: 889940-13-0 | Purity: 97% | 3,3,3-Trifluoro-2,2-dimethylpropanoic acid | ESD-844737-250MG |
Cas.: 889940-13-0 | Purity: 97% | 3,3,3-Trifluoro-2,2-dimethylpropanoic acid | ESD-844737-1G |
Cas.: 6840-45-5 | Purity: 98% | 3-Bromoimidazo[1,2-a]pyrimidine | ESD-844738-250MG |
Cas.: 6840-45-5 | Purity: 98% | 3-Bromoimidazo[1,2-a]pyrimidine | ESD-844738-1G |
Cas.: 847170-51-8 | Purity: 98% | 1-(4-Chloro-3-nitrobenzenesulfonyl)-1,2,3,4-tetrahydroquinoline | ESD-844739-250MG |
Cas.: 847170-51-8 | Purity: 98% | 1-(4-Chloro-3-nitrobenzenesulfonyl)-1,2,3,4-tetrahydroquinoline | ESD-844739-1G |
Cas.: 17334-09-7 | Purity: 96% | Methyl 1H-imidazole-2-carboxylate | ESD-844740-250MG |
Cas.: 17334-09-7 | Purity: 96% | Methyl 1H-imidazole-2-carboxylate | ESD-844740-1G |
Cas.: 889865-45-6 | Purity: 95% | 2,3-Dichloro-4-iodopyridine | ESD-844741-250MG |
Cas.: 889865-45-6 | Purity: 95% | 2,3-Dichloro-4-iodopyridine | ESD-844741-1G |
Cas.: 21594-52-5 | Purity: 98% | 6-Bromo-3H-oxazolo[4,5-b]pyridin-2-one | ESD-844743-250MG |
Cas.: 21594-52-5 | Purity: 98% | 6-Bromo-3H-oxazolo[4,5-b]pyridin-2-one | ESD-844743-1G |
Cas.: 113808-86-9 | Purity: 98% | 3,5-Dimethyl-1H-pyrazole-4-carboxylic acid | ESD-844744-250MG |
Cas.: 113808-86-9 | Purity: 98% | 3,5-Dimethyl-1H-pyrazole-4-carboxylic acid | ESD-844744-1G |
Cas.: 459133-66-5 | Purity: 98% | 5-Bromo-3-iodo-1H-indazole | ESD-844745-250MG |
Cas.: 459133-66-5 | Purity: 98% | 5-Bromo-3-iodo-1H-indazole | ESD-844745-1G |
Cas.: 618-30-4 | Purity: 97% | 5-Chlorofuran-2-carboxylic acid | ESD-844746-250MG |
Cas.: 618-30-4 | Purity: 97% | 5-Chlorofuran-2-carboxylic acid | ESD-844746-1G |
Cas.: 749849-14-7 | Purity: 98% | 6-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid | ESD-844747-250MG |
Cas.: 749849-14-7 | Purity: 98% | 6-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid | ESD-844747-1G |
Cas.: 137-51-9 | Purity: 97% | 4-Aminobenzene-1,3-disulfonic acid | ESD-844748-250MG |
Cas.: 137-51-9 | Purity: 97% | 4-Aminobenzene-1,3-disulfonic acid | ESD-844748-1G |
Cas.: 99359-32-7 | Purity: 97% | H-Phe(4-Br)-Ome.HCl | ESD-844749-250MG |
Cas.: 99359-32-7 | Purity: 97% | H-Phe(4-Br)-Ome.HCl | ESD-844749-1G |
Cas.: 252932-49-3 | Purity: 97% | Ethyl 3-amino-1H-pyrrole-2-carboxylate hydrochloride | ESD-844750-250MG |
Cas.: 252932-49-3 | Purity: 97% | Ethyl 3-amino-1H-pyrrole-2-carboxylate hydrochloride | ESD-844750-1G |
Cas.: 5307-05-1 | Purity: 98% | 4-Hydroxy-3-methylanisol | ESD-844751-250MG |
Cas.: 5307-05-1 | Purity: 98% | 4-Hydroxy-3-methylanisol | ESD-844751-1G |
Cas.: 1588441-21-7 | Purity: 95% | 4-Chloro-6-hydrazinylpyrimidine hydrate | ESD-844752-250MG |
Cas.: 1588441-21-7 | Purity: 95% | 4-Chloro-6-hydrazinylpyrimidine hydrate | ESD-844752-1G |
Cas.: 372089-59-3 | Purity: 97% | Methyl 6-bromo-1H-indole-2-carboxylate | ESD-844753-250MG |
Cas.: 372089-59-3 | Purity: 97% | Methyl 6-bromo-1H-indole-2-carboxylate | ESD-844753-1G |
Cas.: 78468-34-5 | Purity: 98% | 2-Amino-4-nitrobenzenemethanol | ESD-844754-250MG |
Cas.: 78468-34-5 | Purity: 98% | 2-Amino-4-nitrobenzenemethanol | ESD-844754-1G |
Cas.: 914349-14-7 | Purity: 95% | tert-Butyl 5-(benzyloxy)-3-(hydroxymethyl)-1H-indole-1-carboxylate | ESD-844755-250MG |
Cas.: 914349-14-7 | Purity: 95% | tert-Butyl 5-(benzyloxy)-3-(hydroxymethyl)-1H-indole-1-carboxylate | ESD-844755-1G |
Cas.: 261762-97-4 | Purity: 97% | 2-(5-Chloro-2-fluorophenyl)acetic acid | ESD-844756-250MG |
Cas.: 261762-97-4 | Purity: 97% | 2-(5-Chloro-2-fluorophenyl)acetic acid | ESD-844756-1G |
Cas.: 161957-61-5 | Purity: 98% | 1-(3-Bromo-2-fluorophenyl)ethanone | ESD-844757-250MG |
Cas.: 161957-61-5 | Purity: 98% | 1-(3-Bromo-2-fluorophenyl)ethanone | ESD-844757-1G |
Cas.: 163260-77-3 | Purity: 95% | 4-(Pyrrolidin-1-yl)aniline dihydrochloride | ESD-844758-250MG |
Cas.: 163260-77-3 | Purity: 95% | 4-(Pyrrolidin-1-yl)aniline dihydrochloride | ESD-844758-1G |
Cas.: 130309-37-4 | Purity: 98% | Fmoc-Oic-OH | ESD-844759-50MG |
Cas.: 130309-37-4 | Purity: 98% | Fmoc-Oic-OH | ESD-844759-250MG |
Cas.: 1023301-84-9 | Purity: 97% | tert-Butyl 2,7-diazaspiro[3.5]nonane-7-carboxylate hydrochloride | ESD-844760-50MG |
Cas.: 1023301-84-9 | Purity: 97% | tert-Butyl 2,7-diazaspiro[3.5]nonane-7-carboxylate hydrochloride | ESD-844760-250MG |
Cas.: 1151802-22-0 | Purity: 95% | 1-Cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-844761-50MG |
Cas.: 1151802-22-0 | Purity: 95% | 1-Cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-844761-250MG |
Cas.: 1462950-92-0 | Purity: 95% | 1-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine hydrochloride | ESD-844762-50MG |
Cas.: 1462950-92-0 | Purity: 95% | 1-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine hydrochloride | ESD-844762-250MG |
Cas.: 362609-92-5 | Purity: 95% | 2-(Benzo[d][1,3]dioxol-5-yl)-2-oxoacetaldehyde hydrate | ESD-844763-250MG |
Cas.: 362609-92-5 | Purity: 95% | 2-(Benzo[d][1,3]dioxol-5-yl)-2-oxoacetaldehyde hydrate | ESD-844763-1G |
Cas.: 34091-51-5 | Purity: 97% | 5-Iodo-1-methyl-1H-pyrazole | ESD-844764-250MG |
Cas.: 34091-51-5 | Purity: 97% | 5-Iodo-1-methyl-1H-pyrazole | ESD-844764-1G |
Cas.: 150319-83-8 | Purity: 95% | Methyl 2-(3-aminophenyl)acetate hydrochloride | ESD-844765-250MG |
Cas.: 150319-83-8 | Purity: 95% | Methyl 2-(3-aminophenyl)acetate hydrochloride | ESD-844765-1G |
Cas.: 6406-74-2 | Purity: 97% | 4-((Dimethylamino)methyl)aniline | ESD-844766-250MG |
Cas.: 6406-74-2 | Purity: 97% | 4-((Dimethylamino)methyl)aniline | ESD-844766-1G |
Cas.: 105191-41-1 | Purity: 98% | 4-Chloro-3-formylbenzonitrile | ESD-844767-250MG |
Cas.: 105191-41-1 | Purity: 98% | 4-Chloro-3-formylbenzonitrile | ESD-844767-1G |
Cas.: 1216620-65-3 | Purity: 95% | N,N-DiBoc-2-amino-4-bromopyridine | ESD-844768-50MG |
Cas.: 1216620-65-3 | Purity: 95% | N,N-DiBoc-2-amino-4-bromopyridine | ESD-844768-250MG |
Cas.: 1214686-81-3 | Purity: 97% | Methyl morpholine-3-carboxylate hydrochloride | ESD-844769-50MG |
Cas.: 1214686-81-3 | Purity: 97% | Methyl morpholine-3-carboxylate hydrochloride | ESD-844769-250MG |
Cas.: 83683-82-3 | Purity: 98% | 4-Nitro-7-azindole | ESD-844770-50MG |
Cas.: 83683-82-3 | Purity: 98% | 4-Nitro-7-azindole | ESD-844770-250MG |
Cas.: 76196-79-7 | Purity: 98% | Ethyl 6-cyanonicotinate | ESD-844771-50MG |
Cas.: 76196-79-7 | Purity: 98% | Ethyl 6-cyanonicotinate | ESD-844771-250MG |
Cas.: 74531-15-0 | Purity: 98% | 4,5-Dimethylthiazole-2-carbaldehyde | ESD-844772-250MG |
Cas.: 74531-15-0 | Purity: 98% | 4,5-Dimethylthiazole-2-carbaldehyde | ESD-844772-1G |
Cas.: 787585-29-9 | Purity: 98% | Methyl 2-(3-fluoro-4-methylphenyl)acetate | ESD-844773-250MG |
Cas.: 787585-29-9 | Purity: 98% | Methyl 2-(3-fluoro-4-methylphenyl)acetate | ESD-844773-1G |
Cas.: 38739-13-8 | Purity: 97% | (S)-2-Amino-3-(3-bromo-4-hydroxyphenyl)propanoic acid | ESD-844774-250MG |
Cas.: 38739-13-8 | Purity: 97% | (S)-2-Amino-3-(3-bromo-4-hydroxyphenyl)propanoic acid | ESD-844774-1G |
Cas.: 79722-21-7 | Purity: 97% | tert-Butyl benzyloxycarbamate | ESD-844775-1G |
Cas.: 79722-21-7 | Purity: 97% | tert-Butyl benzyloxycarbamate | ESD-844775-5G |
Cas.: 169048-83-3 | Purity: 95% | (S)-5-(Chloromethyl)oxazolidin-2-one | ESD-844776-250MG |
Cas.: 169048-83-3 | Purity: 95% | (S)-5-(Chloromethyl)oxazolidin-2-one | ESD-844776-1G |
Cas.: 4370-22-3 | Purity: 95% | 2-(Chloromethyl)-3-methylpyridine hydrochloride | ESD-844777-50MG |
Cas.: 4370-22-3 | Purity: 95% | 2-(Chloromethyl)-3-methylpyridine hydrochloride | ESD-844777-250MG |
Cas.: 59839-23-5 | Purity: 97% | 1,2,3,4-Tetrahydroisoquinolin-6-ol hydrobrimide | ESD-844778-50MG |
Cas.: 59839-23-5 | Purity: 97% | 1,2,3,4-Tetrahydroisoquinolin-6-ol hydrobrimide | ESD-844778-250MG |
Cas.: 1677-48-1 | Purity: 96% | 5,6-Dichloroindoline-2,3-dione | ESD-844779-50MG |
Cas.: 1677-48-1 | Purity: 96% | 5,6-Dichloroindoline-2,3-dione | ESD-844779-250MG |
Cas.: 274910-19-9 | Purity: 97% | (2,3-Dihydrobenzo[b][1,4]dioxin-5-yl)methanol | ESD-844780-50MG |
Cas.: 274910-19-9 | Purity: 97% | (2,3-Dihydrobenzo[b][1,4]dioxin-5-yl)methanol | ESD-844780-250MG |
Cas.: 943751-93-7 | Purity: 98% | 7-Bromo-1,2-dihydroisoquinolin-3(4H)-one | ESD-844781-50MG |
Cas.: 943751-93-7 | Purity: 98% | 7-Bromo-1,2-dihydroisoquinolin-3(4H)-one | ESD-844781-250MG |
Cas.: 1189983-26-3 | Purity: 97% | Ethyl 2-(aminomethyl)isonicotinate hydrochloride | ESD-844782-50MG |
Cas.: 1189983-26-3 | Purity: 97% | Ethyl 2-(aminomethyl)isonicotinate hydrochloride | ESD-844782-250MG |
Cas.: 129012-04-0 | Purity: 97% | 6-Bromopyridine-2,3-diamine | ESD-844783-50MG |
Cas.: 129012-04-0 | Purity: 97% | 6-Bromopyridine-2,3-diamine | ESD-844783-250MG |
Cas.: 25625-57-4 | Purity: 98% | 2-Bromo-N-(3-(trifluoromethyl)phenyl)acetamide | ESD-844784-50MG |
Cas.: 25625-57-4 | Purity: 98% | 2-Bromo-N-(3-(trifluoromethyl)phenyl)acetamide | ESD-844784-250MG |
Cas.: 209459-11-0 | Purity: 97% | Methyl 2-aminobenzo[d]thiazole-7-carboxylate | ESD-844785-50MG |
Cas.: 209459-11-0 | Purity: 97% | Methyl 2-aminobenzo[d]thiazole-7-carboxylate | ESD-844785-250MG |
Cas.: 849237-14-5 | Purity: 98% | 1-Boc-4-(4-Cyanobenzyl)piperazine | ESD-844786-50MG |
Cas.: 849237-14-5 | Purity: 98% | 1-Boc-4-(4-Cyanobenzyl)piperazine | ESD-844786-250MG |
Cas.: 56962-13-1 | Purity: 95% | 2,4-Dichloro-3-hydroxybenzaldehyde | ESD-844788-50MG |
Cas.: 56962-13-1 | Purity: 95% | 2,4-Dichloro-3-hydroxybenzaldehyde | ESD-844788-250MG |
Cas.: 68963-75-7 | Purity: 97% | 4,6-Dichloropyridin-2(1H)-one | ESD-844789-50MG |
Cas.: 68963-75-7 | Purity: 97% | 4,6-Dichloropyridin-2(1H)-one | ESD-844789-250MG |
Cas.: 1060804-39-8 | Purity: 97% | 3-Fluoro-5-nitropyridine | ESD-844790-50MG |
Cas.: 1060804-39-8 | Purity: 97% | 3-Fluoro-5-nitropyridine | ESD-844790-250MG |
Cas.: 1187451-28-0 | Purity: 97% | (4-(Thiazol-2-yl)phenyl)methanamine hydrochloride | ESD-844791-50MG |
Cas.: 1187451-28-0 | Purity: 97% | (4-(Thiazol-2-yl)phenyl)methanamine hydrochloride | ESD-844791-250MG |
Cas.: 774608-89-8 | Purity: 98% | Ethyl 5-bromo-1H-1,2,4-triazole-3-carboxylate | ESD-844792-50MG |
Cas.: 774608-89-8 | Purity: 98% | Ethyl 5-bromo-1H-1,2,4-triazole-3-carboxylate | ESD-844792-250MG |
Cas.: 42538-31-8 | Purity: 97% | (S)-3-Aminopipidin-2-one hydrochloride | ESD-844793-50MG |
Cas.: 42538-31-8 | Purity: 97% | (S)-3-Aminopipidin-2-one hydrochloride | ESD-844793-250MG |
Cas.: 173405-78-2 | Purity: 97% | 3-Boc-3,9-Diazaspiro[5.5]undecane | ESD-844794-50MG |
Cas.: 173405-78-2 | Purity: 97% | 3-Boc-3,9-Diazaspiro[5.5]undecane | ESD-844794-250MG |
Cas.: 198821-79-3 | Purity: 98% | 3-Methoxy-4-(oxazol-5-yl)aniline | ESD-844795-50MG |
Cas.: 198821-79-3 | Purity: 98% | 3-Methoxy-4-(oxazol-5-yl)aniline | ESD-844795-250MG |
Cas.: 1138445-61-0 | Purity: 95% | 2-Bromo-N-hexadecylacetamide | ESD-844796-250MG |
Cas.: 1138445-61-0 | Purity: 95% | 2-Bromo-N-hexadecylacetamide | ESD-844796-1G |
Cas.: 288315-03-7 | Purity: 98% | 3,3-Difluoroazetidine hydrochloride | ESD-844797-250MG |
Cas.: 288315-03-7 | Purity: 98% | 3,3-Difluoroazetidine hydrochloride | ESD-844797-1G |
Cas.: 13096-96-3 | Purity: 95% | 4-Chloro-1H-indazole | ESD-844798-250MG |
Cas.: 13096-96-3 | Purity: 95% | 4-Chloro-1H-indazole | ESD-844798-1G |
Cas.: 115170-40-6 | Purity: 98% | 5-Bromo-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine | ESD-844799-250MG |
Cas.: 115170-40-6 | Purity: 98% | 5-Bromo-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine | ESD-844799-1G |
Cas.: 71079-03-3 | Purity: 97% | 2-Amino-2-(4-bromophenyl)acetic acid | ESD-844800-250MG |
Cas.: 71079-03-3 | Purity: 97% | 2-Amino-2-(4-bromophenyl)acetic acid | ESD-844800-1G |
Cas.: 115630-49-4 | Purity: 97% | H-DL-Pro-NH2.HCl | ESD-844801-250MG |
Cas.: 115630-49-4 | Purity: 97% | H-DL-Pro-NH2.HCl | ESD-844801-1G |
Cas.: 1189684-40-9 | Purity: 97% | 1-(Piperidine-4-carbonyl)piperidine-4-one hydrochloride | ESD-844802-250MG |
Cas.: 1189684-40-9 | Purity: 97% | 1-(Piperidine-4-carbonyl)piperidine-4-one hydrochloride | ESD-844802-1G |
Cas.: 122263-03-0 | Purity: 97% | 2-Acetoxy-2′,4′-difluoroacetophenone | ESD-844803-250MG |
Cas.: 122263-03-0 | Purity: 97% | 2-Acetoxy-2′,4′-difluoroacetophenone | ESD-844803-1G |
Cas.: 679394-11-7 | Purity: 95% | N-(4-Bromo-1-methyl-1H-pyrazol-5-yl)pivalamide | ESD-844804-250MG |
Cas.: 679394-11-7 | Purity: 95% | N-(4-Bromo-1-methyl-1H-pyrazol-5-yl)pivalamide | ESD-844804-1G |
Cas.: 86239-00-1 | Purity: 98% | Ethyl 3-fluoro-4-methylbenzoate | ESD-844805-250MG |
Cas.: 86239-00-1 | Purity: 98% | Ethyl 3-fluoro-4-methylbenzoate | ESD-844805-1G |
Cas.: 110301-23-0 | Purity: 98% | 4-Amino-3,5-difluorobenzonitrile | ESD-844806-250MG |
Cas.: 110301-23-0 | Purity: 98% | 4-Amino-3,5-difluorobenzonitrile | ESD-844806-1G |
Cas.: 851472-82-7 | Purity: 98% | 1-(Bis(4-fluorophenyl)methyl)-4-(4-nitrophenyl)piperazine | ESD-844807-250MG |
Cas.: 851472-82-7 | Purity: 98% | 1-(Bis(4-fluorophenyl)methyl)-4-(4-nitrophenyl)piperazine | ESD-844807-1G |
Cas.: 1330-70-7 | Purity: 95% | 2-Hydroxyoctadecanoic acid | ESD-844808-250MG |
Cas.: 1330-70-7 | Purity: 95% | 2-Hydroxyoctadecanoic acid | ESD-844808-1G |
Cas.: 132178-78-0 | Purity: 97% | 1,5-Dibromonaphthalene-2,6-diol | ESD-844809-250MG |
Cas.: 132178-78-0 | Purity: 97% | 1,5-Dibromonaphthalene-2,6-diol | ESD-844809-1G |
Cas.: 928664-98-6 | Purity: 98% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)isoxazole | ESD-844810-50MG |
Cas.: 928664-98-6 | Purity: 98% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)isoxazole | ESD-844810-250MG |
Cas.: 403854-21-7 | Purity: 98% | 4,5-Dichloropyrimidin-2-amine | ESD-844811-50MG |
Cas.: 403854-21-7 | Purity: 98% | 4,5-Dichloropyrimidin-2-amine | ESD-844811-250MG |
Cas.: 871332-76-2 | Purity: 98% | (4-Chloro-3-(dimethylcarbamoyl)phenyl)boronic acid | ESD-844812-50MG |
Cas.: 871332-76-2 | Purity: 98% | (4-Chloro-3-(dimethylcarbamoyl)phenyl)boronic acid | ESD-844812-250MG |
Cas.: 1112982-76-9 | Purity: 95% | N-(5-Bromothiazolo[5,4-b]pyridin-2-yl)acetamide | ESD-844813-50MG |
Cas.: 1112982-76-9 | Purity: 95% | N-(5-Bromothiazolo[5,4-b]pyridin-2-yl)acetamide | ESD-844813-250MG |
Cas.: 13626-60-3 | Purity: 97% | 3-Hydroxyisoxazole-5-carboxylic acid | ESD-844814-50MG |
Cas.: 13626-60-3 | Purity: 97% | 3-Hydroxyisoxazole-5-carboxylic acid | ESD-844814-250MG |
Cas.: 85107-56-8 | Purity: 98% | (4-(Methoxycarbonyl)-3-nitrophenyl)boronic acid | ESD-844815-50MG |
Cas.: 85107-56-8 | Purity: 98% | (4-(Methoxycarbonyl)-3-nitrophenyl)boronic acid | ESD-844815-250MG |
Cas.: 21440-97-1 | Purity: 97% | 6-Bromo-4,4-dimethyl-1,4-dihydrobenzo[d][1,3]oxazin-2-one | ESD-844816-50MG |
Cas.: 21440-97-1 | Purity: 97% | 6-Bromo-4,4-dimethyl-1,4-dihydrobenzo[d][1,3]oxazin-2-one | ESD-844816-250MG |
Cas.: 796969-15-8 | Purity: 98% | 4-Bromobenzo[d]isoxazol-3-amine | ESD-844817-50MG |
Cas.: 796969-15-8 | Purity: 98% | 4-Bromobenzo[d]isoxazol-3-amine | ESD-844817-250MG |
Cas.: 165894-10-0 | Purity: 95% | 5,6,7,8-Tetrahydroimidazo[1,5-a]pyrazine dihydrochloride | ESD-844818-50MG |
Cas.: 165894-10-0 | Purity: 95% | 5,6,7,8-Tetrahydroimidazo[1,5-a]pyrazine dihydrochloride | ESD-844818-250MG |
Cas.: 860624-90-4 | Purity: 97% | 5-Bromo-1H-indole-7-carboxylic acid | ESD-844819-50MG |
Cas.: 860624-90-4 | Purity: 97% | 5-Bromo-1H-indole-7-carboxylic acid | ESD-844819-250MG |
Cas.: 862730-04-9 | Purity: 97% | 3-Iodo-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine | ESD-844820-50MG |
Cas.: 862730-04-9 | Purity: 97% | 3-Iodo-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine | ESD-844820-250MG |
Cas.: 87698-82-6 | Purity: 97% | 4-(2-Bromophenyl)morpholine | ESD-844821-50MG |
Cas.: 87698-82-6 | Purity: 97% | 4-(2-Bromophenyl)morpholine | ESD-844821-250MG |
Cas.: 90004-04-9 | Purity: 98% | 1H-Indazole-3-carboxamide | ESD-844822-50MG |
Cas.: 90004-04-9 | Purity: 98% | 1H-Indazole-3-carboxamide | ESD-844822-250MG |
Cas.: 1214330-79-6 | Purity: 97% | 3-Chloro-5-fluoropyridin-2-amine | ESD-844823-50MG |
Cas.: 1214330-79-6 | Purity: 97% | 3-Chloro-5-fluoropyridin-2-amine | ESD-844823-250MG |
Cas.: 478163-35-8 | Purity: 95% | (2-Fluoro-6-methylphenyl)methanol | ESD-844824-50MG |
Cas.: 478163-35-8 | Purity: 95% | (2-Fluoro-6-methylphenyl)methanol | ESD-844824-250MG |
Cas.: 35726-62-6 | Purity: 97% | (S)-2-(((Benzyloxy)carbonyl)amino)-5-ethoxy-5-oxopentanoic acid | ESD-844825-250MG |
Cas.: 35726-62-6 | Purity: 97% | (S)-2-(((Benzyloxy)carbonyl)amino)-5-ethoxy-5-oxopentanoic acid | ESD-844825-1G |
Cas.: 71702-01-7 | Purity: 98% | 5-Bromo-6-chloronicotinonitrile | ESD-844826-250MG |
Cas.: 71702-01-7 | Purity: 98% | 5-Bromo-6-chloronicotinonitrile | ESD-844826-1G |
Cas.: 1849-76-9 | Purity: 98% | 3-Bromo-5-chloro-4-hydroxybenzaldehyde | ESD-844827-250MG |
Cas.: 1849-76-9 | Purity: 98% | 3-Bromo-5-chloro-4-hydroxybenzaldehyde | ESD-844827-1G |
Cas.: 332121-92-3 | Purity: 95% | 2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-chlorobenzoic acid | ESD-844828-250MG |
Cas.: 332121-92-3 | Purity: 95% | 2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-chlorobenzoic acid | ESD-844828-1G |
Cas.: 132873-57-5 | Purity: 98% | (S)-1-(4-Nitrophenyl)ethanamine hydrochloride | ESD-844829-250MG |
Cas.: 132873-57-5 | Purity: 98% | (S)-1-(4-Nitrophenyl)ethanamine hydrochloride | ESD-844829-1G |
Cas.: 15925-18-5 | Purity: 95% | 2,2-Dimethylpropan-1-amine hydrochloride | ESD-844830-250MG |
Cas.: 15925-18-5 | Purity: 95% | 2,2-Dimethylpropan-1-amine hydrochloride | ESD-844830-1G |
Cas.: 2243-56-3 | Purity: 98% | Naphthalen-1-ylhydrazine hydrochloride | ESD-844831-250MG |
Cas.: 2243-56-3 | Purity: 98% | Naphthalen-1-ylhydrazine hydrochloride | ESD-844831-1G |
Cas.: 36725-28-7 | Purity: 98% | 6-(4-Aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one | ESD-844832-250MG |
Cas.: 36725-28-7 | Purity: 98% | 6-(4-Aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one | ESD-844832-1G |
Cas.: 185411-12-5 | Purity: 97% | Methyl 3-(trimethylsilyl)pent-4-enoate | ESD-844833-250MG |
Cas.: 185411-12-5 | Purity: 97% | Methyl 3-(trimethylsilyl)pent-4-enoate | ESD-844833-1G |
Cas.: 893755-98-1 | Purity: 95% | 1-(Pyrimidin-2-yl)piperidin-4-ol | ESD-844834-250MG |
Cas.: 893755-98-1 | Purity: 95% | 1-(Pyrimidin-2-yl)piperidin-4-ol | ESD-844834-1G |
Cas.: 1161362-01-1 | Purity: 98% | 3-Bromo-5-(trifluoromethyl)phenylacetic acid | ESD-844835-250MG |
Cas.: 1161362-01-1 | Purity: 98% | 3-Bromo-5-(trifluoromethyl)phenylacetic acid | ESD-844835-1G |
Cas.: 948014-34-4 | Purity: 98% | 2-Chloro-3-fluoro-6-nitroaniline | ESD-844836-250MG |
Cas.: 948014-34-4 | Purity: 98% | 2-Chloro-3-fluoro-6-nitroaniline | ESD-844836-1G |
Cas.: 17321-29-8 | Purity: 98% | 3-Bromo-6-methoxypyridazine | ESD-844837-250MG |
Cas.: 17321-29-8 | Purity: 98% | 3-Bromo-6-methoxypyridazine | ESD-844837-1G |
Cas.: 172215-91-7 | Purity: 98% | 3-Bromo-4-(trifluoromethyl)aniline | ESD-844838-250MG |
Cas.: 172215-91-7 | Purity: 98% | 3-Bromo-4-(trifluoromethyl)aniline | ESD-844838-1G |
Cas.: 650638-17-8 | Purity: 98% | 3-Hydrazinylpyridine hydrochloride | ESD-844839-250MG |
Cas.: 650638-17-8 | Purity: 98% | 3-Hydrazinylpyridine hydrochloride | ESD-844839-1G |
Cas.: 886498-30-2 | Purity: 98% | 2,6-Difluoro-3-methoxybenzoic acid | ESD-844840-250MG |
Cas.: 886498-30-2 | Purity: 98% | 2,6-Difluoro-3-methoxybenzoic acid | ESD-844840-1G |
Cas.: 330786-24-8 | Purity: 98% | 3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | ESD-844841-250MG |
Cas.: 330786-24-8 | Purity: 98% | 3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | ESD-844841-1G |
Cas.: 51301-86-1 | Purity: 98% | 2-((tert-Butoxycarbonyl)amino)-3-(4-chlorophenyl)propanoic acid | ESD-844842-250MG |
Cas.: 51301-86-1 | Purity: 98% | 2-((tert-Butoxycarbonyl)amino)-3-(4-chlorophenyl)propanoic acid | ESD-844842-1G |
Cas.: 195435-23-5 | Purity: 98% | Triphenylvalsartan | ESD-844843-250MG |
Cas.: 195435-23-5 | Purity: 98% | Triphenylvalsartan | ESD-844843-1G |
Cas.: 150008-24-5 | Purity: 98% | tert-Butyl 4-(hydroxyimino)piperidine-1-carboxylate | ESD-844844-1G |
Cas.: 150008-24-5 | Purity: 98% | tert-Butyl 4-(hydroxyimino)piperidine-1-carboxylate | ESD-844844-5G |
Cas.: 914349-11-4 | Purity: 95% | tert-Butyl 5-cyano-3-(hydroxymethyl)-1H-indole-1-carboxylate | ESD-844845-250MG |
Cas.: 914349-11-4 | Purity: 95% | tert-Butyl 5-cyano-3-(hydroxymethyl)-1H-indole-1-carboxylate | ESD-844845-1G |
Cas.: 68208-17-3 | Purity: 98% | 3-Amino-3-(m-tolyl)propanoic acid | ESD-844846-250MG |
Cas.: 68208-17-3 | Purity: 98% | 3-Amino-3-(m-tolyl)propanoic acid | ESD-844846-1G |
Cas.: 345954-83-8 | Purity: 97% | Azetidine-3-carbonitrile hydrochloride | ESD-844847-250MG |
Cas.: 345954-83-8 | Purity: 97% | Azetidine-3-carbonitrile hydrochloride | ESD-844847-1G |
Cas.: 6168-83-8 | Purity: 98% | (S)-3-Hydroxybutanoic acid | ESD-844848-50MG |
Cas.: 6168-83-8 | Purity: 98% | (S)-3-Hydroxybutanoic acid | ESD-844848-250MG |
Cas.: 13877-55-9 | Purity: 98% | 7-Hydroxypyrazolo[4,3-d]pyrimidine | ESD-844849-50MG |
Cas.: 13877-55-9 | Purity: 98% | 7-Hydroxypyrazolo[4,3-d]pyrimidine | ESD-844849-250MG |
Cas.: 54745-74-3 | Purity: 97% | 8-Oxa-3-azabicyclo[3.2.1]octane hydrochloride | ESD-844850-50MG |
Cas.: 54745-74-3 | Purity: 97% | 8-Oxa-3-azabicyclo[3.2.1]octane hydrochloride | ESD-844850-250MG |
Cas.: 330786-09-9 | Purity: 98% | Methyl 3,5-dichloropyrazine-2-carboxylate | ESD-844851-50MG |
Cas.: 330786-09-9 | Purity: 98% | Methyl 3,5-dichloropyrazine-2-carboxylate | ESD-844851-250MG |
Cas.: 1263283-69-7 | Purity: 97% | Methyl 4-(chloromethyl)-3,5-difluorobenzoate | ESD-844852-50MG |
Cas.: 1263283-69-7 | Purity: 97% | Methyl 4-(chloromethyl)-3,5-difluorobenzoate | ESD-844852-250MG |
Cas.: 902837-40-5 | Purity: 95% | 6-Bromo-2-chloro-1,8-naphthyridine | ESD-844853-50MG |
Cas.: 902837-40-5 | Purity: 95% | 6-Bromo-2-chloro-1,8-naphthyridine | ESD-844853-250MG |
Cas.: 1197294-80-6 | Purity: 95% | tert-Butyl 4-(4-bromopyridin-2-yl)piperazine-1-carboxylate | ESD-844854-50MG |
Cas.: 1197294-80-6 | Purity: 95% | tert-Butyl 4-(4-bromopyridin-2-yl)piperazine-1-carboxylate | ESD-844854-250MG |
Cas.: 608141-42-0 | Purity: 98% | (S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanamine | ESD-844855-50MG |
Cas.: 608141-42-0 | Purity: 98% | (S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanamine | ESD-844855-250MG |
Cas.: 262847-54-1 | Purity: 98% | 2,3-Dihydrobenzofuran-5-carboxamide | ESD-844856-50MG |
Cas.: 262847-54-1 | Purity: 98% | 2,3-Dihydrobenzofuran-5-carboxamide | ESD-844856-250MG |
Cas.: 870851-59-5 | Purity: 95% | (2,3-Dihydrobenzo[b][1,4]dioxin-5-yl)methanamine hydrochloride | ESD-844857-50MG |
Cas.: 870851-59-5 | Purity: 95% | (2,3-Dihydrobenzo[b][1,4]dioxin-5-yl)methanamine hydrochloride | ESD-844857-250MG |
Cas.: 447464-03-1 | Purity: 95% | 2-Fluoro-3-iodobenzoic acid | ESD-844858-250MG |
Cas.: 447464-03-1 | Purity: 95% | 2-Fluoro-3-iodobenzoic acid | ESD-844858-1G |
Cas.: 55876-82-9 | Purity: 98% | Ethyl 5-methylpicolinate | ESD-844859-250MG |
Cas.: 55876-82-9 | Purity: 98% | Ethyl 5-methylpicolinate | ESD-844859-1G |
Cas.: 131020-57-0 | Purity: 95% | 4,5,6,7-Tetrahydro-1H-benzo[d]imidazole-5-carboxylic acid hydrochloride | ESD-844860-250MG |
Cas.: 131020-57-0 | Purity: 95% | 4,5,6,7-Tetrahydro-1H-benzo[d]imidazole-5-carboxylic acid hydrochloride | ESD-844860-1G |
Cas.: 492-98-8 | Purity: 97% | 1H,1’H-2,2′-Bimimidazole | ESD-844861-250MG |
Cas.: 492-98-8 | Purity: 97% | 1H,1’H-2,2′-Bimimidazole | ESD-844861-1G |
Cas.: 842136-32-7 | Purity: 98% | Methyl 5-bromo-2-(trifluoromethyl)benzoate | ESD-844862-50MG |
Cas.: 842136-32-7 | Purity: 98% | Methyl 5-bromo-2-(trifluoromethyl)benzoate | ESD-844862-250MG |
Cas.: 74367-78-5 | Purity: 97% | 1-(Chloromethyl)-3,5-dinitrobenzene | ESD-844863-250MG |
Cas.: 74367-78-5 | Purity: 97% | 1-(Chloromethyl)-3,5-dinitrobenzene | ESD-844863-1G |
Cas.: 30384-96-4 | Purity: 98% | 6-Bromoimidazo[1,2-a]pyridine-3-carbaldehyde | ESD-844864-50MG |
Cas.: 30384-96-4 | Purity: 98% | 6-Bromoimidazo[1,2-a]pyridine-3-carbaldehyde | ESD-844864-250MG |
Cas.: 847728-89-6 | Purity: ≥95% | (S)-tert-Butyl (1-(4-bromophenyl)ethyl)carbamate | ESD-844865-50MG |
Cas.: 847728-89-6 | Purity: ≥95% | (S)-tert-Butyl (1-(4-bromophenyl)ethyl)carbamate | ESD-844865-250MG |
Cas.: 137778-20-2 | Purity: 95% | 5-Bromo-6-methylpicolinic acid | ESD-844866-50MG |
Cas.: 137778-20-2 | Purity: 95% | 5-Bromo-6-methylpicolinic acid | ESD-844866-250MG |
Cas.: 6188-43-8 | Purity: 98% | Imidazo[1,2-a]pyridine-3-carbaldehyde | ESD-844867-50MG |
Cas.: 6188-43-8 | Purity: 98% | Imidazo[1,2-a]pyridine-3-carbaldehyde | ESD-844867-250MG |
Cas.: 672-41-3 | Purity: 98% | 6-(Trifluoromethyl)pyrimidin-4-amine | ESD-844868-50MG |
Cas.: 672-41-3 | Purity: 98% | 6-(Trifluoromethyl)pyrimidin-4-amine | ESD-844868-250MG |
Cas.: 90657-53-7 | Purity: 95% | H-Tic-OMe.HCl | ESD-844869-250MG |
Cas.: 90657-53-7 | Purity: 95% | H-Tic-OMe.HCl | ESD-844869-1G |
Cas.: 123171-59-5 | Purity: 98% | Cefepime dihydrochloride | ESD-844870-250MG |
Cas.: 123171-59-5 | Purity: 98% | Cefepime dihydrochloride | ESD-844870-1G |
Cas.: 136725-53-6 | Purity: 97% | (S)-3-Fluoropyrrolidine hydrochloride | ESD-844871-250MG |
Cas.: 136725-53-6 | Purity: 97% | (S)-3-Fluoropyrrolidine hydrochloride | ESD-844871-1G |
Cas.: 699-51-4 | Purity: 97% | 1,3-Diazaspiro[4.4]nonane-2,4-dione | ESD-844872-250MG |
Cas.: 699-51-4 | Purity: 97% | 1,3-Diazaspiro[4.4]nonane-2,4-dione | ESD-844872-1G |
Cas.: 849937-96-8 | Purity: 98% | 5-Bromo-2,4-dichloropyridine | ESD-844873-250MG |
Cas.: 849937-96-8 | Purity: 98% | 5-Bromo-2,4-dichloropyridine | ESD-844873-1G |
Cas.: 41339-17-7 | Purity: 98% | 5-Nitro-1H-indazol-3-amine | ESD-844874-250MG |
Cas.: 41339-17-7 | Purity: 98% | 5-Nitro-1H-indazol-3-amine | ESD-844874-1G |
Cas.: 66899-02-3 | Purity: 97% | 4,4-Dimethylpyrrolidin-2-one | ESD-844875-250MG |
Cas.: 66899-02-3 | Purity: 97% | 4,4-Dimethylpyrrolidin-2-one | ESD-844875-1G |
Cas.: 98447-30-4 | Purity: 98% | 2-Bromo-4-methoxy-1-nitrobenzene | ESD-844876-250MG |
Cas.: 98447-30-4 | Purity: 98% | 2-Bromo-4-methoxy-1-nitrobenzene | ESD-844876-1G |
Cas.: 114636-37-2 | Purity: 95% | (S)-tert-Butyl 3-acetamidopyrrolidine-1-carboxylate | ESD-844877-250MG |
Cas.: 114636-37-2 | Purity: 95% | (S)-tert-Butyl 3-acetamidopyrrolidine-1-carboxylate | ESD-844877-1G |
Cas.: 70796-17-7 | Purity: 95% | L-Citrulline DL-malate (1:1) | ESD-844878-250MG |
Cas.: 70796-17-7 | Purity: 95% | L-Citrulline DL-malate (1:1) | ESD-844878-1G |
Cas.: 1120-82-7 | Purity: 97% | (1H-Pyrazol-1-yl)methanol | ESD-844879-250MG |
Cas.: 1120-82-7 | Purity: 97% | (1H-Pyrazol-1-yl)methanol | ESD-844879-1G |
Cas.: 914349-48-7 | Purity: 97% | (2-(1H-1,2,4-Triazol-1-yl)phenyl)methanol | ESD-844880-250MG |
Cas.: 914349-48-7 | Purity: 97% | (2-(1H-1,2,4-Triazol-1-yl)phenyl)methanol | ESD-844880-1G |
Cas.: 914349-64-7 | Purity: 97% | 1-(Bis(4-fluorophenyl)methyl)-4-(4-nitrobenzyl)piperazine | ESD-844881-250MG |
Cas.: 914349-64-7 | Purity: 97% | 1-(Bis(4-fluorophenyl)methyl)-4-(4-nitrobenzyl)piperazine | ESD-844881-1G |
Cas.: 772311-98-5 | Purity: 95% | 4-((2-Methyl-1H-imidazol-1-yl)methyl)aniline | ESD-844882-250MG |
Cas.: 772311-98-5 | Purity: 95% | 4-((2-Methyl-1H-imidazol-1-yl)methyl)aniline | ESD-844882-1G |
Cas.: 862574-88-7 | Purity: 95% | 1-(2,2-Difluorobenzo[1,3]dioxol-5-yl)-cyclopropanecarboxylic acid | ESD-844883-250MG |
Cas.: 862574-88-7 | Purity: 95% | 1-(2,2-Difluorobenzo[1,3]dioxol-5-yl)-cyclopropanecarboxylic acid | ESD-844883-1G |
Cas.: 25016-12-0 | Purity: 97% | 1,3-Dimethyl-1H-pyrazole-4-carbaldehyde | ESD-844884-250MG |
Cas.: 25016-12-0 | Purity: 97% | 1,3-Dimethyl-1H-pyrazole-4-carbaldehyde | ESD-844884-1G |
Cas.: 368429-78-1 | Purity: 95% | 1-Benzylpiperidin-3-amine hydrochloride | ESD-844885-250MG |
Cas.: 368429-78-1 | Purity: 95% | 1-Benzylpiperidin-3-amine hydrochloride | ESD-844885-1G |
Cas.: 19230-27-4 | Purity: 95% | 1,3-Dibromo-2-chlorobenzene | ESD-844886-250MG |
Cas.: 19230-27-4 | Purity: 95% | 1,3-Dibromo-2-chlorobenzene | ESD-844886-1G |
Cas.: 326888-32-8 | Purity: 97% | N1,N1,N2-Trimethylethane-1,2-diamine dihydrochloride | ESD-844887-250MG |
Cas.: 326888-32-8 | Purity: 97% | N1,N1,N2-Trimethylethane-1,2-diamine dihydrochloride | ESD-844887-1G |
Cas.: 586389-90-4 | Purity: 98% | (2-Fluoro-4-isopropoxyphenyl)boronic acid | ESD-844888-250MG |
Cas.: 586389-90-4 | Purity: 98% | (2-Fluoro-4-isopropoxyphenyl)boronic acid | ESD-844888-1G |
Cas.: 105986-54-7 | Purity: 97% | Ethyl 4-(4-bromophenyl)butanoate | ESD-844889-250MG |
Cas.: 105986-54-7 | Purity: 97% | Ethyl 4-(4-bromophenyl)butanoate | ESD-844889-1G |
Cas.: 1130155-48-4 | Purity: 98% | (E)-4-(Dimethylamino)but-2-enoic acid xhydrochloride | ESD-844890-250MG |
Cas.: 1130155-48-4 | Purity: 98% | (E)-4-(Dimethylamino)but-2-enoic acid xhydrochloride | ESD-844890-1G |
Cas.: 957121-05-0 | Purity: 98% | (3-Cyano-2-fluorophenyl)boronic acid | ESD-844891-250MG |
Cas.: 957121-05-0 | Purity: 98% | (3-Cyano-2-fluorophenyl)boronic acid | ESD-844891-1G |
Cas.: 1126367-34-7 | Purity: 98% | 1-Bromo-2-chloro-4-methyl-5-nitrobenzene | ESD-844892-250MG |
Cas.: 1126367-34-7 | Purity: 98% | 1-Bromo-2-chloro-4-methyl-5-nitrobenzene | ESD-844892-1G |
Cas.: 1619264-45-7 | Purity: 95% | Methyl 2-amino-6-chlorobenzoate hydrochloride | ESD-844894-250MG |
Cas.: 1619264-45-7 | Purity: 95% | Methyl 2-amino-6-chlorobenzoate hydrochloride | ESD-844894-1G |
Cas.: 50585-87-0 | Purity: 95% | 1-Methylpyrrolidine-3-carboxylic acid hydrochloride | ESD-844895-250MG |
Cas.: 50585-87-0 | Purity: 95% | 1-Methylpyrrolidine-3-carboxylic acid hydrochloride | ESD-844895-1G |
Cas.: 454703-20-9 | Purity: 95% | tert-Butyl 3-(methylamino)azetidine-1-carboxylate | ESD-844896-250MG |
Cas.: 454703-20-9 | Purity: 95% | tert-Butyl 3-(methylamino)azetidine-1-carboxylate | ESD-844896-1G |
Cas.: 126674-94-0 | Purity: 97% | 2-Amino-3,5-difluorobenzonitrile | ESD-844897-250MG |
Cas.: 126674-94-0 | Purity: 97% | 2-Amino-3,5-difluorobenzonitrile | ESD-844897-1G |
Cas.: 825-40-1 | Purity: 98% | 1-(2-Bromo-4-chlorophenyl)ethanone | ESD-844898-250MG |
Cas.: 825-40-1 | Purity: 98% | 1-(2-Bromo-4-chlorophenyl)ethanone | ESD-844898-1G |
Cas.: 913613-82-8 | Purity: 97% | 7-(4-Chlorobutoxy)quinolin-2(1H)-one | ESD-844899-250MG |
Cas.: 913613-82-8 | Purity: 97% | 7-(4-Chlorobutoxy)quinolin-2(1H)-one | ESD-844899-1G |
Cas.: 68301-59-7 | Purity: 98% | 1-(2-Chloro-4-hydroxyphenyl)ethanone | ESD-844900-250MG |
Cas.: 68301-59-7 | Purity: 98% | 1-(2-Chloro-4-hydroxyphenyl)ethanone | ESD-844900-1G |
Cas.: 914347-79-8 | Purity: 95% | 1-Boc-3-(5-Bromopyrimidin-2-yloxy)pyrrolidine | ESD-844901-250MG |
Cas.: 914347-79-8 | Purity: 95% | 1-Boc-3-(5-Bromopyrimidin-2-yloxy)pyrrolidine | ESD-844901-1G |
Cas.: 885520-33-2 | Purity: 97% | 3-Bromo-5-methylbenzene-1-sulfonyl chloride | ESD-844902-250MG |
Cas.: 885520-33-2 | Purity: 97% | 3-Bromo-5-methylbenzene-1-sulfonyl chloride | ESD-844902-1G |
Cas.: 171110-72-8 | Purity: 97% | Methyl (2S,4S)-1-Boc-4-aminopyrrolidine-2-carboxylate hydrochloride | ESD-844903-50MG |
Cas.: 171110-72-8 | Purity: 97% | Methyl (2S,4S)-1-Boc-4-aminopyrrolidine-2-carboxylate hydrochloride | ESD-844903-250MG |
Cas.: 162959-94-6 | Purity: 98% | 1-(Thiophen-2-yl)cyclopropanecarboxylic acid | ESD-844904-50MG |
Cas.: 162959-94-6 | Purity: 98% | 1-(Thiophen-2-yl)cyclopropanecarboxylic acid | ESD-844904-250MG |
Cas.: 21737-58-6 | Purity: 98% | 5H-Dibenzo[b,f]azepin-10(11H)-one | ESD-844905-50MG |
Cas.: 21737-58-6 | Purity: 98% | 5H-Dibenzo[b,f]azepin-10(11H)-one | ESD-844905-250MG |
Cas.: 3743-23-5 | Purity: 97% | 5-Chloro-2-methoxyphenol | ESD-844906-50MG |
Cas.: 3743-23-5 | Purity: 97% | 5-Chloro-2-methoxyphenol | ESD-844906-250MG |
Cas.: 889939-42-8 | Purity: 96% | 4-Bromo-7H-pyrrolo[2,3-d]pyrimidine | ESD-844907-50MG |
Cas.: 889939-42-8 | Purity: 96% | 4-Bromo-7H-pyrrolo[2,3-d]pyrimidine | ESD-844907-250MG |
Cas.: 193357-26-5 | Purity: 95% | 4-(2-Fluorobenzyl)piperidine hydrochloride | ESD-844908-50MG |
Cas.: 193357-26-5 | Purity: 95% | 4-(2-Fluorobenzyl)piperidine hydrochloride | ESD-844908-250MG |
Cas.: 515131-35-8 | Purity: 95% | 4-Methyl-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)benzoic acid | ESD-844909-50MG |
Cas.: 515131-35-8 | Purity: 95% | 4-Methyl-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)benzoic acid | ESD-844909-250MG |
Cas.: 39828-47-2 | Purity: 97% | 2-Oxo-2,3-dihydro-1H-imidazole-4-carboxylic acid | ESD-844910-50MG |
Cas.: 39828-47-2 | Purity: 97% | 2-Oxo-2,3-dihydro-1H-imidazole-4-carboxylic acid | ESD-844910-250MG |
Cas.: 22808-29-3 | Purity: 97% | 4-tert-Butyl-3,6-dichloropyridazine | ESD-844911-50MG |
Cas.: 22808-29-3 | Purity: 97% | 4-tert-Butyl-3,6-dichloropyridazine | ESD-844911-250MG |
Cas.: 108655-63-6 | Purity: 95% | 3-(Trifluoromethyl)isoxazol-5-amine | ESD-844912-50MG |
Cas.: 108655-63-6 | Purity: 95% | 3-(Trifluoromethyl)isoxazol-5-amine | ESD-844912-250MG |
Cas.: 14345-98-3 | Purity: 98% | 2-Chlorothiophene-3-carbaldehyde | ESD-844913-50MG |
Cas.: 14345-98-3 | Purity: 98% | 2-Chlorothiophene-3-carbaldehyde | ESD-844913-250MG |
Cas.: 654655-69-3 | Purity: 95% | 3-Benzyl-6-bromo-2-methoxyquinoline | ESD-844914-250MG |
Cas.: 139502-01-5 | Purity: 97% | 5-Bromo-2-chloro-4-morpholinopyrimidine | ESD-844915-50MG |
Cas.: 139502-01-5 | Purity: 97% | 5-Bromo-2-chloro-4-morpholinopyrimidine | ESD-844915-250MG |
Cas.: 3788-56-5 | Purity: 98% | 9-Hydroxynonanoic acid | ESD-844916-50MG |
Cas.: 436088-66-3 | Purity: 95% | 2-Methoxyethyl 2-aminobenzo[d]thiazole-6-carboxylate | ESD-844917-50MG |
Cas.: 436088-66-3 | Purity: 95% | 2-Methoxyethyl 2-aminobenzo[d]thiazole-6-carboxylate | ESD-844917-250MG |
Cas.: 72580-54-2 | Purity: 95% | (R)-Pyrrolidine-3-carboxylic acid | ESD-844918-50MG |
Cas.: 72580-54-2 | Purity: 95% | (R)-Pyrrolidine-3-carboxylic acid | ESD-844918-250MG |
Cas.: 223137-87-9 | Purity: 98% | 2,2′,3,3′-Tetrahydro-1,1′-spirobi[indene]-7,7′-diol | ESD-844919-50MG |
Cas.: 223137-87-9 | Purity: 98% | 2,2′,3,3′-Tetrahydro-1,1′-spirobi[indene]-7,7′-diol | ESD-844919-250MG |
Cas.: 948571-47-9 | Purity: 98% | 2-(4-Amino-1H-pyrazol-1-yl)ethanol | ESD-844920-50MG |
Cas.: 948571-47-9 | Purity: 98% | 2-(4-Amino-1H-pyrazol-1-yl)ethanol | ESD-844920-250MG |
Cas.: 50-80-6 | Purity: 98% | 1-(5-Amino-2-hydroxyphenyl)ethanone | ESD-844921-50MG |
Cas.: 50-80-6 | Purity: 98% | 1-(5-Amino-2-hydroxyphenyl)ethanone | ESD-844921-250MG |
Cas.: 847818-71-7 | Purity: 95% | 1-(2-Methoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-844922-50MG |
Cas.: 847818-71-7 | Purity: 95% | 1-(2-Methoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-844922-250MG |
Cas.: 32454-33-4 | Purity: 95% | Methyl 2-(3-methoxyphenyl)-2-methylpropanoate | ESD-844923-50MG |
Cas.: 32454-33-4 | Purity: 95% | Methyl 2-(3-methoxyphenyl)-2-methylpropanoate | ESD-844923-250MG |
Cas.: 55686-94-7 | Purity: 97% | 2-Chloro-7-nitroquinoxaline | ESD-844924-50MG |
Cas.: 55686-94-7 | Purity: 97% | 2-Chloro-7-nitroquinoxaline | ESD-844924-250MG |
Cas.: 920965-87-3 | Purity: 97% | 4-Chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile | ESD-844925-50MG |
Cas.: 920965-87-3 | Purity: 97% | 4-Chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile | ESD-844925-250MG |
Cas.: 33421-36-2 | Purity: 97% | 2-(Pyridin-2-yl)phenol | ESD-844926-50MG |
Cas.: 33421-36-2 | Purity: 97% | 2-(Pyridin-2-yl)phenol | ESD-844926-250MG |
Cas.: 1616526-80-7 | Purity: 98% | 1,5-Difluoro-3-methyl-2-nitrobenzene | ESD-844927-50MG |
Cas.: 1616526-80-7 | Purity: 98% | 1,5-Difluoro-3-methyl-2-nitrobenzene | ESD-844927-250MG |
Cas.: 180624-08-2 | Purity: 98% | 4-Bromo-2-iodo-6-nitroaniline | ESD-844928-50MG |
Cas.: 180624-08-2 | Purity: 98% | 4-Bromo-2-iodo-6-nitroaniline | ESD-844928-250MG |
Cas.: 912999-79-2 | Purity: 98% | 5-Chloroisoindoline hydrochloride | ESD-844929-50MG |
Cas.: 912999-79-2 | Purity: 98% | 5-Chloroisoindoline hydrochloride | ESD-844929-250MG |
Cas.: 35757-20-1 | Purity: 95% | 2-Bromo-3-nitroaniline | ESD-844930-50MG |
Cas.: 35757-20-1 | Purity: 95% | 2-Bromo-3-nitroaniline | ESD-844930-250MG |
Cas.: 116118-99-1 | Purity: 95% | 4,5,6,7-Tetrahydrothieno[3,2-c]pyridine-2-carboxylic acid hydrochloride | ESD-844931-50MG |
Cas.: 116118-99-1 | Purity: 95% | 4,5,6,7-Tetrahydrothieno[3,2-c]pyridine-2-carboxylic acid hydrochloride | ESD-844931-250MG |
Cas.: 2818-07-7 | Purity: 97% | Dimethyl 1H-pyrrole-2,4-dicarboxylate | ESD-844932-50MG |
Cas.: 2818-07-7 | Purity: 97% | Dimethyl 1H-pyrrole-2,4-dicarboxylate | ESD-844932-250MG |
Cas.: 1134529-25-1 | Purity: 97% | 2-(Aminomethyl)benzonitrile hydrochloride | ESD-844933-50MG |
Cas.: 1134529-25-1 | Purity: 97% | 2-(Aminomethyl)benzonitrile hydrochloride | ESD-844933-250MG |
Cas.: 112566-20-8 | Purity: 95% | Imidazo[1,2-a]pyridin-2-ol | ESD-844934-50MG |
Cas.: 112566-20-8 | Purity: 95% | Imidazo[1,2-a]pyridin-2-ol | ESD-844934-250MG |
Cas.: 937783-91-0 | Purity: 95% | (2-Fluoro-4-nitrophenyl)methanamine hydrochloride | ESD-844935-50MG |
Cas.: 937783-91-0 | Purity: 95% | (2-Fluoro-4-nitrophenyl)methanamine hydrochloride | ESD-844935-250MG |
Cas.: 72617-82-4 | Purity: 98% | 6-(2,2,2-Trifluoroethoxy)pyridin-3-amine | ESD-844936-50MG |
Cas.: 72617-82-4 | Purity: 98% | 6-(2,2,2-Trifluoroethoxy)pyridin-3-amine | ESD-844936-250MG |
Cas.: 1033712-94-5 | Purity: 97% | (3R,4S)-Tetrahydrofuran-3,4-diamine dihydrochloride | ESD-844937-50MG |
Cas.: 1033712-94-5 | Purity: 97% | (3R,4S)-Tetrahydrofuran-3,4-diamine dihydrochloride | ESD-844937-250MG |
Cas.: 885523-43-3 | Purity: 95% | 4-Bromo-1H-indazole-6-carboxylic acid | ESD-844938-50MG |
Cas.: 885523-43-3 | Purity: 95% | 4-Bromo-1H-indazole-6-carboxylic acid | ESD-844938-250MG |
Cas.: 579525-46-5 | Purity: 97% | [6-(Dimethylamino)pyridin-3-yl]boronic acid | ESD-844939-50MG |
Cas.: 579525-46-5 | Purity: 97% | [6-(Dimethylamino)pyridin-3-yl]boronic acid | ESD-844939-250MG |
Cas.: 647854-72-6 | Purity: 97% | (R)-Azetidine-2-carboxylic acid hydrochloride | ESD-844940-50MG |
Cas.: 647854-72-6 | Purity: 97% | (R)-Azetidine-2-carboxylic acid hydrochloride | ESD-844940-250MG |
Cas.: 847728-91-0 | Purity: 98% | (S)-Methyl 4-(1-aminoethyl)benzoate hydrochloride | ESD-844941-50MG |
Cas.: 847728-91-0 | Purity: 98% | (S)-Methyl 4-(1-aminoethyl)benzoate hydrochloride | ESD-844941-250MG |
Cas.: 339-58-2 | Purity: 97% | 2-Amino-1-(4-(trifluoromethyl)phenyl)ethanone hydrochloride | ESD-844942-50MG |
Cas.: 339-58-2 | Purity: 97% | 2-Amino-1-(4-(trifluoromethyl)phenyl)ethanone hydrochloride | ESD-844942-250MG |
Cas.: 1198615-87-0 | Purity: 95% | Ethyl 2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate | ESD-844943-50MG |
Cas.: 1198615-87-0 | Purity: 95% | Ethyl 2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate | ESD-844943-250MG |
Cas.: 856767-09-4 | Purity: 97% | 4-Bromo-2-fluoro-6-methoxybenzaldehyde | ESD-844944-50MG |
Cas.: 856767-09-4 | Purity: 97% | 4-Bromo-2-fluoro-6-methoxybenzaldehyde | ESD-844944-250MG |
Cas.: 1337958-87-8 | Purity: 96% | Dimethyl 2,5-dibromoisophthalate | ESD-844945-50MG |
Cas.: 1337958-87-8 | Purity: 96% | Dimethyl 2,5-dibromoisophthalate | ESD-844945-250MG |
Cas.: 189249-10-3 | Purity: 98% | (2S,4S)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-4-hydroxypyrrolidine-2-carboxylic acid | ESD-844947-50MG |
Cas.: 189249-10-3 | Purity: 98% | (2S,4S)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-4-hydroxypyrrolidine-2-carboxylic acid | ESD-844947-250MG |
Cas.: 2005-10-9 | Purity: 96% | 6H-Benzo[c]chromen-6-one | ESD-844948-50MG |
Cas.: 2005-10-9 | Purity: 96% | 6H-Benzo[c]chromen-6-one | ESD-844948-250MG |
Cas.: 1208075-41-5 | Purity: 97% | 4-Bromo-5-chloro-2-fluorobenzene-1-sulfonyl chloride | ESD-844949-50MG |
Cas.: 1208075-41-5 | Purity: 97% | 4-Bromo-5-chloro-2-fluorobenzene-1-sulfonyl chloride | ESD-844949-250MG |
Cas.: 1147124-23-9 | Purity: 97% | 6,6′-Dibromo-1,1′-bis(2-ethylhexyl)-[3,3′-biindolinylidene]-2,2′-dione | ESD-844950-50MG |
Cas.: 1147124-23-9 | Purity: 97% | 6,6′-Dibromo-1,1′-bis(2-ethylhexyl)-[3,3′-biindolinylidene]-2,2′-dione | ESD-844950-250MG |
Cas.: 216237-52-4 | Purity: 97% | (S)-Pentan-2-amine hydrochloride | ESD-844951-50MG |
Cas.: 216237-52-4 | Purity: 97% | (S)-Pentan-2-amine hydrochloride | ESD-844951-250MG |
Cas.: 159873-64-0 | Purity: 97% | 1-(6-Nitrobenzo[d][1,3]dioxol-5-yl)ethanol | ESD-844952-50MG |
Cas.: 159873-64-0 | Purity: 97% | 1-(6-Nitrobenzo[d][1,3]dioxol-5-yl)ethanol | ESD-844952-250MG |
Cas.: 317335-15-2 | Purity: 97% | Methyl 4-(hydroxymethyl)picolinate | ESD-844953-50MG |
Cas.: 317335-15-2 | Purity: 97% | Methyl 4-(hydroxymethyl)picolinate | ESD-844953-250MG |
Cas.: 4181-97-9 | Purity: 95% | Phenyl 4-methoxybenzoate | ESD-844954-50MG |
Cas.: 4181-97-9 | Purity: 95% | Phenyl 4-methoxybenzoate | ESD-844954-250MG |
Cas.: 932373-92-7 | Purity: 98% | 1,3-Difluoro-5-methyl-2-nitrobenzene | ESD-844955-50MG |
Cas.: 932373-92-7 | Purity: 98% | 1,3-Difluoro-5-methyl-2-nitrobenzene | ESD-844955-250MG |
Cas.: 141419-94-5 | Purity: 93%, isomer mixture | Ethyl 4-oxotetrahydro-2H-pyran-3-carboxylate | ESD-844956-50MG |
Cas.: 141419-94-5 | Purity: 93%, isomer mixture | Ethyl 4-oxotetrahydro-2H-pyran-3-carboxylate | ESD-844956-250MG |
Cas.: 76697-50-2 | Purity: 98% | 1-Amino-2-(isopropylsulphonyl)benzene | ESD-844957-250MG |
Cas.: 76697-50-2 | Purity: 98% | 1-Amino-2-(isopropylsulphonyl)benzene | ESD-844957-1G |
Cas.: 6639-79-8 | Purity: 95% | 6-Chloroquinoxaline-2,3-diol | ESD-844958-250MG |
Cas.: 6639-79-8 | Purity: 95% | 6-Chloroquinoxaline-2,3-diol | ESD-844958-1G |
Cas.: 69812-51-7 | Purity: 97% | Methyl 4-chlorosulfonylbenzoate | ESD-844959-250MG |
Cas.: 69812-51-7 | Purity: 97% | Methyl 4-chlorosulfonylbenzoate | ESD-844959-1G |
Cas.: 7466-72-0 | Purity: 95% | 2-Oxo-2-(p-tolyl)acetaldehyde hydrate | ESD-844960-250MG |
Cas.: 7466-72-0 | Purity: 95% | 2-Oxo-2-(p-tolyl)acetaldehyde hydrate | ESD-844960-1G |
Cas.: 39890-45-4 | Purity: 95% | 1-(Pyrrolidinocarbonylmethyl)piperazine | ESD-844961-250MG |
Cas.: 39890-45-4 | Purity: 95% | 1-(Pyrrolidinocarbonylmethyl)piperazine | ESD-844961-1G |
Cas.: 881189-65-7 | Purity: 97% | 3-(4-Chloro-3-fluorophenyl)propionic acid | ESD-844962-250MG |
Cas.: 881189-65-7 | Purity: 97% | 3-(4-Chloro-3-fluorophenyl)propionic acid | ESD-844962-1G |
Cas.: 425378-68-3 | Purity: 98% | 2-(2-Fluoro-5-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-844963-250MG |
Cas.: 425378-68-3 | Purity: 98% | 2-(2-Fluoro-5-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-844963-1G |
Cas.: 1010811-75-2 | Purity: 95% | (1R,2R)-2-(Benzyloxy)cyclohexanamine hydrochloride | ESD-844964-250MG |
Cas.: 1010811-75-2 | Purity: 95% | (1R,2R)-2-(Benzyloxy)cyclohexanamine hydrochloride | ESD-844964-1G |
Cas.: 769951-32-8 | Purity: 95% | 7H-Pyrrolo[2,3-d]pyrimidin-4-amine sulfate | ESD-844965-250MG |
Cas.: 769951-32-8 | Purity: 95% | 7H-Pyrrolo[2,3-d]pyrimidin-4-amine sulfate | ESD-844965-1G |
Cas.: 864550-40-3 | Purity: 95% | 5-Bromo-2-methyl-3-nitroaniline | ESD-844966-250MG |
Cas.: 864550-40-3 | Purity: 95% | 5-Bromo-2-methyl-3-nitroaniline | ESD-844966-1G |
Cas.: 90607-21-9 | Purity: 97% | 5-(tert-Butyl)isoxazole-3-carboxylic acid | ESD-844967-50MG |
Cas.: 90607-21-9 | Purity: 97% | 5-(tert-Butyl)isoxazole-3-carboxylic acid | ESD-844967-250MG |
Cas.: 4319-85-1 | Purity: 98% | 5-Bromo-4-methoxypyrimidine | ESD-844968-50MG |
Cas.: 4319-85-1 | Purity: 98% | 5-Bromo-4-methoxypyrimidine | ESD-844968-250MG |
Cas.: 17100-58-2 | Purity: 98% | (4-Bromo-2-methylphenyl)methanol | ESD-844969-250MG |
Cas.: 17100-58-2 | Purity: 98% | (4-Bromo-2-methylphenyl)methanol | ESD-844969-1G |
Cas.: 23126-82-1 | Purity: 98% | 6-Chloro-N-methyl-5-nitro-4-pyrimidinamine | ESD-844970-50MG |
Cas.: 23126-82-1 | Purity: 98% | 6-Chloro-N-methyl-5-nitro-4-pyrimidinamine | ESD-844970-250MG |
Cas.: 852054-42-3 | Purity: 95% | 7-Bromo-2,3-dihydrothieno[3,4-b][1,4]dioxine-5-carbaldehyde | ESD-844971-50MG |
Cas.: 852054-42-3 | Purity: 95% | 7-Bromo-2,3-dihydrothieno[3,4-b][1,4]dioxine-5-carbaldehyde | ESD-844971-250MG |
Cas.: 84996-40-7 | Purity: 97% | 2-Amino-3-(methylamino)pyrazine | ESD-844972-50MG |
Cas.: 84996-40-7 | Purity: 97% | 2-Amino-3-(methylamino)pyrazine | ESD-844972-250MG |
Cas.: 2002-59-7 | Purity: 98% | 6-Thioxo-6,9-dihydro-1H-purin-2(3H)-one | ESD-844973-50MG |
Cas.: 2002-59-7 | Purity: 98% | 6-Thioxo-6,9-dihydro-1H-purin-2(3H)-one | ESD-844973-250MG |
Cas.: 1259952-24-3 | Purity: 97% | 1-Methyl-1,2,3,4-tetrahydroquinoxaline dihydrochloride | ESD-844974-50MG |
Cas.: 1259952-24-3 | Purity: 97% | 1-Methyl-1,2,3,4-tetrahydroquinoxaline dihydrochloride | ESD-844974-250MG |
Cas.: 401930-07-2 | Purity: 95% | 1-(4-(Trifluoromethyl)pyrimidin-2-yl)piperidin-4-ol | ESD-844975-50MG |
Cas.: 401930-07-2 | Purity: 95% | 1-(4-(Trifluoromethyl)pyrimidin-2-yl)piperidin-4-ol | ESD-844975-250MG |
Cas.: 824429-51-8 | Purity: 95% | tert-Butyl (2-(hydroxymethyl)pyridin-3-yl)carbamate | ESD-844976-50MG |
Cas.: 824429-51-8 | Purity: 95% | tert-Butyl (2-(hydroxymethyl)pyridin-3-yl)carbamate | ESD-844976-250MG |
Cas.: 20417-61-2 | Purity: 95% | Ethyl 2-formylcyclopropanecarboxylate | ESD-844977-50MG |
Cas.: 20417-61-2 | Purity: 95% | Ethyl 2-formylcyclopropanecarboxylate | ESD-844977-250MG |
Cas.: 4786-72-5 | Purity: 98% | 5-Bromo-2-chloro-4,6-dimethylpyrimidine | ESD-844978-50MG |
Cas.: 4786-72-5 | Purity: 98% | 5-Bromo-2-chloro-4,6-dimethylpyrimidine | ESD-844978-250MG |
Cas.: 82031-32-1 | Purity: 97% | 7-Bromoquinoxalin-2(1H)-one | ESD-844979-50MG |
Cas.: 82031-32-1 | Purity: 97% | 7-Bromoquinoxalin-2(1H)-one | ESD-844979-250MG |
Cas.: 949922-62-7 | Purity: 95% | tert-Butyl 2-bromo-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-carboxylate | ESD-844980-50MG |
Cas.: 949922-62-7 | Purity: 95% | tert-Butyl 2-bromo-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-carboxylate | ESD-844980-250MG |
Cas.: 866648-53-5 | Purity: 98% | 6-Chloro-N,N-dimethyl-2-(trifluoromethyl)pyrimidin-4-amine | ESD-844981-50MG |
Cas.: 866648-53-5 | Purity: 98% | 6-Chloro-N,N-dimethyl-2-(trifluoromethyl)pyrimidin-4-amine | ESD-844981-250MG |
Cas.: 946126-95-0 | Purity: 95% | (2-Fluoro-3-nitrophenyl)methanol | ESD-844982-50MG |
Cas.: 946126-95-0 | Purity: 95% | (2-Fluoro-3-nitrophenyl)methanol | ESD-844982-250MG |
Cas.: 944709-74-4 | Purity: 97% | 2-Bromo-6-methoxypyrimidine | ESD-844983-50MG |
Cas.: 944709-74-4 | Purity: 97% | 2-Bromo-6-methoxypyrimidine | ESD-844983-250MG |
Cas.: 954265-75-9 | Purity: 95% | 5-(2-Methyl-1H-imidazol-1-yl)-2-nitrobenzoic acid | ESD-844984-50MG |
Cas.: 954265-75-9 | Purity: 95% | 5-(2-Methyl-1H-imidazol-1-yl)-2-nitrobenzoic acid | ESD-844984-250MG |
Cas.: 15884-86-3 | Purity: 97% | 5-(Methoxymethyl)-1,3,4-thiadiazol-2-amine | ESD-844986-50MG |
Cas.: 15884-86-3 | Purity: 97% | 5-(Methoxymethyl)-1,3,4-thiadiazol-2-amine | ESD-844986-250MG |
Cas.: 455323-66-7 | Purity: 95% | Methyl 4-(pipidin-4-yloxy)benzoate hydrochloride | ESD-844987-50MG |
Cas.: 455323-66-7 | Purity: 95% | Methyl 4-(pipidin-4-yloxy)benzoate hydrochloride | ESD-844987-250MG |
Cas.: 372195-85-2 | Purity: 95% | 4-Butylpiperidine hydrochloride | ESD-844988-50MG |
Cas.: 372195-85-2 | Purity: 95% | 4-Butylpiperidine hydrochloride | ESD-844988-250MG |
Cas.: 932-65-0 | Purity: 95% | 4-Bromo-1H-pyrazole-3-carboxamide | ESD-844989-50MG |
Cas.: 932-65-0 | Purity: 95% | 4-Bromo-1H-pyrazole-3-carboxamide | ESD-844989-250MG |
Cas.: 41731-39-9 | Purity: 97% | 2-Bromo-4-(trifluoromethyl)thiazole | ESD-844990-50MG |
Cas.: 41731-39-9 | Purity: 97% | 2-Bromo-4-(trifluoromethyl)thiazole | ESD-844990-250MG |
Cas.: 1260794-25-9 | Purity: 95% | 4-(Methylamino)cyclohexanone hydrochloride | ESD-844991-50MG |
Cas.: 1260794-25-9 | Purity: 95% | 4-(Methylamino)cyclohexanone hydrochloride | ESD-844991-250MG |
Cas.: 1211517-76-8 | Purity: 97% | 3-Bromo-5-fluoro-4-methylpyridine | ESD-844992-50MG |
Cas.: 1211517-76-8 | Purity: 97% | 3-Bromo-5-fluoro-4-methylpyridine | ESD-844992-250MG |
Cas.: 865156-59-8 | Purity: 98% | 4-Bromo-6-methylpyridin-2-ol | ESD-844993-50MG |
Cas.: 865156-59-8 | Purity: 98% | 4-Bromo-6-methylpyridin-2-ol | ESD-844993-250MG |
Cas.: 6931-16-4 | Purity: 98% | 2-Methoxyquinoline | ESD-844994-50MG |
Cas.: 6931-16-4 | Purity: 98% | 2-Methoxyquinoline | ESD-844994-250MG |
Cas.: 914349-42-1 | Purity: 95% | 5-(m-Tolyl)pyrimidin-2-amine | ESD-844995-50MG |
Cas.: 914349-42-1 | Purity: 95% | 5-(m-Tolyl)pyrimidin-2-amine | ESD-844995-250MG |
Cas.: 111043-09-5 | Purity: 95% | 1-(3-Bromopyridin-2-yl)ethanone | ESD-844996-50MG |
Cas.: 111043-09-5 | Purity: 95% | 1-(3-Bromopyridin-2-yl)ethanone | ESD-844996-250MG |
Cas.: 1261573-04-9 | Purity: 95% | 2-Cyano-5-methoxybenzene-1-sulfonyl chloride | ESD-844997-50MG |
Cas.: 1261573-04-9 | Purity: 95% | 2-Cyano-5-methoxybenzene-1-sulfonyl chloride | ESD-844997-250MG |
Cas.: 74459-19-1 | Purity: 97% | 4-Methyl-1,2,3,4-tetrahydroquinoline hydrochloride | ESD-844998-50MG |
Cas.: 74459-19-1 | Purity: 97% | 4-Methyl-1,2,3,4-tetrahydroquinoline hydrochloride | ESD-844998-250MG |
Cas.: 1646152-46-6 | Purity: 97% | 2-(Difluoromethyl)-5-nitropyridine | ESD-844999-50MG |
Cas.: 1646152-46-6 | Purity: 97% | 2-(Difluoromethyl)-5-nitropyridine | ESD-844999-250MG |
Cas.: 27582-14-5 | Purity: 98% | 4-Amino-2-methyl-3-nitropyridine | ESD-845000-50MG |
Cas.: 27582-14-5 | Purity: 98% | 4-Amino-2-methyl-3-nitropyridine | ESD-845000-250MG |
Cas.: 187973-44-0 | Purity: 95% | 2-Amino-3-benzyloxy-5-bromopyrazine | ESD-845001-50MG |
Cas.: 187973-44-0 | Purity: 95% | 2-Amino-3-benzyloxy-5-bromopyrazine | ESD-845001-250MG |
Cas.: 50432-67-2 | Purity: 95% | 2-Chloro-N4-methylpyridine-3,4-diamine | ESD-845002-50MG |
Cas.: 50432-67-2 | Purity: 95% | 2-Chloro-N4-methylpyridine-3,4-diamine | ESD-845002-250MG |
Cas.: 10243-15-9 | Purity: 97% | 3-Bromo-2-methylbenzo[b]thiophene | ESD-845003-50MG |
Cas.: 10243-15-9 | Purity: 97% | 3-Bromo-2-methylbenzo[b]thiophene | ESD-845003-250MG |
Cas.: 128562-95-8 | Purity: 98% | 4-(Trifluoromethyl)-1H-indole | ESD-845004-50MG |
Cas.: 128562-95-8 | Purity: 98% | 4-(Trifluoromethyl)-1H-indole | ESD-845004-250MG |
Cas.: 625080-60-6 | Purity: 97% | 4-Chloro-6,7-difluoroquinazoline | ESD-845005-50MG |
Cas.: 625080-60-6 | Purity: 97% | 4-Chloro-6,7-difluoroquinazoline | ESD-845005-250MG |
Cas.: 104599-36-2 | Purity: 95% | 3,5-Dibromo-4-nitro-1H-pyrazole | ESD-845006-250MG |
Cas.: 104599-36-2 | Purity: 95% | 3,5-Dibromo-4-nitro-1H-pyrazole | ESD-845006-1G |
Cas.: 74733-30-5 | Purity: 95% | Methyl 4-(bromomethyl)-3-chlorobenzoate | ESD-845007-250MG |
Cas.: 74733-30-5 | Purity: 95% | Methyl 4-(bromomethyl)-3-chlorobenzoate | ESD-845007-1G |
Cas.: 29897-82-3 | Purity: 97% | 1-Benzylpyrrolidine | ESD-845008-250MG |
Cas.: 29897-82-3 | Purity: 97% | 1-Benzylpyrrolidine | ESD-845008-1G |
Cas.: 103261-67-2 | Purity: 98% | Methyl 4-cyano-2-methylbenzoate | ESD-845009-250MG |
Cas.: 103261-67-2 | Purity: 98% | Methyl 4-cyano-2-methylbenzoate | ESD-845009-1G |
Cas.: 144797-57-9 | Purity: 95% | 4-Chloro-3,5-difluorobenzonitrile | ESD-845010-250MG |
Cas.: 144797-57-9 | Purity: 95% | 4-Chloro-3,5-difluorobenzonitrile | ESD-845010-1G |
Cas.: 619-03-4 | Purity: 97% | 3,4-Dibromobenzoic acid | ESD-845011-250MG |
Cas.: 619-03-4 | Purity: 97% | 3,4-Dibromobenzoic acid | ESD-845011-1G |
Cas.: 5689-33-8 | Purity: 97% | 3-(Cyanomethyl)benzoic acid | ESD-845012-250MG |
Cas.: 5689-33-8 | Purity: 97% | 3-(Cyanomethyl)benzoic acid | ESD-845012-1G |
Cas.: 1159981-95-9 | Purity: 97% | 5-Bromopyrazolo[1,5-a]pyrimidine | ESD-845013-50MG |
Cas.: 1159981-95-9 | Purity: 97% | 5-Bromopyrazolo[1,5-a]pyrimidine | ESD-845013-250MG |
Cas.: 938-50-1 | Purity: 98% | 2-(2,6-Dimethylphenyl)acetic acid | ESD-845014-50MG |
Cas.: 938-50-1 | Purity: 98% | 2-(2,6-Dimethylphenyl)acetic acid | ESD-845014-250MG |
Cas.: 1188374-88-0 | Purity: 97% | 3-[3-(Trifluoromethyl)phenoxy]-azetidine hydrochloride | ESD-845015-50MG |
Cas.: 1188374-88-0 | Purity: 97% | 3-[3-(Trifluoromethyl)phenoxy]-azetidine hydrochloride | ESD-845015-250MG |
Cas.: 13096-62-3 | Purity: 97% | 2,3,4,6-Tetra-O-benzyl-D-glucono-1,5-lactone | ESD-845016-50MG |
Cas.: 13096-62-3 | Purity: 97% | 2,3,4,6-Tetra-O-benzyl-D-glucono-1,5-lactone | ESD-845016-250MG |
Cas.: 681508-70-3 | Purity: 98% | 1-(4-Trifluoromethylphenyl)piperidin-4-ol | ESD-845017-250MG |
Cas.: 681508-70-3 | Purity: 98% | 1-(4-Trifluoromethylphenyl)piperidin-4-ol | ESD-845017-1G |
Cas.: 1194804-60-8 | Purity: 97% | 3-(Methylamino)benzoic acid hydrochloride | ESD-845018-50MG |
Cas.: 1194804-60-8 | Purity: 97% | 3-(Methylamino)benzoic acid hydrochloride | ESD-845018-250MG |
Cas.: 41253-01-4 | Purity: 97% | 3-Nitro-5-iodobenzotrifluoride | ESD-845019-50MG |
Cas.: 41253-01-4 | Purity: 97% | 3-Nitro-5-iodobenzotrifluoride | ESD-845019-250MG |
Cas.: 27383-86-4 | Purity: 97% | Methyl benzo[d]oxazole-2-carboxylate | ESD-845020-50MG |
Cas.: 27383-86-4 | Purity: 97% | Methyl benzo[d]oxazole-2-carboxylate | ESD-845020-250MG |
Cas.: 179688-54-1 | Purity: 97% | 4-Chloro-7-methoxyquinazolin-6-yl acetate hydrochloride | ESD-845021-50MG |
Cas.: 179688-54-1 | Purity: 97% | 4-Chloro-7-methoxyquinazolin-6-yl acetate hydrochloride | ESD-845021-250MG |
Cas.: 20090-69-1 | Purity: 98% | 2-Chloro-4-methylpyrimidin-5-amine | ESD-845022-50MG |
Cas.: 20090-69-1 | Purity: 98% | 2-Chloro-4-methylpyrimidin-5-amine | ESD-845022-250MG |
Cas.: 37074-40-1 | Purity: 98% | 1-(4-Bromo-3-methylphenyl)ethanone | ESD-845023-50MG |
Cas.: 37074-40-1 | Purity: 98% | 1-(4-Bromo-3-methylphenyl)ethanone | ESD-845023-250MG |
Cas.: 1126424-50-7 | Purity: 95% | 1-tert-Butyl 6-methyl 1H-indazole-1,6-dicarboxylate | ESD-845024-50MG |
Cas.: 1126424-50-7 | Purity: 95% | 1-tert-Butyl 6-methyl 1H-indazole-1,6-dicarboxylate | ESD-845024-250MG |
Cas.: 1242339-16-7 | Purity: 95% | 2-Bromo-1-chloro-5-fluoro-3-methylbenzene | ESD-845025-50MG |
Cas.: 1242339-16-7 | Purity: 95% | 2-Bromo-1-chloro-5-fluoro-3-methylbenzene | ESD-845025-250MG |
Cas.: 1256345-67-1 | Purity: 98% | (4-Cyano-2-methoxyphenyl)boronic acid | ESD-845026-50MG |
Cas.: 1256345-67-1 | Purity: 98% | (4-Cyano-2-methoxyphenyl)boronic acid | ESD-845026-250MG |
Cas.: 328400-86-8 | Purity: 98% | 2-Bromo-4-methoxy-5-methylaniline | ESD-845027-50MG |
Cas.: 328400-86-8 | Purity: 98% | 2-Bromo-4-methoxy-5-methylaniline | ESD-845027-250MG |
Cas.: 851785-21-2 | Purity: 98% | (S)-Methyl 2-amino-3-(3-(methylsulfonyl)phenyl)propanoate hydrochloride | ESD-845028-50MG |
Cas.: 851785-21-2 | Purity: 98% | (S)-Methyl 2-amino-3-(3-(methylsulfonyl)phenyl)propanoate hydrochloride | ESD-845028-250MG |
Cas.: 19759-66-1 | Purity: 95% | 2-Aminobenzothiazole-6-carbonitrile | ESD-845029-50MG |
Cas.: 19759-66-1 | Purity: 95% | 2-Aminobenzothiazole-6-carbonitrile | ESD-845029-250MG |
Cas.: 905710-14-7 | Purity: 95% | tert-Butyl 5-bromo-3-(hydroxymethyl)-1H-indole-1-carboxylate | ESD-845030-250MG |
Cas.: 905710-14-7 | Purity: 95% | tert-Butyl 5-bromo-3-(hydroxymethyl)-1H-indole-1-carboxylate | ESD-845030-1G |
Cas.: 261904-39-6 | Purity: 97% | (2R)-3-Bromo-2-hydroxy-2-methylpropanoic acid | ESD-845031-250MG |
Cas.: 261904-39-6 | Purity: 97% | (2R)-3-Bromo-2-hydroxy-2-methylpropanoic acid | ESD-845031-1G |
Cas.: 52867-35-3 | Purity: 98% | 1-Methyl-1H-pyrazol-3(2H)-one | ESD-845032-250MG |
Cas.: 52867-35-3 | Purity: 98% | 1-Methyl-1H-pyrazol-3(2H)-one | ESD-845032-1G |
Cas.: 69778-83-2 | Purity: 97% | 4-Methoxy-1H-pyrrol-2(5H)-one | ESD-845033-250MG |
Cas.: 69778-83-2 | Purity: 97% | 4-Methoxy-1H-pyrrol-2(5H)-one | ESD-845033-1G |
Cas.: 916317-00-5 | Purity: 98% | 4-(Methoxymethyl)piperidine hydrochloride | ESD-845034-250MG |
Cas.: 916317-00-5 | Purity: 98% | 4-(Methoxymethyl)piperidine hydrochloride | ESD-845034-1G |
Cas.: 845885-90-7 | Purity: 97% | 4-Fluoro-3-formylbenzoic acid | ESD-845035-250MG |
Cas.: 845885-90-7 | Purity: 97% | 4-Fluoro-3-formylbenzoic acid | ESD-845035-1G |
Cas.: 850429-62-8 | Purity: 95% | Methyl 2-Boc-aminothiazole-4-carboxylate | ESD-845036-250MG |
Cas.: 850429-62-8 | Purity: 95% | Methyl 2-Boc-aminothiazole-4-carboxylate | ESD-845036-1G |
Cas.: 774531-43-0 | Purity: 95% | 1-(Pyridin-4-ylmethyl)piperidine-4-carboxylic acid | ESD-845037-250MG |
Cas.: 774531-43-0 | Purity: 95% | 1-(Pyridin-4-ylmethyl)piperidine-4-carboxylic acid | ESD-845037-1G |
Cas.: 328955-61-9 | Purity: 95% | 6-Bromo-4-(trifluoromethyl)quinolin-2(1H)-one | ESD-845038-250MG |
Cas.: 328955-61-9 | Purity: 95% | 6-Bromo-4-(trifluoromethyl)quinolin-2(1H)-one | ESD-845038-1G |
Cas.: 146-78-1 | Purity: 96% | (2R,3R,4S,5R)-2-(6-Amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol | ESD-845039-250MG |
Cas.: 146-78-1 | Purity: 96% | (2R,3R,4S,5R)-2-(6-Amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol | ESD-845039-1G |
Cas.: 214147-48-5 | Purity: 95% | 1-(4-Aminopipidin-1-yl)ethanone hydrochloride | ESD-845040-250MG |
Cas.: 214147-48-5 | Purity: 95% | 1-(4-Aminopipidin-1-yl)ethanone hydrochloride | ESD-845040-1G |
Cas.: 7470-38-4 | Purity: 95% | 4-Morpholinobenzoic acid | ESD-845041-250MG |
Cas.: 7470-38-4 | Purity: 95% | 4-Morpholinobenzoic acid | ESD-845041-1G |
Cas.: 54771-60-7 | Purity: 98% | 4-Acetyl-2-methoxyphenyl acetate | ESD-845042-250MG |
Cas.: 54771-60-7 | Purity: 98% | 4-Acetyl-2-methoxyphenyl acetate | ESD-845042-1G |
Cas.: 90365-74-5 | Purity: 97% | (3S,4S)-(+)-1-Benzyl-3,4-pyrrolidindiol | ESD-845043-250MG |
Cas.: 90365-74-5 | Purity: 97% | (3S,4S)-(+)-1-Benzyl-3,4-pyrrolidindiol | ESD-845043-1G |
Cas.: 57677-79-9 | Purity: 98% | Ethyl 2-(4-methoxyphenyl)thiazole-4-carboxylate | ESD-845044-250MG |
Cas.: 57677-79-9 | Purity: 98% | Ethyl 2-(4-methoxyphenyl)thiazole-4-carboxylate | ESD-845044-1G |
Cas.: 215184-78-4 | Purity: 98% | tert-Butyl 5-bromo-3,4-dihydroisoquinoline-2(1H)-carboxylate | ESD-845045-250MG |
Cas.: 215184-78-4 | Purity: 98% | tert-Butyl 5-bromo-3,4-dihydroisoquinoline-2(1H)-carboxylate | ESD-845045-1G |
Cas.: 5454-82-0 | Purity: 98% | Cyclobutylmethanamine hydrochloride | ESD-845046-250MG |
Cas.: 5454-82-0 | Purity: 98% | Cyclobutylmethanamine hydrochloride | ESD-845046-1G |
Cas.: 63845-28-3 | Purity: 95% | 2-(1-((Benzyloxy)carbonyl)piperidin-4-yl)acetic acid | ESD-845047-250MG |
Cas.: 63845-28-3 | Purity: 95% | 2-(1-((Benzyloxy)carbonyl)piperidin-4-yl)acetic acid | ESD-845047-1G |
Cas.: 103614-40-0 | Purity: 98% | (S)-tert-Butyl 2-(methylamino)propanoate hydrochloride | ESD-845048-250MG |
Cas.: 103614-40-0 | Purity: 98% | (S)-tert-Butyl 2-(methylamino)propanoate hydrochloride | ESD-845048-1G |
Cas.: 157327-41-8 | Purity: 95% | tert-Butyl 3-((dimethylamino)methylene)-4-oxopiperidine-1-carboxylate | ESD-845049-250MG |
Cas.: 157327-41-8 | Purity: 95% | tert-Butyl 3-((dimethylamino)methylene)-4-oxopiperidine-1-carboxylate | ESD-845049-1G |
Cas.: 397308-78-0 | Purity: 97% | 4-Hydroxy-2-(methylthio)pyrimidine-5-carboxylic acid | ESD-845050-250MG |
Cas.: 397308-78-0 | Purity: 97% | 4-Hydroxy-2-(methylthio)pyrimidine-5-carboxylic acid | ESD-845050-1G |
Cas.: 138377-80-7 | Purity: 95% | 3-Aminopipidin-2-one hydrochloride | ESD-845051-250MG |
Cas.: 138377-80-7 | Purity: 95% | 3-Aminopipidin-2-one hydrochloride | ESD-845051-1G |
Cas.: 88982-82-5 | Purity: 97% | 4-Bromo-1,3-thiazole-2-carboxylic acid | ESD-845052-250MG |
Cas.: 88982-82-5 | Purity: 97% | 4-Bromo-1,3-thiazole-2-carboxylic acid | ESD-845052-1G |
Cas.: 89180-51-8 | Purity: 96% | 2,5-Dichloropyrimidin-4-amine | ESD-845053-250MG |
Cas.: 89180-51-8 | Purity: 96% | 2,5-Dichloropyrimidin-4-amine | ESD-845053-1G |
Cas.: 179110-74-8 | Purity: 95% | tert-Butyl piperidin-4-ylcarbamate hydrochloride | ESD-845054-250MG |
Cas.: 179110-74-8 | Purity: 95% | tert-Butyl piperidin-4-ylcarbamate hydrochloride | ESD-845054-1G |
Cas.: 860296-24-8 | Purity: 97% | 6-Chloro-5-fluoropicolinic acid | ESD-845055-250MG |
Cas.: 860296-24-8 | Purity: 97% | 6-Chloro-5-fluoropicolinic acid | ESD-845055-1G |
Cas.: 117296-92-1 | Purity: 95% | Ethyl 2-(1H-imidazol-1-yl)benzoate | ESD-845056-250MG |
Cas.: 117296-92-1 | Purity: 95% | Ethyl 2-(1H-imidazol-1-yl)benzoate | ESD-845056-1G |
Cas.: 65001-80-1 | Purity: 98% | 1-Bromo-2,4-dichloro-5-nitrobenzene | ESD-845057-250MG |
Cas.: 65001-80-1 | Purity: 98% | 1-Bromo-2,4-dichloro-5-nitrobenzene | ESD-845057-1G |
Cas.: 204930-37-0 | Purity: 98% | 5-Bromo-1,3-dichloro-2-methylbenzene | ESD-845058-250MG |
Cas.: 204930-37-0 | Purity: 98% | 5-Bromo-1,3-dichloro-2-methylbenzene | ESD-845058-1G |
Cas.: 882679-96-1 | Purity: 97% | Methyl 4-bromo-1H-indole-6-carboxylate | ESD-845059-250MG |
Cas.: 882679-96-1 | Purity: 97% | Methyl 4-bromo-1H-indole-6-carboxylate | ESD-845059-1G |
Cas.: 99979-77-8 | Purity: 97% | 2-Chloro-5-methoxypyrimidin-4-amine | ESD-845060-250MG |
Cas.: 99979-77-8 | Purity: 97% | 2-Chloro-5-methoxypyrimidin-4-amine | ESD-845060-1G |
Cas.: 90725-67-0 | Purity: 98% | 1-(5-Bromo-2-hydroxy-3-nitrophenyl)propan-1-one | ESD-845061-250MG |
Cas.: 90725-67-0 | Purity: 98% | 1-(5-Bromo-2-hydroxy-3-nitrophenyl)propan-1-one | ESD-845061-1G |
Cas.: 132945-75-6 | Purity: 97% | (S)-tert-Butyl 3-((methylsulfonyl)oxy)pyrrolidine-1-carboxylate | ESD-845062-250MG |
Cas.: 132945-75-6 | Purity: 97% | (S)-tert-Butyl 3-((methylsulfonyl)oxy)pyrrolidine-1-carboxylate | ESD-845062-1G |
Cas.: 1610028-41-5 | Purity: 95% | tert-Butyl methyl(pyrrolidin-3-yl)carbamate hydrochloride | ESD-845063-250MG |
Cas.: 1610028-41-5 | Purity: 95% | tert-Butyl methyl(pyrrolidin-3-yl)carbamate hydrochloride | ESD-845063-1G |
Cas.: 1632286-18-0 | Purity: 95% | (4-(4-Methylpiperazin-1-yl)phenyl)methanamine 2,2,2-trifluoroacetate | ESD-845064-250MG |
Cas.: 1632286-18-0 | Purity: 95% | (4-(4-Methylpiperazin-1-yl)phenyl)methanamine 2,2,2-trifluoroacetate | ESD-845064-1G |
Cas.: 96736-00-4 | Purity: 96% | 4-(2-(tert-Butoxycarbonyl)hydrazinyl)benzoic acid | ESD-845065-250MG |
Cas.: 96736-00-4 | Purity: 96% | 4-(2-(tert-Butoxycarbonyl)hydrazinyl)benzoic acid | ESD-845065-1G |
Cas.: 3775-73-3 | Purity: 97% | (R)-3-Aminobutanoic acid | ESD-845066-250MG |
Cas.: 3775-73-3 | Purity: 97% | (R)-3-Aminobutanoic acid | ESD-845066-1G |
Cas.: 16686-11-6 | Purity: 97% | 2-(3-Chloropropyl)-1,3-dioxolane | ESD-845067-250MG |
Cas.: 16686-11-6 | Purity: 97% | 2-(3-Chloropropyl)-1,3-dioxolane | ESD-845067-1G |
Cas.: 22426-14-8 | Purity: 98% | 2-Bromo-1,10-phenanthroline | ESD-845068-250MG |
Cas.: 22426-14-8 | Purity: 98% | 2-Bromo-1,10-phenanthroline | ESD-845068-1G |
Cas.: 91063-19-3 | Purity: 98% | 3-(Benzyloxy)-6-chloropyridazine | ESD-845069-250MG |
Cas.: 91063-19-3 | Purity: 98% | 3-(Benzyloxy)-6-chloropyridazine | ESD-845069-1G |
Cas.: 618-61-1 | Purity: 98% | 3-Methyl-5-nitroaniline | ESD-845070-250MG |
Cas.: 618-61-1 | Purity: 98% | 3-Methyl-5-nitroaniline | ESD-845070-1G |
Cas.: 4269-94-7 | Purity: 95% | 6-Iodouracil | ESD-845071-250MG |
Cas.: 4269-94-7 | Purity: 95% | 6-Iodouracil | ESD-845071-1G |
Cas.: 675112-40-0 | Purity: 95% | 4-Aminocyclohexanone hydrochloride | ESD-845072-250MG |
Cas.: 675112-40-0 | Purity: 95% | 4-Aminocyclohexanone hydrochloride | ESD-845072-1G |
Cas.: 875-66-1 | Purity: 97% | Cinnolin-4-ol | ESD-845073-250MG |
Cas.: 875-66-1 | Purity: 97% | Cinnolin-4-ol | ESD-845073-1G |
Cas.: 834868-54-1 | Purity: 97% | 5-(3-Methoxyphenyl)-1H-pyrazole-3-carboxylic acid | ESD-845074-250MG |
Cas.: 834868-54-1 | Purity: 97% | 5-(3-Methoxyphenyl)-1H-pyrazole-3-carboxylic acid | ESD-845074-1G |
Cas.: 5818-89-3 | Purity: 95% | Chroman-2,3-dione | ESD-845075-250MG |
Cas.: 5818-89-3 | Purity: 95% | Chroman-2,3-dione | ESD-845075-1G |
Cas.: 139366-35-1 | Purity: 95% | 8-Bromo-5-nitroquinoline | ESD-845076-250MG |
Cas.: 139366-35-1 | Purity: 95% | 8-Bromo-5-nitroquinoline | ESD-845076-1G |
Cas.: 256936-11-5 | Purity: 97% | Methyl 1,2-dimethyl-1H-benzo[d]imidazole-5-carboxylate | ESD-845077-250MG |
Cas.: 256936-11-5 | Purity: 97% | Methyl 1,2-dimethyl-1H-benzo[d]imidazole-5-carboxylate | ESD-845077-1G |
Cas.: 30818-28-1 | Purity: 95% | 4-Chloro-2-hydroxybenzonitrile | ESD-845078-250MG |
Cas.: 30818-28-1 | Purity: 95% | 4-Chloro-2-hydroxybenzonitrile | ESD-845078-1G |
Cas.: 785777-94-8 | Purity: 95% | 4,5-Dibromo-6-(trifluoromethyl)pyrimidine | ESD-845079-250MG |
Cas.: 785777-94-8 | Purity: 95% | 4,5-Dibromo-6-(trifluoromethyl)pyrimidine | ESD-845079-1G |
Cas.: 90050-59-2 | Purity: 97% | 5-Bromo-2-methylbenzaldehyde | ESD-845080-250MG |
Cas.: 90050-59-2 | Purity: 97% | 5-Bromo-2-methylbenzaldehyde | ESD-845080-1G |
Cas.: 148017-28-1 | Purity: 97% | tert-Butyl sulfamoylcarbamate | ESD-845081-250MG |
Cas.: 148017-28-1 | Purity: 97% | tert-Butyl sulfamoylcarbamate | ESD-845081-1G |
Cas.: 1150566-27-0 | Purity: 98% | Ethyl 6-chloroimidazo[1,2-b]pyridazine-3-carboxylate | ESD-845082-50MG |
Cas.: 1150566-27-0 | Purity: 98% | Ethyl 6-chloroimidazo[1,2-b]pyridazine-3-carboxylate | ESD-845082-250MG |
Cas.: 73568-27-1 | Purity: 97% | 2-Chloro-6-methylquinoline-3-carbaldehyde | ESD-845083-1G |
Cas.: 73568-27-1 | Purity: 97% | 2-Chloro-6-methylquinoline-3-carbaldehyde | ESD-845083-5G |
Cas.: 1000340-34-0 | Purity: 95% | 4-Bromo-3-iodo-7-azaindole | ESD-845084-50MG |
Cas.: 1000340-34-0 | Purity: 95% | 4-Bromo-3-iodo-7-azaindole | ESD-845084-250MG |
Cas.: 1262769-75-4 | Purity: 95% | 3-Bromopyrrolidine hydrobromide | ESD-845085-250MG |
Cas.: 1262769-75-4 | Purity: 95% | 3-Bromopyrrolidine hydrobromide | ESD-845085-1G |
Cas.: 162816-08-2 | Purity: 95% | 3-Methyloxetan-3-ol | ESD-845086-50MG |
Cas.: 162816-08-2 | Purity: 95% | 3-Methyloxetan-3-ol | ESD-845086-250MG |
Cas.: 926304-76-9 | Purity: 98% | Methyl 4-((5-bromopyrimidin-2-yl)oxy)benzoate | ESD-845087-250MG |
Cas.: 926304-76-9 | Purity: 98% | Methyl 4-((5-bromopyrimidin-2-yl)oxy)benzoate | ESD-845087-1G |
Cas.: 1022094-03-6 | Purity: 97% | (S)-3-Methylmorpholine hydrochloride | ESD-845088-250MG |
Cas.: 1022094-03-6 | Purity: 97% | (S)-3-Methylmorpholine hydrochloride | ESD-845088-1G |
Cas.: 83846-66-6 | Purity: 98% | 1-(p-Tolyl)cyclopropanecarboxylic acid | ESD-845089-250MG |
Cas.: 83846-66-6 | Purity: 98% | 1-(p-Tolyl)cyclopropanecarboxylic acid | ESD-845089-1G |
Cas.: 1172965-47-7 | Purity: 97% | 2-(3-Methoxyphenyl)-2-oxoacetaldehyde hydrate | ESD-845090-250MG |
Cas.: 1172965-47-7 | Purity: 97% | 2-(3-Methoxyphenyl)-2-oxoacetaldehyde hydrate | ESD-845090-1G |
Cas.: 878285-12-2 | Purity: 98% | 4-Chloro-2,3-difluoroaniline | ESD-845091-250MG |
Cas.: 878285-12-2 | Purity: 98% | 4-Chloro-2,3-difluoroaniline | ESD-845091-1G |
Cas.: 1214342-44-5 | Purity: 97% | 3-Bromo-5-fluorobenzene-1-sulfonyl chloride | ESD-845092-250MG |
Cas.: 1214342-44-5 | Purity: 97% | 3-Bromo-5-fluorobenzene-1-sulfonyl chloride | ESD-845092-1G |
Cas.: 64863-10-1 | Purity: 97% | 3-Chloro-2-methyl-4-nitroaniline | ESD-845093-250MG |
Cas.: 64863-10-1 | Purity: 97% | 3-Chloro-2-methyl-4-nitroaniline | ESD-845093-1G |
Cas.: 1210278-19-5 | Purity: 97% | N-Boc-2-Amino-4-cyanothiazole | ESD-845094-50MG |
Cas.: 1210278-19-5 | Purity: 97% | N-Boc-2-Amino-4-cyanothiazole | ESD-845094-250MG |
Cas.: 1159512-34-1 | Purity: 98% | 3-Bromo-2-chloro-6-(trifluoromethyl)pyridine | ESD-845095-50MG |
Cas.: 1159512-34-1 | Purity: 98% | 3-Bromo-2-chloro-6-(trifluoromethyl)pyridine | ESD-845095-250MG |
Cas.: 74654-07-2 | Purity: 98% | 2-(2-(2-Methoxyethoxy)ethoxy)ethanamine | ESD-845096-50MG |
Cas.: 74654-07-2 | Purity: 98% | 2-(2-(2-Methoxyethoxy)ethoxy)ethanamine | ESD-845096-250MG |
Cas.: 1101120-80-2 | Purity: 97% | 5-Cyano-2-fluorobenzene-1-sulfonyl chloride | ESD-845097-50MG |
Cas.: 1101120-80-2 | Purity: 97% | 5-Cyano-2-fluorobenzene-1-sulfonyl chloride | ESD-845097-250MG |
Cas.: 175461-33-3 | Purity: 98% | 2,6-Dichloro-N-methylpyridin-4-amine | ESD-845098-50MG |
Cas.: 175461-33-3 | Purity: 98% | 2,6-Dichloro-N-methylpyridin-4-amine | ESD-845098-250MG |
Cas.: 957345-95-8 | Purity: 95% | 4-Bromofuran-2-carboxamide | ESD-845099-50MG |
Cas.: 957345-95-8 | Purity: 95% | 4-Bromofuran-2-carboxamide | ESD-845099-250MG |
Cas.: 14719-21-2 | Purity: 98% | 2,2,2-Trifluoro-N-(prop-2-yn-1-yl)acetamide | ESD-845100-50MG |
Cas.: 14719-21-2 | Purity: 98% | 2,2,2-Trifluoro-N-(prop-2-yn-1-yl)acetamide | ESD-845100-250MG |
Cas.: 517870-22-3 | Purity: 98% | Methyl 5-(tert-butyl)isoxazole-3-carboxylate | ESD-845101-50MG |
Cas.: 517870-22-3 | Purity: 98% | Methyl 5-(tert-butyl)isoxazole-3-carboxylate | ESD-845101-250MG |
Cas.: 18075-64-4 | Purity: 97% | 1-Phenyl-1H-imidazole-4-carboxylic acid | ESD-845102-50MG |
Cas.: 18075-64-4 | Purity: 97% | 1-Phenyl-1H-imidazole-4-carboxylic acid | ESD-845102-250MG |
Cas.: 37795-77-0 | Purity: 97% | 6-Methoxy-1H-benzo[d][1,3]oxazine-2,4-dione | ESD-845103-250MG |
Cas.: 37795-77-0 | Purity: 97% | 6-Methoxy-1H-benzo[d][1,3]oxazine-2,4-dione | ESD-845103-1G |
Cas.: 192642-85-6 | Purity: 95% | 2-(5-Bromopyridin-2-yl)acetic acid | ESD-845104-250MG |
Cas.: 192642-85-6 | Purity: 95% | 2-(5-Bromopyridin-2-yl)acetic acid | ESD-845104-1G |
Cas.: 80028-44-0 | Purity: 95% | Ethyl pyrrolidine-3-carboxylate hydrochloride | ESD-845105-250MG |
Cas.: 80028-44-0 | Purity: 95% | Ethyl pyrrolidine-3-carboxylate hydrochloride | ESD-845105-1G |
Cas.: 938043-30-2 | Purity: 97% | 1-Methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl]piperazine | ESD-845106-250MG |
Cas.: 938043-30-2 | Purity: 97% | 1-Methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl]piperazine | ESD-845106-1G |
Cas.: 145908-29-8 | Purity: 98% | Methyl 2-(bromomethyl)-4-chlorobenzoate | ESD-845107-250MG |
Cas.: 145908-29-8 | Purity: 98% | Methyl 2-(bromomethyl)-4-chlorobenzoate | ESD-845107-1G |
Cas.: 78238-12-7 | Purity: 98% | 3-Methoxy-5-nitrobenzoic acid | ESD-845108-250MG |
Cas.: 78238-12-7 | Purity: 98% | 3-Methoxy-5-nitrobenzoic acid | ESD-845108-1G |
Cas.: 136866-30-3 | Purity: 98% | 3,5-Dichloro-2-iodopyrazine | ESD-845109-50MG |
Cas.: 136866-30-3 | Purity: 98% | 3,5-Dichloro-2-iodopyrazine | ESD-845109-250MG |
Cas.: 20826-03-3 | Purity: 97% | 5-Methoxynicotinic acid | ESD-845110-250MG |
Cas.: 20826-03-3 | Purity: 97% | 5-Methoxynicotinic acid | ESD-845110-1G |
Cas.: 229178-74-9 | Purity: 98% | 2,6-Difluoro-3-iodobenzoic acid | ESD-845111-250MG |
Cas.: 229178-74-9 | Purity: 98% | 2,6-Difluoro-3-iodobenzoic acid | ESD-845111-1G |
Cas.: 3775-72-2 | Purity: 98% | (S)-3-Aminobutanoic acid | ESD-845112-250MG |
Cas.: 3775-72-2 | Purity: 98% | (S)-3-Aminobutanoic acid | ESD-845112-1G |
Cas.: 1435-54-7 | Purity: 98% | 1,3-Dibromo-2-fluorobenzene | ESD-845113-250MG |
Cas.: 1435-54-7 | Purity: 98% | 1,3-Dibromo-2-fluorobenzene | ESD-845113-1G |
Cas.: 858839-90-4 | Purity: 97% | 4-Iodopyridin-2(1H)-one | ESD-845114-50MG |
Cas.: 858839-90-4 | Purity: 97% | 4-Iodopyridin-2(1H)-one | ESD-845114-250MG |
Cas.: 1082662-38-1 | Purity: 95% | 1-Phenylpiperidin-4-amine dihydrochloride | ESD-845115-50MG |
Cas.: 1082662-38-1 | Purity: 95% | 1-Phenylpiperidin-4-amine dihydrochloride | ESD-845115-250MG |
Cas.: 4964-69-6 | Purity: 98% | 5-Chloro-2-methylquinoline | ESD-845116-50MG |
Cas.: 4964-69-6 | Purity: 98% | 5-Chloro-2-methylquinoline | ESD-845116-250MG |
Cas.: 67500-19-0 | Purity: 98% | 1-(5-Amino-2-fluorophenyl)ethanone | ESD-845117-50MG |
Cas.: 67500-19-0 | Purity: 98% | 1-(5-Amino-2-fluorophenyl)ethanone | ESD-845117-250MG |
Cas.: 10160-28-8 | Purity: 95% | Non-8-yn-1-ol | ESD-845118-50MG |
Cas.: 10160-28-8 | Purity: 95% | Non-8-yn-1-ol | ESD-845118-250MG |
Cas.: 685828-16-4 | Purity: 95% | (S)-3-Methoxypyrrolidine hydrochloride | ESD-845119-50MG |
Cas.: 685828-16-4 | Purity: 95% | (S)-3-Methoxypyrrolidine hydrochloride | ESD-845119-250MG |
Cas.: 127426-30-6 | Purity: 97% | 2,5-Dichlorothiazole-4-carboxylic acid | ESD-845120-50MG |
Cas.: 127426-30-6 | Purity: 97% | 2,5-Dichlorothiazole-4-carboxylic acid | ESD-845120-250MG |
Cas.: 29274-22-4 | Purity: 98% | Pyrazolo[1,5-a]pyrimidin-5-ol | ESD-845121-50MG |
Cas.: 29274-22-4 | Purity: 98% | Pyrazolo[1,5-a]pyrimidin-5-ol | ESD-845121-250MG |
Cas.: 7051-15-2 | Purity: 98% | 2-Chloro-1,3-dimethoxybenzene | ESD-845122-50MG |
Cas.: 7051-15-2 | Purity: 98% | 2-Chloro-1,3-dimethoxybenzene | ESD-845122-250MG |
Cas.: 6245-89-2 | Purity: 95% | (1H-Indol-3-yl)-1-propanamine | ESD-845123-50MG |
Cas.: 6245-89-2 | Purity: 95% | (1H-Indol-3-yl)-1-propanamine | ESD-845123-250MG |
Cas.: 897019-59-9 | Purity: 97% | 3-(Benzyloxy)azetidine hydrochloride | ESD-845124-50MG |
Cas.: 897019-59-9 | Purity: 97% | 3-(Benzyloxy)azetidine hydrochloride | ESD-845124-250MG |
Cas.: 38875-74-0 | Purity: 97% | 4-Chloro-2-methylpyrimidine-5-carbonitrile | ESD-845125-50MG |
Cas.: 38875-74-0 | Purity: 97% | 4-Chloro-2-methylpyrimidine-5-carbonitrile | ESD-845125-250MG |
Cas.: 821767-61-7 | Purity: 97% | tert-Butyl 4-formyl-1H-pyrazole-1-carboxylate | ESD-845126-50MG |
Cas.: 821767-61-7 | Purity: 97% | tert-Butyl 4-formyl-1H-pyrazole-1-carboxylate | ESD-845126-250MG |
Cas.: 84889-09-8 | Purity: 95% | (S)-2-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-phenylpropanamido)-3-phenylpropanoic acid | ESD-845127-50MG |
Cas.: 84889-09-8 | Purity: 95% | (S)-2-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-phenylpropanamido)-3-phenylpropanoic acid | ESD-845127-250MG |
Cas.: 1022092-33-6 | Purity: 95% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-propanenitrile | ESD-845128-50MG |
Cas.: 1022092-33-6 | Purity: 95% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-propanenitrile | ESD-845128-250MG |
Cas.: 89943-11-3 | Purity: 98% | 5-Ethoxypyridin-2-amine | ESD-845129-50MG |
Cas.: 89943-11-3 | Purity: 98% | 5-Ethoxypyridin-2-amine | ESD-845129-250MG |
Cas.: 88145-90-8 | Purity: 98% | 6-Fluoroquinazoline-2,4-diol | ESD-845130-50MG |
Cas.: 88145-90-8 | Purity: 98% | 6-Fluoroquinazoline-2,4-diol | ESD-845130-250MG |
Cas.: 1255098-88-4 | Purity: 97% | Sodium oxazole-2-carboxylate | ESD-845131-50MG |
Cas.: 1255098-88-4 | Purity: 97% | Sodium oxazole-2-carboxylate | ESD-845131-250MG |
Cas.: 1123169-23-2 | Purity: 97% | Methyl 6-bromobenzo[d]isoxazole-3-carboxylate | ESD-845132-50MG |
Cas.: 1123169-23-2 | Purity: 97% | Methyl 6-bromobenzo[d]isoxazole-3-carboxylate | ESD-845132-250MG |
Cas.: 686747-51-3 | Purity: 95% | Methyl 5-nitro-1H-indole-3-carboxylate | ESD-845133-50MG |
Cas.: 686747-51-3 | Purity: 95% | Methyl 5-nitro-1H-indole-3-carboxylate | ESD-845133-250MG |
Cas.: 509073-67-0 | Purity: 95% | 3-(Bromomethyl)benzamide | ESD-845134-50MG |
Cas.: 509073-67-0 | Purity: 95% | 3-(Bromomethyl)benzamide | ESD-845134-250MG |
Cas.: 21943-14-6 | Purity: 95% | 3-Amino-6-bromopyrazin-2(1H)-one | ESD-845135-50MG |
Cas.: 21943-14-6 | Purity: 95% | 3-Amino-6-bromopyrazin-2(1H)-one | ESD-845135-250MG |
Cas.: 855300-09-3 | Purity: 98% | 3-Acetylphenyl ethyl(methyl)carbamate | ESD-845136-50MG |
Cas.: 855300-09-3 | Purity: 98% | 3-Acetylphenyl ethyl(methyl)carbamate | ESD-845136-250MG |
Cas.: 1233026-52-2 | Purity: 95% | 4-Bromo-2-chloro-3-fluorophenol | ESD-845137-50MG |
Cas.: 1233026-52-2 | Purity: 95% | 4-Bromo-2-chloro-3-fluorophenol | ESD-845137-250MG |
Cas.: 366453-22-7 | Purity: 95% | 4-Methoxyisoindolin-1-one | ESD-845138-50MG |
Cas.: 366453-22-7 | Purity: 95% | 4-Methoxyisoindolin-1-one | ESD-845138-250MG |
Cas.: 937046-98-5 | Purity: 97% | 7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine | ESD-845139-250MG |
Cas.: 65001-79-8 | Purity: 98% | 5-Chloro-4-fluoro-2-nitrophenol | ESD-845140-250MG |
Cas.: 65001-79-8 | Purity: 98% | 5-Chloro-4-fluoro-2-nitrophenol | ESD-845140-1G |
Cas.: 132201-32-2 | Purity: 97% | (2R,3S)-3-Phenyliserine hydrochloride | ESD-845141-250MG |
Cas.: 132201-32-2 | Purity: 97% | (2R,3S)-3-Phenyliserine hydrochloride | ESD-845141-1G |
Cas.: 145901-11-7 | Purity: 98% | 1H-Pyrrolo[2,3-b]pyridin-6-amine | ESD-845142-50MG |
Cas.: 145901-11-7 | Purity: 98% | 1H-Pyrrolo[2,3-b]pyridin-6-amine | ESD-845142-250MG |
Cas.: 116-38-1 | Purity: 98% | Edrophonium chloride | ESD-845143-50MG |
Cas.: 116-38-1 | Purity: 98% | Edrophonium chloride | ESD-845143-250MG |
Cas.: 796090-24-9 | Purity: 98% | 6-Chloro-3-(trifluoromethyl)pyridine-2-carboxylic acid | ESD-845144-50MG |
Cas.: 796090-24-9 | Purity: 98% | 6-Chloro-3-(trifluoromethyl)pyridine-2-carboxylic acid | ESD-845144-250MG |
Cas.: 52545-13-8 | Purity: 95% | 4-Methoxypyridin-2(1H)-one | ESD-845145-50MG |
Cas.: 52545-13-8 | Purity: 95% | 4-Methoxypyridin-2(1H)-one | ESD-845145-250MG |
Cas.: 1060802-88-1 | Purity: 98% | 6-Bromo-1,2-benzisoxazole | ESD-845146-50MG |
Cas.: 1060802-88-1 | Purity: 98% | 6-Bromo-1,2-benzisoxazole | ESD-845146-250MG |
Cas.: 648423-79-4 | Purity: 97% | 2-Cyclopropyl-pyrimidine-5-carboxylic acid | ESD-845147-50MG |
Cas.: 648423-79-4 | Purity: 97% | 2-Cyclopropyl-pyrimidine-5-carboxylic acid | ESD-845147-250MG |
Cas.: 1108668-25-2 | Purity: 97% | Ethyl 2-amino-4,5-dichlorobenzoate | ESD-845148-50MG |
Cas.: 1108668-25-2 | Purity: 97% | Ethyl 2-amino-4,5-dichlorobenzoate | ESD-845148-250MG |
Cas.: 668262-52-0 | Purity: 98% | Methyl 2-(bromomethyl)-5-chlorobenzoate | ESD-845149-50MG |
Cas.: 668262-52-0 | Purity: 98% | Methyl 2-(bromomethyl)-5-chlorobenzoate | ESD-845149-250MG |
Cas.: 136834-21-4 | Purity: 95% | DMT-2′-F-Bz-dA | ESD-845150-50MG |
Cas.: 136834-21-4 | Purity: 95% | DMT-2′-F-Bz-dA | ESD-845150-250MG |
Cas.: 877149-10-5 | Purity: 98% | Methyl 4-bromo-2-chloro-6-methylbenzoate | ESD-845151-50MG |
Cas.: 877149-10-5 | Purity: 98% | Methyl 4-bromo-2-chloro-6-methylbenzoate | ESD-845151-250MG |
Cas.: 342613-67-6 | Purity: 98% | 3-Bromo-7-chloroimidazo[1,2-a]pyridine | ESD-845152-50MG |
Cas.: 342613-67-6 | Purity: 98% | 3-Bromo-7-chloroimidazo[1,2-a]pyridine | ESD-845152-250MG |
Cas.: 1197050-28-4 | Purity: 95% | 3-Bromo-2-chlorobenzaldehyde | ESD-845153-250MG |
Cas.: 1197050-28-4 | Purity: 95% | 3-Bromo-2-chlorobenzaldehyde | ESD-845153-1G |
Cas.: 1187931-23-2 | Purity: 95% | (R)-Benzyl 2-(aminomethyl)pyrrolidine-1-carboxylate | ESD-845154-250MG |
Cas.: 1187931-23-2 | Purity: 95% | (R)-Benzyl 2-(aminomethyl)pyrrolidine-1-carboxylate | ESD-845154-1G |
Cas.: 1370411-48-5 | Purity: 95% | Pyrazine-2,6-diamine hydrochloride | ESD-845155-250MG |
Cas.: 1370411-48-5 | Purity: 95% | Pyrazine-2,6-diamine hydrochloride | ESD-845155-1G |
Cas.: 1244642-73-6 | Purity: 97% | 3-Bromo-4,5-difluorobenzoic acid | ESD-845156-250MG |
Cas.: 1244642-73-6 | Purity: 97% | 3-Bromo-4,5-difluorobenzoic acid | ESD-845156-1G |
Cas.: 2148-57-4 | Purity: 98% | 4,7-Dichloroquinazoline | ESD-845157-250MG |
Cas.: 2148-57-4 | Purity: 98% | 4,7-Dichloroquinazoline | ESD-845157-1G |
Cas.: 55094-52-5 | Purity: 98% | (3R,4R,5R)-3,4-Bis(benzyloxy)-5-((benzyloxy)methyl)dihydrofuran-2(3H)-one | ESD-845158-250MG |
Cas.: 55094-52-5 | Purity: 98% | (3R,4R,5R)-3,4-Bis(benzyloxy)-5-((benzyloxy)methyl)dihydrofuran-2(3H)-one | ESD-845158-1G |
Cas.: 937636-18-5 | Purity: 95% | Methyl 3-fluoro-4-(hydroxymethyl)benzoate | ESD-845159-250MG |
Cas.: 937636-18-5 | Purity: 95% | Methyl 3-fluoro-4-(hydroxymethyl)benzoate | ESD-845159-1G |
Cas.: 1045332-30-6 | Purity: 98% | (4-(Pyridin-4-yl)phenyl)boronic acid | ESD-845160-250MG |
Cas.: 1045332-30-6 | Purity: 98% | (4-(Pyridin-4-yl)phenyl)boronic acid | ESD-845160-1G |
Cas.: 104010-37-9 | Purity: 98% | Ceftiofur sodium | ESD-845161-1G |
Cas.: 104010-37-9 | Purity: 98% | Ceftiofur sodium | ESD-845161-5G |
Cas.: 942189-65-3 | Purity: 97% | 2-(6-Bromopyridin-3-yl)pyrimidine | ESD-845162-50MG |
Cas.: 942189-65-3 | Purity: 97% | 2-(6-Bromopyridin-3-yl)pyrimidine | ESD-845162-250MG |
Cas.: 73038-85-4 | Purity: 98% | 4-Chloro-6-hydroxynicotinic acid | ESD-845163-50MG |
Cas.: 73038-85-4 | Purity: 98% | 4-Chloro-6-hydroxynicotinic acid | ESD-845163-250MG |
Cas.: 108258-54-4 | Purity: 98% | Methyl 2,3-dichloroquinoxaline-6-carboxylate | ESD-845164-50MG |
Cas.: 108258-54-4 | Purity: 98% | Methyl 2,3-dichloroquinoxaline-6-carboxylate | ESD-845164-250MG |
Cas.: 1172902-07-6 | Purity: 95% | Methyl 1-(aminomethyl)cyclobutanecarboxylate hydrochloride | ESD-845165-50MG |
Cas.: 1172902-07-6 | Purity: 95% | Methyl 1-(aminomethyl)cyclobutanecarboxylate hydrochloride | ESD-845165-250MG |
Cas.: 154012-15-4 | Purity: 97% | Ethyl 4,6-dichloro-5-nitronicotinate | ESD-845166-50MG |
Cas.: 154012-15-4 | Purity: 97% | Ethyl 4,6-dichloro-5-nitronicotinate | ESD-845166-250MG |
Cas.: 150374-99-5 | Purity: 95% | 4-(Chlorosulfonyl)phenyl pivalate | ESD-845167-50MG |
Cas.: 150374-99-5 | Purity: 95% | 4-(Chlorosulfonyl)phenyl pivalate | ESD-845167-250MG |
Cas.: 106536-48-5 | Purity: 95% | 1-(2-Bromoethyl)pyrrolidine hydrochloride | ESD-845168-50MG |
Cas.: 106536-48-5 | Purity: 95% | 1-(2-Bromoethyl)pyrrolidine hydrochloride | ESD-845168-250MG |
Cas.: 327156-95-6 | Purity: 97% | 2-(cis-4-((tert-Butoxycarbonyl)amino)cyclohexyl)acetic acid | ESD-845169-50MG |
Cas.: 327156-95-6 | Purity: 97% | 2-(cis-4-((tert-Butoxycarbonyl)amino)cyclohexyl)acetic acid | ESD-845169-250MG |
Cas.: 1260765-26-1 | Purity: 98% | 4-(Pyridin-2-yl)-1H-pyrazole-3-carboxylic acid | ESD-845170-50MG |
Cas.: 1260765-26-1 | Purity: 98% | 4-(Pyridin-2-yl)-1H-pyrazole-3-carboxylic acid | ESD-845170-250MG |
Cas.: 30321-94-9 | Purity: 95% | 5-Bromo-2-(methylsulfonyl)pyrimidine-4-carboxylic acid | ESD-845171-50MG |
Cas.: 30321-94-9 | Purity: 95% | 5-Bromo-2-(methylsulfonyl)pyrimidine-4-carboxylic acid | ESD-845171-250MG |
Cas.: 149990-27-2 | Purity: 98% | tert-Butyl but-3-yn-1-ylcarbamate | ESD-845172-50MG |
Cas.: 149990-27-2 | Purity: 98% | tert-Butyl but-3-yn-1-ylcarbamate | ESD-845172-250MG |
Cas.: 90942-47-5 | Purity: 98% | Methyl 5-(aminomethyl)-2-chlorobenzoate hydrochloride | ESD-845173-50MG |
Cas.: 90942-47-5 | Purity: 98% | Methyl 5-(aminomethyl)-2-chlorobenzoate hydrochloride | ESD-845173-250MG |
Cas.: 178264-57-8 | Purity: 97% | Ethyl 6-(bromomethyl)nicotinate | ESD-845174-50MG |
Cas.: 178264-57-8 | Purity: 97% | Ethyl 6-(bromomethyl)nicotinate | ESD-845174-250MG |
Cas.: 70138-19-1 | Purity: 97% | 1-(m-Tolyl)ethanamine | ESD-845175-50MG |
Cas.: 70138-19-1 | Purity: 97% | 1-(m-Tolyl)ethanamine | ESD-845175-250MG |
Cas.: 194278-45-0 | Purity: 95% | 3-Methyl-1H-pyrazolo[4,3-b]pyridine | ESD-845176-50MG |
Cas.: 194278-45-0 | Purity: 95% | 3-Methyl-1H-pyrazolo[4,3-b]pyridine | ESD-845176-250MG |
Cas.: 136888-79-4 | Purity: 98% | 2-Fluoro-5-methoxypyridine | ESD-845177-50MG |
Cas.: 136888-79-4 | Purity: 98% | 2-Fluoro-5-methoxypyridine | ESD-845177-250MG |
Cas.: 65948-19-8 | Purity: 98% | 6-Phenoxybenzo[d]thiazol-2-amine | ESD-845178-50MG |
Cas.: 65948-19-8 | Purity: 98% | 6-Phenoxybenzo[d]thiazol-2-amine | ESD-845178-250MG |
Cas.: 169447-86-3 | Purity: 95% | (S)-tert-Butyl 2-benzylpiperazine-1-carboxylate | ESD-845179-50MG |
Cas.: 169447-86-3 | Purity: 95% | (S)-tert-Butyl 2-benzylpiperazine-1-carboxylate | ESD-845179-250MG |
Cas.: 54126-45-3 | Purity: 98% | 3-Chloro-N,N-dimethylpyrazin-2-amine | ESD-845180-50MG |
Cas.: 54126-45-3 | Purity: 98% | 3-Chloro-N,N-dimethylpyrazin-2-amine | ESD-845180-250MG |
Cas.: 1214328-20-7 | Purity: 98% | 2-Fluoro-3-nitrobenzonitrile | ESD-845182-250MG |
Cas.: 1214328-20-7 | Purity: 98% | 2-Fluoro-3-nitrobenzonitrile | ESD-845182-1G |
Cas.: 4740-24-3 | Purity: 98% | 4-(Butylamino)benzoic acid | ESD-845183-250MG |
Cas.: 4740-24-3 | Purity: 98% | 4-(Butylamino)benzoic acid | ESD-845183-1G |
Cas.: 63279-58-3 | Purity: 98% | 1-Bromo-4-iodonaphthalene | ESD-845184-250MG |
Cas.: 63279-58-3 | Purity: 98% | 1-Bromo-4-iodonaphthalene | ESD-845184-1G |
Cas.: 18442-22-3 | Purity: 98% | 7-Bromochroman-4-one | ESD-845185-250MG |
Cas.: 18442-22-3 | Purity: 98% | 7-Bromochroman-4-one | ESD-845185-1G |
Cas.: 571189-49-6 | Purity: 98% | 5-(4-Methylpiperazin-1-yl)pyridin-2-amine | ESD-845186-250MG |
Cas.: 571189-49-6 | Purity: 98% | 5-(4-Methylpiperazin-1-yl)pyridin-2-amine | ESD-845186-1G |
Cas.: 26845-47-6 | Purity: 97% | Methyl 1,4-dioxaspiro[4.5]decane-8-carboxylate | ESD-845187-250MG |
Cas.: 26845-47-6 | Purity: 97% | Methyl 1,4-dioxaspiro[4.5]decane-8-carboxylate | ESD-845187-1G |
Cas.: 16096-13-2 | Purity: 98% | 2-Isopropoxypyridine | ESD-845188-250MG |
Cas.: 16096-13-2 | Purity: 98% | 2-Isopropoxypyridine | ESD-845188-1G |
Cas.: 34582-33-7 | Purity: 97% | (S)-1-tert-butyl 5-methyl 2-aminopentanedioate hydrochloride | ESD-845189-250MG |
Cas.: 34582-33-7 | Purity: 97% | (S)-1-tert-butyl 5-methyl 2-aminopentanedioate hydrochloride | ESD-845189-1G |
Cas.: 26081-03-8 | Purity: 97% | (R)-3-Aminoazepan-2-one hydrochloride | ESD-845190-250MG |
Cas.: 26081-03-8 | Purity: 97% | (R)-3-Aminoazepan-2-one hydrochloride | ESD-845190-1G |
Cas.: 180976-09-4 | Purity: 97% | tert-Butyl (cyanomethyl)(methyl)carbamate | ESD-845191-250MG |
Cas.: 180976-09-4 | Purity: 97% | tert-Butyl (cyanomethyl)(methyl)carbamate | ESD-845191-1G |
Cas.: 114843-08-2 | Purity: 97% | 3-Amino-1-phenylpropan-1-ol oxalate | ESD-845192-250MG |
Cas.: 114843-08-2 | Purity: 97% | 3-Amino-1-phenylpropan-1-ol oxalate | ESD-845192-1G |
Cas.: 942947-95-7 | Purity: 97% | 2-Amino-5-bromo-4-chloro-3-nitropyridine | ESD-845193-250MG |
Cas.: 942947-95-7 | Purity: 97% | 2-Amino-5-bromo-4-chloro-3-nitropyridine | ESD-845193-1G |
Cas.: 855836-62-3 | Purity: 98% | 2-Bromo-3-chlorophenol | ESD-845194-250MG |
Cas.: 855836-62-3 | Purity: 98% | 2-Bromo-3-chlorophenol | ESD-845194-1G |
Cas.: 53078-69-6 | Purity: 98% | 2-Methoxy-4-methylbenzonitrile | ESD-845195-250MG |
Cas.: 53078-69-6 | Purity: 98% | 2-Methoxy-4-methylbenzonitrile | ESD-845195-1G |
Cas.: 86477-09-0 | Purity: 95% | Ethyl 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole-2-carboxylate | ESD-845196-50MG |
Cas.: 86477-09-0 | Purity: 95% | Ethyl 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole-2-carboxylate | ESD-845196-250MG |
Cas.: 125224-62-6 | Purity: 97% | (1S,4S)-2-Methyl-2,5-diazabicyclo[2.2.1]heptane dihydrobromide | ESD-845197-50MG |
Cas.: 125224-62-6 | Purity: 97% | (1S,4S)-2-Methyl-2,5-diazabicyclo[2.2.1]heptane dihydrobromide | ESD-845197-250MG |
Cas.: 936250-18-9 | Purity: 95% | 2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)acetonitrile | ESD-845198-50MG |
Cas.: 936250-18-9 | Purity: 95% | 2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)acetonitrile | ESD-845198-250MG |
Cas.: 154578-26-4 | Purity: 97% | 6-Chloroimidazo[1,2-b]pyridazine-3-carbaldehyde | ESD-845199-50MG |
Cas.: 154578-26-4 | Purity: 97% | 6-Chloroimidazo[1,2-b]pyridazine-3-carbaldehyde | ESD-845199-250MG |
Cas.: 958452-00-1 | Purity: 98% | 5-Bromoquinazoline | ESD-845200-50MG |
Cas.: 958452-00-1 | Purity: 98% | 5-Bromoquinazoline | ESD-845200-250MG |
Cas.: 5919-26-6 | Purity: 97% | 2-Nitro-1H-pyrrole | ESD-845201-50MG |
Cas.: 5919-26-6 | Purity: 97% | 2-Nitro-1H-pyrrole | ESD-845201-250MG |
Cas.: 722549-98-6 | Purity: 95% | 4-Morpholinopyridin-2-amine | ESD-845202-50MG |
Cas.: 722549-98-6 | Purity: 95% | 4-Morpholinopyridin-2-amine | ESD-845202-250MG |
Cas.: 141990-91-2 | Purity: 95% | N-(3-Cyanophenyl)benzamide | ESD-845203-50MG |
Cas.: 141990-91-2 | Purity: 95% | N-(3-Cyanophenyl)benzamide | ESD-845203-250MG |
Cas.: 1065181-58-9 | Purity: 98% | Ethyl 5-bromo-1H-indole-7-carboxylate | ESD-845204-50MG |
Cas.: 1065181-58-9 | Purity: 98% | Ethyl 5-bromo-1H-indole-7-carboxylate | ESD-845204-250MG |
Cas.: 14248-01-2 | Purity: 98% | 5-Bromo-1-methylpyrimidin-2(1H)-one | ESD-845205-50MG |
Cas.: 14248-01-2 | Purity: 98% | 5-Bromo-1-methylpyrimidin-2(1H)-one | ESD-845205-250MG |
Cas.: 15950-17-1 | Purity: 97% | 4-Chloro-N-methyl-2-nitroaniline | ESD-845206-50MG |
Cas.: 15950-17-1 | Purity: 97% | 4-Chloro-N-methyl-2-nitroaniline | ESD-845206-250MG |
Cas.: 1624260-21-4 | Purity: 95% | 2-Amino-3-(pyridin-4-yl)propanoic acid hydrochloride | ESD-845207-50MG |
Cas.: 1624260-21-4 | Purity: 95% | 2-Amino-3-(pyridin-4-yl)propanoic acid hydrochloride | ESD-845207-250MG |
Cas.: 31181-84-7 | Purity: 96% | (5-(Trifluoromethyl)pyridin-2-yl)methanol | ESD-845208-50MG |
Cas.: 31181-84-7 | Purity: 96% | (5-(Trifluoromethyl)pyridin-2-yl)methanol | ESD-845208-250MG |
Cas.: 392307-25-4 | Purity: 98% | 4-(3-Bromophenyl)pyrimidin-2-amine | ESD-845209-50MG |
Cas.: 392307-25-4 | Purity: 98% | 4-(3-Bromophenyl)pyrimidin-2-amine | ESD-845209-250MG |
Cas.: 42383-05-1 | Purity: 97% | 2-(4-(Aminomethyl)phenyl)acetic acid hydrochloride | ESD-845210-50MG |
Cas.: 42383-05-1 | Purity: 97% | 2-(4-(Aminomethyl)phenyl)acetic acid hydrochloride | ESD-845210-250MG |
Cas.: 4687-25-6 | Purity: 95% | Benzofuran-3-carbaldehyde | ESD-845211-50MG |
Cas.: 4687-25-6 | Purity: 95% | Benzofuran-3-carbaldehyde | ESD-845211-250MG |
Cas.: 95652-77-0 | Purity: 97% | Methyl 2-chloro-6-methoxynicotinate | ESD-845212-50MG |
Cas.: 95652-77-0 | Purity: 97% | Methyl 2-chloro-6-methoxynicotinate | ESD-845212-250MG |
Cas.: 916792-23-9 | Purity: 98% | 4-Bromo-2-fluoro-5-methylbenzaldehyde | ESD-845213-50MG |
Cas.: 916792-23-9 | Purity: 98% | 4-Bromo-2-fluoro-5-methylbenzaldehyde | ESD-845213-250MG |
Cas.: 1043688-99-8 | Purity: 98% | 2-Bromo-5-methoxypyridin-3-amine | ESD-845214-50MG |
Cas.: 1043688-99-8 | Purity: 98% | 2-Bromo-5-methoxypyridin-3-amine | ESD-845214-250MG |
Cas.: 220880-12-6 | Purity: 95% | 4-(Trifluoromethyl)pyrimidine-5-carboxylic acid | ESD-845215-50MG |
Cas.: 220880-12-6 | Purity: 95% | 4-(Trifluoromethyl)pyrimidine-5-carboxylic acid | ESD-845215-250MG |
Cas.: 1137576-38-5 | Purity: 98% | 4,6-Dichloro-5-iodopyrimidine | ESD-845216-50MG |
Cas.: 1137576-38-5 | Purity: 98% | 4,6-Dichloro-5-iodopyrimidine | ESD-845216-250MG |
Cas.: 133081-25-1 | Purity: 95% | 6-(2-(tert-Butoxycarbonyl)hydrazinyl)nicotinic acid | ESD-845217-50MG |
Cas.: 133081-25-1 | Purity: 95% | 6-(2-(tert-Butoxycarbonyl)hydrazinyl)nicotinic acid | ESD-845217-250MG |
Cas.: 145576-28-9 | Purity: 95% | ethyl 4-methylenecyclohexane-1-carboxylate | ESD-845218-50MG |
Cas.: 145576-28-9 | Purity: 95% | ethyl 4-methylenecyclohexane-1-carboxylate | ESD-845218-250MG |
Cas.: 1082843-72-8 | Purity: 98% | 6-Bromo-3-chloropyrazin-2-amine | ESD-845219-50MG |
Cas.: 1082843-72-8 | Purity: 98% | 6-Bromo-3-chloropyrazin-2-amine | ESD-845219-250MG |
Cas.: 193014-01-6 | Purity: 98% | Ethyl 3-amino-2-nitrobenzoate | ESD-845220-50MG |
Cas.: 193014-01-6 | Purity: 98% | Ethyl 3-amino-2-nitrobenzoate | ESD-845220-250MG |
Cas.: 183059-24-7 | Purity: 98% | tert-Butyl 2-hydroxy-2-methylpropylcarbamate | ESD-845221-50MG |
Cas.: 183059-24-7 | Purity: 98% | tert-Butyl 2-hydroxy-2-methylpropylcarbamate | ESD-845221-250MG |
Cas.: 579474-47-8 | Purity: 98% | tert-Butyl 2-amino-4-fluorophenylcarbamate | ESD-845222-50MG |
Cas.: 579474-47-8 | Purity: 98% | tert-Butyl 2-amino-4-fluorophenylcarbamate | ESD-845222-250MG |
Cas.: 1209264-64-1 | Purity: 95% | 5,6,7,8-Tetrahydroimidazo[1,2-a]pyrimidine hydrochloride | ESD-845223-50MG |
Cas.: 1209264-64-1 | Purity: 95% | 5,6,7,8-Tetrahydroimidazo[1,2-a]pyrimidine hydrochloride | ESD-845223-250MG |
Cas.: 210366-15-7 | Purity: 97% | 1-(Benzyloxy)-6-oxo-1,6-dihydropyridine-2-carboxylic acid | ESD-845224-50MG |
Cas.: 210366-15-7 | Purity: 97% | 1-(Benzyloxy)-6-oxo-1,6-dihydropyridine-2-carboxylic acid | ESD-845224-250MG |
Cas.: 775351-56-9 | Purity: 95% | 2-Hydroxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile | ESD-845225-50MG |
Cas.: 775351-56-9 | Purity: 95% | 2-Hydroxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile | ESD-845225-250MG |
Cas.: 179543-88-5 | Purity: 97% | 5-Hydrazinyl-2-methoxypyridine hydrochloride | ESD-845226-50MG |
Cas.: 179543-88-5 | Purity: 97% | 5-Hydrazinyl-2-methoxypyridine hydrochloride | ESD-845226-250MG |
Cas.: 886365-06-6 | Purity: 97% | Methyl 5-bromo-4-methylpicolinate | ESD-845227-50MG |
Cas.: 886365-06-6 | Purity: 97% | Methyl 5-bromo-4-methylpicolinate | ESD-845227-250MG |
Cas.: 76429-69-1 | Purity: 98% | 5-Chloro-2,3-dihydrobenzofuran | ESD-845228-50MG |
Cas.: 76429-69-1 | Purity: 98% | 5-Chloro-2,3-dihydrobenzofuran | ESD-845228-250MG |
Cas.: 90390-46-8 | Purity: 98% | (3-Amino-5-nitrophenyl)methanol | ESD-845229-50MG |
Cas.: 90390-46-8 | Purity: 98% | (3-Amino-5-nitrophenyl)methanol | ESD-845229-250MG |
Cas.: 55289-04-8 | Purity: 98% | 3-Hydroxy-2-methylbenzonitrile | ESD-845230-50MG |
Cas.: 55289-04-8 | Purity: 98% | 3-Hydroxy-2-methylbenzonitrile | ESD-845230-250MG |
Cas.: 313339-35-4 | Purity: 98% | 4,6-Dichloro-2-(methylthio)pyrimidine-5-carboxylic acid | ESD-845231-250MG |
Cas.: 313339-35-4 | Purity: 98% | 4,6-Dichloro-2-(methylthio)pyrimidine-5-carboxylic acid | ESD-845231-1G |
Cas.: 7126-39-8 | Purity: 97% | 1H-Pyrrole-3-carbaldehyde | ESD-845232-250MG |
Cas.: 7126-39-8 | Purity: 97% | 1H-Pyrrole-3-carbaldehyde | ESD-845232-1G |
Cas.: 65550-79-0 | Purity: 98% | 2-Bromo-5-chloronicotinic acid | ESD-845233-250MG |
Cas.: 65550-79-0 | Purity: 98% | 2-Bromo-5-chloronicotinic acid | ESD-845233-1G |
Cas.: 886500-93-2 | Purity: 95% | 4-(Bromomethyl)-1-chloro-2-(trifluoromethoxy)benzene | ESD-845234-250MG |
Cas.: 886500-93-2 | Purity: 95% | 4-(Bromomethyl)-1-chloro-2-(trifluoromethoxy)benzene | ESD-845234-1G |
Cas.: 1159823-45-6 | Purity: 95% | 2-(2-Aminoethyl)aniline dihydrochloride | ESD-845235-250MG |
Cas.: 1159823-45-6 | Purity: 95% | 2-(2-Aminoethyl)aniline dihydrochloride | ESD-845235-1G |
Cas.: 197223-39-5 | Purity: 98% | (3,5-Di-tert-butylphenyl)boronic acid | ESD-845236-250MG |
Cas.: 197223-39-5 | Purity: 98% | (3,5-Di-tert-butylphenyl)boronic acid | ESD-845236-1G |
Cas.: 158937-25-8 | Purity: 95% | (4′-(Pentyloxy)-[1,1′-biphenyl]-4-yl)boronic acid | ESD-845237-250MG |
Cas.: 158937-25-8 | Purity: 95% | (4′-(Pentyloxy)-[1,1′-biphenyl]-4-yl)boronic acid | ESD-845237-1G |
Cas.: 634-60-6 | Purity: 98% | 2-Aminobenzene-1,3-diol hydrochloride | ESD-845238-250MG |
Cas.: 634-60-6 | Purity: 98% | 2-Aminobenzene-1,3-diol hydrochloride | ESD-845238-1G |
Cas.: 252940-35-5 | Purity: 97% | (R)-(5-tert-Butoxycarbonylamino-6-hydroxyhexyl)carbamic acid benzyl ester | ESD-845239-250MG |
Cas.: 252940-35-5 | Purity: 97% | (R)-(5-tert-Butoxycarbonylamino-6-hydroxyhexyl)carbamic acid benzyl ester | ESD-845239-1G |
Cas.: 58291-77-3 | Purity: 98% | 3-Chloro-5-methylphenol | ESD-845240-250MG |
Cas.: 58291-77-3 | Purity: 98% | 3-Chloro-5-methylphenol | ESD-845240-1G |
Cas.: 157327-50-9 | Purity: 95% | 5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidin-2-amine dihydrochloride | ESD-845241-250MG |
Cas.: 157327-50-9 | Purity: 95% | 5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidin-2-amine dihydrochloride | ESD-845241-1G |
Cas.: 83621-01-6 | Purity: 98% | 6-Methoxypyridine-2-carbonitrile | ESD-845242-250MG |
Cas.: 83621-01-6 | Purity: 98% | 6-Methoxypyridine-2-carbonitrile | ESD-845242-1G |
Cas.: 208167-83-3 | Purity: 98% | tert-Butyl 4-(2-chloroethyl)piperazine-1-carboxylate | ESD-845243-250MG |
Cas.: 208167-83-3 | Purity: 98% | tert-Butyl 4-(2-chloroethyl)piperazine-1-carboxylate | ESD-845243-1G |
Cas.: 952182-01-3 | Purity: 98% | 4-Amino-1-methylpyridin-2(1H)-one | ESD-845244-50MG |
Cas.: 952182-01-3 | Purity: 98% | 4-Amino-1-methylpyridin-2(1H)-one | ESD-845244-250MG |
Cas.: 136117-74-3 | Purity: 98% | Imidazo[1,2-a]pyridine-8-carbaldehyde | ESD-845245-50MG |
Cas.: 136117-74-3 | Purity: 98% | Imidazo[1,2-a]pyridine-8-carbaldehyde | ESD-845245-250MG |
Cas.: 1646152-49-9 | Purity: 97% | 2-(Bromomethyl)-5-chloropyridine hydrobromide | ESD-845246-50MG |
Cas.: 1646152-49-9 | Purity: 97% | 2-(Bromomethyl)-5-chloropyridine hydrobromide | ESD-845246-250MG |
Cas.: 20317-40-2 | Purity: 97% | Methyl isoquinoline-4-carboxylate | ESD-845247-250MG |
Cas.: 20317-40-2 | Purity: 97% | Methyl isoquinoline-4-carboxylate | ESD-845247-1G |
Cas.: 57470-54-9 | Purity: 97% | Imidazo[1,2-b]pyridazin-6-ol | ESD-845248-250MG |
Cas.: 57470-54-9 | Purity: 97% | Imidazo[1,2-b]pyridazin-6-ol | ESD-845248-1G |
Cas.: 1123172-88-2 | Purity: 98% | 3,5-Difluoro-4-nitrobenzonitrile | ESD-845249-250MG |
Cas.: 1123172-88-2 | Purity: 98% | 3,5-Difluoro-4-nitrobenzonitrile | ESD-845249-1G |
Cas.: 18992-65-9 | Purity: 98% | 2,7-Dimethyl-9H-carbazole | ESD-845250-50MG |
Cas.: 18992-65-9 | Purity: 98% | 2,7-Dimethyl-9H-carbazole | ESD-845250-250MG |
Cas.: 1048925-02-5 | Purity: 98% | 5-Methyl-3-nitro-1H-pyrazole | ESD-845251-1G |
Cas.: 1048925-02-5 | Purity: 98% | 5-Methyl-3-nitro-1H-pyrazole | ESD-845251-5G |
Cas.: 1445781-45-2 | Purity: 98% | Methyl 5-bromoquinoline-8-carboxylate | ESD-845252-50MG |
Cas.: 1445781-45-2 | Purity: 98% | Methyl 5-bromoquinoline-8-carboxylate | ESD-845252-250MG |
Cas.: 3883-94-1 | Purity: 97% | 2-Amino-1-(4-methoxyphenyl)ethanone hydrochloride | ESD-845253-250MG |
Cas.: 3883-94-1 | Purity: 97% | 2-Amino-1-(4-methoxyphenyl)ethanone hydrochloride | ESD-845253-1G |
Cas.: 40598-76-3 | Purity: 95% | 3,5-Dibromo-1H-indazole | ESD-845254-250MG |
Cas.: 40598-76-3 | Purity: 95% | 3,5-Dibromo-1H-indazole | ESD-845254-1G |
Cas.: 322-97-4 | Purity: 97% | 4-Hydroxy-7-(trifluoromethyl)quinoline | ESD-845255-250MG |
Cas.: 322-97-4 | Purity: 97% | 4-Hydroxy-7-(trifluoromethyl)quinoline | ESD-845255-1G |
Cas.: 940868-64-4 | Purity: 95% | Bis(2-methoxyethyl)diazene-1,2-dicarboxylate | ESD-845256-250MG |
Cas.: 940868-64-4 | Purity: 95% | Bis(2-methoxyethyl)diazene-1,2-dicarboxylate | ESD-845256-1G |
Cas.: 40126-30-5 | Purity: 95% | Methyl (2S,4S)-4-hydroxypyrrolidine-2-carboxylate hydrochloride | ESD-845257-250MG |
Cas.: 40126-30-5 | Purity: 95% | Methyl (2S,4S)-4-hydroxypyrrolidine-2-carboxylate hydrochloride | ESD-845257-1G |
Cas.: 88751-06-8 | Purity: 97% | 5-Methylimidazo[1,2-a]pyridine-2-carboxylic acid | ESD-845258-250MG |
Cas.: 88751-06-8 | Purity: 97% | 5-Methylimidazo[1,2-a]pyridine-2-carboxylic acid | ESD-845258-1G |
Cas.: 3709-98-6 | Purity: 95% | 2-Ethyl-4,6-dihydroxypyrimidine | ESD-845259-250MG |
Cas.: 3709-98-6 | Purity: 95% | 2-Ethyl-4,6-dihydroxypyrimidine | ESD-845259-1G |
Cas.: 845866-85-5 | Purity: 98% | 3-Fluoro-5-iodobromobenzene | ESD-845261-250MG |
Cas.: 845866-85-5 | Purity: 98% | 3-Fluoro-5-iodobromobenzene | ESD-845261-1G |
Cas.: 802541-13-5 | Purity: 97% | Ethyl 1-methyl-7-oxo-4,5,6,7-tetrahydro-1H-indazole-3-carboxylate | ESD-845262-50MG |
Cas.: 802541-13-5 | Purity: 97% | Ethyl 1-methyl-7-oxo-4,5,6,7-tetrahydro-1H-indazole-3-carboxylate | ESD-845262-250MG |
Cas.: 3163-76-6 | Purity: 96% | Benzene-1,3,5-tricarbaldehyde | ESD-845263-50MG |
Cas.: 3163-76-6 | Purity: 96% | Benzene-1,3,5-tricarbaldehyde | ESD-845263-250MG |
Cas.: 74124-04-2 | Purity: 97% | O-(Cyclopropylmethyl)hydroxylamine hydrochloride | ESD-845264-50MG |
Cas.: 74124-04-2 | Purity: 97% | O-(Cyclopropylmethyl)hydroxylamine hydrochloride | ESD-845264-250MG |
Cas.: 133046-46-5 | Purity: 95% | Ethyl 2-(trifluoromethyl)thiazole-4-carboxylate | ESD-845265-50MG |
Cas.: 133046-46-5 | Purity: 95% | Ethyl 2-(trifluoromethyl)thiazole-4-carboxylate | ESD-845265-250MG |
Cas.: 959616-64-9 | Purity: 95% | Methyl 2-chloro-5-fluoro-6-methoxynicotinate | ESD-845266-50MG |
Cas.: 959616-64-9 | Purity: 95% | Methyl 2-chloro-5-fluoro-6-methoxynicotinate | ESD-845266-250MG |
Cas.: 70158-59-7 | Purity: 97% | 2,5-Dichloro-3-(trifluoromethyl)pyridine | ESD-845267-50MG |
Cas.: 70158-59-7 | Purity: 97% | 2,5-Dichloro-3-(trifluoromethyl)pyridine | ESD-845267-250MG |
Cas.: 89283-94-3 | Purity: 97% | 5-Bromo-2-chloro-3-methoxypyrazine | ESD-845268-50MG |
Cas.: 89283-94-3 | Purity: 97% | 5-Bromo-2-chloro-3-methoxypyrazine | ESD-845268-250MG |
Cas.: 79474-35-4 | Purity: 98% | 2-Fluoro-4,5-dimethoxybenzoic acid | ESD-845269-50MG |
Cas.: 79474-35-4 | Purity: 98% | 2-Fluoro-4,5-dimethoxybenzoic acid | ESD-845269-250MG |
Cas.: 1588441-31-9 | Purity: 97% | 6-Aminocotinaldehyde hydrochloride | ESD-845270-50MG |
Cas.: 1588441-31-9 | Purity: 97% | 6-Aminocotinaldehyde hydrochloride | ESD-845270-250MG |
Cas.: 89459-38-1 | Purity: 98% | 2-Iodo-4-nitrobenzoic acid | ESD-845271-50MG |
Cas.: 89459-38-1 | Purity: 98% | 2-Iodo-4-nitrobenzoic acid | ESD-845271-250MG |
Cas.: 89892-22-8 | Purity: 98% | 7-Bromoquinazoline | ESD-845272-50MG |
Cas.: 89892-22-8 | Purity: 98% | 7-Bromoquinazoline | ESD-845272-250MG |
Cas.: 63480-10-4 | Purity: 95% | 7-Nitro-1H-benzo[d][1,3]oxazine-2,4-dione | ESD-845273-250MG |
Cas.: 63480-10-4 | Purity: 95% | 7-Nitro-1H-benzo[d][1,3]oxazine-2,4-dione | ESD-845273-1G |
Cas.: 861069-45-6 | Purity: 98% | 2-(4-Isopropoxy-3-methoxyphenyl)acetonitrile | ESD-845274-250MG |
Cas.: 861069-45-6 | Purity: 98% | 2-(4-Isopropoxy-3-methoxyphenyl)acetonitrile | ESD-845274-1G |
Cas.: 92932-74-6 | Purity: 95% | 1,2,3,4-Tetrahydroisoquinoline-1-carboxylic acid hydrochloride | ESD-845275-50MG |
Cas.: 92932-74-6 | Purity: 95% | 1,2,3,4-Tetrahydroisoquinoline-1-carboxylic acid hydrochloride | ESD-845275-250MG |
Cas.: 64064-71-7 | Purity: 98% | 6-Bromo-3-nitroimidazo[1,2-a]pyridine | ESD-845276-50MG |
Cas.: 64064-71-7 | Purity: 98% | 6-Bromo-3-nitroimidazo[1,2-a]pyridine | ESD-845276-250MG |
Cas.: 1030613-07-0 | Purity: 98% | Ethyl 5-bromo-1,3,4-thiadiazole-2-carboxylate | ESD-845277-50MG |
Cas.: 1030613-07-0 | Purity: 98% | Ethyl 5-bromo-1,3,4-thiadiazole-2-carboxylate | ESD-845277-250MG |
Cas.: 366453-21-6 | Purity: 95% | 4-Hydroxy-2,3-dihydroisoindol-1-one | ESD-845278-50MG |
Cas.: 366453-21-6 | Purity: 95% | 4-Hydroxy-2,3-dihydroisoindol-1-one | ESD-845278-250MG |
Cas.: 75104-92-6 | Purity: 98% | 6-Bromo-N-methylbenzo[d]thiazol-2-amine | ESD-845279-50MG |
Cas.: 75104-92-6 | Purity: 98% | 6-Bromo-N-methylbenzo[d]thiazol-2-amine | ESD-845279-250MG |
Cas.: 53572-98-8 | Purity: 98% | Imidazo[2,1-b]thiazole-6-carboxylic acid | ESD-845280-250MG |
Cas.: 53572-98-8 | Purity: 98% | Imidazo[2,1-b]thiazole-6-carboxylic acid | ESD-845280-1G |
Cas.: 14572-89-5 | Purity: 95% | 1-(4-Aminophenyl)ethanol | ESD-845281-250MG |
Cas.: 14572-89-5 | Purity: 95% | 1-(4-Aminophenyl)ethanol | ESD-845281-1G |
Cas.: 146679-66-5 | Purity: 98% | (3-Bromopyridin-4-yl)methanol | ESD-845282-250MG |
Cas.: 146679-66-5 | Purity: 98% | (3-Bromopyridin-4-yl)methanol | ESD-845282-1G |
Cas.: 850462-64-5 | Purity: 97% | 5-Fluoro-2-methyl-3-nitrobenzoic acid | ESD-845283-250MG |
Cas.: 850462-64-5 | Purity: 97% | 5-Fluoro-2-methyl-3-nitrobenzoic acid | ESD-845283-1G |
Cas.: 455-75-4 | Purity: 97% | Ethyl 3-amino-4-fluorobenzoate | ESD-845284-1G |
Cas.: 455-75-4 | Purity: 97% | Ethyl 3-amino-4-fluorobenzoate | ESD-845284-5G |
Cas.: 934758-27-7 | Purity: 95% | 2-Amino-6-bromopyridin-3-ol | ESD-845285-50MG |
Cas.: 934758-27-7 | Purity: 95% | 2-Amino-6-bromopyridin-3-ol | ESD-845285-250MG |
Cas.: 628326-05-6 | Purity: 95% | tert-Butyl 4-(4-bromo-2-formylphenyl)piperazine-1-carboxylate | ESD-845286-50MG |
Cas.: 628326-05-6 | Purity: 95% | tert-Butyl 4-(4-bromo-2-formylphenyl)piperazine-1-carboxylate | ESD-845286-250MG |
Cas.: 1188263-67-3 | Purity: 95% | tert-Butyl (3-aminopropyl)(methyl)carbamate hydrochloride | ESD-845287-250MG |
Cas.: 1188263-67-3 | Purity: 95% | tert-Butyl (3-aminopropyl)(methyl)carbamate hydrochloride | ESD-845287-1G |
Cas.: 51688-75-6 | Purity: 98% | 4-Amino-3-ethylbenzoic acid | ESD-845288-250MG |
Cas.: 51688-75-6 | Purity: 98% | 4-Amino-3-ethylbenzoic acid | ESD-845288-1G |
Cas.: 18513-79-6 | Purity: 98% | 1,2,3,6-Tetrahydropyridine hydrochloride | ESD-845289-250MG |
Cas.: 18513-79-6 | Purity: 98% | 1,2,3,6-Tetrahydropyridine hydrochloride | ESD-845289-1G |
Cas.: 595610-50-7 | Purity: 95% | 5-(3-Chlorophenyl)-1H-pyrazole-3-carboxylic acid | ESD-845290-250MG |
Cas.: 595610-50-7 | Purity: 95% | 5-(3-Chlorophenyl)-1H-pyrazole-3-carboxylic acid | ESD-845290-1G |
Cas.: 610-17-3 | Purity: 95% | N,N-Dimethyl-2-nitroaniline | ESD-845291-250MG |
Cas.: 610-17-3 | Purity: 95% | N,N-Dimethyl-2-nitroaniline | ESD-845291-1G |
Cas.: 766545-20-4 | Purity: 98% | 2-Chloro-5,6,7,8-tetrahydro-1,6-naphthyridine hydrochloride | ESD-845292-250MG |
Cas.: 766545-20-4 | Purity: 98% | 2-Chloro-5,6,7,8-tetrahydro-1,6-naphthyridine hydrochloride | ESD-845292-1G |
Cas.: 66584-31-4 | Purity: 95% | 3-Methoxy-5-methylaniline | ESD-845293-250MG |
Cas.: 66584-31-4 | Purity: 95% | 3-Methoxy-5-methylaniline | ESD-845293-1G |
Cas.: 62002-31-7 | Purity: 95% | 4,5,6,7-Tetrahydro-3H-imidazo[4,5-c]pyridine dihydrochloride | ESD-845294-250MG |
Cas.: 62002-31-7 | Purity: 95% | 4,5,6,7-Tetrahydro-3H-imidazo[4,5-c]pyridine dihydrochloride | ESD-845294-1G |
Cas.: 13625-39-3 | Purity: 97% | 1,3,8-Triazaspiro[4.5]decane-2,4-dione | ESD-845295-250MG |
Cas.: 13625-39-3 | Purity: 97% | 1,3,8-Triazaspiro[4.5]decane-2,4-dione | ESD-845295-1G |
Cas.: 227939-01-7 | Purity: 95% | tert-Butyl (5-bromopyridin-2-yl)(methyl)carbamate | ESD-845296-50MG |
Cas.: 227939-01-7 | Purity: 95% | tert-Butyl (5-bromopyridin-2-yl)(methyl)carbamate | ESD-845296-250MG |
Cas.: 164650-68-4 | Purity: 95% | 3-Chloro-5-methoxybenzaldehyde | ESD-845297-250MG |
Cas.: 164650-68-4 | Purity: 95% | 3-Chloro-5-methoxybenzaldehyde | ESD-845297-1G |
Cas.: 64096-87-3 | Purity: 97% | Tetrahydro-2H-thiopyran-4-carboxylic acid 1,1-dioxide | ESD-845299-250MG |
Cas.: 64096-87-3 | Purity: 97% | Tetrahydro-2H-thiopyran-4-carboxylic acid 1,1-dioxide | ESD-845299-1G |
Cas.: 77532-78-6 | Purity: 98% | 2-Bromo-6-methylbenzonitrile | ESD-845300-250MG |
Cas.: 77532-78-6 | Purity: 98% | 2-Bromo-6-methylbenzonitrile | ESD-845300-1G |
Cas.: 716-31-4 | Purity: 98% | 5-Methoxy-2-(trifluoromethyl)benzoic acid | ESD-845301-250MG |
Cas.: 716-31-4 | Purity: 98% | 5-Methoxy-2-(trifluoromethyl)benzoic acid | ESD-845301-1G |
Cas.: 90407-21-9 | Purity: 98% | 2-Bromo-3-nitrobenzaldehyde | ESD-845302-250MG |
Cas.: 90407-21-9 | Purity: 98% | 2-Bromo-3-nitrobenzaldehyde | ESD-845302-1G |
Cas.: 1049730-91-7 | Purity: 98% | 2-Bromo-4-methoxy-1-(trifluoromethoxy)benzene | ESD-845303-250MG |
Cas.: 1049730-91-7 | Purity: 98% | 2-Bromo-4-methoxy-1-(trifluoromethoxy)benzene | ESD-845303-1G |
Cas.: 86118-11-8 | Purity: 97% | (R)-2-Amino-3-methoxypropanoic acid | ESD-845304-250MG |
Cas.: 86118-11-8 | Purity: 97% | (R)-2-Amino-3-methoxypropanoic acid | ESD-845304-1G |
Cas.: 62980-03-4 | Purity: 95% | 3-Trifluoromethylbenzamidinehydrochloride | ESD-845305-250MG |
Cas.: 62980-03-4 | Purity: 95% | 3-Trifluoromethylbenzamidinehydrochloride | ESD-845305-1G |
Cas.: 55306-66-6 | Purity: 97% | 4-Chloropyridine-2,6-dicarbonitrile | ESD-845306-250MG |
Cas.: 55306-66-6 | Purity: 97% | 4-Chloropyridine-2,6-dicarbonitrile | ESD-845306-1G |
Cas.: 17617-34-4 | Purity: 95% | Sodium 2-(2-aminophenyl)-2-oxoacetate | ESD-845307-50MG |
Cas.: 17617-34-4 | Purity: 95% | Sodium 2-(2-aminophenyl)-2-oxoacetate | ESD-845307-250MG |
Cas.: 428-97-7 | Purity: 97% | Diethyl 2,2-difluoropentanedioate | ESD-845308-50MG |
Cas.: 428-97-7 | Purity: 97% | Diethyl 2,2-difluoropentanedioate | ESD-845308-250MG |
Cas.: 1638487-42-9 | Purity: 97% | 5-(Aminomethyl)-2-fluorobenzonitrile hydrochloride | ESD-845309-50MG |
Cas.: 1638487-42-9 | Purity: 97% | 5-(Aminomethyl)-2-fluorobenzonitrile hydrochloride | ESD-845309-250MG |
Cas.: 16352-06-0 | Purity: 97% | 4-Amino-6-methyl-1,3,5-triazin-2-ol | ESD-845310-50MG |
Cas.: 16352-06-0 | Purity: 97% | 4-Amino-6-methyl-1,3,5-triazin-2-ol | ESD-845310-250MG |
Cas.: 67858-47-3 | Purity: 98% | Methyl 4-formyl-1-methyl-1H-pyrrole-2-carboxylate | ESD-845311-50MG |
Cas.: 67858-47-3 | Purity: 98% | Methyl 4-formyl-1-methyl-1H-pyrrole-2-carboxylate | ESD-845311-250MG |
Cas.: 122567-97-9 | Purity: 97% | ((2S,5R)-5-(5-Methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2,5-dihydrofuran-2-yl)methyl benzoate | ESD-845312-50MG |
Cas.: 122567-97-9 | Purity: 97% | ((2S,5R)-5-(5-Methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2,5-dihydrofuran-2-yl)methyl benzoate | ESD-845312-250MG |
Cas.: 1235342-53-6 | Purity: 95% | 3-(Bromomethyl)-5-methylpyridine hydrobromide | ESD-845313-50MG |
Cas.: 1235342-53-6 | Purity: 95% | 3-(Bromomethyl)-5-methylpyridine hydrobromide | ESD-845313-250MG |
Cas.: 888504-27-6 | Purity: 98% | Methyl 2-(2-(((benzyloxy)carbonyl)amino)propan-2-yl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxylate | ESD-845314-250MG |
Cas.: 205672-19-1 | Purity: 98% | 4-(Benzyloxy)-5-bromo-2-chloropyrimidine | ESD-845315-50MG |
Cas.: 205672-19-1 | Purity: 98% | 4-(Benzyloxy)-5-bromo-2-chloropyrimidine | ESD-845315-250MG |
Cas.: 54656-96-1 | Purity: 98% | (S)-1-(Pyridin-4-yl)ethanol | ESD-845316-50MG |
Cas.: 54656-96-1 | Purity: 98% | (S)-1-(Pyridin-4-yl)ethanol | ESD-845316-250MG |
Cas.: 49607-51-4 | Purity: 98% | 1-Methyl-1H-1,2,4-triazol-3-amine | ESD-845317-50MG |
Cas.: 49607-51-4 | Purity: 98% | 1-Methyl-1H-1,2,4-triazol-3-amine | ESD-845317-250MG |
Cas.: 916792-62-6 | Purity: 97% | 3-Fluoro-2-iodobenzonitrile | ESD-845318-50MG |
Cas.: 916792-62-6 | Purity: 97% | 3-Fluoro-2-iodobenzonitrile | ESD-845318-250MG |
Cas.: 109608-77-7 | Purity: 98% | tert-Butyl (2-methyl-1-oxopropan-2-yl)carbamate | ESD-845319-50MG |
Cas.: 109608-77-7 | Purity: 98% | tert-Butyl (2-methyl-1-oxopropan-2-yl)carbamate | ESD-845319-250MG |
Cas.: 1159811-97-8 | Purity: 98% | 6-Bromo-2-methylimidazo[1,2-a]pyrazine | ESD-845320-50MG |
Cas.: 1159811-97-8 | Purity: 98% | 6-Bromo-2-methylimidazo[1,2-a]pyrazine | ESD-845320-250MG |
Cas.: 56962-00-6 | Purity: 98% | 2-Amino-3-chlorophenol | ESD-845321-50MG |
Cas.: 56962-00-6 | Purity: 98% | 2-Amino-3-chlorophenol | ESD-845321-250MG |
Cas.: 1188477-11-3 | Purity: 98% | tert-Butyl ((5-bromopyridin-2-yl)methyl)carbamate | ESD-845322-50MG |
Cas.: 1188477-11-3 | Purity: 98% | tert-Butyl ((5-bromopyridin-2-yl)methyl)carbamate | ESD-845322-250MG |
Cas.: 1051899-73-0 | Purity: 97% | (3-Amino-2-fluorophenyl)methanol | ESD-845323-50MG |
Cas.: 1051899-73-0 | Purity: 97% | (3-Amino-2-fluorophenyl)methanol | ESD-845323-250MG |
Cas.: 18424-96-9 | Purity: 97% | 4-Methylmorpholin-2-one | ESD-845324-50MG |
Cas.: 18424-96-9 | Purity: 97% | 4-Methylmorpholin-2-one | ESD-845324-250MG |
Cas.: 925672-89-5 | Purity: 95% | 4-Bromo-2-cyanobenzeneacetonitrile | ESD-845325-50MG |
Cas.: 925672-89-5 | Purity: 95% | 4-Bromo-2-cyanobenzeneacetonitrile | ESD-845325-250MG |
Cas.: 1001020-17-2 | Purity: 97% | 3-(tert-Butyl)-1H-pyrazole-4-carbaldehyde | ESD-845326-50MG |
Cas.: 1001020-17-2 | Purity: 97% | 3-(tert-Butyl)-1H-pyrazole-4-carbaldehyde | ESD-845326-250MG |
Cas.: 944709-42-6 | Purity: 98% | 6,8-Dibromo[1,2,4]triazolo[1,5-a]pyrazine | ESD-845327-50MG |
Cas.: 944709-42-6 | Purity: 98% | 6,8-Dibromo[1,2,4]triazolo[1,5-a]pyrazine | ESD-845327-250MG |
Cas.: 14736-50-6 | Purity: 98% | 2-(2-Methoxy-2-oxoethyl)benzoic acid | ESD-845328-50MG |
Cas.: 14736-50-6 | Purity: 98% | 2-(2-Methoxy-2-oxoethyl)benzoic acid | ESD-845328-250MG |
Cas.: 907606-68-2 | Purity: 95% | (1S,3aR,6aS)-tert-Butyl octahydrocyclopenta[c]pyrrole-1-carboxylate oxalate | ESD-845329-50MG |
Cas.: 147081-80-9 | Purity: 97% | tert-Butyl piperazin-1-ylcarbamate | ESD-845330-50MG |
Cas.: 147081-80-9 | Purity: 97% | tert-Butyl piperazin-1-ylcarbamate | ESD-845330-250MG |
Cas.: 7150-72-3 | Purity: ≥95% | tert-Butyl vinylcarbamate | ESD-845331-50MG |
Cas.: 7150-72-3 | Purity: ≥95% | tert-Butyl vinylcarbamate | ESD-845331-250MG |
Cas.: 133047-46-8 | Purity: 98% | 2-Isopropylthiazole-4-carbaldehyde | ESD-845332-50MG |
Cas.: 133047-46-8 | Purity: 98% | 2-Isopropylthiazole-4-carbaldehyde | ESD-845332-250MG |
Cas.: 907545-47-5 | Purity: 98% | 2-Chloro-5-nitroisonicotinic acid | ESD-845333-50MG |
Cas.: 907545-47-5 | Purity: 98% | 2-Chloro-5-nitroisonicotinic acid | ESD-845333-250MG |
Cas.: 955372-86-8 | Purity: 96% | 3-Bromo-5-fluoroisonicotinic acid | ESD-845334-50MG |
Cas.: 955372-86-8 | Purity: 96% | 3-Bromo-5-fluoroisonicotinic acid | ESD-845334-250MG |
Cas.: 19295-57-9 | Purity: 98% | 3-Hydroxy-2,2-dimethylpropanenitrile | ESD-845335-50MG |
Cas.: 19295-57-9 | Purity: 98% | 3-Hydroxy-2,2-dimethylpropanenitrile | ESD-845335-250MG |
Cas.: 1456-22-0 | Purity: 95% | 3-Phenyl-1,2,4-oxadiazol-5-ol | ESD-845336-50MG |
Cas.: 1456-22-0 | Purity: 95% | 3-Phenyl-1,2,4-oxadiazol-5-ol | ESD-845336-250MG |
Cas.: 168038-14-0 | Purity: 98% | (R)-2-Methylmorpholine hydrochloride | ESD-845337-50MG |
Cas.: 168038-14-0 | Purity: 98% | (R)-2-Methylmorpholine hydrochloride | ESD-845337-250MG |
Cas.: 83400-91-3 | Purity: 95% | Potassium 2,2-dimethyl-1,3-dioxolane-4-carboxylate | ESD-845338-50MG |
Cas.: 83400-91-3 | Purity: 95% | Potassium 2,2-dimethyl-1,3-dioxolane-4-carboxylate | ESD-845338-250MG |
Cas.: 1002334-12-4 | Purity: 97% | 1-Phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-845339-50MG |
Cas.: 1002334-12-4 | Purity: 97% | 1-Phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-845339-250MG |
Cas.: 65147-89-9 | Purity: 97% | 6-Bromo-2-phenyl-1H-imidazo[4,5-b]pyridine | ESD-845340-50MG |
Cas.: 65147-89-9 | Purity: 97% | 6-Bromo-2-phenyl-1H-imidazo[4,5-b]pyridine | ESD-845340-250MG |
Cas.: 500011-86-9 | Purity: 96% | 3-Bromo-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carboxylic acid | ESD-845341-50MG |
Cas.: 500011-86-9 | Purity: 96% | 3-Bromo-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carboxylic acid | ESD-845341-250MG |
Cas.: 127956-11-0 | Purity: 95% | Methyl 4-oxotetrahydro-2H-pyran-3-carboxylate | ESD-845342-50MG |
Cas.: 127956-11-0 | Purity: 95% | Methyl 4-oxotetrahydro-2H-pyran-3-carboxylate | ESD-845342-250MG |
Cas.: 37519-04-3 | Purity: 97% | Benzyl 1-methylhydrazinecarboxylate | ESD-845343-50MG |
Cas.: 37519-04-3 | Purity: 97% | Benzyl 1-methylhydrazinecarboxylate | ESD-845343-250MG |
Cas.: 626220-76-6 | Purity: 95% | (R)-1-Methoxypropan-2-amine hydrochloride | ESD-845344-50MG |
Cas.: 626220-76-6 | Purity: 95% | (R)-1-Methoxypropan-2-amine hydrochloride | ESD-845344-250MG |
Cas.: 1624260-26-9 | Purity: 97% | tert-Butyl 2,2-dimethylpiperazine-1-carboxylate hydrochloride | ESD-845345-50MG |
Cas.: 1624260-26-9 | Purity: 97% | tert-Butyl 2,2-dimethylpiperazine-1-carboxylate hydrochloride | ESD-845345-250MG |
Cas.: 1086111-17-2 | Purity: 97% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-845346-250MG |
Cas.: 954240-46-1 | Purity: 97% | 4-Bromo-6-methylpyridazin-3(2H)-one | ESD-845347-50MG |
Cas.: 954240-46-1 | Purity: 97% | 4-Bromo-6-methylpyridazin-3(2H)-one | ESD-845347-250MG |
Cas.: 942199-56-6 | Purity: 96% | 2-Chloro-5-cyanobenzene-1-sulfonyl chloride | ESD-845348-50MG |
Cas.: 942199-56-6 | Purity: 96% | 2-Chloro-5-cyanobenzene-1-sulfonyl chloride | ESD-845348-250MG |
Cas.: 131674-40-3 | Purity: 98% | 1-(2-Methoxypyridin-3-yl)ethanone | ESD-845349-50MG |
Cas.: 131674-40-3 | Purity: 98% | 1-(2-Methoxypyridin-3-yl)ethanone | ESD-845349-250MG |
Cas.: 1217598-28-1 | Purity: 95% | (R)-1-Benzyl 2-methyl piperazine-1,2-dicarboxylate | ESD-845350-50MG |
Cas.: 1217598-28-1 | Purity: 95% | (R)-1-Benzyl 2-methyl piperazine-1,2-dicarboxylate | ESD-845350-250MG |
Cas.: 1914-02-9 | Purity: 98% | 3,3-Dimethylindoline | ESD-845351-50MG |
Cas.: 1914-02-9 | Purity: 98% | 3,3-Dimethylindoline | ESD-845351-250MG |
Cas.: 65360-27-2 | Purity: 95% | Boc-D-Lys(Boc)-OH | ESD-845352-50MG |
Cas.: 65360-27-2 | Purity: 95% | Boc-D-Lys(Boc)-OH | ESD-845352-250MG |
Cas.: 661463-12-3 | Purity: 95% | 4-Bromo-2-fluoro-5-nitrophenol | ESD-845353-50MG |
Cas.: 661463-12-3 | Purity: 95% | 4-Bromo-2-fluoro-5-nitrophenol | ESD-845353-250MG |
Cas.: 173290-17-0 | Purity: 98% | Methyl 3-iodopyrazine-2-carboxylate | ESD-845354-50MG |
Cas.: 173290-17-0 | Purity: 98% | Methyl 3-iodopyrazine-2-carboxylate | ESD-845354-250MG |
Cas.: 1260657-19-9 | Purity: 97% | 8-Bromoquinazolin-4-amine | ESD-845355-50MG |
Cas.: 1260657-19-9 | Purity: 97% | 8-Bromoquinazolin-4-amine | ESD-845355-250MG |
Cas.: 461432-25-7 | Purity: 98% | (2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate | ESD-845356-50MG |
Cas.: 461432-25-7 | Purity: 98% | (2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate | ESD-845356-250MG |
Cas.: 1330061-11-4 | Purity: 95% | 2-Bromo-3,4,5-trichloropyridine | ESD-845357-50MG |
Cas.: 1330061-11-4 | Purity: 95% | 2-Bromo-3,4,5-trichloropyridine | ESD-845357-250MG |
Cas.: 110860-60-1 | Purity: 98% | Methyl 5-amino-1-methyl-1H-pyrazole-4-carboxylate | ESD-845358-50MG |
Cas.: 110860-60-1 | Purity: 98% | Methyl 5-amino-1-methyl-1H-pyrazole-4-carboxylate | ESD-845358-250MG |
Cas.: 35980-77-9 | Purity: 98% | 2-Morpholinopyridin-4-amine | ESD-845359-50MG |
Cas.: 35980-77-9 | Purity: 98% | 2-Morpholinopyridin-4-amine | ESD-845359-250MG |
Cas.: 54013-05-7 | Purity: 98% | Ethyl 5-methoxypyrazine-2-carboxylate | ESD-845360-50MG |
Cas.: 54013-05-7 | Purity: 98% | Ethyl 5-methoxypyrazine-2-carboxylate | ESD-845360-250MG |
Cas.: 93233-21-7 | Purity: 97% | 3-Iodo-5-methyl-1H-pyrazole | ESD-845361-50MG |
Cas.: 93233-21-7 | Purity: 97% | 3-Iodo-5-methyl-1H-pyrazole | ESD-845361-250MG |
Cas.: 131674-39-0 | Purity: 96% | 1-(2-Chloropyridin-3-yl)ethanol | ESD-845362-50MG |
Cas.: 131674-39-0 | Purity: 96% | 1-(2-Chloropyridin-3-yl)ethanol | ESD-845362-250MG |
Cas.: 771-81-3 | Purity: 98% | 4-Amino-2-(methylthio)pyrimidine-5-carboxylic acid | ESD-845363-50MG |
Cas.: 771-81-3 | Purity: 98% | 4-Amino-2-(methylthio)pyrimidine-5-carboxylic acid | ESD-845363-250MG |
Cas.: 866545-96-2 | Purity: 98% | 1-(5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)ethanone | ESD-845364-50MG |
Cas.: 866545-96-2 | Purity: 98% | 1-(5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)ethanone | ESD-845364-250MG |
Cas.: 1205-39-6 | Purity: 98% | 2-Methyl-N-phenylaniline | ESD-845365-50MG |
Cas.: 1205-39-6 | Purity: 98% | 2-Methyl-N-phenylaniline | ESD-845365-250MG |
Cas.: 883107-68-4 | Purity: 98% | 6-Chloro-2-fluoropyridin-3-ol | ESD-845366-50MG |
Cas.: 883107-68-4 | Purity: 98% | 6-Chloro-2-fluoropyridin-3-ol | ESD-845366-250MG |
Cas.: 264194-31-2 | Purity: 98% | 3-(Difluoromethoxy)-4-methylaniline | ESD-845367-50MG |
Cas.: 264194-31-2 | Purity: 98% | 3-(Difluoromethoxy)-4-methylaniline | ESD-845367-250MG |
Cas.: 201138-91-2 | Purity: 98% | 4,6-Dibromodibenzo[b,d]furan | ESD-845368-50MG |
Cas.: 201138-91-2 | Purity: 98% | 4,6-Dibromodibenzo[b,d]furan | ESD-845368-250MG |
Cas.: 885278-36-4 | Purity: 97% | 5,6-Difluoro-1H-indazole-3-carbonitrile | ESD-845369-50MG |
Cas.: 885278-36-4 | Purity: 97% | 5,6-Difluoro-1H-indazole-3-carbonitrile | ESD-845369-250MG |
Cas.: 885276-93-7 | Purity: 98% | Ethyl 5-bromopyrazolo[1,5-a]pyridine-3-carboxylate | ESD-845370-50MG |
Cas.: 885276-93-7 | Purity: 98% | Ethyl 5-bromopyrazolo[1,5-a]pyridine-3-carboxylate | ESD-845370-250MG |
Cas.: 1379325-64-0 | Purity: 98% | 1-(3-Bromo-5-methylphenyl)ethanone | ESD-845371-50MG |
Cas.: 1379325-64-0 | Purity: 98% | 1-(3-Bromo-5-methylphenyl)ethanone | ESD-845371-250MG |
Cas.: 1286208-55-6 | Purity: 95% | (R)-1-(3-Aminopyrrolidin-1-yl)ethanone hydrochloride | ESD-845372-50MG |
Cas.: 1286208-55-6 | Purity: 95% | (R)-1-(3-Aminopyrrolidin-1-yl)ethanone hydrochloride | ESD-845372-250MG |
Cas.: 180307-01-1 | Purity: 97% | 2-(1H-Imidazol-5-yl)ethanol hydrochloride | ESD-845373-50MG |
Cas.: 180307-01-1 | Purity: 97% | 2-(1H-Imidazol-5-yl)ethanol hydrochloride | ESD-845373-250MG |
Cas.: 220247-87-0 | Purity: 97% | 7-(Trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-845374-50MG |
Cas.: 220247-87-0 | Purity: 97% | 7-(Trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-845374-250MG |
Cas.: 1609406-56-5 | Purity: 98% | 4-Methyl-1H-benzo[d]imidazol-2-amine hydrobromide | ESD-845375-50MG |
Cas.: 1609406-56-5 | Purity: 98% | 4-Methyl-1H-benzo[d]imidazol-2-amine hydrobromide | ESD-845375-250MG |
Cas.: 872509-56-3 | Purity: 98% | 2,6-Dichloro-3,5-dimethoxyaniline | ESD-845377-50MG |
Cas.: 872509-56-3 | Purity: 98% | 2,6-Dichloro-3,5-dimethoxyaniline | ESD-845377-250MG |
Cas.: 83-10-3 | Purity: 95% | 1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxylic acid | ESD-845378-50MG |
Cas.: 83-10-3 | Purity: 95% | 1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxylic acid | ESD-845378-250MG |
Cas.: 770718-92-8 | Purity: 98% | 3-Bromo-5-hydroxybenzonitrile | ESD-845379-50MG |
Cas.: 770718-92-8 | Purity: 98% | 3-Bromo-5-hydroxybenzonitrile | ESD-845379-250MG |
Cas.: 75416-50-1 | Purity: 98% | 8-Chloro-1,2,3,4-tetrahydroisoquinoline | ESD-845380-50MG |
Cas.: 75416-50-1 | Purity: 98% | 8-Chloro-1,2,3,4-tetrahydroisoquinoline | ESD-845380-250MG |
Cas.: 1192657-15-0 | Purity: 97% | Octahydropyrrolo[1,2-a]pyrazine oxalate | ESD-845381-50MG |
Cas.: 1192657-15-0 | Purity: 97% | Octahydropyrrolo[1,2-a]pyrazine oxalate | ESD-845381-250MG |
Cas.: 123811-75-6 | Purity: 95% | 4-(tert-Butyl)picolinic acid hydrochloride | ESD-845382-50MG |
Cas.: 123811-75-6 | Purity: 95% | 4-(tert-Butyl)picolinic acid hydrochloride | ESD-845382-250MG |
Cas.: 60481-34-7 | Purity: 98% | (2-Iodophenyl)hydrazine hydrochloride | ESD-845383-50MG |
Cas.: 60481-34-7 | Purity: 98% | (2-Iodophenyl)hydrazine hydrochloride | ESD-845383-250MG |
Cas.: 1208087-83-5 | Purity: 95% | 1-(2-Chloropyrimdin-4-yl)piperidine-4-carboxylic acid | ESD-845384-50MG |
Cas.: 1208087-83-5 | Purity: 95% | 1-(2-Chloropyrimdin-4-yl)piperidine-4-carboxylic acid | ESD-845384-250MG |
Cas.: 40594-98-7 | Purity: 96% | Ethyl 1H-1,2,3-triazole-4-carboxylate | ESD-845385-50MG |
Cas.: 40594-98-7 | Purity: 96% | Ethyl 1H-1,2,3-triazole-4-carboxylate | ESD-845385-250MG |
Cas.: 80567-66-4 | Purity: 95% | 4-Methoxybenzo[d]thiazol-2(3H)-one | ESD-845386-50MG |
Cas.: 80567-66-4 | Purity: 95% | 4-Methoxybenzo[d]thiazol-2(3H)-one | ESD-845386-250MG |
Cas.: 73418-87-8 | Purity: 98% | 2-(Trifluoromethyl)pyrimidin-5-amine | ESD-845387-50MG |
Cas.: 73418-87-8 | Purity: 98% | 2-(Trifluoromethyl)pyrimidin-5-amine | ESD-845387-250MG |
Cas.: 85743-02-8 | Purity: 97% | 2-Amino-4-(methoxycarbonyl)benzoic acid | ESD-845388-50MG |
Cas.: 85743-02-8 | Purity: 97% | 2-Amino-4-(methoxycarbonyl)benzoic acid | ESD-845388-250MG |
Cas.: 175205-88-6 | Purity: 95% | 1-(2,6-Dichloro-4-(trifluoromethyl)phenyl)ethanone | ESD-845389-50MG |
Cas.: 175205-88-6 | Purity: 95% | 1-(2,6-Dichloro-4-(trifluoromethyl)phenyl)ethanone | ESD-845389-250MG |
Cas.: 7377-13-1 | Purity: 96% | 4-(4-Nitrobenzoyl)benzoic acid | ESD-845390-50MG |
Cas.: 7377-13-1 | Purity: 96% | 4-(4-Nitrobenzoyl)benzoic acid | ESD-845390-250MG |
Cas.: 40318-15-8 | Purity: 95% | Methyl 4-methyl-1H-pyrrole-3-carboxylate | ESD-845391-50MG |
Cas.: 40318-15-8 | Purity: 95% | Methyl 4-methyl-1H-pyrrole-3-carboxylate | ESD-845391-250MG |
Cas.: 61693-43-4 | Purity: 98% | 2,4-Dichloro-3-aminophenol hydrochloride | ESD-845392-50MG |
Cas.: 61693-43-4 | Purity: 98% | 2,4-Dichloro-3-aminophenol hydrochloride | ESD-845392-250MG |
Cas.: 211949-57-4 | Purity: 98% | Oxazolo[4,5-b]pyridine-2-thiol | ESD-845393-250MG |
Cas.: 211949-57-4 | Purity: 98% | Oxazolo[4,5-b]pyridine-2-thiol | ESD-845393-1G |
Cas.: 885275-00-3 | Purity: 95% | Benzyl 4-iodopiperidine-1-carboxylate | ESD-845394-250MG |
Cas.: 885275-00-3 | Purity: 95% | Benzyl 4-iodopiperidine-1-carboxylate | ESD-845394-1G |
Cas.: 1099646-61-3 | Purity: 98% | (S)-Methyl pyrrolidine-3-carboxylate hydrochloride | ESD-845395-50MG |
Cas.: 1099646-61-3 | Purity: 98% | (S)-Methyl pyrrolidine-3-carboxylate hydrochloride | ESD-845395-250MG |
Cas.: 176707-77-0 | Purity: 98% | (R)-1-(3-Bromophenyl)ethanamine | ESD-845396-250MG |
Cas.: 176707-77-0 | Purity: 98% | (R)-1-(3-Bromophenyl)ethanamine | ESD-845396-1G |
Cas.: 51207-86-4 | Purity: 98% | (4-Aminophenyl)(morpholino)methanone | ESD-845397-250MG |
Cas.: 51207-86-4 | Purity: 98% | (4-Aminophenyl)(morpholino)methanone | ESD-845397-1G |
Cas.: 14793-00-1 | Purity: 95% | 6-Chloro-2-methylimidazo[1,2-b]pyridazine | ESD-845398-250MG |
Cas.: 14793-00-1 | Purity: 95% | 6-Chloro-2-methylimidazo[1,2-b]pyridazine | ESD-845398-1G |
Cas.: 94838-59-2 | Purity: 98% | tert-Butyl 4-aminophenethylcarbamate | ESD-845399-250MG |
Cas.: 94838-59-2 | Purity: 98% | tert-Butyl 4-aminophenethylcarbamate | ESD-845399-1G |
Cas.: 151230-42-1 | Purity: 98% | 6-Bromo-2-methylbenzo[d]oxazole | ESD-845400-250MG |
Cas.: 151230-42-1 | Purity: 98% | 6-Bromo-2-methylbenzo[d]oxazole | ESD-845400-1G |
Cas.: 74474-31-0 | Purity: 95% | N1,N1-Diethyl-N2-(naphthalen-1-yl)ethane-1,2-diamine xoxalate | ESD-845401-250MG |
Cas.: 74474-31-0 | Purity: 95% | N1,N1-Diethyl-N2-(naphthalen-1-yl)ethane-1,2-diamine xoxalate | ESD-845401-1G |
Cas.: 22171-15-9 | Purity: 95% | (4-(Benzyloxy)phenyl)methanamine | ESD-845402-250MG |
Cas.: 22171-15-9 | Purity: 95% | (4-(Benzyloxy)phenyl)methanamine | ESD-845402-1G |
Cas.: 201162-53-0 | Purity: 98% | 3-Boc-3,8-Diazabicyclo[3.2.1]octane | ESD-845403-50MG |
Cas.: 201162-53-0 | Purity: 98% | 3-Boc-3,8-Diazabicyclo[3.2.1]octane | ESD-845403-250MG |
Cas.: 19810-79-8 | Purity: 97% | 2-Morpholinopyrimidin-4-ol | ESD-845404-50MG |
Cas.: 19810-79-8 | Purity: 97% | 2-Morpholinopyrimidin-4-ol | ESD-845404-250MG |
Cas.: 82358-07-4 | Purity: 97% | 2-Hydroxythiazole | ESD-845405-50MG |
Cas.: 82358-07-4 | Purity: 97% | 2-Hydroxythiazole | ESD-845405-250MG |
Cas.: 80945-82-0 | Purity: 98% | 5-Amino-2-chlorobenzothiazole | ESD-845406-50MG |
Cas.: 80945-82-0 | Purity: 98% | 5-Amino-2-chlorobenzothiazole | ESD-845406-250MG |
Cas.: 3286-55-3 | Purity: 97% | 6-Chloro-2-methoxypyrimidin-4-amine | ESD-845407-50MG |
Cas.: 3286-55-3 | Purity: 97% | 6-Chloro-2-methoxypyrimidin-4-amine | ESD-845407-250MG |
Cas.: 857266-59-2 | Purity: 97% | tert-Butyl (5-iodopyridin-3-yl)carbamate | ESD-845408-50MG |
Cas.: 857266-59-2 | Purity: 97% | tert-Butyl (5-iodopyridin-3-yl)carbamate | ESD-845408-250MG |
Cas.: 173999-23-0 | Purity: 95% | (5-Bromopyridin-2-yl)methanamine | ESD-845409-50MG |
Cas.: 173999-23-0 | Purity: 95% | (5-Bromopyridin-2-yl)methanamine | ESD-845409-250MG |
Cas.: 861031-56-3 | Purity: 98% | 2-Amino-4-morpholin-4-yl-pyrimidine | ESD-845410-50MG |
Cas.: 861031-56-3 | Purity: 98% | 2-Amino-4-morpholin-4-yl-pyrimidine | ESD-845410-250MG |
Cas.: 185099-68-7 | Purity: 97% | 8-Boc-3-(trifluoromethylsulfonyloxy)-8-azabicyclo[3.2.1]oct-3-ene | ESD-845411-50MG |
Cas.: 185099-68-7 | Purity: 97% | 8-Boc-3-(trifluoromethylsulfonyloxy)-8-azabicyclo[3.2.1]oct-3-ene | ESD-845411-250MG |
Cas.: 35197-64-9 | Purity: 95% | 2-Bromo-4-(1,3-dioxoisoindolin-2-yl)butanoic acid | ESD-845412-50MG |
Cas.: 35197-64-9 | Purity: 95% | 2-Bromo-4-(1,3-dioxoisoindolin-2-yl)butanoic acid | ESD-845412-250MG |
Cas.: 1209458-16-1 | Purity: 97% | 4-Bromo-N-methylpyrimidin-2-amine | ESD-845413-50MG |
Cas.: 1209458-16-1 | Purity: 97% | 4-Bromo-N-methylpyrimidin-2-amine | ESD-845413-250MG |
Cas.: 1267093-87-7 | Purity: 95% | 4-(Morpholin-4-yl)benzene-1-carboximidamide hydrochloride | ESD-845414-50MG |
Cas.: 1267093-87-7 | Purity: 95% | 4-(Morpholin-4-yl)benzene-1-carboximidamide hydrochloride | ESD-845414-250MG |
Cas.: 696589-32-9 | Purity: 95% | 1-(2,4-Difluorophenyl)-N-methylmethanamine | ESD-845415-50MG |
Cas.: 696589-32-9 | Purity: 95% | 1-(2,4-Difluorophenyl)-N-methylmethanamine | ESD-845415-250MG |
Cas.: 41790-30-1 | Purity: 97% | (5,6,7,8-Tetrahydronaphthalen-1-yl)methanol | ESD-845416-50MG |
Cas.: 41790-30-1 | Purity: 97% | (5,6,7,8-Tetrahydronaphthalen-1-yl)methanol | ESD-845416-250MG |
Cas.: 1005515-26-3 | Purity: 96% | (4-(Trifluoromethyl)pyridin-2-yl)methanamine hydrochloride | ESD-845417-50MG |
Cas.: 1005515-26-3 | Purity: 96% | (4-(Trifluoromethyl)pyridin-2-yl)methanamine hydrochloride | ESD-845417-250MG |
Cas.: 1384972-83-1 | Purity: 97% | 3-(Bromomethyl)-4-methylpyridine hydrobromide | ESD-845418-50MG |
Cas.: 1384972-83-1 | Purity: 97% | 3-(Bromomethyl)-4-methylpyridine hydrobromide | ESD-845418-250MG |
Cas.: 29458-38-6 | Purity: 98% | 6-Methoxypyrimidine-2,4(1H,3H)-dione | ESD-845419-50MG |
Cas.: 29458-38-6 | Purity: 98% | 6-Methoxypyrimidine-2,4(1H,3H)-dione | ESD-845419-250MG |
Cas.: 39859-36-4 | Purity: 98% | 2-Benzoyl-4-bromoaniline | ESD-845420-250MG |
Cas.: 39859-36-4 | Purity: 98% | 2-Benzoyl-4-bromoaniline | ESD-845420-1G |
Cas.: 77186-95-9 | Purity: 97% | Benzo[d]oxazol-2-ylmethanol | ESD-845421-250MG |
Cas.: 77186-95-9 | Purity: 97% | Benzo[d]oxazol-2-ylmethanol | ESD-845421-1G |
Cas.: 154057-58-6 | Purity: 98% | ((2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)methyl)triphenylphosphonium bromide | ESD-845422-250MG |
Cas.: 154057-58-6 | Purity: 98% | ((2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)methyl)triphenylphosphonium bromide | ESD-845422-1G |
Cas.: 55052-27-2 | Purity: 98% | 6-Chloro-1H-pyrrolo[2,3-b]pyridine | ESD-845423-250MG |
Cas.: 55052-27-2 | Purity: 98% | 6-Chloro-1H-pyrrolo[2,3-b]pyridine | ESD-845423-1G |
Cas.: 716362-10-6 | Purity: 98% | 6-Chloro-4-methoxynicotinic acid | ESD-845424-250MG |
Cas.: 716362-10-6 | Purity: 98% | 6-Chloro-4-methoxynicotinic acid | ESD-845424-1G |
Cas.: 221050-88-0 | Purity: 97% | tert-Butyl 4-(2-chloropyrimidin-4-yl)piperazine-1-carboxylate | ESD-845425-250MG |
Cas.: 221050-88-0 | Purity: 97% | tert-Butyl 4-(2-chloropyrimidin-4-yl)piperazine-1-carboxylate | ESD-845425-1G |
Cas.: 40359-34-0 | Purity: 95% | Methyl 2-(2-formylphenoxy)acetate | ESD-845426-250MG |
Cas.: 1829-33-0 | Purity: 97% | 3-Chloro-5-hydroxybenzaldehyde | ESD-845427-250MG |
Cas.: 1829-33-0 | Purity: 97% | 3-Chloro-5-hydroxybenzaldehyde | ESD-845427-1G |
Cas.: 88427-96-7 | Purity: 95% | 4-(2-Methyl-1H-imidazol-1-yl)benzaldehyde | ESD-845428-250MG |
Cas.: 88427-96-7 | Purity: 95% | 4-(2-Methyl-1H-imidazol-1-yl)benzaldehyde | ESD-845428-1G |
Cas.: 320407-92-9 | Purity: 97% | 4-(Bromomethyl)-2-chloro-1-methoxybenzene | ESD-845429-250MG |
Cas.: 320407-92-9 | Purity: 97% | 4-(Bromomethyl)-2-chloro-1-methoxybenzene | ESD-845429-1G |
Cas.: 19808-30-1 | Purity: 98% | 5-Bromopyrimidin-4(3H)-one | ESD-845430-250MG |
Cas.: 19808-30-1 | Purity: 98% | 5-Bromopyrimidin-4(3H)-one | ESD-845430-1G |
Cas.: 175596-01-7 | Purity: 96% | Methyl 4-cyano-2-fluorobenzoate | ESD-845431-250MG |
Cas.: 175596-01-7 | Purity: 96% | Methyl 4-cyano-2-fluorobenzoate | ESD-845431-1G |
Cas.: 7310-94-3 | Purity: 98% | 2-Chloro-5-hydroxybenzaldehyde | ESD-845432-250MG |
Cas.: 7310-94-3 | Purity: 98% | 2-Chloro-5-hydroxybenzaldehyde | ESD-845432-1G |
Cas.: 1185303-62-1 | Purity: 95% | 4-Amino-1,3,5-trimethylpyrazole hydrochloride | ESD-845433-250MG |
Cas.: 1185303-62-1 | Purity: 95% | 4-Amino-1,3,5-trimethylpyrazole hydrochloride | ESD-845433-1G |
Cas.: 947249-01-6 | Purity: 95% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)pyridin-2-amine | ESD-845434-50MG |
Cas.: 947249-01-6 | Purity: 95% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)pyridin-2-amine | ESD-845434-250MG |
Cas.: 82911-79-3 | Purity: 95% | (S)-Methyl 2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-hydroxyphenyl)propanoate | ESD-845435-1G |
Cas.: 82911-79-3 | Purity: 95% | (S)-Methyl 2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-hydroxyphenyl)propanoate | ESD-845435-5G |
Cas.: 64611-67-2 | Purity: 98% | 2-Hydroxy-1-(4-nitrophenyl)ethanone | ESD-845436-50MG |
Cas.: 64611-67-2 | Purity: 98% | 2-Hydroxy-1-(4-nitrophenyl)ethanone | ESD-845436-250MG |
Cas.: 68755-42-0 | Purity: 98% | 4-(Trifluoromethyl)-1-indanone | ESD-845437-50MG |
Cas.: 68755-42-0 | Purity: 98% | 4-(Trifluoromethyl)-1-indanone | ESD-845437-250MG |
Cas.: 54584-22-4 | Purity: 97% | 2-Methyl-1H-indol-6-ol | ESD-845438-50MG |
Cas.: 54584-22-4 | Purity: 97% | 2-Methyl-1H-indol-6-ol | ESD-845438-250MG |
Cas.: 331763-54-3 | Purity: 95% | (S)-3-Amino-4-(3-chlorophenyl)butanoic acid hydrochloride | ESD-845439-50MG |
Cas.: 331763-54-3 | Purity: 95% | (S)-3-Amino-4-(3-chlorophenyl)butanoic acid hydrochloride | ESD-845439-250MG |
Cas.: 225385-03-5 | Purity: 97% | 6-Bromo-4-chlorothieno[3,2-d]pyrimidine | ESD-845440-50MG |
Cas.: 225385-03-5 | Purity: 97% | 6-Bromo-4-chlorothieno[3,2-d]pyrimidine | ESD-845440-250MG |
Cas.: 946000-27-7 | Purity: 98% | 4-Bromo-N,N-dimethylpyridin-2-amine | ESD-845441-50MG |
Cas.: 946000-27-7 | Purity: 98% | 4-Bromo-N,N-dimethylpyridin-2-amine | ESD-845441-250MG |
Cas.: 157327-42-9 | Purity: 97% | tert-Butyl 3-((dimethylamino)methylene)-4-oxopyrrolidine-1-carboxylate | ESD-845442-50MG |
Cas.: 157327-42-9 | Purity: 97% | tert-Butyl 3-((dimethylamino)methylene)-4-oxopyrrolidine-1-carboxylate | ESD-845442-250MG |
Cas.: 75476-86-7 | Purity: 98% | 6-Bromo-2,3-dihydro-1H-inden-1-ol | ESD-845443-50MG |
Cas.: 75476-86-7 | Purity: 98% | 6-Bromo-2,3-dihydro-1H-inden-1-ol | ESD-845443-250MG |
Cas.: 1646152-54-6 | Purity: 97% | 1-Bromo-2,5-dimethoxy-4-((4-methoxybenzyl)oxy)benzene | ESD-845444-50MG |
Cas.: 1646152-54-6 | Purity: 97% | 1-Bromo-2,5-dimethoxy-4-((4-methoxybenzyl)oxy)benzene | ESD-845444-250MG |
Cas.: 1187927-35-0 | Purity: 95% | 2-(3,5-Dimethyl-1H-1,2,4-triazol-1-yl)acetic acid hydrochloride | ESD-845445-50MG |
Cas.: 1187927-35-0 | Purity: 95% | 2-(3,5-Dimethyl-1H-1,2,4-triazol-1-yl)acetic acid hydrochloride | ESD-845445-250MG |
Cas.: 1370411-44-1 | Purity: 95% | Benzyl 2,4-dichloro-5,6-dihydropyrido[3,4-d]pyrimidine-7(8H)-carboxylate | ESD-845446-50MG |
Cas.: 1370411-44-1 | Purity: 95% | Benzyl 2,4-dichloro-5,6-dihydropyrido[3,4-d]pyrimidine-7(8H)-carboxylate | ESD-845446-250MG |
Cas.: 1190312-27-6 | Purity: 98% | 6-Bromo-1H-pyrrolo[3,2-b]pyridine-3-carbaldehyde | ESD-845447-50MG |
Cas.: 1190312-27-6 | Purity: 98% | 6-Bromo-1H-pyrrolo[3,2-b]pyridine-3-carbaldehyde | ESD-845447-250MG |
Cas.: 123158-31-6 | Purity: 95% | Methyl 4-hydroxy-6-(trifluoromethyl)quinoline-2-carboxylate | ESD-845448-50MG |
Cas.: 123158-31-6 | Purity: 95% | Methyl 4-hydroxy-6-(trifluoromethyl)quinoline-2-carboxylate | ESD-845448-250MG |
Cas.: 947191-69-7 | Purity: 95% | 2-(Cyclopropylmethoxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-845449-50MG |
Cas.: 947191-69-7 | Purity: 95% | 2-(Cyclopropylmethoxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-845449-250MG |
Cas.: 113269-06-0 | Purity: 97% | 4-Fluoro-5-nitrobenzene-1,2-diamine | ESD-845450-50MG |
Cas.: 113269-06-0 | Purity: 97% | 4-Fluoro-5-nitrobenzene-1,2-diamine | ESD-845450-250MG |
Cas.: 1251032-65-1 | Purity: 96% | 1-Bromo-4-(tert-butyl)-2-chlorobenzene | ESD-845451-250MG |
Cas.: 1251032-65-1 | Purity: 96% | 1-Bromo-4-(tert-butyl)-2-chlorobenzene | ESD-845451-1G |
Cas.: 23772-41-0 | Purity: 95% | 1-(6-Amino-5-methoxyindolin-1-yl)ethanone | ESD-845452-25MG |
Cas.: 23772-41-0 | Purity: 95% | 1-(6-Amino-5-methoxyindolin-1-yl)ethanone | ESD-845452-100MG |
Cas.: 174350-05-1 | Purity: 98% | 1-Ethoxy-2,3-difluoro-4-((1s,4r)-4-propylcyclohexyl)benzene | ESD-845453-250MG |
Cas.: 174350-05-1 | Purity: 98% | 1-Ethoxy-2,3-difluoro-4-((1s,4r)-4-propylcyclohexyl)benzene | ESD-845453-1G |
Cas.: 950739-21-6 | Purity: 97% | 3-Bromo-1H-pyrazol-5-amine | ESD-845454-250MG |
Cas.: 950739-21-6 | Purity: 97% | 3-Bromo-1H-pyrazol-5-amine | ESD-845454-1G |
Cas.: 877399-00-3 | Purity: 98% | (R)-5-Bromo-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine | ESD-845455-250MG |
Cas.: 877399-00-3 | Purity: 98% | (R)-5-Bromo-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine | ESD-845455-1G |
Cas.: 959235-95-1 | Purity: 98% | 6-(Trifluoromethoxy)indoline | ESD-845456-25MG |
Cas.: 959235-95-1 | Purity: 98% | 6-(Trifluoromethoxy)indoline | ESD-845456-100MG |
Cas.: 168770-44-3 | Purity: 95% | 5-Fluoro-2-methyl-3-nitroaniline | ESD-845457-25MG |
Cas.: 168770-44-3 | Purity: 95% | 5-Fluoro-2-methyl-3-nitroaniline | ESD-845457-100MG |
Cas.: 1154870-59-3 | Purity: 97% | tert-Butyl (3-hydroxycyclopentyl)carbamate | ESD-845458-25MG |
Cas.: 1154870-59-3 | Purity: 97% | tert-Butyl (3-hydroxycyclopentyl)carbamate | ESD-845458-100MG |
Cas.: 1186663-33-1 | Purity: 97% | Ethyl 4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylate hydrochloride | ESD-845459-25MG |
Cas.: 1186663-33-1 | Purity: 97% | Ethyl 4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylate hydrochloride | ESD-845459-100MG |
Cas.: 60069-96-7 | Purity: 95% | 2,2′-(Perchloro-1,2-phenylene)diacetonitrile | ESD-845460-25MG |
Cas.: 60069-96-7 | Purity: 95% | 2,2′-(Perchloro-1,2-phenylene)diacetonitrile | ESD-845460-100MG |
Cas.: 955370-07-7 | Purity: 97% | 2-(6-Bromopyridin-2-yl)ethanol | ESD-845461-25MG |
Cas.: 955370-07-7 | Purity: 97% | 2-(6-Bromopyridin-2-yl)ethanol | ESD-845461-100MG |
Cas.: 1260672-03-4 | Purity: 95% | 5-Phenylmorpholin-3-one | ESD-845462-25MG |
Cas.: 1260672-03-4 | Purity: 95% | 5-Phenylmorpholin-3-one | ESD-845462-100MG |
Cas.: 262593-63-5 | Purity: 98% | 5-(Trifluoromethoxy)-1H-indole | ESD-845463-25MG |
Cas.: 262593-63-5 | Purity: 98% | 5-(Trifluoromethoxy)-1H-indole | ESD-845463-100MG |
Cas.: 100821-50-9 | Purity: 96% | Ethyl 6-chloro-1H-indole-3-carboxylate | ESD-845464-25MG |
Cas.: 100821-50-9 | Purity: 96% | Ethyl 6-chloro-1H-indole-3-carboxylate | ESD-845464-100MG |
Cas.: 1193162-18-3 | Purity: 98% | Methyl 4-bromo-2-fluoro-6-hydroxybenzoate | ESD-845465-25MG |
Cas.: 1193162-18-3 | Purity: 98% | Methyl 4-bromo-2-fluoro-6-hydroxybenzoate | ESD-845465-100MG |
Cas.: 101803-06-9 | Purity: 97% | 5-Iodo-2-methoxypyrimidine | ESD-845466-25MG |
Cas.: 101803-06-9 | Purity: 97% | 5-Iodo-2-methoxypyrimidine | ESD-845466-100MG |
Cas.: 17847-26-6 | Purity: 97% | 4-((Dimethylamino)methyl)benzoic acid hydrochloride | ESD-845467-25MG |
Cas.: 17847-26-6 | Purity: 97% | 4-((Dimethylamino)methyl)benzoic acid hydrochloride | ESD-845467-100MG |
Cas.: 51039-53-3 | Purity: 95% | 2-Bromo-5-phenyl-1,3,4-oxadiazole | ESD-845468-25MG |
Cas.: 51039-53-3 | Purity: 95% | 2-Bromo-5-phenyl-1,3,4-oxadiazole | ESD-845468-100MG |
Cas.: 876461-55-1 | Purity: 97% | (S)-Benzyl 3-aminopiperidine-1-carboxylate | ESD-845469-250MG |
Cas.: 876461-55-1 | Purity: 97% | (S)-Benzyl 3-aminopiperidine-1-carboxylate | ESD-845469-1G |
Cas.: 374679-63-7 | Purity: 97% | Methyl 4-(3,4-dichlorophenyl)-2,4-dioxobutanoate | ESD-845470-250MG |
Cas.: 374679-63-7 | Purity: 97% | Methyl 4-(3,4-dichlorophenyl)-2,4-dioxobutanoate | ESD-845470-1G |
Cas.: 782-45-6 | Purity: 97% | 4-Amino-N-phenylbenzamide | ESD-845471-250MG |
Cas.: 782-45-6 | Purity: 97% | 4-Amino-N-phenylbenzamide | ESD-845471-1G |
Cas.: 173943-92-5 | Purity: 97% | Ethyl 4-hydroxy-4-(2-(2-hydroxyethyl)phenyl)piperidine-1-carboxylate | ESD-845472-250MG |
Cas.: 173943-92-5 | Purity: 97% | Ethyl 4-hydroxy-4-(2-(2-hydroxyethyl)phenyl)piperidine-1-carboxylate | ESD-845472-1G |
Cas.: 876317-19-0 | Purity: 97% | 1-(tert-Butoxycarbonyl)-4-oxopyrrolidine-2-carboxylic acid | ESD-845473-250MG |
Cas.: 876317-19-0 | Purity: 97% | 1-(tert-Butoxycarbonyl)-4-oxopyrrolidine-2-carboxylic acid | ESD-845473-1G |
Cas.: 51572-93-1 | Purity: 97% | O-(2,4-Dichlorobenzyl)hydroxylamine hydrochloride | ESD-845474-250MG |
Cas.: 51572-93-1 | Purity: 97% | O-(2,4-Dichlorobenzyl)hydroxylamine hydrochloride | ESD-845474-1G |
Cas.: 113479-65-5 | Purity: 95% | (6R,7R)-4-Methoxybenzyl 7-amino-3-(chloromethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate hydrochloride | ESD-845475-250MG |
Cas.: 113479-65-5 | Purity: 95% | (6R,7R)-4-Methoxybenzyl 7-amino-3-(chloromethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate hydrochloride | ESD-845475-1G |
Cas.: 380430-68-2 | Purity: 97% | (3-Boc-Aminophenyl)boronic acid | ESD-845476-250MG |
Cas.: 380430-68-2 | Purity: 97% | (3-Boc-Aminophenyl)boronic acid | ESD-845476-1G |
Cas.: 215599-91-0 | Purity: 98% | O-(2-Fluorobenzyl)hydroxylamine hydrochloride | ESD-845477-250MG |
Cas.: 215599-91-0 | Purity: 98% | O-(2-Fluorobenzyl)hydroxylamine hydrochloride | ESD-845477-1G |
Cas.: 88088-95-3 | Purity: 95% | Tris(1H-benzo[d][1,2,3]triazol-1-yl)methane | ESD-845478-250MG |
Cas.: 88088-95-3 | Purity: 95% | Tris(1H-benzo[d][1,2,3]triazol-1-yl)methane | ESD-845478-1G |
Cas.: 6953-65-7 | Purity: 95% | (6-Chloro-1H-benzo[d]imidazol-2-yl)methanol | ESD-845479-250MG |
Cas.: 6953-65-7 | Purity: 95% | (6-Chloro-1H-benzo[d]imidazol-2-yl)methanol | ESD-845479-1G |
Cas.: 22514-58-5 | Purity: 95% | 2-Bromobenzo[d]thiazole-6-carboxylic acid | ESD-845480-250MG |
Cas.: 22514-58-5 | Purity: 95% | 2-Bromobenzo[d]thiazole-6-carboxylic acid | ESD-845480-1G |
Cas.: 16227-06-8 | Purity: 95% | N’-((Dimethylamino)methylene)-N,N-dimethylformohydrazonamide dihydrochloride | ESD-845481-250MG |
Cas.: 16227-06-8 | Purity: 95% | N’-((Dimethylamino)methylene)-N,N-dimethylformohydrazonamide dihydrochloride | ESD-845481-1G |
Cas.: 932-01-4 | Purity: 98% | 4,4-Dimethylcyclohexanol | ESD-845482-250MG |
Cas.: 932-01-4 | Purity: 98% | 4,4-Dimethylcyclohexanol | ESD-845482-1G |
Cas.: 70639-77-9 | Purity: 97% | 2-Oxo-1,2,3,4-tetrahydroquinoline-6-carboxylic acid | ESD-845483-250MG |
Cas.: 70639-77-9 | Purity: 97% | 2-Oxo-1,2,3,4-tetrahydroquinoline-6-carboxylic acid | ESD-845483-1G |
Cas.: 3939-15-9 | Purity: 97% | 6-Fluoropicolinonitrile | ESD-845484-250MG |
Cas.: 3939-15-9 | Purity: 97% | 6-Fluoropicolinonitrile | ESD-845484-1G |
Cas.: 107582-20-7 | Purity: 98% | Methyl 2,3-diaminobenzoate | ESD-845485-250MG |
Cas.: 107582-20-7 | Purity: 98% | Methyl 2,3-diaminobenzoate | ESD-845485-1G |
Cas.: 39895-56-2 | Purity: 95% | 4-Aminomethylbenzyl alcohol | ESD-845486-250MG |
Cas.: 39895-56-2 | Purity: 95% | 4-Aminomethylbenzyl alcohol | ESD-845486-1G |
Cas.: 15298-58-5 | Purity: 97% | 1,4-Dichloroisoquinoline | ESD-845487-250MG |
Cas.: 15298-58-5 | Purity: 97% | 1,4-Dichloroisoquinoline | ESD-845487-1G |
Cas.: 5521-38-0 | Purity: 95% | 2-(4-(4-Nitrophenyl)piperazin-1-yl)ethanol | ESD-845488-250MG |
Cas.: 5521-38-0 | Purity: 95% | 2-(4-(4-Nitrophenyl)piperazin-1-yl)ethanol | ESD-845488-1G |
Cas.: 102029-87-8 | Purity: 97% | Adenosine 5′-diphosphate bis(cyclohexylammonium) salt | ESD-845489-250MG |
Cas.: 102029-87-8 | Purity: 97% | Adenosine 5′-diphosphate bis(cyclohexylammonium) salt | ESD-845489-1G |
Cas.: 7737-17-9 | Purity: 95% | 1-Aminopropan-2-one hydrochloride | ESD-845490-250MG |
Cas.: 7737-17-9 | Purity: 95% | 1-Aminopropan-2-one hydrochloride | ESD-845490-1G |
Cas.: 172217-11-7 | Purity: 98% | Ethyl 2-amino-6-chlorobenzoate | ESD-845491-250MG |
Cas.: 172217-11-7 | Purity: 98% | Ethyl 2-amino-6-chlorobenzoate | ESD-845491-1G |
Cas.: 105628-07-7 | Purity: 98% | Fasudil Hydrochloride | ESD-845492-250MG |
Cas.: 105628-07-7 | Purity: 98% | Fasudil Hydrochloride | ESD-845492-1G |
Cas.: 220497-61-0 | Purity: 98% | Fmoc-Cpg-OH | ESD-845493-250MG |
Cas.: 220497-61-0 | Purity: 98% | Fmoc-Cpg-OH | ESD-845493-1G |
Cas.: 65564-05-8 | Purity: 97% | Benzyl 3-oxopropylcarbamate | ESD-845494-250MG |
Cas.: 65564-05-8 | Purity: 97% | Benzyl 3-oxopropylcarbamate | ESD-845494-1G |
Cas.: 923591-51-9 | Purity: 98% | 5-Bromo-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-845495-250MG |
Cas.: 923591-51-9 | Purity: 98% | 5-Bromo-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-845495-1G |
Cas.: 145166-06-9 | Purity: 97% | tert-Butyl ((1S,2S)-2-hydroxycyclohexyl)carbamate | ESD-845496-250MG |
Cas.: 145166-06-9 | Purity: 97% | tert-Butyl ((1S,2S)-2-hydroxycyclohexyl)carbamate | ESD-845496-1G |
Cas.: 97234-97-4 | Purity: 95% | 5-Bromopyrimidin-4(3H)-one sulfate(2:1) | ESD-845497-250MG |
Cas.: 97234-97-4 | Purity: 95% | 5-Bromopyrimidin-4(3H)-one sulfate(2:1) | ESD-845497-1G |
Cas.: 1245648-93-4 | Purity: 95% | 2-Bromo-6-iodobenzonitrile | ESD-845498-250MG |
Cas.: 1245648-93-4 | Purity: 95% | 2-Bromo-6-iodobenzonitrile | ESD-845498-1G |
Cas.: 22902-86-9 | Purity: 97% | 4-Chloro-3-(trifluoromethyl)phenylacetic acid | ESD-845499-250MG |
Cas.: 22902-86-9 | Purity: 97% | 4-Chloro-3-(trifluoromethyl)phenylacetic acid | ESD-845499-1G |
Cas.: 123148-66-3 | Purity: 98% | (2-Methoxypyridin-4-yl)methanol | ESD-845500-250MG |
Cas.: 123148-66-3 | Purity: 98% | (2-Methoxypyridin-4-yl)methanol | ESD-845500-1G |
Cas.: 7025-06-1 | Purity: 98% | 1-Bromo-2-phenoxybenzene | ESD-845501-250MG |
Cas.: 7025-06-1 | Purity: 98% | 1-Bromo-2-phenoxybenzene | ESD-845501-1G |
Cas.: 51773-92-3 | Purity: 98% | Mefloquine hydrochloride | ESD-845502-250MG |
Cas.: 51773-92-3 | Purity: 98% | Mefloquine hydrochloride | ESD-845502-1G |
Cas.: 884497-46-5 | Purity: 98% | Methyl 3-amino-5-fluorobenzoate | ESD-845503-250MG |
Cas.: 884497-46-5 | Purity: 98% | Methyl 3-amino-5-fluorobenzoate | ESD-845503-1G |
Cas.: 463976-21-8 | Purity: 98% | 2-Iodo-4-(trifluoromethyl)phenol | ESD-845504-250MG |
Cas.: 463976-21-8 | Purity: 98% | 2-Iodo-4-(trifluoromethyl)phenol | ESD-845504-1G |
Cas.: 91004-46-5 | Purity: 95% | 3-(3-Nitrophenoxy)propionic acid | ESD-845505-250MG |
Cas.: 91004-46-5 | Purity: 95% | 3-(3-Nitrophenoxy)propionic acid | ESD-845505-1G |
Cas.: 451459-92-0 | Purity: 95% | 2-(4-Methylpiperazin-1-yl)-5-nitrobenzonitrile | ESD-845506-250MG |
Cas.: 451459-92-0 | Purity: 95% | 2-(4-Methylpiperazin-1-yl)-5-nitrobenzonitrile | ESD-845506-1G |
Cas.: 1185303-65-4 | Purity: 97% | (4-Chlorobenzyl)hydrazine dihydrochloride | ESD-845507-250MG |
Cas.: 1185303-65-4 | Purity: 97% | (4-Chlorobenzyl)hydrazine dihydrochloride | ESD-845507-1G |
Cas.: 846589-98-8 | Purity: 98% | Lorcaserin Hydrochloride | ESD-845508-250MG |
Cas.: 846589-98-8 | Purity: 98% | Lorcaserin Hydrochloride | ESD-845508-1G |
Cas.: 1160574-77-5 | Purity: 98% | Methyl 3-bromo-4,5-dichlorobenzoate | ESD-845509-250MG |
Cas.: 1160574-77-5 | Purity: 98% | Methyl 3-bromo-4,5-dichlorobenzoate | ESD-845509-1G |
Cas.: 175965-83-0 | Purity: 97% | 2-Fluoro-4-methoxypyridine | ESD-845510-250MG |
Cas.: 175965-83-0 | Purity: 97% | 2-Fluoro-4-methoxypyridine | ESD-845510-1G |
Cas.: 55215-57-1 | Purity: 95% | 3-Bromo-5-nitroaniline | ESD-845511-250MG |
Cas.: 55215-57-1 | Purity: 95% | 3-Bromo-5-nitroaniline | ESD-845511-1G |
Cas.: 878285-14-4 | Purity: 95% | 2,5-Difluoro-4-methylaniline | ESD-845512-250MG |
Cas.: 878285-14-4 | Purity: 95% | 2,5-Difluoro-4-methylaniline | ESD-845512-1G |
Cas.: 1373253-22-5 | Purity: 95% | Methyl morpholine-2-carboxylate 2,2,2-trifluoroacetate | ESD-845513-250MG |
Cas.: 1373253-22-5 | Purity: 95% | Methyl morpholine-2-carboxylate 2,2,2-trifluoroacetate | ESD-845513-1G |
Cas.: 885519-56-2 | Purity: 95% | 6-Chloro-4-iodo-1H-indazole | ESD-845514-250MG |
Cas.: 885519-56-2 | Purity: 95% | 6-Chloro-4-iodo-1H-indazole | ESD-845514-1G |
Cas.: 114559-25-0 | Purity: 97% | H-Dapa(Boc)-OMe.HCl | ESD-845515-250MG |
Cas.: 114559-25-0 | Purity: 97% | H-Dapa(Boc)-OMe.HCl | ESD-845515-1G |
Cas.: 90213-67-5 | Purity: 97% | 2,4-Dichloro-7-methyl-7H-pyrrolo[2,3-d]pyrimidine | ESD-845516-250MG |
Cas.: 90213-67-5 | Purity: 97% | 2,4-Dichloro-7-methyl-7H-pyrrolo[2,3-d]pyrimidine | ESD-845516-1G |
Cas.: 232275-51-3 | Purity: 98% | 4-Bromo-2,6-dichlorobenzoic acid | ESD-845517-250MG |
Cas.: 232275-51-3 | Purity: 98% | 4-Bromo-2,6-dichlorobenzoic acid | ESD-845517-1G |
Cas.: 500791-70-8 | Purity: 97% | (5-Amino-2-butylbenzofuran-3-yl)(4-(3-(dibutylamino)propoxy)phenyl)methanone oxalate | ESD-845518-250MG |
Cas.: 500791-70-8 | Purity: 97% | (5-Amino-2-butylbenzofuran-3-yl)(4-(3-(dibutylamino)propoxy)phenyl)methanone oxalate | ESD-845518-1G |
Cas.: 41373-39-1 | Purity: 97% | (S)-Piperidin-2-ylmethanol | ESD-845519-250MG |
Cas.: 41373-39-1 | Purity: 97% | (S)-Piperidin-2-ylmethanol | ESD-845519-1G |
Cas.: 898543-06-1 | Purity: 97% | (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one hydrochloride | ESD-845520-250MG |
Cas.: 898543-06-1 | Purity: 97% | (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one hydrochloride | ESD-845520-1G |
Cas.: 41404-59-5 | Purity: 95% | 2,6-Dibromo-3-fluoropyridine | ESD-845521-250MG |
Cas.: 41404-59-5 | Purity: 95% | 2,6-Dibromo-3-fluoropyridine | ESD-845521-1G |
Cas.: 847818-57-9 | Purity: 95% | (1-Propyl-1H-pyrazol-4-yl)boronic acid | ESD-845522-250MG |
Cas.: 847818-57-9 | Purity: 95% | (1-Propyl-1H-pyrazol-4-yl)boronic acid | ESD-845522-1G |
Cas.: 220141-75-3 | Purity: 97% | 1-(4-Methoxy-2-(trifluoromethyl)phenyl)ethanone | ESD-845523-250MG |
Cas.: 220141-75-3 | Purity: 97% | 1-(4-Methoxy-2-(trifluoromethyl)phenyl)ethanone | ESD-845523-1G |
Cas.: 815619-80-8 | Purity: 97% | Fmoc-Lys-OAll.HCl | ESD-845524-250MG |
Cas.: 815619-80-8 | Purity: 97% | Fmoc-Lys-OAll.HCl | ESD-845524-1G |
Cas.: 13053-88-8 | Purity: 97% | N-(Pyrimidin-2-yl)acetamide | ESD-845525-250MG |
Cas.: 13053-88-8 | Purity: 97% | N-(Pyrimidin-2-yl)acetamide | ESD-845525-1G |
Cas.: 944719-96-4 | Purity: 97% | N-(2,5-Dibromophenyl)benzothioamide | ESD-845526-250MG |
Cas.: 944719-96-4 | Purity: 97% | N-(2,5-Dibromophenyl)benzothioamide | ESD-845526-1G |
Cas.: 90259-30-6 | Purity: 95% | Ethyl 2-fluoro-6-methylbenzoate | ESD-845527-250MG |
Cas.: 90259-30-6 | Purity: 95% | Ethyl 2-fluoro-6-methylbenzoate | ESD-845527-1G |
Cas.: 1624261-85-3 | Purity: 95% | Lithium 3-morpholinopropanoate | ESD-845528-250MG |
Cas.: 1624261-85-3 | Purity: 95% | Lithium 3-morpholinopropanoate | ESD-845528-1G |
Cas.: 1628556-99-9 | Purity: 97% | 3-Bromo-5-fluoro-2-nitrobenzoic acid | ESD-845529-250MG |
Cas.: 1628556-99-9 | Purity: 97% | 3-Bromo-5-fluoro-2-nitrobenzoic acid | ESD-845529-1G |
Cas.: 610302-03-9 | Purity: 95% | tert-Butyl (3-hydroxycyclohexyl)carbamate | ESD-845530-250MG |
Cas.: 610302-03-9 | Purity: 95% | tert-Butyl (3-hydroxycyclohexyl)carbamate | ESD-845530-1G |
Cas.: 1439904-14-9 | Purity: 98% | 1-Bromo-2,5-difluoro-4-(trifluoromethoxy)benzene | ESD-845531-250MG |
Cas.: 1439904-14-9 | Purity: 98% | 1-Bromo-2,5-difluoro-4-(trifluoromethoxy)benzene | ESD-845531-1G |
Cas.: 98549-88-3 | Purity: 98% | 1H-Pyrrolo[2,3-b]pyridin-5-ol | ESD-845532-250MG |
Cas.: 98549-88-3 | Purity: 98% | 1H-Pyrrolo[2,3-b]pyridin-5-ol | ESD-845532-1G |
Cas.: 116783-26-7 | Purity: 97% | (S)-2-Aminooctanoic acid | ESD-845533-250MG |
Cas.: 116783-26-7 | Purity: 97% | (S)-2-Aminooctanoic acid | ESD-845533-1G |
Cas.: 834869-10-2 | Purity: 97% | Methyl 3-ethyl-1H-pyrazole-5-carboxylate | ESD-845534-250MG |
Cas.: 834869-10-2 | Purity: 97% | Methyl 3-ethyl-1H-pyrazole-5-carboxylate | ESD-845534-1G |
Cas.: 863377-22-4 | Purity: 97% | (3-Morpholinophenyl)boronic acid | ESD-845535-250MG |
Cas.: 863377-22-4 | Purity: 97% | (3-Morpholinophenyl)boronic acid | ESD-845535-1G |
Cas.: 31181-79-0 | Purity: 98% | (3-Fluoropyrid-2-yl)methanol | ESD-845536-250MG |
Cas.: 31181-79-0 | Purity: 98% | (3-Fluoropyrid-2-yl)methanol | ESD-845536-1G |
Cas.: 88377-29-1 | Purity: 98% | 2-Bromo-3-methoxybenzoic acid | ESD-845537-250MG |
Cas.: 88377-29-1 | Purity: 98% | 2-Bromo-3-methoxybenzoic acid | ESD-845537-1G |
Cas.: 637031-93-7 | Purity: 97% | 3,3-difluorocyclobutanamine hydrochloride | ESD-845538-250MG |
Cas.: 637031-93-7 | Purity: 97% | 3,3-difluorocyclobutanamine hydrochloride | ESD-845538-1G |
Cas.: 77332-89-9 | Purity: 98% | 3-Chloro-2-iodopyridine | ESD-845539-250MG |
Cas.: 77332-89-9 | Purity: 98% | 3-Chloro-2-iodopyridine | ESD-845539-1G |
Cas.: 42185-06-8 | Purity: 97% | 3-Methylmorpholine | ESD-845540-250MG |
Cas.: 42185-06-8 | Purity: 97% | 3-Methylmorpholine | ESD-845540-1G |
Cas.: 56181-39-6 | Purity: 98% | 5-Bromo-4-chloropyrimidine | ESD-845541-250MG |
Cas.: 56181-39-6 | Purity: 98% | 5-Bromo-4-chloropyrimidine | ESD-845541-1G |
Cas.: 1017779-69-9 | Purity: 95% | 3-Fluoro-4-(trifluoromethoxy)aniline | ESD-845542-250MG |
Cas.: 1017779-69-9 | Purity: 95% | 3-Fluoro-4-(trifluoromethoxy)aniline | ESD-845542-1G |
Cas.: 115655-08-8 | Purity: 95% | (S)-Ethyl piperidine-3-carboxylate hydrochloride | ESD-845543-250MG |
Cas.: 115655-08-8 | Purity: 95% | (S)-Ethyl piperidine-3-carboxylate hydrochloride | ESD-845543-1G |
Cas.: 5442-00-2 | Purity: 95% | 2-Cyclohexylpropan-1-ol | ESD-845544-250MG |
Cas.: 5442-00-2 | Purity: 95% | 2-Cyclohexylpropan-1-ol | ESD-845544-1G |
Cas.: 16064-27-0 | Purity: 97% | 8-Methoxyquinazolin-4-ol | ESD-845545-50MG |
Cas.: 16064-27-0 | Purity: 97% | 8-Methoxyquinazolin-4-ol | ESD-845545-250MG |
Cas.: 50681-26-0 | Purity: 98% | 6-Chloro-3-hydroxypyridazine-4-carboxylic acid | ESD-845546-50MG |
Cas.: 50681-26-0 | Purity: 98% | 6-Chloro-3-hydroxypyridazine-4-carboxylic acid | ESD-845546-250MG |
Cas.: 114040-29-8 | Purity: 98% | Ethyl 5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxylate | ESD-845547-50MG |
Cas.: 114040-29-8 | Purity: 98% | Ethyl 5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxylate | ESD-845547-250MG |
Cas.: 914947-26-5 | Purity: 97% | (6-Bromopyridin-2-yl)methanamine hydrochloride | ESD-845548-50MG |
Cas.: 914947-26-5 | Purity: 97% | (6-Bromopyridin-2-yl)methanamine hydrochloride | ESD-845548-250MG |
Cas.: 112900-82-0 | Purity: 98% | 3-Methyl-4-morpholinoaniline | ESD-845549-50MG |
Cas.: 112900-82-0 | Purity: 98% | 3-Methyl-4-morpholinoaniline | ESD-845549-250MG |
Cas.: 221297-82-1 | Purity: 98% | 3-Bromo-4-chloropyridin-2-amine | ESD-845550-50MG |
Cas.: 221297-82-1 | Purity: 98% | 3-Bromo-4-chloropyridin-2-amine | ESD-845550-250MG |
Cas.: 3106-18-1 | Purity: 95% | Sodium ((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogenphosphate | ESD-845552-50MG |
Cas.: 3106-18-1 | Purity: 95% | Sodium ((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogenphosphate | ESD-845552-250MG |
Cas.: 38396-39-3 | Purity: 97% | 1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide | ESD-845553-1G |
Cas.: 38396-39-3 | Purity: 97% | 1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide | ESD-845553-5G |
Cas.: 173159-45-0 | Purity: 95% | 2-Methylimidazo[1,2-a]pyridin-8-ylamine hydrochloride | ESD-845554-50MG |
Cas.: 173159-45-0 | Purity: 95% | 2-Methylimidazo[1,2-a]pyridin-8-ylamine hydrochloride | ESD-845554-250MG |
Cas.: 704911-47-7 | Purity: 97% | Methyl 5-bromo-1H-1,2,4-triazole-3-carboxylate | ESD-845556-50MG |
Cas.: 704911-47-7 | Purity: 97% | Methyl 5-bromo-1H-1,2,4-triazole-3-carboxylate | ESD-845556-250MG |
Cas.: 651558-58-6 | Purity: 97% | 2,3-Dihydro-1H-pyrrolo[3,4-c]pyridine hydrochloride | ESD-845557-50MG |
Cas.: 651558-58-6 | Purity: 97% | 2,3-Dihydro-1H-pyrrolo[3,4-c]pyridine hydrochloride | ESD-845557-250MG |
Cas.: 159870-80-1 | Purity: 95% | 5-Fluoro-2-iodopyridine | ESD-845558-50MG |
Cas.: 159870-80-1 | Purity: 95% | 5-Fluoro-2-iodopyridine | ESD-845558-250MG |
Cas.: 1210824-80-8 | Purity: 97% | 2-Bromo-5-nitropyrimidine | ESD-845559-50MG |
Cas.: 1210824-80-8 | Purity: 97% | 2-Bromo-5-nitropyrimidine | ESD-845559-250MG |
Cas.: 114080-93-2 | Purity: 98% | Isoxazolo[4,5-b]pyridin-3-amine | ESD-845560-50MG |
Cas.: 114080-93-2 | Purity: 98% | Isoxazolo[4,5-b]pyridin-3-amine | ESD-845560-250MG |
Cas.: 37900-81-5 | Purity: 98% | 3-Chloro-4-trifluoromethylphenol | ESD-845561-50MG |
Cas.: 37900-81-5 | Purity: 98% | 3-Chloro-4-trifluoromethylphenol | ESD-845561-250MG |
Cas.: 714975-53-8 | Purity: 98% | Methyl 4-aminopyrimidine-5-carboxylate | ESD-845562-50MG |
Cas.: 714975-53-8 | Purity: 98% | Methyl 4-aminopyrimidine-5-carboxylate | ESD-845562-250MG |
Cas.: 128071-77-2 | Purity: 97% | 4-Bromo-2-fluoronicotinaldehyde | ESD-845563-50MG |
Cas.: 128071-77-2 | Purity: 97% | 4-Bromo-2-fluoronicotinaldehyde | ESD-845563-250MG |
Cas.: 1185312-44-0 | Purity: 95% | N-(Piperidin-3-yl)pyrimidin-2-amine hydrochloride | ESD-845564-50MG |
Cas.: 1185312-44-0 | Purity: 95% | N-(Piperidin-3-yl)pyrimidin-2-amine hydrochloride | ESD-845564-250MG |
Cas.: 898747-24-5 | Purity: 98% | Methyl 5-bromo-1H-indazole-7-carboxylate | ESD-845565-50MG |
Cas.: 898747-24-5 | Purity: 98% | Methyl 5-bromo-1H-indazole-7-carboxylate | ESD-845565-250MG |
Cas.: 892112-24-2 | Purity: 97% | 4-(Trityloxy)benzaldehyde | ESD-845566-50MG |
Cas.: 892112-24-2 | Purity: 97% | 4-(Trityloxy)benzaldehyde | ESD-845566-250MG |
Cas.: 159847-80-0 | Purity: 98% | Methyl 4-amino-3-cyanobenzoate | ESD-845567-50MG |
Cas.: 159847-80-0 | Purity: 98% | Methyl 4-amino-3-cyanobenzoate | ESD-845567-250MG |
Cas.: 19178-25-7 | Purity: 98% | Pyrido[3,4-d]pyrimidin-4(3H)-one | ESD-845568-50MG |
Cas.: 19178-25-7 | Purity: 98% | Pyrido[3,4-d]pyrimidin-4(3H)-one | ESD-845568-250MG |
Cas.: 1053228-28-6 | Purity: 98% | 2,4,5-Trichloro-7H-pyrrolo[2,3-d]pyrimidine | ESD-845569-50MG |
Cas.: 1053228-28-6 | Purity: 98% | 2,4,5-Trichloro-7H-pyrrolo[2,3-d]pyrimidine | ESD-845569-250MG |
Cas.: 85692-37-1 | Purity: 95% | 1-(1-Methyl-1H-imidazol-2-yl)ethanone | ESD-845570-50MG |
Cas.: 85692-37-1 | Purity: 95% | 1-(1-Methyl-1H-imidazol-2-yl)ethanone | ESD-845570-250MG |
Cas.: 14160-91-9 | Purity: 97% | 4,6-Dichloro-2-methylpyrimidine-5-carbaldehyde | ESD-845571-50MG |
Cas.: 14160-91-9 | Purity: 97% | 4,6-Dichloro-2-methylpyrimidine-5-carbaldehyde | ESD-845571-250MG |
Cas.: 610278-88-1 | Purity: 98% | 3,5-Dichloro-2-nitropyridine | ESD-845572-50MG |
Cas.: 610278-88-1 | Purity: 98% | 3,5-Dichloro-2-nitropyridine | ESD-845572-250MG |
Cas.: 185315-51-9 | Purity: 98% | 2-(5-Chloropyridin-2-yl)acetonitrile | ESD-845573-50MG |
Cas.: 185315-51-9 | Purity: 98% | 2-(5-Chloropyridin-2-yl)acetonitrile | ESD-845573-250MG |
Cas.: 67354-34-1 | Purity: 95% | Ethyl 4-(benzyloxy)-3-oxobutanoate | ESD-845574-50MG |
Cas.: 67354-34-1 | Purity: 95% | Ethyl 4-(benzyloxy)-3-oxobutanoate | ESD-845574-250MG |
Cas.: 62606-00-2 | Purity: 98% | 3-Bromo-5-(methylsulfonyl)aniline | ESD-845575-50MG |
Cas.: 62606-00-2 | Purity: 98% | 3-Bromo-5-(methylsulfonyl)aniline | ESD-845575-250MG |
Cas.: 916814-29-4 | Purity: 95% | Ethyl 4-oxopyrrolidine-3-carboxylate hydrochloride | ESD-845576-50MG |
Cas.: 916814-29-4 | Purity: 95% | Ethyl 4-oxopyrrolidine-3-carboxylate hydrochloride | ESD-845576-250MG |
Cas.: 365547-20-2 | Purity: 95% | 4,4-Bis(2-ethylhexyl)-4H-cyclopenta[1,2-b:5,4-b’]dithiophene | ESD-845577-50MG |
Cas.: 365547-20-2 | Purity: 95% | 4,4-Bis(2-ethylhexyl)-4H-cyclopenta[1,2-b:5,4-b’]dithiophene | ESD-845577-250MG |
Cas.: 1807542-80-8 | Purity: 98% | 7-Methoxy-4-methylquinoline hydrochloride | ESD-845578-50MG |
Cas.: 1807542-80-8 | Purity: 98% | 7-Methoxy-4-methylquinoline hydrochloride | ESD-845578-250MG |
Cas.: 34662-24-3 | Purity: 98% | 2-Chloro-3-nitrobenzonitrile | ESD-845579-250MG |
Cas.: 34662-24-3 | Purity: 98% | 2-Chloro-3-nitrobenzonitrile | ESD-845579-1G |
Cas.: 1134328-09-8 | Purity: 98% | tert-Butyl (3-(methylamino)phenyl)carbamate | ESD-845580-50MG |
Cas.: 1134328-09-8 | Purity: 98% | tert-Butyl (3-(methylamino)phenyl)carbamate | ESD-845580-250MG |
Cas.: 17228-38-5 | Purity: 95% | N-Methyl-1H-benzo[d]imidazol-2-amine | ESD-845581-25MG |
Cas.: 17228-38-5 | Purity: 95% | N-Methyl-1H-benzo[d]imidazol-2-amine | ESD-845581-100MG |
Cas.: 174610-11-8 | Purity: 98% | N-(1H-Pyrrolo[2,3-c]pyridin-5-yl)acetamide | ESD-845582-25MG |
Cas.: 174610-11-8 | Purity: 98% | N-(1H-Pyrrolo[2,3-c]pyridin-5-yl)acetamide | ESD-845582-100MG |
Cas.: 1160791-13-8 | Purity: 97% | 2-Amino-6-bromothiazolo[5,4-b]pyridine | ESD-845583-25MG |
Cas.: 1160791-13-8 | Purity: 97% | 2-Amino-6-bromothiazolo[5,4-b]pyridine | ESD-845583-100MG |
Cas.: 54368-62-6 | Purity: 95% | Ethyl 5-amino-2,6-dichloropyrimidine-4-carboxylate | ESD-845584-25MG |
Cas.: 54368-62-6 | Purity: 95% | Ethyl 5-amino-2,6-dichloropyrimidine-4-carboxylate | ESD-845584-100MG |
Cas.: 690261-64-4 | Purity: 95% | 2-(Piperidin-4-yl)pyrimidine hydrochloride | ESD-845585-25MG |
Cas.: 690261-64-4 | Purity: 95% | 2-(Piperidin-4-yl)pyrimidine hydrochloride | ESD-845585-100MG |
Cas.: 443144-24-9 | Purity: 95% | Methyl 3-cyano-1H-indole-7-carboxylate | ESD-845586-25MG |
Cas.: 443144-24-9 | Purity: 95% | Methyl 3-cyano-1H-indole-7-carboxylate | ESD-845586-100MG |
Cas.: 99980-40-2 | Purity: 97% | 2-(Pyridin-3-yl)propan-2-amine | ESD-845587-25MG |
Cas.: 99980-40-2 | Purity: 97% | 2-(Pyridin-3-yl)propan-2-amine | ESD-845587-100MG |
Cas.: 69814-56-8 | Purity: 95% | 2-Methylene-1,3-dioxepane | ESD-845588-25MG |
Cas.: 69814-56-8 | Purity: 95% | 2-Methylene-1,3-dioxepane | ESD-845588-100MG |
Cas.: 954235-78-0 | Purity: 97% | 4-Bromo-2-(difluoromethoxy)-1-fluorobenzene | ESD-845589-250MG |
Cas.: 954235-78-0 | Purity: 97% | 4-Bromo-2-(difluoromethoxy)-1-fluorobenzene | ESD-845589-1G |
Cas.: 82578-45-8 | Purity: 95% | (S)-tert-Butyl 3-hydroxybutanoate | ESD-845591-250MG |
Cas.: 221636-18-6 | Purity: 97% | 5-Bromo-1-phenyl-1H-benzo[d]imidazole | ESD-845592-250MG |
Cas.: 221636-18-6 | Purity: 97% | 5-Bromo-1-phenyl-1H-benzo[d]imidazole | ESD-845592-1G |
Cas.: 31408-17-0 | Purity: 95% | 5-(p-Tolyl)pyrimidin-2-amine | ESD-845593-250MG |
Cas.: 31408-17-0 | Purity: 95% | 5-(p-Tolyl)pyrimidin-2-amine | ESD-845593-1G |
Cas.: 1189494-84-5 | Purity: 95% | 4-(4-Methylpiperidin-1-yl)-3-(trifluoromethyl)aniline dihydrochloride | ESD-845594-250MG |
Cas.: 1189494-84-5 | Purity: 95% | 4-(4-Methylpiperidin-1-yl)-3-(trifluoromethyl)aniline dihydrochloride | ESD-845594-1G |
Cas.: 914349-03-4 | Purity: 95% | tert-Butyl 3-(hydroxymethyl)-5-methyl-1H-indole-1-carboxylate | ESD-845595-250MG |
Cas.: 914349-03-4 | Purity: 95% | tert-Butyl 3-(hydroxymethyl)-5-methyl-1H-indole-1-carboxylate | ESD-845595-1G |
Cas.: 914349-10-3 | Purity: 95% | tert-Butyl 3-(hydroxymethyl)-7-methyl-1H-indole-1-carboxylate | ESD-845596-250MG |
Cas.: 914349-10-3 | Purity: 95% | tert-Butyl 3-(hydroxymethyl)-7-methyl-1H-indole-1-carboxylate | ESD-845596-1G |
Cas.: 914349-12-5 | Purity: 95% | tert-Butyl 4-hydroxy-3-(hydroxymethyl)-1H-indole-1-carboxylate | ESD-845597-250MG |
Cas.: 914349-12-5 | Purity: 95% | tert-Butyl 4-hydroxy-3-(hydroxymethyl)-1H-indole-1-carboxylate | ESD-845597-1G |
Cas.: 914349-52-3 | Purity: 95% | 2-(2-Aminopyrimidin-5-yl)benzaldehyde | ESD-845598-250MG |
Cas.: 914349-52-3 | Purity: 95% | 2-(2-Aminopyrimidin-5-yl)benzaldehyde | ESD-845598-1G |
Cas.: 914349-55-6 | Purity: 95% | 3-(3-Bromo-4-methoxyphenyl)pyridine | ESD-845599-250MG |
Cas.: 914349-55-6 | Purity: 95% | 3-(3-Bromo-4-methoxyphenyl)pyridine | ESD-845599-1G |
Cas.: 503536-74-1 | Purity: 98% | 5-(p-Tolyl)pyridin-2-amine | ESD-845600-250MG |
Cas.: 503536-74-1 | Purity: 98% | 5-(p-Tolyl)pyridin-2-amine | ESD-845600-1G |
Cas.: 1189734-03-9 | Purity: 97% | (4-((5-Bromopyrimidin-2-yl)oxy)phenyl)methanol | ESD-845601-250MG |
Cas.: 1189734-03-9 | Purity: 97% | (4-((5-Bromopyrimidin-2-yl)oxy)phenyl)methanol | ESD-845601-1G |
Cas.: 85333-26-2 | Purity: 98% | 4-(Benzyloxy)pyridin-2-amine | ESD-845602-250MG |
Cas.: 85333-26-2 | Purity: 98% | 4-(Benzyloxy)pyridin-2-amine | ESD-845602-1G |
Cas.: 52508-88-0 | Purity: 98% | 5-Methoxy-2-oxoindoline-3-carbaldehyde | ESD-845603-250MG |
Cas.: 52508-88-0 | Purity: 98% | 5-Methoxy-2-oxoindoline-3-carbaldehyde | ESD-845603-1G |
Cas.: 363607-69-6 | Purity: 98% | [1,1′-Binaphthalen]-4-ylboronic acid | ESD-845604-250MG |
Cas.: 153851-71-9 | Purity: 95% | 6,7-dihydro-6-mercapto-5H-Pyrazolo[1,2-a][1,2,4]triazol-4-ium chloride | ESD-845605-250MG |
Cas.: 153851-71-9 | Purity: 95% | 6,7-dihydro-6-mercapto-5H-Pyrazolo[1,2-a][1,2,4]triazol-4-ium chloride | ESD-845605-1G |
Cas.: 433711-95-6 | Purity: 98% | tert-Butyl (2-bromopyridin-4-yl)carbamate | ESD-845606-250MG |
Cas.: 433711-95-6 | Purity: 98% | tert-Butyl (2-bromopyridin-4-yl)carbamate | ESD-845606-1G |
Cas.: 607354-69-8 | Purity: 97% | 1-(4-Trifluoromethylphenyl)piperidine-4-carboxylic acid | ESD-845607-250MG |
Cas.: 607354-69-8 | Purity: 97% | 1-(4-Trifluoromethylphenyl)piperidine-4-carboxylic acid | ESD-845607-1G |
Cas.: 168823-65-2 | Purity: 98% | 2-(3-Bromo-4-methoxyphenyl)pyridine | ESD-845608-250MG |
Cas.: 168823-65-2 | Purity: 98% | 2-(3-Bromo-4-methoxyphenyl)pyridine | ESD-845608-1G |
Cas.: 1256355-30-2 | Purity: 98% | (5-Fluoro-2-formylphenyl)boronic acid | ESD-845609-1G |
Cas.: 1256355-30-2 | Purity: 98% | (5-Fluoro-2-formylphenyl)boronic acid | ESD-845609-5G |
Cas.: 884494-38-6 | Purity: 98% | 2-Bromo-4,6-difluoronitrobenzene | ESD-845610-250MG |
Cas.: 884494-38-6 | Purity: 98% | 2-Bromo-4,6-difluoronitrobenzene | ESD-845610-1G |
Cas.: 256956-42-0 | Purity: 95% | 3-(4-(Bromomethyl)phenyl)-5-methyl-1,2,4-oxadiazole | ESD-845611-50MG |
Cas.: 256956-42-0 | Purity: 95% | 3-(4-(Bromomethyl)phenyl)-5-methyl-1,2,4-oxadiazole | ESD-845611-250MG |
Cas.: 176486-63-8 | Purity: 95% | (2S,4R)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid | ESD-845612-50MG |
Cas.: 176486-63-8 | Purity: 95% | (2S,4R)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid | ESD-845612-250MG |
Cas.: 69861-71-8 | Purity: 97% | Bis(tri-o-tolylphosphine)palladium(0) | ESD-845613-50MG |
Cas.: 69861-71-8 | Purity: 97% | Bis(tri-o-tolylphosphine)palladium(0) | ESD-845613-250MG |
Cas.: 6317-97-1 | Purity: 95% | Ethyl 4,6-dihydroxy-5-nitronicotinate | ESD-845614-50MG |
Cas.: 6317-97-1 | Purity: 95% | Ethyl 4,6-dihydroxy-5-nitronicotinate | ESD-845614-250MG |
Cas.: 89291-23-6 | Purity: 97% | 2-(Dimethylamine)phenylboronic acid | ESD-845615-50MG |
Cas.: 89291-23-6 | Purity: 97% | 2-(Dimethylamine)phenylboronic acid | ESD-845615-250MG |
Cas.: 885518-99-0 | Purity: 97% | 6-Bromo-4-chloro-1H-indazole | ESD-845616-50MG |
Cas.: 885518-99-0 | Purity: 97% | 6-Bromo-4-chloro-1H-indazole | ESD-845616-250MG |
Cas.: 1159512-38-5 | Purity: 98% | 2-Bromo-3-fluoro-6-(trifluoromethyl)pyridine | ESD-845617-50MG |
Cas.: 1159512-38-5 | Purity: 98% | 2-Bromo-3-fluoro-6-(trifluoromethyl)pyridine | ESD-845617-250MG |
Cas.: 679406-03-2 | Purity: 97% | Ethyl 4,6-dichloropyridazine-3-carboxylate | ESD-845618-50MG |
Cas.: 679406-03-2 | Purity: 97% | Ethyl 4,6-dichloropyridazine-3-carboxylate | ESD-845618-250MG |
Cas.: 126534-87-0 | Purity: 98% | 3-Formylbenzamide | ESD-845619-50MG |
Cas.: 126534-87-0 | Purity: 98% | 3-Formylbenzamide | ESD-845619-250MG |
Cas.: 934342-39-9 | Purity: 97% | 1-(tert-Butoxycarbonyl)-3-fluoropiperidine-3-carboxylic acid | ESD-845620-50MG |
Cas.: 934342-39-9 | Purity: 97% | 1-(tert-Butoxycarbonyl)-3-fluoropiperidine-3-carboxylic acid | ESD-845620-250MG |
Cas.: 3470-55-1 | Purity: 97% | 2-Amino-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-one | ESD-845621-50MG |
Cas.: 3470-55-1 | Purity: 97% | 2-Amino-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-one | ESD-845621-250MG |
Cas.: 62783-63-5 | Purity: 97% | Methyl 2-cyclohexyl-2-oxoacetate | ESD-845622-50MG |
Cas.: 62783-63-5 | Purity: 97% | Methyl 2-cyclohexyl-2-oxoacetate | ESD-845622-250MG |
Cas.: 495414-64-7 | Purity: 97% | 1-(tert-Butoxycarbonyl)-4-hydroxypiperidine-4-carboxylic acid | ESD-845623-50MG |
Cas.: 495414-64-7 | Purity: 97% | 1-(tert-Butoxycarbonyl)-4-hydroxypiperidine-4-carboxylic acid | ESD-845623-250MG |
Cas.: 4965-26-8 | Purity: 95% | 5-Nitrobenzo[b]thiophene | ESD-845624-50MG |
Cas.: 4965-26-8 | Purity: 95% | 5-Nitrobenzo[b]thiophene | ESD-845624-250MG |
Cas.: 474708-88-8 | Purity: 97% | 6-Bromo-8-chloroimidazo[1,2-a]pyridine | ESD-845625-50MG |
Cas.: 474708-88-8 | Purity: 97% | 6-Bromo-8-chloroimidazo[1,2-a]pyridine | ESD-845625-250MG |
Cas.: 259807-91-5 | Purity: 98% | 4-Bromo-2,3-dimethylpyridine | ESD-845626-50MG |
Cas.: 259807-91-5 | Purity: 98% | 4-Bromo-2,3-dimethylpyridine | ESD-845626-250MG |
Cas.: 89026-78-8 | Purity: 98% | 6-Chloro-N-methylpyridin-2-amine | ESD-845627-250MG |
Cas.: 89026-78-8 | Purity: 98% | 6-Chloro-N-methylpyridin-2-amine | ESD-845627-1G |
Cas.: 113942-30-6 | Purity: 97% | 3-Methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid | ESD-845628-25MG |
Cas.: 113942-30-6 | Purity: 97% | 3-Methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid | ESD-845628-100MG |
Cas.: 20386-22-5 | Purity: 95% | 1-Aminopyrrolidin-2-one hydrochloride | ESD-845629-25MG |
Cas.: 20386-22-5 | Purity: 95% | 1-Aminopyrrolidin-2-one hydrochloride | ESD-845629-100MG |
Cas.: 840522-20-5 | Purity: 95% | 3-(3-Fluorophenyl)phenethyl alcohol | ESD-845630-25MG |
Cas.: 840522-20-5 | Purity: 95% | 3-(3-Fluorophenyl)phenethyl alcohol | ESD-845630-100MG |
Cas.: 1651840-84-4 | Purity: 97% | 8-Oxa-2-azaspiro[4.5]decane oxalate(2:1) | ESD-845631-25MG |
Cas.: 1651840-84-4 | Purity: 97% | 8-Oxa-2-azaspiro[4.5]decane oxalate(2:1) | ESD-845631-100MG |
Cas.: 181365-26-4 | Purity: 96% | (1-(tert-Butoxycarbonyl)-1H-indol-3-yl)boronic acid | ESD-845632-25MG |
Cas.: 181365-26-4 | Purity: 96% | (1-(tert-Butoxycarbonyl)-1H-indol-3-yl)boronic acid | ESD-845632-100MG |
Cas.: 33557-57-2 | Purity: 95% | 3-Methylpiperidin-4-ol | ESD-845633-25MG |
Cas.: 33557-57-2 | Purity: 95% | 3-Methylpiperidin-4-ol | ESD-845633-100MG |
Cas.: 858515-65-8 | Purity: 97% | 4-Methyl-1H-indole-3-carboxylic acid | ESD-845634-25MG |
Cas.: 858515-65-8 | Purity: 97% | 4-Methyl-1H-indole-3-carboxylic acid | ESD-845634-100MG |
Cas.: 886500-50-1 | Purity: 98% | 4-Chloro-3-(trifluoromethoxy)benzoic acid | ESD-845635-250MG |
Cas.: 886500-50-1 | Purity: 98% | 4-Chloro-3-(trifluoromethoxy)benzoic acid | ESD-845635-1G |
Cas.: 749922-34-7 | Purity: 95% | 7-(Benzyloxy)quinolin-4-ol | ESD-845636-250MG |
Cas.: 749922-34-7 | Purity: 95% | 7-(Benzyloxy)quinolin-4-ol | ESD-845636-1G |
Cas.: 175543-06-3 | Purity: 95% | 4-Chloro-2-(pyrrolidin-1-yl)thiazole-5-carbaldehyde | ESD-845637-250MG |
Cas.: 175543-06-3 | Purity: 95% | 4-Chloro-2-(pyrrolidin-1-yl)thiazole-5-carbaldehyde | ESD-845637-1G |
Cas.: 1209289-08-6 | Purity: 98% | 2-Amino-5-bromo-3-ethynylpyrazine | ESD-845638-50MG |
Cas.: 1209289-08-6 | Purity: 98% | 2-Amino-5-bromo-3-ethynylpyrazine | ESD-845638-250MG |
Cas.: 42823-72-3 | Purity: 97% | 4-Carbamimidoylbenzoic acid hydrochloride | ESD-845639-250MG |
Cas.: 42823-72-3 | Purity: 97% | 4-Carbamimidoylbenzoic acid hydrochloride | ESD-845639-1G |
Cas.: 1211449-75-0 | Purity: 95% | (3-((2-Isopropyl-1H-imidazol-1-yl)methyl)phenyl)amine dihydrochloride | ESD-845640-50MG |
Cas.: 1211449-75-0 | Purity: 95% | (3-((2-Isopropyl-1H-imidazol-1-yl)methyl)phenyl)amine dihydrochloride | ESD-845640-250MG |
Cas.: 38693-82-2 | Purity: 98% | 5-Methyl-1H-pyrazole-3-carbonitrile | ESD-845641-50MG |
Cas.: 38693-82-2 | Purity: 98% | 5-Methyl-1H-pyrazole-3-carbonitrile | ESD-845641-250MG |
Cas.: 6093-71-6 | Purity: 97% | Ethyl 7-hydroxy-2-oxo-2H-chromene-3-carboxylate | ESD-845642-50MG |
Cas.: 6093-71-6 | Purity: 97% | Ethyl 7-hydroxy-2-oxo-2H-chromene-3-carboxylate | ESD-845642-250MG |
Cas.: 270596-42-4 | Purity: 98% | (S)-3-((tert-Butoxycarbonyl)amino)-4-(4-chlorophenyl)butanoic acid | ESD-845643-50MG |
Cas.: 929302-18-1 | Purity: 97% | tert-Butyl 2,7-diazaspiro[3.5]nonane-2-carboxylate hydrochloride | ESD-845644-50MG |
Cas.: 929302-18-1 | Purity: 97% | tert-Butyl 2,7-diazaspiro[3.5]nonane-2-carboxylate hydrochloride | ESD-845644-250MG |
Cas.: 799293-85-9 | Purity: 98% | 3-Bromothieno[3,2-c]pyridin-4-amine | ESD-845645-50MG |
Cas.: 799293-85-9 | Purity: 98% | 3-Bromothieno[3,2-c]pyridin-4-amine | ESD-845645-250MG |
Cas.: 105003-88-1 | Purity: 95% | 2-(3-Fluoro-2-nitrophenyl)acetonitrile | ESD-845646-50MG |
Cas.: 105003-88-1 | Purity: 95% | 2-(3-Fluoro-2-nitrophenyl)acetonitrile | ESD-845646-250MG |
Cas.: 126541-82-0 | Purity: 98% | Methyl 3-amino-4-(trifluoromethyl)benzoate | ESD-845647-50MG |
Cas.: 126541-82-0 | Purity: 98% | Methyl 3-amino-4-(trifluoromethyl)benzoate | ESD-845647-250MG |
Cas.: 1588440-98-5 | Purity: 95% | 2-Amino-4-fluoro-6-methylphenol hydrochloride | ESD-845648-50MG |
Cas.: 1588440-98-5 | Purity: 95% | 2-Amino-4-fluoro-6-methylphenol hydrochloride | ESD-845648-250MG |
Cas.: 1440799-70-1 | Purity: 95% | (1-Methylpiperidin-2-yl)methanamine dihydrochloride | ESD-845649-50MG |
Cas.: 1440799-70-1 | Purity: 95% | (1-Methylpiperidin-2-yl)methanamine dihydrochloride | ESD-845649-250MG |
Cas.: 81167-60-4 | Purity: 97% | 4-(tert-Butyl)-2-chloropyridine | ESD-845650-250MG |
Cas.: 1408076-14-1 | Purity: 95% | 1-Oxa-7-azaspiro[3.5]nonane oxalate | ESD-845651-50MG |
Cas.: 1408076-14-1 | Purity: 95% | 1-Oxa-7-azaspiro[3.5]nonane oxalate | ESD-845651-250MG |
Cas.: 52992-48-0 | Purity: 97% | (R)-4-Amino-3-phenylbutanoic acid hydrochloride | ESD-845652-50MG |
Cas.: 52992-48-0 | Purity: 97% | (R)-4-Amino-3-phenylbutanoic acid hydrochloride | ESD-845652-250MG |
Cas.: 5425-81-0 | Purity: 97% | 2-Amino-1-(4-nitrophenyl)ethanone hydrochloride | ESD-845653-250MG |
Cas.: 5425-81-0 | Purity: 97% | 2-Amino-1-(4-nitrophenyl)ethanone hydrochloride | ESD-845653-1G |
Cas.: 52853-40-4 | Purity: 90% | 6-(Bromomethyl)pteridine-2,4-diamine hydrobromide | ESD-845654-250MG |
Cas.: 52853-40-4 | Purity: 90% | 6-(Bromomethyl)pteridine-2,4-diamine hydrobromide | ESD-845654-1G |
Cas.: 327056-74-6 | Purity: 98% | 3-Cyano-5-fluorobenzoic acid | ESD-845655-250MG |
Cas.: 327056-74-6 | Purity: 98% | 3-Cyano-5-fluorobenzoic acid | ESD-845655-1G |
Cas.: 130307-08-3 | Purity: 97% | 1-(4-Bromophenyl)-4-methylpiperazine | ESD-845656-250MG |
Cas.: 130307-08-3 | Purity: 97% | 1-(4-Bromophenyl)-4-methylpiperazine | ESD-845656-1G |
Cas.: 2305-30-8 | Purity: 95% | trans-Cyclohexane-1,3-dicarboxylic acid | ESD-845657-250MG |
Cas.: 2305-30-8 | Purity: 95% | trans-Cyclohexane-1,3-dicarboxylic acid | ESD-845657-1G |
Cas.: 132089-35-1 | Purity: 95% | Ethyl 2-(4-fluorophenyl)thiazole-4-carboxylate | ESD-845658-250MG |
Cas.: 132089-35-1 | Purity: 95% | Ethyl 2-(4-fluorophenyl)thiazole-4-carboxylate | ESD-845658-1G |
Cas.: 90055-47-3 | Purity: 95% | Methyl 2-chloro-2-(2-chlorophenyl)acetate | ESD-845659-250MG |
Cas.: 90055-47-3 | Purity: 95% | Methyl 2-chloro-2-(2-chlorophenyl)acetate | ESD-845659-1G |
Cas.: 106402-41-9 | Purity: 97% | H-Ser-Otbu.HCl | ESD-845660-250MG |
Cas.: 106402-41-9 | Purity: 97% | H-Ser-Otbu.HCl | ESD-845660-1G |
Cas.: 805250-17-3 | Purity: 97% | Methyl 2-(6-hydroxy-2,3-dihydrobenzofuran-3-yl)acetate | ESD-845661-50MG |
Cas.: 805250-17-3 | Purity: 97% | Methyl 2-(6-hydroxy-2,3-dihydrobenzofuran-3-yl)acetate | ESD-845661-250MG |
Cas.: 32710-14-8 | Purity: 95% | 3-Aminopyrazine-2-carbaldehyde | ESD-845662-25MG |
Cas.: 32710-14-8 | Purity: 95% | 3-Aminopyrazine-2-carbaldehyde | ESD-845662-100MG |
Cas.: 245117-16-2 | Purity: 95% | 4-(1H-Indol-5-yl)morpholine | ESD-845663-25MG |
Cas.: 245117-16-2 | Purity: 95% | 4-(1H-Indol-5-yl)morpholine | ESD-845663-100MG |
Cas.: 944804-88-0 | Purity: 95% | tert-Butyl-4-bromothiazol-2-ylcarbamate | ESD-845664-25MG |
Cas.: 944804-88-0 | Purity: 95% | tert-Butyl-4-bromothiazol-2-ylcarbamate | ESD-845664-100MG |
Cas.: 1000576-79-3 | Purity: 95% | tert-Butyl (4-bromothiazol-2-yl)(methyl)carbamate | ESD-845665-25MG |
Cas.: 1000576-79-3 | Purity: 95% | tert-Butyl (4-bromothiazol-2-yl)(methyl)carbamate | ESD-845665-100MG |
Cas.: 1187830-63-2 | Purity: 95% | 6-Bromo-4,4-dimethyl-1,2,3,4-tetrahydroquinoline hydrochloride | ESD-845666-25MG |
Cas.: 1187830-63-2 | Purity: 95% | 6-Bromo-4,4-dimethyl-1,2,3,4-tetrahydroquinoline hydrochloride | ESD-845666-100MG |
Cas.: 51498-33-0 | Purity: 97% | Ethyl 4-aminocyclohexanecarboxylate | ESD-845667-25MG |
Cas.: 51498-33-0 | Purity: 97% | Ethyl 4-aminocyclohexanecarboxylate | ESD-845667-100MG |
Cas.: 952800-39-4 | Purity: 97% | Methyl 1H-pyrrolo[3,2-b]pyridine-3-carboxylate | ESD-845668-25MG |
Cas.: 952800-39-4 | Purity: 97% | Methyl 1H-pyrrolo[3,2-b]pyridine-3-carboxylate | ESD-845668-100MG |
Cas.: 297171-80-3 | Purity: 97% | 4-(4-Methyl-4H-1,2,4-triazol-3-yl)piperidine hydrochloride | ESD-845669-25MG |
Cas.: 297171-80-3 | Purity: 97% | 4-(4-Methyl-4H-1,2,4-triazol-3-yl)piperidine hydrochloride | ESD-845669-100MG |
Cas.: 1251033-05-2 | Purity: 95% | 2-(3,4-Difluorophenyl)morpholine hydrochloride | ESD-845670-25MG |
Cas.: 1251033-05-2 | Purity: 95% | 2-(3,4-Difluorophenyl)morpholine hydrochloride | ESD-845670-100MG |
Cas.: 131747-68-7 | Purity: 98% | 5-Formylpicolinonitrile | ESD-845671-25MG |
Cas.: 131747-68-7 | Purity: 98% | 5-Formylpicolinonitrile | ESD-845671-100MG |
Cas.: 90032-83-0 | Purity: 97% | 3,3,5,5-Tetramethylmorpholin-2-one | ESD-845672-25MG |
Cas.: 90032-83-0 | Purity: 97% | 3,3,5,5-Tetramethylmorpholin-2-one | ESD-845672-100MG |
Cas.: 91183-17-4 | Purity: 98% | 5-(Benzyloxy)-2,4-dichloropyrimidine | ESD-845673-25MG |
Cas.: 91183-17-4 | Purity: 98% | 5-(Benzyloxy)-2,4-dichloropyrimidine | ESD-845673-100MG |
Cas.: 1212377-10-0 | Purity: 95% | (R)-Morpholin-3-ylmethanol hydrochloride | ESD-845674-25MG |
Cas.: 1212377-10-0 | Purity: 95% | (R)-Morpholin-3-ylmethanol hydrochloride | ESD-845674-100MG |
Cas.: 1264193-11-4 | Purity: 97% | 6-Bromopyrazolo[1,5-a]pyridine | ESD-845675-25MG |
Cas.: 1264193-11-4 | Purity: 97% | 6-Bromopyrazolo[1,5-a]pyridine | ESD-845675-100MG |
Cas.: 64241-77-6 | Purity: 98% | 3-Fluoro-2,2-dimethylpropanoic acid | ESD-845676-25MG |
Cas.: 64241-77-6 | Purity: 98% | 3-Fluoro-2,2-dimethylpropanoic acid | ESD-845676-100MG |
Cas.: 517920-59-1 | Purity: 95% | 2-(3-Chlorobenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-845677-25MG |
Cas.: 517920-59-1 | Purity: 95% | 2-(3-Chlorobenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-845677-100MG |
Cas.: 1354703-91-5 | Purity: 96% | 4-Iodo-1H-pyrazole-5-carbonitrile | ESD-845678-25MG |
Cas.: 1354703-91-5 | Purity: 96% | 4-Iodo-1H-pyrazole-5-carbonitrile | ESD-845678-100MG |
Cas.: 1167414-88-1 | Purity: 97% | (R)-1-(m-Tolyl)ethanamine hydrochloride | ESD-845679-25MG |
Cas.: 1167414-88-1 | Purity: 97% | (R)-1-(m-Tolyl)ethanamine hydrochloride | ESD-845679-100MG |
Cas.: 507462-26-2 | Purity: 98% | 5-Bromo-3-nitro-1H-pyrrolo[2,3-b]pyridine | ESD-845680-25MG |
Cas.: 507462-26-2 | Purity: 98% | 5-Bromo-3-nitro-1H-pyrrolo[2,3-b]pyridine | ESD-845680-100MG |
Cas.: 34589-97-4 | Purity: 98% | 2-Amino-1-(2-methoxyphenyl)ethanone hydrochloride | ESD-845681-25MG |
Cas.: 34589-97-4 | Purity: 98% | 2-Amino-1-(2-methoxyphenyl)ethanone hydrochloride | ESD-845681-100MG |
Cas.: 1217446-43-9 | Purity: 95% | (2R,4S)-1-tert-Butyl 2-methyl 4-aminopyrrolidine-1,2-dicarboxylate hydrochloride | ESD-845683-25MG |
Cas.: 1217446-43-9 | Purity: 95% | (2R,4S)-1-tert-Butyl 2-methyl 4-aminopyrrolidine-1,2-dicarboxylate hydrochloride | ESD-845683-100MG |
Cas.: 89782-90-1 | Purity: 97% | (3-Methoxyphenyl)methanesulfonamide | ESD-845684-25MG |
Cas.: 89782-90-1 | Purity: 97% | (3-Methoxyphenyl)methanesulfonamide | ESD-845684-100MG |
Cas.: 2690-84-8 | Purity: 97% | 2-(1H-Benzo[d][1,2,3]triazol-1-yl)ethanamine hydrochloride | ESD-845685-25MG |
Cas.: 2690-84-8 | Purity: 97% | 2-(1H-Benzo[d][1,2,3]triazol-1-yl)ethanamine hydrochloride | ESD-845685-100MG |
Cas.: 350480-55-6 | Purity: 95% | (5-Chloro-2-methoxyphenyl)methanamine hydrochloride | ESD-845686-25MG |
Cas.: 350480-55-6 | Purity: 95% | (5-Chloro-2-methoxyphenyl)methanamine hydrochloride | ESD-845686-100MG |
Cas.: 51344-14-0 | Purity: 97% | N,N-Dimethyl-2-(p-tolyloxy)ethanamine | ESD-845687-25MG |
Cas.: 51344-14-0 | Purity: 97% | N,N-Dimethyl-2-(p-tolyloxy)ethanamine | ESD-845687-100MG |
Cas.: 1799439-18-1 | Purity: 97% | 3-Chloropyrazolo[1,5-a]pyridine | ESD-845688-25MG |
Cas.: 1799439-18-1 | Purity: 97% | 3-Chloropyrazolo[1,5-a]pyridine | ESD-845688-100MG |
Cas.: 83279-44-1 | Purity: 97% | 1H-Imidazol-1-amine hydrochloride | ESD-845689-25MG |
Cas.: 83279-44-1 | Purity: 97% | 1H-Imidazol-1-amine hydrochloride | ESD-845689-100MG |
Cas.: 13729-77-6 | Purity: 98% | 2-Methylpiperidin-4-one hydrochloride | ESD-845690-25MG |
Cas.: 13729-77-6 | Purity: 98% | 2-Methylpiperidin-4-one hydrochloride | ESD-845690-100MG |
Cas.: 58888-76-9 | Purity: 97% | 3-Hydroxy-3-methylhexanoic acid | ESD-845691-25MG |
Cas.: 58888-76-9 | Purity: 97% | 3-Hydroxy-3-methylhexanoic acid | ESD-845691-100MG |
Cas.: 698985-06-7 | Purity: 97% | Methyl 4-((2-methoxy-2-oxoethyl)amino)-3-nitrobenzoate | ESD-845692-250MG |
Cas.: 698985-06-7 | Purity: 97% | Methyl 4-((2-methoxy-2-oxoethyl)amino)-3-nitrobenzoate | ESD-845692-1G |
Cas.: 50727-06-5 | Purity: 98% | 5-Hydroxyisoindoline-1,3-dione | ESD-845693-50MG |
Cas.: 50727-06-5 | Purity: 98% | 5-Hydroxyisoindoline-1,3-dione | ESD-845693-250MG |
Cas.: 1086382-38-8 | Purity: 95% | 4-Bromo-6-hydroxypyrimidine | ESD-845694-50MG |
Cas.: 1086382-38-8 | Purity: 95% | 4-Bromo-6-hydroxypyrimidine | ESD-845694-250MG |
Cas.: 342617-08-7 | Purity: 98% | 3-(3-Bromophenyl)-4H-1,2,4-triazole | ESD-845695-50MG |
Cas.: 342617-08-7 | Purity: 98% | 3-(3-Bromophenyl)-4H-1,2,4-triazole | ESD-845695-250MG |
Cas.: 21120-76-3 | Purity: 98% | Methyl 4-(4-iodophenoxy)benzoate | ESD-845696-50MG |
Cas.: 21120-76-3 | Purity: 98% | Methyl 4-(4-iodophenoxy)benzoate | ESD-845696-250MG |
Cas.: 26727-22-0 | Purity: 95% | H-γ-Abu-Obzl.TosOH | ESD-845697-250MG |
Cas.: 26727-22-0 | Purity: 95% | H-γ-Abu-Obzl.TosOH | ESD-845697-1G |
Cas.: 894779-76-1 | Purity: 97% | 4-Fluoro-2-formylbenzonitrile | ESD-845698-250MG |
Cas.: 894779-76-1 | Purity: 97% | 4-Fluoro-2-formylbenzonitrile | ESD-845698-1G |
Cas.: 1160561-31-8 | Purity: 97% | (3-Chloro-5-(trifluoromethyl)phenyl)boronic acid | ESD-845699-250MG |
Cas.: 1160561-31-8 | Purity: 97% | (3-Chloro-5-(trifluoromethyl)phenyl)boronic acid | ESD-845699-1G |
Cas.: 1159811-44-5 | Purity: 95% | 4-Bromo-3-fluoropyridine hydrochloride | ESD-845700-250MG |
Cas.: 1159811-44-5 | Purity: 95% | 4-Bromo-3-fluoropyridine hydrochloride | ESD-845700-1G |
Cas.: 15356-74-8 | Purity: 97% | 4,4,7a-Trimethyl-5,6,7,7a-tetrahydrobenzofuran-2(4H)-one | ESD-845701-250MG |
Cas.: 15356-74-8 | Purity: 97% | 4,4,7a-Trimethyl-5,6,7,7a-tetrahydrobenzofuran-2(4H)-one | ESD-845701-1G |
Cas.: 914349-04-5 | Purity: 95% | tert-Butyl 3-(hydroxymethyl)-6-methyl-1H-indole-1-carboxylate | ESD-845702-250MG |
Cas.: 914349-04-5 | Purity: 95% | tert-Butyl 3-(hydroxymethyl)-6-methyl-1H-indole-1-carboxylate | ESD-845702-1G |
Cas.: 914349-37-4 | Purity: 97% | 1-Boc-3-Bromo-7-nitroindole | ESD-845703-250MG |
Cas.: 914349-37-4 | Purity: 97% | 1-Boc-3-Bromo-7-nitroindole | ESD-845703-1G |
Cas.: 29969-57-1 | Purity: 98% | 2-Chloro-6-nitroquinoline | ESD-845704-50MG |
Cas.: 29969-57-1 | Purity: 98% | 2-Chloro-6-nitroquinoline | ESD-845704-250MG |
Cas.: 155726-05-9 | Purity: 95% | (R)-1-((1-Methylpyrrolidin-2-yl)methyl)piperidine | ESD-845705-50MG |
Cas.: 155726-05-9 | Purity: 95% | (R)-1-((1-Methylpyrrolidin-2-yl)methyl)piperidine | ESD-845705-250MG |
Cas.: 887354-02-1 | Purity: 97% | (3-Chlorophenyl)(pipidin-4-yl)methanone | ESD-845706-50MG |
Cas.: 887354-02-1 | Purity: 97% | (3-Chlorophenyl)(pipidin-4-yl)methanone | ESD-845706-250MG |
Cas.: 1201186-54-0 | Purity: 98% | 2-Bromo-5-tosyl-5H-pyrrolo[2,3-b]pyrazine | ESD-845707-50MG |
Cas.: 1201186-54-0 | Purity: 98% | 2-Bromo-5-tosyl-5H-pyrrolo[2,3-b]pyrazine | ESD-845707-250MG |
Cas.: 180160-97-8 | Purity: 97% | Spiro[isochroman-1,4′-piperidine] | ESD-845708-50MG |
Cas.: 180160-97-8 | Purity: 97% | Spiro[isochroman-1,4′-piperidine] | ESD-845708-250MG |
Cas.: 63195-39-1 | Purity: 98% | 2,5,6-Trichloro-4-methylnicotinonitrile | ESD-845709-50MG |
Cas.: 63195-39-1 | Purity: 98% | 2,5,6-Trichloro-4-methylnicotinonitrile | ESD-845709-250MG |
Cas.: 23123-11-7 | Purity: 95% | 3-(4-Fluorophenoxy)pyrrolidine hydrochloride | ESD-845710-50MG |
Cas.: 23123-11-7 | Purity: 95% | 3-(4-Fluorophenoxy)pyrrolidine hydrochloride | ESD-845710-250MG |
Cas.: 1157457-17-4 | Purity: 95% | N-(5-Bromo-2-methylphenyl)-3-cyanobenzamide | ESD-845711-50MG |
Cas.: 1157457-17-4 | Purity: 95% | N-(5-Bromo-2-methylphenyl)-3-cyanobenzamide | ESD-845711-250MG |
Cas.: 238749-50-3 | Purity: 98% | Ethyl 2-bromo-4H-thieno[3,2-b]pyrrole-5-carboxylate | ESD-845712-50MG |
Cas.: 238749-50-3 | Purity: 98% | Ethyl 2-bromo-4H-thieno[3,2-b]pyrrole-5-carboxylate | ESD-845712-250MG |
Cas.: 368866-09-5 | Purity: 95% | 4-(Fmoc-Amino)-4-piperidinecarboxylic acid hydrochloride | ESD-845713-50MG |
Cas.: 368866-09-5 | Purity: 95% | 4-(Fmoc-Amino)-4-piperidinecarboxylic acid hydrochloride | ESD-845713-250MG |
Cas.: 944900-49-6 | Purity: 98% | Ethyl 5-bromo-1H-imidazole-2-carboxylate | ESD-845714-50MG |
Cas.: 944900-49-6 | Purity: 98% | Ethyl 5-bromo-1H-imidazole-2-carboxylate | ESD-845714-250MG |
Cas.: 948594-80-7 | Purity: 98% | Methyl 2-(5-bromopyrimidin-2-yl)acetate | ESD-845715-50MG |
Cas.: 948594-80-7 | Purity: 98% | Methyl 2-(5-bromopyrimidin-2-yl)acetate | ESD-845715-250MG |
Cas.: 188861-58-7 | Purity: 97% | Ethyl isoquinoline-6-carboxylate | ESD-845716-50MG |
Cas.: 188861-58-7 | Purity: 97% | Ethyl isoquinoline-6-carboxylate | ESD-845716-250MG |
Cas.: 500789-41-3 | Purity: 97% | 4-tert-Butyl 2-methyl morpholine-2,4-dicarboxylate | ESD-845717-50MG |
Cas.: 500789-41-3 | Purity: 97% | 4-tert-Butyl 2-methyl morpholine-2,4-dicarboxylate | ESD-845717-250MG |
Cas.: 312736-50-8 | Purity: 98% | 3,5-Dichloropyrazine-2-carboxamide | ESD-845718-50MG |
Cas.: 312736-50-8 | Purity: 98% | 3,5-Dichloropyrazine-2-carboxamide | ESD-845718-250MG |
Cas.: 886372-88-9 | Purity: 98% | 6-Bromothiazolo[5,4-b]pyridine | ESD-845719-50MG |
Cas.: 886372-88-9 | Purity: 98% | 6-Bromothiazolo[5,4-b]pyridine | ESD-845719-250MG |
Cas.: 66102-69-0 | Purity: 97% | 3-Amino-2-benzylpropan-1-ol | ESD-845720-50MG |
Cas.: 66102-69-0 | Purity: 97% | 3-Amino-2-benzylpropan-1-ol | ESD-845720-250MG |
Cas.: 877399-47-8 | Purity: 98% | (R)-5-Bromo-N,N-bis-(tert-butoxycarbonyl)-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine | ESD-845721-50MG |
Cas.: 877399-47-8 | Purity: 98% | (R)-5-Bromo-N,N-bis-(tert-butoxycarbonyl)-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine | ESD-845721-250MG |
Cas.: 23746-76-1 | Purity: 95% | 5-Chloro-2-phenyl-1H-indole | ESD-845722-50MG |
Cas.: 23746-76-1 | Purity: 95% | 5-Chloro-2-phenyl-1H-indole | ESD-845722-250MG |
Cas.: 758684-29-6 | Purity: 97% | Methyl 3,4-dihydro-2H-benzo[1,4]oxazine-6-carboxylate | ESD-845723-50MG |
Cas.: 758684-29-6 | Purity: 97% | Methyl 3,4-dihydro-2H-benzo[1,4]oxazine-6-carboxylate | ESD-845723-250MG |
Cas.: 3350-13-8 | Purity: 97% | Dicyclohexylamine (S)-2-(((benzyloxy)carbonyl)amino)-4-((tert-butoxycarbonyl)amino)butanoate | ESD-845724-250MG |
Cas.: 83621-33-4 | Purity: 95% | Benzyl 4-oxoazepane-1-carboxylate | ESD-845726-250MG |
Cas.: 83621-33-4 | Purity: 95% | Benzyl 4-oxoazepane-1-carboxylate | ESD-845726-1G |
Cas.: 53662-85-4 | Purity: 98% | Methyl tetrahydrofuran-3-carboxylate | ESD-845727-250MG |
Cas.: 53662-85-4 | Purity: 98% | Methyl tetrahydrofuran-3-carboxylate | ESD-845727-1G |
Cas.: 590371-90-7 | Purity: 98% | 4-Chloro-3-iodoquinoline | ESD-845728-250MG |
Cas.: 590371-90-7 | Purity: 98% | 4-Chloro-3-iodoquinoline | ESD-845728-1G |
Cas.: 67984-81-0 | Purity: 98% | 2,3-Dihydroxybenzonitrile | ESD-845729-250MG |
Cas.: 67984-81-0 | Purity: 98% | 2,3-Dihydroxybenzonitrile | ESD-845729-1G |
Cas.: 938066-17-2 | Purity: 95% | 4-Iodo-1-(tetrahydropyran-2-yl)-1H-pyrazole | ESD-845730-250MG |
Cas.: 938066-17-2 | Purity: 95% | 4-Iodo-1-(tetrahydropyran-2-yl)-1H-pyrazole | ESD-845730-1G |
Cas.: 80096-64-6 | Purity: 98% | 6-Hydroxy-chroman-4-one | ESD-845731-25MG |
Cas.: 80096-64-6 | Purity: 98% | 6-Hydroxy-chroman-4-one | ESD-845731-100MG |
Cas.: 5521-39-1 | Purity: 97% | 2-(4-(4-Aminophenyl)piperazin-1-yl)ethanol | ESD-845732-25MG |
Cas.: 5521-39-1 | Purity: 97% | 2-(4-(4-Aminophenyl)piperazin-1-yl)ethanol | ESD-845732-100MG |
Cas.: 1001056-83-2 | Purity: 98% | 3-Bromo-4,5-dichloropyridine | ESD-845733-25MG |
Cas.: 1001056-83-2 | Purity: 98% | 3-Bromo-4,5-dichloropyridine | ESD-845733-100MG |
Cas.: 719310-31-3 | Purity: 95% | tert-Butyl 6-bromo-2H-benzo[b][1,4]oxazine-4(3H)-carboxylate | ESD-845734-25MG |
Cas.: 719310-31-3 | Purity: 95% | tert-Butyl 6-bromo-2H-benzo[b][1,4]oxazine-4(3H)-carboxylate | ESD-845734-100MG |
Cas.: 610261-34-2 | Purity: 98% | 3,5-Dibromo-2-nitropyridine | ESD-845735-25MG |
Cas.: 610261-34-2 | Purity: 98% | 3,5-Dibromo-2-nitropyridine | ESD-845735-100MG |
Cas.: 6136-71-6 | Purity: 97% | 1-(3-(tert-Butyl)phenyl)ethanone | ESD-845736-250MG |
Cas.: 6136-71-6 | Purity: 97% | 1-(3-(tert-Butyl)phenyl)ethanone | ESD-845736-1G |
Cas.: 389890-43-1 | Purity: 97% | tert-Butyl (cis-3-hydroxycyclobutyl)carbamate | ESD-845737-250MG |
Cas.: 389890-43-1 | Purity: 97% | tert-Butyl (cis-3-hydroxycyclobutyl)carbamate | ESD-845737-1G |
Cas.: 201274-81-9 | Purity: 97% | HD-Thr(tBu)-OH | ESD-845738-250MG |
Cas.: 201274-81-9 | Purity: 97% | HD-Thr(tBu)-OH | ESD-845738-1G |
Cas.: 640735-23-5 | Purity: 98% | 4-Fluoro-7-azaindole | ESD-845739-50MG |
Cas.: 640735-23-5 | Purity: 98% | 4-Fluoro-7-azaindole | ESD-845739-250MG |
Cas.: 1793091-29-8 | Purity: 95% | (2-Amino-5-(trifluoromethyl)phenyl)boronic acid | ESD-845740-50MG |
Cas.: 1793091-29-8 | Purity: 95% | (2-Amino-5-(trifluoromethyl)phenyl)boronic acid | ESD-845740-250MG |
Cas.: 391211-97-5 | Purity: 98% | 3,4-Difluoro-2-((2-fluoro-4-iodophenyl)amino)benzoic acid | ESD-845741-50MG |
Cas.: 391211-97-5 | Purity: 98% | 3,4-Difluoro-2-((2-fluoro-4-iodophenyl)amino)benzoic acid | ESD-845741-250MG |
Cas.: 77-36-1 | Purity: 98% | Chlorthalidone | ESD-845742-50MG |
Cas.: 77-36-1 | Purity: 98% | Chlorthalidone | ESD-845742-250MG |
Cas.: 933708-92-0 | Purity: 97% | [1,2,4]Triazolo[4,3-a]pyridine-6-carboxylic acid | ESD-845743-50MG |
Cas.: 933708-92-0 | Purity: 97% | [1,2,4]Triazolo[4,3-a]pyridine-6-carboxylic acid | ESD-845743-250MG |
Cas.: 862274-39-3 | Purity: 95% | 6-Fluoro-1H-indazol-3(2H)-one | ESD-845744-50MG |
Cas.: 862274-39-3 | Purity: 95% | 6-Fluoro-1H-indazol-3(2H)-one | ESD-845744-250MG |
Cas.: 20351-79-5 | Purity: 98% | 8-Methoxychroman-4-one | ESD-845745-50MG |
Cas.: 20351-79-5 | Purity: 98% | 8-Methoxychroman-4-one | ESD-845745-250MG |
Cas.: 334542-44-8 | Purity: 95% | 4-Chloro-2-(methylsulfanyl)pyridine | ESD-845746-50MG |
Cas.: 334542-44-8 | Purity: 95% | 4-Chloro-2-(methylsulfanyl)pyridine | ESD-845746-250MG |
Cas.: 953780-42-2 | Purity: 95% | 5-Fluoro-6-methoxynicotinic acid | ESD-845747-50MG |
Cas.: 953780-42-2 | Purity: 95% | 5-Fluoro-6-methoxynicotinic acid | ESD-845747-250MG |
Cas.: 122323-87-9 | Purity: 96% | Piperazin-2-ylmethanol dihydrochloride | ESD-845748-50MG |
Cas.: 122323-87-9 | Purity: 96% | Piperazin-2-ylmethanol dihydrochloride | ESD-845748-250MG |
Cas.: 1341405-19-3 | Purity: 97% | 4-(5-Bromo-1,3,4-thiadiazol-2-yl)morpholine | ESD-845749-50MG |
Cas.: 1341405-19-3 | Purity: 97% | 4-(5-Bromo-1,3,4-thiadiazol-2-yl)morpholine | ESD-845749-250MG |
Cas.: 14339-33-4 | Purity: 98% | 3-Chloro-1H-pyrazole | ESD-845750-50MG |
Cas.: 14339-33-4 | Purity: 98% | 3-Chloro-1H-pyrazole | ESD-845750-250MG |
Cas.: 1314538-55-0 | Purity: 95% | Potassium (((tert-butoxycarbonyl)amino)methyl)trifluoroborate | ESD-845751-50MG |
Cas.: 1314538-55-0 | Purity: 95% | Potassium (((tert-butoxycarbonyl)amino)methyl)trifluoroborate | ESD-845751-250MG |
Cas.: 108511-98-4 | Purity: 97% | 4-Aminoisoxazole hydrochloride | ESD-845752-50MG |
Cas.: 108511-98-4 | Purity: 97% | 4-Aminoisoxazole hydrochloride | ESD-845752-250MG |
Cas.: 123858-51-5 | Purity: 98% | 1-(2-Amino-4-bromophenyl)ethanone | ESD-845753-50MG |
Cas.: 123858-51-5 | Purity: 98% | 1-(2-Amino-4-bromophenyl)ethanone | ESD-845753-250MG |
Cas.: 149632-73-5 | Purity: 98% | tert-Butyl (1-aminopropan-2-yl)carbamate | ESD-845754-50MG |
Cas.: 149632-73-5 | Purity: 98% | tert-Butyl (1-aminopropan-2-yl)carbamate | ESD-845754-250MG |
Cas.: 23579-79-5 | Purity: 98% | 3,5-Dibromo-1-methyl-1H-1,2,4-triazole | ESD-845755-50MG |
Cas.: 23579-79-5 | Purity: 98% | 3,5-Dibromo-1-methyl-1H-1,2,4-triazole | ESD-845755-250MG |
Cas.: 78071-37-1 | Purity: 98% | Methyl 4-bromothiophene-3-carboxylate | ESD-845756-50MG |
Cas.: 78071-37-1 | Purity: 98% | Methyl 4-bromothiophene-3-carboxylate | ESD-845756-250MG |
Cas.: 1060815-89-5 | Purity: 98% | 7H-Pyrrolo[2,3-d]pyrimidine-5-carbaldehyde | ESD-845757-50MG |
Cas.: 1060815-89-5 | Purity: 98% | 7H-Pyrrolo[2,3-d]pyrimidine-5-carbaldehyde | ESD-845757-250MG |
Cas.: 624741-47-5 | Purity: 95% | 3-Fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile | ESD-845758-50MG |
Cas.: 624741-47-5 | Purity: 95% | 3-Fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile | ESD-845758-250MG |
Cas.: 35333-26-7 | Purity: 97% | 5-(4-Bromophenyl)-5-oxopentanoic acid | ESD-845759-50MG |
Cas.: 35333-26-7 | Purity: 97% | 5-(4-Bromophenyl)-5-oxopentanoic acid | ESD-845759-250MG |
Cas.: 63485-51-8 | Purity: 95% | trans-Methyl 3-hydroxycyclobutanecarboxylate | ESD-845760-50MG |
Cas.: 63485-51-8 | Purity: 95% | trans-Methyl 3-hydroxycyclobutanecarboxylate | ESD-845760-250MG |
Cas.: 58422-60-9 | Purity: 95% | 2-(o-Tolyl)propanenitrile | ESD-845761-50MG |
Cas.: 58422-60-9 | Purity: 95% | 2-(o-Tolyl)propanenitrile | ESD-845761-250MG |
Cas.: 191609-45-7 | Purity: 95% | 6-Fluorochroman-4-amine hydrochloride | ESD-845762-50MG |
Cas.: 191609-45-7 | Purity: 95% | 6-Fluorochroman-4-amine hydrochloride | ESD-845762-250MG |
Cas.: 138457-19-9 | Purity: 97% | (R)-1-m-Tolylethanamine | ESD-845763-50MG |
Cas.: 138457-19-9 | Purity: 97% | (R)-1-m-Tolylethanamine | ESD-845763-250MG |
Cas.: 18655-50-0 | Purity: 95% | 3-(4-Chlorophenyl)propan-1-amine | ESD-845764-50MG |
Cas.: 18655-50-0 | Purity: 95% | 3-(4-Chlorophenyl)propan-1-amine | ESD-845764-250MG |
Cas.: 5650-52-2 | Purity: 95% | 4H-Cyclopenta[b]thiophen-6(5H)-one | ESD-845765-50MG |
Cas.: 5650-52-2 | Purity: 95% | 4H-Cyclopenta[b]thiophen-6(5H)-one | ESD-845765-250MG |
Cas.: 1220886-29-2 | Purity: 98% | Methyl 4-bromo-5-fluoro-2-nitrobenzoate | ESD-845766-250MG |
Cas.: 1220886-29-2 | Purity: 98% | Methyl 4-bromo-5-fluoro-2-nitrobenzoate | ESD-845766-1G |
Cas.: 79456-28-3 | Purity: 98% | 6-Chloro-5-(trifluoromethyl)pyridin-2-amine | ESD-845767-50MG |
Cas.: 79456-28-3 | Purity: 98% | 6-Chloro-5-(trifluoromethyl)pyridin-2-amine | ESD-845767-250MG |
Cas.: 453566-15-9 | Purity: 97% | Methyl 3-bromo-5-cyanobenzoate | ESD-845768-50MG |
Cas.: 453566-15-9 | Purity: 97% | Methyl 3-bromo-5-cyanobenzoate | ESD-845768-250MG |
Cas.: 854778-30-6 | Purity: 96% | (2-Chloro-3-methoxyphenyl)boronic acid | ESD-845769-50MG |
Cas.: 854778-30-6 | Purity: 96% | (2-Chloro-3-methoxyphenyl)boronic acid | ESD-845769-250MG |
Cas.: 15018-56-1 | Purity: 97% | 5-Bromo-6-methylpyrimidine-2,4-diol | ESD-845770-250MG |
Cas.: 15018-56-1 | Purity: 97% | 5-Bromo-6-methylpyrimidine-2,4-diol | ESD-845770-1G |
Cas.: 1215597-17-3 | Purity: 95% | 2-Amino-5-bromopyrimidin-4-ol hydrobromide | ESD-845771-250MG |
Cas.: 1215597-17-3 | Purity: 95% | 2-Amino-5-bromopyrimidin-4-ol hydrobromide | ESD-845771-1G |
Cas.: 1532-91-8 | Purity: 98% | 4-Chloroisoquinoline | ESD-845772-250MG |
Cas.: 1532-91-8 | Purity: 98% | 4-Chloroisoquinoline | ESD-845772-1G |
Cas.: 914347-01-6 | Purity: 98% | Methyl 1-(5-bromopyrimidin-2-yl)piperidine-4-carboxylate | ESD-845773-250MG |
Cas.: 914347-01-6 | Purity: 98% | Methyl 1-(5-bromopyrimidin-2-yl)piperidine-4-carboxylate | ESD-845773-1G |
Cas.: 86867-68-7 | Purity: 97% | 2-(Difluoromethoxy)phenylacetic acid | ESD-845774-250MG |
Cas.: 86867-68-7 | Purity: 97% | 2-(Difluoromethoxy)phenylacetic acid | ESD-845774-1G |
Cas.: 475250-43-2 | Purity: 97% | 4-((4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)benzonitrile | ESD-845775-25MG |
Cas.: 475250-43-2 | Purity: 97% | 4-((4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)benzonitrile | ESD-845775-100MG |
Cas.: 767-70-4 | Purity: 98% | 7-Bromobenzo[d]thiazole | ESD-845776-25MG |
Cas.: 767-70-4 | Purity: 98% | 7-Bromobenzo[d]thiazole | ESD-845776-100MG |
Cas.: 1259224-00-4 | Purity: 96% | tert-Butyl (1-(4-aminophenyl)cyclobutyl)carbamate | ESD-845777-25MG |
Cas.: 1259224-00-4 | Purity: 96% | tert-Butyl (1-(4-aminophenyl)cyclobutyl)carbamate | ESD-845777-100MG |
Cas.: 1187830-50-7 | Purity: 97% | 2,4-Dichloro-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine 6,6-dioxide | ESD-845778-25MG |
Cas.: 1187830-50-7 | Purity: 97% | 2,4-Dichloro-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine 6,6-dioxide | ESD-845778-100MG |
Cas.: 7194-78-7 | Purity: 98% | 2-(3-Bromophenyl)-2-oxoacetic acid | ESD-845779-25MG |
Cas.: 7194-78-7 | Purity: 98% | 2-(3-Bromophenyl)-2-oxoacetic acid | ESD-845779-100MG |
Cas.: 37844-07-8 | Purity: 97% | 2-Amino-3-(2-chlorophenyl)propan-1-ol | ESD-845780-25MG |
Cas.: 37844-07-8 | Purity: 97% | 2-Amino-3-(2-chlorophenyl)propan-1-ol | ESD-845780-100MG |
Cas.: 233278-56-3 | Purity: 98% | 5,6,7,8-Tetrahydro[1,2,4]triazolo[1,5-a]pyrazine | ESD-845781-25MG |
Cas.: 233278-56-3 | Purity: 98% | 5,6,7,8-Tetrahydro[1,2,4]triazolo[1,5-a]pyrazine | ESD-845781-100MG |
Cas.: 60463-12-9 | Purity: 98% | 3-(Hydroxymethyl)-4-nitrophenol | ESD-845782-250MG |
Cas.: 60463-12-9 | Purity: 98% | 3-(Hydroxymethyl)-4-nitrophenol | ESD-845782-1G |
Cas.: 675112-70-6 | Purity: 98% | 4,4-Difluorocyclohexanamine hydrochloride | ESD-845783-250MG |
Cas.: 675112-70-6 | Purity: 98% | 4,4-Difluorocyclohexanamine hydrochloride | ESD-845783-1G |
Cas.: 31804-36-1 | Purity: 97% | 1-Bromo-3-methoxy-2-methylbenzene | ESD-845784-250MG |
Cas.: 31804-36-1 | Purity: 97% | 1-Bromo-3-methoxy-2-methylbenzene | ESD-845784-1G |
Cas.: 908350-80-1 | Purity: 95% | 2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine | ESD-845785-250MG |
Cas.: 908350-80-1 | Purity: 95% | 2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine | ESD-845785-1G |
Cas.: 362527-61-5 | Purity: 95% | Ethyl 3-bromo-4-cyanobenzoate | ESD-845786-250MG |
Cas.: 362527-61-5 | Purity: 95% | Ethyl 3-bromo-4-cyanobenzoate | ESD-845786-1G |
Cas.: 850567-26-9 | Purity: 98% | (3-(Methoxycarbamoyl)phenyl)boronic acid | ESD-845787-250MG |
Cas.: 850567-26-9 | Purity: 98% | (3-(Methoxycarbamoyl)phenyl)boronic acid | ESD-845787-1G |
Cas.: 116529-31-8 | Purity: 97% | 4-Aminotetrahydro-2H-thiopyran 1,1-dioxide hydrochloride | ESD-845788-250MG |
Cas.: 116529-31-8 | Purity: 97% | 4-Aminotetrahydro-2H-thiopyran 1,1-dioxide hydrochloride | ESD-845788-1G |
Cas.: 1196157-51-3 | Purity: 98% | 2-Amino-6-bromonicotinic acid | ESD-845789-50MG |
Cas.: 1196157-51-3 | Purity: 98% | 2-Amino-6-bromonicotinic acid | ESD-845789-250MG |
Cas.: 884495-38-9 | Purity: 98% | 6-Chloro-4-methylnicotinaldehyde | ESD-845790-50MG |
Cas.: 884495-38-9 | Purity: 98% | 6-Chloro-4-methylnicotinaldehyde | ESD-845790-250MG |
Cas.: 219297-12-8 | Purity: 96% | (R)-3-((tert-Butoxycarbonyl)amino)-4-(4-nitrophenyl)butanoic acid | ESD-845791-50MG |
Cas.: 219297-12-8 | Purity: 96% | (R)-3-((tert-Butoxycarbonyl)amino)-4-(4-nitrophenyl)butanoic acid | ESD-845791-250MG |
Cas.: 32863-33-5 | Purity: 97% | Benzo[c][1,2,5]oxadiazole-5-carbaldehyde | ESD-845792-50MG |
Cas.: 32863-33-5 | Purity: 97% | Benzo[c][1,2,5]oxadiazole-5-carbaldehyde | ESD-845792-250MG |
Cas.: 66405-41-2 | Purity: 98% | Methyl 2-(4-oxocyclohexyl)acetate | ESD-845793-50MG |
Cas.: 66405-41-2 | Purity: 98% | Methyl 2-(4-oxocyclohexyl)acetate | ESD-845793-250MG |
Cas.: 791595-74-9 | Purity: 97% | 5-Bromo-1H-benzo[d]imidazol-2-amine | ESD-845794-50MG |
Cas.: 791595-74-9 | Purity: 97% | 5-Bromo-1H-benzo[d]imidazol-2-amine | ESD-845794-250MG |
Cas.: 887602-89-3 | Purity: 98% | Methyl indolizine-7-carboxylate | ESD-845795-50MG |
Cas.: 887602-89-3 | Purity: 98% | Methyl indolizine-7-carboxylate | ESD-845795-250MG |
Cas.: 194152-05-1 | Purity: 98% | 4-Hydroxytetrahydro-2H-thiopyran 1,1-dioxide | ESD-845796-50MG |
Cas.: 194152-05-1 | Purity: 98% | 4-Hydroxytetrahydro-2H-thiopyran 1,1-dioxide | ESD-845796-250MG |
Cas.: 137129-98-7 | Purity: 98% | 6-Chloro-2-methylnicotinic acid | ESD-845798-50MG |
Cas.: 137129-98-7 | Purity: 98% | 6-Chloro-2-methylnicotinic acid | ESD-845798-250MG |
Cas.: 1166828-13-2 | Purity: 98% | 6-Chloro-5-methylpyridine-2-carboxylic acid | ESD-845799-50MG |
Cas.: 1166828-13-2 | Purity: 98% | 6-Chloro-5-methylpyridine-2-carboxylic acid | ESD-845799-250MG |
Cas.: 25688-18-0 | Purity: 95% | 1-(3-Nitrophenyl)-1H-pyrazole | ESD-845800-50MG |
Cas.: 25688-18-0 | Purity: 95% | 1-(3-Nitrophenyl)-1H-pyrazole | ESD-845800-250MG |
Cas.: 139004-93-6 | Purity: 95% | (S)-tert-Butyl (pipidin-2-ylmethyl)carbamate | ESD-845801-50MG |
Cas.: 139004-93-6 | Purity: 95% | (S)-tert-Butyl (pipidin-2-ylmethyl)carbamate | ESD-845801-250MG |
Cas.: 1034924-06-5 | Purity: 98% | (2-Methylpyrimidin-5-yl)boronic acid | ESD-845802-50MG |
Cas.: 1034924-06-5 | Purity: 98% | (2-Methylpyrimidin-5-yl)boronic acid | ESD-845802-250MG |
Cas.: 1028307-48-3 | Purity: 98% | 3-(2-((2-Methoxybenzyl)amino)ethyl)quinazoline-2,4(1H,3H)-dione | ESD-845803-50MG |
Cas.: 1028307-48-3 | Purity: 98% | 3-(2-((2-Methoxybenzyl)amino)ethyl)quinazoline-2,4(1H,3H)-dione | ESD-845803-250MG |
Cas.: 1082040-43-4 | Purity: 98% | Methyl 6-fluoro-1H-indole-4-carboxylate | ESD-845804-50MG |
Cas.: 1082040-43-4 | Purity: 98% | Methyl 6-fluoro-1H-indole-4-carboxylate | ESD-845804-250MG |
Cas.: 400822-47-1 | Purity: 98% | 4-Bromo-3,5-dimethylbenzaldehyde | ESD-845805-50MG |
Cas.: 400822-47-1 | Purity: 98% | 4-Bromo-3,5-dimethylbenzaldehyde | ESD-845805-250MG |
Cas.: 201469-31-0 | Purity: 95% | (S)-2,5-Dihydro-1H-pyrrole-2-carboxylic acid hydrochloride | ESD-845806-50MG |
Cas.: 201469-31-0 | Purity: 95% | (S)-2,5-Dihydro-1H-pyrrole-2-carboxylic acid hydrochloride | ESD-845806-250MG |
Cas.: 52834-08-9 | Purity: 97% | 4-Amino-5-bromonicotinic acid | ESD-845807-50MG |
Cas.: 52834-08-9 | Purity: 97% | 4-Amino-5-bromonicotinic acid | ESD-845807-250MG |
Cas.: 18994-78-0 | Purity: 95% | 1-(2-Chloroethyl)-1H-imidazole hydrochloride | ESD-845808-250MG |
Cas.: 18994-78-0 | Purity: 95% | 1-(2-Chloroethyl)-1H-imidazole hydrochloride | ESD-845808-1G |
Cas.: 160911-11-5 | Purity: 98% | 1-Fluoro-3-methoxy-5-methylbenzene | ESD-845809-250MG |
Cas.: 160911-11-5 | Purity: 98% | 1-Fluoro-3-methoxy-5-methylbenzene | ESD-845809-1G |
Cas.: 656235-44-8 | Purity: 95% | (2-Cyano-6-fluorophenyl)boronic acid | ESD-845810-50MG |
Cas.: 656235-44-8 | Purity: 95% | (2-Cyano-6-fluorophenyl)boronic acid | ESD-845810-250MG |
Cas.: 3356-96-5 | Purity: 98% | Ethyl 5-chloro-4-methylisoxazole-3-carboxylate | ESD-845811-50MG |
Cas.: 3356-96-5 | Purity: 98% | Ethyl 5-chloro-4-methylisoxazole-3-carboxylate | ESD-845811-250MG |
Cas.: 243145-83-7 | Purity: 95% | 2-(4-Fluorobenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-845812-50MG |
Cas.: 243145-83-7 | Purity: 95% | 2-(4-Fluorobenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-845812-250MG |
Cas.: 38866-59-0 | Purity: 95% | 2-Cyanobenzyl acetate | ESD-845813-250MG |
Cas.: 38866-59-0 | Purity: 95% | 2-Cyanobenzyl acetate | ESD-845813-1G |
Cas.: 40369-91-3 | Purity: 97% | 1,4-Dioxa-7-azaspiro[4.5]decane | ESD-845814-25MG |
Cas.: 40369-91-3 | Purity: 97% | 1,4-Dioxa-7-azaspiro[4.5]decane | ESD-845814-100MG |
Cas.: 19406-00-9 | Purity: 97% | Methyl 2-oxotetrahydrofuran-3-carboxylate | ESD-845815-25MG |
Cas.: 19406-00-9 | Purity: 97% | Methyl 2-oxotetrahydrofuran-3-carboxylate | ESD-845815-100MG |
Cas.: 1171892-40-2 | Purity: 95% | 3-Ethoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-845816-25MG |
Cas.: 1171892-40-2 | Purity: 95% | 3-Ethoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-845816-100MG |
Cas.: 3445-52-1 | Purity: 97% | 5-Methylisoxazole-3-carboxamide | ESD-845817-250MG |
Cas.: 3445-52-1 | Purity: 97% | 5-Methylisoxazole-3-carboxamide | ESD-845817-1G |
Cas.: 2240-25-7 | Purity: 95% | 4-Amino-5-bromopyrimidin-2(1H)-one | ESD-845818-250MG |
Cas.: 2240-25-7 | Purity: 95% | 4-Amino-5-bromopyrimidin-2(1H)-one | ESD-845818-1G |
Cas.: 79387-69-2 | Purity: 95% | 5-Iodopyrimidin-2(1H)-one | ESD-845819-250MG |
Cas.: 79387-69-2 | Purity: 95% | 5-Iodopyrimidin-2(1H)-one | ESD-845819-1G |
Cas.: 121282-70-0 | Purity: 97% | tert-Butyl (trans-2-hydroxycyclohexyl)carbamate | ESD-845820-250MG |
Cas.: 121282-70-0 | Purity: 97% | tert-Butyl (trans-2-hydroxycyclohexyl)carbamate | ESD-845820-1G |
Cas.: 4316-94-3 | Purity: 97% | 6-Chloro-5-nitropyrimidin-4-amine | ESD-845821-250MG |
Cas.: 4316-94-3 | Purity: 97% | 6-Chloro-5-nitropyrimidin-4-amine | ESD-845821-1G |
Cas.: 954235-83-7 | Purity: 98% | 1-Bromo-2-(difluoromethoxy)-4-fluorobenzene | ESD-845822-250MG |
Cas.: 954235-83-7 | Purity: 98% | 1-Bromo-2-(difluoromethoxy)-4-fluorobenzene | ESD-845822-1G |
Cas.: 929203-04-3 | Purity: 95% | 3-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine | ESD-845823-250MG |
Cas.: 929203-04-3 | Purity: 95% | 3-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine | ESD-845823-1G |
Cas.: 18650-38-9 | Purity: 95% | HD-HoPro-OMe.HCl | ESD-845824-250MG |
Cas.: 18650-38-9 | Purity: 95% | HD-HoPro-OMe.HCl | ESD-845824-1G |
Cas.: 684221-26-9 | Purity: 97% | 2-Cyclopentylethanamine hydrochloride | ESD-845825-250MG |
Cas.: 684221-26-9 | Purity: 97% | 2-Cyclopentylethanamine hydrochloride | ESD-845825-1G |
Cas.: 165741-71-9 | Purity: 98% | 1-(3,4-Dimethylphenyl)-N-methylmethanamine | ESD-845826-250MG |
Cas.: 165741-71-9 | Purity: 98% | 1-(3,4-Dimethylphenyl)-N-methylmethanamine | ESD-845826-1G |
Cas.: 137571-73-4 | Purity: 95% | 5,7-Dihydroxy-2,2-dimethyl-4H-1,3-benzodioxin-4-one | ESD-845827-250MG |
Cas.: 137571-73-4 | Purity: 95% | 5,7-Dihydroxy-2,2-dimethyl-4H-1,3-benzodioxin-4-one | ESD-845827-1G |
Cas.: 1107663-03-5 | Purity: 97% | Ethyl 2-iodooxazole-4-carboxylate | ESD-845828-50MG |
Cas.: 1107663-03-5 | Purity: 97% | Ethyl 2-iodooxazole-4-carboxylate | ESD-845828-250MG |
Cas.: 129365-93-1 | Purity: 96% | 4,5-Diaminophthalonitrile | ESD-845829-50MG |
Cas.: 129365-93-1 | Purity: 96% | 4,5-Diaminophthalonitrile | ESD-845829-250MG |
Cas.: 874964-22-4 | Purity: 97% | (R)-Methyl pyrrolidine-3-carboxylate hydrochloride | ESD-845830-50MG |
Cas.: 874964-22-4 | Purity: 97% | (R)-Methyl pyrrolidine-3-carboxylate hydrochloride | ESD-845830-250MG |
Cas.: 883195-40-2 | Purity: 97% | 3-Amino-5-chlorophenol | ESD-845831-50MG |
Cas.: 883195-40-2 | Purity: 97% | 3-Amino-5-chlorophenol | ESD-845831-250MG |
Cas.: 1588441-12-6 | Purity: 95% | 4-(Trifluoromethoxy)-2-(trifluoromethyl)aniline hydrochloride | ESD-845832-50MG |
Cas.: 1588441-12-6 | Purity: 95% | 4-(Trifluoromethoxy)-2-(trifluoromethyl)aniline hydrochloride | ESD-845832-250MG |
Cas.: 6647-93-4 | Purity: 95% | 4-Iodo-1H-pyrazole-5-carboxylic acid | ESD-845833-50MG |
Cas.: 6647-93-4 | Purity: 95% | 4-Iodo-1H-pyrazole-5-carboxylic acid | ESD-845833-250MG |
Cas.: 142167-36-0 | Purity: 95% | 2-Hydroxy-5-trifluoromethylbenzonitrile | ESD-845834-250MG |
Cas.: 142167-36-0 | Purity: 95% | 2-Hydroxy-5-trifluoromethylbenzonitrile | ESD-845834-1G |
Cas.: 113882-33-0 | Purity: 98% | 3-Methyl-5-nitrobenzoic acid | ESD-845835-250MG |
Cas.: 113882-33-0 | Purity: 98% | 3-Methyl-5-nitrobenzoic acid | ESD-845835-1G |
Cas.: 135072-15-0 | Purity: 96% | 4-Benzyl-2-morpholinecarboxylic acid hydrochloride | ESD-845836-250MG |
Cas.: 135072-15-0 | Purity: 96% | 4-Benzyl-2-morpholinecarboxylic acid hydrochloride | ESD-845836-1G |
Cas.: 89640-03-9 | Purity: 95% | Ethyl 5-chloro-4-nitrothiophene-2-carboxylate | ESD-845837-250MG |
Cas.: 89640-03-9 | Purity: 95% | Ethyl 5-chloro-4-nitrothiophene-2-carboxylate | ESD-845837-1G |
Cas.: 1185013-84-6 | Purity: 95% | (4-Benzylpiperazin-1-yl)(piperidin-4-yl)methanone dihydrochloride | ESD-845838-250MG |
Cas.: 1185013-84-6 | Purity: 95% | (4-Benzylpiperazin-1-yl)(piperidin-4-yl)methanone dihydrochloride | ESD-845838-1G |
Cas.: 1184996-07-3 | Purity: 95% | (4-Phenylpiperazin-1-yl)(piperidin-4-yl)methanone dihydrochloride | ESD-845839-250MG |
Cas.: 1184996-07-3 | Purity: 95% | (4-Phenylpiperazin-1-yl)(piperidin-4-yl)methanone dihydrochloride | ESD-845839-1G |
Cas.: 1189437-95-3 | Purity: 95% | 1-(2-(Hydroxymethyl)phenyl)piperidin-4-ol hydrochloride | ESD-845840-250MG |
Cas.: 1189437-95-3 | Purity: 95% | 1-(2-(Hydroxymethyl)phenyl)piperidin-4-ol hydrochloride | ESD-845840-1G |
Cas.: 723286-67-7 | Purity: 95% | Ethyl[1,2,4]triazolo[4,3-a]pyrazine-3-carboxylate | ESD-845841-250MG |
Cas.: 723286-67-7 | Purity: 95% | Ethyl[1,2,4]triazolo[4,3-a]pyrazine-3-carboxylate | ESD-845841-1G |
Cas.: 56962-12-0 | Purity: 98% | 4-Chloro-3-hydroxybenzaldehyde | ESD-845842-250MG |
Cas.: 56962-12-0 | Purity: 98% | 4-Chloro-3-hydroxybenzaldehyde | ESD-845842-1G |
Cas.: 84964-24-9 | Purity: 98% | 1-(3-Bromophenyl)piperidine | ESD-845844-250MG |
Cas.: 84964-24-9 | Purity: 98% | 1-(3-Bromophenyl)piperidine | ESD-845844-1G |
Cas.: 1104636-73-8 | Purity: 95% | 6-Methyl-2-vinyl-1,3,6,2-dioxazaborocane-4,8-dione | ESD-845845-50MG |
Cas.: 1104636-73-8 | Purity: 95% | 6-Methyl-2-vinyl-1,3,6,2-dioxazaborocane-4,8-dione | ESD-845845-250MG |
Cas.: 54409-13-1 | Purity: 95% | 6-(Methylamino)pyrazine-2-carboxylic acid | ESD-845846-50MG |
Cas.: 54409-13-1 | Purity: 95% | 6-(Methylamino)pyrazine-2-carboxylic acid | ESD-845846-250MG |
Cas.: 473-81-4 | Purity: 95%, 20% in Water | 2,3-Dihydroxypropanoic acid (20% in water) | ESD-845847-1G |
Cas.: 473-81-4 | Purity: 95%, 20% in Water | 2,3-Dihydroxypropanoic acid (20% in water) | ESD-845847-10G |
Cas.: 876343-10-1 | Purity: 98% | 4-Chloro-6-iodo-7H-pyrrolo[2,3-d]pyrimidine | ESD-845848-50MG |
Cas.: 876343-10-1 | Purity: 98% | 4-Chloro-6-iodo-7H-pyrrolo[2,3-d]pyrimidine | ESD-845848-250MG |
Cas.: 850349-22-3 | Purity: 95% | 2-(Azetidin-1-yl)-5-bromopyrimidine | ESD-845849-50MG |
Cas.: 850349-22-3 | Purity: 95% | 2-(Azetidin-1-yl)-5-bromopyrimidine | ESD-845849-250MG |
Cas.: 212688-53-4 | Purity: 95% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-aminopropanoic acid hydrochloride | ESD-845850-50MG |
Cas.: 212688-53-4 | Purity: 95% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-aminopropanoic acid hydrochloride | ESD-845850-250MG |
Cas.: 1190321-08-4 | Purity: 98% | 3-Bromo-6-chloro-7-azindole | ESD-845851-50MG |
Cas.: 1190321-08-4 | Purity: 98% | 3-Bromo-6-chloro-7-azindole | ESD-845851-250MG |
Cas.: 3875-78-3 | Purity: 98% | 6-Bromochroman | ESD-845852-50MG |
Cas.: 3875-78-3 | Purity: 98% | 6-Bromochroman | ESD-845852-250MG |
Cas.: 883107-61-7 | Purity: 95% | 4-Chloro-2-(4-hydroxypiperidin-1-yl)thiazole-5-carbaldehyde | ESD-845853-50MG |
Cas.: 883107-61-7 | Purity: 95% | 4-Chloro-2-(4-hydroxypiperidin-1-yl)thiazole-5-carbaldehyde | ESD-845853-250MG |
Cas.: 35808-45-8 | Purity: 98% | Pyrido[2,3-b]pyrazin-6(5H)-one | ESD-845854-25MG |
Cas.: 35808-45-8 | Purity: 98% | Pyrido[2,3-b]pyrazin-6(5H)-one | ESD-845854-100MG |
Cas.: 24056-34-6 | Purity: 97% | 4-Hydroxycyclohexanecarbonitrile | ESD-845855-25MG |
Cas.: 24056-34-6 | Purity: 97% | 4-Hydroxycyclohexanecarbonitrile | ESD-845855-100MG |
Cas.: 89284-11-7 | Purity: 97% | 5,6-Dibromopyridin-2-amine | ESD-845856-250MG |
Cas.: 89284-11-7 | Purity: 97% | 5,6-Dibromopyridin-2-amine | ESD-845856-1G |
Cas.: 58249-57-3 | Purity: 98% | Benzo[d]thiazole-5-carbonitrile | ESD-845857-50MG |
Cas.: 58249-57-3 | Purity: 98% | Benzo[d]thiazole-5-carbonitrile | ESD-845857-250MG |
Cas.: 25125-21-7 | Purity: 97% | 1-Hydroxymethyl-3-cyclopentene | ESD-845858-250MG |
Cas.: 25125-21-7 | Purity: 97% | 1-Hydroxymethyl-3-cyclopentene | ESD-845858-1G |
Cas.: 89891-65-6 | Purity: ≥95% | 7-Bromo-2-chloroquinoxaline | ESD-845859-250MG |
Cas.: 89891-65-6 | Purity: ≥95% | 7-Bromo-2-chloroquinoxaline | ESD-845859-1G |
Cas.: 220996-81-6 | Purity: 97% | (4-Bromo-2-(trifluoromethoxy)phenyl)methanol | ESD-845860-250MG |
Cas.: 220996-81-6 | Purity: 97% | (4-Bromo-2-(trifluoromethoxy)phenyl)methanol | ESD-845860-1G |
Cas.: 341028-37-3 | Purity: 98% | 4,5-Dimethyl-3-(2-oxo-2-phenylethyl)thiazol-3-ium chloride | ESD-845861-250MG |
Cas.: 341028-37-3 | Purity: 98% | 4,5-Dimethyl-3-(2-oxo-2-phenylethyl)thiazol-3-ium chloride | ESD-845861-1G |
Cas.: 335013-18-8 | Purity: 98% | 4-Bromo-1-(bromomethyl)-2-(trifluoromethyl)benzene | ESD-845862-250MG |
Cas.: 335013-18-8 | Purity: 98% | 4-Bromo-1-(bromomethyl)-2-(trifluoromethyl)benzene | ESD-845862-1G |
Cas.: 145143-60-8 | Purity: 95% | Ethyl 1-aminocyclobutanecarboxylate hydrochloride | ESD-845863-250MG |
Cas.: 145143-60-8 | Purity: 95% | Ethyl 1-aminocyclobutanecarboxylate hydrochloride | ESD-845863-1G |
Cas.: 1199773-75-5 | Purity: 97% | Piperidine-3-carbonitrile hydrochloride | ESD-845864-250MG |
Cas.: 1199773-75-5 | Purity: 97% | Piperidine-3-carbonitrile hydrochloride | ESD-845864-1G |
Cas.: 139243-54-2 | Purity: 97% | (R)-Methyl 3-aminobutanoate hydrochloride | ESD-845865-250MG |
Cas.: 139243-54-2 | Purity: 97% | (R)-Methyl 3-aminobutanoate hydrochloride | ESD-845865-1G |
Cas.: 63449-68-3 | Purity: 95% | Naphthalen-2-yl 2-aminobenzoate | ESD-845866-50MG |
Cas.: 63449-68-3 | Purity: 95% | Naphthalen-2-yl 2-aminobenzoate | ESD-845866-250MG |
Cas.: 65364-63-8 | Purity: 95% | Ethyl 2-cyano-2-(pyrimidin-2-yl)acetate | ESD-845867-50MG |
Cas.: 65364-63-8 | Purity: 95% | Ethyl 2-cyano-2-(pyrimidin-2-yl)acetate | ESD-845867-250MG |
Cas.: 40851-98-7 | Purity: 95% | 5-Chloro-1H-imidazo[4,5-b]pyridin-2(3H)-one | ESD-845868-50MG |
Cas.: 40851-98-7 | Purity: 95% | 5-Chloro-1H-imidazo[4,5-b]pyridin-2(3H)-one | ESD-845868-250MG |
Cas.: 330681-18-0 | Purity: 98% | (3R,4R)-tert-Butyl 3-amino-4-hydroxypyrrolidine-1-carboxylate | ESD-845869-50MG |
Cas.: 330681-18-0 | Purity: 98% | (3R,4R)-tert-Butyl 3-amino-4-hydroxypyrrolidine-1-carboxylate | ESD-845869-250MG |
Cas.: 1209534-87-1 | Purity: 95% | 6-Fluoro-1-methyl-1H-indazole | ESD-845870-50MG |
Cas.: 1209534-87-1 | Purity: 95% | 6-Fluoro-1-methyl-1H-indazole | ESD-845870-250MG |
Cas.: 851607-27-7 | Purity: 98% | 5-Bromo-4-chloro-2-methoxypyridine | ESD-845871-50MG |
Cas.: 851607-27-7 | Purity: 98% | 5-Bromo-4-chloro-2-methoxypyridine | ESD-845871-250MG |
Cas.: 914637-07-3 | Purity: 96% | 2-Bromo-3-(trifluoromethyl)benzonitrile | ESD-845872-50MG |
Cas.: 914637-07-3 | Purity: 96% | 2-Bromo-3-(trifluoromethyl)benzonitrile | ESD-845872-250MG |
Cas.: 16420-39-6 | Purity: 98% | Methyl 5-bromo-1H-pyrrole-3-carboxylate | ESD-845873-50MG |
Cas.: 16420-39-6 | Purity: 98% | Methyl 5-bromo-1H-pyrrole-3-carboxylate | ESD-845873-250MG |
Cas.: 1588441-03-5 | Purity: 95% | 2-Oxa-8-azaspiro[4.5]decane oxalate | ESD-845874-50MG |
Cas.: 1588441-03-5 | Purity: 95% | 2-Oxa-8-azaspiro[4.5]decane oxalate | ESD-845874-250MG |
Cas.: 19365-07-2 | Purity: 98% | 5-Hydroxypiperidin-2-one | ESD-845875-50MG |
Cas.: 19365-07-2 | Purity: 98% | 5-Hydroxypiperidin-2-one | ESD-845875-250MG |
Cas.: 885519-16-4 | Purity: 98% | 3-Bromo-5-iodo-1H-indazole | ESD-845876-50MG |
Cas.: 885519-16-4 | Purity: 98% | 3-Bromo-5-iodo-1H-indazole | ESD-845876-250MG |
Cas.: 950846-26-1 | Purity: 95% | (4-Bromo-2,5-dimethoxyphenyl)boronic acid | ESD-845877-50MG |
Cas.: 950846-26-1 | Purity: 95% | (4-Bromo-2,5-dimethoxyphenyl)boronic acid | ESD-845877-250MG |
Cas.: 60186-13-2 | Purity: 97% | 2,4,6-Trichloro-3-nitropyridine | ESD-845878-50MG |
Cas.: 60186-13-2 | Purity: 97% | 2,4,6-Trichloro-3-nitropyridine | ESD-845878-250MG |
Cas.: 1263282-40-1 | Purity: 97% | 4-Fluoro-3-methylpyridine hydrochloride | ESD-845879-50MG |
Cas.: 1263282-40-1 | Purity: 97% | 4-Fluoro-3-methylpyridine hydrochloride | ESD-845879-250MG |
Cas.: 871826-13-0 | Purity: 97% | (5-Chloropyridin-2-yl)methanamine hydrochloride | ESD-845880-50MG |
Cas.: 871826-13-0 | Purity: 97% | (5-Chloropyridin-2-yl)methanamine hydrochloride | ESD-845880-250MG |
Cas.: 121772-95-0 | Purity: 98% | 3-(Trichloromethyl)pyridine hydrochloride | ESD-845881-50MG |
Cas.: 121772-95-0 | Purity: 98% | 3-(Trichloromethyl)pyridine hydrochloride | ESD-845881-250MG |
Cas.: 53499-40-4 | Purity: 95% | 2-(Benzhydryloxy)-N-methylethanamine hydrochloride | ESD-845882-250MG |
Cas.: 53499-40-4 | Purity: 95% | 2-(Benzhydryloxy)-N-methylethanamine hydrochloride | ESD-845882-1G |
Cas.: 97944-42-8 | Purity: 95% | 3-Chloro-5-methylpyridin-4-amine | ESD-845883-250MG |
Cas.: 97944-42-8 | Purity: 95% | 3-Chloro-5-methylpyridin-4-amine | ESD-845883-1G |
Cas.: 474710-78-6 | Purity: 98% | Methyl 6-bromoquinazoline-4-carboxylate | ESD-845884-250MG |
Cas.: 474710-78-6 | Purity: 98% | Methyl 6-bromoquinazoline-4-carboxylate | ESD-845884-1G |
Cas.: 80353-93-1 | Purity: 95% | 6-Methylimidazo[1,2-a]pyridine-2-carboxylic acid | ESD-845885-250MG |
Cas.: 80353-93-1 | Purity: 95% | 6-Methylimidazo[1,2-a]pyridine-2-carboxylic acid | ESD-845885-1G |
Cas.: 870606-29-4 | Purity: 98% | 5-Chloro-3-iodo-2-methylaniline | ESD-845886-25MG |
Cas.: 870606-29-4 | Purity: 98% | 5-Chloro-3-iodo-2-methylaniline | ESD-845886-100MG |
Cas.: 40253-47-2 | Purity: 97% | Ethyl 5-methyl-1H-1,2,4-triazole-3-carboxylate | ESD-845887-25MG |
Cas.: 40253-47-2 | Purity: 97% | Ethyl 5-methyl-1H-1,2,4-triazole-3-carboxylate | ESD-845887-100MG |
Cas.: 75091-93-9 | Purity: 98% | trans-4-(Trifluoromethyl)cyclohexanol | ESD-845888-25MG |
Cas.: 75091-93-9 | Purity: 98% | trans-4-(Trifluoromethyl)cyclohexanol | ESD-845888-100MG |
Cas.: 1256781-74-4 | Purity: 96% | 2-(2-Chloro-3,5-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-845889-25MG |
Cas.: 1256781-74-4 | Purity: 96% | 2-(2-Chloro-3,5-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-845889-100MG |
Cas.: 1031417-41-0 | Purity: 96% | 7-Methyl-1H-indazole-5-carboxylic acid | ESD-845890-25MG |
Cas.: 1031417-41-0 | Purity: 96% | 7-Methyl-1H-indazole-5-carboxylic acid | ESD-845890-100MG |
Cas.: 1037298-16-0 | Purity: 97% | 2-Amino-4,5-dibromophenol | ESD-845891-25MG |
Cas.: 1037298-16-0 | Purity: 97% | 2-Amino-4,5-dibromophenol | ESD-845891-100MG |
Cas.: 343306-50-3 | Purity: 95% | tert-Butyl 4-(3-formyl-4-hydroxyphenyl)piperazine-1-carboxylate | ESD-845892-25MG |
Cas.: 343306-50-3 | Purity: 95% | tert-Butyl 4-(3-formyl-4-hydroxyphenyl)piperazine-1-carboxylate | ESD-845892-100MG |
Cas.: 1000523-07-8 | Purity: 95% | 2-(2-Chloro-3-fluorophenyl)acetic acid | ESD-845893-250MG |
Cas.: 1000523-07-8 | Purity: 95% | 2-(2-Chloro-3-fluorophenyl)acetic acid | ESD-845893-1G |
Cas.: 145123-24-6 | Purity: 98% | 2-Amino-3-bromobenzaldehyde | ESD-845894-50MG |
Cas.: 145123-24-6 | Purity: 98% | 2-Amino-3-bromobenzaldehyde | ESD-845894-250MG |
Cas.: 2004-03-7 | Purity: 98% | 6-Methylpurine | ESD-845895-50MG |
Cas.: 2004-03-7 | Purity: 98% | 6-Methylpurine | ESD-845895-250MG |
Cas.: 56891-64-6 | Purity: 95% | Isothiazolo[5,4-b]pyridin-3-amine | ESD-845896-50MG |
Cas.: 56891-64-6 | Purity: 95% | Isothiazolo[5,4-b]pyridin-3-amine | ESD-845896-250MG |
Cas.: 55687-23-5 | Purity: 95% | 6-Fluoroquinoxalin-2(1H)-one | ESD-845897-50MG |
Cas.: 55687-23-5 | Purity: 95% | 6-Fluoroquinoxalin-2(1H)-one | ESD-845897-250MG |
Cas.: 601-99-0 | Purity: 98% | 2-Hydroxy-6-nitrobenzoic acid | ESD-845898-50MG |
Cas.: 601-99-0 | Purity: 98% | 2-Hydroxy-6-nitrobenzoic acid | ESD-845898-250MG |
Cas.: 1001414-95-4 | Purity: 97% | (4-Bromopyridin-2-yl)methanamine hydrochloride | ESD-845899-50MG |
Cas.: 1001414-95-4 | Purity: 97% | (4-Bromopyridin-2-yl)methanamine hydrochloride | ESD-845899-250MG |
Cas.: 723284-81-9 | Purity: 95% | (R)-3-Amino-3-(3-fluorophenyl)propanoic acid | ESD-845900-50MG |
Cas.: 723284-81-9 | Purity: 95% | (R)-3-Amino-3-(3-fluorophenyl)propanoic acid | ESD-845900-250MG |
Cas.: 479685-13-7 | Purity: 95% | 1-Boc-4-(3-Amino-6-bromopyrazin-2-yl)piperazine | ESD-845901-50MG |
Cas.: 479685-13-7 | Purity: 95% | 1-Boc-4-(3-Amino-6-bromopyrazin-2-yl)piperazine | ESD-845901-250MG |
Cas.: 1209183-93-6 | Purity: 95% | 1-Boc-5,6-Dichloro-1H-indole | ESD-845902-50MG |
Cas.: 1209183-93-6 | Purity: 95% | 1-Boc-5,6-Dichloro-1H-indole | ESD-845902-250MG |
Cas.: 1373253-28-1 | Purity: 97% | 4-Oxopiperidine-3-carbonitrile hydrochloride | ESD-845903-50MG |
Cas.: 1373253-28-1 | Purity: 97% | 4-Oxopiperidine-3-carbonitrile hydrochloride | ESD-845903-250MG |
Cas.: 914348-85-9 | Purity: 95% | 2-(3,4-Dimethoxyphenyl)thiazole-5-carbaldehyde | ESD-845904-50MG |
Cas.: 914348-85-9 | Purity: 95% | 2-(3,4-Dimethoxyphenyl)thiazole-5-carbaldehyde | ESD-845904-250MG |
Cas.: 135651-46-6 | Purity: 95% | Methyl 2-(morpholinomethyl)benzoate | ESD-845905-50MG |
Cas.: 135651-46-6 | Purity: 95% | Methyl 2-(morpholinomethyl)benzoate | ESD-845905-250MG |
Cas.: 912773-15-0 | Purity: 95% | 2-Amino-3-(ethylamino)pyrazine | ESD-845906-50MG |
Cas.: 912773-15-0 | Purity: 95% | 2-Amino-3-(ethylamino)pyrazine | ESD-845906-250MG |
Cas.: 867130-58-3 | Purity: 95% | 6-Oxo-1,6-dihydropyridazine-4-carboxylic acid | ESD-845907-50MG |
Cas.: 867130-58-3 | Purity: 95% | 6-Oxo-1,6-dihydropyridazine-4-carboxylic acid | ESD-845907-250MG |
Cas.: 375857-65-1 | Purity: 97% | 3-Bromo-7-(trifluoromethyl)imidazo[1,2-a]pyrimidine | ESD-845908-50MG |
Cas.: 375857-65-1 | Purity: 97% | 3-Bromo-7-(trifluoromethyl)imidazo[1,2-a]pyrimidine | ESD-845908-250MG |
Cas.: 34334-96-8 | Purity: 97% | 3-Methyl-5-nitro-1H-pyrazole | ESD-845909-1G |
Cas.: 34334-96-8 | Purity: 97% | 3-Methyl-5-nitro-1H-pyrazole | ESD-845909-5G |
Cas.: 824-52-2 | Purity: 97% | 5-Methyl-1H-pyrrolo[2,3-b]pyridine | ESD-845910-50MG |
Cas.: 824-52-2 | Purity: 97% | 5-Methyl-1H-pyrrolo[2,3-b]pyridine | ESD-845910-250MG |
Cas.: 918538-05-3 | Purity: 95% | 2,4-Dichloropyrrolo[2,1-f][1,2,4]triazine | ESD-845911-50MG |
Cas.: 918538-05-3 | Purity: 95% | 2,4-Dichloropyrrolo[2,1-f][1,2,4]triazine | ESD-845911-250MG |
Cas.: 1245647-95-3 | Purity: 98% | tert-Butyl (2-bromothiazol-4-yl)carbamate | ESD-845912-50MG |
Cas.: 1245647-95-3 | Purity: 98% | tert-Butyl (2-bromothiazol-4-yl)carbamate | ESD-845912-250MG |
Cas.: 688782-02-7 | Purity: 95% | 4-Chloro-3-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-845913-50MG |
Cas.: 688782-02-7 | Purity: 95% | 4-Chloro-3-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-845913-250MG |
Cas.: 883231-20-7 | Purity: 98% | (6-((tert-Butoxycarbonyl)amino)pyridin-3-yl)boronic acid | ESD-845914-50MG |
Cas.: 883231-20-7 | Purity: 98% | (6-((tert-Butoxycarbonyl)amino)pyridin-3-yl)boronic acid | ESD-845914-250MG |
Cas.: 959237-68-4 | Purity: 97% | 7-Bromo-2,4-dichloroquinazoline | ESD-845915-50MG |
Cas.: 959237-68-4 | Purity: 97% | 7-Bromo-2,4-dichloroquinazoline | ESD-845915-250MG |
Cas.: 552330-94-6 | Purity: 98% | 6-Bromoquinolin-3-ol | ESD-845916-50MG |
Cas.: 552330-94-6 | Purity: 98% | 6-Bromoquinolin-3-ol | ESD-845916-250MG |
Cas.: 20925-62-6 | Purity: 95% | 3-Amino-1H-indazole-5-carbonitrile | ESD-845917-50MG |
Cas.: 20925-62-6 | Purity: 95% | 3-Amino-1H-indazole-5-carbonitrile | ESD-845917-250MG |
Cas.: 65269-18-3 | Purity: 97% | Ethyl 4-chloro-2-methoxypyrimidine-5-carboxylate | ESD-845918-50MG |
Cas.: 65269-18-3 | Purity: 97% | Ethyl 4-chloro-2-methoxypyrimidine-5-carboxylate | ESD-845918-250MG |
Cas.: 51047-52-0 | Purity: 97% | 4-(Piperazin-1-yl)pyrimidine | ESD-845919-50MG |
Cas.: 51047-52-0 | Purity: 97% | 4-(Piperazin-1-yl)pyrimidine | ESD-845919-250MG |
Cas.: 1227577-03-8 | Purity: 96% | 2-Chloro-3-fluoropyridin-4-amine | ESD-845920-50MG |
Cas.: 1227577-03-8 | Purity: 96% | 2-Chloro-3-fluoropyridin-4-amine | ESD-845920-250MG |
Cas.: 1000342-71-1 | Purity: 98% | 6-Bromo-1H-pyrrolo[3,2-c]pyridine | ESD-845921-50MG |
Cas.: 1000342-71-1 | Purity: 98% | 6-Bromo-1H-pyrrolo[3,2-c]pyridine | ESD-845921-250MG |
Cas.: 108128-12-7 | Purity: 98% | Methyl 1H-pyrrolo[2,3-c]pyridine-3-carboxylate | ESD-845922-50MG |
Cas.: 108128-12-7 | Purity: 98% | Methyl 1H-pyrrolo[2,3-c]pyridine-3-carboxylate | ESD-845922-250MG |
Cas.: 1150114-44-5 | Purity: 98% | (5-(Ethoxycarbonyl)furan-2-yl)boronic acid | ESD-845923-50MG |
Cas.: 1150114-44-5 | Purity: 98% | (5-(Ethoxycarbonyl)furan-2-yl)boronic acid | ESD-845923-250MG |
Cas.: 1268954-77-3 | Purity: 97% | 1-(4′-Bromo-[1,1′-biphenyl]-3-yl)naphthalene | ESD-845924-50MG |
Cas.: 1268954-77-3 | Purity: 97% | 1-(4′-Bromo-[1,1′-biphenyl]-3-yl)naphthalene | ESD-845924-250MG |
Cas.: 114086-15-6 | Purity: 95% | 2-Methyl-2,5-diazabicyclo[2.2.1]heptane dihydrobromide | ESD-845925-50MG |
Cas.: 114086-15-6 | Purity: 95% | 2-Methyl-2,5-diazabicyclo[2.2.1]heptane dihydrobromide | ESD-845925-250MG |
Cas.: 190792-72-4 | Purity: 95% | (1R,2S)-2-Aminocyclohexanol hydrochloride | ESD-845926-250MG |
Cas.: 190792-72-4 | Purity: 95% | (1R,2S)-2-Aminocyclohexanol hydrochloride | ESD-845926-1G |
Cas.: 702641-04-1 | Purity: 97% | 2-Iodo-5-(trifluoromethyl)benzoic acid | ESD-845927-250MG |
Cas.: 702641-04-1 | Purity: 97% | 2-Iodo-5-(trifluoromethyl)benzoic acid | ESD-845927-1G |
Cas.: 1073355-14-2 | Purity: 95% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[c][1,2,5]oxadiazole | ESD-845928-250MG |
Cas.: 1073355-14-2 | Purity: 95% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[c][1,2,5]oxadiazole | ESD-845928-1G |
Cas.: 872624-52-7 | Purity: 97% | Methyl 2-amino-5-iodo-4-(trifluoromethyl)benzoate | ESD-845929-250MG |
Cas.: 872624-52-7 | Purity: 97% | Methyl 2-amino-5-iodo-4-(trifluoromethyl)benzoate | ESD-845929-1G |
Cas.: 405513-14-6 | Purity: 97% | (R)-tert-Butyl 2-(methylamino)propanoate hydrochloride | ESD-845930-250MG |
Cas.: 405513-14-6 | Purity: 97% | (R)-tert-Butyl 2-(methylamino)propanoate hydrochloride | ESD-845930-1G |
Cas.: 84477-72-5 | Purity: 97% | 2,2-Dimethylpiperazine | ESD-845931-250MG |
Cas.: 84477-72-5 | Purity: 97% | 2,2-Dimethylpiperazine | ESD-845931-1G |
Cas.: 494769-44-7 | Purity: 98% | tert-Butyl (4-(hydroxymethyl)thiazol-2-yl)carbamate | ESD-845932-250MG |
Cas.: 494769-44-7 | Purity: 98% | tert-Butyl (4-(hydroxymethyl)thiazol-2-yl)carbamate | ESD-845932-1G |
Cas.: 4706-43-8 | Purity: 95% | 1-Benzyl-1H-benzo[d][1,2,3]triazole | ESD-845933-50MG |
Cas.: 4706-43-8 | Purity: 95% | 1-Benzyl-1H-benzo[d][1,2,3]triazole | ESD-845933-250MG |
Cas.: 68755-31-7 | Purity: 98% | 5,6-Dichloro-2,3-dihydro-1H-inden-1-one | ESD-845934-250MG |
Cas.: 68755-31-7 | Purity: 98% | 5,6-Dichloro-2,3-dihydro-1H-inden-1-one | ESD-845934-1G |
Cas.: 824-51-1 | Purity: 98% | 6-Methyl-1H-pyrrolo[2,3-b]pyridine | ESD-845935-50MG |
Cas.: 824-51-1 | Purity: 98% | 6-Methyl-1H-pyrrolo[2,3-b]pyridine | ESD-845935-250MG |
Cas.: 1114560-76-7 | Purity: 98% | 4-Bromo-2-methylpyrimidine | ESD-845936-50MG |
Cas.: 1114560-76-7 | Purity: 98% | 4-Bromo-2-methylpyrimidine | ESD-845936-250MG |
Cas.: 2955-46-6 | Purity: 95% | 2-(4-Methoxyphenyl)-2-methylpropanoic acid | ESD-845937-50MG |
Cas.: 2955-46-6 | Purity: 95% | 2-(4-Methoxyphenyl)-2-methylpropanoic acid | ESD-845937-250MG |
Cas.: 40133-07-1 | Purity: 98% | 4,5,6,7-Tetrahydrobenzo[b]thiophene-2-carboxylic acid | ESD-845938-250MG |
Cas.: 40133-07-1 | Purity: 98% | 4,5,6,7-Tetrahydrobenzo[b]thiophene-2-carboxylic acid | ESD-845938-1G |
Cas.: 4490-81-7 | Purity: 98% | O-Isopropylhydroxylamine hydrochloride | ESD-845939-250MG |
Cas.: 4490-81-7 | Purity: 98% | O-Isopropylhydroxylamine hydrochloride | ESD-845939-1G |
Cas.: 187283-17-6 | Purity: 97% | tert-Butyl 4-(bromomethyl)benzylcarbamate | ESD-845940-250MG |
Cas.: 187283-17-6 | Purity: 97% | tert-Butyl 4-(bromomethyl)benzylcarbamate | ESD-845940-1G |
Cas.: 151038-94-7 | Purity: 97% | 6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanehydrazide 2,2,2-trifluoroacetate | ESD-845941-25MG |
Cas.: 151038-94-7 | Purity: 97% | 6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanehydrazide 2,2,2-trifluoroacetate | ESD-845941-100MG |
Cas.: 38214-45-8 | Purity: 98% | 6-Methoxypyrimidine-4-carboxylic acid | ESD-845942-25MG |
Cas.: 38214-45-8 | Purity: 98% | 6-Methoxypyrimidine-4-carboxylic acid | ESD-845942-100MG |
Cas.: 183945-52-0 | Purity: 95% | 3-Methyl-4-(trifluoromethoxy)aniline | ESD-845943-25MG |
Cas.: 183945-52-0 | Purity: 95% | 3-Methyl-4-(trifluoromethoxy)aniline | ESD-845943-100MG |
Cas.: 176035-15-7 | Purity: 98% | 2-Amino-3-(4-methoxyphenyl)propan-1-ol | ESD-845944-25MG |
Cas.: 176035-15-7 | Purity: 98% | 2-Amino-3-(4-methoxyphenyl)propan-1-ol | ESD-845944-100MG |
Cas.: 349-56-4 | Purity: 97% | 3-Methoxy-5-(trifluoromethyl)phenol | ESD-845945-250MG |
Cas.: 349-56-4 | Purity: 97% | 3-Methoxy-5-(trifluoromethyl)phenol | ESD-845945-1G |
Cas.: 287196-80-9 | Purity: 95% | 2,6-Dichloro-4-(pipidin-1-ylcarbonyl)pyridine | ESD-845946-50MG |
Cas.: 287196-80-9 | Purity: 95% | 2,6-Dichloro-4-(pipidin-1-ylcarbonyl)pyridine | ESD-845946-250MG |
Cas.: 59143-60-1 | Purity: 98% | Cephalosporin C zinc salt | ESD-845947-50MG |
Cas.: 59143-60-1 | Purity: 98% | Cephalosporin C zinc salt | ESD-845947-250MG |
Cas.: 10292-61-2 | Purity: 98% | 4-Cyclopropylphenol | ESD-845948-50MG |
Cas.: 10292-61-2 | Purity: 98% | 4-Cyclopropylphenol | ESD-845948-250MG |
Cas.: 927800-62-2 | Purity: 95% | 4-Bromo-8-methoxy-2-methylquinoline | ESD-845949-50MG |
Cas.: 927800-62-2 | Purity: 95% | 4-Bromo-8-methoxy-2-methylquinoline | ESD-845949-250MG |
Cas.: 90562-33-7 | Purity: 95% | 5-Chloro-1,2,3,4-tetrahydroquinoline hydrochloride | ESD-845950-50MG |
Cas.: 90562-33-7 | Purity: 95% | 5-Chloro-1,2,3,4-tetrahydroquinoline hydrochloride | ESD-845950-250MG |
Cas.: 73790-19-9 | Purity: 95% | 5-Bromo-2,2-dimethylbenzo[d][1,3]dioxole | ESD-845951-50MG |
Cas.: 73790-19-9 | Purity: 95% | 5-Bromo-2,2-dimethylbenzo[d][1,3]dioxole | ESD-845951-250MG |
Cas.: 215878-20-9 | Purity: 97% | 3-(4-Piperidinyl)-1,3-benzoxazol-2(3H)-one | ESD-845952-50MG |
Cas.: 215878-20-9 | Purity: 97% | 3-(4-Piperidinyl)-1,3-benzoxazol-2(3H)-one | ESD-845952-250MG |
Cas.: 73672-37-4 | Purity: 98% | Ethyl 2-oxo-2-(pyridin-3-yl)acetate | ESD-845953-50MG |
Cas.: 73672-37-4 | Purity: 98% | Ethyl 2-oxo-2-(pyridin-3-yl)acetate | ESD-845953-250MG |
Cas.: 857641-46-4 | Purity: 95% | 2-(4-Bromo-1H-pyrazol-1-yl)pyrimidine | ESD-845954-50MG |
Cas.: 857641-46-4 | Purity: 95% | 2-(4-Bromo-1H-pyrazol-1-yl)pyrimidine | ESD-845954-250MG |
Cas.: 930798-25-7 | Purity: 97% | 2-(6-Chloropyrazin-2-yl)acetic acid | ESD-845955-50MG |
Cas.: 930798-25-7 | Purity: 97% | 2-(6-Chloropyrazin-2-yl)acetic acid | ESD-845955-250MG |
Cas.: 36314-98-4 | Purity: 98% | 2-Amino-4-cyanopyrimidine | ESD-845956-50MG |
Cas.: 36314-98-4 | Purity: 98% | 2-Amino-4-cyanopyrimidine | ESD-845956-250MG |
Cas.: 1012343-72-4 | Purity: 95% | 4-(3-Bromoimidazo[1,2-b]pyridazin-6-yl)morpholine | ESD-845957-50MG |
Cas.: 1012343-72-4 | Purity: 95% | 4-(3-Bromoimidazo[1,2-b]pyridazin-6-yl)morpholine | ESD-845957-250MG |
Cas.: 5556-22-9 | Purity: 95% | Methyl 3-hydroxy-5-methyl-2-thiophenecarboxylate | ESD-845958-50MG |
Cas.: 5556-22-9 | Purity: 95% | Methyl 3-hydroxy-5-methyl-2-thiophenecarboxylate | ESD-845958-250MG |
Cas.: 89322-66-7 | Purity: 98% | 2-Amino-5-iodo-4-methoxypyrimidine | ESD-845959-50MG |
Cas.: 89322-66-7 | Purity: 98% | 2-Amino-5-iodo-4-methoxypyrimidine | ESD-845959-250MG |
Cas.: 69271-42-7 | Purity: 98% | 1-(1-Methyl-1H-indazol-3-yl)ethanone | ESD-845960-50MG |
Cas.: 69271-42-7 | Purity: 98% | 1-(1-Methyl-1H-indazol-3-yl)ethanone | ESD-845960-250MG |
Cas.: 868733-96-4 | Purity: 98% | 2-Boc-Amino-3-iodo-4-chloropyridine | ESD-845961-50MG |
Cas.: 868733-96-4 | Purity: 98% | 2-Boc-Amino-3-iodo-4-chloropyridine | ESD-845961-250MG |
Cas.: 274-45-3 | Purity: 97% | Pyrrolo[1,2-a]pyrazine | ESD-845962-50MG |
Cas.: 274-45-3 | Purity: 97% | Pyrrolo[1,2-a]pyrazine | ESD-845962-250MG |
Cas.: 54722-74-6 | Purity: 97% | 1,2-Oxazinane hydrochloride | ESD-845963-50MG |
Cas.: 54722-74-6 | Purity: 97% | 1,2-Oxazinane hydrochloride | ESD-845963-250MG |
Cas.: 22614-72-8 | Purity: 95% | 7-Chloro-2-hydroxyquinoline | ESD-845964-50MG |
Cas.: 22614-72-8 | Purity: 95% | 7-Chloro-2-hydroxyquinoline | ESD-845964-250MG |
Cas.: 1219960-66-3 | Purity: 97% | 2-(Cyclobutanecarboxamido)-2-methylpropanoic acid | ESD-845965-50MG |
Cas.: 1219960-66-3 | Purity: 97% | 2-(Cyclobutanecarboxamido)-2-methylpropanoic acid | ESD-845965-250MG |
Cas.: 1186608-71-8 | Purity: 97% | 3-Bromo-1H-pyrazolo[3,4-b]pyridin-5-amine | ESD-845966-50MG |
Cas.: 1186608-71-8 | Purity: 97% | 3-Bromo-1H-pyrazolo[3,4-b]pyridin-5-amine | ESD-845966-250MG |
Cas.: 891855-87-1 | Purity: 98% | 4-Amino-2-ethylaminopyridine | ESD-845967-50MG |
Cas.: 891855-87-1 | Purity: 98% | 4-Amino-2-ethylaminopyridine | ESD-845967-250MG |
Cas.: 114857-00-0 | Purity: 97% | tert-Butyl (1-oxopropan-2-yl)carbamate | ESD-845968-50MG |
Cas.: 114857-00-0 | Purity: 97% | tert-Butyl (1-oxopropan-2-yl)carbamate | ESD-845968-250MG |
Cas.: 954219-68-2 | Purity: 98% | 2,3-Difluoro-5-nitropyridine | ESD-845969-50MG |
Cas.: 954219-68-2 | Purity: 98% | 2,3-Difluoro-5-nitropyridine | ESD-845969-250MG |
Cas.: 249736-95-6 | Purity: 98% | 6,7-Dimethoxy-4-(trifluoromethyl)quinolin-2(1H)-one | ESD-845970-50MG |
Cas.: 249736-95-6 | Purity: 98% | 6,7-Dimethoxy-4-(trifluoromethyl)quinolin-2(1H)-one | ESD-845970-250MG |
Cas.: 4464-60-2 | Purity: 95% | Bis(benzo[d]thiazol-2-yl)methanone | ESD-845971-50MG |
Cas.: 4464-60-2 | Purity: 95% | Bis(benzo[d]thiazol-2-yl)methanone | ESD-845971-250MG |
Cas.: 66080-45-3 | Purity: 95% | 2-Methoxypyridin-4-ol | ESD-845972-50MG |
Cas.: 66080-45-3 | Purity: 95% | 2-Methoxypyridin-4-ol | ESD-845972-250MG |
Cas.: 699-89-8 | Purity: 95% | 4,7-Dichlorothieno[2,3-d]pyridazine | ESD-845973-50MG |
Cas.: 699-89-8 | Purity: 95% | 4,7-Dichlorothieno[2,3-d]pyridazine | ESD-845973-250MG |
Cas.: 892292-63-6 | Purity: 95% | 2-(Methyl(phenyl)amino)-4H-thieno[3,2-d][1,3]thiazin-4-one | ESD-845974-50MG |
Cas.: 892292-63-6 | Purity: 95% | 2-(Methyl(phenyl)amino)-4H-thieno[3,2-d][1,3]thiazin-4-one | ESD-845974-250MG |
Cas.: 167631-21-2 | Purity: 96% | Ethyl 5-fluoro-3-iodo-1H-indole-2-carboxylate | ESD-845975-50MG |
Cas.: 167631-21-2 | Purity: 96% | Ethyl 5-fluoro-3-iodo-1H-indole-2-carboxylate | ESD-845975-250MG |
Cas.: 914347-67-4 | Purity: 97% | 1-(5-Bromopyrimidin-2-yl)-3-piperidinol | ESD-845976-50MG |
Cas.: 914347-67-4 | Purity: 97% | 1-(5-Bromopyrimidin-2-yl)-3-piperidinol | ESD-845976-250MG |
Cas.: 850689-13-3 | Purity: 98% | Methyl 4,5-diaminopicolinate | ESD-845977-50MG |
Cas.: 850689-13-3 | Purity: 98% | Methyl 4,5-diaminopicolinate | ESD-845977-250MG |
Cas.: 1003048-72-3 | Purity: 97% | 4-Bromo-7-fluoro-2,3-dihydro-1H-inden-1-one | ESD-845978-50MG |
Cas.: 1003048-72-3 | Purity: 97% | 4-Bromo-7-fluoro-2,3-dihydro-1H-inden-1-one | ESD-845978-250MG |
Cas.: 193746-84-8 | Purity: 97% | 4-(Dimethoxymethyl)-2-methoxypyrimidine | ESD-845979-50MG |
Cas.: 193746-84-8 | Purity: 97% | 4-(Dimethoxymethyl)-2-methoxypyrimidine | ESD-845979-250MG |
Cas.: 13589-71-4 | Purity: 98% | 2-Hydroxy-3-methylbenzonitrile | ESD-845980-50MG |
Cas.: 13589-71-4 | Purity: 98% | 2-Hydroxy-3-methylbenzonitrile | ESD-845980-250MG |
Cas.: 80096-60-2 | Purity: 95% | 4-(Aminomethyl)chroman-4-ol hydrochloride | ESD-845981-50MG |
Cas.: 80096-60-2 | Purity: 95% | 4-(Aminomethyl)chroman-4-ol hydrochloride | ESD-845981-250MG |
Cas.: 78233-48-4 | Purity: 95% | 1,3-Thiazinane-2-carboxylic acid | ESD-845982-50MG |
Cas.: 78233-48-4 | Purity: 95% | 1,3-Thiazinane-2-carboxylic acid | ESD-845982-250MG |
Cas.: 1640995-62-5 | Purity: 97% | (2-Aminothiazol-5-yl)methanol hydrochloride | ESD-845983-50MG |
Cas.: 1640995-62-5 | Purity: 97% | (2-Aminothiazol-5-yl)methanol hydrochloride | ESD-845983-250MG |
Cas.: 1073968-64-5 | Purity: 97% | 5-Bromo-1,2,3,4-tetrahydroquinoline hydrochloride | ESD-845984-50MG |
Cas.: 1073968-64-5 | Purity: 97% | 5-Bromo-1,2,3,4-tetrahydroquinoline hydrochloride | ESD-845984-250MG |
Cas.: 267875-30-9 | Purity: 97% | 2-Cyano-4-methyl-5-nitropyridine | ESD-845985-50MG |
Cas.: 267875-30-9 | Purity: 97% | 2-Cyano-4-methyl-5-nitropyridine | ESD-845985-250MG |
Cas.: 1073968-65-6 | Purity: 95% | 5-Methoxy-1,2,3,4-tetrahydroquinoline hydrochloride | ESD-845986-50MG |
Cas.: 1073968-65-6 | Purity: 95% | 5-Methoxy-1,2,3,4-tetrahydroquinoline hydrochloride | ESD-845986-250MG |
Cas.: 700871-88-1 | Purity: 97% | 4,7-Dibromoquinoline | ESD-845987-50MG |
Cas.: 700871-88-1 | Purity: 97% | 4,7-Dibromoquinoline | ESD-845987-250MG |
Cas.: 88806-08-0 | Purity: 97% | 1-(3-Bromopropyl)pyrrolidine hydrobromide | ESD-845988-50MG |
Cas.: 88806-08-0 | Purity: 97% | 1-(3-Bromopropyl)pyrrolidine hydrobromide | ESD-845988-250MG |
Cas.: 898746-82-2 | Purity: 98% | tert-Butyl 6-hydroxy-1H-indole-1-carboxylate | ESD-845989-50MG |
Cas.: 898746-82-2 | Purity: 98% | tert-Butyl 6-hydroxy-1H-indole-1-carboxylate | ESD-845989-250MG |
Cas.: 4662-03-7 | Purity: 98% | 2-(2-Phenyl-1H-indol-3-yl)acetic acid | ESD-845990-50MG |
Cas.: 4662-03-7 | Purity: 98% | 2-(2-Phenyl-1H-indol-3-yl)acetic acid | ESD-845990-250MG |
Cas.: 78831-87-5 | Purity: 95% | 1-(Bromomethyl)-2,4-dimethylbenzene | ESD-845991-250MG |
Cas.: 78831-87-5 | Purity: 95% | 1-(Bromomethyl)-2,4-dimethylbenzene | ESD-845991-1G |
Cas.: 5845-30-7 | Purity: 97% | 3-Bromo-N,N-dimethylpropan-1-amine hydrobromide | ESD-845992-250MG |
Cas.: 5845-30-7 | Purity: 97% | 3-Bromo-N,N-dimethylpropan-1-amine hydrobromide | ESD-845992-1G |
Cas.: 914349-20-5 | Purity: 95% | 1-(4-(Hydroxymethyl)phenyl)piperidin-4-ol | ESD-845993-250MG |
Cas.: 914349-20-5 | Purity: 95% | 1-(4-(Hydroxymethyl)phenyl)piperidin-4-ol | ESD-845993-1G |
Cas.: 13674-16-3 | Purity: 97% | Methyl 2-hydroxy-3-phenylpropanoate | ESD-845994-250MG |
Cas.: 13674-16-3 | Purity: 97% | Methyl 2-hydroxy-3-phenylpropanoate | ESD-845994-1G |
Cas.: 1260885-46-8 | Purity: 97% | Ethyl 5-(trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylate | ESD-845995-50MG |
Cas.: 1260885-46-8 | Purity: 97% | Ethyl 5-(trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylate | ESD-845995-250MG |
Cas.: 102065-89-4 | Purity: 97% | Azetidin-3-amine dihydrochloride | ESD-845996-250MG |
Cas.: 102065-89-4 | Purity: 97% | Azetidin-3-amine dihydrochloride | ESD-845996-1G |
Cas.: 153652-70-1 | Purity: 95% | (4S,5R)-3-Benzoyl-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid | ESD-845997-250MG |
Cas.: 153652-70-1 | Purity: 95% | (4S,5R)-3-Benzoyl-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid | ESD-845997-1G |
Cas.: 517-21-5 | Purity: 95% | Sodium 1,2-dihydroxyethane-1,2-disulfonate | ESD-845998-25G |
Cas.: 517-21-5 | Purity: 95% | Sodium 1,2-dihydroxyethane-1,2-disulfonate | ESD-845998-100G |
Cas.: 5233-04-5 | Purity: 97% | 3,5-Dichlorobenzene-1,2-diamine | ESD-845999-250MG |
Cas.: 5233-04-5 | Purity: 97% | 3,5-Dichlorobenzene-1,2-diamine | ESD-845999-1G |
Cas.: 29473-53-8 | Purity: 95% | N1,N1-Diethyl-N2-(naphthalen-1-yl)ethane-1,2-diamine oxalate | ESD-846000-250MG |
Cas.: 29473-53-8 | Purity: 95% | N1,N1-Diethyl-N2-(naphthalen-1-yl)ethane-1,2-diamine oxalate | ESD-846000-1G |
Cas.: 101990-69-6 | Purity: 95% | 2,6-Dichloropyridine-4-methanol | ESD-846001-250MG |
Cas.: 101990-69-6 | Purity: 95% | 2,6-Dichloropyridine-4-methanol | ESD-846001-1G |
Cas.: 192704-56-6 | Purity: 97% | 11-A-Hydroxy canrenone methyl ester | ESD-846002-250MG |
Cas.: 192704-56-6 | Purity: 97% | 11-A-Hydroxy canrenone methyl ester | ESD-846002-1G |
Cas.: 65976-77-4 | Purity: 98% | Ethyl 2-(3,5-dimethoxyphenyl)acetate | ESD-846003-250MG |
Cas.: 65976-77-4 | Purity: 98% | Ethyl 2-(3,5-dimethoxyphenyl)acetate | ESD-846003-1G |
Cas.: 106910-77-4 | Purity: 97% | (R)-2-(Benzylamino)-3-hydroxypropanoic acid | ESD-846004-250MG |
Cas.: 106910-77-4 | Purity: 97% | (R)-2-(Benzylamino)-3-hydroxypropanoic acid | ESD-846004-1G |
Cas.: 114312-57-1 | Purity: 98% | Ethyl 3-fluoro-2-methylbenzoate | ESD-846005-250MG |
Cas.: 114312-57-1 | Purity: 98% | Ethyl 3-fluoro-2-methylbenzoate | ESD-846005-1G |
Cas.: 117528-58-2 | Purity: 98% | 2,4-Dichloro-3-cyano-5-fluorobenzoic acid | ESD-846006-25MG |
Cas.: 117528-58-2 | Purity: 98% | 2,4-Dichloro-3-cyano-5-fluorobenzoic acid | ESD-846006-100MG |
Cas.: 92028-21-2 | Purity: 97% | 6-Methoxy-[1,1′-biphenyl]-3-amine hydrochloride | ESD-846007-25MG |
Cas.: 92028-21-2 | Purity: 97% | 6-Methoxy-[1,1′-biphenyl]-3-amine hydrochloride | ESD-846007-100MG |
Cas.: 951626-95-2 | Purity: 98% | Ethyl 4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxylate | ESD-846008-25MG |
Cas.: 951626-95-2 | Purity: 98% | Ethyl 4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxylate | ESD-846008-100MG |
Cas.: 1119280-66-8 | Purity: 95% | 2-Chloro-5H-pyrrolo[3,2-d]pyrimidine | ESD-846009-25MG |
Cas.: 1119280-66-8 | Purity: 95% | 2-Chloro-5H-pyrrolo[3,2-d]pyrimidine | ESD-846009-100MG |
Cas.: 1080026-94-3 | Purity: 95% | Ethyl 4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-carboxylate | ESD-846010-25MG |
Cas.: 1080026-94-3 | Purity: 95% | Ethyl 4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-carboxylate | ESD-846010-100MG |
Cas.: 1138443-83-0 | Purity: 98% | 3-Iodo-5-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-846011-25MG |
Cas.: 1138443-83-0 | Purity: 98% | 3-Iodo-5-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-846011-100MG |
Cas.: 1203498-99-0 | Purity: 97% | 5-Chloro-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid | ESD-846012-25MG |
Cas.: 1203498-99-0 | Purity: 97% | 5-Chloro-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid | ESD-846012-100MG |
Cas.: 81803-60-3 | Purity: 98% | Ethyl imidazo[1,5-a]pyridine-3-carboxylate | ESD-846013-25MG |
Cas.: 81803-60-3 | Purity: 98% | Ethyl imidazo[1,5-a]pyridine-3-carboxylate | ESD-846013-100MG |
Cas.: 112146-10-8 | Purity: 97% | 4-Bromo-2-methylbenzo[d]thiazole | ESD-846014-25MG |
Cas.: 112146-10-8 | Purity: 97% | 4-Bromo-2-methylbenzo[d]thiazole | ESD-846014-100MG |
Cas.: 849217-60-3 | Purity: 95% | N-(4-Fluorophenyl)-N’-(4-hydroxyphenyl)cyclopropane-1,1-dicarboxamide | ESD-846015-25MG |
Cas.: 849217-60-3 | Purity: 95% | N-(4-Fluorophenyl)-N’-(4-hydroxyphenyl)cyclopropane-1,1-dicarboxamide | ESD-846015-100MG |
Cas.: 827-55-4 | Purity: 97% | 1-Cyclopentyl-4-methylbenzene | ESD-846016-25MG |
Cas.: 827-55-4 | Purity: 97% | 1-Cyclopentyl-4-methylbenzene | ESD-846016-100MG |
Cas.: 1260874-86-9 | Purity: 98% | 5-Chloro-1-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-846017-25MG |
Cas.: 1260874-86-9 | Purity: 98% | 5-Chloro-1-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-846017-100MG |
Cas.: 2084-28-8 | Purity: 95% | trans-Ethyl 4-aminocyclohexanecarboxylate hydrochloride | ESD-846019-25MG |
Cas.: 2084-28-8 | Purity: 95% | trans-Ethyl 4-aminocyclohexanecarboxylate hydrochloride | ESD-846019-100MG |
Cas.: 359015-11-5 | Purity: 95% | Ethyl 6-(aminomethyl)picolinate hydrochloride | ESD-846020-25MG |
Cas.: 359015-11-5 | Purity: 95% | Ethyl 6-(aminomethyl)picolinate hydrochloride | ESD-846020-100MG |
Cas.: 37844-06-7 | Purity: 98% | 2-Amino-3-(3-chlorophenyl)propan-1-ol | ESD-846022-25MG |
Cas.: 37844-06-7 | Purity: 98% | 2-Amino-3-(3-chlorophenyl)propan-1-ol | ESD-846022-100MG |
Cas.: 83741-35-9 | Purity: 98% | 4-Bromo-1H-benzoimidazole | ESD-846023-250MG |
Cas.: 83741-35-9 | Purity: 98% | 4-Bromo-1H-benzoimidazole | ESD-846023-1G |
Cas.: 938458-80-1 | Purity: 98% | 5-Bromo-2-ethylbenzo[d]oxazole | ESD-846024-250MG |
Cas.: 938458-80-1 | Purity: 98% | 5-Bromo-2-ethylbenzo[d]oxazole | ESD-846024-1G |
Cas.: 21304-38-1 | Purity: 97% | 4-Iodobenzene-1,2-diamine | ESD-846025-250MG |
Cas.: 21304-38-1 | Purity: 97% | 4-Iodobenzene-1,2-diamine | ESD-846025-1G |
Cas.: 2216-68-4 | Purity: 97% | N-Methylnaphthalen-1-amine | ESD-846026-250MG |
Cas.: 2216-68-4 | Purity: 97% | N-Methylnaphthalen-1-amine | ESD-846026-1G |
Cas.: 2217-08-5 | Purity: 95% | 5,5-Dipropylbarbituric acid | ESD-846027-250MG |
Cas.: 2217-08-5 | Purity: 95% | 5,5-Dipropylbarbituric acid | ESD-846027-1G |
Cas.: 51887-88-8 | Purity: 95% | (S)-2-Amino-3-chloropropanoic acid hydrochloride | ESD-846028-250MG |
Cas.: 51887-88-8 | Purity: 95% | (S)-2-Amino-3-chloropropanoic acid hydrochloride | ESD-846028-1G |
Cas.: 10250-63-2 | Purity: 95% | Ethyl 1-methyl-3-phenyl-1H-pyrazole-5-carboxylate | ESD-846029-250MG |
Cas.: 163485-86-7 | Purity: 98% | 8-Bromo-2-chloroquinoline | ESD-846030-250MG |
Cas.: 163485-86-7 | Purity: 98% | 8-Bromo-2-chloroquinoline | ESD-846030-1G |
Cas.: 123531-52-2 | Purity: 97% | Ethyl imidazo[1,2-a]pyridine-3-carboxylate | ESD-846031-250MG |
Cas.: 123531-52-2 | Purity: 97% | Ethyl imidazo[1,2-a]pyridine-3-carboxylate | ESD-846031-1G |
Cas.: 247037-82-7 | Purity: 97% | Thiazole-2-carboximidamide hydrochloride | ESD-846032-250MG |
Cas.: 247037-82-7 | Purity: 97% | Thiazole-2-carboximidamide hydrochloride | ESD-846032-1G |
Cas.: 1452487-57-8 | Purity: 97% | 3,6-Dichloropyridazin-4-ol dihydrate | ESD-846033-250MG |
Cas.: 1452487-57-8 | Purity: 97% | 3,6-Dichloropyridazin-4-ol dihydrate | ESD-846033-1G |
Cas.: 41270-66-0 | Purity: 98% | 5-Chloro-2,3-diphenylpyrazine | ESD-846034-250MG |
Cas.: 41270-66-0 | Purity: 98% | 5-Chloro-2,3-diphenylpyrazine | ESD-846034-1G |
Cas.: 747411-47-8 | Purity: 98% | 3-Propylisoxazol-5-amine | ESD-846035-250MG |
Cas.: 747411-47-8 | Purity: 98% | 3-Propylisoxazol-5-amine | ESD-846035-1G |
Cas.: 658-89-9 | Purity: 98% | 4-(Trifluoromethoxy)benzene-1,2-diamine | ESD-846036-250MG |
Cas.: 658-89-9 | Purity: 98% | 4-(Trifluoromethoxy)benzene-1,2-diamine | ESD-846036-1G |
Cas.: 13036-81-2 | Purity: 95% | 1,3,5-Tripropyl-1,3,5-triazinane | ESD-846037-250MG |
Cas.: 13036-81-2 | Purity: 95% | 1,3,5-Tripropyl-1,3,5-triazinane | ESD-846037-1G |
Cas.: 1208082-91-0 | Purity: 95% | 6,8-Dibromo-2-methylimidazo[1,2-a]pyrazine | ESD-846038-250MG |
Cas.: 1208082-91-0 | Purity: 95% | 6,8-Dibromo-2-methylimidazo[1,2-a]pyrazine | ESD-846038-1G |
Cas.: 474706-74-6 | Purity: 96% | 6-Bromo-3-iodoimidazo[1,2-a]pyridine | ESD-846039-50MG |
Cas.: 474706-74-6 | Purity: 96% | 6-Bromo-3-iodoimidazo[1,2-a]pyridine | ESD-846039-250MG |
Cas.: 79865-89-7 | Purity: 98% | 4-(Ethylamino)benzaldehyde | ESD-846040-50MG |
Cas.: 79865-89-7 | Purity: 98% | 4-(Ethylamino)benzaldehyde | ESD-846040-250MG |
Cas.: 91271-63-5 | Purity: 98% | (2-(Morpholinomethyl)phenyl)methanol | ESD-846041-50MG |
Cas.: 91271-63-5 | Purity: 98% | (2-(Morpholinomethyl)phenyl)methanol | ESD-846041-250MG |
Cas.: 196799-45-8 | Purity: 98% | 2,3-Dihydrobenzofuran-7-carbaldehyde | ESD-846042-50MG |
Cas.: 196799-45-8 | Purity: 98% | 2,3-Dihydrobenzofuran-7-carbaldehyde | ESD-846042-250MG |
Cas.: 5888-51-7 | Purity: 95% | 4-Ethyl-1,2-dimethoxybenzene | ESD-846043-50MG |
Cas.: 5888-51-7 | Purity: 95% | 4-Ethyl-1,2-dimethoxybenzene | ESD-846043-250MG |
Cas.: 756839-14-2 | Purity: 98% | 1-Methyl-1H-indazol-5-ol | ESD-846044-50MG |
Cas.: 756839-14-2 | Purity: 98% | 1-Methyl-1H-indazol-5-ol | ESD-846044-250MG |
Cas.: 153086-37-4 | Purity: 95% | 3-(Dipropylamino)-4-methoxybenzenesulfonic acid | ESD-846045-50MG |
Cas.: 153086-37-4 | Purity: 95% | 3-(Dipropylamino)-4-methoxybenzenesulfonic acid | ESD-846045-250MG |
Cas.: 726139-60-2 | Purity: 97% | Ethyl 2-(pyrrolidin-3-yl)acetate hydrochloride | ESD-846046-50MG |
Cas.: 726139-60-2 | Purity: 97% | Ethyl 2-(pyrrolidin-3-yl)acetate hydrochloride | ESD-846046-250MG |
Cas.: 896133-77-0 | Purity: 95% | 1-(6-Methylpyridin-3-yl)hydrazine hydrochloride | ESD-846047-50MG |
Cas.: 896133-77-0 | Purity: 95% | 1-(6-Methylpyridin-3-yl)hydrazine hydrochloride | ESD-846047-250MG |
Cas.: 956010-88-1 | Purity: 98% | 1H-Pyrazolo[3,4-b]pyridine-3-carbonitrile | ESD-846048-50MG |
Cas.: 956010-88-1 | Purity: 98% | 1H-Pyrazolo[3,4-b]pyridine-3-carbonitrile | ESD-846048-250MG |
Cas.: 21038-22-2 | Purity: 95% | O-(4-Methoxybenzyl)hydroxylamine | ESD-846049-50MG |
Cas.: 21038-22-2 | Purity: 95% | O-(4-Methoxybenzyl)hydroxylamine | ESD-846049-250MG |
Cas.: 17321-38-9 | Purity: 97% | 3-Iodo-6-isopropoxypyridazine | ESD-846050-50MG |
Cas.: 17321-38-9 | Purity: 97% | 3-Iodo-6-isopropoxypyridazine | ESD-846050-250MG |
Cas.: 183500-94-9 | Purity: 97% | 1-(3-Chlorophenyl)piperazin-2-one hydrochloride | ESD-846051-50MG |
Cas.: 183500-94-9 | Purity: 97% | 1-(3-Chlorophenyl)piperazin-2-one hydrochloride | ESD-846051-250MG |
Cas.: 3414-19-5 | Purity: 95% | 5-Hydroxy-1H-indole-3-carbaldehyde | ESD-846052-50MG |
Cas.: 3414-19-5 | Purity: 95% | 5-Hydroxy-1H-indole-3-carbaldehyde | ESD-846052-250MG |
Cas.: 623155-53-3 | Purity: 95% | (4-Methyl-3-nitrophenyl)methanamine | ESD-846053-50MG |
Cas.: 623155-53-3 | Purity: 95% | (4-Methyl-3-nitrophenyl)methanamine | ESD-846053-250MG |
Cas.: 52753-43-2 | Purity: 98% | 1-Chloro-4,5-dimethyl-2-nitrobenzene | ESD-846054-50MG |
Cas.: 52753-43-2 | Purity: 98% | 1-Chloro-4,5-dimethyl-2-nitrobenzene | ESD-846054-250MG |
Cas.: 159847-81-1 | Purity: 98% | Methyl 2-amino-5-cyanobenzoate | ESD-846055-50MG |
Cas.: 159847-81-1 | Purity: 98% | Methyl 2-amino-5-cyanobenzoate | ESD-846055-250MG |
Cas.: 124555-33-5 | Purity: 95% | trans-3-Aminocyclopentanol hydrochloride | ESD-846056-50MG |
Cas.: 124555-33-5 | Purity: 95% | trans-3-Aminocyclopentanol hydrochloride | ESD-846056-250MG |
Cas.: 840521-88-2 | Purity: 95% | 3-(4-Fluorophenyl)phenethyl alcohol | ESD-846057-50MG |
Cas.: 840521-88-2 | Purity: 95% | 3-(4-Fluorophenyl)phenethyl alcohol | ESD-846057-250MG |
Cas.: 174607-36-4 | Purity: 97% | 6-(Trifluoromethyl)pyridazin-3(2H)-one | ESD-846058-50MG |
Cas.: 174607-36-4 | Purity: 97% | 6-(Trifluoromethyl)pyridazin-3(2H)-one | ESD-846058-250MG |
Cas.: 83004-14-2 | Purity: 98% | 2-Bromo-4-(bromomethyl)pyridine | ESD-846059-50MG |
Cas.: 83004-14-2 | Purity: 98% | 2-Bromo-4-(bromomethyl)pyridine | ESD-846059-250MG |
Cas.: 876601-43-3 | Purity: 95% | (2-Cyano-4-fluorophenyl)boronic acid | ESD-846060-50MG |
Cas.: 876601-43-3 | Purity: 95% | (2-Cyano-4-fluorophenyl)boronic acid | ESD-846060-250MG |
Cas.: 23082-30-6 | Purity: 95% | (2S,3S)-2-((tert-Butoxycarbonyl)amino)-3-hydroxybutanoic acid | ESD-846061-50MG |
Cas.: 23082-30-6 | Purity: 95% | (2S,3S)-2-((tert-Butoxycarbonyl)amino)-3-hydroxybutanoic acid | ESD-846061-250MG |
Cas.: 77150-36-8 | Purity: 98% | 8-Iodoquinazolin-4(3H)-one | ESD-846062-50MG |
Cas.: 77150-36-8 | Purity: 98% | 8-Iodoquinazolin-4(3H)-one | ESD-846062-250MG |
Cas.: 56621-99-9 | Purity: 95% | N2,N2-Dimethylpyrimidine-2,5-diamine | ESD-846063-50MG |
Cas.: 56621-99-9 | Purity: 95% | N2,N2-Dimethylpyrimidine-2,5-diamine | ESD-846063-250MG |
Cas.: 1207443-48-8 | Purity: 97% | (4-Ethoxy-2-methoxyphenyl)boronic acid | ESD-846064-50MG |
Cas.: 1207443-48-8 | Purity: 97% | (4-Ethoxy-2-methoxyphenyl)boronic acid | ESD-846064-250MG |
Cas.: 1245724-46-2 | Purity: 97% | (S)-Tetrahydro-2H-pyran-3-amine hydrochloride | ESD-846065-50MG |
Cas.: 1245724-46-2 | Purity: 97% | (S)-Tetrahydro-2H-pyran-3-amine hydrochloride | ESD-846065-250MG |
Cas.: 88912-24-7 | Purity: 98% | 5,6-Dichloropicolinic acid | ESD-846066-250MG |
Cas.: 88912-24-7 | Purity: 98% | 5,6-Dichloropicolinic acid | ESD-846066-1G |
Cas.: 7153-08-4 | Purity: 96% | 3,5-Diiodopyridin-4-ol | ESD-846067-250MG |
Cas.: 7153-08-4 | Purity: 96% | 3,5-Diiodopyridin-4-ol | ESD-846067-1G |
Cas.: 38956-79-5 | Purity: 95% | 3-Hydrazinyl-6-methylpyridazine | ESD-846068-250MG |
Cas.: 38956-79-5 | Purity: 95% | 3-Hydrazinyl-6-methylpyridazine | ESD-846068-1G |
Cas.: 885271-64-7 | Purity: 97% | 5-(Trifluoromethyl)-1H-indazole | ESD-846069-250MG |
Cas.: 885271-64-7 | Purity: 97% | 5-(Trifluoromethyl)-1H-indazole | ESD-846069-1G |
Cas.: 143982-54-1 | Purity: 98% | Ethyl 3-bromoimidazo[1,2-a]pyridine-2-carboxylate | ESD-846070-250MG |
Cas.: 143982-54-1 | Purity: 98% | Ethyl 3-bromoimidazo[1,2-a]pyridine-2-carboxylate | ESD-846070-1G |
Cas.: 35431-26-6 | Purity: 98% | 5-Hydroxy-2-methoxybenzaldehyde | ESD-846071-50MG |
Cas.: 35431-26-6 | Purity: 98% | 5-Hydroxy-2-methoxybenzaldehyde | ESD-846071-250MG |
Cas.: 538342-98-2 | Purity: 95% | (4-Propylphenyl)methanamine | ESD-846072-50MG |
Cas.: 538342-98-2 | Purity: 95% | (4-Propylphenyl)methanamine | ESD-846072-250MG |
Cas.: 351324-70-4 | Purity: 97% | tert-Butyl 7-amino-3,4-dihydroquinoline-1(2H)-carboxylate | ESD-846073-50MG |
Cas.: 351324-70-4 | Purity: 97% | tert-Butyl 7-amino-3,4-dihydroquinoline-1(2H)-carboxylate | ESD-846073-250MG |
Cas.: 55270-33-2 | Purity: 97% | 4-Iodoisoquinoline | ESD-846074-50MG |
Cas.: 55270-33-2 | Purity: 97% | 4-Iodoisoquinoline | ESD-846074-250MG |
Cas.: 16554-47-5 | Purity: 98% | 3-Methoxy-2-nitroaniline | ESD-846075-50MG |
Cas.: 16554-47-5 | Purity: 98% | 3-Methoxy-2-nitroaniline | ESD-846075-250MG |
Cas.: 152300-56-6 | Purity: 98% | Methyl 4-bromo-1,2,5-thiadiazole-3-carboxylate | ESD-846076-50MG |
Cas.: 152300-56-6 | Purity: 98% | Methyl 4-bromo-1,2,5-thiadiazole-3-carboxylate | ESD-846076-250MG |
Cas.: 918145-29-6 | Purity: 98% | 3-Bromo-6-chloro-2,4-dimethylpyridine | ESD-846077-25MG |
Cas.: 918145-29-6 | Purity: 98% | 3-Bromo-6-chloro-2,4-dimethylpyridine | ESD-846077-100MG |
Cas.: 53903-51-8 | Purity: 95% | 4-Chloro-2-(trifluoromethyl)phenol | ESD-846078-25MG |
Cas.: 53903-51-8 | Purity: 95% | 4-Chloro-2-(trifluoromethyl)phenol | ESD-846078-100MG |
Cas.: 1036760-03-8 | Purity: 97% | (3-(1-Hydroxyethyl)phenyl)boronic acid | ESD-846079-25MG |
Cas.: 1036760-03-8 | Purity: 97% | (3-(1-Hydroxyethyl)phenyl)boronic acid | ESD-846079-100MG |
Cas.: 127657-46-9 | Purity: 97% | 2-(Imidazo[1,2-a]pyridin-3-yl)acetic acid hydrochloride | ESD-846080-25MG |
Cas.: 127657-46-9 | Purity: 97% | 2-(Imidazo[1,2-a]pyridin-3-yl)acetic acid hydrochloride | ESD-846080-100MG |
Cas.: 15931-19-8 | Purity: 95% | 2-Methylpyridine-3,4-diamine | ESD-846081-25MG |
Cas.: 15931-19-8 | Purity: 95% | 2-Methylpyridine-3,4-diamine | ESD-846081-100MG |
Cas.: 124655-63-6 | Purity: 95% | Tetrahydro-1H-pyrrolizine-7a(5H)-acetic acid hydrochloride | ESD-846082-250MG |
Cas.: 175018-77-6 | Purity: 95% | 4-(2-Bromoethyl)-1,2-difluorobenzene | ESD-846083-250MG |
Cas.: 175018-77-6 | Purity: 95% | 4-(2-Bromoethyl)-1,2-difluorobenzene | ESD-846083-1G |
Cas.: 94952-46-2 | Purity: 98% | 1-(5-Chloropyridin-2-yl)ethanone | ESD-846084-250MG |
Cas.: 94952-46-2 | Purity: 98% | 1-(5-Chloropyridin-2-yl)ethanone | ESD-846084-1G |
Cas.: 73930-39-9 | Purity: 97% | 1-Phenylcyclopropanamine hydrochloride | ESD-846085-250MG |
Cas.: 73930-39-9 | Purity: 97% | 1-Phenylcyclopropanamine hydrochloride | ESD-846085-1G |
Cas.: 16375-90-9 | Purity: 97% | N-(4-hydroxy-3-methylphenyl)acetamide | ESD-846086-50MG |
Cas.: 16375-90-9 | Purity: 97% | N-(4-hydroxy-3-methylphenyl)acetamide | ESD-846086-250MG |
Cas.: 1159811-23-0 | Purity: 97% | 7-Chloro-[1,2,4]triazolo[1,5-c]pyrimidine | ESD-846087-50MG |
Cas.: 1159811-23-0 | Purity: 97% | 7-Chloro-[1,2,4]triazolo[1,5-c]pyrimidine | ESD-846087-250MG |
Cas.: 62484-29-1 | Purity: 97% | 2,4,8-Trichloroquinazoline | ESD-846088-50MG |
Cas.: 62484-29-1 | Purity: 97% | 2,4,8-Trichloroquinazoline | ESD-846088-250MG |
Cas.: 252723-17-4 | Purity: 95% | 5-Bromo-4-chloro-7-(phenylsulfonyl)-7H-pyrrolo[2,3-d]pyrimidine | ESD-846089-50MG |
Cas.: 252723-17-4 | Purity: 95% | 5-Bromo-4-chloro-7-(phenylsulfonyl)-7H-pyrrolo[2,3-d]pyrimidine | ESD-846089-250MG |
Cas.: 1050423-87-4 | Purity: 98% | 3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid | ESD-846090-250MG |
Cas.: 1050423-87-4 | Purity: 98% | 3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid | ESD-846090-1G |
Cas.: 287976-94-7 | Purity: 98% | 4-Bromo-N-(4-bromophenyl)-N-(4-(sec-butyl)phenyl)aniline | ESD-846091-50MG |
Cas.: 287976-94-7 | Purity: 98% | 4-Bromo-N-(4-bromophenyl)-N-(4-(sec-butyl)phenyl)aniline | ESD-846091-250MG |
Cas.: 1160790-18-0 | Purity: 97% | 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridine | ESD-846092-50MG |
Cas.: 1160790-18-0 | Purity: 97% | 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridine | ESD-846092-250MG |
Cas.: 35808-40-3 | Purity: 97% | 1,2,3,4-Tetrahydropyrido[2,3-b]pyrazine | ESD-846093-50MG |
Cas.: 35808-40-3 | Purity: 97% | 1,2,3,4-Tetrahydropyrido[2,3-b]pyrazine | ESD-846093-250MG |
Cas.: 940-07-8 | Purity: 95% | Pyrazine-2,6-dicarboxylic acid | ESD-846094-50MG |
Cas.: 940-07-8 | Purity: 95% | Pyrazine-2,6-dicarboxylic acid | ESD-846094-250MG |
Cas.: 30201-72-0 | Purity: 97% | 2-Amino-5-ethyl-6-hydroxypyrimidin-4(3H)-one | ESD-846095-50MG |
Cas.: 30201-72-0 | Purity: 97% | 2-Amino-5-ethyl-6-hydroxypyrimidin-4(3H)-one | ESD-846095-250MG |
Cas.: 3943-73-5 | Purity: 98% | Ethyl 2,3-dihydroxybenzoate | ESD-846096-50MG |
Cas.: 3943-73-5 | Purity: 98% | Ethyl 2,3-dihydroxybenzoate | ESD-846096-250MG |
Cas.: 89381-03-3 | Purity: 97% | 3,3-Dimethylazetidine hydrochloride | ESD-846097-50MG |
Cas.: 89381-03-3 | Purity: 97% | 3,3-Dimethylazetidine hydrochloride | ESD-846097-250MG |
Cas.: 32046-43-8 | Purity: 98% | 5-Iodopicolinic acid | ESD-846098-50MG |
Cas.: 32046-43-8 | Purity: 98% | 5-Iodopicolinic acid | ESD-846098-250MG |
Cas.: 403850-89-5 | Purity: 95% | 7-Bromo-2-methylquinazolin-4(3H)-one | ESD-846099-50MG |
Cas.: 403850-89-5 | Purity: 95% | 7-Bromo-2-methylquinazolin-4(3H)-one | ESD-846099-250MG |
Cas.: 1014613-64-9 | Purity: 98% | 4-Bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-846100-50MG |
Cas.: 1014613-64-9 | Purity: 98% | 4-Bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-846100-250MG |
Cas.: 134517-55-8 | Purity: 97% | 2,4,5-Trichloroquinazoline | ESD-846101-50MG |
Cas.: 134517-55-8 | Purity: 97% | 2,4,5-Trichloroquinazoline | ESD-846101-250MG |
Cas.: 1005474-88-3 | Purity: 97% | 5-Fluoro-6-methylpyridine-2-carboxylic acid | ESD-846102-50MG |
Cas.: 1005474-88-3 | Purity: 97% | 5-Fluoro-6-methylpyridine-2-carboxylic acid | ESD-846102-250MG |
Cas.: 126053-15-4 | Purity: 98% | 4-Chloro-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol | ESD-846103-50MG |
Cas.: 126053-15-4 | Purity: 98% | 4-Chloro-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol | ESD-846103-250MG |
Cas.: 1092961-12-0 | Purity: 98% | (1-Methyl-1H-indazol-4-yl)methanol | ESD-846104-50MG |
Cas.: 1092961-12-0 | Purity: 98% | (1-Methyl-1H-indazol-4-yl)methanol | ESD-846104-250MG |
Cas.: 325975-67-5 | Purity: 95% | 3-(1-Methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-pyrrolo[2,3-b]pyridine | ESD-846105-50MG |
Cas.: 325975-67-5 | Purity: 95% | 3-(1-Methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-pyrrolo[2,3-b]pyridine | ESD-846105-250MG |
Cas.: 101084-20-2 | Purity: 97% | 3-Amino-5-bromopyridin-4-ol | ESD-846106-50MG |
Cas.: 101084-20-2 | Purity: 97% | 3-Amino-5-bromopyridin-4-ol | ESD-846106-250MG |
Cas.: 135463-81-9 | Purity: 98% | Coluracetam | ESD-846107-50MG |
Cas.: 135463-81-9 | Purity: 98% | Coluracetam | ESD-846107-250MG |
Cas.: 41085-27-2 | Purity: 98% | 1-(2-Hydroxy-6-methylphenyl)ethanone | ESD-846108-50MG |
Cas.: 41085-27-2 | Purity: 98% | 1-(2-Hydroxy-6-methylphenyl)ethanone | ESD-846108-250MG |
Cas.: 36155-85-8 | Purity: 98% | 5-Chlorothiophene-3-carbaldehyde | ESD-846109-50MG |
Cas.: 36155-85-8 | Purity: 98% | 5-Chlorothiophene-3-carbaldehyde | ESD-846109-250MG |
Cas.: 1030287-80-9 | Purity: 97% | 2-Hydrazinylbenzonitrile hydrochloride | ESD-846110-50MG |
Cas.: 1030287-80-9 | Purity: 97% | 2-Hydrazinylbenzonitrile hydrochloride | ESD-846110-250MG |
Cas.: 924304-73-4 | Purity: 98% | 4-Chloroisoindoline hydrochloride | ESD-846111-50MG |
Cas.: 924304-73-4 | Purity: 98% | 4-Chloroisoindoline hydrochloride | ESD-846111-250MG |
Cas.: 394223-38-2 | Purity: 97% | Benzo[d]thiazole-5-carbaldehyde | ESD-846112-50MG |
Cas.: 394223-38-2 | Purity: 97% | Benzo[d]thiazole-5-carbaldehyde | ESD-846112-250MG |
Cas.: 1240621-87-7 | Purity: 97% | 2-Bromopyrimidin-5-ol | ESD-846113-50MG |
Cas.: 1240621-87-7 | Purity: 97% | 2-Bromopyrimidin-5-ol | ESD-846113-250MG |
Cas.: 870281-82-6 | Purity: 98% | CAL-101 | ESD-846114-50MG |
Cas.: 870281-82-6 | Purity: 98% | CAL-101 | ESD-846114-250MG |
Cas.: 1125-01-5 | Purity: 98% | 3-Azaspiro[5.5]undecane hydrochloride | ESD-846115-50MG |
Cas.: 1125-01-5 | Purity: 98% | 3-Azaspiro[5.5]undecane hydrochloride | ESD-846115-250MG |
Cas.: 1000342-95-9 | Purity: 97% | 4-Bromo-6-(trifluoromethyl)-1H-indazole | ESD-846116-50MG |
Cas.: 1000342-95-9 | Purity: 97% | 4-Bromo-6-(trifluoromethyl)-1H-indazole | ESD-846116-250MG |
Cas.: 663611-73-2 | Purity: 97% | (S)-2-Amino-2-(3-chlorophenyl)ethanol | ESD-846117-50MG |
Cas.: 663611-73-2 | Purity: 97% | (S)-2-Amino-2-(3-chlorophenyl)ethanol | ESD-846117-250MG |
Cas.: 271261-71-3 | Purity: 95% | Methyl 2,4-dihydroxy-5-nitrobenzoate | ESD-846118-50MG |
Cas.: 271261-71-3 | Purity: 95% | Methyl 2,4-dihydroxy-5-nitrobenzoate | ESD-846118-250MG |
Cas.: 945016-63-7 | Purity: 96% | 3-(2-Chloropyrimidin-4-yl)-1H-indole | ESD-846119-50MG |
Cas.: 945016-63-7 | Purity: 96% | 3-(2-Chloropyrimidin-4-yl)-1H-indole | ESD-846119-250MG |
Cas.: 17823-69-7 | Purity: 97% | 2-Cyano-3,3-bis(methylthio)acrylamide | ESD-846120-50MG |
Cas.: 17823-69-7 | Purity: 97% | 2-Cyano-3,3-bis(methylthio)acrylamide | ESD-846120-250MG |
Cas.: 1203705-58-1 | Purity: 98% | 2-Bromo-7-chloropyrazolo[1,5-a]pyrimidine | ESD-846121-50MG |
Cas.: 1203705-58-1 | Purity: 98% | 2-Bromo-7-chloropyrazolo[1,5-a]pyrimidine | ESD-846121-250MG |
Cas.: 82788-37-2 | Purity: 96% | Methyl 6-methylbenzofuran-2-carboxylate | ESD-846122-50MG |
Cas.: 82788-37-2 | Purity: 96% | Methyl 6-methylbenzofuran-2-carboxylate | ESD-846122-250MG |
Cas.: 4770-03-0 | Purity: 98% | 3-Nitro-1H-indole | ESD-846123-50MG |
Cas.: 4770-03-0 | Purity: 98% | 3-Nitro-1H-indole | ESD-846123-250MG |
Cas.: 1027785-19-8 | Purity: 98% | (6-Amino-5-bromopyridin-3-yl)methanol | ESD-846124-50MG |
Cas.: 1027785-19-8 | Purity: 98% | (6-Amino-5-bromopyridin-3-yl)methanol | ESD-846124-250MG |
Cas.: 34662-29-8 | Purity: 98% | 3-Chloro-4-nitrobenzonitrile | ESD-846125-50MG |
Cas.: 34662-29-8 | Purity: 98% | 3-Chloro-4-nitrobenzonitrile | ESD-846125-250MG |
Cas.: 553652-34-9 | Purity: 98% | N-(2-Bromophenyl)-N-methylmethanesulfonamide | ESD-846126-50MG |
Cas.: 553652-34-9 | Purity: 98% | N-(2-Bromophenyl)-N-methylmethanesulfonamide | ESD-846126-250MG |
Cas.: 1360438-13-6 | Purity: 95% | tert-Butyl 2-(pipidin-4-yl)acetate oxalate | ESD-846127-50MG |
Cas.: 1360438-13-6 | Purity: 95% | tert-Butyl 2-(pipidin-4-yl)acetate oxalate | ESD-846127-250MG |
Cas.: 56671-67-1 | Purity: 97% | Imidazo[1,5-a]pyridine-1-carbaldehyde | ESD-846128-50MG |
Cas.: 56671-67-1 | Purity: 97% | Imidazo[1,5-a]pyridine-1-carbaldehyde | ESD-846128-250MG |
Cas.: 1008119-09-2 | Purity: 98% | 4-Acetyl-N,N-dimethylbenzamide | ESD-846129-50MG |
Cas.: 1008119-09-2 | Purity: 98% | 4-Acetyl-N,N-dimethylbenzamide | ESD-846129-250MG |
Cas.: 52574-06-8 | Purity: 97% | (S)-1-Methyl-5-oxopyrrolidine-2-carboxylic acid | ESD-846130-50MG |
Cas.: 52574-06-8 | Purity: 97% | (S)-1-Methyl-5-oxopyrrolidine-2-carboxylic acid | ESD-846130-250MG |
Cas.: 1158533-04-0 | Purity: 95% | 1-(4-Methoxybenzyl)piperidin-4-amine hydrochloride | ESD-846131-50MG |
Cas.: 1158533-04-0 | Purity: 95% | 1-(4-Methoxybenzyl)piperidin-4-amine hydrochloride | ESD-846131-250MG |
Cas.: 50424-28-7 | Purity: 95% | 4-Chloro-6-methoxyquinazoline | ESD-846132-50MG |
Cas.: 50424-28-7 | Purity: 95% | 4-Chloro-6-methoxyquinazoline | ESD-846132-250MG |
Cas.: 19673-14-4 | Purity: 95% | Ethyl 5-oxoazepane-4-carboxylate hydrochloride | ESD-846133-50MG |
Cas.: 19673-14-4 | Purity: 95% | Ethyl 5-oxoazepane-4-carboxylate hydrochloride | ESD-846133-250MG |
Cas.: 55330-60-4 | Purity: 95% | Methylhydrazine dihydrochloride | ESD-846134-50MG |
Cas.: 55330-60-4 | Purity: 95% | Methylhydrazine dihydrochloride | ESD-846134-250MG |
Cas.: 301693-50-5 | Purity: 98% | 4-(3-Fluorophenyl)-2,2-dimethyl-5-(4-(methylthio)phenyl)furan-3(2H)-one | ESD-846135-50MG |
Cas.: 301693-50-5 | Purity: 98% | 4-(3-Fluorophenyl)-2,2-dimethyl-5-(4-(methylthio)phenyl)furan-3(2H)-one | ESD-846135-250MG |
Cas.: 147403-52-9 | Purity: 98% | Methyl 2-ethoxy-1-((2′-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1′-biphenyl]-4-yl)methyl )-1H-benzo[d]imidazole-7-carboxylate | ESD-846136-50MG |
Cas.: 147403-52-9 | Purity: 98% | Methyl 2-ethoxy-1-((2′-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1′-biphenyl]-4-yl)methyl )-1H-benzo[d]imidazole-7-carboxylate | ESD-846136-250MG |
Cas.: 1523570-95-7 | Purity: 98% | 3-Amino-1-methylpyridin-2(1H)-one hydrochloride | ESD-846137-50MG |
Cas.: 1523570-95-7 | Purity: 98% | 3-Amino-1-methylpyridin-2(1H)-one hydrochloride | ESD-846137-250MG |
Cas.: 1041055-24-6 | Purity: 97% | (S)-2,6-Diaminohexan-1-ol dihydrochloride | ESD-846138-50MG |
Cas.: 1041055-24-6 | Purity: 97% | (S)-2,6-Diaminohexan-1-ol dihydrochloride | ESD-846138-250MG |
Cas.: 60481-35-8 | Purity: 97% | (2-Bromo-5-fluorophenyl)hydrazine hydrochloride | ESD-846139-50MG |
Cas.: 60481-35-8 | Purity: 97% | (2-Bromo-5-fluorophenyl)hydrazine hydrochloride | ESD-846139-250MG |
Cas.: 220400-04-4 | Purity: 97% | (S)-2-(((Benzyloxy)carbonyl)amino)-3-(4-iodophenyl)propanoic acid | ESD-846140-50MG |
Cas.: 220400-04-4 | Purity: 97% | (S)-2-(((Benzyloxy)carbonyl)amino)-3-(4-iodophenyl)propanoic acid | ESD-846140-250MG |
Cas.: 74866-17-4 | Purity: 98% | 1-Bromo-3,4-dimethoxy-2-methylbenzene | ESD-846141-50MG |
Cas.: 74866-17-4 | Purity: 98% | 1-Bromo-3,4-dimethoxy-2-methylbenzene | ESD-846141-250MG |
Cas.: 355836-08-7 | Purity: 97% | (2-Methoxy-4,6-dimethylphenyl)boronic acid | ESD-846142-50MG |
Cas.: 355836-08-7 | Purity: 97% | (2-Methoxy-4,6-dimethylphenyl)boronic acid | ESD-846142-250MG |
Cas.: 119396-04-2 | Purity: 97% | 4-Chloro-2-(chloromethyl)pyridine hydrochloride | ESD-846143-50MG |
Cas.: 119396-04-2 | Purity: 97% | 4-Chloro-2-(chloromethyl)pyridine hydrochloride | ESD-846143-250MG |
Cas.: 1214373-91-7 | Purity: 95% | 5-Chloro-6-methoxypicolinic acid | ESD-846144-25MG |
Cas.: 1214373-91-7 | Purity: 95% | 5-Chloro-6-methoxypicolinic acid | ESD-846144-100MG |
Cas.: 824-24-8 | Purity: 97% | 4-Methyl-1H-pyrrolo[2,3-b]pyridine | ESD-846145-25MG |
Cas.: 824-24-8 | Purity: 97% | 4-Methyl-1H-pyrrolo[2,3-b]pyridine | ESD-846145-100MG |
Cas.: 3147-58-8 | Purity: 98% | 1,3-Dihydroxy-2-naphthoic acid | ESD-846146-25MG |
Cas.: 3147-58-8 | Purity: 98% | 1,3-Dihydroxy-2-naphthoic acid | ESD-846146-100MG |
Cas.: 108661-54-7 | Purity: 97% | 1-Aminobutan-2-one hydrochloride | ESD-846147-25MG |
Cas.: 108661-54-7 | Purity: 97% | 1-Aminobutan-2-one hydrochloride | ESD-846147-100MG |
Cas.: 769109-13-9 | Purity: 98% | Imidazo[1,2-b]pyridazine-6-carboxylic acid | ESD-846148-25MG |
Cas.: 769109-13-9 | Purity: 98% | Imidazo[1,2-b]pyridazine-6-carboxylic acid | ESD-846148-100MG |
Cas.: 20034-50-8 | Purity: 98% | 4-Cyclopropylbenzaldehyde | ESD-846149-25MG |
Cas.: 20034-50-8 | Purity: 98% | 4-Cyclopropylbenzaldehyde | ESD-846149-100MG |
Cas.: 116008-52-7 | Purity: 97% | 4-Amino-1H-pyrazole-3-carboxylic acid | ESD-846150-25MG |
Cas.: 116008-52-7 | Purity: 97% | 4-Amino-1H-pyrazole-3-carboxylic acid | ESD-846150-100MG |
Cas.: 13223-43-3 | Purity: 98% | 5,7-Dimethoxy-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine | ESD-846151-25MG |
Cas.: 13223-43-3 | Purity: 98% | 5,7-Dimethoxy-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine | ESD-846151-100MG |
Cas.: 926291-77-2 | Purity: 97% | (R)-2-Amino-2-(3-chlorophenyl)ethanol | ESD-846152-25MG |
Cas.: 926291-77-2 | Purity: 97% | (R)-2-Amino-2-(3-chlorophenyl)ethanol | ESD-846152-100MG |
Cas.: 55737-77-4 | Purity: 98% | 3-Chloro-4-(methoxycarbonyl)benzoic acid | ESD-846153-25MG |
Cas.: 55737-77-4 | Purity: 98% | 3-Chloro-4-(methoxycarbonyl)benzoic acid | ESD-846153-100MG |
Cas.: 1194374-25-8 | Purity: 97% | 2-Bromo-5-methylthiazole-4-carboxylic acid | ESD-846154-25MG |
Cas.: 1194374-25-8 | Purity: 97% | 2-Bromo-5-methylthiazole-4-carboxylic acid | ESD-846154-100MG |
Cas.: 1246765-38-7 | Purity: 95% | 6-Bromo-3,4-dihydroquinazolin-2(1H)-one | ESD-846155-25MG |
Cas.: 1246765-38-7 | Purity: 95% | 6-Bromo-3,4-dihydroquinazolin-2(1H)-one | ESD-846155-100MG |
Cas.: 1209335-53-4 | Purity: 97% | 4-Bromo-3-methoxypyridine hydrochloride | ESD-846156-25MG |
Cas.: 1209335-53-4 | Purity: 97% | 4-Bromo-3-methoxypyridine hydrochloride | ESD-846156-100MG |
Cas.: 1008119-07-0 | Purity: 98% | 2,6-Difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid | ESD-846157-25MG |
Cas.: 1008119-07-0 | Purity: 98% | 2,6-Difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid | ESD-846157-100MG |
Cas.: 610791-39-4 | Purity: 98% | 1-(Pyridin-3-yl)cyclopropanecarboxylic acid | ESD-846158-25MG |
Cas.: 610791-39-4 | Purity: 98% | 1-(Pyridin-3-yl)cyclopropanecarboxylic acid | ESD-846158-100MG |
Cas.: 232600-93-0 | Purity: 97% | 3-Aminopyrazolo[1,5-a]pyrimidine | ESD-846159-25MG |
Cas.: 232600-93-0 | Purity: 97% | 3-Aminopyrazolo[1,5-a]pyrimidine | ESD-846159-100MG |
Cas.: 1017781-37-1 | Purity: 95% | 3-Ethyl-1-phenyl-1H-pyrazol-5-amine | ESD-846160-25MG |
Cas.: 1017781-37-1 | Purity: 95% | 3-Ethyl-1-phenyl-1H-pyrazol-5-amine | ESD-846160-100MG |
Cas.: 100202-78-6 | Purity: 95% | 2-(Bromomethyl)-6-fluoropyridine | ESD-846161-25MG |
Cas.: 100202-78-6 | Purity: 95% | 2-(Bromomethyl)-6-fluoropyridine | ESD-846161-100MG |
Cas.: 1171334-07-8 | Purity: 97% | 5,6,7,8-Tetrahydropyrido[3,4-d]pyrimidin-4(3H)-one hydrochloride | ESD-846162-25MG |
Cas.: 1171334-07-8 | Purity: 97% | 5,6,7,8-Tetrahydropyrido[3,4-d]pyrimidin-4(3H)-one hydrochloride | ESD-846162-100MG |
Cas.: 79221-15-1 | Purity: 98% | Ethyl 2-amino-4-methyloxazole-5-carboxylate | ESD-846163-25MG |
Cas.: 79221-15-1 | Purity: 98% | Ethyl 2-amino-4-methyloxazole-5-carboxylate | ESD-846163-100MG |
Cas.: 203663-30-3 | Purity: 97% | tert-Butyl 2-formyl-4,5-dihydrothieno[2,3-c]pyridine-6(7H)-carboxylate | ESD-846164-25MG |
Cas.: 203663-30-3 | Purity: 97% | tert-Butyl 2-formyl-4,5-dihydrothieno[2,3-c]pyridine-6(7H)-carboxylate | ESD-846164-100MG |
Cas.: 1192-07-0 | Purity: 98% | Isoxazolidin-3-one | ESD-846165-25MG |
Cas.: 1192-07-0 | Purity: 98% | Isoxazolidin-3-one | ESD-846165-100MG |
Cas.: 1353636-66-4 | Purity: 97% | 3-Bromo-5-fluoroisonicotinonitrile | ESD-846166-25MG |
Cas.: 1353636-66-4 | Purity: 97% | 3-Bromo-5-fluoroisonicotinonitrile | ESD-846166-100MG |
Cas.: 79491-46-6 | Purity: 97% | 2,6-Dibromo-3-methoxy-5-nitropyridine | ESD-846167-25MG |
Cas.: 79491-46-6 | Purity: 97% | 2,6-Dibromo-3-methoxy-5-nitropyridine | ESD-846167-100MG |
Cas.: 1158750-91-4 | Purity: 95% | tert-Butyl 3-oxo-2,7-diazaspiro[4.5]decane-7-carboxylate | ESD-846168-25MG |
Cas.: 1158750-91-4 | Purity: 95% | tert-Butyl 3-oxo-2,7-diazaspiro[4.5]decane-7-carboxylate | ESD-846168-100MG |
Cas.: 948883-68-9 | Purity: 97% | cis-4-(Methylamino)cyclohexanol hydrochloride | ESD-846169-25MG |
Cas.: 948883-68-9 | Purity: 97% | cis-4-(Methylamino)cyclohexanol hydrochloride | ESD-846169-100MG |
Cas.: 29520-88-5 | Purity: 98% | Azepane-2,4-dione | ESD-846170-25MG |
Cas.: 29520-88-5 | Purity: 98% | Azepane-2,4-dione | ESD-846170-100MG |
Cas.: 1632286-11-3 | Purity: 98% | 5-Bromo-2-(pipidin-3-yloxy)pyrimidine hydrochloride | ESD-846171-25MG |
Cas.: 1632286-11-3 | Purity: 98% | 5-Bromo-2-(pipidin-3-yloxy)pyrimidine hydrochloride | ESD-846171-100MG |
Cas.: 191805-29-5 | Purity: 97% | tert-Butyl 1-oxo-8-azaspiro[4.5]decane-8-carboxylate | ESD-846172-25MG |
Cas.: 191805-29-5 | Purity: 97% | tert-Butyl 1-oxo-8-azaspiro[4.5]decane-8-carboxylate | ESD-846172-100MG |
Cas.: 41112-74-7 | Purity: 95% | 2-Chloro-4-hydrazinylbenzoic acid hydrochloride | ESD-846173-25MG |
Cas.: 41112-74-7 | Purity: 95% | 2-Chloro-4-hydrazinylbenzoic acid hydrochloride | ESD-846173-100MG |
Cas.: 121562-09-2 | Purity: 97% | Ethyl 3-bromo-1,2,4-oxadiazole-5-carboxylate | ESD-846174-25MG |
Cas.: 121562-09-2 | Purity: 97% | Ethyl 3-bromo-1,2,4-oxadiazole-5-carboxylate | ESD-846174-100MG |
Cas.: 186593-26-0 | Purity: 98% | 5-Nitropyridin-3-ol | ESD-846175-25MG |
Cas.: 186593-26-0 | Purity: 98% | 5-Nitropyridin-3-ol | ESD-846175-100MG |
Cas.: 3240-72-0 | Purity: 95% | 5,6-Diaminopyrimidine-2,4-diol | ESD-846176-250MG |
Cas.: 3240-72-0 | Purity: 95% | 5,6-Diaminopyrimidine-2,4-diol | ESD-846176-1G |
Cas.: 499785-52-3 | Purity: 98% | Ethyl 1-methyl-1H-benzo[d][1,2,3]triazole-5-carboxylate | ESD-846177-250MG |
Cas.: 499785-52-3 | Purity: 98% | Ethyl 1-methyl-1H-benzo[d][1,2,3]triazole-5-carboxylate | ESD-846177-1G |
Cas.: 1752-88-1 | Purity: 98% | 3-Pyrazolidinone hydrochloride | ESD-846178-250MG |
Cas.: 1752-88-1 | Purity: 98% | 3-Pyrazolidinone hydrochloride | ESD-846178-1G |
Cas.: 62484-12-2 | Purity: 95% | 7-Methoxyquinazoline-2,4-diol | ESD-846179-250MG |
Cas.: 62484-12-2 | Purity: 95% | 7-Methoxyquinazoline-2,4-diol | ESD-846179-1G |
Cas.: 1123-99-5 | Purity: 95% | 2-Iodobenzo[d]thiazole | ESD-846180-250MG |
Cas.: 1123-99-5 | Purity: 95% | 2-Iodobenzo[d]thiazole | ESD-846180-1G |
Cas.: 10341-26-1 | Purity: 98% | 1,4-Oxazepan-5-one | ESD-846181-250MG |
Cas.: 10341-26-1 | Purity: 98% | 1,4-Oxazepan-5-one | ESD-846181-1G |
Cas.: 84832-00-8 | Purity: 98% | (5-Amino-2-fluorophenyl)methanol | ESD-846182-250MG |
Cas.: 84832-00-8 | Purity: 98% | (5-Amino-2-fluorophenyl)methanol | ESD-846182-1G |
Cas.: 25458-44-0 | Purity: 98% | 4-(Methoxymethoxy)benzoic acid | ESD-846184-250MG |
Cas.: 25458-44-0 | Purity: 98% | 4-(Methoxymethoxy)benzoic acid | ESD-846184-1G |
Cas.: 1463-17-8 | Purity: 97% | 2,8-Dimethylquinoline | ESD-846185-250MG |
Cas.: 1463-17-8 | Purity: 97% | 2,8-Dimethylquinoline | ESD-846185-1G |
Cas.: 1464025-91-9 | Purity: 95% | Dicyclohexylamine (2S,3S)-2-((tert-butoxycarbonyl)amino)-3-hydroxybutanoate | ESD-846186-250MG |
Cas.: 1464025-91-9 | Purity: 95% | Dicyclohexylamine (2S,3S)-2-((tert-butoxycarbonyl)amino)-3-hydroxybutanoate | ESD-846186-1G |
Cas.: 10406-24-3 | Purity: 97% | 3-(Aminomethyl)benzonitrile | ESD-846187-250MG |
Cas.: 10406-24-3 | Purity: 97% | 3-(Aminomethyl)benzonitrile | ESD-846187-1G |
Cas.: 2339-58-4 | Purity: 98% | 3-Fluoro-5-methoxyaniline | ESD-846188-250MG |
Cas.: 2339-58-4 | Purity: 98% | 3-Fluoro-5-methoxyaniline | ESD-846188-1G |
Cas.: 96245-97-5 | Purity: 98% | 3-Bromo-4-hydroxypyridin-2(1H)-one | ESD-846189-250MG |
Cas.: 96245-97-5 | Purity: 98% | 3-Bromo-4-hydroxypyridin-2(1H)-one | ESD-846189-1G |
Cas.: 49674-16-0 | Purity: 95% | 5-Amino-3-bromobenzonitrile | ESD-846190-250MG |
Cas.: 49674-16-0 | Purity: 95% | 5-Amino-3-bromobenzonitrile | ESD-846190-1G |
Cas.: 883231-25-2 | Purity: 95% | (2-((tert-Butoxycarbonyl)amino)pyrimidin-5-yl)boronic acid | ESD-846191-250MG |
Cas.: 883231-25-2 | Purity: 95% | (2-((tert-Butoxycarbonyl)amino)pyrimidin-5-yl)boronic acid | ESD-846191-1G |
Cas.: 33922-96-2 | Purity: 98% | Methyl 5-bromo-2-(methylamino)benzoate | ESD-846192-250MG |
Cas.: 33922-96-2 | Purity: 98% | Methyl 5-bromo-2-(methylamino)benzoate | ESD-846192-1G |
Cas.: 119018-29-0 | Purity: 98% | 4-[2-[(3-Ethyl-4-methyl-2-oxo-3-pyrrolin-1-yl)carboxamido]ethyl]benzenesulfonamide | ESD-846193-1G |
Cas.: 1092683-57-2 | Purity: 95% | 4-Bromo-1H-pyrazole-5-carboxylic acid | ESD-846194-250MG |
Cas.: 1092683-57-2 | Purity: 95% | 4-Bromo-1H-pyrazole-5-carboxylic acid | ESD-846194-1G |
Cas.: 30925-12-3 | Purity: 95% | Boc-DN-Me-Phg-OH | ESD-846195-250MG |
Cas.: 30925-12-3 | Purity: 95% | Boc-DN-Me-Phg-OH | ESD-846195-1G |
Cas.: 914916-98-6 | Purity: 98% | 6-Amino-5-chloro-4-pyrimidinecarboxylic acid | ESD-846196-250MG |
Cas.: 914916-98-6 | Purity: 98% | 6-Amino-5-chloro-4-pyrimidinecarboxylic acid | ESD-846196-1G |
Cas.: 448-38-4 | Purity: 98% | 4-Chloro-2-nitro-1-(trifluoromethoxy)benzene | ESD-846197-250MG |
Cas.: 448-38-4 | Purity: 98% | 4-Chloro-2-nitro-1-(trifluoromethoxy)benzene | ESD-846197-1G |
Cas.: 7116-38-3 | Purity: 96% | Ethyl 3-(4-fluorophenyl)propanoate | ESD-846198-250MG |
Cas.: 7116-38-3 | Purity: 96% | Ethyl 3-(4-fluorophenyl)propanoate | ESD-846198-1G |
Cas.: 43141-66-8 | Purity: 98% | 1-Chloro-4-(difluoromethyl)benzene | ESD-846199-250MG |
Cas.: 43141-66-8 | Purity: 98% | 1-Chloro-4-(difluoromethyl)benzene | ESD-846199-1G |
Cas.: 86028-91-3 | Purity: 98% | (R)-Ethyl thiazolidine-4-carboxylate hydrochloride | ESD-846200-250MG |
Cas.: 86028-91-3 | Purity: 98% | (R)-Ethyl thiazolidine-4-carboxylate hydrochloride | ESD-846200-1G |
Cas.: 89283-92-1 | Purity: 98% | 5-Bromo-4-chloropyridin-3-amine | ESD-846201-250MG |
Cas.: 89283-92-1 | Purity: 98% | 5-Bromo-4-chloropyridin-3-amine | ESD-846201-1G |
Cas.: 886369-02-4 | Purity: 98% | 2-(3-Bromophenyl)thiazole-4-carboxylic acid | ESD-846202-250MG |
Cas.: 886369-02-4 | Purity: 98% | 2-(3-Bromophenyl)thiazole-4-carboxylic acid | ESD-846202-1G |
Cas.: 1433960-19-0 | Purity: 95% | Sodium 2-(dimethylamino)-1-hydroxyethanesulfonate | ESD-846203-250MG |
Cas.: 1354050-38-6 | Purity: 97% | 4-Bromo-2,6-dimethoxybenzaldehyde | ESD-846204-250MG |
Cas.: 1354050-38-6 | Purity: 97% | 4-Bromo-2,6-dimethoxybenzaldehyde | ESD-846204-1G |
Cas.: 1022150-12-4 | Purity: 98% | Btk inhibitor 1 R enantiomer | ESD-846205-250MG |
Cas.: 1022150-12-4 | Purity: 98% | Btk inhibitor 1 R enantiomer | ESD-846205-1G |
Cas.: 173435-41-1 | Purity: 98% | Methyl 3-amino-2-chloroisonicotinate | ESD-846206-250MG |
Cas.: 173435-41-1 | Purity: 98% | Methyl 3-amino-2-chloroisonicotinate | ESD-846206-1G |
Cas.: 20845-17-4 | Purity: 95% | (S)-Allyl 2-aminopropanoate 4-methylbenzenesulfonate | ESD-846207-250MG |
Cas.: 20845-17-4 | Purity: 95% | (S)-Allyl 2-aminopropanoate 4-methylbenzenesulfonate | ESD-846207-1G |
Cas.: 32968-78-8 | Purity: 97% | (2S,4R)-4-Hydroxypyrrolidine-2-carboxylic acid hydrochloride | ESD-846208-250MG |
Cas.: 32968-78-8 | Purity: 97% | (2S,4R)-4-Hydroxypyrrolidine-2-carboxylic acid hydrochloride | ESD-846208-1G |
Cas.: 14920-92-4 | Purity: 95% | 1,1,1,3,3-Pentamethyl-3-phenyldisiloxane | ESD-846209-250MG |
Cas.: 14920-92-4 | Purity: 95% | 1,1,1,3,3-Pentamethyl-3-phenyldisiloxane | ESD-846209-1G |
Cas.: 1263374-42-0 | Purity: 98% | (2,3-Difluoropyridin-4-yl)boronic acid | ESD-846210-250MG |
Cas.: 1263374-42-0 | Purity: 98% | (2,3-Difluoropyridin-4-yl)boronic acid | ESD-846210-1G |
Cas.: 312325-72-7 | Purity: 97% | 2-(5-Bromopyridin-2-yl)acetonitrile | ESD-846211-250MG |
Cas.: 312325-72-7 | Purity: 97% | 2-(5-Bromopyridin-2-yl)acetonitrile | ESD-846211-1G |
Cas.: 116423-58-6 | Purity: 98% | 2-Amino-5-hydroxybenzonitrile | ESD-846212-250MG |
Cas.: 116423-58-6 | Purity: 98% | 2-Amino-5-hydroxybenzonitrile | ESD-846212-1G |
Cas.: 77-38-3 | Purity: 98% | Chlorphenoxamine | ESD-846213-50MG |
Cas.: 1072433-59-0 | Purity: 98% | 5-Iodo-1-methyl-1H-indazole | ESD-846214-50MG |
Cas.: 1072433-59-0 | Purity: 98% | 5-Iodo-1-methyl-1H-indazole | ESD-846214-250MG |
Cas.: 95891-30-8 | Purity: 98% | 6-Hydroxynicotinonitrile | ESD-846215-250MG |
Cas.: 95891-30-8 | Purity: 98% | 6-Hydroxynicotinonitrile | ESD-846215-1G |
Cas.: 1210781-03-5 | Purity: 98% | 6-Chloro-1-methyl-1H-indazole | ESD-846216-50MG |
Cas.: 1210781-03-5 | Purity: 98% | 6-Chloro-1-methyl-1H-indazole | ESD-846216-250MG |
Cas.: 1150102-47-8 | Purity: 97% | 6-Bromo-N1-methylbenzene-1,2-diamine | ESD-846217-50MG |
Cas.: 1150102-47-8 | Purity: 97% | 6-Bromo-N1-methylbenzene-1,2-diamine | ESD-846217-250MG |
Cas.: 1035458-54-8 | Purity: 95% | 4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)quinoline | ESD-846218-50MG |
Cas.: 1035458-54-8 | Purity: 95% | 4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)quinoline | ESD-846218-250MG |
Cas.: 947249-13-0 | Purity: 98% | 5-Bromo-3-(difluoromethoxy)pyridin-2-amine | ESD-846219-50MG |
Cas.: 947249-13-0 | Purity: 98% | 5-Bromo-3-(difluoromethoxy)pyridin-2-amine | ESD-846219-250MG |
Cas.: 588720-14-3 | Purity: 95% | 7-Chloropyrrolo[1,2-c]pyrimidine-3-carboxylic acid hydrochloride | ESD-846220-50MG |
Cas.: 588720-14-3 | Purity: 95% | 7-Chloropyrrolo[1,2-c]pyrimidine-3-carboxylic acid hydrochloride | ESD-846220-250MG |
Cas.: 73406-50-5 | Purity: 98% | Ethyl 3-hydroxypicolinate | ESD-846221-50MG |
Cas.: 73406-50-5 | Purity: 98% | Ethyl 3-hydroxypicolinate | ESD-846221-250MG |
Cas.: 1131587-92-2 | Purity: 98% | Methyl 5-bromo-2-hydroxy-4-(trifluoromethyl)benzoate | ESD-846222-50MG |
Cas.: 1131587-92-2 | Purity: 98% | Methyl 5-bromo-2-hydroxy-4-(trifluoromethyl)benzoate | ESD-846222-250MG |
Cas.: 30451-49-1 | Purity: 98% | 3-Methyl-[1,1′-biphenyl]-4-ol | ESD-846223-50MG |
Cas.: 30451-49-1 | Purity: 98% | 3-Methyl-[1,1′-biphenyl]-4-ol | ESD-846223-250MG |
Cas.: 101410-18-8 | Purity: ≥98% | (S)-tert-Butyl 2-carbamothioylpyrrolidine-1-carboxylate | ESD-846224-50MG |
Cas.: 101410-18-8 | Purity: ≥98% | (S)-tert-Butyl 2-carbamothioylpyrrolidine-1-carboxylate | ESD-846224-250MG |
Cas.: 956218-04-5 | Purity: 97% | 2-Bromo-4-cyanobenzoic acid | ESD-846225-50MG |
Cas.: 956218-04-5 | Purity: 97% | 2-Bromo-4-cyanobenzoic acid | ESD-846225-250MG |
Cas.: 1187928-58-0 | Purity: 97% | 1-Isopropylpiperazin-2-one hydrochloride | ESD-846226-50MG |
Cas.: 1187928-58-0 | Purity: 97% | 1-Isopropylpiperazin-2-one hydrochloride | ESD-846226-250MG |
Cas.: 90345-24-7 | Purity: 95% | 2-Amino-1-(pyridin-2-yl)ethanol dihydrochloride | ESD-846227-50MG |
Cas.: 90345-24-7 | Purity: 95% | 2-Amino-1-(pyridin-2-yl)ethanol dihydrochloride | ESD-846227-250MG |
Cas.: 119248-43-0 | Purity: 98% | 1H-Pyrrolo[3,2-c]pyridine-3-carboxylic acid | ESD-846228-50MG |
Cas.: 119248-43-0 | Purity: 98% | 1H-Pyrrolo[3,2-c]pyridine-3-carboxylic acid | ESD-846228-250MG |
Cas.: 37964-17-3 | Purity: 98% | Ethyl 1H-pyrrole-3-carboxylate | ESD-846229-25MG |
Cas.: 37964-17-3 | Purity: 98% | Ethyl 1H-pyrrole-3-carboxylate | ESD-846229-100MG |
Cas.: 941717-06-2 | Purity: 95% | 4-((2-(Bromomethyl)phenyl)sulfonyl)morpholine | ESD-846230-25MG |
Cas.: 941717-06-2 | Purity: 95% | 4-((2-(Bromomethyl)phenyl)sulfonyl)morpholine | ESD-846230-100MG |
Cas.: 552331-87-0 | Purity: 97% | 7-Bromo-2-methylquinazoline | ESD-846231-25MG |
Cas.: 552331-87-0 | Purity: 97% | 7-Bromo-2-methylquinazoline | ESD-846231-100MG |
Cas.: 54396-74-6 | Purity: 97% | Methyl 3-oxocyclohex-1-enecarboxylate | ESD-846232-25MG |
Cas.: 54396-74-6 | Purity: 97% | Methyl 3-oxocyclohex-1-enecarboxylate | ESD-846232-100MG |
Cas.: 87611-00-5 | Purity: 97% | 2,4-Dichloro-5-fluoroquinazoline | ESD-846233-25MG |
Cas.: 87611-00-5 | Purity: 97% | 2,4-Dichloro-5-fluoroquinazoline | ESD-846233-100MG |
Cas.: 884860-63-3 | Purity: 97% | 2-Chlorothiazolo[4,5-c]pyridine | ESD-846234-25MG |
Cas.: 884860-63-3 | Purity: 97% | 2-Chlorothiazolo[4,5-c]pyridine | ESD-846234-100MG |
Cas.: 898044-55-8 | Purity: 98% | 4-Chloro-5-fluoro-6-methylpyrimidine | ESD-846235-25MG |
Cas.: 898044-55-8 | Purity: 98% | 4-Chloro-5-fluoro-6-methylpyrimidine | ESD-846235-100MG |
Cas.: 263012-63-1 | Purity: 95% | 2-Chloro-5-ethynylpyridine | ESD-846236-25MG |
Cas.: 263012-63-1 | Purity: 95% | 2-Chloro-5-ethynylpyridine | ESD-846236-100MG |
Cas.: 1060805-97-1 | Purity: 98% | 6-Bromo-2-methylnicotinic acid | ESD-846237-25MG |
Cas.: 1060805-97-1 | Purity: 98% | 6-Bromo-2-methylnicotinic acid | ESD-846237-100MG |
Cas.: 858279-01-3 | Purity: 97% | 2,4-Dichloro-5,6,7,8-tetrahydroquinoline | ESD-846238-25MG |
Cas.: 858279-01-3 | Purity: 97% | 2,4-Dichloro-5,6,7,8-tetrahydroquinoline | ESD-846238-100MG |
Cas.: 67346-74-1 | Purity: 97% | 3-Ethynylpyridin-2-amine | ESD-846239-25MG |
Cas.: 67346-74-1 | Purity: 97% | 3-Ethynylpyridin-2-amine | ESD-846239-100MG |
Cas.: 304876-29-7 | Purity: 97% | 2′,3′,5′,6′-Tetrahydrospiro[indoline-3,4′-pyran]-2-one | ESD-846240-25MG |
Cas.: 304876-29-7 | Purity: 97% | 2′,3′,5′,6′-Tetrahydrospiro[indoline-3,4′-pyran]-2-one | ESD-846240-100MG |
Cas.: 58123-72-1 | Purity: 96% | 3-Chloro-4-iodobenzoic acid | ESD-846241-25MG |
Cas.: 58123-72-1 | Purity: 96% | 3-Chloro-4-iodobenzoic acid | ESD-846241-100MG |
Cas.: 5400-75-9 | Purity: 97% | 5-Methyl-1H-benzo[d]imidazol-2(3H)-one | ESD-846242-250MG |
Cas.: 5400-75-9 | Purity: 97% | 5-Methyl-1H-benzo[d]imidazol-2(3H)-one | ESD-846242-1G |
Cas.: 1193389-40-0 | Purity: 97% | 1-(4-Bromophenyl)cyclobutanamine hydrochloride | ESD-846243-25MG |
Cas.: 1193389-40-0 | Purity: 97% | 1-(4-Bromophenyl)cyclobutanamine hydrochloride | ESD-846243-100MG |
Cas.: 1186049-30-8 | Purity: 95% | (R)-1,1,1-Trifluoro-N-(pyrrolidin-2-ylmethyl)methanesulfonamide | ESD-846244-25MG |
Cas.: 1186049-30-8 | Purity: 95% | (R)-1,1,1-Trifluoro-N-(pyrrolidin-2-ylmethyl)methanesulfonamide | ESD-846244-100MG |
Cas.: 34170-21-3 | Purity: 97% | 2-(Methylthio)-5,6,7,8-tetrahydroquinazolin-4(3H)-one | ESD-846245-25MG |
Cas.: 34170-21-3 | Purity: 97% | 2-(Methylthio)-5,6,7,8-tetrahydroquinazolin-4(3H)-one | ESD-846245-100MG |
Cas.: 101079-62-3 | Purity: 98% | 6-Chloro-3-methylpyrimidin-4(3H)-one | ESD-846246-25MG |
Cas.: 101079-62-3 | Purity: 98% | 6-Chloro-3-methylpyrimidin-4(3H)-one | ESD-846246-100MG |
Cas.: 317334-58-0 | Purity: 97% | Methyl 4-methylpyrimidine-2-carboxylate | ESD-846247-25MG |
Cas.: 317334-58-0 | Purity: 97% | Methyl 4-methylpyrimidine-2-carboxylate | ESD-846247-100MG |
Cas.: 955400-50-7 | Purity: 98% | 2-(4-(Dimethylamino)phenyl)thiazole-4-carboxylic acid | ESD-846248-25MG |
Cas.: 955400-50-7 | Purity: 98% | 2-(4-(Dimethylamino)phenyl)thiazole-4-carboxylic acid | ESD-846248-100MG |
Cas.: 887267-08-5 | Purity: 97% | 3-Fluoro-5-hydroxy-4-methylbenzoic acid | ESD-846249-25MG |
Cas.: 887267-08-5 | Purity: 97% | 3-Fluoro-5-hydroxy-4-methylbenzoic acid | ESD-846249-100MG |
Cas.: 193274-53-2 | Purity: 95% | Methyl 1-Boc-3-methyl-4-oxo-piperidine-3-carboxylate | ESD-846250-25MG |
Cas.: 193274-53-2 | Purity: 95% | Methyl 1-Boc-3-methyl-4-oxo-piperidine-3-carboxylate | ESD-846250-100MG |
Cas.: 613262-16-1 | Purity: 95% | 5-Bromobenzo[d]isothiazol-3-amine | ESD-846251-25MG |
Cas.: 613262-16-1 | Purity: 95% | 5-Bromobenzo[d]isothiazol-3-amine | ESD-846251-100MG |
Cas.: 193966-70-0 | Purity: 97% | Methyl 5-(bromomethyl)pyrazine-2-carboxylate | ESD-846252-25MG |
Cas.: 193966-70-0 | Purity: 97% | Methyl 5-(bromomethyl)pyrazine-2-carboxylate | ESD-846252-100MG |
Cas.: 104291-83-0 | Purity: 97% | Methyl 6-cyano-1H-indole-2-carboxylate | ESD-846253-25MG |
Cas.: 104291-83-0 | Purity: 97% | Methyl 6-cyano-1H-indole-2-carboxylate | ESD-846253-100MG |
Cas.: 1023814-35-8 | Purity: 95% | 2-Amino-5-methylnicotinaldehyde | ESD-846254-25MG |
Cas.: 1023814-35-8 | Purity: 95% | 2-Amino-5-methylnicotinaldehyde | ESD-846254-100MG |
Cas.: 84538-40-9 | Purity: 98% | 2,4-Dimethoxy-5H-pyrrolo[3,2-d]pyrimidine | ESD-846256-25MG |
Cas.: 84538-40-9 | Purity: 98% | 2,4-Dimethoxy-5H-pyrrolo[3,2-d]pyrimidine | ESD-846256-100MG |
Cas.: 37641-35-3 | Purity: 95% | Methyl 5-methyl-1,3,4-oxadiazole-2-carboxylate | ESD-846257-25MG |
Cas.: 37641-35-3 | Purity: 95% | Methyl 5-methyl-1,3,4-oxadiazole-2-carboxylate | ESD-846257-100MG |
Cas.: 1060815-92-0 | Purity: 97% | 4-Chloro-5-iodo-2-methyl-7H-pyrrolo[2,3-d]pyrimidine | ESD-846258-25MG |
Cas.: 1060815-92-0 | Purity: 97% | 4-Chloro-5-iodo-2-methyl-7H-pyrrolo[2,3-d]pyrimidine | ESD-846258-100MG |
Cas.: 1196156-95-2 | Purity: 95% | 5-Chloro-2-ethynylpyrimidine | ESD-846259-25MG |
Cas.: 1196156-95-2 | Purity: 95% | 5-Chloro-2-ethynylpyrimidine | ESD-846259-100MG |
Cas.: 214759-66-7 | Purity: 98% | Methyl 3-chloro-4-cyanobenzoate | ESD-846260-25MG |
Cas.: 214759-66-7 | Purity: 98% | Methyl 3-chloro-4-cyanobenzoate | ESD-846260-100MG |
Cas.: 80238-12-6 | Purity: 96% | 2,6-Dimethylterephthalic acid | ESD-846261-25MG |
Cas.: 80238-12-6 | Purity: 96% | 2,6-Dimethylterephthalic acid | ESD-846261-100MG |
Cas.: 53242-51-6 | Purity: 95% | 5-(4-Methoxyphenyl)pyridin-2(1H)-one | ESD-846262-25MG |
Cas.: 53242-51-6 | Purity: 95% | 5-(4-Methoxyphenyl)pyridin-2(1H)-one | ESD-846262-100MG |
Cas.: 99822-24-9 | Purity: 98% | 6-Fluorobenzo[d]isoxazol-3(2H)-one | ESD-846263-25MG |
Cas.: 99822-24-9 | Purity: 98% | 6-Fluorobenzo[d]isoxazol-3(2H)-one | ESD-846263-100MG |
Cas.: 132475-93-5 | Purity: 97% | 2-Isopropyl-5-nitroaniline | ESD-846264-25MG |
Cas.: 132475-93-5 | Purity: 97% | 2-Isopropyl-5-nitroaniline | ESD-846264-100MG |
Cas.: 1256819-16-5 | Purity: 98% | 5-Chloro-2-methylnicotinonitrile | ESD-846265-25MG |
Cas.: 1256819-16-5 | Purity: 98% | 5-Chloro-2-methylnicotinonitrile | ESD-846265-100MG |
Cas.: 882679-56-3 | Purity: 97% | Ethyl 6-bromoisoquinoline-3-carboxylate | ESD-846266-25MG |
Cas.: 882679-56-3 | Purity: 97% | Ethyl 6-bromoisoquinoline-3-carboxylate | ESD-846266-100MG |
Cas.: 1001020-14-9 | Purity: 97% | 3-(Trifluoromethyl)-1H-pyrazole-4-carbaldehyde | ESD-846267-25MG |
Cas.: 1001020-14-9 | Purity: 97% | 3-(Trifluoromethyl)-1H-pyrazole-4-carbaldehyde | ESD-846267-100MG |
Cas.: 408314-14-7 | Purity: 95% | 6-Chloro-1H-[1,2,3]triazolo[4,5-b]pyridine | ESD-846268-25MG |
Cas.: 408314-14-7 | Purity: 95% | 6-Chloro-1H-[1,2,3]triazolo[4,5-b]pyridine | ESD-846268-100MG |
Cas.: 6629-29-4 | Purity: 98% | 4-Methyl-5-nitrobenzene-1,3-diamine | ESD-846269-25MG |
Cas.: 6629-29-4 | Purity: 98% | 4-Methyl-5-nitrobenzene-1,3-diamine | ESD-846269-100MG |
Cas.: 222978-02-1 | Purity: 98% | 2-Fluoro-4-(hydroxymethyl)benzonitrile | ESD-846270-250MG |
Cas.: 222978-02-1 | Purity: 98% | 2-Fluoro-4-(hydroxymethyl)benzonitrile | ESD-846270-1G |
Cas.: 41959-35-7 | Purity: 98% | 6-Nitro-1,2,3,4-tetrahydroquinoxaline | ESD-846271-250MG |
Cas.: 41959-35-7 | Purity: 98% | 6-Nitro-1,2,3,4-tetrahydroquinoxaline | ESD-846271-1G |
Cas.: 937591-69-0 | Purity: 97% | 2-(2,3-Dihydrobenzofuran-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-846272-250MG |
Cas.: 937591-69-0 | Purity: 97% | 2-(2,3-Dihydrobenzofuran-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-846272-1G |
Cas.: 94166-64-0 | Purity: 97% | 2-Chloro-6-nitropyridine | ESD-846273-250MG |
Cas.: 94166-64-0 | Purity: 97% | 2-Chloro-6-nitropyridine | ESD-846273-1G |
Cas.: 206997-15-1 | Purity: 98% | 2-Amino-5-bromonicotinaldehyde | ESD-846274-50MG |
Cas.: 206997-15-1 | Purity: 98% | 2-Amino-5-bromonicotinaldehyde | ESD-846274-250MG |
Cas.: 898547-72-3 | Purity: 95% | 5-(Methylsulfonyl)-2-nitrobenzoic acid | ESD-846275-50MG |
Cas.: 898547-72-3 | Purity: 95% | 5-(Methylsulfonyl)-2-nitrobenzoic acid | ESD-846275-250MG |
Cas.: 832710-65-3 | Purity: 97% | 2,8-Diazaspiro[4.5]decan-1-one hydrochloride | ESD-846276-50MG |
Cas.: 832710-65-3 | Purity: 97% | 2,8-Diazaspiro[4.5]decan-1-one hydrochloride | ESD-846276-250MG |
Cas.: 65214-86-0 | Purity: 95% | 4-Diphenylmethoxypiperidine hydrochloride | ESD-846277-50MG |
Cas.: 65214-86-0 | Purity: 95% | 4-Diphenylmethoxypiperidine hydrochloride | ESD-846277-250MG |
Cas.: 1227489-72-6 | Purity: 97% | 3-Nitro-4-(trifluoromethyl)benzonitrile | ESD-846278-50MG |
Cas.: 1227489-72-6 | Purity: 97% | 3-Nitro-4-(trifluoromethyl)benzonitrile | ESD-846278-250MG |
Cas.: 1001413-01-9 | Purity: 95% | 1-(3,4-Difluorobenzyl)-2-oxo-1,2-dihydropyridine-3-carboxylic acid | ESD-846279-50MG |
Cas.: 1001413-01-9 | Purity: 95% | 1-(3,4-Difluorobenzyl)-2-oxo-1,2-dihydropyridine-3-carboxylic acid | ESD-846279-250MG |
Cas.: 1186663-54-6 | Purity: 95% | 2-Chloro-4-(1H-pyrazol-1-yl)benzaldehyde | ESD-846281-250MG |
Cas.: 1186663-54-6 | Purity: 95% | 2-Chloro-4-(1H-pyrazol-1-yl)benzaldehyde | ESD-846281-1G |
Cas.: 134044-63-6 | Purity: 97% | Ethyl 3-bromoimidazo[1,2-a]pyrimidine-2-carboxylate | ESD-846282-50MG |
Cas.: 134044-63-6 | Purity: 97% | Ethyl 3-bromoimidazo[1,2-a]pyrimidine-2-carboxylate | ESD-846282-250MG |
Cas.: 37866-45-8 | Purity: 97% | 2-(Aminooxy)ethanamine dihydrochloride | ESD-846283-50MG |
Cas.: 37866-45-8 | Purity: 97% | 2-(Aminooxy)ethanamine dihydrochloride | ESD-846283-250MG |
Cas.: 73101-09-4 | Purity: 97% | 2-Amino-2-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)acetic acid | ESD-846284-50MG |
Cas.: 73101-09-4 | Purity: 97% | 2-Amino-2-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)acetic acid | ESD-846284-250MG |
Cas.: 86447-11-2 | Purity: 98% | 1-Boc-1,2,5,6-tetrahydropyridine-3-carboxylic acid | ESD-846285-50MG |
Cas.: 86447-11-2 | Purity: 98% | 1-Boc-1,2,5,6-tetrahydropyridine-3-carboxylic acid | ESD-846285-250MG |
Cas.: 24188-72-5 | Purity: 97% | 5-Methylisoquinolin-1(2H)-one | ESD-846286-50MG |
Cas.: 24188-72-5 | Purity: 97% | 5-Methylisoquinolin-1(2H)-one | ESD-846286-250MG |
Cas.: 1095708-32-9 | Purity: 98% | tert-Butyl (4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)carbamate | ESD-846287-50MG |
Cas.: 1095708-32-9 | Purity: 98% | tert-Butyl (4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)carbamate | ESD-846287-250MG |
Cas.: 908248-27-1 | Purity: 95% | 2-Amino-5-nitropyridin-3-ol | ESD-846288-50MG |
Cas.: 908248-27-1 | Purity: 95% | 2-Amino-5-nitropyridin-3-ol | ESD-846288-250MG |
Cas.: 1122090-95-2 | Purity: 95% | 2,5-Dichloro-4-methoxypyridine | ESD-846289-50MG |
Cas.: 1122090-95-2 | Purity: 95% | 2,5-Dichloro-4-methoxypyridine | ESD-846289-250MG |
Cas.: 433683-01-3 | Purity: 95% | tert-Butyl 4-acetyl-2,2-dimethyloxazolidine-3-carboxylate | ESD-846290-50MG |
Cas.: 433683-01-3 | Purity: 95% | tert-Butyl 4-acetyl-2,2-dimethyloxazolidine-3-carboxylate | ESD-846290-250MG |
Cas.: 1254073-41-0 | Purity: 95% | 5-Fluoropicolinohydrazide | ESD-846291-50MG |
Cas.: 1254073-41-0 | Purity: 95% | 5-Fluoropicolinohydrazide | ESD-846291-250MG |
Cas.: 1260771-53-6 | Purity: 97% | 1H-Pyrrolo[3,2-b]pyridin-5-amine hydrochloride | ESD-846292-50MG |
Cas.: 1260771-53-6 | Purity: 97% | 1H-Pyrrolo[3,2-b]pyridin-5-amine hydrochloride | ESD-846292-250MG |
Cas.: 1251734-12-9 | Purity: 97% | tert-Butyl (5-methylthiophen-3-yl)carbamate | ESD-846293-50MG |
Cas.: 1251734-12-9 | Purity: 97% | tert-Butyl (5-methylthiophen-3-yl)carbamate | ESD-846293-250MG |
Cas.: 109113-98-6 | Purity: 97% | 6-(Trifluoromethyl)imidazo[2,1-b]thiazole | ESD-846294-50MG |
Cas.: 109113-98-6 | Purity: 97% | 6-(Trifluoromethyl)imidazo[2,1-b]thiazole | ESD-846294-250MG |
Cas.: 57699-28-2 | Purity: 97% | Methyl 2-(4-bromophenyl)-2-oxoacetate | ESD-846295-50MG |
Cas.: 57699-28-2 | Purity: 97% | Methyl 2-(4-bromophenyl)-2-oxoacetate | ESD-846295-250MG |
Cas.: 1206977-80-1 | Purity: 98% | 2-Chloro-3-(difluoromethoxy)pyridine | ESD-846296-50MG |
Cas.: 1206977-80-1 | Purity: 98% | 2-Chloro-3-(difluoromethoxy)pyridine | ESD-846296-250MG |
Cas.: 20090-58-8 | Purity: 97% | 4-Chloro-5-methylpyrimidin-2-amine | ESD-846297-250MG |
Cas.: 20090-58-8 | Purity: 97% | 4-Chloro-5-methylpyrimidin-2-amine | ESD-846297-1G |
Cas.: 601515-49-5 | Purity: 95% | 5,6,7,8-Tetrahydroimidazo[1,5-a]pyrazine hydrochloride | ESD-846298-25MG |
Cas.: 601515-49-5 | Purity: 95% | 5,6,7,8-Tetrahydroimidazo[1,5-a]pyrazine hydrochloride | ESD-846298-100MG |
Cas.: 50741-36-1 | Purity: 97% | 1,2,3,4-Tetrahydroquinoline-6-carbonitrile | ESD-846299-25MG |
Cas.: 50741-36-1 | Purity: 97% | 1,2,3,4-Tetrahydroquinoline-6-carbonitrile | ESD-846299-100MG |
Cas.: 149572-97-4 | Purity: 95% | (R)-3-Aminooxetan-2-one 4-methylbenzenesulfonate | ESD-846300-25MG |
Cas.: 149572-97-4 | Purity: 95% | (R)-3-Aminooxetan-2-one 4-methylbenzenesulfonate | ESD-846300-100MG |
Cas.: 199177-26-9 | Purity: 98% | 3-Bromo-5-hydroxybenzaldehyde | ESD-846301-250MG |
Cas.: 199177-26-9 | Purity: 98% | 3-Bromo-5-hydroxybenzaldehyde | ESD-846301-1G |
Cas.: 70049-46-6 | Purity: 98% | 2,4-Dichloro-6-methoxyquinoline | ESD-846302-50MG |
Cas.: 70049-46-6 | Purity: 98% | 2,4-Dichloro-6-methoxyquinoline | ESD-846302-250MG |
Cas.: 101860-97-3 | Purity: 95% | 2-(2-Aminopyridin-3-yl)acetic acid | ESD-846303-25MG |
Cas.: 101860-97-3 | Purity: 95% | 2-(2-Aminopyridin-3-yl)acetic acid | ESD-846303-100MG |
Cas.: 137081-41-5 | Purity: 97% | 1-Fluorocyclopropanecarboxylic acid | ESD-846304-25MG |
Cas.: 137081-41-5 | Purity: 97% | 1-Fluorocyclopropanecarboxylic acid | ESD-846304-100MG |
Cas.: 127199-45-5 | Purity: 98% | (S)-tert-Butyl 5-azaspiro[2.4]heptan-7-ylcarbamate | ESD-846305-25MG |
Cas.: 127199-45-5 | Purity: 98% | (S)-tert-Butyl 5-azaspiro[2.4]heptan-7-ylcarbamate | ESD-846305-100MG |
Cas.: 221095-80-3 | Purity: 97% | Azetidin-3-ylmethanamine dihydrochloride | ESD-846306-25MG |
Cas.: 221095-80-3 | Purity: 97% | Azetidin-3-ylmethanamine dihydrochloride | ESD-846306-100MG |
Cas.: 86882-92-0 | Purity: 98% | Ethyl 3-amino-5,6-dichloropyrazine-2-carboxylate | ESD-846307-25MG |
Cas.: 86882-92-0 | Purity: 98% | Ethyl 3-amino-5,6-dichloropyrazine-2-carboxylate | ESD-846307-100MG |
Cas.: 1254319-51-1 | Purity: 97% | 6-Bromo-2-methylisoindolin-1-one | ESD-846308-25MG |
Cas.: 1254319-51-1 | Purity: 97% | 6-Bromo-2-methylisoindolin-1-one | ESD-846308-100MG |
Cas.: 223576-64-5 | Purity: 98% | (5-Chlorobenzofuran-2-yl)boronic acid | ESD-846309-25MG |
Cas.: 223576-64-5 | Purity: 98% | (5-Chlorobenzofuran-2-yl)boronic acid | ESD-846309-100MG |
Cas.: 141646-00-6 | Purity: 97% | Mometasone furoate hydrate | ESD-846310-25MG |
Cas.: 141646-00-6 | Purity: 97% | Mometasone furoate hydrate | ESD-846310-100MG |
Cas.: 954236-44-3 | Purity: 97% | tert-Butyl 3-oxo-1-oxa-8-azaspiro[4.5]decane-8-carboxylate | ESD-846311-25MG |
Cas.: 954236-44-3 | Purity: 97% | tert-Butyl 3-oxo-1-oxa-8-azaspiro[4.5]decane-8-carboxylate | ESD-846311-100MG |
Cas.: 29655-79-6 | Purity: 95% | Ethyl 2-((2-ethoxy-2-oxoethyl)amino)-2-oxoacetate | ESD-846312-250MG |
Cas.: 29655-79-6 | Purity: 95% | Ethyl 2-((2-ethoxy-2-oxoethyl)amino)-2-oxoacetate | ESD-846312-1G |
Cas.: 13627-49-1 | Purity: 97% | 2-Methylpyrimidine-4-carboxylic acid | ESD-846313-250MG |
Cas.: 13627-49-1 | Purity: 97% | 2-Methylpyrimidine-4-carboxylic acid | ESD-846313-1G |
Cas.: 13138-33-5 | Purity: 98% | 3-Aminopropylphosphonic acid | ESD-846314-250MG |
Cas.: 13138-33-5 | Purity: 98% | 3-Aminopropylphosphonic acid | ESD-846314-1G |
Cas.: 689291-89-2 | Purity: 98% | 5-Bromo-2-iodobenzaldehyde | ESD-846315-250MG |
Cas.: 689291-89-2 | Purity: 98% | 5-Bromo-2-iodobenzaldehyde | ESD-846315-1G |
Cas.: 206055-86-9 | Purity: 97% | [3-(4-Methoxyphenyl)isoxazol-5-yl]methanol | ESD-846316-250MG |
Cas.: 206055-86-9 | Purity: 97% | [3-(4-Methoxyphenyl)isoxazol-5-yl]methanol | ESD-846316-1G |
Cas.: 344296-05-5 | Purity: 95% | 2-Bromo-6-methoxy-3-nitropyridine | ESD-846317-250MG |
Cas.: 344296-05-5 | Purity: 95% | 2-Bromo-6-methoxy-3-nitropyridine | ESD-846317-1G |
Cas.: 6083-47-2 | Purity: 98% | 4-(Dimethylamino)benzamide | ESD-846318-250MG |
Cas.: 6083-47-2 | Purity: 98% | 4-(Dimethylamino)benzamide | ESD-846318-1G |
Cas.: 82096-91-1 | Purity: 97% | 2-Chloro-4-(trifluoromethyl)benzaldehyde | ESD-846319-250MG |
Cas.: 82096-91-1 | Purity: 97% | 2-Chloro-4-(trifluoromethyl)benzaldehyde | ESD-846319-1G |
Cas.: 1027833-17-5 | Purity: 98% | 1-Bromo-2-chloro-5-fluoro-4-nitrobenzene | ESD-846320-250MG |
Cas.: 1027833-17-5 | Purity: 98% | 1-Bromo-2-chloro-5-fluoro-4-nitrobenzene | ESD-846320-1G |
Cas.: 1158741-90-2 | Purity: 97% | 1-(2,3-Dimethoxyphenyl)-N-methylmethanamine hydrochloride | ESD-846321-250MG |
Cas.: 1158741-90-2 | Purity: 97% | 1-(2,3-Dimethoxyphenyl)-N-methylmethanamine hydrochloride | ESD-846321-1G |
Cas.: 53934-76-2 | Purity: 97% | 2-Oxo-1-pyrrolidineacetic acid | ESD-846322-250MG |
Cas.: 53934-76-2 | Purity: 97% | 2-Oxo-1-pyrrolidineacetic acid | ESD-846322-1G |
Cas.: 7397-68-4 | Purity: 98% | 1H-Imidazo[4,5-c]pyridin-2(3H)-one | ESD-846323-250MG |
Cas.: 7397-68-4 | Purity: 98% | 1H-Imidazo[4,5-c]pyridin-2(3H)-one | ESD-846323-1G |
Cas.: 13258-59-8 | Purity: 97% | 2-Ethyl-6-methylpyridin-3-ol hydrochloride | ESD-846324-250MG |
Cas.: 13258-59-8 | Purity: 97% | 2-Ethyl-6-methylpyridin-3-ol hydrochloride | ESD-846324-1G |
Cas.: 3622-04-6 | Purity: 97% | Benzothiazole-2-carboxylic acid | ESD-846325-250MG |
Cas.: 3622-04-6 | Purity: 97% | Benzothiazole-2-carboxylic acid | ESD-846325-1G |
Cas.: 439918-59-9 | Purity: 98% | (R)-2-(Pyrrolidin-2-yl)acetic acid hydrochloride | ESD-846326-50MG |
Cas.: 439918-59-9 | Purity: 98% | (R)-2-(Pyrrolidin-2-yl)acetic acid hydrochloride | ESD-846326-250MG |
Cas.: 97421-13-1 | Purity: 98% | 1-(tert-Butyl)-1H-pyrazol-4-amine | ESD-846327-50MG |
Cas.: 97421-13-1 | Purity: 98% | 1-(tert-Butyl)-1H-pyrazol-4-amine | ESD-846327-250MG |
Cas.: 1184919-69-4 | Purity: 95% | 3-Aminocyclopentanol hydrochloride | ESD-846328-50MG |
Cas.: 1184919-69-4 | Purity: 95% | 3-Aminocyclopentanol hydrochloride | ESD-846328-250MG |
Cas.: 331958-90-8 | Purity: 97% | 4,4,5,5-Tetramethyl-2-(tetrahydrofuran-3-yl)-1,3,2-dioxaborolane | ESD-846329-50MG |
Cas.: 331958-90-8 | Purity: 97% | 4,4,5,5-Tetramethyl-2-(tetrahydrofuran-3-yl)-1,3,2-dioxaborolane | ESD-846329-250MG |
Cas.: 26829-43-6 | Purity: 97% | 6-Methoxyisoquinolin-1(2H)-one | ESD-846330-50MG |
Cas.: 26829-43-6 | Purity: 97% | 6-Methoxyisoquinolin-1(2H)-one | ESD-846330-250MG |
Cas.: 50870-44-5 | Purity: 96% | 1-(4-Bromo-3-methoxyphenyl)ethanone | ESD-846331-50MG |
Cas.: 50870-44-5 | Purity: 96% | 1-(4-Bromo-3-methoxyphenyl)ethanone | ESD-846331-250MG |
Cas.: 1356113-07-9 | Purity: 98% | 4-Bromo-3-fluoro-5-methylaniline | ESD-846332-50MG |
Cas.: 1356113-07-9 | Purity: 98% | 4-Bromo-3-fluoro-5-methylaniline | ESD-846332-250MG |
Cas.: 38480-94-3 | Purity: 97% | 2′,3′-Dimethoxyacetophenone | ESD-846333-50MG |
Cas.: 38480-94-3 | Purity: 97% | 2′,3′-Dimethoxyacetophenone | ESD-846333-250MG |
Cas.: 1111638-02-8 | Purity: 97% | 5-Bromo-2-methyl-7-azaindole | ESD-846334-25MG |
Cas.: 1111638-02-8 | Purity: 97% | 5-Bromo-2-methyl-7-azaindole | ESD-846334-100MG |
Cas.: 31872-98-7 | Purity: 95% | H-HoLeu-OH | ESD-846335-25MG |
Cas.: 31872-98-7 | Purity: 95% | H-HoLeu-OH | ESD-846335-100MG |
Cas.: 6149-52-6 | Purity: 97% | cis-Ethyl 2-hydroxycyclohexanecarboxylate | ESD-846336-25MG |
Cas.: 6149-52-6 | Purity: 97% | cis-Ethyl 2-hydroxycyclohexanecarboxylate | ESD-846336-100MG |
Cas.: 106047-38-5 | Purity: 95% | 5-Bromo-3,4′-bipyridine | ESD-846337-25MG |
Cas.: 106047-38-5 | Purity: 95% | 5-Bromo-3,4′-bipyridine | ESD-846337-100MG |
Cas.: 1315500-31-2 | Purity: 97% | (R)-Tetrahydro-2H-pyran-3-amine hydrochloride | ESD-846338-25MG |
Cas.: 1315500-31-2 | Purity: 97% | (R)-Tetrahydro-2H-pyran-3-amine hydrochloride | ESD-846338-100MG |
Cas.: 20090-59-9 | Purity: 98% | 4-Chloro-2-methylpyrimidin-5-amine | ESD-846339-25MG |
Cas.: 20090-59-9 | Purity: 98% | 4-Chloro-2-methylpyrimidin-5-amine | ESD-846339-100MG |
Cas.: 133099-11-3 | Purity: 97% | (S)-a,a-Diphenyl-3-pyrrolidineacetamide | ESD-846340-25MG |
Cas.: 133099-11-3 | Purity: 97% | (S)-a,a-Diphenyl-3-pyrrolidineacetamide | ESD-846340-100MG |
Cas.: 156816-78-3 | Purity: 97% | 2-Fluorocyclopropanecarboxylic acid | ESD-846341-25MG |
Cas.: 156816-78-3 | Purity: 97% | 2-Fluorocyclopropanecarboxylic acid | ESD-846341-100MG |
Cas.: 195045-26-2 | Purity: 98% | 3,5-Dichloro-2-methylpyridin-4-amine | ESD-846342-25MG |
Cas.: 195045-26-2 | Purity: 98% | 3,5-Dichloro-2-methylpyridin-4-amine | ESD-846342-100MG |
Cas.: 844501-00-4 | Purity: 97% | (1-(tert-Butoxycarbonyl)-1,2,3,6-tetrahydropyridin-4-yl)boronic acid | ESD-846343-25MG |
Cas.: 844501-00-4 | Purity: 97% | (1-(tert-Butoxycarbonyl)-1,2,3,6-tetrahydropyridin-4-yl)boronic acid | ESD-846343-100MG |
Cas.: 136927-63-4 | Purity: 98% | Pyrrolo[1,2-a]pyrazin-1(2H)-one | ESD-846344-25MG |
Cas.: 136927-63-4 | Purity: 98% | Pyrrolo[1,2-a]pyrazin-1(2H)-one | ESD-846344-100MG |
Cas.: 159087-46-4 | Purity: 95% | Trimethyl((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethynyl)silane | ESD-846345-25MG |
Cas.: 159087-46-4 | Purity: 95% | Trimethyl((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethynyl)silane | ESD-846345-100MG |
Cas.: 331949-55-4 | Purity: 95% | (6-Chloro-1-methyl-1H-benzo[d]imidazol-2-yl)methanol | ESD-846346-25MG |
Cas.: 331949-55-4 | Purity: 95% | (6-Chloro-1-methyl-1H-benzo[d]imidazol-2-yl)methanol | ESD-846346-100MG |
Cas.: 81606-48-6 | Purity: 98% | 2-(3-Bromophenyl)-2-methylpropan-1-ol | ESD-846347-25MG |
Cas.: 81606-48-6 | Purity: 98% | 2-(3-Bromophenyl)-2-methylpropan-1-ol | ESD-846347-100MG |
Cas.: 473416-33-0 | Purity: 98% | (5-Fluorobenzofuran-2-yl)boronic acid | ESD-846348-25MG |
Cas.: 473416-33-0 | Purity: 98% | (5-Fluorobenzofuran-2-yl)boronic acid | ESD-846348-100MG |
Cas.: 1708924-46-2 | Purity: 97% | N,N-Dimethyl-2-(3,4,5-trifluorophenoxy)ethanamine | ESD-846349-25MG |
Cas.: 1708924-46-2 | Purity: 97% | N,N-Dimethyl-2-(3,4,5-trifluorophenoxy)ethanamine | ESD-846349-100MG |
Cas.: 1708924-47-3 | Purity: 97% | 2-(3,4-Difluorophenoxy)-N,N-dimethylethanamine | ESD-846350-25MG |
Cas.: 1708924-47-3 | Purity: 97% | 2-(3,4-Difluorophenoxy)-N,N-dimethylethanamine | ESD-846350-100MG |
Cas.: 23600-83-1 | Purity: 98% | 1-(4-(Phenylamino)phenyl)ethanone | ESD-846351-25MG |
Cas.: 23600-83-1 | Purity: 98% | 1-(4-(Phenylamino)phenyl)ethanone | ESD-846351-100MG |
Cas.: 1052410-02-2 | Purity: 97% | 2-Phenyl-1H-imidazole-4-carboxylic acid hydrate | ESD-846352-25MG |
Cas.: 1052410-02-2 | Purity: 97% | 2-Phenyl-1H-imidazole-4-carboxylic acid hydrate | ESD-846352-100MG |
Cas.: 6200-60-8 | Purity: 98% | Imidazo[1,2-a]pyridine-3-carboxylic acid | ESD-846353-250MG |
Cas.: 6200-60-8 | Purity: 98% | Imidazo[1,2-a]pyridine-3-carboxylic acid | ESD-846353-1G |
Cas.: 26456-59-7 | Purity: 98% | Pyrimidin-5-ol | ESD-846354-250MG |
Cas.: 26456-59-7 | Purity: 98% | Pyrimidin-5-ol | ESD-846354-1G |
Cas.: 885519-03-9 | Purity: 98% | 4-Bromo-6-chloro-1H-indazole | ESD-846355-250MG |
Cas.: 885519-03-9 | Purity: 98% | 4-Bromo-6-chloro-1H-indazole | ESD-846355-1G |
Cas.: 36034-54-5 | Purity: 95% | 4-Methoxyisoquinoline | ESD-846356-250MG |
Cas.: 36034-54-5 | Purity: 95% | 4-Methoxyisoquinoline | ESD-846356-1G |
Cas.: 370104-72-6 | Purity: 98% | 5-Chloropyridine-2-carboxamide | ESD-846357-250MG |
Cas.: 370104-72-6 | Purity: 98% | 5-Chloropyridine-2-carboxamide | ESD-846357-1G |
Cas.: 66367-67-7 | Purity: 95% | 4-Methyl-5-phenyl-2H-pyrazol-3-ylamine | ESD-846358-250MG |
Cas.: 66367-67-7 | Purity: 95% | 4-Methyl-5-phenyl-2H-pyrazol-3-ylamine | ESD-846358-1G |
Cas.: 154590-34-8 | Purity: 95% | tert-Butyl 4-(2-fluoro-4-nitrophenyl)piperazine-1-carboxylate | ESD-846359-250MG |
Cas.: 154590-34-8 | Purity: 95% | tert-Butyl 4-(2-fluoro-4-nitrophenyl)piperazine-1-carboxylate | ESD-846359-1G |
Cas.: 158602-35-8 | Purity: 95% | tert-Butyl 3-(2-ethoxy-2-oxoethyl)azetidine-1-carboxylate | ESD-846360-250MG |
Cas.: 158602-35-8 | Purity: 95% | tert-Butyl 3-(2-ethoxy-2-oxoethyl)azetidine-1-carboxylate | ESD-846360-1G |
Cas.: 1202897-48-0 | Purity: 97% | Methyl 5-fluoro-2-iodobenzoate | ESD-846361-250MG |
Cas.: 1202897-48-0 | Purity: 97% | Methyl 5-fluoro-2-iodobenzoate | ESD-846361-1G |
Cas.: 517920-69-3 | Purity: 98% | 5-Bromo-3-fluorobenzene-1,2-diamine | ESD-846362-250MG |
Cas.: 517920-69-3 | Purity: 98% | 5-Bromo-3-fluorobenzene-1,2-diamine | ESD-846362-1G |
Cas.: 754214-42-1 | Purity: 98% | 1H-pyrrolo[2,3-b]pyridine-5-carboxylic acid | ESD-846363-250MG |
Cas.: 754214-42-1 | Purity: 98% | 1H-pyrrolo[2,3-b]pyridine-5-carboxylic acid | ESD-846363-1G |
Cas.: 59278-65-8 | Purity: 98% | 2-Amino-4-bromobenzaldehyde | ESD-846364-250MG |
Cas.: 59278-65-8 | Purity: 98% | 2-Amino-4-bromobenzaldehyde | ESD-846364-1G |
Cas.: 129872-81-7 | Purity: 97% | 2,4-Dichloro-5-methyl-5H-pyrrolo[3,2-d]pyrimidine | ESD-846365-50MG |
Cas.: 129872-81-7 | Purity: 97% | 2,4-Dichloro-5-methyl-5H-pyrrolo[3,2-d]pyrimidine | ESD-846365-250MG |
Cas.: 885223-65-4 | Purity: 95% | 5-Bromo-3-methyl-1H-pyrazolo[3,4-b]pyridine | ESD-846366-50MG |
Cas.: 885223-65-4 | Purity: 95% | 5-Bromo-3-methyl-1H-pyrazolo[3,4-b]pyridine | ESD-846366-250MG |
Cas.: 501907-61-5 | Purity: 95% | tert-Butyl (2,6-dichloropyridin-4-yl)carbamate | ESD-846367-50MG |
Cas.: 501907-61-5 | Purity: 95% | tert-Butyl (2,6-dichloropyridin-4-yl)carbamate | ESD-846367-250MG |
Cas.: 937013-66-6 | Purity: 98% | 2-(3-Bromophenyl)-1H-imidazole | ESD-846368-50MG |
Cas.: 937013-66-6 | Purity: 98% | 2-(3-Bromophenyl)-1H-imidazole | ESD-846368-250MG |
Cas.: 17282-40-5 | Purity: 98% | 1-(2-Ethoxy-2-oxoethyl)pyridin-1-ium bromide | ESD-846369-250MG |
Cas.: 17282-40-5 | Purity: 98% | 1-(2-Ethoxy-2-oxoethyl)pyridin-1-ium bromide | ESD-846369-1G |
Cas.: 1245014-05-4 | Purity: 95% | (4-(Benzyloxy)-3-(trifluoromethyl)phenyl)boronic acid | ESD-846370-250MG |
Cas.: 1245014-05-4 | Purity: 95% | (4-(Benzyloxy)-3-(trifluoromethyl)phenyl)boronic acid | ESD-846370-1G |
Cas.: 4558-59-2 | Purity: 96% | 4,6-Dimethoxypyrimidine-5-carbaldehyde | ESD-846371-25MG |
Cas.: 4558-59-2 | Purity: 96% | 4,6-Dimethoxypyrimidine-5-carbaldehyde | ESD-846371-100MG |
Cas.: 179028-65-0 | Purity: 95% | 2-Cyano-5-methoxybenzoic acid | ESD-846372-25MG |
Cas.: 179028-65-0 | Purity: 95% | 2-Cyano-5-methoxybenzoic acid | ESD-846372-100MG |
Cas.: 1018441-16-1 | Purity: 97% | N-Methyl-1H-pyrrolo[2,3-b]pyridin-6-amine | ESD-846373-25MG |
Cas.: 1018441-16-1 | Purity: 97% | N-Methyl-1H-pyrrolo[2,3-b]pyridin-6-amine | ESD-846373-100MG |
Cas.: 6702-95-0 | Purity: 98% | Ethyl 5-chloro-1,2,3-thiadiazole-4-carboxylate | ESD-846374-25MG |
Cas.: 6702-95-0 | Purity: 98% | Ethyl 5-chloro-1,2,3-thiadiazole-4-carboxylate | ESD-846374-100MG |
Cas.: 92-99-9 | Purity: 97% | N,N,2-Trimethylquinolin-6-amine | ESD-846375-25MG |
Cas.: 92-99-9 | Purity: 97% | N,N,2-Trimethylquinolin-6-amine | ESD-846375-100MG |
Cas.: 539822-98-5 | Purity: 95% | tert-Butyl 4-(2-(methylamino)ethyl)piperazine-1-carboxylate | ESD-846376-25MG |
Cas.: 539822-98-5 | Purity: 95% | tert-Butyl 4-(2-(methylamino)ethyl)piperazine-1-carboxylate | ESD-846376-100MG |
Cas.: 959238-11-0 | Purity: 95% | 4-Chloro-6-fluoro-2-(trifluoromethyl)quinazoline | ESD-846377-25MG |
Cas.: 959238-11-0 | Purity: 95% | 4-Chloro-6-fluoro-2-(trifluoromethyl)quinazoline | ESD-846377-100MG |
Cas.: 932702-11-9 | Purity: 95% | 1H-Pyrazolo[4,3-c]pyridine-3-carboxylic acid | ESD-846378-25MG |
Cas.: 932702-11-9 | Purity: 95% | 1H-Pyrazolo[4,3-c]pyridine-3-carboxylic acid | ESD-846378-100MG |
Cas.: 849807-09-6 | Purity: 98% | Methyl 2-chloroquinoline-6-carboxylate | ESD-846379-25MG |
Cas.: 849807-09-6 | Purity: 98% | Methyl 2-chloroquinoline-6-carboxylate | ESD-846379-100MG |
Cas.: 885522-04-3 | Purity: 95% | 3-Bromo-6-fluoro-1H-indazole | ESD-846380-25MG |
Cas.: 885522-04-3 | Purity: 95% | 3-Bromo-6-fluoro-1H-indazole | ESD-846380-100MG |
Cas.: 31576-51-9 | Purity: 98% | 2-(2-Methoxyethoxy)ethanamine | ESD-846381-25MG |
Cas.: 31576-51-9 | Purity: 98% | 2-(2-Methoxyethoxy)ethanamine | ESD-846381-100MG |
Cas.: 1083326-46-8 | Purity: 95% | 2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)acetamide | ESD-846382-25MG |
Cas.: 1083326-46-8 | Purity: 95% | 2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)acetamide | ESD-846382-100MG |
Cas.: 945723-36-4 | Purity: 95% | (trans-4-Methylpyrrolidin-3-yl)methanol | ESD-846383-25MG |
Cas.: 945723-36-4 | Purity: 95% | (trans-4-Methylpyrrolidin-3-yl)methanol | ESD-846383-100MG |
Cas.: 950858-65-8 | Purity: 98% | 1-tert-Butyl-1H-pyrazole-4-carboxylic acid | ESD-846384-25MG |
Cas.: 950858-65-8 | Purity: 98% | 1-tert-Butyl-1H-pyrazole-4-carboxylic acid | ESD-846384-100MG |
Cas.: 99580-50-4 | Purity: 95% | 2-Amino-4-hydroxythiophene-3-carbonitrile | ESD-846385-25MG |
Cas.: 99580-50-4 | Purity: 95% | 2-Amino-4-hydroxythiophene-3-carbonitrile | ESD-846385-100MG |
Cas.: 83101-12-6 | Purity: 97% | 4-(3-Hydroxypropyl)benzonitrile | ESD-846386-25MG |
Cas.: 83101-12-6 | Purity: 97% | 4-(3-Hydroxypropyl)benzonitrile | ESD-846386-100MG |
Cas.: 86443-51-8 | Purity: 98% | 2-Chloro-N-ethylpyrimidin-4-amine | ESD-846387-25MG |
Cas.: 86443-51-8 | Purity: 98% | 2-Chloro-N-ethylpyrimidin-4-amine | ESD-846387-100MG |
Cas.: 400877-53-4 | Purity: 98% | Ethyl 4-bromo-1-methyl-1H-pyrazole-3-carboxylate | ESD-846388-25MG |
Cas.: 400877-53-4 | Purity: 98% | Ethyl 4-bromo-1-methyl-1H-pyrazole-3-carboxylate | ESD-846388-100MG |
Cas.: 1187830-68-7 | Purity: 97% | 1-Methyl-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole hydrochloride | ESD-846389-25MG |
Cas.: 1187830-68-7 | Purity: 97% | 1-Methyl-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole hydrochloride | ESD-846389-100MG |
Cas.: 152533-47-6 | Purity: 97% | tert-Butyl 2-oxo-7-azabicyclo[2.2.1]heptane-7-carboxylate | ESD-846390-25MG |
Cas.: 152533-47-6 | Purity: 97% | tert-Butyl 2-oxo-7-azabicyclo[2.2.1]heptane-7-carboxylate | ESD-846390-100MG |
Cas.: 855230-60-3 | Purity: 97% | (2-Fluoro-3-hydroxyphenyl)boronic acid | ESD-846391-25MG |
Cas.: 855230-60-3 | Purity: 97% | (2-Fluoro-3-hydroxyphenyl)boronic acid | ESD-846391-100MG |
Cas.: 1025736-43-9 | Purity: 98% | (3′,4′-Dichloro-[1,1′-biphenyl]-4-yl)boronic acid | ESD-846392-25MG |
Cas.: 1025736-43-9 | Purity: 98% | (3′,4′-Dichloro-[1,1′-biphenyl]-4-yl)boronic acid | ESD-846392-100MG |
Cas.: 292600-22-7 | Purity: 97% | Methyl 2-(5-nitropyridin-2-yl)acetate | ESD-846393-25MG |
Cas.: 292600-22-7 | Purity: 97% | Methyl 2-(5-nitropyridin-2-yl)acetate | ESD-846393-100MG |
Cas.: 61548-52-5 | Purity: 97% | Methyl 3-hydroxy-6-methylpicolinate | ESD-846394-25MG |
Cas.: 61548-52-5 | Purity: 97% | Methyl 3-hydroxy-6-methylpicolinate | ESD-846394-100MG |
Cas.: 1588440-94-1 | Purity: 95% | 4-Cyclopropylaniline hydrochloride | ESD-846395-25MG |
Cas.: 1588440-94-1 | Purity: 95% | 4-Cyclopropylaniline hydrochloride | ESD-846395-100MG |
Cas.: 99548-53-5 | Purity: 97% | 3-Bromo-4-ethylbenzoic acid | ESD-846396-25MG |
Cas.: 99548-53-5 | Purity: 97% | 3-Bromo-4-ethylbenzoic acid | ESD-846396-100MG |
Cas.: 122851-60-9 | Purity: 98% | 2-(3-Bromopyridin-2-yl)acetonitrile | ESD-846397-25MG |
Cas.: 122851-60-9 | Purity: 98% | 2-(3-Bromopyridin-2-yl)acetonitrile | ESD-846397-100MG |
Cas.: 59139-93-4 | Purity: 98% | 2-(1-Oxoisoquinolin-2(1H)-yl)acetic acid | ESD-846398-25MG |
Cas.: 59139-93-4 | Purity: 98% | 2-(1-Oxoisoquinolin-2(1H)-yl)acetic acid | ESD-846398-100MG |
Cas.: 1588441-33-1 | Purity: 95% | (2-(Pyrrolidin-1-yl)pyridin-3-yl)methanamine hydrochloride | ESD-846399-25MG |
Cas.: 1588441-33-1 | Purity: 95% | (2-(Pyrrolidin-1-yl)pyridin-3-yl)methanamine hydrochloride | ESD-846399-100MG |
Cas.: 478834-25-2 | Purity: 98% | 4-Chloro-1H-indazol-5-ol | ESD-846400-25MG |
Cas.: 478834-25-2 | Purity: 98% | 4-Chloro-1H-indazol-5-ol | ESD-846400-100MG |
Cas.: 1000343-13-4 | Purity: 97% | 5-Bromo-6-methyl-1H-indole | ESD-846401-25MG |
Cas.: 1000343-13-4 | Purity: 97% | 5-Bromo-6-methyl-1H-indole | ESD-846401-100MG |
Cas.: 885520-26-3 | Purity: 98% | 4,6-Difluoro-1H-indazole | ESD-846402-25MG |
Cas.: 885520-26-3 | Purity: 98% | 4,6-Difluoro-1H-indazole | ESD-846402-100MG |
Cas.: 112279-64-8 | Purity: 98% | 3-Bromo-2,5-difluorobenzaldehyde | ESD-846403-25MG |
Cas.: 112279-64-8 | Purity: 98% | 3-Bromo-2,5-difluorobenzaldehyde | ESD-846403-100MG |
Cas.: 28751-70-4 | Purity: 98% | 5-Chloro-1H-indazole-3-carboxamide | ESD-846404-25MG |
Cas.: 28751-70-4 | Purity: 98% | 5-Chloro-1H-indazole-3-carboxamide | ESD-846404-100MG |
Cas.: 898795-81-8 | Purity: 98% | 6-(3-Fluorophenyl)nicotinaldehyde | ESD-846405-25MG |
Cas.: 898795-81-8 | Purity: 98% | 6-(3-Fluorophenyl)nicotinaldehyde | ESD-846405-100MG |
Cas.: 869500-07-2 | Purity: 98% | 1-Bromo-2-iodo-3-methylbenzene | ESD-846406-100MG |
Cas.: 2346-26-1 | Purity: 97% | Oxazolidine-2,4-dione | ESD-846407-25MG |
Cas.: 2346-26-1 | Purity: 97% | Oxazolidine-2,4-dione | ESD-846407-100MG |
Cas.: 205383-87-5 | Purity: 95% | tert-Butyl 2-oxospiro[indoline-3,3′-pyrrolidine]-1′-carboxylate | ESD-846408-25MG |
Cas.: 205383-87-5 | Purity: 95% | tert-Butyl 2-oxospiro[indoline-3,3′-pyrrolidine]-1′-carboxylate | ESD-846408-100MG |
Cas.: 2498-46-6 | Purity: 97% | 2-Phenylacetimidamide hydrochloride | ESD-846409-25MG |
Cas.: 2498-46-6 | Purity: 97% | 2-Phenylacetimidamide hydrochloride | ESD-846409-100MG |
Cas.: 1260848-51-8 | Purity: 95% | Methyl 4-amino-2-methyl-5-nitrobenzoate | ESD-846410-25MG |
Cas.: 1260848-51-8 | Purity: 95% | Methyl 4-amino-2-methyl-5-nitrobenzoate | ESD-846410-100MG |
Cas.: 146307-51-9 | Purity: 97% | trans-Methyl 4-((tert-butoxycarbonyl)amino)cyclohexanecarboxylate | ESD-846411-250MG |
Cas.: 146307-51-9 | Purity: 97% | trans-Methyl 4-((tert-butoxycarbonyl)amino)cyclohexanecarboxylate | ESD-846411-1G |
Cas.: 654664-63-8 | Purity: 98% | Triphenylen-2-ylboronic acid | ESD-846412-250MG |
Cas.: 654664-63-8 | Purity: 98% | Triphenylen-2-ylboronic acid | ESD-846412-1G |
Cas.: 346-34-9 | Purity: 98% | 4-Fluoroindoline-2,3-dione | ESD-846413-250MG |
Cas.: 346-34-9 | Purity: 98% | 4-Fluoroindoline-2,3-dione | ESD-846413-1G |
Cas.: 6090-38-6 | Purity: 98% | 5-Fluoro-2-(methylsulfonyl)pyrimidine | ESD-846414-50MG |
Cas.: 6090-38-6 | Purity: 98% | 5-Fluoro-2-(methylsulfonyl)pyrimidine | ESD-846414-250MG |
Cas.: 141704-11-2 | Purity: 98% | Ethyl 2-(thiazol-2-yl)acetate | ESD-846415-50MG |
Cas.: 141704-11-2 | Purity: 98% | Ethyl 2-(thiazol-2-yl)acetate | ESD-846415-250MG |
Cas.: 106595-91-9 | Purity: 97% | 4-Benzyl-1,3-dihydroquinoxalin-2-one | ESD-846416-25MG |
Cas.: 106595-91-9 | Purity: 97% | 4-Benzyl-1,3-dihydroquinoxalin-2-one | ESD-846416-100MG |
Cas.: 679433-94-4 | Purity: 98% | 5-Bromo-8-fluoroisoquinoline | ESD-846417-25MG |
Cas.: 679433-94-4 | Purity: 98% | 5-Bromo-8-fluoroisoquinoline | ESD-846417-100MG |
Cas.: 22162-22-7 | Purity: 98% | 1-Bromo-2,3-dimethyl-5-nitrobenzene | ESD-846418-25MG |
Cas.: 22162-22-7 | Purity: 98% | 1-Bromo-2,3-dimethyl-5-nitrobenzene | ESD-846418-100MG |
Cas.: 63954-77-8 | Purity: 98% | 3,5-Difluoro-2-hydroxybenzaldehyde | ESD-846419-250MG |
Cas.: 63954-77-8 | Purity: 98% | 3,5-Difluoro-2-hydroxybenzaldehyde | ESD-846419-1G |
Cas.: 33842-16-9 | Purity: 98% | Methyl benzo[d][1,3]dioxole-4-carboxylate | ESD-846420-250MG |
Cas.: 33842-16-9 | Purity: 98% | Methyl benzo[d][1,3]dioxole-4-carboxylate | ESD-846420-1G |
Cas.: 24807-40-7 | Purity: 95% | Methyl 3-(4-(benzyloxy)phenyl)propanoate | ESD-846421-250MG |
Cas.: 24807-40-7 | Purity: 95% | Methyl 3-(4-(benzyloxy)phenyl)propanoate | ESD-846421-1G |
Cas.: 29096-59-1 | Purity: 97% | 6-Chloroimidazo[1,2-a]pyridine-3-carbaldehyde | ESD-846422-250MG |
Cas.: 29096-59-1 | Purity: 97% | 6-Chloroimidazo[1,2-a]pyridine-3-carbaldehyde | ESD-846422-1G |
Cas.: 57805-85-3 | Purity: 98% | Methyl 3-amino-2-benzo[b]furancarboxylate | ESD-846423-250MG |
Cas.: 57805-85-3 | Purity: 98% | Methyl 3-amino-2-benzo[b]furancarboxylate | ESD-846423-1G |
Cas.: 946122-05-0 | Purity: 97% | (2-Amino-4-bromophenyl)methanol | ESD-846424-250MG |
Cas.: 946122-05-0 | Purity: 97% | (2-Amino-4-bromophenyl)methanol | ESD-846424-1G |
Cas.: 1187929-04-9 | Purity: 97% | (S)-Morpholine-3-carboxylic acid hydrochloride | ESD-846425-250MG |
Cas.: 1187929-04-9 | Purity: 97% | (S)-Morpholine-3-carboxylic acid hydrochloride | ESD-846425-1G |
Cas.: 1217074-64-0 | Purity: 95% | 1-(Piperidin-4-yl)piperazine trihydrochloride | ESD-846426-50MG |
Cas.: 1217074-64-0 | Purity: 95% | 1-(Piperidin-4-yl)piperazine trihydrochloride | ESD-846426-250MG |
Cas.: 50551-63-8 | Purity: 98% | 6-Methoxybenzofuran | ESD-846427-50MG |
Cas.: 50551-63-8 | Purity: 98% | 6-Methoxybenzofuran | ESD-846427-250MG |
Cas.: 924305-06-6 | Purity: 95% | 4-Fluoroisoindoline hydrochloride | ESD-846428-250MG |
Cas.: 924305-06-6 | Purity: 95% | 4-Fluoroisoindoline hydrochloride | ESD-846428-1G |
Cas.: 84575-27-9 | Purity: 97% | 7-Methoxyindoline-2,3-dione | ESD-846429-250MG |
Cas.: 84575-27-9 | Purity: 97% | 7-Methoxyindoline-2,3-dione | ESD-846429-1G |
Cas.: 879668-17-4 | Purity: 98% | 4,5,6,7-Tetrahydro-3H-imidazo[4,5-c]pyridine hydrochloride | ESD-846430-250MG |
Cas.: 879668-17-4 | Purity: 98% | 4,5,6,7-Tetrahydro-3H-imidazo[4,5-c]pyridine hydrochloride | ESD-846430-1G |
Cas.: 217448-86-7 | Purity: 98% | Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate | ESD-846431-50MG |
Cas.: 217448-86-7 | Purity: 98% | Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate | ESD-846431-250MG |
Cas.: 98276-57-4 | Purity: 98% | 2,4-Diaminobenzaldehyde | ESD-846432-50MG |
Cas.: 98276-57-4 | Purity: 98% | 2,4-Diaminobenzaldehyde | ESD-846432-250MG |
Cas.: 908279-57-2 | Purity: 95% | 3-Iodo-2-methoxyisonicotinonitrile | ESD-846433-50MG |
Cas.: 908279-57-2 | Purity: 95% | 3-Iodo-2-methoxyisonicotinonitrile | ESD-846433-250MG |
Cas.: 182349-12-8 | Purity: 98% | Rupatadin Fumarate | ESD-846434-50MG |
Cas.: 182349-12-8 | Purity: 98% | Rupatadin Fumarate | ESD-846434-250MG |
Cas.: 101328-85-2 | Purity: 97% | (R)-6-(4-Aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one | ESD-846435-50MG |
Cas.: 101328-85-2 | Purity: 97% | (R)-6-(4-Aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one | ESD-846435-250MG |
Cas.: 6312-71-6 | Purity: 98% | 6-Amino-5-bromopyrimidin-4(3H)-one | ESD-846436-50MG |
Cas.: 6312-71-6 | Purity: 98% | 6-Amino-5-bromopyrimidin-4(3H)-one | ESD-846436-250MG |
Cas.: 884507-17-9 | Purity: 98% | (1-Methyl-1H-indol-5-yl)methanamine | ESD-846437-50MG |
Cas.: 884507-17-9 | Purity: 98% | (1-Methyl-1H-indol-5-yl)methanamine | ESD-846437-250MG |
Cas.: 342613-63-2 | Purity: 95% | Methyl 3-bromoimidazo[1,2-a]pyridine-7-carboxylate | ESD-846438-50MG |
Cas.: 342613-63-2 | Purity: 95% | Methyl 3-bromoimidazo[1,2-a]pyridine-7-carboxylate | ESD-846438-250MG |
Cas.: 20367-38-8 | Purity: 98% | Methyl (6-chloro-1H-benzo[d]imidazol-2-yl)carbamate | ESD-846439-50MG |
Cas.: 20367-38-8 | Purity: 98% | Methyl (6-chloro-1H-benzo[d]imidazol-2-yl)carbamate | ESD-846439-250MG |
Cas.: 1192064-63-3 | Purity: 98% | 2,5-Dichloro-4-methylpyrimidine | ESD-846440-50MG |
Cas.: 1192064-63-3 | Purity: 98% | 2,5-Dichloro-4-methylpyrimidine | ESD-846440-250MG |
Cas.: 228421-83-8 | Purity: 98% | 3,5-Difluoro-4-(hydroxymethyl)benzonitrile | ESD-846441-50MG |
Cas.: 228421-83-8 | Purity: 98% | 3,5-Difluoro-4-(hydroxymethyl)benzonitrile | ESD-846441-250MG |
Cas.: 1309981-45-0 | Purity: 97% | 3-Phenoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-846442-50MG |
Cas.: 1309981-45-0 | Purity: 97% | 3-Phenoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-846442-250MG |
Cas.: 885272-25-3 | Purity: 95% | 2-(5-Methoxy-2-oxoindolin-3-yl)acetic acid | ESD-846443-50MG |
Cas.: 885272-25-3 | Purity: 95% | 2-(5-Methoxy-2-oxoindolin-3-yl)acetic acid | ESD-846443-250MG |
Cas.: 100927-10-4 | Purity: 98% | (R)-tert-Butyl (1-aminopropan-2-yl)carbamate | ESD-846444-50MG |
Cas.: 100927-10-4 | Purity: 98% | (R)-tert-Butyl (1-aminopropan-2-yl)carbamate | ESD-846444-250MG |
Cas.: 959992-62-2 | Purity: 98% | 6-Bromo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine | ESD-846445-50MG |
Cas.: 959992-62-2 | Purity: 98% | 6-Bromo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine | ESD-846445-250MG |
Cas.: 1147108-99-3 | Purity: 98% | (S)-2-Methylmorpholine hydrochloride | ESD-846446-50MG |
Cas.: 1147108-99-3 | Purity: 98% | (S)-2-Methylmorpholine hydrochloride | ESD-846446-250MG |
Cas.: 75894-07-4 | Purity: 95% | 2-(Benzo[b]thiophen-2-yl)acetic acid | ESD-846447-50MG |
Cas.: 75894-07-4 | Purity: 95% | 2-(Benzo[b]thiophen-2-yl)acetic acid | ESD-846447-250MG |
Cas.: 141052-31-5 | Purity: 98% | 7-Bromo-4-methylquinoline | ESD-846448-50MG |
Cas.: 141052-31-5 | Purity: 98% | 7-Bromo-4-methylquinoline | ESD-846448-250MG |
Cas.: 1220330-11-9 | Purity: 95% | 5-Ethoxypyrazine-2-carboxylic acid | ESD-846449-50MG |
Cas.: 1220330-11-9 | Purity: 95% | 5-Ethoxypyrazine-2-carboxylic acid | ESD-846449-250MG |
Cas.: 921760-46-5 | Purity: 95% | 6-Bromospiro[chroman-2,4′-piperidin]-4-one hydrochloride | ESD-846450-50MG |
Cas.: 921760-46-5 | Purity: 95% | 6-Bromospiro[chroman-2,4′-piperidin]-4-one hydrochloride | ESD-846450-250MG |
Cas.: 138907-73-0 | Purity: 98% | Ethyl 1-(4-fluorophenyl)-1H-pyrazole-4-carboxylate | ESD-846451-50MG |
Cas.: 138907-73-0 | Purity: 98% | Ethyl 1-(4-fluorophenyl)-1H-pyrazole-4-carboxylate | ESD-846451-250MG |
Cas.: 959236-79-4 | Purity: 98% | 8-Iodoquinazoline-2,4(1H,3H)-dione | ESD-846452-50MG |
Cas.: 959236-79-4 | Purity: 98% | 8-Iodoquinazoline-2,4(1H,3H)-dione | ESD-846452-250MG |
Cas.: 138326-68-8 | Purity: 97% | (S)-Methyl 2-amino-2-cyclopropylacetate hydrochloride | ESD-846453-50MG |
Cas.: 138326-68-8 | Purity: 97% | (S)-Methyl 2-amino-2-cyclopropylacetate hydrochloride | ESD-846453-250MG |
Cas.: 890904-66-2 | Purity: 96% | 6-(Methoxymethyl)picolinaldehyde | ESD-846454-50MG |
Cas.: 890904-66-2 | Purity: 96% | 6-(Methoxymethyl)picolinaldehyde | ESD-846454-250MG |
Cas.: 379270-37-8 | Purity: 98% | GS-7340 | ESD-846455-50MG |
Cas.: 379270-37-8 | Purity: 98% | GS-7340 | ESD-846455-250MG |
Cas.: 911466-96-1 | Purity: 97% | 2-(Ethoxycarbonyl)thiazole-4-carboxylic acid | ESD-846456-50MG |
Cas.: 911466-96-1 | Purity: 97% | 2-(Ethoxycarbonyl)thiazole-4-carboxylic acid | ESD-846456-250MG |
Cas.: 148728-48-7 | Purity: 95% | Dimethyl 3-bromo-2-oxopentanedioate | ESD-846457-50MG |
Cas.: 148728-48-7 | Purity: 95% | Dimethyl 3-bromo-2-oxopentanedioate | ESD-846457-250MG |
Cas.: 114676-79-8 | Purity: 97% | tert-Butyl 2-oxa-5-azabicyclo[2.2.1]heptane-5-carboxylate | ESD-846458-50MG |
Cas.: 114676-79-8 | Purity: 97% | tert-Butyl 2-oxa-5-azabicyclo[2.2.1]heptane-5-carboxylate | ESD-846458-250MG |
Cas.: 28682-73-7 | Purity: 98% | 4,5-Diaminopyridazin-3(2H)-one | ESD-846459-50MG |
Cas.: 28682-73-7 | Purity: 98% | 4,5-Diaminopyridazin-3(2H)-one | ESD-846459-250MG |
Cas.: 26740-71-6 | Purity: 98% | 4,5-Dichloro-2-methylpyrimidine | ESD-846460-50MG |
Cas.: 26740-71-6 | Purity: 98% | 4,5-Dichloro-2-methylpyrimidine | ESD-846460-250MG |
Cas.: 1240518-54-0 | Purity: 98% | 3-Amino-1H-indazole-4-carbonitrile | ESD-846461-50MG |
Cas.: 1240518-54-0 | Purity: 98% | 3-Amino-1H-indazole-4-carbonitrile | ESD-846461-250MG |
Cas.: 942067-98-3 | Purity: 98% | 4-Iodopyrimidin-5-amine | ESD-846462-50MG |
Cas.: 942067-98-3 | Purity: 98% | 4-Iodopyrimidin-5-amine | ESD-846462-250MG |
Cas.: 99552-78-0 | Purity: 95% | Methyl 2-bromo-2-(2-methoxyphenyl)acetate | ESD-846463-50MG |
Cas.: 99552-78-0 | Purity: 95% | Methyl 2-bromo-2-(2-methoxyphenyl)acetate | ESD-846463-250MG |
Cas.: 57179-35-8 | Purity: 98% | 3-Hydroxy-5-methoxybenzaldehyde | ESD-846464-50MG |
Cas.: 57179-35-8 | Purity: 98% | 3-Hydroxy-5-methoxybenzaldehyde | ESD-846464-250MG |
Cas.: 65169-43-9 | Purity: 97% | Methyl 2-chloro-5-methylnicotinate | ESD-846465-50MG |
Cas.: 65169-43-9 | Purity: 97% | Methyl 2-chloro-5-methylnicotinate | ESD-846465-250MG |
Cas.: 158401-00-4 | Purity: 95% | 2,2,2-Trifluoro-1-(3,4,5-trichlorophenyl)ethanone | ESD-846466-50MG |
Cas.: 158401-00-4 | Purity: 95% | 2,2,2-Trifluoro-1-(3,4,5-trichlorophenyl)ethanone | ESD-846466-250MG |
Cas.: 100922-96-1 | Purity: 98% | 1H-Indazol-3-ol | ESD-846467-50MG |
Cas.: 100922-96-1 | Purity: 98% | 1H-Indazol-3-ol | ESD-846467-250MG |
Cas.: 134612-80-9 | Purity: 98% | (4-Hydroxy-3-methoxy-5-nitrophenyl)(p-tolyl)methanone | ESD-846468-50MG |
Cas.: 134612-80-9 | Purity: 98% | (4-Hydroxy-3-methoxy-5-nitrophenyl)(p-tolyl)methanone | ESD-846468-250MG |
Cas.: 339151-88-1 | Purity: 97% | Methyl 2-chloro-4,6-dimethylnicotinate | ESD-846469-50MG |
Cas.: 339151-88-1 | Purity: 97% | Methyl 2-chloro-4,6-dimethylnicotinate | ESD-846469-250MG |
Cas.: 1588441-09-1 | Purity: 97% | trans-4-Morpholinocyclohexanol hydrochloride | ESD-846470-50MG |
Cas.: 1588441-09-1 | Purity: 97% | trans-4-Morpholinocyclohexanol hydrochloride | ESD-846470-250MG |
Cas.: 175461-34-4 | Purity: 98% | 2,6-Dichloro-N,N-dimethylpyridin-4-amine | ESD-846471-50MG |
Cas.: 175461-34-4 | Purity: 98% | 2,6-Dichloro-N,N-dimethylpyridin-4-amine | ESD-846471-250MG |
Cas.: 1439373-55-3 | Purity: 95% | (S)-Morpholine-2-carboxylic acid hydrochloride | ESD-846472-50MG |
Cas.: 1439373-55-3 | Purity: 95% | (S)-Morpholine-2-carboxylic acid hydrochloride | ESD-846472-250MG |
Cas.: 183557-81-5 | Purity: 95% | 3-Morpholinobenzamide | ESD-846473-50MG |
Cas.: 183557-81-5 | Purity: 95% | 3-Morpholinobenzamide | ESD-846473-250MG |
Cas.: 1209458-45-6 | Purity: 97% | 4-Bromo-6-(methylthio)pyrimidine | ESD-846474-50MG |
Cas.: 1209458-45-6 | Purity: 97% | 4-Bromo-6-(methylthio)pyrimidine | ESD-846474-250MG |
Cas.: 573762-62-6 | Purity: ≥95% | 5-Amino-3-(trifluoromethyl)picolinonitrile | ESD-846475-50MG |
Cas.: 573762-62-6 | Purity: ≥95% | 5-Amino-3-(trifluoromethyl)picolinonitrile | ESD-846475-250MG |
Cas.: 1485417-01-3 | Purity: 97% | (3-((Dimethylamino)methyl)phenyl)boronic acid hydrochloride | ESD-846476-50MG |
Cas.: 1485417-01-3 | Purity: 97% | (3-((Dimethylamino)methyl)phenyl)boronic acid hydrochloride | ESD-846476-250MG |
Cas.: 1640995-60-3 | Purity: 97% | tert-Butyl ((6-chloropyridin-2-yl)methyl)carbamate | ESD-846477-50MG |
Cas.: 1640995-60-3 | Purity: 97% | tert-Butyl ((6-chloropyridin-2-yl)methyl)carbamate | ESD-846477-250MG |
Cas.: 651013-72-8 | Purity: 95% | 3-Benzyl-4-methoxy-4-oxobutanoic acid | ESD-846478-50MG |
Cas.: 651013-72-8 | Purity: 95% | 3-Benzyl-4-methoxy-4-oxobutanoic acid | ESD-846478-250MG |
Cas.: 187458-77-1 | Purity: 95% | (R)-4-Amino-5-methoxy-5-oxopentanoic acid hydrochloride | ESD-846479-50MG |
Cas.: 187458-77-1 | Purity: 95% | (R)-4-Amino-5-methoxy-5-oxopentanoic acid hydrochloride | ESD-846479-250MG |
Cas.: 1616526-83-0 | Purity: 95% | Imidazo[1,5-a]pyridine-7-carboxylic acid dihydrochloride | ESD-846480-50MG |
Cas.: 1616526-83-0 | Purity: 95% | Imidazo[1,5-a]pyridine-7-carboxylic acid dihydrochloride | ESD-846480-250MG |
Cas.: 26103-78-6 | Purity: 97% | Diethyl 2-oxo-3-propylsuccinate | ESD-846481-50MG |
Cas.: 26103-78-6 | Purity: 97% | Diethyl 2-oxo-3-propylsuccinate | ESD-846481-250MG |
Cas.: 1624260-73-6 | Purity: 97% | 5-(Pyrrolidin-1-yl)pentan-1-amine dihydrochloride | ESD-846482-50MG |
Cas.: 1624260-73-6 | Purity: 97% | 5-(Pyrrolidin-1-yl)pentan-1-amine dihydrochloride | ESD-846482-250MG |
Cas.: 776297-69-9 | Purity: 98% | Isopentyl pentyl phthalate | ESD-846483-50MG |
Cas.: 776297-69-9 | Purity: 98% | Isopentyl pentyl phthalate | ESD-846483-250MG |
Cas.: 861519-29-1 | Purity: 98% | 5-Chloro-4-methylbenzene-1,3-diamine | ESD-846484-50MG |
Cas.: 861519-29-1 | Purity: 98% | 5-Chloro-4-methylbenzene-1,3-diamine | ESD-846484-250MG |
Cas.: 725738-57-8 | Purity: 97% | 4-(Bromomethyl)-2-methylthiazole hydrobromide | ESD-846485-50MG |
Cas.: 725738-57-8 | Purity: 97% | 4-(Bromomethyl)-2-methylthiazole hydrobromide | ESD-846485-250MG |
Cas.: 103030-25-7 | Purity: 97% | 6-(Bromomethyl)quinoline hydrobromide | ESD-846486-50MG |
Cas.: 103030-25-7 | Purity: 97% | 6-(Bromomethyl)quinoline hydrobromide | ESD-846486-250MG |
Cas.: 596793-30-5 | Purity: 98% | (3S,4S)-Benzyl 3,4-dihydroxypyrrolidine-1-carboxylate | ESD-846487-50MG |
Cas.: 596793-30-5 | Purity: 98% | (3S,4S)-Benzyl 3,4-dihydroxypyrrolidine-1-carboxylate | ESD-846487-250MG |
Cas.: 30611-21-3 | Purity: 98% | Methyl 4-pentanoylbenzoate | ESD-846488-50MG |
Cas.: 30611-21-3 | Purity: 98% | Methyl 4-pentanoylbenzoate | ESD-846488-250MG |
Cas.: 248602-16-6 | Purity: 98% | 6-Bromo-5-methyl-1H-indole | ESD-846489-25MG |
Cas.: 248602-16-6 | Purity: 98% | 6-Bromo-5-methyl-1H-indole | ESD-846489-100MG |
Cas.: 874822-98-7 | Purity: 98% | (5-Fluoro-2-methoxypyridin-3-yl)methanol | ESD-846490-25MG |
Cas.: 874822-98-7 | Purity: 98% | (5-Fluoro-2-methoxypyridin-3-yl)methanol | ESD-846490-100MG |
Cas.: 171178-47-5 | Purity: 97% | 6-Chloropyrido[3,4-d]pyrimidin-4(3H)-one | ESD-846491-25MG |
Cas.: 171178-47-5 | Purity: 97% | 6-Chloropyrido[3,4-d]pyrimidin-4(3H)-one | ESD-846491-100MG |
Cas.: 872355-63-0 | Purity: 98% | Methyl 1H-pyrrolo[3,2-b]pyridine-5-carboxylate | ESD-846492-25MG |
Cas.: 872355-63-0 | Purity: 98% | Methyl 1H-pyrrolo[3,2-b]pyridine-5-carboxylate | ESD-846492-100MG |
Cas.: 871115-32-1 | Purity: 97% | tert-Butyl 4-amino-4-(aminomethyl)piperidine-1-carboxylate | ESD-846493-25MG |
Cas.: 871115-32-1 | Purity: 97% | tert-Butyl 4-amino-4-(aminomethyl)piperidine-1-carboxylate | ESD-846493-100MG |
Cas.: 89639-74-7 | Purity: 98% | 3,4-Dimethylthiophene-2-carboxylic acid | ESD-846494-25MG |
Cas.: 89639-74-7 | Purity: 98% | 3,4-Dimethylthiophene-2-carboxylic acid | ESD-846494-100MG |
Cas.: 159635-46-8 | Purity: 95% | Benzyl spiro[indoline-3,4′-piperidine]-1-carboxylate hydrochloride | ESD-846495-25MG |
Cas.: 159635-46-8 | Purity: 95% | Benzyl spiro[indoline-3,4′-piperidine]-1-carboxylate hydrochloride | ESD-846495-100MG |
Cas.: 1245647-25-9 | Purity: 96% | 5-Bromo-1-chloro-6-methylisoquinoline | ESD-846496-25MG |
Cas.: 1245647-25-9 | Purity: 96% | 5-Bromo-1-chloro-6-methylisoquinoline | ESD-846496-100MG |
Cas.: 59288-43-6 | Purity: 97% | 5-Hydroxy-6-nitronicotinic acid | ESD-846497-25MG |
Cas.: 59288-43-6 | Purity: 97% | 5-Hydroxy-6-nitronicotinic acid | ESD-846497-100MG |
Cas.: 20734-66-1 | Purity: 95% | 3-Aminobenzene-1,2-diol | ESD-846498-25MG |
Cas.: 20734-66-1 | Purity: 95% | 3-Aminobenzene-1,2-diol | ESD-846498-100MG |
Cas.: 184416-83-9 | Purity: 98% | 2,3-Dichloropyridin-4-amine | ESD-846499-25MG |
Cas.: 184416-83-9 | Purity: 98% | 2,3-Dichloropyridin-4-amine | ESD-846499-100MG |
Cas.: 1038408-36-4 | Purity: 97% | 6-Bromo-1-isopropyl-2-methyl-1H-benzo[d]imidazole | ESD-846502-25MG |
Cas.: 1038408-36-4 | Purity: 97% | 6-Bromo-1-isopropyl-2-methyl-1H-benzo[d]imidazole | ESD-846502-100MG |
Cas.: 124870-33-3 | Purity: 97% | Methyl 2-(3-cyanopyridin-4-yl)acetate | ESD-846503-25MG |
Cas.: 124870-33-3 | Purity: 97% | Methyl 2-(3-cyanopyridin-4-yl)acetate | ESD-846503-100MG |
Cas.: 1424-69-7 | Purity: 95% | 4-(Dimethylamino)-3-methylbenzaldehyde | ESD-846504-25MG |
Cas.: 1424-69-7 | Purity: 95% | 4-(Dimethylamino)-3-methylbenzaldehyde | ESD-846504-100MG |
Cas.: 1219019-22-3 | Purity: 97% | cis-3-Aminocyclobutanol hydrochloride | ESD-846505-25MG |
Cas.: 1219019-22-3 | Purity: 97% | cis-3-Aminocyclobutanol hydrochloride | ESD-846505-100MG |
Cas.: 92093-23-7 | Purity: 98% | 1-(4-Bromophenyl)ethane-1,2-diol | ESD-846506-25MG |
Cas.: 92093-23-7 | Purity: 98% | 1-(4-Bromophenyl)ethane-1,2-diol | ESD-846506-100MG |
Cas.: 99780-97-9 | Purity: 97% | tert-Butyl (2-oxopyrrolidin-3-yl)carbamate | ESD-846507-25MG |
Cas.: 99780-97-9 | Purity: 97% | tert-Butyl (2-oxopyrrolidin-3-yl)carbamate | ESD-846507-100MG |
Cas.: 74290-68-9 | Purity: 97% | 6-Bromo-5-methylpyrazin-2-amine | ESD-846508-25MG |
Cas.: 74290-68-9 | Purity: 97% | 6-Bromo-5-methylpyrazin-2-amine | ESD-846508-100MG |
Cas.: 921194-97-0 | Purity: 98% | Methyl 6-chloro-1H-indole-3-carboxylate | ESD-846509-25MG |
Cas.: 921194-97-0 | Purity: 98% | Methyl 6-chloro-1H-indole-3-carboxylate | ESD-846509-100MG |
Cas.: 161611-46-7 | Purity: 95% | Ethyl 6-chloropyrazine-2-carboxylate | ESD-846510-25MG |
Cas.: 161611-46-7 | Purity: 95% | Ethyl 6-chloropyrazine-2-carboxylate | ESD-846510-100MG |
Cas.: 1012085-50-5 | Purity: 97% | 3,5-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-846511-25MG |
Cas.: 1012085-50-5 | Purity: 97% | 3,5-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-846511-100MG |
Cas.: 40276-63-9 | Purity: 96% | (2-Benzylphenyl)boronic acid | ESD-846512-25MG |
Cas.: 40276-63-9 | Purity: 96% | (2-Benzylphenyl)boronic acid | ESD-846512-100MG |
Cas.: 439937-54-9 | Purity: 98% | Methyl 5-bromo-2-ethylbenzoate | ESD-846513-25MG |
Cas.: 439937-54-9 | Purity: 98% | Methyl 5-bromo-2-ethylbenzoate | ESD-846513-100MG |
Cas.: 169468-81-9 | Purity: 98% | 5-Chloro-1,2-difluoro-3-nitrobenzene | ESD-846514-25MG |
Cas.: 169468-81-9 | Purity: 98% | 5-Chloro-1,2-difluoro-3-nitrobenzene | ESD-846514-100MG |
Cas.: 66491-03-0 | Purity: 95% | 7-Amino-3,4-dihydroisoquinolin-1(2H)-one | ESD-846515-25MG |
Cas.: 66491-03-0 | Purity: 95% | 7-Amino-3,4-dihydroisoquinolin-1(2H)-one | ESD-846515-100MG |
Cas.: 118511-81-2 | Purity: 98% | 1-(Piperidin-4-yl)-1H-indole | ESD-846516-25MG |
Cas.: 118511-81-2 | Purity: 98% | 1-(Piperidin-4-yl)-1H-indole | ESD-846516-100MG |
Cas.: 769944-39-0 | Purity: 95% | tert-Butyl 2-(4-chlorophenyl)piperazine-1-carboxylate | ESD-846517-25MG |
Cas.: 769944-39-0 | Purity: 95% | tert-Butyl 2-(4-chlorophenyl)piperazine-1-carboxylate | ESD-846517-100MG |
Cas.: 868241-48-9 | Purity: 97% | 2,2-Difluoropropan-1-amine hydrochloride | ESD-846518-25MG |
Cas.: 868241-48-9 | Purity: 97% | 2,2-Difluoropropan-1-amine hydrochloride | ESD-846518-100MG |
Cas.: 4080-48-2 | Purity: 96% | 6-Ethylpicolinic acid | ESD-846519-25MG |
Cas.: 4080-48-2 | Purity: 96% | 6-Ethylpicolinic acid | ESD-846519-100MG |
Cas.: 351003-10-6 | Purity: 96% | 3-Amino-4-methoxybenzaldehyde | ESD-846520-25MG |
Cas.: 351003-10-6 | Purity: 96% | 3-Amino-4-methoxybenzaldehyde | ESD-846520-100MG |
Cas.: 1201924-32-4 | Purity: 95% | 6-Chloro-3-methylpicolinic acid | ESD-846521-250MG |
Cas.: 1201924-32-4 | Purity: 95% | 6-Chloro-3-methylpicolinic acid | ESD-846521-1G |
Cas.: 51940-63-7 | Purity: 95% | Ethyl 6-chloropyrimidine-4-carboxylate | ESD-846522-250MG |
Cas.: 51940-63-7 | Purity: 95% | Ethyl 6-chloropyrimidine-4-carboxylate | ESD-846522-1G |
Cas.: 915226-43-6 | Purity: 95% | (R)-tert-Butyl 3-carbamoylpiperidine-1-carboxylate | ESD-846523-250MG |
Cas.: 915226-43-6 | Purity: 95% | (R)-tert-Butyl 3-carbamoylpiperidine-1-carboxylate | ESD-846523-1G |
Cas.: 136333-97-6 | Purity: 97% | Methyl 4-(2-bromoethyl)benzoate | ESD-846524-250MG |
Cas.: 136333-97-6 | Purity: 97% | Methyl 4-(2-bromoethyl)benzoate | ESD-846524-1G |
Cas.: 21091-98-5 | Purity: 95% | (4-Methylpiperazin-1-yl)(4-nitrophenyl)methanone | ESD-846525-250MG |
Cas.: 21091-98-5 | Purity: 95% | (4-Methylpiperazin-1-yl)(4-nitrophenyl)methanone | ESD-846525-1G |
Cas.: 618-63-3 | Purity: 95% | 3-Chloro-5-nitrophenol | ESD-846526-250MG |
Cas.: 618-63-3 | Purity: 95% | 3-Chloro-5-nitrophenol | ESD-846526-1G |
Cas.: 612532-52-2 | Purity: 97% | 3-Amino-3-(4-fluorophenyl)propan-1-ol | ESD-846527-250MG |
Cas.: 612532-52-2 | Purity: 97% | 3-Amino-3-(4-fluorophenyl)propan-1-ol | ESD-846527-1G |
Cas.: 1836-05-1 | Purity: 98% | 1-(3-Bromo-2-hydroxyphenyl)ethanone | ESD-846528-250MG |
Cas.: 1836-05-1 | Purity: 98% | 1-(3-Bromo-2-hydroxyphenyl)ethanone | ESD-846528-1G |
Cas.: 5077-67-8 | Purity: 98% | 1-Hydroxybutan-2-one | ESD-846529-250MG |
Cas.: 5077-67-8 | Purity: 98% | 1-Hydroxybutan-2-one | ESD-846529-1G |
Cas.: 4063-31-4 | Purity: 95% | Methyl 3-((furan-2-ylmethyl)amino)propanoate | ESD-846530-25MG |
Cas.: 4063-31-4 | Purity: 95% | Methyl 3-((furan-2-ylmethyl)amino)propanoate | ESD-846530-100MG |
Cas.: 207857-15-6 | Purity: 98% | 1,3-Di-Boc-2-(trifluoromethylsulfonyl)guanidine | ESD-846531-250MG |
Cas.: 207857-15-6 | Purity: 98% | 1,3-Di-Boc-2-(trifluoromethylsulfonyl)guanidine | ESD-846531-1G |
Cas.: 1187830-47-2 | Purity: 95% | 4,5,6,7-Tetrahydro-2H-pyrazolo[4,3-b]pyridine hydrochloride | ESD-846532-25MG |
Cas.: 1187830-47-2 | Purity: 95% | 4,5,6,7-Tetrahydro-2H-pyrazolo[4,3-b]pyridine hydrochloride | ESD-846532-100MG |
Cas.: 75534-35-9 | Purity: 97% | 2-(2-Bromo-5-methoxyphenyl)ethanol | ESD-846533-25MG |
Cas.: 75534-35-9 | Purity: 97% | 2-(2-Bromo-5-methoxyphenyl)ethanol | ESD-846533-100MG |
Cas.: 1193116-74-3 | Purity: 98% | 5-Bromo-2-(bromomethyl)pyrimidine | ESD-846534-25MG |
Cas.: 1193116-74-3 | Purity: 98% | 5-Bromo-2-(bromomethyl)pyrimidine | ESD-846534-100MG |
Cas.: 1177494-20-0 | Purity: 97% | 2-Amino-N-methylthiazole-5-carboxamide | ESD-846535-25MG |
Cas.: 1177494-20-0 | Purity: 97% | 2-Amino-N-methylthiazole-5-carboxamide | ESD-846535-100MG |
Cas.: 55219-11-9 | Purity: 95% | Benzo[b]thiophene-2-carbonitrile | ESD-846536-250MG |
Cas.: 55219-11-9 | Purity: 95% | Benzo[b]thiophene-2-carbonitrile | ESD-846536-1G |
Cas.: 136618-42-3 | Purity: 98% | Benzyl 4-iodobenzoate | ESD-846537-250MG |
Cas.: 136618-42-3 | Purity: 98% | Benzyl 4-iodobenzoate | ESD-846537-1G |
Cas.: 7142-09-8 | Purity: 97% | 6-Chloro-2-methylquinazolin-4(3H)-one | ESD-846538-250MG |
Cas.: 7142-09-8 | Purity: 97% | 6-Chloro-2-methylquinazolin-4(3H)-one | ESD-846538-1G |
Cas.: 914349-54-5 | Purity: 95% | 2-(4-Ethylpiperazin-1-ylmethyl)benzoic acid | ESD-846539-250MG |
Cas.: 914349-54-5 | Purity: 95% | 2-(4-Ethylpiperazin-1-ylmethyl)benzoic acid | ESD-846539-1G |
Cas.: 224434-01-9 | Purity: 97% | (S)-2-Amino-2-(4-fluorophenyl)ethanol | ESD-846540-50MG |
Cas.: 224434-01-9 | Purity: 97% | (S)-2-Amino-2-(4-fluorophenyl)ethanol | ESD-846540-250MG |
Cas.: 137730-67-7 | Purity: 95% | Spiro[indene-1,4′-piperidine] hydrochloride | ESD-846541-50MG |
Cas.: 137730-67-7 | Purity: 95% | Spiro[indene-1,4′-piperidine] hydrochloride | ESD-846541-250MG |
Cas.: 10222-61-4 | Purity: 98% | 2-Butoxyquinoline-4-carboxylic acid | ESD-846542-50MG |
Cas.: 10222-61-4 | Purity: 98% | 2-Butoxyquinoline-4-carboxylic acid | ESD-846542-250MG |
Cas.: 24469-50-9 | Purity: 97% | (E)-tert-Butyl 2-benzylidenehydrazinecarboxylate | ESD-846543-250MG |
Cas.: 24469-50-9 | Purity: 97% | (E)-tert-Butyl 2-benzylidenehydrazinecarboxylate | ESD-846543-1G |
Cas.: 1214366-31-0 | Purity: 97% | (2-Fluoro-6-methoxyphenyl)methanamine hydrochloride | ESD-846544-250MG |
Cas.: 1214366-31-0 | Purity: 97% | (2-Fluoro-6-methoxyphenyl)methanamine hydrochloride | ESD-846544-1G |
Cas.: 73675-45-3 | Purity: 97% | 2-(4-(tert-Butyl)phenoxy)-N,N-dimethylethanamine | ESD-846545-250MG |
Cas.: 73675-45-3 | Purity: 97% | 2-(4-(tert-Butyl)phenoxy)-N,N-dimethylethanamine | ESD-846545-1G |
Cas.: 7400-06-8 | Purity: 97% | 6-Amino-5-(2,2-diethoxyethyl)pyrimidin-4-ol | ESD-846546-25MG |
Cas.: 7400-06-8 | Purity: 97% | 6-Amino-5-(2,2-diethoxyethyl)pyrimidin-4-ol | ESD-846546-100MG |
Cas.: 114969-94-7 | Purity: 98% | 5-Chloro-4-methoxypyrimidine | ESD-846547-25MG |
Cas.: 114969-94-7 | Purity: 98% | 5-Chloro-4-methoxypyrimidine | ESD-846547-100MG |
Cas.: 16675-62-0 | Purity: 98% | Methyl quinoline-5-carboxylate | ESD-846548-25MG |
Cas.: 16675-62-0 | Purity: 98% | Methyl quinoline-5-carboxylate | ESD-846548-100MG |
Cas.: 331846-99-2 | Purity: 98% | (S)-3-Amino-4-(naphthalen-1-yl)butanoic acid hydrochloride | ESD-846549-25MG |
Cas.: 331846-99-2 | Purity: 98% | (S)-3-Amino-4-(naphthalen-1-yl)butanoic acid hydrochloride | ESD-846549-100MG |
Cas.: 27063-93-0 | Purity: 98% | 3-Bromo-2,4-dimethylpyridine | ESD-846550-25MG |
Cas.: 27063-93-0 | Purity: 98% | 3-Bromo-2,4-dimethylpyridine | ESD-846550-100MG |
Cas.: 162045-53-6 | Purity: 97% | tert-Butyl 4-(2-oxobenzo[d]oxazol-3(2H)-yl)piperidine-1-carboxylate | ESD-846551-25MG |
Cas.: 162045-53-6 | Purity: 97% | tert-Butyl 4-(2-oxobenzo[d]oxazol-3(2H)-yl)piperidine-1-carboxylate | ESD-846551-100MG |
Cas.: 925672-85-1 | Purity: 95% | 1,6-Dibromoisoquinolin-3-amine | ESD-846552-25MG |
Cas.: 925672-85-1 | Purity: 95% | 1,6-Dibromoisoquinolin-3-amine | ESD-846552-100MG |
Cas.: 1240725-66-9 | Purity: 98% | 5-Chloro-1H-pyrazolo[3,4-b]pyridine | ESD-846553-25MG |
Cas.: 1240725-66-9 | Purity: 98% | 5-Chloro-1H-pyrazolo[3,4-b]pyridine | ESD-846553-100MG |
Cas.: 1179361-35-3 | Purity: 97% | 1-N-Boc-2-Methylpropane-1,2-diamine hydrochloride | ESD-846554-25MG |
Cas.: 1179361-35-3 | Purity: 97% | 1-N-Boc-2-Methylpropane-1,2-diamine hydrochloride | ESD-846554-100MG |
Cas.: 93885-41-7 | Purity: 95% | 5-Methoxy-2,3-dihydrobenzofuran-2-carboxylic acid | ESD-846555-25MG |
Cas.: 93885-41-7 | Purity: 95% | 5-Methoxy-2,3-dihydrobenzofuran-2-carboxylic acid | ESD-846555-100MG |
Cas.: 1228829-43-3 | Purity: 98% | 2-Bromo-5-formylbenzonitrile | ESD-846556-25MG |
Cas.: 1228829-43-3 | Purity: 98% | 2-Bromo-5-formylbenzonitrile | ESD-846556-100MG |
Cas.: 1106295-93-5 | Purity: 97% | 2-Chloro-4-methoxypyrimidine-5-carbonitrile | ESD-846557-25MG |
Cas.: 1106295-93-5 | Purity: 97% | 2-Chloro-4-methoxypyrimidine-5-carbonitrile | ESD-846557-100MG |
Cas.: 1190314-60-3 | Purity: 95% | 5-Chloro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one | ESD-846558-25MG |
Cas.: 1190314-60-3 | Purity: 95% | 5-Chloro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one | ESD-846558-100MG |
Cas.: 1033610-45-5 | Purity: 98% | 4-Bromo-3,5-dimethoxypyridine | ESD-846559-25MG |
Cas.: 1033610-45-5 | Purity: 98% | 4-Bromo-3,5-dimethoxypyridine | ESD-846559-100MG |
Cas.: 52798-09-1 | Purity: 98% | 2-(4-Carbamimidoylphenyl)acetic acid hydrochloride | ESD-846560-25MG |
Cas.: 52798-09-1 | Purity: 98% | 2-(4-Carbamimidoylphenyl)acetic acid hydrochloride | ESD-846560-100MG |
Cas.: 172217-02-6 | Purity: 98% | 7-(Trifluoromethyl)-1H-indole | ESD-846561-25MG |
Cas.: 172217-02-6 | Purity: 98% | 7-(Trifluoromethyl)-1H-indole | ESD-846561-100MG |
Cas.: 81528-48-5 | Purity: 98% | Methyl 4-amino-5-methylthiophene-3-carboxylate | ESD-846562-25MG |
Cas.: 81528-48-5 | Purity: 98% | Methyl 4-amino-5-methylthiophene-3-carboxylate | ESD-846562-100MG |
Cas.: 1340111-89-8 | Purity: 95% | (7-Chloro-1-methyl-1H-benzo[d]imidazol-2-yl)methanol | ESD-846563-25MG |
Cas.: 1340111-89-8 | Purity: 95% | (7-Chloro-1-methyl-1H-benzo[d]imidazol-2-yl)methanol | ESD-846563-100MG |
Cas.: 72459-45-1 | Purity: 98% | 1-(2-Bromobenzyl)-1H-imidazole | ESD-846564-25MG |
Cas.: 72459-45-1 | Purity: 98% | 1-(2-Bromobenzyl)-1H-imidazole | ESD-846564-100MG |
Cas.: 1616526-82-9 | Purity: 97% | 5-Hydroxypyrimidin-4(3H)-one hydrochloride | ESD-846565-25MG |
Cas.: 1616526-82-9 | Purity: 97% | 5-Hydroxypyrimidin-4(3H)-one hydrochloride | ESD-846565-100MG |
Cas.: 5169-93-7 | Purity: 95% | 2-(Piperazin-2-yl)ethanol dihydrochloride | ESD-846566-25MG |
Cas.: 5169-93-7 | Purity: 95% | 2-(Piperazin-2-yl)ethanol dihydrochloride | ESD-846566-100MG |
Cas.: 290368-00-2 | Purity: 98% | tert-Butyl 3-iodo-1H-indazole-1-carboxylate | ESD-846567-250MG |
Cas.: 290368-00-2 | Purity: 98% | tert-Butyl 3-iodo-1H-indazole-1-carboxylate | ESD-846567-1G |
Cas.: 82782-85-2 | Purity: 98% | Methyl 4H-thieno[3,2-b]pyrrole-5-carboxylate | ESD-846568-250MG |
Cas.: 82782-85-2 | Purity: 98% | Methyl 4H-thieno[3,2-b]pyrrole-5-carboxylate | ESD-846568-1G |
Cas.: 69574-07-8 | Purity: 96% | 3,5-Diethyl-4-hydroxybenzaldehyde | ESD-846569-250MG |
Cas.: 69574-07-8 | Purity: 96% | 3,5-Diethyl-4-hydroxybenzaldehyde | ESD-846569-1G |
Cas.: 756817-82-0 | Purity: 98% | (2-(Dimethylamino)pyrimidin-5-yl)boronic acid | ESD-846570-250MG |
Cas.: 756817-82-0 | Purity: 98% | (2-(Dimethylamino)pyrimidin-5-yl)boronic acid | ESD-846570-1G |
Cas.: 1159826-67-1 | Purity: 97% | tert-Butyl (pipidin-3-ylmethyl)carbamate hydrochloride | ESD-846571-250MG |
Cas.: 1159826-67-1 | Purity: 97% | tert-Butyl (pipidin-3-ylmethyl)carbamate hydrochloride | ESD-846571-1G |
Cas.: 1187929-81-2 | Purity: 95% | tert-Butyl (azetidin-3-ylmethyl)carbamate oxalate | ESD-846572-250MG |
Cas.: 1187929-81-2 | Purity: 95% | tert-Butyl (azetidin-3-ylmethyl)carbamate oxalate | ESD-846572-1G |
Cas.: 59229-57-1 | Purity: 97% | 2-Methylmorpholine hydrochloride | ESD-846573-250MG |
Cas.: 59229-57-1 | Purity: 97% | 2-Methylmorpholine hydrochloride | ESD-846573-1G |
Cas.: 73221-18-8 | Purity: 96% | Imidazo[1,2-a]pyridin-8-ylamine | ESD-846574-250MG |
Cas.: 73221-18-8 | Purity: 96% | Imidazo[1,2-a]pyridin-8-ylamine | ESD-846574-1G |
Cas.: 100252-25-3 | Purity: 97% | N,N-Dimethyl-2-(2-phenoxyethoxy)ethanamine | ESD-846575-50MG |
Cas.: 100252-25-3 | Purity: 97% | N,N-Dimethyl-2-(2-phenoxyethoxy)ethanamine | ESD-846575-250MG |
Cas.: 1204483-99-7 | Purity: 97% | 2-Chloro-5-isopropoxypyridine | ESD-846576-50MG |
Cas.: 1204483-99-7 | Purity: 97% | 2-Chloro-5-isopropoxypyridine | ESD-846576-250MG |
Cas.: 61367-17-7 | Purity: 97% | cis-Ethyl 4-aminocyclohexanecarboxylate hydrochloride | ESD-846577-50MG |
Cas.: 61367-17-7 | Purity: 97% | cis-Ethyl 4-aminocyclohexanecarboxylate hydrochloride | ESD-846577-250MG |
Cas.: 115012-09-4 | Purity: 95% | 7-Hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-5-one | ESD-846578-50MG |
Cas.: 115012-09-4 | Purity: 95% | 7-Hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-5-one | ESD-846578-250MG |
Cas.: 705240-99-9 | Purity: 98% | 2-(4-Amino-3-methylphenyl)acetic acid | ESD-846579-50MG |
Cas.: 705240-99-9 | Purity: 98% | 2-(4-Amino-3-methylphenyl)acetic acid | ESD-846579-250MG |
Cas.: 1260637-54-4 | Purity: 95% | Methyl 2-amino-2-(tetrahydro-2H-pyran-4-yl)acetate hydrochloride | ESD-846580-50MG |
Cas.: 1260637-54-4 | Purity: 95% | Methyl 2-amino-2-(tetrahydro-2H-pyran-4-yl)acetate hydrochloride | ESD-846580-250MG |
Cas.: 113824-76-3 | Purity: 95% | 2-(Methyl(2-phenoxyethyl)amino)ethanol | ESD-846581-50MG |
Cas.: 113824-76-3 | Purity: 95% | 2-(Methyl(2-phenoxyethyl)amino)ethanol | ESD-846581-250MG |
Cas.: 552331-30-3 | Purity: 98% | 5-Bromo-1,3-dimethyl-1H-indazole | ESD-846582-50MG |
Cas.: 552331-30-3 | Purity: 98% | 5-Bromo-1,3-dimethyl-1H-indazole | ESD-846582-250MG |
Cas.: 6855-64-7 | Purity: 97% | 2-Phenyl-1H-indol-5-amine | ESD-846583-50MG |
Cas.: 6855-64-7 | Purity: 97% | 2-Phenyl-1H-indol-5-amine | ESD-846583-250MG |
Cas.: 156939-62-7 | Purity: 98% | (9H-Fluoren-9-yl)methyl 2-oxoethylcarbamate | ESD-846584-50MG |
Cas.: 156939-62-7 | Purity: 98% | (9H-Fluoren-9-yl)methyl 2-oxoethylcarbamate | ESD-846584-250MG |
Cas.: 2942-43-0 | Purity: 97% | 1H-Pyrazolo[3,4-b]pyridin-3(2H)-one | ESD-846585-50MG |
Cas.: 2942-43-0 | Purity: 97% | 1H-Pyrazolo[3,4-b]pyridin-3(2H)-one | ESD-846585-250MG |
Cas.: 5446-05-9 | Purity: 98% | 4-Chloro-1-iodo-2-nitrobenzene | ESD-846586-1G |
Cas.: 5446-05-9 | Purity: 98% | 4-Chloro-1-iodo-2-nitrobenzene | ESD-846586-5G |
Cas.: 519018-52-1 | Purity: 98% | 7-Bromobenzofuran-3(2H)-one | ESD-846587-50MG |
Cas.: 519018-52-1 | Purity: 98% | 7-Bromobenzofuran-3(2H)-one | ESD-846587-250MG |
Cas.: 3356-94-3 | Purity: 96% | Ethyl 5-chloro-3-methylisoxazole-4-carboxylate | ESD-846588-50MG |
Cas.: 3356-94-3 | Purity: 96% | Ethyl 5-chloro-3-methylisoxazole-4-carboxylate | ESD-846588-250MG |
Cas.: 1000018-56-3 | Purity: 95% | 6-Bromoimidazo[1,2-a]pyrazine-2-carboxylic acid | ESD-846589-50MG |
Cas.: 1000018-56-3 | Purity: 95% | 6-Bromoimidazo[1,2-a]pyrazine-2-carboxylic acid | ESD-846589-250MG |
Cas.: 101555-61-7 | Purity: 95% | Boc-D-beta-Homophenylalanine | ESD-846590-50MG |
Cas.: 101555-61-7 | Purity: 95% | Boc-D-beta-Homophenylalanine | ESD-846590-250MG |
Cas.: 1220033-11-3 | Purity: 95% | 3-((2,4-Dichlorobenzyl)oxy)pyrrolidine hydrochloride | ESD-846591-50MG |
Cas.: 1220033-11-3 | Purity: 95% | 3-((2,4-Dichlorobenzyl)oxy)pyrrolidine hydrochloride | ESD-846591-250MG |
Cas.: 677746-35-9 | Purity: 98% | (2-Methoxy-5-nitrophenyl)boronic acid | ESD-846592-50MG |
Cas.: 677746-35-9 | Purity: 98% | (2-Methoxy-5-nitrophenyl)boronic acid | ESD-846592-250MG |
Cas.: 915763-60-9 | Purity: 98% | (3-Chloro-5-cyanophenyl)boronic acid | ESD-846593-50MG |
Cas.: 915763-60-9 | Purity: 98% | (3-Chloro-5-cyanophenyl)boronic acid | ESD-846593-250MG |
Cas.: 690632-08-7 | Purity: 97% | 6-Bromospiro[chroman-2,4′-piperidin]-4-one | ESD-846594-50MG |
Cas.: 690632-08-7 | Purity: 97% | 6-Bromospiro[chroman-2,4′-piperidin]-4-one | ESD-846594-250MG |
Cas.: 118543-96-7 | Purity: 95% | 5-Acetylpyrazine-2-carboxylic acid | ESD-846595-50MG |
Cas.: 118543-96-7 | Purity: 95% | 5-Acetylpyrazine-2-carboxylic acid | ESD-846595-250MG |
Cas.: 1205037-95-1 | Purity: 95% | trans-3-Aminocyclobutanol hydrochloride | ESD-846596-50MG |
Cas.: 1205037-95-1 | Purity: 95% | trans-3-Aminocyclobutanol hydrochloride | ESD-846596-250MG |
Cas.: 1378814-84-6 | Purity: 98% | (2,6-Dichloro-3-methylphenyl)methanol | ESD-846597-50MG |
Cas.: 1378814-84-6 | Purity: 98% | (2,6-Dichloro-3-methylphenyl)methanol | ESD-846597-250MG |
Cas.: 54346-27-9 | Purity: 95% | Pyrazolo[1,5-a][1,3,5]triazin-4(3H)-one | ESD-846598-50MG |
Cas.: 54346-27-9 | Purity: 95% | Pyrazolo[1,5-a][1,3,5]triazin-4(3H)-one | ESD-846598-250MG |
Cas.: 137159-36-5 | Purity: 97% | Ethyl 5-formyl-1H-imidazole-4-carboxylate | ESD-846599-50MG |
Cas.: 137159-36-5 | Purity: 97% | Ethyl 5-formyl-1H-imidazole-4-carboxylate | ESD-846599-250MG |
Cas.: 24463-41-0 | Purity: 97% | 1-Methyl-4-oxocyclohexanecarboxylic acid | ESD-846600-50MG |
Cas.: 24463-41-0 | Purity: 97% | 1-Methyl-4-oxocyclohexanecarboxylic acid | ESD-846600-250MG |
Cas.: 81114-96-7 | Purity: 95% | Methyl 2-methoxy-3-oxobutanoate | ESD-846601-50MG |
Cas.: 81114-96-7 | Purity: 95% | Methyl 2-methoxy-3-oxobutanoate | ESD-846601-250MG |
Cas.: 854159-45-8 | Purity: 98% | 1-(2-Chloropyridin-4-yl)piperazine | ESD-846602-50MG |
Cas.: 854159-45-8 | Purity: 98% | 1-(2-Chloropyridin-4-yl)piperazine | ESD-846602-250MG |
Cas.: 84743-77-1 | Purity: 95% | 2-Bromobenzene-1,3,5-triol | ESD-846603-50MG |
Cas.: 84743-77-1 | Purity: 95% | 2-Bromobenzene-1,3,5-triol | ESD-846603-250MG |
Cas.: 676560-15-9 | Purity: 95% | Ethyl 4-((tert-butyldimethylsilyl)oxy)cyclohexanecarboxylate | ESD-846604-50MG |
Cas.: 676560-15-9 | Purity: 95% | Ethyl 4-((tert-butyldimethylsilyl)oxy)cyclohexanecarboxylate | ESD-846604-250MG |
Cas.: 852203-17-9 | Purity: 98% | 2,4-Dichloro-6-(trifluoromethyl)quinoline | ESD-846605-50MG |
Cas.: 852203-17-9 | Purity: 98% | 2,4-Dichloro-6-(trifluoromethyl)quinoline | ESD-846605-250MG |
Cas.: 327056-65-5 | Purity: 97% | N-Hydroxy-5-methoxypicolinimidamide | ESD-846606-50MG |
Cas.: 327056-65-5 | Purity: 97% | N-Hydroxy-5-methoxypicolinimidamide | ESD-846606-250MG |
Cas.: 197632-75-0 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(1-(tert-butoxycarbonyl)-1H-indol-3-yl)propanoic acid | ESD-846607-50MG |
Cas.: 197632-75-0 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(1-(tert-butoxycarbonyl)-1H-indol-3-yl)propanoic acid | ESD-846607-250MG |
Cas.: 105285-21-0 | Purity: 97% | 4-(tert-Butyl)-1H-pyrazole | ESD-846608-50MG |
Cas.: 105285-21-0 | Purity: 97% | 4-(tert-Butyl)-1H-pyrazole | ESD-846608-250MG |
Cas.: 1256789-95-3 | Purity: 98% | Methyl 5-bromo-4-methoxypicolinate | ESD-846609-50MG |
Cas.: 1256789-95-3 | Purity: 98% | Methyl 5-bromo-4-methoxypicolinate | ESD-846609-250MG |
Cas.: 77150-35-7 | Purity: 95% | 8-Bromoquinazolin-4(1H)-one | ESD-846610-250MG |
Cas.: 77150-35-7 | Purity: 95% | 8-Bromoquinazolin-4(1H)-one | ESD-846610-1G |
Cas.: 695-85-2 | Purity: 98% | 4-Chloro-5-methoxypyrimidine | ESD-846611-25MG |
Cas.: 695-85-2 | Purity: 98% | 4-Chloro-5-methoxypyrimidine | ESD-846611-100MG |
Cas.: 1196145-38-6 | Purity: 97% | (5-Fluoropyrimdin-2-yl)acetic acid | ESD-846613-25MG |
Cas.: 1196145-38-6 | Purity: 97% | (5-Fluoropyrimdin-2-yl)acetic acid | ESD-846613-100MG |
Cas.: 60736-71-2 | Purity: 98% | 4-(Chloromethyl)-1-methoxy-2-methylbenzene | ESD-846614-250MG |
Cas.: 60736-71-2 | Purity: 98% | 4-(Chloromethyl)-1-methoxy-2-methylbenzene | ESD-846614-1G |
Cas.: 187725-00-4 | Purity: 98% | Ethyl 4-chloro-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylate | ESD-846615-25MG |
Cas.: 187725-00-4 | Purity: 98% | Ethyl 4-chloro-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylate | ESD-846615-100MG |
Cas.: 69879-22-7 | Purity: 98% | 6-Aminocotinaldehyde | ESD-846616-25MG |
Cas.: 69879-22-7 | Purity: 98% | 6-Aminocotinaldehyde | ESD-846616-100MG |
Cas.: 1109230-25-2 | Purity: 98% | 5-Bromo-3,4-dihydroisoquinolin-1(2H)-one | ESD-846617-25MG |
Cas.: 1109230-25-2 | Purity: 98% | 5-Bromo-3,4-dihydroisoquinolin-1(2H)-one | ESD-846617-100MG |
Cas.: 36639-50-6 | Purity: 98% | Sodium (4-nitrophenyl)methanesulfonate | ESD-846618-25MG |
Cas.: 36639-50-6 | Purity: 98% | Sodium (4-nitrophenyl)methanesulfonate | ESD-846618-100MG |
Cas.: 67073-96-5 | Purity: 98% | 1-(6-Methylpyrimidin-4-yl)ethanone | ESD-846619-25MG |
Cas.: 67073-96-5 | Purity: 98% | 1-(6-Methylpyrimidin-4-yl)ethanone | ESD-846619-100MG |
Cas.: 746668-59-7 | Purity: 98% | 6-Bromo-5-methyl[1,2,4]triazolo[1,5-a]pyridine | ESD-846620-25MG |
Cas.: 746668-59-7 | Purity: 98% | 6-Bromo-5-methyl[1,2,4]triazolo[1,5-a]pyridine | ESD-846620-100MG |
Cas.: 1209905-41-8 | Purity: 95% | 2-Bromo-3-methoxypyrazine | ESD-846621-25MG |
Cas.: 1209905-41-8 | Purity: 95% | 2-Bromo-3-methoxypyrazine | ESD-846621-100MG |
Cas.: 1233026-31-7 | Purity: 97% | 2-Chloro-4-(methylsulfonyl)pyrimidine | ESD-846622-25MG |
Cas.: 1233026-31-7 | Purity: 97% | 2-Chloro-4-(methylsulfonyl)pyrimidine | ESD-846622-100MG |
Cas.: 99835-27-5 | Purity: 98% | 4-Bromo-2,6-dichlorobenzonitrile | ESD-846623-25MG |
Cas.: 99835-27-5 | Purity: 98% | 4-Bromo-2,6-dichlorobenzonitrile | ESD-846623-100MG |
Cas.: 573675-29-3 | Purity: 95% | 7-Bromopyrido[3,2-d]pyrimidin-4(3H)-one | ESD-846624-25MG |
Cas.: 573675-29-3 | Purity: 95% | 7-Bromopyrido[3,2-d]pyrimidin-4(3H)-one | ESD-846624-100MG |
Cas.: 63870-39-3 | Purity: 95% | (3-Amino-1H-1,2,4-triazol-5-yl)methanol compound with 2-hydroxyacetic acid | ESD-846625-25MG |
Cas.: 63870-39-3 | Purity: 95% | (3-Amino-1H-1,2,4-triazol-5-yl)methanol compound with 2-hydroxyacetic acid | ESD-846625-100MG |
Cas.: 270912-79-3 | Purity: 98% | 2-((5-Bromopyrimidin-2-yl)oxy)acetic acid | ESD-846626-25MG |
Cas.: 270912-79-3 | Purity: 98% | 2-((5-Bromopyrimidin-2-yl)oxy)acetic acid | ESD-846626-100MG |
Cas.: 1260843-59-1 | Purity: 95% | 3,4-Dibromo-5-fluoropyridine | ESD-846627-25MG |
Cas.: 1260843-59-1 | Purity: 95% | 3,4-Dibromo-5-fluoropyridine | ESD-846627-100MG |
Cas.: 1044766-09-7 | Purity: 98% | 5-(2-Fluorophenyl)-1,3,4-oxadiazol-2(3H)-one | ESD-846628-25MG |
Cas.: 1044766-09-7 | Purity: 98% | 5-(2-Fluorophenyl)-1,3,4-oxadiazol-2(3H)-one | ESD-846628-100MG |
Cas.: 914208-15-4 | Purity: 98% | 8-Bromoquinoline-2-carboxylic acid | ESD-846629-25MG |
Cas.: 914208-15-4 | Purity: 98% | 8-Bromoquinoline-2-carboxylic acid | ESD-846629-100MG |
Cas.: 16263-54-0 | Purity: 97% | 3,6-Dichlorobenzo[d]isoxazole | ESD-846630-25MG |
Cas.: 16263-54-0 | Purity: 97% | 3,6-Dichlorobenzo[d]isoxazole | ESD-846630-100MG |
Cas.: 893444-21-8 | Purity: 97% | 3-Nitro-6-(trifluoromethyl)pyridin-2-amine | ESD-846631-25MG |
Cas.: 893444-21-8 | Purity: 97% | 3-Nitro-6-(trifluoromethyl)pyridin-2-amine | ESD-846631-100MG |
Cas.: 59864-31-2 | Purity: 98% | 1-Methyl-6-oxo-1,6-dihydropyridine-2-carboxylic acid | ESD-846632-25MG |
Cas.: 59864-31-2 | Purity: 98% | 1-Methyl-6-oxo-1,6-dihydropyridine-2-carboxylic acid | ESD-846632-100MG |
Cas.: 178984-69-5 | Purity: 98% | Methyl 4-chloroquinoline-7-carboxylate | ESD-846633-25MG |
Cas.: 178984-69-5 | Purity: 98% | Methyl 4-chloroquinoline-7-carboxylate | ESD-846633-100MG |
Cas.: 1227270-32-7 | Purity: 98% | 2-Iodo-1H-pyrrolo[2,3-b]pyridine | ESD-846634-25MG |
Cas.: 1227270-32-7 | Purity: 98% | 2-Iodo-1H-pyrrolo[2,3-b]pyridine | ESD-846634-100MG |
Cas.: 1384430-75-4 | Purity: 98% | 2-(Chloromethyl)-5-methylpyrimidine hydrochloride | ESD-846635-25MG |
Cas.: 1384430-75-4 | Purity: 98% | 2-(Chloromethyl)-5-methylpyrimidine hydrochloride | ESD-846635-100MG |
Cas.: 959236-72-7 | Purity: 96% | 7-Iodoquinazoline-2,4(1H,3H)-dione | ESD-846636-25MG |
Cas.: 959236-72-7 | Purity: 96% | 7-Iodoquinazoline-2,4(1H,3H)-dione | ESD-846636-100MG |
Cas.: 73907-95-6 | Purity: 98% | 6-Amino-1H-indazole-7-carboxylic acid | ESD-846637-25MG |
Cas.: 73907-95-6 | Purity: 98% | 6-Amino-1H-indazole-7-carboxylic acid | ESD-846637-100MG |
Cas.: 149142-67-6 | Purity: 95% | 5-Bromo-1H-pyrrolo[2,3-b]pyridine-2,3-dione | ESD-846638-25MG |
Cas.: 149142-67-6 | Purity: 95% | 5-Bromo-1H-pyrrolo[2,3-b]pyridine-2,3-dione | ESD-846638-100MG |
Cas.: 123664-84-6 | Purity: 98% | N-(5-Methoxy-2-phenoxyphenyl)methanesulfonamide | ESD-846639-25MG |
Cas.: 123664-84-6 | Purity: 98% | N-(5-Methoxy-2-phenoxyphenyl)methanesulfonamide | ESD-846639-100MG |
Cas.: 22049-95-2 | Purity: 95% | Methyl 2-oxopyrrolidine-3-carboxylate | ESD-846640-25MG |
Cas.: 22049-95-2 | Purity: 95% | Methyl 2-oxopyrrolidine-3-carboxylate | ESD-846640-100MG |
Cas.: 141196-39-6 | Purity: 97% | (R)-2-(Methoxymethyl)morpholine hydrochloride | ESD-846641-25MG |
Cas.: 141196-39-6 | Purity: 97% | (R)-2-(Methoxymethyl)morpholine hydrochloride | ESD-846641-100MG |
Cas.: 1224944-51-7 | Purity: 98% | Methyl 5-chloropyrazolo[1,5-a]pyrimidine-3-carboxylate | ESD-846642-25MG |
Cas.: 1224944-51-7 | Purity: 98% | Methyl 5-chloropyrazolo[1,5-a]pyrimidine-3-carboxylate | ESD-846642-100MG |
Cas.: 38170-02-4 | Purity: 97% | 2-Hydroxy-4-iodobenzaldehyde | ESD-846643-25MG |
Cas.: 38170-02-4 | Purity: 97% | 2-Hydroxy-4-iodobenzaldehyde | ESD-846643-100MG |
Cas.: 849937-80-0 | Purity: 97% | 2-Fluoro-N,N-dimethylpyridin-4-amine | ESD-846644-25MG |
Cas.: 849937-80-0 | Purity: 97% | 2-Fluoro-N,N-dimethylpyridin-4-amine | ESD-846644-100MG |
Cas.: 862175-17-5 | Purity: 97% | N-Methylhex-5-en-1-amine hydrochloride | ESD-846645-25MG |
Cas.: 862175-17-5 | Purity: 97% | N-Methylhex-5-en-1-amine hydrochloride | ESD-846645-100MG |
Cas.: 1430341-84-6 | Purity: 96% | 6-Bromo-2-chloro-3-nitropyridine | ESD-846646-25MG |
Cas.: 1430341-84-6 | Purity: 96% | 6-Bromo-2-chloro-3-nitropyridine | ESD-846646-100MG |
Cas.: 1004997-73-2 | Purity: 97% | 2-(Aminomethyl)-4-bromoaniline dihydrochloride | ESD-846647-25MG |
Cas.: 1004997-73-2 | Purity: 97% | 2-(Aminomethyl)-4-bromoaniline dihydrochloride | ESD-846647-100MG |
Cas.: 19520-74-2 | Purity: 97% | Methyl 3-hydroxy-5-methoxybenzoate | ESD-846648-25MG |
Cas.: 19520-74-2 | Purity: 97% | Methyl 3-hydroxy-5-methoxybenzoate | ESD-846648-100MG |
Cas.: 655248-57-0 | Purity: 97% | 4-Amino-2-bromobenzaldehyde | ESD-846649-25MG |
Cas.: 655248-57-0 | Purity: 97% | 4-Amino-2-bromobenzaldehyde | ESD-846649-100MG |
Cas.: 150188-64-0 | Purity: 98% | 2-(3-(Dimethylamino)phenoxy)acetic acid | ESD-846650-25MG |
Cas.: 150188-64-0 | Purity: 98% | 2-(3-(Dimethylamino)phenoxy)acetic acid | ESD-846650-100MG |
Cas.: 256519-10-5 | Purity: 97% | 4-Fluoro-1H-benzo[d]imidazol-2(3H)-one | ESD-846651-25MG |
Cas.: 256519-10-5 | Purity: 97% | 4-Fluoro-1H-benzo[d]imidazol-2(3H)-one | ESD-846651-100MG |
Cas.: 66336-42-3 | Purity: 98% | 8-Methyl-1,4-dioxaspiro[4.5]decan-8-ol | ESD-846652-25MG |
Cas.: 66336-42-3 | Purity: 98% | 8-Methyl-1,4-dioxaspiro[4.5]decan-8-ol | ESD-846652-100MG |
Cas.: 27613-33-8 | Purity: 98% | 2-Formyl-5-methylbenzonitrile | ESD-846653-25MG |
Cas.: 27613-33-8 | Purity: 98% | 2-Formyl-5-methylbenzonitrile | ESD-846653-100MG |
Cas.: 861118-00-5 | Purity: 97% | 3,5-Diiodo-4-methylbenzaldehyde | ESD-846654-25MG |
Cas.: 861118-00-5 | Purity: 97% | 3,5-Diiodo-4-methylbenzaldehyde | ESD-846654-100MG |
Cas.: 57602-02-5 | Purity: 98% | 1,14-Dibromo-3,6,9,12-tetraoxatetradecane | ESD-846655-25MG |
Cas.: 57602-02-5 | Purity: 98% | 1,14-Dibromo-3,6,9,12-tetraoxatetradecane | ESD-846655-100MG |
Cas.: 13278-39-2 | Purity: 95% | 2-((3-Bromophenyl)amino)benzoic acid | ESD-846656-25MG |
Cas.: 13278-39-2 | Purity: 95% | 2-((3-Bromophenyl)amino)benzoic acid | ESD-846656-100MG |
Cas.: 22976-68-7 | Purity: 95% | 2-Amino-3-(2-methoxyphenyl)propanoic acid | ESD-846657-25MG |
Cas.: 22976-68-7 | Purity: 95% | 2-Amino-3-(2-methoxyphenyl)propanoic acid | ESD-846657-100MG |
Cas.: 501433-05-2 | Purity: 97% | 2,3-Difluoro-4-iodobenzoic acid | ESD-846658-25MG |
Cas.: 501433-05-2 | Purity: 97% | 2,3-Difluoro-4-iodobenzoic acid | ESD-846658-100MG |
Cas.: 501357-89-7 | Purity: 98% | 8-Chloro[1,2,4]triazolo[4,3-a]pyridine | ESD-846659-250MG |
Cas.: 501357-89-7 | Purity: 98% | 8-Chloro[1,2,4]triazolo[4,3-a]pyridine | ESD-846659-1G |
Cas.: 61070-99-3 | Purity: 98% | Pyridazine-3,6-diamine | ESD-846660-250MG |
Cas.: 61070-99-3 | Purity: 98% | Pyridazine-3,6-diamine | ESD-846660-1G |
Cas.: 77901-52-1 | Purity: 98% | Methyl 2-methoxy-6-nitrobenzoate | ESD-846661-250MG |
Cas.: 77901-52-1 | Purity: 98% | Methyl 2-methoxy-6-nitrobenzoate | ESD-846661-1G |
Cas.: 63658-16-2 | Purity: 97% | (Z)-Methyl 2-(tert-butoxycarbonylamino)but-2-enoate | ESD-846662-250MG |
Cas.: 63658-16-2 | Purity: 97% | (Z)-Methyl 2-(tert-butoxycarbonylamino)but-2-enoate | ESD-846662-1G |
Cas.: 77532-88-8 | Purity: 98% | 5-Chloro-2-formylbenzonitrile | ESD-846663-250MG |
Cas.: 77532-88-8 | Purity: 98% | 5-Chloro-2-formylbenzonitrile | ESD-846663-1G |
Cas.: 75464-52-7 | Purity: 97% | 2,5-Diaminobenzene-1,4-dithiol dihydrochloride | ESD-846664-250MG |
Cas.: 75464-52-7 | Purity: 97% | 2,5-Diaminobenzene-1,4-dithiol dihydrochloride | ESD-846664-1G |
Cas.: 55039-89-9 | Purity: 97% | 2,2-Difluoropent-4-enoic acid | ESD-846665-250MG |
Cas.: 55039-89-9 | Purity: 97% | 2,2-Difluoropent-4-enoic acid | ESD-846665-1G |
Cas.: 70478-63-6 | Purity: 98% | 4-Bromoisoindoline-1,3-dione | ESD-846666-50MG |
Cas.: 70478-63-6 | Purity: 98% | 4-Bromoisoindoline-1,3-dione | ESD-846666-250MG |
Cas.: 1217090-32-8 | Purity: 98% | N-Methyl-5-bromo-4,7-diazaindole | ESD-846667-50MG |
Cas.: 1217090-32-8 | Purity: 98% | N-Methyl-5-bromo-4,7-diazaindole | ESD-846667-250MG |
Cas.: 1260863-86-2 | Purity: 95% | 6-Bromooxazolo[4,5-b]pyridine | ESD-846668-50MG |
Cas.: 1260863-86-2 | Purity: 95% | 6-Bromooxazolo[4,5-b]pyridine | ESD-846668-250MG |
Cas.: 928839-62-7 | Purity: 98% | 5-Bromoquinoline-8-carboxylic acid | ESD-846669-50MG |
Cas.: 928839-62-7 | Purity: 98% | 5-Bromoquinoline-8-carboxylic acid | ESD-846669-250MG |
Cas.: 269058-49-3 | Purity: 97% | 3-Bromo-6-methoxypicolinaldehyde | ESD-846670-50MG |
Cas.: 269058-49-3 | Purity: 97% | 3-Bromo-6-methoxypicolinaldehyde | ESD-846670-250MG |
Cas.: 1228788-32-6 | Purity: 95% | (5-Fluoropyridin-2-yl)methanamine hydrochloride | ESD-846671-50MG |
Cas.: 1228788-32-6 | Purity: 95% | (5-Fluoropyridin-2-yl)methanamine hydrochloride | ESD-846671-250MG |
Cas.: 63071-12-5 | Purity: 97% | (6-Methoxypyridin-2-yl)methanol | ESD-846672-50MG |
Cas.: 63071-12-5 | Purity: 97% | (6-Methoxypyridin-2-yl)methanol | ESD-846672-250MG |
Cas.: 1245644-46-5 | Purity: 97% | 8-Bromo-3-iodoimidazo[1,2-a]pyrazine | ESD-846673-50MG |
Cas.: 1245644-46-5 | Purity: 97% | 8-Bromo-3-iodoimidazo[1,2-a]pyrazine | ESD-846673-250MG |
Cas.: 95658-81-4 | Purity: 95% | 3-Hydroxy-5-methylbenzonitrile | ESD-846674-50MG |
Cas.: 95658-81-4 | Purity: 95% | 3-Hydroxy-5-methylbenzonitrile | ESD-846674-250MG |
Cas.: 193017-26-4 | Purity: 98% | 4-(Thiazol-2-yl)aniline | ESD-846675-50MG |
Cas.: 193017-26-4 | Purity: 98% | 4-(Thiazol-2-yl)aniline | ESD-846675-250MG |
Cas.: 119165-68-3 | Purity: 98% | 2-(1H-Imidazol-2-yl)pyrazine | ESD-846676-50MG |
Cas.: 119165-68-3 | Purity: 98% | 2-(1H-Imidazol-2-yl)pyrazine | ESD-846676-250MG |
Cas.: 34957-73-8 | Purity: 95% | Methyl 9-hydroxynonanoate | ESD-846677-50MG |
Cas.: 34957-73-8 | Purity: 95% | Methyl 9-hydroxynonanoate | ESD-846677-250MG |
Cas.: 1158503-82-2 | Purity: 98% | Methyl 7-bromo-1H-indole-2-carboxylate | ESD-846678-50MG |
Cas.: 1158503-82-2 | Purity: 98% | Methyl 7-bromo-1H-indole-2-carboxylate | ESD-846678-250MG |
Cas.: 37827-68-2 | Purity: 97% | 7-Hydroxy-3,4-dihydro-1H-naphthalen-2-one | ESD-846679-250MG |
Cas.: 37827-68-2 | Purity: 97% | 7-Hydroxy-3,4-dihydro-1H-naphthalen-2-one | ESD-846679-1G |
Cas.: 88511-25-5 | Purity: 97% | 6-Iodopyridin-2-amine | ESD-846680-25MG |
Cas.: 88511-25-5 | Purity: 97% | 6-Iodopyridin-2-amine | ESD-846680-100MG |
Cas.: 68236-26-0 | Purity: 97% | N-(5-Bromothiophen-2-yl)acetamide | ESD-846681-25MG |
Cas.: 68236-26-0 | Purity: 97% | N-(5-Bromothiophen-2-yl)acetamide | ESD-846681-100MG |
Cas.: 1053656-57-7 | Purity: 95% | tert-Butyl 4-chloro-5,6-dihydropyrido[3,4-d]pyrimidine-7(8H)-carboxylate | ESD-846682-25MG |
Cas.: 1053656-57-7 | Purity: 95% | tert-Butyl 4-chloro-5,6-dihydropyrido[3,4-d]pyrimidine-7(8H)-carboxylate | ESD-846682-100MG |
Cas.: 863704-60-3 | Purity: 96% | 6-(4-Fluorophenyl)picolinic acid | ESD-846683-25MG |
Cas.: 863704-60-3 | Purity: 96% | 6-(4-Fluorophenyl)picolinic acid | ESD-846683-100MG |
Cas.: 1356066-65-3 | Purity: 95% | 3-Fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinonitrile | ESD-846684-25MG |
Cas.: 1356066-65-3 | Purity: 95% | 3-Fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinonitrile | ESD-846684-100MG |
Cas.: 937369-77-2 | Purity: 97% | 5-Phenylthiazole-2-carboxylic acid | ESD-846685-25MG |
Cas.: 937369-77-2 | Purity: 97% | 5-Phenylthiazole-2-carboxylic acid | ESD-846685-100MG |
Cas.: 1207175-68-5 | Purity: 98% | 7-Bromo-3,4-dihydroquinazolin-2(1H)-one | ESD-846686-25MG |
Cas.: 1207175-68-5 | Purity: 98% | 7-Bromo-3,4-dihydroquinazolin-2(1H)-one | ESD-846686-100MG |
Cas.: 1201597-23-0 | Purity: 98% | 2,6-Difluoro-4-methylbenzoic acid | ESD-846687-25MG |
Cas.: 1201597-23-0 | Purity: 98% | 2,6-Difluoro-4-methylbenzoic acid | ESD-846687-100MG |
Cas.: 383875-59-0 | Purity: 98% | 6-Chloro-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde | ESD-846688-25MG |
Cas.: 383875-59-0 | Purity: 98% | 6-Chloro-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde | ESD-846688-100MG |
Cas.: 1261269-66-2 | Purity: 97% | 2,4,6-Trichloronicotinaldehyde | ESD-846689-25MG |
Cas.: 1261269-66-2 | Purity: 97% | 2,4,6-Trichloronicotinaldehyde | ESD-846689-100MG |
Cas.: 1146970-26-4 | Purity: 97% | 5-Chloro-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine | ESD-846690-25MG |
Cas.: 1146970-26-4 | Purity: 97% | 5-Chloro-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine | ESD-846690-100MG |
Cas.: 1013112-48-5 | Purity: 98% | 2-Formyl-4,5-dimethoxybenzonitrile | ESD-846691-25MG |
Cas.: 1013112-48-5 | Purity: 98% | 2-Formyl-4,5-dimethoxybenzonitrile | ESD-846691-100MG |
Cas.: 1640995-63-6 | Purity: 97% | (4-Chloropyridin-2-yl)methanamine hydrochloride | ESD-846692-25MG |
Cas.: 1640995-63-6 | Purity: 97% | (4-Chloropyridin-2-yl)methanamine hydrochloride | ESD-846692-100MG |
Cas.: 1063733-81-2 | Purity: 98% | 2-(3,5-Difluorophenyl)propan-2-amine hydrochloride | ESD-846693-25MG |
Cas.: 1063733-81-2 | Purity: 98% | 2-(3,5-Difluorophenyl)propan-2-amine hydrochloride | ESD-846693-100MG |
Cas.: 1439900-32-9 | Purity: 95% | 2-(3-(trifluoromethyl)phenyl)propan-2-amine hydrochloride | ESD-846694-25MG |
Cas.: 1439900-32-9 | Purity: 95% | 2-(3-(trifluoromethyl)phenyl)propan-2-amine hydrochloride | ESD-846694-100MG |
Cas.: 91832-40-5 | Purity: 98% | Cefdinir | ESD-846695-250MG |
Cas.: 91832-40-5 | Purity: 98% | Cefdinir | ESD-846695-1G |
Cas.: 88598-08-7 | Purity: 98% | 1,2,5-Oxadiazole-3-carboxylic acid | ESD-846696-250MG |
Cas.: 88598-08-7 | Purity: 98% | 1,2,5-Oxadiazole-3-carboxylic acid | ESD-846696-1G |
Cas.: 825633-94-1 | Purity: 95% | 5-Iodo-2,3-dihydropyridazin-3-one | ESD-846697-250MG |
Cas.: 825633-94-1 | Purity: 95% | 5-Iodo-2,3-dihydropyridazin-3-one | ESD-846697-1G |
Cas.: 64951-06-0 | Purity: 97% | Ethyl imidazo[1,2-a]pyrimidine-2-carboxylate | ESD-846698-250MG |
Cas.: 64951-06-0 | Purity: 97% | Ethyl imidazo[1,2-a]pyrimidine-2-carboxylate | ESD-846698-1G |
Cas.: 34569-15-8 | Purity: 98% | 6-Chloro-2-ethyl-1H-benzo[d]imidazole | ESD-846699-250MG |
Cas.: 34569-15-8 | Purity: 98% | 6-Chloro-2-ethyl-1H-benzo[d]imidazole | ESD-846699-1G |
Cas.: 364782-34-3 | Purity: 98% | Cinacalcet hydrochloride | ESD-846700-250MG |
Cas.: 364782-34-3 | Purity: 98% | Cinacalcet hydrochloride | ESD-846700-1G |
Cas.: 103365-69-1 | Purity: 97% | (S)-1-Methyl-2,6-dioxohexahydropyrimidine-4-carboxylic acid | ESD-846701-250MG |
Cas.: 103365-69-1 | Purity: 97% | (S)-1-Methyl-2,6-dioxohexahydropyrimidine-4-carboxylic acid | ESD-846701-1G |
Cas.: 186663-83-2 | Purity: 97% | 3-(Fmoc-amino)propyl bromide | ESD-846702-250MG |
Cas.: 186663-83-2 | Purity: 97% | 3-(Fmoc-amino)propyl bromide | ESD-846702-1G |
Cas.: 194920-62-2 | Purity: 97% | tert-Butyl (3-(2-(2-(3-aminopropoxy)ethoxy)ethoxy)propyl)carbamate | ESD-846703-250MG |
Cas.: 194920-62-2 | Purity: 97% | tert-Butyl (3-(2-(2-(3-aminopropoxy)ethoxy)ethoxy)propyl)carbamate | ESD-846703-1G |
Cas.: 13602-82-9 | Purity: 98% | N-(2-Chloropyridin-4-yl)acetamide | ESD-846704-250MG |
Cas.: 13602-82-9 | Purity: 98% | N-(2-Chloropyridin-4-yl)acetamide | ESD-846704-1G |
Cas.: 3350-15-0 | Purity: 97% | (S)-Methyl 2-amino-4-((tert-butoxycarbonyl)amino)butanoate hydrochloride | ESD-846705-250MG |
Cas.: 3350-15-0 | Purity: 97% | (S)-Methyl 2-amino-4-((tert-butoxycarbonyl)amino)butanoate hydrochloride | ESD-846705-1G |
Cas.: 934236-35-8 | Purity: 97% | Methyl 2-chlorooxazole-4-carboxylate | ESD-846706-250MG |
Cas.: 934236-35-8 | Purity: 97% | Methyl 2-chlorooxazole-4-carboxylate | ESD-846706-1G |
Cas.: 931105-37-2 | Purity: 98% | Methyl 5-bromo-2-fluoronicotinate | ESD-846707-250MG |
Cas.: 931105-37-2 | Purity: 98% | Methyl 5-bromo-2-fluoronicotinate | ESD-846707-1G |
Cas.: 875237-46-0 | Purity: 95% | 2-Hydroxy-4-methylthiazole-5-carboxylic acid | ESD-846708-250MG |
Cas.: 875237-46-0 | Purity: 95% | 2-Hydroxy-4-methylthiazole-5-carboxylic acid | ESD-846708-1G |
Cas.: 748812-61-5 | Purity: 98% | tert-Butyl (5-bromo-3-methylpyridin-2-yl)carbamate | ESD-846709-250MG |
Cas.: 748812-61-5 | Purity: 98% | tert-Butyl (5-bromo-3-methylpyridin-2-yl)carbamate | ESD-846709-1G |
Cas.: 5685-72-3 | Purity: 98% | 3-Amino-5-chloro-1H-indazole | ESD-846710-250MG |
Cas.: 5685-72-3 | Purity: 98% | 3-Amino-5-chloro-1H-indazole | ESD-846710-1G |
Cas.: 19959-77-4 | Purity: 95% | 2-(5-Methyl-1H-pyrazol-3-yl)pyridine | ESD-846711-250MG |
Cas.: 19959-77-4 | Purity: 95% | 2-(5-Methyl-1H-pyrazol-3-yl)pyridine | ESD-846711-1G |
Cas.: 177476-76-5 | Purity: 98% | 4-Amino-3-methoxybenzonitrile | ESD-846712-250MG |
Cas.: 177476-76-5 | Purity: 98% | 4-Amino-3-methoxybenzonitrile | ESD-846712-1G |
Cas.: 939412-86-9 | Purity: 97% | (3-Chloropyrazin-2-yl)methanamine hydrochloride | ESD-846713-250MG |
Cas.: 939412-86-9 | Purity: 97% | (3-Chloropyrazin-2-yl)methanamine hydrochloride | ESD-846713-1G |
Cas.: 942589-45-9 | Purity: 98% | Methyl 3-amino-5-iodo-2-thiophenecarboxylate | ESD-846714-250MG |
Cas.: 942589-45-9 | Purity: 98% | Methyl 3-amino-5-iodo-2-thiophenecarboxylate | ESD-846714-1G |
Cas.: 383135-47-5 | Purity: 98% | 2-(4-(Ethylsulfonyl)phenyl)acetic acid | ESD-846715-250MG |
Cas.: 383135-47-5 | Purity: 98% | 2-(4-(Ethylsulfonyl)phenyl)acetic acid | ESD-846715-1G |
Cas.: 334932-13-7 | Purity: 97% | 3-((tert-Butoxycarbonyl)amino)cyclohexanecarboxylic acid | ESD-846716-250MG |
Cas.: 334932-13-7 | Purity: 97% | 3-((tert-Butoxycarbonyl)amino)cyclohexanecarboxylic acid | ESD-846716-1G |
Cas.: 54675-23-9 | Purity: 97% | 6-Bromo-4-hydroxyquinolin-2(1H)-one | ESD-846717-250MG |
Cas.: 54675-23-9 | Purity: 97% | 6-Bromo-4-hydroxyquinolin-2(1H)-one | ESD-846717-1G |
Cas.: 1282518-60-8 | Purity: 95% | 1-Isopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-846718-250MG |
Cas.: 1282518-60-8 | Purity: 95% | 1-Isopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-846718-1G |
Cas.: 158966-62-2 | Purity: 98% | 2-Chloro-6-methoxyaniline | ESD-846719-250MG |
Cas.: 158966-62-2 | Purity: 98% | 2-Chloro-6-methoxyaniline | ESD-846719-1G |
Cas.: 1203306-05-1 | Purity: 95% | 3-Aminocyclopentanecarboxylic acid hydrochloride | ESD-846720-250MG |
Cas.: 1203306-05-1 | Purity: 95% | 3-Aminocyclopentanecarboxylic acid hydrochloride | ESD-846720-1G |
Cas.: 1243395-68-7 | Purity: 96% | 4-Hydroxy-2-(trifluoromethyl)benzaldehyde | ESD-846721-250MG |
Cas.: 1243395-68-7 | Purity: 96% | 4-Hydroxy-2-(trifluoromethyl)benzaldehyde | ESD-846721-1G |
Cas.: 159503-91-0 | Purity: 95% | tert-Butyl 4-bromo-5,6-dihydropyridine-1(2H)-carboxylate | ESD-846722-250MG |
Cas.: 159503-91-0 | Purity: 95% | tert-Butyl 4-bromo-5,6-dihydropyridine-1(2H)-carboxylate | ESD-846722-1G |
Cas.: 625854-02-6 | Purity: 98% | 9-(4-Bromophenyl)-10-phenylanthracene | ESD-846723-250MG |
Cas.: 625854-02-6 | Purity: 98% | 9-(4-Bromophenyl)-10-phenylanthracene | ESD-846723-1G |
Cas.: 1092114-59-4 | Purity: 95% | 3-Iodo-1H-indole-5-carbonitrile | ESD-846725-250MG |
Cas.: 1092114-59-4 | Purity: 95% | 3-Iodo-1H-indole-5-carbonitrile | ESD-846725-1G |
Cas.: 80407-64-3 | Purity: 95% | 3,4-Bis(2-methoxyethoxy)benzaldehyde | ESD-846726-250MG |
Cas.: 80407-64-3 | Purity: 95% | 3,4-Bis(2-methoxyethoxy)benzaldehyde | ESD-846726-1G |
Cas.: 455330-37-7 | Purity: 95% | Sodium tetrakis(3,5-bis(trifluoromethyl)phenyl)borate xhydrate | ESD-846727-250MG |
Cas.: 455330-37-7 | Purity: 95% | Sodium tetrakis(3,5-bis(trifluoromethyl)phenyl)borate xhydrate | ESD-846727-1G |
Cas.: 331730-08-6 | Purity: 95% | Dicyclohexylamine (S)-2-((tert-butoxycarbonyl)amino)-3-(furan-2-yl)propanoate | ESD-846728-250MG |
Cas.: 331730-08-6 | Purity: 95% | Dicyclohexylamine (S)-2-((tert-butoxycarbonyl)amino)-3-(furan-2-yl)propanoate | ESD-846728-1G |
Cas.: 50907-57-8 | Purity: 97% | (2-Chloro-6-nitrophenyl)methanol | ESD-846729-250MG |
Cas.: 50907-57-8 | Purity: 97% | (2-Chloro-6-nitrophenyl)methanol | ESD-846729-1G |
Cas.: 33414-62-9 | Purity: 98% | 2-(Tetrahydrofuran-2-yl)acetonitrile | ESD-846730-250MG |
Cas.: 33414-62-9 | Purity: 98% | 2-(Tetrahydrofuran-2-yl)acetonitrile | ESD-846730-1G |
Cas.: 51642-03-6 | Purity: 97% | 3-Aminotetrahydrothiophene 1,1-dioxide hydrochloride | ESD-846731-250MG |
Cas.: 51642-03-6 | Purity: 97% | 3-Aminotetrahydrothiophene 1,1-dioxide hydrochloride | ESD-846731-1G |
Cas.: 133407-38-2 | Purity: 95% | (R)-N-(Methoxymethyl)-1-phenyl-N-((trimethylsilyl)methyl)ethanamine | ESD-846732-250MG |
Cas.: 133407-38-2 | Purity: 95% | (R)-N-(Methoxymethyl)-1-phenyl-N-((trimethylsilyl)methyl)ethanamine | ESD-846732-1G |
Cas.: 71224-95-8 | Purity: 97% | 2-Aminobenzo[d]thiazole-7-carboxylic acid | ESD-846733-25MG |
Cas.: 71224-95-8 | Purity: 97% | 2-Aminobenzo[d]thiazole-7-carboxylic acid | ESD-846733-100MG |
Cas.: 1111638-10-8 | Purity: 97% | 3-Chloro-5H-pyrrolo[2,3-b]pyrazine | ESD-846734-25MG |
Cas.: 1111638-10-8 | Purity: 97% | 3-Chloro-5H-pyrrolo[2,3-b]pyrazine | ESD-846734-100MG |
Cas.: 1035093-81-2 | Purity: 97% | (S)-Chroman-4-amine hydrochloride | ESD-846735-25MG |
Cas.: 1035093-81-2 | Purity: 97% | (S)-Chroman-4-amine hydrochloride | ESD-846735-100MG |
Cas.: 82657-76-9 | Purity: 98% | 1-(Bromomethyl)-3-(methylsulfonyl)benzene | ESD-846736-25MG |
Cas.: 82657-76-9 | Purity: 98% | 1-(Bromomethyl)-3-(methylsulfonyl)benzene | ESD-846736-100MG |
Cas.: 13885-13-7 | Purity: 98% | 2-Cyclopropyl-2-oxoacetic acid | ESD-846737-25MG |
Cas.: 13885-13-7 | Purity: 98% | 2-Cyclopropyl-2-oxoacetic acid | ESD-846737-100MG |
Cas.: 20141-83-7 | Purity: 97% | 7-Nitroisoquinolin-1(2H)-one | ESD-846738-25MG |
Cas.: 20141-83-7 | Purity: 97% | 7-Nitroisoquinolin-1(2H)-one | ESD-846738-100MG |
Cas.: 4472-55-3 | Purity: 97% | 2-(Chloromethyl)-4,6-dimethylpyridine | ESD-846739-25MG |
Cas.: 4472-55-3 | Purity: 97% | 2-(Chloromethyl)-4,6-dimethylpyridine | ESD-846739-100MG |
Cas.: 1214333-68-2 | Purity: 98% | 2-(Difluoromethoxy)-6-fluorobenzaldehyde | ESD-846740-250MG |
Cas.: 1214333-68-2 | Purity: 98% | 2-(Difluoromethoxy)-6-fluorobenzaldehyde | ESD-846740-1G |
Cas.: 60032-63-5 | Purity: 95% | 4-Hydroxy-3-iodobenzaldehyde | ESD-846741-50MG |
Cas.: 60032-63-5 | Purity: 95% | 4-Hydroxy-3-iodobenzaldehyde | ESD-846741-250MG |
Cas.: 98027-25-9 | Purity: 97% | 4-(Bromomethyl)thiazole hydrobromide | ESD-846742-50MG |
Cas.: 98027-25-9 | Purity: 97% | 4-(Bromomethyl)thiazole hydrobromide | ESD-846742-250MG |
Cas.: 89831-40-3 | Purity: 95% | 3,4-Dimethyl-1H-pyrazole-5-carboxylic acid | ESD-846743-50MG |
Cas.: 89831-40-3 | Purity: 95% | 3,4-Dimethyl-1H-pyrazole-5-carboxylic acid | ESD-846743-250MG |
Cas.: 101667-98-5 | Purity: 97% | Ethyl 4-chloro-5-methylthieno[2,3-d]pyrimidine-6-carboxylate | ESD-846744-50MG |
Cas.: 101667-98-5 | Purity: 97% | Ethyl 4-chloro-5-methylthieno[2,3-d]pyrimidine-6-carboxylate | ESD-846744-250MG |
Cas.: 1056934-87-2 | Purity: 98% | tert-Butyl 4-chloro-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate | ESD-846745-50MG |
Cas.: 1056934-87-2 | Purity: 98% | tert-Butyl 4-chloro-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate | ESD-846745-250MG |
Cas.: 112950-94-4 | Purity: 95% | N,N-Dimethylpiperidine-3-carboxamide hydrochloride | ESD-846746-50MG |
Cas.: 112950-94-4 | Purity: 95% | N,N-Dimethylpiperidine-3-carboxamide hydrochloride | ESD-846746-250MG |
Cas.: 35857-93-3 | Purity: 98% | 3,6-Dichloropyridazine-4-carbonitrile | ESD-846747-50MG |
Cas.: 35857-93-3 | Purity: 98% | 3,6-Dichloropyridazine-4-carbonitrile | ESD-846747-250MG |
Cas.: 212127-83-8 | Purity: 97% | tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,5-dihydro-1H-pyrrole-1-carboxylate | ESD-846748-50MG |
Cas.: 212127-83-8 | Purity: 97% | tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,5-dihydro-1H-pyrrole-1-carboxylate | ESD-846748-250MG |
Cas.: 1062368-71-1 | Purity: 97% | Methyl 4-bromopyrazolo[1,5-a]pyridine-3-carboxylate | ESD-846749-50MG |
Cas.: 1062368-71-1 | Purity: 97% | Methyl 4-bromopyrazolo[1,5-a]pyridine-3-carboxylate | ESD-846749-250MG |
Cas.: 1220219-59-9 | Purity: 95% | 3-Methyl-5-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)benzonitrile | ESD-846750-50MG |
Cas.: 1220219-59-9 | Purity: 95% | 3-Methyl-5-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)benzonitrile | ESD-846750-250MG |
Cas.: 67058-73-5 | Purity: 98% | Ethyl 1H-pyrrolo[2,3-c]pyridine-3-carboxylate | ESD-846751-50MG |
Cas.: 67058-73-5 | Purity: 98% | Ethyl 1H-pyrrolo[2,3-c]pyridine-3-carboxylate | ESD-846751-250MG |
Cas.: 51352-87-5 | Purity: 96% | Methyl 3-(2-(benzyl(methyl)amino)ethyl)benzoate hydrochloride | ESD-846752-50MG |
Cas.: 51352-87-5 | Purity: 96% | Methyl 3-(2-(benzyl(methyl)amino)ethyl)benzoate hydrochloride | ESD-846752-250MG |
Cas.: 60549-26-0 | Purity: 98% | 3-Hydroxy-5-methylbenzaldehyde | ESD-846753-50MG |
Cas.: 60549-26-0 | Purity: 98% | 3-Hydroxy-5-methylbenzaldehyde | ESD-846753-250MG |
Cas.: 205683-34-7 | Purity: 98% | 2,4-Dibromo-6-fluorobenzaldehyde | ESD-846754-50MG |
Cas.: 205683-34-7 | Purity: 98% | 2,4-Dibromo-6-fluorobenzaldehyde | ESD-846754-250MG |
Cas.: 1260670-18-5 | Purity: 98% | Methyl 3-methyloxetane-3-carboxylate | ESD-846755-50MG |
Cas.: 1260670-18-5 | Purity: 98% | Methyl 3-methyloxetane-3-carboxylate | ESD-846755-250MG |
Cas.: 1815-99-2 | Purity: 95% | 4-Decylpyridine | ESD-846756-50MG |
Cas.: 1815-99-2 | Purity: 95% | 4-Decylpyridine | ESD-846756-250MG |
Cas.: 32405-70-2 | Purity: 98% | N-Ethylpyridin-3-amine | ESD-846757-50MG |
Cas.: 32405-70-2 | Purity: 98% | N-Ethylpyridin-3-amine | ESD-846757-250MG |
Cas.: 163263-91-0 | Purity: 97% | 2,4-Dichloro-6-(4-methoxyphenyl)pyrimidine | ESD-846758-50MG |
Cas.: 163263-91-0 | Purity: 97% | 2,4-Dichloro-6-(4-methoxyphenyl)pyrimidine | ESD-846758-250MG |
Cas.: 847658-45-1 | Purity: 97% | Fmoc-Lys-OMe.HCl | ESD-846759-50MG |
Cas.: 847658-45-1 | Purity: 97% | Fmoc-Lys-OMe.HCl | ESD-846759-250MG |
Cas.: 59681-66-2 | Purity: 97% | 4-Chloro-N1-methylbenzene-1,2-diamine | ESD-846760-50MG |
Cas.: 59681-66-2 | Purity: 97% | 4-Chloro-N1-methylbenzene-1,2-diamine | ESD-846760-250MG |
Cas.: 1190321-49-3 | Purity: 97% | Methyl 5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carboxylate | ESD-846761-50MG |
Cas.: 1190321-49-3 | Purity: 97% | Methyl 5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carboxylate | ESD-846761-250MG |
Cas.: 33839-11-1 | Purity: 98% | 4-Bromo-2-ethyl-1-methoxybenzene | ESD-846762-50MG |
Cas.: 33839-11-1 | Purity: 98% | 4-Bromo-2-ethyl-1-methoxybenzene | ESD-846762-250MG |
Cas.: 58533-15-6 | Purity: 97% | 2-Chloro-1-ethyl-1H-benzo[d]imidazole | ESD-846763-50MG |
Cas.: 58533-15-6 | Purity: 97% | 2-Chloro-1-ethyl-1H-benzo[d]imidazole | ESD-846763-250MG |
Cas.: 485402-39-9 | Purity: 97% | 2-Methyl-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridine dihydrochloride | ESD-846764-50MG |
Cas.: 485402-39-9 | Purity: 97% | 2-Methyl-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridine dihydrochloride | ESD-846764-250MG |
Cas.: 1082041-26-6 | Purity: 97% | Methyl 3-cyano-5-methylbenzoate | ESD-846765-50MG |
Cas.: 1082041-26-6 | Purity: 97% | Methyl 3-cyano-5-methylbenzoate | ESD-846765-250MG |
Cas.: 1196156-45-2 | Purity: 95% | Oxazol-5-ylmethanamine hydrochloride | ESD-846766-50MG |
Cas.: 1196156-45-2 | Purity: 95% | Oxazol-5-ylmethanamine hydrochloride | ESD-846766-250MG |
Cas.: 4083-58-3 | Purity: 97% | 2,4-Dimethylpentan-3-amine hydrochloride | ESD-846767-50MG |
Cas.: 4083-58-3 | Purity: 97% | 2,4-Dimethylpentan-3-amine hydrochloride | ESD-846767-250MG |
Cas.: 89775-13-3 | Purity: 97% | 1-(Prop-2-yn-1-yl)pyrrolidine hydrochloride | ESD-846768-50MG |
Cas.: 89775-13-3 | Purity: 97% | 1-(Prop-2-yn-1-yl)pyrrolidine hydrochloride | ESD-846768-250MG |
Cas.: 886766-25-2 | Purity: 97% | 1-Boc-2-Isopropylpiperazine | ESD-846769-50MG |
Cas.: 886766-25-2 | Purity: 97% | 1-Boc-2-Isopropylpiperazine | ESD-846769-250MG |
Cas.: 924818-16-6 | Purity: 97% | (5-Chloro-2,4-difluorophenyl)methanamine | ESD-846770-50MG |
Cas.: 924818-16-6 | Purity: 97% | (5-Chloro-2,4-difluorophenyl)methanamine | ESD-846770-250MG |
Cas.: 5397-64-8 | Purity: 97% | 4-Chloro-1,2-dihydropyridazine-3,6-dione | ESD-846771-50MG |
Cas.: 5397-64-8 | Purity: 97% | 4-Chloro-1,2-dihydropyridazine-3,6-dione | ESD-846771-250MG |
Cas.: 78790-88-2 | Purity: 95% | 3-Ethoxyisonicotinic acid | ESD-846772-50MG |
Cas.: 78790-88-2 | Purity: 95% | 3-Ethoxyisonicotinic acid | ESD-846772-250MG |
Cas.: 1666-04-2 | Purity: 95% | 2-Hydroxy-3,6-dimethylbenzaldehyde | ESD-846773-250MG |
Cas.: 1666-04-2 | Purity: 95% | 2-Hydroxy-3,6-dimethylbenzaldehyde | ESD-846773-1G |
Cas.: 674799-96-3 | Purity: 97% | 6-((4-(Aminomethyl)benzyl)oxy)-7H-purin-2-amine | ESD-846774-25MG |
Cas.: 674799-96-3 | Purity: 97% | 6-((4-(Aminomethyl)benzyl)oxy)-7H-purin-2-amine | ESD-846774-100MG |
Cas.: 36082-45-8 | Purity: 96% | 5-Bromo-4-methoxypyrimidin-2-amine | ESD-846775-250MG |
Cas.: 36082-45-8 | Purity: 96% | 5-Bromo-4-methoxypyrimidin-2-amine | ESD-846775-1G |
Cas.: 942070-45-3 | Purity: 95% | tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate | ESD-846776-250MG |
Cas.: 942070-45-3 | Purity: 95% | tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate | ESD-846776-1G |
Cas.: 153505-33-0 | Purity: 98% | 3-Chloro-5-fluorobenzene-1,2-diamine | ESD-846777-50MG |
Cas.: 153505-33-0 | Purity: 98% | 3-Chloro-5-fluorobenzene-1,2-diamine | ESD-846777-250MG |
Cas.: 668484-45-5 | Purity: 98% | 2-(4-(tert-Butoxycarbonyl)piperazin-1-yl)thiazole-4-carboxylic acid | ESD-846778-50MG |
Cas.: 668484-45-5 | Purity: 98% | 2-(4-(tert-Butoxycarbonyl)piperazin-1-yl)thiazole-4-carboxylic acid | ESD-846778-250MG |
Cas.: 137832-56-5 | Purity: 97% | Methyl 4-amino-5-iodo-2-methoxybenzoate | ESD-846779-50MG |
Cas.: 137832-56-5 | Purity: 97% | Methyl 4-amino-5-iodo-2-methoxybenzoate | ESD-846779-250MG |
Cas.: 4886-29-7 | Purity: 98% | 6-Chloro-2-isopropyl-1H-benzo[d]imidazole | ESD-846780-50MG |
Cas.: 4886-29-7 | Purity: 98% | 6-Chloro-2-isopropyl-1H-benzo[d]imidazole | ESD-846780-250MG |
Cas.: 785777-87-9 | Purity: 98% | 2-Bromo-4-(trifluoromethyl)pyrimidine | ESD-846781-250MG |
Cas.: 785777-87-9 | Purity: 98% | 2-Bromo-4-(trifluoromethyl)pyrimidine | ESD-846781-1G |
Cas.: 43189-50-0 | Purity: 98% | 3-(4-Methyl-2,5-dioxoimidazolidin-4-yl)propanoic acid | ESD-846782-25MG |
Cas.: 43189-50-0 | Purity: 98% | 3-(4-Methyl-2,5-dioxoimidazolidin-4-yl)propanoic acid | ESD-846782-100MG |
Cas.: 900514-08-1 | Purity: 97% | 5-Chloro-3-iodo-7-azaindole | ESD-846783-25MG |
Cas.: 900514-08-1 | Purity: 97% | 5-Chloro-3-iodo-7-azaindole | ESD-846783-100MG |
Cas.: 184351-56-2 | Purity: 97% | Potassium 2,3,3-trimethyl-3H-indole-5-sulfonate | ESD-846784-25MG |
Cas.: 184351-56-2 | Purity: 97% | Potassium 2,3,3-trimethyl-3H-indole-5-sulfonate | ESD-846784-100MG |
Cas.: 5858-28-6 | Purity: 97% | 5-Methyl-2-nitrobenzaldehyde | ESD-846785-25MG |
Cas.: 5858-28-6 | Purity: 97% | 5-Methyl-2-nitrobenzaldehyde | ESD-846785-100MG |
Cas.: 3994-46-5 | Purity: 95% | 1H-Pyrazol-1-amine | ESD-846786-25MG |
Cas.: 3994-46-5 | Purity: 95% | 1H-Pyrazol-1-amine | ESD-846786-100MG |
Cas.: 1235441-67-4 | Purity: 98% | (3-(Cyclopentyloxy)phenyl)methanamine hydrochloride | ESD-846787-25MG |
Cas.: 1235441-67-4 | Purity: 98% | (3-(Cyclopentyloxy)phenyl)methanamine hydrochloride | ESD-846787-100MG |
Cas.: 172734-32-6 | Purity: 95% | 4-(Pyridin-2-yl)piperidin-4-ol dihydrochloride | ESD-846788-25MG |
Cas.: 172734-32-6 | Purity: 95% | 4-(Pyridin-2-yl)piperidin-4-ol dihydrochloride | ESD-846788-100MG |
Cas.: 1000340-29-3 | Purity: 97% | 3-Iodo-6-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-846789-25MG |
Cas.: 1000340-29-3 | Purity: 97% | 3-Iodo-6-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-846789-100MG |
Cas.: 943322-87-0 | Purity: 97% | (S)-tert-Butyl (2-amino-2-phenylethyl)carbamate | ESD-846790-25MG |
Cas.: 943322-87-0 | Purity: 97% | (S)-tert-Butyl (2-amino-2-phenylethyl)carbamate | ESD-846790-100MG |
Cas.: 153936-25-5 | Purity: 97% | (3-Methylpyridin-2-yl)methanamine hydrochloride | ESD-846791-25MG |
Cas.: 153936-25-5 | Purity: 97% | (3-Methylpyridin-2-yl)methanamine hydrochloride | ESD-846791-100MG |
Cas.: 120747-84-4 | Purity: 98% | 2-Aminopyrimidine-5-carbaldehyde | ESD-846792-250MG |
Cas.: 120747-84-4 | Purity: 98% | 2-Aminopyrimidine-5-carbaldehyde | ESD-846792-1G |
Cas.: 20829-96-3 | Purity: 97% | 5-Chloro-1H-benzo[d][1,3]oxazine-2,4-dione | ESD-846793-250MG |
Cas.: 20829-96-3 | Purity: 97% | 5-Chloro-1H-benzo[d][1,3]oxazine-2,4-dione | ESD-846793-1G |
Cas.: 162698-26-2 | Purity: 95% | Methyl azetidine-2-carboxylate hydrochloride | ESD-846794-250MG |
Cas.: 162698-26-2 | Purity: 95% | Methyl azetidine-2-carboxylate hydrochloride | ESD-846794-1G |
Cas.: 22766-68-3 | Purity: 98% | Ethyl quinuclidine-4-carboxylate | ESD-846795-250MG |
Cas.: 22766-68-3 | Purity: 98% | Ethyl quinuclidine-4-carboxylate | ESD-846795-1G |
Cas.: 171096-33-6 | Purity: 97% | Methyl 2-(4,6-dichloropyrimidin-5-yl)acetate | ESD-846796-250MG |
Cas.: 171096-33-6 | Purity: 97% | Methyl 2-(4,6-dichloropyrimidin-5-yl)acetate | ESD-846796-1G |
Cas.: 6323-18-8 | Purity: 97% | 1-(2-Chlorophenyl)propan-1-one | ESD-846797-250MG |
Cas.: 6323-18-8 | Purity: 97% | 1-(2-Chlorophenyl)propan-1-one | ESD-846797-1G |
Cas.: 1322805-15-1 | Purity: 97% | 4-Nitro-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid | ESD-846798-250MG |
Cas.: 1322805-15-1 | Purity: 97% | 4-Nitro-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid | ESD-846798-1G |
Cas.: 63243-76-5 | Purity: 98% | Ethyl 2-amino-5-bromobenzoate | ESD-846799-250MG |
Cas.: 63243-76-5 | Purity: 98% | Ethyl 2-amino-5-bromobenzoate | ESD-846799-1G |
Cas.: 60032-57-7 | Purity: 97% | 2-Methylnicotinaldehyde | ESD-846800-250MG |
Cas.: 60032-57-7 | Purity: 97% | 2-Methylnicotinaldehyde | ESD-846800-1G |
Cas.: 1224288-92-9 | Purity: 98% | 5-Chloropyrazolo[1,5-a]pyrimidine-3-carbonitrile | ESD-846801-25MG |
Cas.: 1224288-92-9 | Purity: 98% | 5-Chloropyrazolo[1,5-a]pyrimidine-3-carbonitrile | ESD-846801-100MG |
Cas.: 103639-57-2 | Purity: 97% | (S)-2-(Piperidin-2-yl)ethanol | ESD-846802-25MG |
Cas.: 103639-57-2 | Purity: 97% | (S)-2-(Piperidin-2-yl)ethanol | ESD-846802-100MG |
Cas.: 1260779-54-1 | Purity: 98% | 5-Bromo-1,2,3,4-tetrahydroisoquinolin-8-amine | ESD-846803-25MG |
Cas.: 1260779-54-1 | Purity: 98% | 5-Bromo-1,2,3,4-tetrahydroisoquinolin-8-amine | ESD-846803-100MG |
Cas.: 31825-29-3 | Purity: 98% | 3-Isopropyl-4-methoxybenzaldehyde | ESD-846804-25MG |
Cas.: 31825-29-3 | Purity: 98% | 3-Isopropyl-4-methoxybenzaldehyde | ESD-846804-100MG |
Cas.: 128942-39-2 | Purity: 98% | 7-Fluoro-4-oxo-4H-chromene-2-carboxylic acid | ESD-846805-50MG |
Cas.: 128942-39-2 | Purity: 98% | 7-Fluoro-4-oxo-4H-chromene-2-carboxylic acid | ESD-846805-250MG |
Cas.: 1677-44-7 | Purity: 95% | 6-Methyl-2,4-dihydroxyquinoline | ESD-846806-50MG |
Cas.: 1677-44-7 | Purity: 95% | 6-Methyl-2,4-dihydroxyquinoline | ESD-846806-250MG |
Cas.: 221874-51-7 | Purity: 95% | (R)-tert-Butyl(2-oxopiperidin-3-yl)carbamate | ESD-846807-50MG |
Cas.: 221874-51-7 | Purity: 95% | (R)-tert-Butyl(2-oxopiperidin-3-yl)carbamate | ESD-846807-250MG |
Cas.: 1260763-32-3 | Purity: 95% | Ethyl 6-bromo-8-fluoroimidazo[1,2-a]pyridine-2-carboxylate | ESD-846808-50MG |
Cas.: 1260763-32-3 | Purity: 95% | Ethyl 6-bromo-8-fluoroimidazo[1,2-a]pyridine-2-carboxylate | ESD-846808-250MG |
Cas.: 832715-99-8 | Purity: 95% | 6-(tert-Butyl)nicotinic acid | ESD-846809-50MG |
Cas.: 832715-99-8 | Purity: 95% | 6-(tert-Butyl)nicotinic acid | ESD-846809-250MG |
Cas.: 762240-09-5 | Purity: 98% | 4-(1H-Pyrazol-1-yl)piperidine | ESD-846810-50MG |
Cas.: 762240-09-5 | Purity: 98% | 4-(1H-Pyrazol-1-yl)piperidine | ESD-846810-250MG |
Cas.: 106877-36-5 | Purity: 97% | 2-Chloro-6-(trifluoromethyl)phenol | ESD-846811-50MG |
Cas.: 106877-36-5 | Purity: 97% | 2-Chloro-6-(trifluoromethyl)phenol | ESD-846811-250MG |
Cas.: 13523-92-7 | Purity: 95% | 1-Methyl-1H-indol-5-ol | ESD-846812-50MG |
Cas.: 13523-92-7 | Purity: 95% | 1-Methyl-1H-indol-5-ol | ESD-846812-250MG |
Cas.: 960298-00-4 | Purity: 95% | 2-(Benzyloxy)-4-bromopyridine | ESD-846813-50MG |
Cas.: 960298-00-4 | Purity: 95% | 2-(Benzyloxy)-4-bromopyridine | ESD-846813-250MG |
Cas.: 41213-32-5 | Purity: 98% | 2-Chloro-6-(trifluoromethyl)quinoxaline | ESD-846814-50MG |
Cas.: 41213-32-5 | Purity: 98% | 2-Chloro-6-(trifluoromethyl)quinoxaline | ESD-846814-250MG |
Cas.: 114080-94-3 | Purity: 97% | Isoxazolo[5,4-c]pyridin-3-amine | ESD-846815-50MG |
Cas.: 114080-94-3 | Purity: 97% | Isoxazolo[5,4-c]pyridin-3-amine | ESD-846815-250MG |
Cas.: 76240-27-2 | Purity: 97% | 7-Hydroxychroman-4-one | ESD-846816-50MG |
Cas.: 76240-27-2 | Purity: 97% | 7-Hydroxychroman-4-one | ESD-846816-250MG |
Cas.: 105003-90-5 | Purity: 95% | 2-(4-Methoxy-2-nitrophenyl)acetonitrile | ESD-846817-25MG |
Cas.: 105003-90-5 | Purity: 95% | 2-(4-Methoxy-2-nitrophenyl)acetonitrile | ESD-846817-100MG |
Cas.: 239132-48-0 | Purity: 96% | 5-(4-Bromophenyl)cyclohexane-1,3-dione | ESD-846818-25MG |
Cas.: 239132-48-0 | Purity: 96% | 5-(4-Bromophenyl)cyclohexane-1,3-dione | ESD-846818-100MG |
Cas.: 843-59-4 | Purity: 95% | Diethyl 2,5-dioxobicyclo[2.2.2]octane-1,4-dicarboxylate | ESD-846819-25MG |
Cas.: 843-59-4 | Purity: 95% | Diethyl 2,5-dioxobicyclo[2.2.2]octane-1,4-dicarboxylate | ESD-846819-100MG |
Cas.: 67092-20-0 | Purity: 97% | 2,8-Dichloroquinazoline | ESD-846820-25MG |
Cas.: 67092-20-0 | Purity: 97% | 2,8-Dichloroquinazoline | ESD-846820-100MG |
Cas.: 1083181-25-2 | Purity: 95% | 2-Bromo-1H-pyrrolo[2,3-b]pyridine | ESD-846821-25MG |
Cas.: 1083181-25-2 | Purity: 95% | 2-Bromo-1H-pyrrolo[2,3-b]pyridine | ESD-846821-100MG |
Cas.: 14399-37-2 | Purity: 95% | 3,6-Dichloropyrazin-2-amine | ESD-846822-25MG |
Cas.: 14399-37-2 | Purity: 95% | 3,6-Dichloropyrazin-2-amine | ESD-846822-100MG |
Cas.: 1261726-80-0 | Purity: 98% | 3-Oxoisoindoline-5-carbonitrile | ESD-846823-25MG |
Cas.: 1261726-80-0 | Purity: 98% | 3-Oxoisoindoline-5-carbonitrile | ESD-846823-100MG |
Cas.: 1260764-76-8 | Purity: 98% | Methyl 4-chloro-3-methylpicolinate | ESD-846824-25MG |
Cas.: 1260764-76-8 | Purity: 98% | Methyl 4-chloro-3-methylpicolinate | ESD-846824-100MG |
Cas.: 1150618-23-7 | Purity: 97% | 1-(3-Bromoquinolin-6-yl)ethanone | ESD-846825-25MG |
Cas.: 1150618-23-7 | Purity: 97% | 1-(3-Bromoquinolin-6-yl)ethanone | ESD-846825-100MG |
Cas.: 944086-09-3 | Purity: 98% | 1-(7-Bromo-1H-indol-3-yl)ethanone | ESD-846826-25MG |
Cas.: 944086-09-3 | Purity: 98% | 1-(7-Bromo-1H-indol-3-yl)ethanone | ESD-846826-100MG |
Cas.: 51307-59-6 | Purity: 97% | N-(4-Methoxybenzyl)hydroxylamine | ESD-846827-25MG |
Cas.: 51307-59-6 | Purity: 97% | N-(4-Methoxybenzyl)hydroxylamine | ESD-846827-100MG |
Cas.: 1000341-21-8 | Purity: 98% | 3-Bromo-6-(trifluoromethyl)-1H-indazole | ESD-846828-25MG |
Cas.: 1000341-21-8 | Purity: 98% | 3-Bromo-6-(trifluoromethyl)-1H-indazole | ESD-846828-100MG |
Cas.: 1179338-62-5 | Purity: 98% | tert-Butyl 4-(2-aminoethyl)-4-hydroxypiperidine-1-carboxylate | ESD-846829-25MG |
Cas.: 1179338-62-5 | Purity: 98% | tert-Butyl 4-(2-aminoethyl)-4-hydroxypiperidine-1-carboxylate | ESD-846829-100MG |
Cas.: 101555-60-6 | Purity: 95% | (R)-2-(1-(tert-Butoxycarbonyl)pyrrolidin-2-yl)acetic acid | ESD-846830-250MG |
Cas.: 101555-60-6 | Purity: 95% | (R)-2-(1-(tert-Butoxycarbonyl)pyrrolidin-2-yl)acetic acid | ESD-846830-1G |
Cas.: 134531-63-8 | Purity: 98% | 6-Oxo-1,6-dihydropyridine-3-carboxylic acid hydrazide | ESD-846831-250MG |
Cas.: 134531-63-8 | Purity: 98% | 6-Oxo-1,6-dihydropyridine-3-carboxylic acid hydrazide | ESD-846831-1G |
Cas.: 39846-84-9 | Purity: 98% | Ethyl 5-nitro-1H-pyrazole-3-carboxylate | ESD-846832-250MG |
Cas.: 39846-84-9 | Purity: 98% | Ethyl 5-nitro-1H-pyrazole-3-carboxylate | ESD-846832-1G |
Cas.: 959236-96-5 | Purity: 95% | 8-Fluoroquinazoline-2,4(1H,3H)-dione | ESD-846833-250MG |
Cas.: 959236-96-5 | Purity: 95% | 8-Fluoroquinazoline-2,4(1H,3H)-dione | ESD-846833-1G |
Cas.: 1454848-65-7 | Purity: 98% | Methyl 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole-2-carboxylate | ESD-846834-50MG |
Cas.: 1454848-65-7 | Purity: 98% | Methyl 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole-2-carboxylate | ESD-846834-250MG |
Cas.: 27808-16-8 | Purity: 98% | 4-Methyl-1H-1,2,3-triazole | ESD-846835-25MG |
Cas.: 27808-16-8 | Purity: 98% | 4-Methyl-1H-1,2,3-triazole | ESD-846835-100MG |
Cas.: 708-15-6 | Purity: 95% | 2-Amino-8-methoxyquinazoline | ESD-846836-25MG |
Cas.: 708-15-6 | Purity: 95% | 2-Amino-8-methoxyquinazoline | ESD-846836-100MG |
Cas.: 52471-07-5 | Purity: 95% | 2-Amino-6-chloronicotinonitrile | ESD-846837-25MG |
Cas.: 52471-07-5 | Purity: 95% | 2-Amino-6-chloronicotinonitrile | ESD-846837-100MG |
Cas.: 13726-21-1 | Purity: 98% | 2-(4-Chloro-3-methoxyphenyl)acetonitrile | ESD-846838-25MG |
Cas.: 13726-21-1 | Purity: 98% | 2-(4-Chloro-3-methoxyphenyl)acetonitrile | ESD-846838-100MG |
Cas.: 37480-41-4 | Purity: 95% | Methyl 1-methyl-4-oxocyclohexanecarboxylate | ESD-846839-25MG |
Cas.: 37480-41-4 | Purity: 95% | Methyl 1-methyl-4-oxocyclohexanecarboxylate | ESD-846839-100MG |
Cas.: 1256789-73-7 | Purity: 96% | Methyl 6-bromo-4-chloronicotinate | ESD-846840-25MG |
Cas.: 1256789-73-7 | Purity: 96% | Methyl 6-bromo-4-chloronicotinate | ESD-846840-100MG |
Cas.: 59315-45-6 | Purity: 97% | 4-Aminopyridin-2-ol | ESD-846841-250MG |
Cas.: 59315-45-6 | Purity: 97% | 4-Aminopyridin-2-ol | ESD-846841-1G |
Cas.: 17100-65-1 | Purity: 98% | Methyl 2-bromo-4-methoxybenzoate | ESD-846842-250MG |
Cas.: 17100-65-1 | Purity: 98% | Methyl 2-bromo-4-methoxybenzoate | ESD-846842-1G |
Cas.: 101020-79-5 | Purity: 97% | SAMe-1,4-Butanedisulfonate | ESD-846843-250MG |
Cas.: 101020-79-5 | Purity: 97% | SAMe-1,4-Butanedisulfonate | ESD-846843-1G |
Cas.: 70705-33-8 | Purity: 95% | Ethyl 7-methylimidazo[1,2-a]pyridine-2-carboxylate | ESD-846844-250MG |
Cas.: 70705-33-8 | Purity: 95% | Ethyl 7-methylimidazo[1,2-a]pyridine-2-carboxylate | ESD-846844-1G |
Cas.: 5395-70-0 | Purity: 97% | N1-Methylbenzene-1,4-diamine dihydrochloride | ESD-846845-250MG |
Cas.: 5395-70-0 | Purity: 97% | N1-Methylbenzene-1,4-diamine dihydrochloride | ESD-846845-1G |
Cas.: 128-59-6 | Purity: 95% | 16,17-Dihydroxyanthra[9,1,2-cde]benzo[rst]pentaphene-5,10-dione | ESD-846846-250MG |
Cas.: 128-59-6 | Purity: 95% | 16,17-Dihydroxyanthra[9,1,2-cde]benzo[rst]pentaphene-5,10-dione | ESD-846846-1G |
Cas.: 58138-79-7 | Purity: 97% | 2,6-Diiodopyrazine | ESD-846847-250MG |
Cas.: 58138-79-7 | Purity: 97% | 2,6-Diiodopyrazine | ESD-846847-1G |
Cas.: 914348-94-0 | Purity: 95% | tert-Butyl 3-formyl-5-methyl-1H-indole-1-carboxylate | ESD-846848-250MG |
Cas.: 914348-94-0 | Purity: 95% | tert-Butyl 3-formyl-5-methyl-1H-indole-1-carboxylate | ESD-846848-1G |
Cas.: 1072015-52-1 | Purity: 97% | (R)-3-Aminotetrahydrofuran hydrochloride | ESD-846849-250MG |
Cas.: 1072015-52-1 | Purity: 97% | (R)-3-Aminotetrahydrofuran hydrochloride | ESD-846849-1G |
Cas.: 914250-82-1 | Purity: 95% | 3-Bromo-2-chlorobenzonitrile | ESD-846850-250MG |
Cas.: 914250-82-1 | Purity: 95% | 3-Bromo-2-chlorobenzonitrile | ESD-846850-1G |
Cas.: 894808-73-2 | Purity: 97% | 1-Methylpiperidin-3-amine dihydrochloride | ESD-846851-250MG |
Cas.: 894808-73-2 | Purity: 97% | 1-Methylpiperidin-3-amine dihydrochloride | ESD-846851-1G |
Cas.: 1010800-27-7 | Purity: 95% | 4-Ethyl-1H-pyrazol-3-amine oxalate | ESD-846852-250MG |
Cas.: 1010800-27-7 | Purity: 95% | 4-Ethyl-1H-pyrazol-3-amine oxalate | ESD-846852-1G |
Cas.: 237386-01-5 | Purity: 97% | 2-Bromo-3′-trifluoromethoxyacetophenone | ESD-846853-250MG |
Cas.: 237386-01-5 | Purity: 97% | 2-Bromo-3′-trifluoromethoxyacetophenone | ESD-846853-1G |
Cas.: 248921-66-6 | Purity: 97% | Boc-D-Ser(tBu)-OH | ESD-846854-1G |
Cas.: 59229-14-0 | Purity: 95% | 3,5-Dibenzyloxyphenylglyoxal hydrate | ESD-846855-250MG |
Cas.: 59229-14-0 | Purity: 95% | 3,5-Dibenzyloxyphenylglyoxal hydrate | ESD-846855-1G |
Cas.: 4021-12-9 | Purity: 97% | 3-Methylisonicotinic acid | ESD-846856-250MG |
Cas.: 4021-12-9 | Purity: 97% | 3-Methylisonicotinic acid | ESD-846856-1G |
Cas.: 4214-85-1 | Purity: 97% | 2-Amino-6-methyl-5-nitro-3H-pyrimidin-4-one | ESD-846857-250MG |
Cas.: 4214-85-1 | Purity: 97% | 2-Amino-6-methyl-5-nitro-3H-pyrimidin-4-one | ESD-846857-1G |
Cas.: 905274-11-5 | Purity: 97% | (Indolin-4-yl)methanol | ESD-846858-50MG |
Cas.: 905274-11-5 | Purity: 97% | (Indolin-4-yl)methanol | ESD-846858-250MG |
Cas.: 885519-50-6 | Purity: 95% | 6-Chloro-4-nitro-1H-indazole | ESD-846859-50MG |
Cas.: 885519-50-6 | Purity: 95% | 6-Chloro-4-nitro-1H-indazole | ESD-846859-250MG |
Cas.: 485402-64-0 | Purity: 98% | 3-Cyclopropylaniline | ESD-846860-50MG |
Cas.: 485402-64-0 | Purity: 98% | 3-Cyclopropylaniline | ESD-846860-250MG |
Cas.: 951625-93-7 | Purity: 98% | Methyl 4-chloro-1H-pyrrolo[2,3-b]pyridine-5-carboxylate | ESD-846861-50MG |
Cas.: 951625-93-7 | Purity: 98% | Methyl 4-chloro-1H-pyrrolo[2,3-b]pyridine-5-carboxylate | ESD-846861-250MG |
Cas.: 78703-53-4 | Purity: 97% | 1,3-Dimethyl-1H-pyrazole-4-carboxylic acid | ESD-846862-250MG |
Cas.: 78703-53-4 | Purity: 97% | 1,3-Dimethyl-1H-pyrazole-4-carboxylic acid | ESD-846862-1G |
Cas.: 1400755-04-5 | Purity: 97% | (4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol | ESD-846863-25MG |
Cas.: 1400755-04-5 | Purity: 97% | (4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol | ESD-846863-100MG |
Cas.: 1208083-37-7 | Purity: 97% | 6-Bromo-8-chloroimidazo[1,2-a]pyrazine | ESD-846864-250MG |
Cas.: 1208083-37-7 | Purity: 97% | 6-Bromo-8-chloroimidazo[1,2-a]pyrazine | ESD-846864-1G |
Cas.: 5001-96-7 | Purity: 97% | 2-(2-Fluoro-[1,1′-biphenyl]-4-yl)acetic acid | ESD-846865-25MG |
Cas.: 5001-96-7 | Purity: 97% | 2-(2-Fluoro-[1,1′-biphenyl]-4-yl)acetic acid | ESD-846865-100MG |
Cas.: 56088-28-9 | Purity: 98% | Thieno[2,3-b]pyrazine | ESD-846866-25MG |
Cas.: 56088-28-9 | Purity: 98% | Thieno[2,3-b]pyrazine | ESD-846866-100MG |
Cas.: 3970-73-8 | Purity: 95% | 4-Methoxy-4-methylpiperidine hydrochloride | ESD-846867-25MG |
Cas.: 3970-73-8 | Purity: 95% | 4-Methoxy-4-methylpiperidine hydrochloride | ESD-846867-100MG |
Cas.: 957344-74-0 | Purity: 97% | 5,8-Dibromoimidazo[1,2-a]pyrazine | ESD-846868-25MG |
Cas.: 957344-74-0 | Purity: 97% | 5,8-Dibromoimidazo[1,2-a]pyrazine | ESD-846868-100MG |
Cas.: 1082066-52-1 | Purity: 98% | (3-Fluoro-4-(hydroxymethyl)phenyl)boronic acid | ESD-846869-25MG |
Cas.: 1082066-52-1 | Purity: 98% | (3-Fluoro-4-(hydroxymethyl)phenyl)boronic acid | ESD-846869-100MG |
Cas.: 198268-98-3 | Purity: 97% | 6-Chloro-5-nitropyridin-2(1H)-one | ESD-846870-25MG |
Cas.: 198268-98-3 | Purity: 97% | 6-Chloro-5-nitropyridin-2(1H)-one | ESD-846870-100MG |
Cas.: 1000341-75-2 | Purity: 98% | 6-Bromo-1H-pyrrolo[3,2-c]pyridine-3-carbaldehyde | ESD-846871-25MG |
Cas.: 1000341-75-2 | Purity: 98% | 6-Bromo-1H-pyrrolo[3,2-c]pyridine-3-carbaldehyde | ESD-846871-100MG |
Cas.: 887250-14-8 | Purity: 95% | Ethyl 3-amino-6-bromobenzofuran-2-carboxylate | ESD-846872-25MG |
Cas.: 887250-14-8 | Purity: 95% | Ethyl 3-amino-6-bromobenzofuran-2-carboxylate | ESD-846872-100MG |
Cas.: 448211-45-8 | Purity: 95% | 2-(1-Cycloocten-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-846873-25MG |
Cas.: 448211-45-8 | Purity: 95% | 2-(1-Cycloocten-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-846873-100MG |
Cas.: 38367-36-1 | Purity: 98% | 2,4-Dichloro-6-methylnicotinonitrile | ESD-846874-25MG |
Cas.: 38367-36-1 | Purity: 98% | 2,4-Dichloro-6-methylnicotinonitrile | ESD-846874-100MG |
Cas.: 1036738-82-5 | Purity: 97% | 1-(Cyclopropylsulfonyl)piperidine-4-carbonitrile | ESD-846875-25MG |
Cas.: 1036738-82-5 | Purity: 97% | 1-(Cyclopropylsulfonyl)piperidine-4-carbonitrile | ESD-846875-100MG |
Cas.: 1313712-35-4 | Purity: 97% | 2-(4-Fluoro-1H-indol-1-yl)acetic acid | ESD-846876-25MG |
Cas.: 1313712-35-4 | Purity: 97% | 2-(4-Fluoro-1H-indol-1-yl)acetic acid | ESD-846876-100MG |
Cas.: 131797-35-8 | Purity: 95% | 5-Chloro-3-(trifluoromethyl)-1H-pyrazole | ESD-846877-25MG |
Cas.: 131797-35-8 | Purity: 95% | 5-Chloro-3-(trifluoromethyl)-1H-pyrazole | ESD-846877-100MG |
Cas.: 52767-92-7 | Purity: 98% | 2-((5-Bromopyrimidin-2-yl)thio)acetic acid | ESD-846878-25MG |
Cas.: 52767-92-7 | Purity: 98% | 2-((5-Bromopyrimidin-2-yl)thio)acetic acid | ESD-846878-100MG |
Cas.: 1345983-89-2 | Purity: 97% | Dimethyl 3-aminopentanedioate acetate | ESD-846879-25MG |
Cas.: 1345983-89-2 | Purity: 97% | Dimethyl 3-aminopentanedioate acetate | ESD-846879-100MG |
Cas.: 336105-43-2 | Purity: 98% | (S)-1-(4-Bromophenyl)-2,2,2-trifluoroethanamine hydrochloride | ESD-846880-25MG |
Cas.: 336105-43-2 | Purity: 98% | (S)-1-(4-Bromophenyl)-2,2,2-trifluoroethanamine hydrochloride | ESD-846880-100MG |
Cas.: 932986-18-0 | Purity: 98% | Azoramide | ESD-846881-25MG |
Cas.: 932986-18-0 | Purity: 98% | Azoramide | ESD-846881-100MG |
Cas.: 1191908-44-7 | Purity: 98% | 6-Fluoro-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-846882-25MG |
Cas.: 1191908-44-7 | Purity: 98% | 6-Fluoro-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-846882-100MG |
Cas.: 799274-07-0 | Purity: 95% | 5-Fluoro-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-846883-25MG |
Cas.: 799274-07-0 | Purity: 95% | 5-Fluoro-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-846883-100MG |
Cas.: 110882-60-5 | Purity: 97% | 3-Fluoro-5-nitrobenzonitrile | ESD-846884-250MG |
Cas.: 110882-60-5 | Purity: 97% | 3-Fluoro-5-nitrobenzonitrile | ESD-846884-1G |
Cas.: 566205-01-4 | Purity: 97% | 3,5-Dibromo-6-chloropyrazin-2-amine | ESD-846885-250MG |
Cas.: 566205-01-4 | Purity: 97% | 3,5-Dibromo-6-chloropyrazin-2-amine | ESD-846885-1G |
Cas.: 19477-73-7 | Purity: 97% | 6-Bromoisobenzofuran-1(3H)-one | ESD-846886-250MG |
Cas.: 19477-73-7 | Purity: 97% | 6-Bromoisobenzofuran-1(3H)-one | ESD-846886-1G |
Cas.: 394223-02-0 | Purity: 95% | Methyl 1H-pyrrolo[2,3-b]pyridine-2-carboxylate | ESD-846887-250MG |
Cas.: 394223-02-0 | Purity: 95% | Methyl 1H-pyrrolo[2,3-b]pyridine-2-carboxylate | ESD-846887-1G |
Cas.: 87486-34-8 | Purity: 98% | 3,5-Dibromo-1-methylpyrazin-2(1H)-one | ESD-846888-250MG |
Cas.: 87486-34-8 | Purity: 98% | 3,5-Dibromo-1-methylpyrazin-2(1H)-one | ESD-846888-1G |
Cas.: 851389-38-3 | Purity: 97% | 4-Methyltetrahydro-2H-pyran-4-amine hydrochloride | ESD-846889-250MG |
Cas.: 851389-38-3 | Purity: 97% | 4-Methyltetrahydro-2H-pyran-4-amine hydrochloride | ESD-846889-1G |
Cas.: 89892-39-7 | Purity: 98% | 3-Bromo-4-(bromomethyl)benzonitrile | ESD-846890-250MG |
Cas.: 89892-39-7 | Purity: 98% | 3-Bromo-4-(bromomethyl)benzonitrile | ESD-846890-1G |
Cas.: 3197-44-2 | Purity: 95% | (R)-Piperidin-2-ylmethanol | ESD-846891-250MG |
Cas.: 3197-44-2 | Purity: 95% | (R)-Piperidin-2-ylmethanol | ESD-846891-1G |
Cas.: 889865-38-7 | Purity: 97% | 4,4,5,5-Tetramethyl-2-(4-((tetrahydro-2H-pyran-2-yl)oxy)phenyl)-1,3,2-dioxaborolane | ESD-846892-250MG |
Cas.: 889865-38-7 | Purity: 97% | 4,4,5,5-Tetramethyl-2-(4-((tetrahydro-2H-pyran-2-yl)oxy)phenyl)-1,3,2-dioxaborolane | ESD-846892-1G |
Cas.: 156731-40-7 | Purity: 97% | tert-Butyl but-3-en-1-ylcarbamate | ESD-846893-250MG |
Cas.: 156731-40-7 | Purity: 97% | tert-Butyl but-3-en-1-ylcarbamate | ESD-846893-1G |
Cas.: 85920-63-4 | Purity: 97% | 5-(1-Hydroxyethylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione | ESD-846894-250MG |
Cas.: 85920-63-4 | Purity: 97% | 5-(1-Hydroxyethylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione | ESD-846894-1G |
Cas.: 107259-05-2 | Purity: 95% | Ethyl 1-((tert-butoxycarbonyl)amino)cyclopropanecarboxylate | ESD-846895-250MG |
Cas.: 107259-05-2 | Purity: 95% | Ethyl 1-((tert-butoxycarbonyl)amino)cyclopropanecarboxylate | ESD-846895-1G |
Cas.: 7251-53-8 | Purity: 98% | Ethyl 3-hydroxy-1H-pyrazole-4-carboxylate | ESD-846896-250MG |
Cas.: 7251-53-8 | Purity: 98% | Ethyl 3-hydroxy-1H-pyrazole-4-carboxylate | ESD-846896-1G |
Cas.: 66937-99-3 | Purity: 95% | Morpholine-3-carboxylic acid hydrochloride | ESD-846897-250MG |
Cas.: 66937-99-3 | Purity: 95% | Morpholine-3-carboxylic acid hydrochloride | ESD-846897-1G |
Cas.: 34662-28-7 | Purity: 96% | 3-Chloro-2-nitrobenzonitrile | ESD-846898-250MG |
Cas.: 34662-28-7 | Purity: 96% | 3-Chloro-2-nitrobenzonitrile | ESD-846898-1G |
Cas.: 60207-18-3 | Purity: 98% | 1-(4-Amino-2-methoxyphenyl)ethanone | ESD-846899-250MG |
Cas.: 60207-18-3 | Purity: 98% | 1-(4-Amino-2-methoxyphenyl)ethanone | ESD-846899-1G |
Cas.: 343926-69-2 | Purity: 97% | 4-Bromopyrimidin-2-amine | ESD-846900-250MG |
Cas.: 343926-69-2 | Purity: 97% | 4-Bromopyrimidin-2-amine | ESD-846900-1G |
Cas.: 56616-91-2 | Purity: 98% | 3-Bromo-1-methyl-1H-1,2,4-triazole | ESD-846901-250MG |
Cas.: 56616-91-2 | Purity: 98% | 3-Bromo-1-methyl-1H-1,2,4-triazole | ESD-846901-1G |
Cas.: 63910-43-0 | Purity: 98% | 4-Chloro-5-methoxypyridazin-3(2H)-one | ESD-846902-250MG |
Cas.: 63910-43-0 | Purity: 98% | 4-Chloro-5-methoxypyridazin-3(2H)-one | ESD-846902-1G |
Cas.: 847416-99-3 | Purity: 97% | tert-Butyl (3-oxocyclopentyl)carbamate | ESD-846903-250MG |
Cas.: 847416-99-3 | Purity: 97% | tert-Butyl (3-oxocyclopentyl)carbamate | ESD-846903-1G |
Cas.: 115576-91-5 | Purity: 98% | (1-Methyl-1H-benzo[d]imidazol-5-yl)methanol | ESD-846904-50MG |
Cas.: 115576-91-5 | Purity: 98% | (1-Methyl-1H-benzo[d]imidazol-5-yl)methanol | ESD-846904-250MG |
Cas.: 1214385-51-9 | Purity: 98% | 5-Bromo-6-hydroxypicolinic acid | ESD-846905-50MG |
Cas.: 1214385-51-9 | Purity: 98% | 5-Bromo-6-hydroxypicolinic acid | ESD-846905-250MG |
Cas.: 59908-47-3 | Purity: 98% | 5-Chloro-1-methyl-1H-indole-2-carboxylic acid | ESD-846906-50MG |
Cas.: 59908-47-3 | Purity: 98% | 5-Chloro-1-methyl-1H-indole-2-carboxylic acid | ESD-846906-250MG |
Cas.: 62071-40-3 | Purity: 98% | 4-(Tetrahydropyran-4-yl)phenylamine | ESD-846907-50MG |
Cas.: 62071-40-3 | Purity: 98% | 4-(Tetrahydropyran-4-yl)phenylamine | ESD-846907-250MG |
Cas.: 170838-26-3 | Purity: 95% | 2-(1-(tert-Butoxycarbonyl)piperidin-4-yl)benzoic acid | ESD-846908-50MG |
Cas.: 170838-26-3 | Purity: 95% | 2-(1-(tert-Butoxycarbonyl)piperidin-4-yl)benzoic acid | ESD-846908-250MG |
Cas.: 56481-29-9 | Purity: 98% | 1-Bromo-3-methylimidazo[1,5-a]pyrazine | ESD-846909-50MG |
Cas.: 56481-29-9 | Purity: 98% | 1-Bromo-3-methylimidazo[1,5-a]pyrazine | ESD-846909-250MG |
Cas.: 221285-25-2 | Purity: 95% | (2-Amino-6-fluorophenyl)methanol | ESD-846910-50MG |
Cas.: 221285-25-2 | Purity: 95% | (2-Amino-6-fluorophenyl)methanol | ESD-846910-250MG |
Cas.: 329794-41-4 | Purity: 97% | 4-Methyl-1,4-diazepan-5-one hydrochloride | ESD-846911-50MG |
Cas.: 329794-41-4 | Purity: 97% | 4-Methyl-1,4-diazepan-5-one hydrochloride | ESD-846911-250MG |
Cas.: 83725-05-7 | Purity: 98% | N-(5-Methyl-1H-pyrazol-3-yl)acetamide | ESD-846912-50MG |
Cas.: 83725-05-7 | Purity: 98% | N-(5-Methyl-1H-pyrazol-3-yl)acetamide | ESD-846912-250MG |
Cas.: 135908-43-9 | Purity: 97% | Methyl 4-aminobicyclo[2.2.2]octane-1-carboxylate hydrochloride | ESD-846913-50MG |
Cas.: 135908-43-9 | Purity: 97% | Methyl 4-aminobicyclo[2.2.2]octane-1-carboxylate hydrochloride | ESD-846913-250MG |
Cas.: 263400-88-0 | Purity: 98% | 3-(Methylsulfonyl)propyl 4-methylbenzenesulfonate | ESD-846914-50MG |
Cas.: 263400-88-0 | Purity: 98% | 3-(Methylsulfonyl)propyl 4-methylbenzenesulfonate | ESD-846914-250MG |
Cas.: 1086111-20-7 | Purity: 95% | N,N-Diethyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)ethanamine | ESD-846915-50MG |
Cas.: 1086111-20-7 | Purity: 95% | N,N-Diethyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)ethanamine | ESD-846915-250MG |
Cas.: 179062-06-7 | Purity: 98% | 4-Fluoro-5-(trifluoromethyl)benzene-1,2-diamine | ESD-846916-50MG |
Cas.: 179062-06-7 | Purity: 98% | 4-Fluoro-5-(trifluoromethyl)benzene-1,2-diamine | ESD-846916-250MG |
Cas.: 85658-55-5 | Purity: 97% | 2-Amino-5-bromo-4-phenylpyrimidine | ESD-846917-25MG |
Cas.: 85658-55-5 | Purity: 97% | 2-Amino-5-bromo-4-phenylpyrimidine | ESD-846917-100MG |
Cas.: 131748-91-9 | Purity: 95% | 2-Bromo-5-(bromomethyl)thiazole | ESD-846918-250MG |
Cas.: 131748-91-9 | Purity: 95% | 2-Bromo-5-(bromomethyl)thiazole | ESD-846918-1G |
Cas.: 319474-34-5 | Purity: 97% | 4-Iodo-7-azaindole | ESD-846919-250MG |
Cas.: 319474-34-5 | Purity: 97% | 4-Iodo-7-azaindole | ESD-846919-1G |
Cas.: 39254-63-2 | Purity: 95% | Acetimidohydrazide hydrochloride | ESD-846920-25MG |
Cas.: 39254-63-2 | Purity: 95% | Acetimidohydrazide hydrochloride | ESD-846920-100MG |
Cas.: 1328893-17-9 | Purity: 97% | Methyl 5-bromo-1H-pyrazole-3-carboxylate | ESD-846921-25MG |
Cas.: 1328893-17-9 | Purity: 97% | Methyl 5-bromo-1H-pyrazole-3-carboxylate | ESD-846921-100MG |
Cas.: 630110-71-3 | Purity: 95% | tert-Butyl 6-(benzyloxy)-3-formyl-1H-indole-1-carboxylate | ESD-846922-250MG |
Cas.: 630110-71-3 | Purity: 95% | tert-Butyl 6-(benzyloxy)-3-formyl-1H-indole-1-carboxylate | ESD-846922-1G |
Cas.: 180302-35-6 | Purity: 97% | 5-(Bromomethyl)-2-fluorobenzonitrile | ESD-846923-250MG |
Cas.: 180302-35-6 | Purity: 97% | 5-(Bromomethyl)-2-fluorobenzonitrile | ESD-846923-1G |
Cas.: 22419-35-8 | Purity: 98% | 4,4-Difluorocyclohexanol | ESD-846924-250MG |
Cas.: 22419-35-8 | Purity: 98% | 4,4-Difluorocyclohexanol | ESD-846924-1G |
Cas.: 85803-49-2 | Purity: 97% | 2-Thiophen-2-yl-piperazine | ESD-846925-250MG |
Cas.: 85803-49-2 | Purity: 97% | 2-Thiophen-2-yl-piperazine | ESD-846925-1G |
Cas.: 148760-75-2 | Purity: 98% | tert-Butyl 1H-pyrrolo[3,2-c]pyridine-1-carboxylate | ESD-846926-250MG |
Cas.: 148760-75-2 | Purity: 98% | tert-Butyl 1H-pyrrolo[3,2-c]pyridine-1-carboxylate | ESD-846926-1G |
Cas.: 33515-62-7 | Purity: 98% | 4-Iodo-1H-pyrrole-2-carbaldehyde | ESD-846927-250MG |
Cas.: 33515-62-7 | Purity: 98% | 4-Iodo-1H-pyrrole-2-carbaldehyde | ESD-846927-1G |
Cas.: 854778-47-5 | Purity: 98% | 1-Ethyl-1H-indole-6-carbaldehyde | ESD-846928-250MG |
Cas.: 854778-47-5 | Purity: 98% | 1-Ethyl-1H-indole-6-carbaldehyde | ESD-846928-1G |
Cas.: 627525-96-6 | Purity: 98% | 2-(4-Chloro-3-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-846929-250MG |
Cas.: 627525-96-6 | Purity: 98% | 2-(4-Chloro-3-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-846929-1G |
Cas.: 178933-04-5 | Purity: 97% | (S)-2-Amino-3-(pyridin-4-yl)propanoic acid dihydrochloride | ESD-846930-250MG |
Cas.: 178933-04-5 | Purity: 97% | (S)-2-Amino-3-(pyridin-4-yl)propanoic acid dihydrochloride | ESD-846930-1G |
Cas.: 852619-28-4 | Purity: 95% | 1-(5-Bromothiophen-2-yl)-2,2-dihydroxyethanone | ESD-846931-250MG |
Cas.: 852619-28-4 | Purity: 95% | 1-(5-Bromothiophen-2-yl)-2,2-dihydroxyethanone | ESD-846931-1G |
Cas.: 675596-31-3 | Purity: 95% | 2′-(Trifluoromethyl)-[1,1′-biphenyl]-3-carbaldehyde | ESD-846932-250MG |
Cas.: 675596-31-3 | Purity: 95% | 2′-(Trifluoromethyl)-[1,1′-biphenyl]-3-carbaldehyde | ESD-846932-1G |
Cas.: 914348-89-3 | Purity: 95% | 2-(4-Nitro-2-(trifluoromethyl)phenyl)-1,2,3,4-tetrahydroisoquinoline | ESD-846933-250MG |
Cas.: 914348-89-3 | Purity: 95% | 2-(4-Nitro-2-(trifluoromethyl)phenyl)-1,2,3,4-tetrahydroisoquinoline | ESD-846933-1G |
Cas.: 914348-96-2 | Purity: 95% | tert-Butyl 3-formyl-7-methyl-1H-indole-1-carboxylate | ESD-846934-250MG |
Cas.: 914348-96-2 | Purity: 95% | tert-Butyl 3-formyl-7-methyl-1H-indole-1-carboxylate | ESD-846934-1G |
Cas.: 914348-99-5 | Purity: 95% | tert-Butyl 7-(benzyloxy)-3-formyl-1H-indole-1-carboxylate | ESD-846935-250MG |
Cas.: 914348-99-5 | Purity: 95% | tert-Butyl 7-(benzyloxy)-3-formyl-1H-indole-1-carboxylate | ESD-846935-1G |
Cas.: 914349-05-6 | Purity: 95% | tert-Butyl 4-bromo-3-(hydroxymethyl)-1H-indole-1-carboxylate | ESD-846936-250MG |
Cas.: 914349-05-6 | Purity: 95% | tert-Butyl 4-bromo-3-(hydroxymethyl)-1H-indole-1-carboxylate | ESD-846936-1G |
Cas.: 914349-06-7 | Purity: 95% | tert-Butyl 3-formyl-5-nitro-1H-indole-1-carboxylate | ESD-846937-250MG |
Cas.: 914349-06-7 | Purity: 95% | tert-Butyl 3-formyl-5-nitro-1H-indole-1-carboxylate | ESD-846937-1G |
Cas.: 914349-19-2 | Purity: 95% | 4-(6-Chloropyridazin-3-yl)benzaldehyde | ESD-846938-250MG |
Cas.: 914349-19-2 | Purity: 95% | 4-(6-Chloropyridazin-3-yl)benzaldehyde | ESD-846938-1G |
Cas.: 914349-71-6 | Purity: 95% | Methyl 5-bromo-2-((tert-butoxycarbonyl)amino)thiazole-4-carboxylate | ESD-846939-250MG |
Cas.: 914349-71-6 | Purity: 95% | Methyl 5-bromo-2-((tert-butoxycarbonyl)amino)thiazole-4-carboxylate | ESD-846939-1G |
Cas.: 914347-09-4 | Purity: 95% | 5-Bromo-2-((tert-butoxycarbonyl)amino)thiazole-4-carboxylic acid | ESD-846940-250MG |
Cas.: 914347-09-4 | Purity: 95% | 5-Bromo-2-((tert-butoxycarbonyl)amino)thiazole-4-carboxylic acid | ESD-846940-1G |
Cas.: 1189482-51-6 | Purity: 95% | 5-Bromo-N-(3-methoxypropyl)pyrimidin-2-amine | ESD-846941-250MG |
Cas.: 1189482-51-6 | Purity: 95% | 5-Bromo-N-(3-methoxypropyl)pyrimidin-2-amine | ESD-846941-1G |
Cas.: 1086379-56-7 | Purity: 95% | 4-((5-Bromopyrimidin-2-yl)oxy)benzoic acid | ESD-846942-250MG |
Cas.: 1086379-56-7 | Purity: 95% | 4-((5-Bromopyrimidin-2-yl)oxy)benzoic acid | ESD-846942-1G |
Cas.: 1158215-71-4 | Purity: 95% | 4-(Pyrrolidin-1-yl)-3-(trifluoromethyl)aniline dihydrochloride | ESD-846943-250MG |
Cas.: 1158215-71-4 | Purity: 95% | 4-(Pyrrolidin-1-yl)-3-(trifluoromethyl)aniline dihydrochloride | ESD-846943-1G |
Cas.: 99512-10-4 | Purity: 97% | 3-Amino-4-nitrobenzonitrile | ESD-846944-250MG |
Cas.: 99512-10-4 | Purity: 97% | 3-Amino-4-nitrobenzonitrile | ESD-846944-1G |
Cas.: 257937-08-9 | Purity: 97% | tert-Butyl (3-bromopyridin-4-yl)carbamate | ESD-846946-250MG |
Cas.: 257937-08-9 | Purity: 97% | tert-Butyl (3-bromopyridin-4-yl)carbamate | ESD-846946-1G |
Cas.: 304873-65-2 | Purity: 98% | tert-Butyl (4-formylpyridin-2-yl)carbamate | ESD-846947-25MG |
Cas.: 304873-65-2 | Purity: 98% | tert-Butyl (4-formylpyridin-2-yl)carbamate | ESD-846947-100MG |
Cas.: 10134-95-9 | Purity: 98% | Benzo[b]thiophene-4-carboxylic acid | ESD-846948-25MG |
Cas.: 10134-95-9 | Purity: 98% | Benzo[b]thiophene-4-carboxylic acid | ESD-846948-100MG |
Cas.: 4003-89-8 | Purity: 97% | 7-Methoxy-1,2,3,4-tetrahydronaphthalen-2-amine | ESD-846949-25MG |
Cas.: 4003-89-8 | Purity: 97% | 7-Methoxy-1,2,3,4-tetrahydronaphthalen-2-amine | ESD-846949-100MG |
Cas.: 150969-56-5 | Purity: 98% | 5-(Trifluoromethyl)-2,3-dihydro-1H-inden-1-one | ESD-846950-25MG |
Cas.: 150969-56-5 | Purity: 98% | 5-(Trifluoromethyl)-2,3-dihydro-1H-inden-1-one | ESD-846950-100MG |
Cas.: 40851-92-1 | Purity: 98% | 5-Chloro-2-methyl-3H-imidazo[4,5-b]pyridine | ESD-846951-25MG |
Cas.: 40851-92-1 | Purity: 98% | 5-Chloro-2-methyl-3H-imidazo[4,5-b]pyridine | ESD-846951-100MG |
Cas.: 80709-78-0 | Purity: 96% | Ethyl 2-methyl-4H-furo[3,2-b]pyrrole-5-carboxylate | ESD-846952-25MG |
Cas.: 80709-78-0 | Purity: 96% | Ethyl 2-methyl-4H-furo[3,2-b]pyrrole-5-carboxylate | ESD-846952-100MG |
Cas.: 167158-70-5 | Purity: 98% | 6-Bromo-2-chloroquinazolin-4(3H)-one | ESD-846953-25MG |
Cas.: 167158-70-5 | Purity: 98% | 6-Bromo-2-chloroquinazolin-4(3H)-one | ESD-846953-100MG |
Cas.: 959833-70-6 | Purity: 98% | (S)-tert-Butyl (1-aminopropan-2-yl)carbamate hydrochloride | ESD-846954-25MG |
Cas.: 959833-70-6 | Purity: 98% | (S)-tert-Butyl (1-aminopropan-2-yl)carbamate hydrochloride | ESD-846954-100MG |
Cas.: 321318-28-9 | Purity: 95% | (R)-1-(3,5-Difluorophenyl)ethanamine hydrochloride | ESD-846955-25MG |
Cas.: 321318-28-9 | Purity: 95% | (R)-1-(3,5-Difluorophenyl)ethanamine hydrochloride | ESD-846955-100MG |
Cas.: 351457-86-8 | Purity: 98% | 5-Bromo-4-methylnicotinaldehyde | ESD-846956-25MG |
Cas.: 351457-86-8 | Purity: 98% | 5-Bromo-4-methylnicotinaldehyde | ESD-846956-100MG |
Cas.: 1109284-33-4 | Purity: 97% | 6-Bromo-3-iodopyrazolo[1,5-a]pyrimidine | ESD-846957-25MG |
Cas.: 1109284-33-4 | Purity: 97% | 6-Bromo-3-iodopyrazolo[1,5-a]pyrimidine | ESD-846957-100MG |
Cas.: 1095823-39-4 | Purity: 97% | 5-Chloro-4-(trifluoromethyl)pyridin-2-amine | ESD-846958-25MG |
Cas.: 1095823-39-4 | Purity: 97% | 5-Chloro-4-(trifluoromethyl)pyridin-2-amine | ESD-846958-100MG |
Cas.: 898746-42-4 | Purity: 97% | 6-Fluoro-1H-pyrrolo[2,3-b]pyridine | ESD-846959-25MG |
Cas.: 898746-42-4 | Purity: 97% | 6-Fluoro-1H-pyrrolo[2,3-b]pyridine | ESD-846959-100MG |
Cas.: 62124-43-0 | Purity: 97% | 2-Chloro-5-phenyloxazole | ESD-846960-25MG |
Cas.: 62124-43-0 | Purity: 97% | 2-Chloro-5-phenyloxazole | ESD-846960-100MG |
Cas.: 136927-64-5 | Purity: 98% | 1-Chloropyrrolo[1,2-a]pyrazine | ESD-846961-25MG |
Cas.: 136927-64-5 | Purity: 98% | 1-Chloropyrrolo[1,2-a]pyrazine | ESD-846961-100MG |
Cas.: 7515-17-5 | Purity: 98% | Methyl 3-(4-methoxyphenyl)propiolate | ESD-846962-25MG |
Cas.: 7515-17-5 | Purity: 98% | Methyl 3-(4-methoxyphenyl)propiolate | ESD-846962-100MG |
Cas.: 1108698-58-3 | Purity: 91% | 1-(3-(trifluoromethyl)phenyl)cyclopropan-1-amine hydrochloride | ESD-846963-25MG |
Cas.: 1108698-58-3 | Purity: 91% | 1-(3-(trifluoromethyl)phenyl)cyclopropan-1-amine hydrochloride | ESD-846963-100MG |
Cas.: 893566-75-1 | Purity: 98% | Tert-butyl 8-bromo-3,4-dihydroisoquinoline-2(1H)-carboxylate | ESD-846964-100MG |
Cas.: 14700-62-0 | Purity: 98% | 2-Benzyl-1H-imidazole | ESD-846965-25MG |
Cas.: 14700-62-0 | Purity: 98% | 2-Benzyl-1H-imidazole | ESD-846965-100MG |
Cas.: 1214346-74-3 | Purity: 98% | Ethyl 5-bromo-6-hydroxypicolinate | ESD-846966-25MG |
Cas.: 1214346-74-3 | Purity: 98% | Ethyl 5-bromo-6-hydroxypicolinate | ESD-846966-100MG |
Cas.: 301666-63-7 | Purity: 97% | 6,7-Dihydro-1,7-naphthyridin-8(5H)-one | ESD-846967-25MG |
Cas.: 301666-63-7 | Purity: 97% | 6,7-Dihydro-1,7-naphthyridin-8(5H)-one | ESD-846967-100MG |
Cas.: 1233932-59-6 | Purity: 95% | 2-Chloro-7-fluoroquinoxaline | ESD-846968-25MG |
Cas.: 1233932-59-6 | Purity: 95% | 2-Chloro-7-fluoroquinoxaline | ESD-846968-100MG |
Cas.: 390816-44-1 | Purity: 95% | Methyl 5-methoxy-6-nitropicolinate | ESD-846969-25MG |
Cas.: 390816-44-1 | Purity: 95% | Methyl 5-methoxy-6-nitropicolinate | ESD-846969-100MG |
Cas.: 477252-20-3 | Purity: 98% | 2-(4-Bromopyridin-2-yl)propan-2-ol | ESD-846970-25MG |
Cas.: 477252-20-3 | Purity: 98% | 2-(4-Bromopyridin-2-yl)propan-2-ol | ESD-846970-100MG |
Cas.: 244132-27-2 | Purity: 95% | (S)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-4-(tert-butoxycarbonyl)piperazine-2-carboxylic acid | ESD-846971-25MG |
Cas.: 244132-27-2 | Purity: 95% | (S)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-4-(tert-butoxycarbonyl)piperazine-2-carboxylic acid | ESD-846971-100MG |
Cas.: 537033-56-0 | Purity: 98% | 4-Bromo-2,3,6-trifluorobenzaldehyde | ESD-846972-25MG |
Cas.: 537033-56-0 | Purity: 98% | 4-Bromo-2,3,6-trifluorobenzaldehyde | ESD-846972-100MG |
Cas.: 209005-67-4 | Purity: 95% | 1-Phenylpiperidine-4-carboxylic acid hydrochloride | ESD-846973-25MG |
Cas.: 209005-67-4 | Purity: 95% | 1-Phenylpiperidine-4-carboxylic acid hydrochloride | ESD-846973-100MG |
Cas.: 1206980-28-0 | Purity: 98% | 2-Chloro-5-(difluoromethoxy)pyridine | ESD-846974-25MG |
Cas.: 1206980-28-0 | Purity: 98% | 2-Chloro-5-(difluoromethoxy)pyridine | ESD-846974-100MG |
Cas.: 77313-10-1 | Purity: 97% | Dimethyl 3-aminopentanedioate hydrochloride | ESD-846975-25MG |
Cas.: 77313-10-1 | Purity: 97% | Dimethyl 3-aminopentanedioate hydrochloride | ESD-846975-100MG |
Cas.: 869937-08-6 | Purity: 98% | 1-(2-Amino-6-fluorophenyl)ethanone | ESD-846976-25MG |
Cas.: 869937-08-6 | Purity: 98% | 1-(2-Amino-6-fluorophenyl)ethanone | ESD-846976-100MG |
Cas.: 22833-69-8 | Purity: 98% | Methyl 2-hydroxy-6-methoxybenzoate | ESD-846977-25MG |
Cas.: 22833-69-8 | Purity: 98% | Methyl 2-hydroxy-6-methoxybenzoate | ESD-846977-100MG |
Cas.: 109179-31-9 | Purity: 98% | 2-Bromo-3-methylbenzaldehyde | ESD-846978-25MG |
Cas.: 109179-31-9 | Purity: 98% | 2-Bromo-3-methylbenzaldehyde | ESD-846978-100MG |
Cas.: 948570-74-9 | Purity: 98% | 1-(2-Methoxyethyl)-1H-pyrazol-4-amine | ESD-846979-25MG |
Cas.: 948570-74-9 | Purity: 98% | 1-(2-Methoxyethyl)-1H-pyrazol-4-amine | ESD-846979-100MG |
Cas.: 573987-48-1 | Purity: 98% | 1-(Cyanomethyl)pyrrolidin-1-ium trifluoromethanesulfonate | ESD-846980-25MG |
Cas.: 573987-48-1 | Purity: 98% | 1-(Cyanomethyl)pyrrolidin-1-ium trifluoromethanesulfonate | ESD-846980-100MG |
Cas.: 1624262-52-7 | Purity: 95% | 2-(5-Methoxypyridin-2-yl)ethanamine hydrochloride | ESD-846981-25MG |
Cas.: 1624262-52-7 | Purity: 95% | 2-(5-Methoxypyridin-2-yl)ethanamine hydrochloride | ESD-846981-100MG |
Cas.: 23735-46-8 | Purity: 97% | 1-(Bicyclo[2.2.2]octan-2-yl)ethanone | ESD-846982-25MG |
Cas.: 23735-46-8 | Purity: 97% | 1-(Bicyclo[2.2.2]octan-2-yl)ethanone | ESD-846982-100MG |
Cas.: 1004618-85-2 | Purity: 97% | 4-(4-(Trifluoromethoxy)phenyl)piperidine hydrochloride | ESD-846983-25MG |
Cas.: 1004618-85-2 | Purity: 97% | 4-(4-(Trifluoromethoxy)phenyl)piperidine hydrochloride | ESD-846983-100MG |
Cas.: 149986-58-3 | Purity: 95% | 4-(3-Methoxybenzyl)piperidine hydrochloride | ESD-846984-25MG |
Cas.: 149986-58-3 | Purity: 95% | 4-(3-Methoxybenzyl)piperidine hydrochloride | ESD-846984-100MG |
Cas.: 2164-67-2 | Purity: 98% | (2-Aminopyrimidin-4-yl)methanol | ESD-846985-25MG |
Cas.: 2164-67-2 | Purity: 98% | (2-Aminopyrimidin-4-yl)methanol | ESD-846985-100MG |
Cas.: 161949-50-4 | Purity: 97% | 2-Chloro-5-iodoanisole | ESD-846986-25MG |
Cas.: 161949-50-4 | Purity: 97% | 2-Chloro-5-iodoanisole | ESD-846986-100MG |
Cas.: 36449-75-9 | Purity: 97% | 1-(2-Bromoethyl)-2-methoxybenzene | ESD-846987-25MG |
Cas.: 36449-75-9 | Purity: 97% | 1-(2-Bromoethyl)-2-methoxybenzene | ESD-846987-100MG |
Cas.: 22235-25-2 | Purity: 97% | Methyl 3-amino-5-(trifluoromethyl)benzoate | ESD-846988-250MG |
Cas.: 22235-25-2 | Purity: 97% | Methyl 3-amino-5-(trifluoromethyl)benzoate | ESD-846988-1G |
Cas.: 769944-79-8 | Purity: 97% | 4-(4-Bromophenyl)piperidine hydrochloride | ESD-846989-250MG |
Cas.: 769944-79-8 | Purity: 97% | 4-(4-Bromophenyl)piperidine hydrochloride | ESD-846989-1G |
Cas.: 109183-72-4 | Purity: 97% | (S)-2-((tert-Butoxycarbonyl)amino)-2-cyclopentylacetic acid | ESD-846990-250MG |
Cas.: 109183-72-4 | Purity: 97% | (S)-2-((tert-Butoxycarbonyl)amino)-2-cyclopentylacetic acid | ESD-846990-1G |
Cas.: 872141-25-8 | Purity: 97% | 2-(3-Fluoro-2-nitrophenyl)acetic acid | ESD-846991-250MG |
Cas.: 872141-25-8 | Purity: 97% | 2-(3-Fluoro-2-nitrophenyl)acetic acid | ESD-846991-1G |
Cas.: 886372-92-5 | Purity: 98% | 6-Bromo-2-methylthiazolo[5,4-b]pyridine | ESD-846992-250MG |
Cas.: 886372-92-5 | Purity: 98% | 6-Bromo-2-methylthiazolo[5,4-b]pyridine | ESD-846992-1G |
Cas.: 858116-66-2 | Purity: 98% | 5-Bromo-1-(triisopropylsilyl)-1H-pyrrolo[2,3-b]pyridine | ESD-846993-250MG |
Cas.: 858116-66-2 | Purity: 98% | 5-Bromo-1-(triisopropylsilyl)-1H-pyrrolo[2,3-b]pyridine | ESD-846993-1G |
Cas.: 518990-20-0 | Purity: 98% | 1,4,6,7-Tetrahydropyrano[4,3-c]pyrazole-3-carboxylic acid | ESD-846994-50MG |
Cas.: 518990-20-0 | Purity: 98% | 1,4,6,7-Tetrahydropyrano[4,3-c]pyrazole-3-carboxylic acid | ESD-846994-250MG |
Cas.: 94781-89-2 | Purity: 97% | 1-Hydroxy-6-oxo-1,6-dihydropyridine-2-carboxylic acid | ESD-846996-50MG |
Cas.: 94781-89-2 | Purity: 97% | 1-Hydroxy-6-oxo-1,6-dihydropyridine-2-carboxylic acid | ESD-846996-250MG |
Cas.: 128156-54-7 | Purity: 98% | Methyl benzo[d]oxazole-4-carboxylate | ESD-846997-50MG |
Cas.: 128156-54-7 | Purity: 98% | Methyl benzo[d]oxazole-4-carboxylate | ESD-846997-250MG |
Cas.: 644971-22-2 | Purity: 98% | Pyrrolidin-3-ylmethanol hydrochloride | ESD-846998-250MG |
Cas.: 644971-22-2 | Purity: 98% | Pyrrolidin-3-ylmethanol hydrochloride | ESD-846998-1G |
Cas.: 374795-76-3 | Purity: 98% | tert-Butyl 5,6-dihydroimidazo[1,5-a]pyrazine-7(8H)-carboxylate | ESD-846999-25MG |
Cas.: 374795-76-3 | Purity: 98% | tert-Butyl 5,6-dihydroimidazo[1,5-a]pyrazine-7(8H)-carboxylate | ESD-846999-100MG |
Cas.: 957120-87-5 | Purity: 98% | 2,4-Dichloro-3-cyanophenylboronic acid | ESD-847000-250MG |
Cas.: 957120-87-5 | Purity: 98% | 2,4-Dichloro-3-cyanophenylboronic acid | ESD-847000-1G |
Cas.: 7238-62-2 | Purity: 98% | Ethyl 2-chloro-4-methylthiazole-5-carboxylate | ESD-847001-250MG |
Cas.: 7238-62-2 | Purity: 98% | Ethyl 2-chloro-4-methylthiazole-5-carboxylate | ESD-847001-1G |
Cas.: 150629-67-7 | Purity: 97% | Fmoc-D-Lys(Dde)-OH | ESD-847002-250MG |
Cas.: 150629-67-7 | Purity: 97% | Fmoc-D-Lys(Dde)-OH | ESD-847002-1G |
Cas.: 87253-62-1 | Purity: 97% | 5,7-Dimethyl-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxylic acid | ESD-847003-250MG |
Cas.: 87253-62-1 | Purity: 97% | 5,7-Dimethyl-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxylic acid | ESD-847003-1G |
Cas.: 98446-54-9 | Purity: 98% | 4-Bromo-2-chloro-5-methoxyaniline | ESD-847004-250MG |
Cas.: 98446-54-9 | Purity: 98% | 4-Bromo-2-chloro-5-methoxyaniline | ESD-847004-1G |
Cas.: 303043-91-6 | Purity: 95% | 3-Fluoro-2-methoxybenzenemethanol | ESD-847005-250MG |
Cas.: 303043-91-6 | Purity: 95% | 3-Fluoro-2-methoxybenzenemethanol | ESD-847005-1G |
Cas.: 502145-18-8 | Purity: 98% | 2-Amino-4-bromothiazole | ESD-847006-250MG |
Cas.: 502145-18-8 | Purity: 98% | 2-Amino-4-bromothiazole | ESD-847006-1G |
Cas.: 5993-98-6 | Purity: 97% | 4-Chloro-2-methyl-6-(trifluoromethyl)pyrimidine | ESD-847007-250MG |
Cas.: 5993-98-6 | Purity: 97% | 4-Chloro-2-methyl-6-(trifluoromethyl)pyrimidine | ESD-847007-1G |
Cas.: 1150617-52-9 | Purity: 98% | 5-Bromo-4-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-847008-25MG |
Cas.: 1150617-52-9 | Purity: 98% | 5-Bromo-4-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-847008-100MG |
Cas.: 920313-67-3 | Purity: 95% | tert-Butyl (5-aminopyrazin-2-yl)carbamate | ESD-847009-25MG |
Cas.: 920313-67-3 | Purity: 95% | tert-Butyl (5-aminopyrazin-2-yl)carbamate | ESD-847009-100MG |
Cas.: 1000895-26-0 | Purity: 98% | (5-Amino-1H-pyrazol-3-yl)methanol | ESD-847010-25MG |
Cas.: 1000895-26-0 | Purity: 98% | (5-Amino-1H-pyrazol-3-yl)methanol | ESD-847010-100MG |
Cas.: 92235-34-2 | Purity: 97% | (S)-tert-Butyl(2-oxopyrrolidin-3-yl)carbamate | ESD-847011-25MG |
Cas.: 92235-34-2 | Purity: 97% | (S)-tert-Butyl(2-oxopyrrolidin-3-yl)carbamate | ESD-847011-100MG |
Cas.: 496-64-0 | Purity: 98% | 3-Hydroxy-2H-pyran-2-one | ESD-847012-25MG |
Cas.: 496-64-0 | Purity: 98% | 3-Hydroxy-2H-pyran-2-one | ESD-847012-100MG |
Cas.: 869198-95-8 | Purity: 98% | tert-Butyl 2-amino-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate | ESD-847013-250MG |
Cas.: 869198-95-8 | Purity: 98% | tert-Butyl 2-amino-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate | ESD-847013-1G |
Cas.: 93668-43-0 | Purity: 98% | 2-(1H-Imidazol-1-yl)ethanamine dihydrochloride | ESD-847014-250MG |
Cas.: 93668-43-0 | Purity: 98% | 2-(1H-Imidazol-1-yl)ethanamine dihydrochloride | ESD-847014-1G |
Cas.: 58357-84-9 | Purity: 98% | 2-(3-Chlorophenyl)acetamide | ESD-847015-250MG |
Cas.: 58357-84-9 | Purity: 98% | 2-(3-Chlorophenyl)acetamide | ESD-847015-1G |
Cas.: 156941-64-9 | Purity: 95% | (3-Fluoro-4-methylphenyl)hydrazine hydrochloride | ESD-847016-250MG |
Cas.: 156941-64-9 | Purity: 95% | (3-Fluoro-4-methylphenyl)hydrazine hydrochloride | ESD-847016-1G |
Cas.: 51123-59-2 | Purity: 95% | 3-Chloro-2-methyl-6-nitroaniline | ESD-847017-50MG |
Cas.: 51123-59-2 | Purity: 95% | 3-Chloro-2-methyl-6-nitroaniline | ESD-847017-250MG |
Cas.: 350684-49-0 | Purity: 95% | tert-Butyl 4-(4-aminobenzoyl)piperazine-1-carboxylate | ESD-847018-50MG |
Cas.: 350684-49-0 | Purity: 95% | tert-Butyl 4-(4-aminobenzoyl)piperazine-1-carboxylate | ESD-847018-250MG |
Cas.: 24068-54-0 | Purity: 95% | 1-(5-Methylisoxazol-3-yl)ethanone | ESD-847019-50MG |
Cas.: 24068-54-0 | Purity: 95% | 1-(5-Methylisoxazol-3-yl)ethanone | ESD-847019-250MG |
Cas.: 22433-68-7 | Purity: 97% | 4-Amino-5-methylpyrimidine | ESD-847020-50MG |
Cas.: 22433-68-7 | Purity: 97% | 4-Amino-5-methylpyrimidine | ESD-847020-250MG |
Cas.: 10535-17-8 | Purity: 98% | 1-(3,4-Dimethoxyphenyl)-2-(2-methoxyphenoxy)propane-1,3-diol | ESD-847021-50MG |
Cas.: 10535-17-8 | Purity: 98% | 1-(3,4-Dimethoxyphenyl)-2-(2-methoxyphenoxy)propane-1,3-diol | ESD-847021-250MG |
Cas.: 1083246-53-0 | Purity: 97% | N-Methyl-1-(pyrimidin-2-yl)methanamine | ESD-847022-50MG |
Cas.: 1083246-53-0 | Purity: 97% | N-Methyl-1-(pyrimidin-2-yl)methanamine | ESD-847022-250MG |
Cas.: 69205-79-4 | Purity: 95% | 2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile | ESD-847023-50MG |
Cas.: 69205-79-4 | Purity: 95% | 2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile | ESD-847023-250MG |
Cas.: 69543-98-2 | Purity: 95% | 4-Bromo-6-methylpyrimidine | ESD-847024-50MG |
Cas.: 69543-98-2 | Purity: 95% | 4-Bromo-6-methylpyrimidine | ESD-847024-250MG |
Cas.: 885518-54-7 | Purity: 95% | 4-Bromo-6-nitro-1H-indazole | ESD-847025-50MG |
Cas.: 885518-54-7 | Purity: 95% | 4-Bromo-6-nitro-1H-indazole | ESD-847025-250MG |
Cas.: 1142211-17-3 | Purity: 97% | tert-Butyl (1-(hydroxymethyl)cyclobutyl)carbamate | ESD-847026-50MG |
Cas.: 1142211-17-3 | Purity: 97% | tert-Butyl (1-(hydroxymethyl)cyclobutyl)carbamate | ESD-847026-250MG |
Cas.: 1201924-31-3 | Purity: 98% | 6-Chloro-3-methylpicolinonitrile | ESD-847027-50MG |
Cas.: 1201924-31-3 | Purity: 98% | 6-Chloro-3-methylpicolinonitrile | ESD-847027-250MG |
Cas.: 71670-71-8 | Purity: 95% | 2-(Chloromethyl)-4-methylpyridine hydrochloride | ESD-847028-50MG |
Cas.: 71670-71-8 | Purity: 95% | 2-(Chloromethyl)-4-methylpyridine hydrochloride | ESD-847028-250MG |
Cas.: 282101-16-0 | Purity: 97% | Ethyl 4-chloroquinoline-7-carboxylate | ESD-847029-50MG |
Cas.: 282101-16-0 | Purity: 97% | Ethyl 4-chloroquinoline-7-carboxylate | ESD-847029-250MG |
Cas.: 952182-02-4 | Purity: 98% | 1H-Pyrazolo[3,4-b]pyridine-5-carboxylic acid | ESD-847030-50MG |
Cas.: 952182-02-4 | Purity: 98% | 1H-Pyrazolo[3,4-b]pyridine-5-carboxylic acid | ESD-847030-250MG |
Cas.: 467451-91-8 | Purity: 97% | 6-(Trifluoromethoxy)-1H-indole | ESD-847031-50MG |
Cas.: 467451-91-8 | Purity: 97% | 6-(Trifluoromethoxy)-1H-indole | ESD-847031-250MG |
Cas.: 1101120-37-9 | Purity: 98% | Pyrazolo[1,5-a]pyridin-5-amine | ESD-847032-50MG |
Cas.: 1101120-37-9 | Purity: 98% | Pyrazolo[1,5-a]pyridin-5-amine | ESD-847032-250MG |
Cas.: 148312-55-4 | Purity: 97% | tert-Butyl thiazolidine-3-carboxylate | ESD-847033-50MG |
Cas.: 148312-55-4 | Purity: 97% | tert-Butyl thiazolidine-3-carboxylate | ESD-847033-250MG |
Cas.: 172319-75-4 | Purity: 96% | 2-Bromo-5-propylthiophene | ESD-847034-50MG |
Cas.: 172319-75-4 | Purity: 96% | 2-Bromo-5-propylthiophene | ESD-847034-250MG |
Cas.: 89603-60-1 | Purity: 98% | 5-Hydroxy-1H-pyrazole-3-carboxylic acid | ESD-847035-50MG |
Cas.: 89603-60-1 | Purity: 98% | 5-Hydroxy-1H-pyrazole-3-carboxylic acid | ESD-847035-250MG |
Cas.: 550370-15-5 | Purity: 97% | 3-Phenylazetidin-3-ol hydrochloride | ESD-847036-50MG |
Cas.: 550370-15-5 | Purity: 97% | 3-Phenylazetidin-3-ol hydrochloride | ESD-847036-250MG |
Cas.: 1256823-65-0 | Purity: 97% | 5-Bromo-6-chloropicolinonitrile | ESD-847037-50MG |
Cas.: 1256823-65-0 | Purity: 97% | 5-Bromo-6-chloropicolinonitrile | ESD-847037-250MG |
Cas.: 90326-54-8 | Purity: 97% | 1-(5-Bromo-2-methylphenyl)ethanone | ESD-847038-50MG |
Cas.: 90326-54-8 | Purity: 97% | 1-(5-Bromo-2-methylphenyl)ethanone | ESD-847038-250MG |
Cas.: 1015845-73-4 | Purity: 97% | 4-(4-(tert-Butyl)phenyl)-1H-pyrazol-3-amine | ESD-847039-50MG |
Cas.: 1015845-73-4 | Purity: 97% | 4-(4-(tert-Butyl)phenyl)-1H-pyrazol-3-amine | ESD-847039-250MG |
Cas.: 1643-39-6 | Purity: 98% | 2-Amino-4,6-di-tert-butylphenol | ESD-847040-50MG |
Cas.: 1643-39-6 | Purity: 98% | 2-Amino-4,6-di-tert-butylphenol | ESD-847040-250MG |
Cas.: 15996-89-1 | Purity: 95% | 2-(4-(Trifluoromethyl)phenyl)propan-2-amine hydrochloride | ESD-847041-50MG |
Cas.: 15996-89-1 | Purity: 95% | 2-(4-(Trifluoromethyl)phenyl)propan-2-amine hydrochloride | ESD-847041-250MG |
Cas.: 1001020-13-8 | Purity: 97% | (3-Trifluoromethyl-1H-pyrazol-4-yl)methanol | ESD-847042-25MG |
Cas.: 1001020-13-8 | Purity: 97% | (3-Trifluoromethyl-1H-pyrazol-4-yl)methanol | ESD-847042-100MG |
Cas.: 66838-42-4 | Purity: 97% | (R)-Tetrahydrofuran-3-carboxylic acid | ESD-847043-25MG |
Cas.: 66838-42-4 | Purity: 97% | (R)-Tetrahydrofuran-3-carboxylic acid | ESD-847043-100MG |
Cas.: 1188265-64-6 | Purity: 97% | tert-Butyl 1-bromo-5,6-dihydroimidazo[1,5-a]pyrazine-7(8H)-carboxylate | ESD-847044-50MG |
Cas.: 1188265-64-6 | Purity: 97% | tert-Butyl 1-bromo-5,6-dihydroimidazo[1,5-a]pyrazine-7(8H)-carboxylate | ESD-847044-250MG |
Cas.: 356783-16-9 | Purity: 98% | 3,6-Dichloropyrazine-2-carbonitrile | ESD-847045-50MG |
Cas.: 356783-16-9 | Purity: 98% | 3,6-Dichloropyrazine-2-carbonitrile | ESD-847045-250MG |
Cas.: 327056-72-4 | Purity: 95% | Methyl 3-chloro-5-cyanobenzoate | ESD-847046-50MG |
Cas.: 327056-72-4 | Purity: 95% | Methyl 3-chloro-5-cyanobenzoate | ESD-847046-250MG |
Cas.: 88377-31-5 | Purity: 95% | 5-Methoxy-9-oxo-9,10-dihydroacridine-4-carboxylic acid | ESD-847047-25MG |
Cas.: 88377-31-5 | Purity: 95% | 5-Methoxy-9-oxo-9,10-dihydroacridine-4-carboxylic acid | ESD-847047-100MG |
Cas.: 327-21-9 | Purity: 96% | Ethyl 6-(trifluoromethyl)-1H-indole-2-carboxylate | ESD-847048-25MG |
Cas.: 327-21-9 | Purity: 96% | Ethyl 6-(trifluoromethyl)-1H-indole-2-carboxylate | ESD-847048-100MG |
Cas.: 1192711-71-9 | Purity: 98% | 2,4-Dichloro-6-methyl-7H-pyrrolo[2,3-d]pyrimidine | ESD-847049-25MG |
Cas.: 1192711-71-9 | Purity: 98% | 2,4-Dichloro-6-methyl-7H-pyrrolo[2,3-d]pyrimidine | ESD-847049-100MG |
Cas.: 886372-63-0 | Purity: 98% | 3-Amino-5-fluoro-6-methoxypyridine | ESD-847050-25MG |
Cas.: 886372-63-0 | Purity: 98% | 3-Amino-5-fluoro-6-methoxypyridine | ESD-847050-100MG |
Cas.: 885687-82-1 | Purity: 95% | 5-Bromo-2-methoxyquinoline-8-carbaldehyde | ESD-847051-25MG |
Cas.: 885687-82-1 | Purity: 95% | 5-Bromo-2-methoxyquinoline-8-carbaldehyde | ESD-847051-100MG |
Cas.: 274-49-7 | Purity: 98% | Imidazo[1,5-a]pyrazine | ESD-847052-25MG |
Cas.: 274-49-7 | Purity: 98% | Imidazo[1,5-a]pyrazine | ESD-847052-100MG |
Cas.: 20924-57-6 | Purity: 95% | Isochroman-4-ol | ESD-847053-25MG |
Cas.: 20924-57-6 | Purity: 95% | Isochroman-4-ol | ESD-847053-100MG |
Cas.: 1167056-96-3 | Purity: 96% | 3-Bromo-5-chloro-1H-pyrrolo[2,3-c]pyridine | ESD-847054-25MG |
Cas.: 1167056-96-3 | Purity: 96% | 3-Bromo-5-chloro-1H-pyrrolo[2,3-c]pyridine | ESD-847054-100MG |
Cas.: 1420865-79-7 | Purity: 97% | 3-Chloro-6-(chloromethyl)pyridazine hydrochloride | ESD-847055-25MG |
Cas.: 1420865-79-7 | Purity: 97% | 3-Chloro-6-(chloromethyl)pyridazine hydrochloride | ESD-847055-100MG |
Cas.: 105242-07-7 | Purity: 95% | 2-(4-Bromophenyl)piperazine | ESD-847056-250MG |
Cas.: 105242-07-7 | Purity: 95% | 2-(4-Bromophenyl)piperazine | ESD-847056-1G |
Cas.: 1007206-54-3 | Purity: 95% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole | ESD-847057-250MG |
Cas.: 1007206-54-3 | Purity: 95% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole | ESD-847057-1G |
Cas.: 144550-76-5 | Purity: 98% | Methyl 2-amino-4-iodobenzoate | ESD-847058-250MG |
Cas.: 144550-76-5 | Purity: 98% | Methyl 2-amino-4-iodobenzoate | ESD-847058-1G |
Cas.: 372198-69-1 | Purity: 98% | Ethyl 6-bromoimidazo[1,2-a]pyridine-3-carboxylate | ESD-847059-250MG |
Cas.: 372198-69-1 | Purity: 98% | Ethyl 6-bromoimidazo[1,2-a]pyridine-3-carboxylate | ESD-847059-1G |
Cas.: 16931-35-4 | Purity: 95% | 7-Chloro-1H-benzo[d]imidazole | ESD-847060-50MG |
Cas.: 16931-35-4 | Purity: 95% | 7-Chloro-1H-benzo[d]imidazole | ESD-847060-250MG |
Cas.: 25027-73-0 | Purity: 95% | N-(4-(Aminomethyl)phenyl)acetamide hydrochloride | ESD-847061-50MG |
Cas.: 25027-73-0 | Purity: 95% | N-(4-(Aminomethyl)phenyl)acetamide hydrochloride | ESD-847061-250MG |
Cas.: 35287-42-4 | Purity: 97% | 4-Bromo-2-(bromomethyl)-1-nitrobenzene | ESD-847062-50MG |
Cas.: 35287-42-4 | Purity: 97% | 4-Bromo-2-(bromomethyl)-1-nitrobenzene | ESD-847062-250MG |
Cas.: 1214743-62-0 | Purity: 95% | tert-Butyl 3,6-diazabicyclo[3.2.2]nonane-6-carboxylate | ESD-847063-25MG |
Cas.: 1214743-62-0 | Purity: 95% | tert-Butyl 3,6-diazabicyclo[3.2.2]nonane-6-carboxylate | ESD-847063-100MG |
Cas.: 82771-59-3 | Purity: 98% | 1-(1,2,3,4-Tetrahydroisoquinolin-7-yl)ethanone | ESD-847064-25MG |
Cas.: 82771-59-3 | Purity: 98% | 1-(1,2,3,4-Tetrahydroisoquinolin-7-yl)ethanone | ESD-847064-100MG |
Cas.: 936011-17-5 | Purity: 98% | 5-Bromo-2-methoxyisonicotinaldehyde | ESD-847065-25MG |
Cas.: 936011-17-5 | Purity: 98% | 5-Bromo-2-methoxyisonicotinaldehyde | ESD-847065-100MG |
Cas.: 1123738-15-7 | Purity: 96% | 3-Bromoquinolin-5-ol | ESD-847066-25MG |
Cas.: 1123738-15-7 | Purity: 96% | 3-Bromoquinolin-5-ol | ESD-847066-100MG |
Cas.: 929288-22-2 | Purity: 95% | 4-Amino-2,6-dichloronicotinic acid | ESD-847067-25MG |
Cas.: 929288-22-2 | Purity: 95% | 4-Amino-2,6-dichloronicotinic acid | ESD-847067-100MG |
Cas.: 475250-49-8 | Purity: 96% | 2-(4-Chlorobenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-847068-25MG |
Cas.: 475250-49-8 | Purity: 96% | 2-(4-Chlorobenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-847068-100MG |
Cas.: 1802489-65-1 | Purity: 97% | tert-Butyl 3-(aminomethyl)morpholine-4-carboxylate hydrochloride | ESD-847069-25MG |
Cas.: 1802489-65-1 | Purity: 97% | tert-Butyl 3-(aminomethyl)morpholine-4-carboxylate hydrochloride | ESD-847069-100MG |
Cas.: 1256825-86-1 | Purity: 95% | Methyl 1H-pyrrolo[2,3-b]pyridine-6-carboxylate | ESD-847070-25MG |
Cas.: 1256825-86-1 | Purity: 95% | Methyl 1H-pyrrolo[2,3-b]pyridine-6-carboxylate | ESD-847070-100MG |
Cas.: 1000068-25-6 | Purity: 97% | (1-(tert-Butoxycarbonyl)-4-fluoro-1H-indol-2-yl)boronic acid | ESD-847071-25MG |
Cas.: 1000068-25-6 | Purity: 97% | (1-(tert-Butoxycarbonyl)-4-fluoro-1H-indol-2-yl)boronic acid | ESD-847071-100MG |
Cas.: 6274-50-6 | Purity: 90% | Methyl 2-(4-methoxyphenyl)-2-methylpropanoate | ESD-847072-25MG |
Cas.: 6274-50-6 | Purity: 90% | Methyl 2-(4-methoxyphenyl)-2-methylpropanoate | ESD-847072-100MG |
Cas.: 1049677-37-3 | Purity: 98% | 1-Propyl-1,2,3,4-tetrahydroquinolin-7-amine | ESD-847073-25MG |
Cas.: 1049677-37-3 | Purity: 98% | 1-Propyl-1,2,3,4-tetrahydroquinolin-7-amine | ESD-847073-100MG |
Cas.: 1219741-19-1 | Purity: 98% | 5-Chloro-6-iodo-2-(methylsulfonyl)-1H-benzo[d]imidazole | ESD-847074-25MG |
Cas.: 1219741-19-1 | Purity: 98% | 5-Chloro-6-iodo-2-(methylsulfonyl)-1H-benzo[d]imidazole | ESD-847074-100MG |
Cas.: 50998-18-0 | Purity: 98% | 6-Iodoquinoxaline | ESD-847075-25MG |
Cas.: 50998-18-0 | Purity: 98% | 6-Iodoquinoxaline | ESD-847075-100MG |
Cas.: 1609409-10-0 | Purity: 97% | (5-Chloropyrimdin-2-yl)methanamine hydrochloride | ESD-847076-25MG |
Cas.: 1609409-10-0 | Purity: 97% | (5-Chloropyrimdin-2-yl)methanamine hydrochloride | ESD-847076-100MG |
Cas.: 186393-22-6 | Purity: 97% | (3R,4S)-tert-Butyl 3,4-dihydroxypyrrolidine-1-carboxylate | ESD-847077-25MG |
Cas.: 186393-22-6 | Purity: 97% | (3R,4S)-tert-Butyl 3,4-dihydroxypyrrolidine-1-carboxylate | ESD-847077-100MG |
Cas.: 847799-64-8 | Purity: 98% | 2-Bromo-N-methylpyridin-4-amine | ESD-847078-25MG |
Cas.: 847799-64-8 | Purity: 98% | 2-Bromo-N-methylpyridin-4-amine | ESD-847078-100MG |
Cas.: 689232-61-9 | Purity: 95% | 2-(3-Fluorophenyl)propan-2-amine hydrochloride | ESD-847079-25MG |
Cas.: 689232-61-9 | Purity: 95% | 2-(3-Fluorophenyl)propan-2-amine hydrochloride | ESD-847079-100MG |
Cas.: 899350-32-4 | Purity: 95% | 4-(3-Bromophenyl)butanoic acid | ESD-847080-25MG |
Cas.: 899350-32-4 | Purity: 95% | 4-(3-Bromophenyl)butanoic acid | ESD-847080-100MG |
Cas.: 177995-39-0 | Purity: 97% | 6-Bromobenzo[d]isoxazol-3-amine | ESD-847081-250MG |
Cas.: 177995-39-0 | Purity: 97% | 6-Bromobenzo[d]isoxazol-3-amine | ESD-847081-1G |
Cas.: 1020253-85-3 | Purity: 97% | 6-Bromo-5-methoxypyridin-3-amine | ESD-847082-50MG |
Cas.: 1020253-85-3 | Purity: 97% | 6-Bromo-5-methoxypyridin-3-amine | ESD-847082-250MG |
Cas.: 138891-51-7 | Purity: 98% | Imidazo[1,5-a]pyridine-1-carboxylic acid | ESD-847083-50MG |
Cas.: 138891-51-7 | Purity: 98% | Imidazo[1,5-a]pyridine-1-carboxylic acid | ESD-847083-250MG |
Cas.: 742076-06-8 | Purity: 95% | 1-(Piperidin-4-yl)-2-(trifluoromethyl)-1H-benzo[d]imidazole | ESD-847084-50MG |
Cas.: 742076-06-8 | Purity: 95% | 1-(Piperidin-4-yl)-2-(trifluoromethyl)-1H-benzo[d]imidazole | ESD-847084-250MG |
Cas.: 864866-92-2 | Purity: 95% | 6-Bromo-2-methylisoquinolin-1(2H)-one | ESD-847085-50MG |
Cas.: 864866-92-2 | Purity: 95% | 6-Bromo-2-methylisoquinolin-1(2H)-one | ESD-847085-250MG |
Cas.: 1209101-50-7 | Purity: 97% | tert-Butyl 5-chloro-6-(trifluoromethyl)-1H-indole-1-carboxylate | ESD-847086-50MG |
Cas.: 1209101-50-7 | Purity: 97% | tert-Butyl 5-chloro-6-(trifluoromethyl)-1H-indole-1-carboxylate | ESD-847086-250MG |
Cas.: 16234-40-5 | Purity: 95% | 2-Chlorothieno[3,2-d]pyrimidin-4-amine | ESD-847087-50MG |
Cas.: 16234-40-5 | Purity: 95% | 2-Chlorothieno[3,2-d]pyrimidin-4-amine | ESD-847087-250MG |
Cas.: 33491-30-4 | Purity: 98% | 8-Bromo-2H-chromen-2-one | ESD-847088-50MG |
Cas.: 33491-30-4 | Purity: 98% | 8-Bromo-2H-chromen-2-one | ESD-847088-250MG |
Cas.: 635698-34-9 | Purity: 98% | 6-Benzyl-6,7-dihydro-1H-pyrrolo[3,4-d]pyrimidine-2,4(3H,5H)-dione | ESD-847089-50MG |
Cas.: 635698-34-9 | Purity: 98% | 6-Benzyl-6,7-dihydro-1H-pyrrolo[3,4-d]pyrimidine-2,4(3H,5H)-dione | ESD-847089-250MG |
Cas.: 6653-96-9 | Purity: 98% | Imidazo[1,2-b]pyridazin-6-amine | ESD-847090-50MG |
Cas.: 6653-96-9 | Purity: 98% | Imidazo[1,2-b]pyridazin-6-amine | ESD-847090-250MG |
Cas.: 925672-88-4 | Purity: 95% | 5-Bromo-2-cyanobenzeneacetonitrile | ESD-847091-50MG |
Cas.: 925672-88-4 | Purity: 95% | 5-Bromo-2-cyanobenzeneacetonitrile | ESD-847091-250MG |
Cas.: 236406-22-7 | Purity: 97% | 1-Boc-4-(Aminomethyl)-4-methylpiperidine | ESD-847092-50MG |
Cas.: 236406-22-7 | Purity: 97% | 1-Boc-4-(Aminomethyl)-4-methylpiperidine | ESD-847092-250MG |
Cas.: 62484-52-0 | Purity: 98% | 4-Ethynylquinoline | ESD-847093-50MG |
Cas.: 62484-52-0 | Purity: 98% | 4-Ethynylquinoline | ESD-847093-250MG |
Cas.: 756813-88-4 | Purity: 98% | Methyl 2-(4-amino-3-iodophenyl)-2-methylpropanoate | ESD-847094-50MG |
Cas.: 756813-88-4 | Purity: 98% | Methyl 2-(4-amino-3-iodophenyl)-2-methylpropanoate | ESD-847094-250MG |
Cas.: 169677-66-1 | Purity: 97% | 2-Chloro-5-(cyclopropylmethoxy)pyrimidine | ESD-847095-50MG |
Cas.: 169677-66-1 | Purity: 97% | 2-Chloro-5-(cyclopropylmethoxy)pyrimidine | ESD-847095-250MG |
Cas.: 38076-76-5 | Purity: 98% | 6-Chloro-2-hydroxynicotinic acid | ESD-847096-50MG |
Cas.: 38076-76-5 | Purity: 98% | 6-Chloro-2-hydroxynicotinic acid | ESD-847096-250MG |
Cas.: 948996-03-0 | Purity: 95% | 2-((6-Chloropyridazin-3-yl)methyl)isoindoline-1,3-dione | ESD-847097-50MG |
Cas.: 948996-03-0 | Purity: 95% | 2-((6-Chloropyridazin-3-yl)methyl)isoindoline-1,3-dione | ESD-847097-250MG |
Cas.: 1703-07-7 | Purity: 98% | 6-Chloro-5-methylpyridazin-3(2H)-one | ESD-847098-50MG |
Cas.: 1703-07-7 | Purity: 98% | 6-Chloro-5-methylpyridazin-3(2H)-one | ESD-847098-250MG |
Cas.: 168899-63-6 | Purity: 96% | 1-Methylindoline-4-carboxylic acid | ESD-847099-50MG |
Cas.: 168899-63-6 | Purity: 96% | 1-Methylindoline-4-carboxylic acid | ESD-847099-250MG |
Cas.: 178421-21-1 | Purity: 98% | Ethyl 6-chloro-5-methylpicolinate | ESD-847100-50MG |
Cas.: 178421-21-1 | Purity: 98% | Ethyl 6-chloro-5-methylpicolinate | ESD-847100-250MG |
Cas.: 90673-35-1 | Purity: 95% | 3,8-Diazabicyclo[3.2.1]octane dihydrochloride | ESD-847101-50MG |
Cas.: 90673-35-1 | Purity: 95% | 3,8-Diazabicyclo[3.2.1]octane dihydrochloride | ESD-847101-250MG |
Cas.: 944900-06-5 | Purity: 97% | 2-Chloro-6-(trifluoromethyl)nicotinaldehyde | ESD-847102-50MG |
Cas.: 944900-06-5 | Purity: 97% | 2-Chloro-6-(trifluoromethyl)nicotinaldehyde | ESD-847102-250MG |
Cas.: 89978-56-3 | Purity: 95% | 1-Bromo-4-methoxy-2-methyl-5-nitrobenzene | ESD-847103-50MG |
Cas.: 89978-56-3 | Purity: 95% | 1-Bromo-4-methoxy-2-methyl-5-nitrobenzene | ESD-847103-250MG |
Cas.: 514798-01-7 | Purity: 97% | 2-Bromo-5-chloro-3-fluoroisonicotinic acid | ESD-847104-50MG |
Cas.: 514798-01-7 | Purity: 97% | 2-Bromo-5-chloro-3-fluoroisonicotinic acid | ESD-847104-250MG |
Cas.: 263403-72-1 | Purity: 97% | tert-Butyl 2-Boc-aminobenzylcarbamate | ESD-847105-50MG |
Cas.: 263403-72-1 | Purity: 97% | tert-Butyl 2-Boc-aminobenzylcarbamate | ESD-847105-250MG |
Cas.: 77378-54-2 | Purity: 97% | 2-(Bromomethyl)-1-methyl-3-nitrobenzene | ESD-847106-50MG |
Cas.: 77378-54-2 | Purity: 97% | 2-(Bromomethyl)-1-methyl-3-nitrobenzene | ESD-847106-250MG |
Cas.: 129053-70-9 | Purity: 95% | 2-Bromo-5-phenyloxazole | ESD-847107-50MG |
Cas.: 129053-70-9 | Purity: 95% | 2-Bromo-5-phenyloxazole | ESD-847107-250MG |
Cas.: 76320-88-2 | Purity: 98% | 2-Methyl-4-nitro-1H-benzo[d]imidazole | ESD-847108-50MG |
Cas.: 76320-88-2 | Purity: 98% | 2-Methyl-4-nitro-1H-benzo[d]imidazole | ESD-847108-250MG |
Cas.: 626248-56-4 | Purity: 97% | 3-(2H-1,2,3-Triazol-2-yl)aniline | ESD-847109-250MG |
Cas.: 626248-56-4 | Purity: 97% | 3-(2H-1,2,3-Triazol-2-yl)aniline | ESD-847109-1G |
Cas.: 3286-56-4 | Purity: 98% | 6-Chloro-2-ethoxypyrimidin-4-amine | ESD-847110-25MG |
Cas.: 3286-56-4 | Purity: 98% | 6-Chloro-2-ethoxypyrimidin-4-amine | ESD-847110-100MG |
Cas.: 17782-81-9 | Purity: 98% | Imidazo[2,1-b]thiazole-5-carboxylic acid | ESD-847111-25MG |
Cas.: 17782-81-9 | Purity: 98% | Imidazo[2,1-b]thiazole-5-carboxylic acid | ESD-847111-100MG |
Cas.: 1208538-52-6 | Purity: 97% | 4-Bromo-2-(methylsulfonyl)pyrimidine | ESD-847112-25MG |
Cas.: 1208538-52-6 | Purity: 97% | 4-Bromo-2-(methylsulfonyl)pyrimidine | ESD-847112-100MG |
Cas.: 180081-10-1 | Purity: 97% | tert-Butyl (2-(4-aminophenyl)-2-methylpropyl)carbamate | ESD-847113-25MG |
Cas.: 180081-10-1 | Purity: 97% | tert-Butyl (2-(4-aminophenyl)-2-methylpropyl)carbamate | ESD-847113-100MG |
Cas.: 73221-20-2 | Purity: 95% | 2-(Trifluoromethyl)imidazo[1,2-a]pyridine-8-carboxylic acid | ESD-847114-25MG |
Cas.: 73221-20-2 | Purity: 95% | 2-(Trifluoromethyl)imidazo[1,2-a]pyridine-8-carboxylic acid | ESD-847114-100MG |
Cas.: 1260862-06-3 | Purity: 95% | 6-Methoxy-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine | ESD-847115-25MG |
Cas.: 1260862-06-3 | Purity: 95% | 6-Methoxy-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine | ESD-847115-100MG |
Cas.: 1269291-43-1 | Purity: 95% | (4-Bromopyrimidin-2-yl)cyclopentylamine | ESD-847116-25MG |
Cas.: 1269291-43-1 | Purity: 95% | (4-Bromopyrimidin-2-yl)cyclopentylamine | ESD-847116-100MG |
Cas.: 1190314-42-1 | Purity: 95% | 7-Bromo-6-methoxy-1H-pyrrolo[3,2-c]pyridine | ESD-847117-25MG |
Cas.: 1190314-42-1 | Purity: 95% | 7-Bromo-6-methoxy-1H-pyrrolo[3,2-c]pyridine | ESD-847117-100MG |
Cas.: 922178-61-8 | Purity: 95% | (R)-3-Methylpiperazin-2-one | ESD-847118-25MG |
Cas.: 922178-61-8 | Purity: 95% | (R)-3-Methylpiperazin-2-one | ESD-847118-100MG |
Cas.: 17759-30-7 | Purity: 97% | (4-(Methylamino)-2-(methylthio)pyrimidin-5-yl)methanol | ESD-847119-25MG |
Cas.: 17759-30-7 | Purity: 97% | (4-(Methylamino)-2-(methylthio)pyrimidin-5-yl)methanol | ESD-847119-100MG |
Cas.: 849106-20-3 | Purity: 95% | tert-Butyl 5-chloro-3-oxo-3H-spiro[isobenzofuran-1,4′-piperidine]-1′-carboxylate | ESD-847120-25MG |
Cas.: 849106-20-3 | Purity: 95% | tert-Butyl 5-chloro-3-oxo-3H-spiro[isobenzofuran-1,4′-piperidine]-1′-carboxylate | ESD-847120-100MG |
Cas.: 332133-92-3 | Purity: 95% | 4-(Tributylstannyl)pyrimidine | ESD-847121-25MG |
Cas.: 332133-92-3 | Purity: 95% | 4-(Tributylstannyl)pyrimidine | ESD-847121-100MG |
Cas.: 83345-44-2 | Purity: 95% | Boc-HoSer-OH | ESD-847122-25MG |
Cas.: 83345-44-2 | Purity: 95% | Boc-HoSer-OH | ESD-847122-100MG |
Cas.: 50609-01-3 | Purity: 97% | 4-(2-(Pyrrolidin-1-yl)ethoxy)aniline | ESD-847123-25MG |
Cas.: 50609-01-3 | Purity: 97% | 4-(2-(Pyrrolidin-1-yl)ethoxy)aniline | ESD-847123-100MG |
Cas.: 220247-69-8 | Purity: 98% | Methyl 1,2,3,4-tetrahydroisoquinoline-7-carboxylate hydrochloride | ESD-847124-50MG |
Cas.: 220247-69-8 | Purity: 98% | Methyl 1,2,3,4-tetrahydroisoquinoline-7-carboxylate hydrochloride | ESD-847124-250MG |
Cas.: 3970-41-0 | Purity: 95% | 2-Chloro-3-nitroaniline | ESD-847125-25MG |
Cas.: 3970-41-0 | Purity: 95% | 2-Chloro-3-nitroaniline | ESD-847125-100MG |
Cas.: 1676-57-9 | Purity: 98% | 5-Bromo-2-methylpyrimidin-4-ol | ESD-847126-250MG |
Cas.: 1676-57-9 | Purity: 98% | 5-Bromo-2-methylpyrimidin-4-ol | ESD-847126-1G |
Cas.: 883539-33-1 | Purity: 95% | 2-(2-Ethyl-1H-imidazol-1-yl)acetic acid | ESD-847127-250MG |
Cas.: 883539-33-1 | Purity: 95% | 2-(2-Ethyl-1H-imidazol-1-yl)acetic acid | ESD-847127-1G |
Cas.: 1011722-07-8 | Purity: 97% | (6-Cyanopyridin-3-yl)boronic acid | ESD-847128-250MG |
Cas.: 1011722-07-8 | Purity: 97% | (6-Cyanopyridin-3-yl)boronic acid | ESD-847128-1G |
Cas.: 886767-49-3 | Purity: 98% | tert-Butyl 3-(4-chlorophenyl)piperazine-1-carboxylate | ESD-847129-250MG |
Cas.: 886767-49-3 | Purity: 98% | tert-Butyl 3-(4-chlorophenyl)piperazine-1-carboxylate | ESD-847129-1G |
Cas.: 4068-71-7 | Purity: 97% | Methyl 3-bromo-5-chloro-2-hydroxybenzoate | ESD-847130-250MG |
Cas.: 4068-71-7 | Purity: 97% | Methyl 3-bromo-5-chloro-2-hydroxybenzoate | ESD-847130-1G |
Cas.: 60166-85-0 | Purity: 95% | 5-Iodothiophene-2-carboxylic acid | ESD-847131-50MG |
Cas.: 60166-85-0 | Purity: 95% | 5-Iodothiophene-2-carboxylic acid | ESD-847131-250MG |
Cas.: 1072438-54-0 | Purity: 97% | Methyl 2-(aminomethyl)pyridine-4-carboxylate hydrochloride | ESD-847132-50MG |
Cas.: 1072438-54-0 | Purity: 97% | Methyl 2-(aminomethyl)pyridine-4-carboxylate hydrochloride | ESD-847132-250MG |
Cas.: 958358-00-4 | Purity: 97% | 5-Bromo-6-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-847133-50MG |
Cas.: 958358-00-4 | Purity: 97% | 5-Bromo-6-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-847133-250MG |
Cas.: 131661-41-1 | Purity: 98% | 3-Methyl-1H-pyrazole-4-carbonitrile | ESD-847134-50MG |
Cas.: 131661-41-1 | Purity: 98% | 3-Methyl-1H-pyrazole-4-carbonitrile | ESD-847134-250MG |
Cas.: 6607-96-1 | Purity: 97% | N-(4-Acetyl-5-hydroxy-2-nitrophenyl)acetamide | ESD-847135-50MG |
Cas.: 6607-96-1 | Purity: 97% | N-(4-Acetyl-5-hydroxy-2-nitrophenyl)acetamide | ESD-847135-250MG |
Cas.: 1188044-87-2 | Purity: 95% | 2-(6-Fluoro-2,3-dihydro-1H-inden-1-yl)acetic acid | ESD-847136-50MG |
Cas.: 1188044-87-2 | Purity: 95% | 2-(6-Fluoro-2,3-dihydro-1H-inden-1-yl)acetic acid | ESD-847136-250MG |
Cas.: 1227563-63-4 | Purity: 97% | 3-Bromo-6-chloro-2-(trifluoromethyl)pyridine | ESD-847137-50MG |
Cas.: 1227563-63-4 | Purity: 97% | 3-Bromo-6-chloro-2-(trifluoromethyl)pyridine | ESD-847137-250MG |
Cas.: 79707-11-2 | Purity: 95% | 2-Methylimidazo[1,2-a]pyridin-8-ol | ESD-847138-50MG |
Cas.: 79707-11-2 | Purity: 95% | 2-Methylimidazo[1,2-a]pyridin-8-ol | ESD-847138-250MG |
Cas.: 318685-01-7 | Purity: 97% | Ethyl 4-chloro-6,7-difluoroquinoline-3-carboxylate | ESD-847139-50MG |
Cas.: 318685-01-7 | Purity: 97% | Ethyl 4-chloro-6,7-difluoroquinoline-3-carboxylate | ESD-847139-250MG |
Cas.: 1072249-89-8 | Purity: 95% | 3-Methyl-1H-pyrazolo[3,4-c]pyridine | ESD-847140-25MG |
Cas.: 1072249-89-8 | Purity: 95% | 3-Methyl-1H-pyrazolo[3,4-c]pyridine | ESD-847140-100MG |
Cas.: 1131622-50-8 | Purity: 98% | 3-Bromo-4-cyclopropylbenzoic acid | ESD-847141-50MG |
Cas.: 1131622-50-8 | Purity: 98% | 3-Bromo-4-cyclopropylbenzoic acid | ESD-847141-250MG |
Cas.: 790696-96-7 | Purity: 98% | 2-chloro-3-methylisonicotinaldehyde | ESD-847142-250MG |
Cas.: 2132-62-9 | Purity: 97% | 1,2-Bis(4-methoxyphenyl)ethyne | ESD-847143-25MG |
Cas.: 2132-62-9 | Purity: 97% | 1,2-Bis(4-methoxyphenyl)ethyne | ESD-847143-100MG |
Cas.: 26510-91-8 | Purity: 97% | 2,4,5-Trimethoxyaniline | ESD-847144-25MG |
Cas.: 26510-91-8 | Purity: 97% | 2,4,5-Trimethoxyaniline | ESD-847144-100MG |
Cas.: 90856-77-2 | Purity: 98% | 4,6-Dimethylpyrimidin-5-amine | ESD-847145-25MG |
Cas.: 90856-77-2 | Purity: 98% | 4,6-Dimethylpyrimidin-5-amine | ESD-847145-100MG |
Cas.: 54212-34-9 | Purity: 98% | 7-Methoxyisochroman-4-one | ESD-847146-25MG |
Cas.: 54212-34-9 | Purity: 98% | 7-Methoxyisochroman-4-one | ESD-847146-100MG |
Cas.: 95453-59-1 | Purity: 95% | 2-Methoxythiazole-5-carbaldehyde | ESD-847147-25MG |
Cas.: 95453-59-1 | Purity: 95% | 2-Methoxythiazole-5-carbaldehyde | ESD-847147-100MG |
Cas.: 147972-27-8 | Purity: 98% | 4-Chloro-2-(trifluoromethyl)thieno[3,2-d]pyrimidine | ESD-847148-25MG |
Cas.: 147972-27-8 | Purity: 98% | 4-Chloro-2-(trifluoromethyl)thieno[3,2-d]pyrimidine | ESD-847148-100MG |
Cas.: 884860-62-2 | Purity: 98% | 2-Chloro-6-(trifluoromethyl)thiazolo[4,5-b]pyridine | ESD-847149-25MG |
Cas.: 884860-62-2 | Purity: 98% | 2-Chloro-6-(trifluoromethyl)thiazolo[4,5-b]pyridine | ESD-847149-100MG |
Cas.: 28269-31-0 | Purity: 98% | Dimethyl 2-methylisophthalate | ESD-847150-25MG |
Cas.: 28269-31-0 | Purity: 98% | Dimethyl 2-methylisophthalate | ESD-847150-100MG |
Cas.: 937640-24-9 | Purity: 98% | 3-Chlorothieno[2,3-b]pyridine-2-carboxylic acid | ESD-847151-25MG |
Cas.: 937640-24-9 | Purity: 98% | 3-Chlorothieno[2,3-b]pyridine-2-carboxylic acid | ESD-847151-100MG |
Cas.: 1027259-01-3 | Purity: 98% | 6-Nitro-1H-indazol-3-amine | ESD-847152-25MG |
Cas.: 1027259-01-3 | Purity: 98% | 6-Nitro-1H-indazol-3-amine | ESD-847152-100MG |
Cas.: 1416450-04-8 | Purity: 95% | (R)-Cyclopropyl(phenyl)methanamine hydrochloride | ESD-847153-25MG |
Cas.: 1416450-04-8 | Purity: 95% | (R)-Cyclopropyl(phenyl)methanamine hydrochloride | ESD-847153-100MG |
Cas.: 40222-77-3 | Purity: 96% | 6-(Hydroxymethyl)pyridin-3-ol | ESD-847154-25MG |
Cas.: 40222-77-3 | Purity: 96% | 6-(Hydroxymethyl)pyridin-3-ol | ESD-847154-100MG |
Cas.: 239097-74-6 | Purity: 98% | Benzo[d]isoxazol-5-amine | ESD-847155-25MG |
Cas.: 239097-74-6 | Purity: 98% | Benzo[d]isoxazol-5-amine | ESD-847155-100MG |
Cas.: 118775-69-2 | Purity: 95% | 3-Bromo-5-(prop-1-en-2-yl)pyridine | ESD-847156-25MG |
Cas.: 118775-69-2 | Purity: 95% | 3-Bromo-5-(prop-1-en-2-yl)pyridine | ESD-847156-100MG |
Cas.: 156990-36-2 | Purity: 95% | (S)-2-Aminoheptan-3-one hydrochloride | ESD-847157-25MG |
Cas.: 156990-36-2 | Purity: 95% | (S)-2-Aminoheptan-3-one hydrochloride | ESD-847157-100MG |
Cas.: 33332-31-9 | Purity: 97% | 2-Chloro-5-methoxypyrazine | ESD-847158-25MG |
Cas.: 33332-31-9 | Purity: 97% | 2-Chloro-5-methoxypyrazine | ESD-847158-100MG |
Cas.: 19090-03-0 | Purity: 95% | Dihydro-2H-thiopyran-3(4H)-one | ESD-847159-25MG |
Cas.: 19090-03-0 | Purity: 95% | Dihydro-2H-thiopyran-3(4H)-one | ESD-847159-100MG |
Cas.: 873-40-5 | Purity: 98% | 2,3,5-Trichloropyrazine | ESD-847160-25MG |
Cas.: 873-40-5 | Purity: 98% | 2,3,5-Trichloropyrazine | ESD-847160-100MG |
Cas.: 605661-83-4 | Purity: 97% | 2-Amino-4-chloronicotinic acid | ESD-847161-25MG |
Cas.: 605661-83-4 | Purity: 97% | 2-Amino-4-chloronicotinic acid | ESD-847161-100MG |
Cas.: 1260898-43-8 | Purity: 95% | 2,6-Dichloro-1,8-naphthyridine | ESD-847162-25MG |
Cas.: 1260898-43-8 | Purity: 95% | 2,6-Dichloro-1,8-naphthyridine | ESD-847162-100MG |
Cas.: 939760-37-9 | Purity: 96% | tert-Butyl 2-(aminomethyl)azetidine-1-carboxylate | ESD-847163-25MG |
Cas.: 939760-37-9 | Purity: 96% | tert-Butyl 2-(aminomethyl)azetidine-1-carboxylate | ESD-847163-100MG |
Cas.: 1416354-44-3 | Purity: 95% | 7-Methyl-2,3,4,5-tetrahydro-1H-benzo[b]azepin-5-amine dihydrochloride | ESD-847164-25MG |
Cas.: 1416354-44-3 | Purity: 95% | 7-Methyl-2,3,4,5-tetrahydro-1H-benzo[b]azepin-5-amine dihydrochloride | ESD-847164-100MG |
Cas.: 49682-96-4 | Purity: 95% | 1-(Cyclopropylmethyl)piperidin-4-one | ESD-847165-25MG |
Cas.: 49682-96-4 | Purity: 95% | 1-(Cyclopropylmethyl)piperidin-4-one | ESD-847165-100MG |
Cas.: 93634-54-9 | Purity: 95% | (Z)-2-Methyl-4-(4-methylbenzylidene)oxazol-5(4H)-one | ESD-847166-25MG |
Cas.: 93634-54-9 | Purity: 95% | (Z)-2-Methyl-4-(4-methylbenzylidene)oxazol-5(4H)-one | ESD-847166-100MG |
Cas.: 56008-20-9 | Purity: 95% | 3,6,6-Trimethyl-6,7-dihydro-1H-indol-4(5H)-one | ESD-847167-25MG |
Cas.: 56008-20-9 | Purity: 95% | 3,6,6-Trimethyl-6,7-dihydro-1H-indol-4(5H)-one | ESD-847167-100MG |
Cas.: 916258-24-7 | Purity: 95% | tert-Butyl 5-bromo-3-methyl-1H-pyrazolo[3,4-b]pyridine-1-carboxylate | ESD-847168-25MG |
Cas.: 916258-24-7 | Purity: 95% | tert-Butyl 5-bromo-3-methyl-1H-pyrazolo[3,4-b]pyridine-1-carboxylate | ESD-847168-100MG |
Cas.: 871013-98-8 | Purity: 97% | tert-Butyl 4-aminoisoindoline-2-carboxylate | ESD-847169-25MG |
Cas.: 871013-98-8 | Purity: 97% | tert-Butyl 4-aminoisoindoline-2-carboxylate | ESD-847169-100MG |
Cas.: 885694-00-8 | Purity: 95% | 7-(Trifluoromethyl)-1H-indazole | ESD-847170-25MG |
Cas.: 885694-00-8 | Purity: 95% | 7-(Trifluoromethyl)-1H-indazole | ESD-847170-100MG |
Cas.: 197774-66-6 | Purity: 97% | Ethyl 4-(pyridin-4-yl)-1H-pyrrole-3-carboxylate | ESD-847171-25MG |
Cas.: 197774-66-6 | Purity: 97% | Ethyl 4-(pyridin-4-yl)-1H-pyrrole-3-carboxylate | ESD-847171-100MG |
Cas.: 127199-27-3 | Purity: 97% | 8-Chloro-6,7-difluoro-1-((1R,2S)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | ESD-847172-25MG |
Cas.: 127199-27-3 | Purity: 97% | 8-Chloro-6,7-difluoro-1-((1R,2S)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | ESD-847172-100MG |
Cas.: 328547-11-1 | Purity: 97% | Methyl 2-amino-5-fluoro-3-nitrobenzoate | ESD-847173-25MG |
Cas.: 328547-11-1 | Purity: 97% | Methyl 2-amino-5-fluoro-3-nitrobenzoate | ESD-847173-100MG |
Cas.: 790230-04-5 | Purity: 98% | 4-Bromo-3-(hydroxymethyl)benzoic acid | ESD-847174-25MG |
Cas.: 790230-04-5 | Purity: 98% | 4-Bromo-3-(hydroxymethyl)benzoic acid | ESD-847174-100MG |
Cas.: 1416713-22-8 | Purity: 97% | 6-Bromoisoquinoline-3-carboxylic acid | ESD-847175-25MG |
Cas.: 1416713-22-8 | Purity: 97% | 6-Bromoisoquinoline-3-carboxylic acid | ESD-847175-100MG |
Cas.: 167405-28-9 | Purity: 95% | 1-(2-Amino-4-(trifluoromethyl)thiazol-5-yl)ethanone | ESD-847176-25MG |
Cas.: 167405-28-9 | Purity: 95% | 1-(2-Amino-4-(trifluoromethyl)thiazol-5-yl)ethanone | ESD-847176-100MG |
Cas.: 1227585-65-0 | Purity: 98% | (2-Bromo-5-chloropyridin-3-yl)methanol | ESD-847177-25MG |
Cas.: 1227585-65-0 | Purity: 98% | (2-Bromo-5-chloropyridin-3-yl)methanol | ESD-847177-100MG |
Cas.: 89521-55-1 | Purity: 98% | 3-(Benzyloxy)benzene-1,2-diamine | ESD-847178-25MG |
Cas.: 89521-55-1 | Purity: 98% | 3-(Benzyloxy)benzene-1,2-diamine | ESD-847178-100MG |
Cas.: 20618-42-2 | Purity: 96% | 2-(Hydroxymethyl)cyclopentanone | ESD-847179-25MG |
Cas.: 20618-42-2 | Purity: 96% | 2-(Hydroxymethyl)cyclopentanone | ESD-847179-100MG |
Cas.: 188721-64-4 | Purity: 98% | 4-Amino-3,5-dibromophenol | ESD-847180-25MG |
Cas.: 188721-64-4 | Purity: 98% | 4-Amino-3,5-dibromophenol | ESD-847180-100MG |
Cas.: 249889-68-7 | Purity: 97% | 8-Chloro-2-methoxy-1,5-naphthyridine | ESD-847181-25MG |
Cas.: 249889-68-7 | Purity: 97% | 8-Chloro-2-methoxy-1,5-naphthyridine | ESD-847181-100MG |
Cas.: 1205551-36-5 | Purity: 97% | 4-Chloro-5-fluoro-2-hydroxybenzaldehyde | ESD-847182-25MG |
Cas.: 1205551-36-5 | Purity: 97% | 4-Chloro-5-fluoro-2-hydroxybenzaldehyde | ESD-847182-100MG |
Cas.: 143381-72-0 | Purity: 98% | (5-Methylbenzofuran-2-yl)boronic acid | ESD-847183-25MG |
Cas.: 143381-72-0 | Purity: 98% | (5-Methylbenzofuran-2-yl)boronic acid | ESD-847183-100MG |
Cas.: 1060808-92-5 | Purity: 97% | 6-Bromo-4-chloronicotinic acid | ESD-847184-25MG |
Cas.: 1060808-92-5 | Purity: 97% | 6-Bromo-4-chloronicotinic acid | ESD-847184-100MG |
Cas.: 105601-13-6 | Purity: 98% | 3-(1-(Dimethylamino)ethyl)phenyl dimethylcarbamate hydrochloride | ESD-847185-25MG |
Cas.: 105601-13-6 | Purity: 98% | 3-(1-(Dimethylamino)ethyl)phenyl dimethylcarbamate hydrochloride | ESD-847185-100MG |
Cas.: 1073159-75-7 | Purity: 97% | N-(3-(Aminomethyl)pyridin-2-yl)-N-methylmethanesulfonamide acetate | ESD-847186-25MG |
Cas.: 1073159-75-7 | Purity: 97% | N-(3-(Aminomethyl)pyridin-2-yl)-N-methylmethanesulfonamide acetate | ESD-847186-100MG |
Cas.: 19500-62-0 | Purity: 97% | 7-Methoxy-1,2,3,4-tetrahydroquinoline hydrochloride | ESD-847187-25MG |
Cas.: 19500-62-0 | Purity: 97% | 7-Methoxy-1,2,3,4-tetrahydroquinoline hydrochloride | ESD-847187-100MG |
Cas.: 678193-44-7 | Purity: 95% | 1,4-Dichloro-5-methylphthalazine | ESD-847188-25MG |
Cas.: 678193-44-7 | Purity: 95% | 1,4-Dichloro-5-methylphthalazine | ESD-847188-100MG |
Cas.: 168902-79-2 | Purity: 98% | 5-Methyl-2,3-dihydro-1H-inden-1-amine | ESD-847189-25MG |
Cas.: 168902-79-2 | Purity: 98% | 5-Methyl-2,3-dihydro-1H-inden-1-amine | ESD-847189-100MG |
Cas.: 6315-51-1 | Purity: 98% | 2-Diphenylaminoethanol | ESD-847190-25MG |
Cas.: 6315-51-1 | Purity: 98% | 2-Diphenylaminoethanol | ESD-847190-100MG |
Cas.: 1235639-75-4 | Purity: 98% | (R)-Methyl 4-benzyl-5-oxomorpholine-3-carboxylate | ESD-847191-250MG |
Cas.: 1235639-75-4 | Purity: 98% | (R)-Methyl 4-benzyl-5-oxomorpholine-3-carboxylate | ESD-847191-1G |
Cas.: 13676-02-3 | Purity: 98% | 2-Chloro-6-methoxyquinoline | ESD-847192-250MG |
Cas.: 13676-02-3 | Purity: 98% | 2-Chloro-6-methoxyquinoline | ESD-847192-1G |
Cas.: 23612-48-8 | Purity: 98% | 2-Methyl-1H-pyrrolo[2,3-b]pyridine | ESD-847194-250MG |
Cas.: 23612-48-8 | Purity: 98% | 2-Methyl-1H-pyrrolo[2,3-b]pyridine | ESD-847194-1G |
Cas.: 80360-20-9 | Purity: 97% | 1-(Phenylsulfonyl)-1H-indole-3-carbaldehyde | ESD-847195-250MG |
Cas.: 80360-20-9 | Purity: 97% | 1-(Phenylsulfonyl)-1H-indole-3-carbaldehyde | ESD-847195-1G |
Cas.: 14916-63-3 | Purity: 98% | 6-Nitropyridin-2-amine | ESD-847196-250MG |
Cas.: 14916-63-3 | Purity: 98% | 6-Nitropyridin-2-amine | ESD-847196-1G |
Cas.: 13490-32-9 | Purity: 97% | 4-Amino-N’-hydroxy-1,2,5-oxadiazole-3-carboximidamide | ESD-847197-250MG |
Cas.: 13490-32-9 | Purity: 97% | 4-Amino-N’-hydroxy-1,2,5-oxadiazole-3-carboximidamide | ESD-847197-1G |
Cas.: 90030-48-1 | Purity: 95% | Sodium 3-methoxy-3-oxopropane-1-sulfinate | ESD-847198-250MG |
Cas.: 90030-48-1 | Purity: 95% | Sodium 3-methoxy-3-oxopropane-1-sulfinate | ESD-847198-1G |
Cas.: 21810-34-4 | Purity: 97% | Potassium 6-hydroxyhexanoate | ESD-847199-250MG |
Cas.: 21810-34-4 | Purity: 97% | Potassium 6-hydroxyhexanoate | ESD-847199-1G |
Cas.: 134395-00-9 | Purity: 98% | (3R,5R)-tert-Butyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate | ESD-847200-250MG |
Cas.: 134395-00-9 | Purity: 98% | (3R,5R)-tert-Butyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate | ESD-847200-1G |
Cas.: 3663-24-9 | Purity: 98% | 5-Butyl-1H-benzo[d][1,2,3]triazole | ESD-847201-250MG |
Cas.: 3663-24-9 | Purity: 98% | 5-Butyl-1H-benzo[d][1,2,3]triazole | ESD-847201-1G |
Cas.: 103-14-0 | Purity: 98% | 4-(Benzylamino)phenol | ESD-847202-250MG |
Cas.: 103-14-0 | Purity: 98% | 4-(Benzylamino)phenol | ESD-847202-1G |
Cas.: 64823-22-9 | Purity: 98% | 3,4-Dimethyl-5-nitroaniline | ESD-847203-250MG |
Cas.: 64823-22-9 | Purity: 98% | 3,4-Dimethyl-5-nitroaniline | ESD-847203-1G |
Cas.: 148254-32-4 | Purity: 97% | 5-Bromo-2-chloro-4-fluorophenol | ESD-847204-250MG |
Cas.: 148254-32-4 | Purity: 97% | 5-Bromo-2-chloro-4-fluorophenol | ESD-847204-1G |
Cas.: 1122-43-6 | Purity: 98% | 2,6-Dimethyl-3-hydroxypyridine | ESD-847205-250MG |
Cas.: 1122-43-6 | Purity: 98% | 2,6-Dimethyl-3-hydroxypyridine | ESD-847205-1G |
Cas.: 30448-16-9 | Purity: 97% | 7-Methyl-1H-indole-3-carboxylic acid | ESD-847206-250MG |
Cas.: 30448-16-9 | Purity: 97% | 7-Methyl-1H-indole-3-carboxylic acid | ESD-847206-1G |
Cas.: 33141-66-1 | Purity: 98% | Ethyl 4-bromo-3-hydroxybenzoate | ESD-847207-250MG |
Cas.: 33141-66-1 | Purity: 98% | Ethyl 4-bromo-3-hydroxybenzoate | ESD-847207-1G |
Cas.: 55736-04-4 | Purity: 98% | 1-(2-Chloro-6-hydroxyphenyl)ethanone | ESD-847208-250MG |
Cas.: 55736-04-4 | Purity: 98% | 1-(2-Chloro-6-hydroxyphenyl)ethanone | ESD-847208-1G |
Cas.: 1753-50-0 | Purity: 97% | 2-Chloropyrimidine-5-carbonitrile | ESD-847209-250MG |
Cas.: 1753-50-0 | Purity: 97% | 2-Chloropyrimidine-5-carbonitrile | ESD-847209-1G |
Cas.: 31560-06-2 | Purity: 97% | (1S,4S)-2-Oxa-5-azabicyclo[2.2.1]heptane hydrochloride | ESD-847210-250MG |
Cas.: 31560-06-2 | Purity: 97% | (1S,4S)-2-Oxa-5-azabicyclo[2.2.1]heptane hydrochloride | ESD-847210-1G |
Cas.: 923595-58-8 | Purity: 98% | 5-Chloro-3-iodopyrazolo[1,5-a]pyrimidine | ESD-847211-250MG |
Cas.: 923595-58-8 | Purity: 98% | 5-Chloro-3-iodopyrazolo[1,5-a]pyrimidine | ESD-847211-1G |
Cas.: 68755-37-3 | Purity: 95% | 6-(Trifluoromethyl)-1-indanone | ESD-847212-250MG |
Cas.: 68755-37-3 | Purity: 95% | 6-(Trifluoromethyl)-1-indanone | ESD-847212-1G |
Cas.: 65754-04-3 | Purity: 97% | 6-Oxo-1,6-dihydropyrimidine-5-carboxylic acid | ESD-847213-250MG |
Cas.: 65754-04-3 | Purity: 97% | 6-Oxo-1,6-dihydropyrimidine-5-carboxylic acid | ESD-847213-1G |
Cas.: 105807-83-8 | Purity: 98% | 7-Amino-2,2-dimethyl-2H-benzo[b][1,4]oxazin-3(4H)-one | ESD-847214-250MG |
Cas.: 105807-83-8 | Purity: 98% | 7-Amino-2,2-dimethyl-2H-benzo[b][1,4]oxazin-3(4H)-one | ESD-847214-1G |
Cas.: 70952-62-4 | Purity: 97% | 3,6-Dichloro-4-methoxypyridazine | ESD-847215-250MG |
Cas.: 70952-62-4 | Purity: 97% | 3,6-Dichloro-4-methoxypyridazine | ESD-847215-1G |
Cas.: 1257849-25-4 | Purity: 95% | 1-Boc-4-(3-Formylphenyl)piperazine | ESD-847216-250MG |
Cas.: 1257849-25-4 | Purity: 95% | 1-Boc-4-(3-Formylphenyl)piperazine | ESD-847216-1G |
Cas.: 1035374-20-9 | Purity: 97% | 3-Aminocyclobutanone hydrochloride | ESD-847217-250MG |
Cas.: 1035374-20-9 | Purity: 97% | 3-Aminocyclobutanone hydrochloride | ESD-847217-1G |
Cas.: 82500-22-9 | Purity: 95% | 1-(Cyclopentylmethyl)piperazine | ESD-847218-250MG |
Cas.: 82500-22-9 | Purity: 95% | 1-(Cyclopentylmethyl)piperazine | ESD-847218-1G |
Cas.: 660845-30-7 | Purity: 98% | 5-Chloro-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carbaldehyde | ESD-847219-250MG |
Cas.: 660845-30-7 | Purity: 98% | 5-Chloro-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carbaldehyde | ESD-847219-1G |
Cas.: 24473-00-5 | Purity: 98% | 2,4,6-Trichlorobenzaldehyde | ESD-847220-250MG |
Cas.: 24473-00-5 | Purity: 98% | 2,4,6-Trichlorobenzaldehyde | ESD-847220-1G |
Cas.: 885518-46-7 | Purity: 97% | 6-Bromo-4-nitro-1H-indazole | ESD-847221-250MG |
Cas.: 885518-46-7 | Purity: 97% | 6-Bromo-4-nitro-1H-indazole | ESD-847221-1G |
Cas.: 5577-13-9 | Purity: 95% | Ethyl tosylcarbamate | ESD-847223-250MG |
Cas.: 5577-13-9 | Purity: 95% | Ethyl tosylcarbamate | ESD-847223-1G |
Cas.: 608128-34-3 | Purity: 97% | (E)-Methyl 4-(4-bromophenyl)-2-oxobut-3-enoate | ESD-847224-250MG |
Cas.: 608128-34-3 | Purity: 97% | (E)-Methyl 4-(4-bromophenyl)-2-oxobut-3-enoate | ESD-847224-1G |
Cas.: 148404-28-8 | Purity: 97% | tert-Butyl 5-oxohexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate | ESD-847225-250MG |
Cas.: 148404-28-8 | Purity: 97% | tert-Butyl 5-oxohexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate | ESD-847225-1G |
Cas.: 870777-33-6 | Purity: 98% | (3-Formyl-5-methylphenyl)boronic acid | ESD-847226-250MG |
Cas.: 870777-33-6 | Purity: 98% | (3-Formyl-5-methylphenyl)boronic acid | ESD-847226-1G |
Cas.: 437998-34-0 | Purity: 95% | 2-Amino-3-bromobenzamide | ESD-847227-250MG |
Cas.: 437998-34-0 | Purity: 95% | 2-Amino-3-bromobenzamide | ESD-847227-1G |
Cas.: 1107601-70-6 | Purity: 97% | (1-Methyl-1H-pyrazol-4-yl)methanamine hydrochloride | ESD-847228-250MG |
Cas.: 1107601-70-6 | Purity: 97% | (1-Methyl-1H-pyrazol-4-yl)methanamine hydrochloride | ESD-847228-1G |
Cas.: 89368-12-7 | Purity: 98% | 1-(4-Bromo-2-methoxyphenyl)ethanone | ESD-847229-250MG |
Cas.: 89368-12-7 | Purity: 98% | 1-(4-Bromo-2-methoxyphenyl)ethanone | ESD-847229-1G |
Cas.: 91944-64-8 | Purity: 95% | N,N-Dimethylpyridin-4-amine 4-methylbenzenesulfonate | ESD-847230-250MG |
Cas.: 91944-64-8 | Purity: 95% | N,N-Dimethylpyridin-4-amine 4-methylbenzenesulfonate | ESD-847230-1G |
Cas.: 172377-05-8 | Purity: 98% | 2,5-Dibromo-4-fluoroaniline | ESD-847231-250MG |
Cas.: 172377-05-8 | Purity: 98% | 2,5-Dibromo-4-fluoroaniline | ESD-847231-1G |
Cas.: 27116-80-9 | Purity: 98% | 5-Methyl-4-nitro-3-(trifluoromethyl)-1H-pyrazole | ESD-847232-250MG |
Cas.: 27116-80-9 | Purity: 98% | 5-Methyl-4-nitro-3-(trifluoromethyl)-1H-pyrazole | ESD-847232-1G |
Cas.: 16281-97-3 | Purity: 97% | Methyl 4-(1-bromoethyl)benzoate | ESD-847233-250MG |
Cas.: 16281-97-3 | Purity: 97% | Methyl 4-(1-bromoethyl)benzoate | ESD-847233-1G |
Cas.: 16900-57-5 | Purity: 97% | 2-Aminopent-4-ynoic acid hydrochloride | ESD-847234-250MG |
Cas.: 16900-57-5 | Purity: 97% | 2-Aminopent-4-ynoic acid hydrochloride | ESD-847234-1G |
Cas.: 412343-21-6 | Purity: 98% | (4-((tert-Butyldimethylsilyl)oxy)-2-chlorophenyl)boronic acid | ESD-847235-250MG |
Cas.: 412343-21-6 | Purity: 98% | (4-((tert-Butyldimethylsilyl)oxy)-2-chlorophenyl)boronic acid | ESD-847235-1G |
Cas.: 86467-39-2 | Purity: 98% | 2-Methyloxazolo[4,5-b]pyridine | ESD-847236-250MG |
Cas.: 86467-39-2 | Purity: 98% | 2-Methyloxazolo[4,5-b]pyridine | ESD-847236-1G |
Cas.: 24091-92-7 | Purity: 97% | Methyl 2-bromo-2-(4-chlorophenyl)acetate | ESD-847237-250MG |
Cas.: 24091-92-7 | Purity: 97% | Methyl 2-bromo-2-(4-chlorophenyl)acetate | ESD-847237-1G |
Cas.: 106896-48-4 | Purity: 96% | Methyl 3-amino-2-bromobenzoate | ESD-847238-250MG |
Cas.: 106896-48-4 | Purity: 96% | Methyl 3-amino-2-bromobenzoate | ESD-847238-1G |
Cas.: 320590-29-2 | Purity: 98% | Benzyl (3-oxocyclohexyl)carbamate | ESD-847239-250MG |
Cas.: 320590-29-2 | Purity: 98% | Benzyl (3-oxocyclohexyl)carbamate | ESD-847239-1G |
Cas.: 19875-04-8 | Purity: 98% | 2-Methylpyrimidin-4(3H)-one | ESD-847240-250MG |
Cas.: 19875-04-8 | Purity: 98% | 2-Methylpyrimidin-4(3H)-one | ESD-847240-1G |
Cas.: 1180678-40-3 | Purity: 98% | 5-Bromo-2-iodopyridin-3-amine | ESD-847241-50MG |
Cas.: 1180678-40-3 | Purity: 98% | 5-Bromo-2-iodopyridin-3-amine | ESD-847241-250MG |
Cas.: 85386-14-7 | Purity: 98% | Ethyl 2-phenylpyrimidine-5-carboxylate | ESD-847242-50MG |
Cas.: 85386-14-7 | Purity: 98% | Ethyl 2-phenylpyrimidine-5-carboxylate | ESD-847242-250MG |
Cas.: 900503-08-4 | Purity: 95% | tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-8-azabicyclo[3.2.1]oct-3-ene-8-carboxylate | ESD-847243-50MG |
Cas.: 900503-08-4 | Purity: 95% | tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-8-azabicyclo[3.2.1]oct-3-ene-8-carboxylate | ESD-847243-250MG |
Cas.: 219832-76-5 | Purity: 97% | Methyl 2-((tert-butoxycarbonyl)amino)-2-(pipidin-4-yl)acetate | ESD-847244-50MG |
Cas.: 219832-76-5 | Purity: 97% | Methyl 2-((tert-butoxycarbonyl)amino)-2-(pipidin-4-yl)acetate | ESD-847244-250MG |
Cas.: 748812-37-5 | Purity: 98% | 5-Bromo-3-fluoropyridin-2-amine | ESD-847245-250MG |
Cas.: 748812-37-5 | Purity: 98% | 5-Bromo-3-fluoropyridin-2-amine | ESD-847245-1G |
Cas.: 164161-49-3 | Purity: 95% | Methyl 5-benzyloxy-4-methoxy-2-nitrobenzoate | ESD-847246-250MG |
Cas.: 164161-49-3 | Purity: 95% | Methyl 5-benzyloxy-4-methoxy-2-nitrobenzoate | ESD-847246-1G |
Cas.: 130627-09-7 | Purity: 95% | 2-Oxopropyl 2-aminobenzoate | ESD-847247-50MG |
Cas.: 130627-09-7 | Purity: 95% | 2-Oxopropyl 2-aminobenzoate | ESD-847247-250MG |
Cas.: 299166-55-5 | Purity: 97% | 1,4,5,6-Tetrahydrocyclopenta[c]pyrazole-3-carbohydrazide | ESD-847248-250MG |
Cas.: 299166-55-5 | Purity: 97% | 1,4,5,6-Tetrahydrocyclopenta[c]pyrazole-3-carbohydrazide | ESD-847248-1G |
Cas.: 149910-98-5 | Purity: 98% | 7-Bromoisochroman | ESD-847249-50MG |
Cas.: 149910-98-5 | Purity: 98% | 7-Bromoisochroman | ESD-847249-250MG |
Cas.: 945954-94-9 | Purity: 98% | Methyl 6-bromo-3-methoxypicolinate | ESD-847250-25MG |
Cas.: 945954-94-9 | Purity: 98% | Methyl 6-bromo-3-methoxypicolinate | ESD-847250-100MG |
Cas.: 1361110-64-6 | Purity: 95% | 7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine | ESD-847251-25MG |
Cas.: 1361110-64-6 | Purity: 95% | 7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine | ESD-847251-100MG |
Cas.: 1079351-20-4 | Purity: 96% | 2-Chloro-4-(trifluoromethoxy)benzaldehyde | ESD-847252-25MG |
Cas.: 1079351-20-4 | Purity: 96% | 2-Chloro-4-(trifluoromethoxy)benzaldehyde | ESD-847252-100MG |
Cas.: 74572-03-5 | Purity: 98% | (R)-3-Phenylmorpholine | ESD-847253-25MG |
Cas.: 74572-03-5 | Purity: 98% | (R)-3-Phenylmorpholine | ESD-847253-100MG |
Cas.: 115132-84-8 | Purity: 98% | Thiophen-3-ylmethanamine hydrochloride | ESD-847254-250MG |
Cas.: 115132-84-8 | Purity: 98% | Thiophen-3-ylmethanamine hydrochloride | ESD-847254-1G |
Cas.: 91307-40-3 | Purity: 98% | Methyl 5-hydroxy-1-naphthoate | ESD-847255-50MG |
Cas.: 91307-40-3 | Purity: 98% | Methyl 5-hydroxy-1-naphthoate | ESD-847255-250MG |
Cas.: 13743-09-4 | Purity: 95% | 2-Methyl-5-phenylthiazole-4-carboxylic acid | ESD-847256-50MG |
Cas.: 13743-09-4 | Purity: 95% | 2-Methyl-5-phenylthiazole-4-carboxylic acid | ESD-847256-250MG |
Cas.: 1000801-75-1 | Purity: 97% | 1-(Cyclopropylmethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-847257-50MG |
Cas.: 1000801-75-1 | Purity: 97% | 1-(Cyclopropylmethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-847257-250MG |
Cas.: 74733-24-7 | Purity: 98% | Methyl 4-formyl-3-methoxybenzoate | ESD-847258-50MG |
Cas.: 74733-24-7 | Purity: 98% | Methyl 4-formyl-3-methoxybenzoate | ESD-847258-250MG |
Cas.: 31970-30-6 | Purity: 98% | [3,3′-Bipyridin]-6-amine | ESD-847259-25MG |
Cas.: 31970-30-6 | Purity: 98% | [3,3′-Bipyridin]-6-amine | ESD-847259-100MG |
Cas.: 1207557-36-5 | Purity: 97% | 6-Bromo-4-methoxypyrazolo[1,5-a]pyridine | ESD-847260-25MG |
Cas.: 1207557-36-5 | Purity: 97% | 6-Bromo-4-methoxypyrazolo[1,5-a]pyridine | ESD-847260-100MG |
Cas.: 67337-73-9 | Purity: 95% | 5-Isobutylimidazolidine-2,4-dione | ESD-847261-250MG |
Cas.: 67337-73-9 | Purity: 95% | 5-Isobutylimidazolidine-2,4-dione | ESD-847261-1G |
Cas.: 6127-18-0 | Purity: 98% | 4-Bromo-2-methyl-1H-indole | ESD-847262-50MG |
Cas.: 6127-18-0 | Purity: 98% | 4-Bromo-2-methyl-1H-indole | ESD-847262-250MG |
Cas.: 5814-37-9 | Purity: 97% | Ethyl 2,4-dioxo-4-(p-tolyl)butanoate | ESD-847263-250MG |
Cas.: 5814-37-9 | Purity: 97% | Ethyl 2,4-dioxo-4-(p-tolyl)butanoate | ESD-847263-1G |
Cas.: 216966-37-9 | Purity: 95% | 3-Amino-5,6,7,8-tetrahydro-6-methyl-1,6-naphthyridine | ESD-847264-25MG |
Cas.: 216966-37-9 | Purity: 95% | 3-Amino-5,6,7,8-tetrahydro-6-methyl-1,6-naphthyridine | ESD-847264-100MG |
Cas.: 60565-89-1 | Purity: 95% | 1-Methyl-1,4-diazepan-2-one | ESD-847265-25MG |
Cas.: 60565-89-1 | Purity: 95% | 1-Methyl-1,4-diazepan-2-one | ESD-847265-100MG |
Cas.: 34771-39-6 | Purity: 97% | 6-Phenyl-5H-pyrrolo[3,2-d]pyrimidine-2,4-diol | ESD-847266-25MG |
Cas.: 34771-39-6 | Purity: 97% | 6-Phenyl-5H-pyrrolo[3,2-d]pyrimidine-2,4-diol | ESD-847266-100MG |
Cas.: 29096-60-4 | Purity: 97% | 1-(2-Methylimidazo[1,2-a]pyridin-3-yl)ethanone | ESD-847267-250MG |
Cas.: 29096-60-4 | Purity: 97% | 1-(2-Methylimidazo[1,2-a]pyridin-3-yl)ethanone | ESD-847267-1G |
Cas.: 13214-64-7 | Purity: 98% | 2-(4-Methoxybenzamido)acetic acid | ESD-847268-250MG |
Cas.: 13214-64-7 | Purity: 98% | 2-(4-Methoxybenzamido)acetic acid | ESD-847268-1G |
Cas.: 158980-21-3 | Purity: 97% | Ethyl 6-aminoimidazo[1,2-a]pyridine-2-carboxylate | ESD-847269-250MG |
Cas.: 158980-21-3 | Purity: 97% | Ethyl 6-aminoimidazo[1,2-a]pyridine-2-carboxylate | ESD-847269-1G |
Cas.: 588727-65-5 | Purity: 97% | 4-(6-Bromopyridin-2-yl)benzaldehyde | ESD-847270-250MG |
Cas.: 588727-65-5 | Purity: 97% | 4-(6-Bromopyridin-2-yl)benzaldehyde | ESD-847270-1G |
Cas.: 5228-52-4 | Purity: 95% | 5-Amino-2-ethyl-2H-indazole | ESD-847271-250MG |
Cas.: 5228-52-4 | Purity: 95% | 5-Amino-2-ethyl-2H-indazole | ESD-847271-1G |
Cas.: 209920-43-4 | Purity: 95% | 6-Methyl-1H-indole-3-carboxylic acid | ESD-847272-250MG |
Cas.: 209920-43-4 | Purity: 95% | 6-Methyl-1H-indole-3-carboxylic acid | ESD-847272-1G |
Cas.: 92398-47-5 | Purity: 98% | Methyl 1-aminocyclobutanecarboxylate hydrochloride | ESD-847273-250MG |
Cas.: 92398-47-5 | Purity: 98% | Methyl 1-aminocyclobutanecarboxylate hydrochloride | ESD-847273-1G |
Cas.: 1240061-39-5 | Purity: 95% | 5-(3-Acetamidophenyl)-1H-pyrazole-3-carboxylic acid | ESD-847274-250MG |
Cas.: 1240061-39-5 | Purity: 95% | 5-(3-Acetamidophenyl)-1H-pyrazole-3-carboxylic acid | ESD-847274-1G |
Cas.: 914349-53-4 | Purity: 95% | 2-((4-(tert-Butoxycarbonyl)piperazin-1-yl)methyl)benzoic acid | ESD-847275-250MG |
Cas.: 914349-53-4 | Purity: 95% | 2-((4-(tert-Butoxycarbonyl)piperazin-1-yl)methyl)benzoic acid | ESD-847275-1G |
Cas.: 1189458-99-8 | Purity: 97% | 5-(m-Tolyl)pyridin-2-amine dihydrochloride | ESD-847276-250MG |
Cas.: 1189458-99-8 | Purity: 97% | 5-(m-Tolyl)pyridin-2-amine dihydrochloride | ESD-847276-1G |
Cas.: 1185081-59-7 | Purity: 97% | 5-(4-Methoxyphenyl)pyridin-2-ylamine dihydrochloride | ESD-847277-250MG |
Cas.: 1185081-59-7 | Purity: 97% | 5-(4-Methoxyphenyl)pyridin-2-ylamine dihydrochloride | ESD-847277-1G |
Cas.: 914349-83-0 | Purity: 97% | Methyl 4-((3-methylpiperazin-1-yl)methyl)benzoate | ESD-847278-250MG |
Cas.: 914349-83-0 | Purity: 97% | Methyl 4-((3-methylpiperazin-1-yl)methyl)benzoate | ESD-847278-1G |
Cas.: 801306-55-8 | Purity: 95% | 1-(3-(Trifluoromethyl)pyridin-2-yl)piperidin-4-one | ESD-847279-250MG |
Cas.: 801306-55-8 | Purity: 95% | 1-(3-(Trifluoromethyl)pyridin-2-yl)piperidin-4-one | ESD-847279-1G |
Cas.: 404010-98-6 | Purity: 97% | 4-Morpholin-4-yl-2-nitrobenzoic acid | ESD-847280-250MG |
Cas.: 404010-98-6 | Purity: 97% | 4-Morpholin-4-yl-2-nitrobenzoic acid | ESD-847280-1G |
Cas.: 33311-29-4 | Purity: 98% | 4-(2-Methoxyethoxy)aniline | ESD-847281-250MG |
Cas.: 33311-29-4 | Purity: 98% | 4-(2-Methoxyethoxy)aniline | ESD-847281-1G |
Cas.: 754125-43-4 | Purity: 95% | Methyl 3-(cyclopentylamino)propanoate | ESD-847282-250MG |
Cas.: 754125-43-4 | Purity: 95% | Methyl 3-(cyclopentylamino)propanoate | ESD-847282-1G |
Cas.: 597551-56-9 | Purity: 98% | 4-Amino-2-chloro-5-iodopyrimidine | ESD-847283-250MG |
Cas.: 597551-56-9 | Purity: 98% | 4-Amino-2-chloro-5-iodopyrimidine | ESD-847283-1G |
Cas.: 515162-19-3 | Purity: 95% | 3-(4-Methylpiperazin-1-ylmethyl)benzylamine | ESD-847284-250MG |
Cas.: 515162-19-3 | Purity: 95% | 3-(4-Methylpiperazin-1-ylmethyl)benzylamine | ESD-847284-1G |
Cas.: 702672-96-6 | Purity: 98% | 2-Bromo-1-methyl-4-(methylsulfonyl)benzene | ESD-847285-250MG |
Cas.: 702672-96-6 | Purity: 98% | 2-Bromo-1-methyl-4-(methylsulfonyl)benzene | ESD-847285-1G |
Cas.: 1217500-59-8 | Purity: 96% | (6-Bromo-1-(tert-butoxycarbonyl)-1H-indol-2-yl)boronic acid | ESD-847286-250MG |
Cas.: 1217500-59-8 | Purity: 96% | (6-Bromo-1-(tert-butoxycarbonyl)-1H-indol-2-yl)boronic acid | ESD-847286-1G |
Cas.: 2327-02-8 | Purity: 98% | 1-(3,4-Dichlorophenyl)urea | ESD-847287-250MG |
Cas.: 2327-02-8 | Purity: 98% | 1-(3,4-Dichlorophenyl)urea | ESD-847287-1G |
Cas.: 13330-65-9 | Purity: 98% | 2,4-Dimethoxyphenol | ESD-847288-250MG |
Cas.: 13330-65-9 | Purity: 98% | 2,4-Dimethoxyphenol | ESD-847288-1G |
Cas.: 60868-41-9 | Purity: 95% | Ethyl 3-(2,4-dichlorophenyl)-3-oxopropanoate | ESD-847289-250MG |
Cas.: 60868-41-9 | Purity: 95% | Ethyl 3-(2,4-dichlorophenyl)-3-oxopropanoate | ESD-847289-1G |
Cas.: 131288-67-0 | Purity: 95% | (S)-2-Amino-3-cyclohexylpropan-1-ol | ESD-847290-50MG |
Cas.: 131288-67-0 | Purity: 95% | (S)-2-Amino-3-cyclohexylpropan-1-ol | ESD-847290-250MG |
Cas.: 66247-84-5 | Purity: 97% | (1H-Imidazol-4-yl)methanamine hydrochloride | ESD-847291-50MG |
Cas.: 66247-84-5 | Purity: 97% | (1H-Imidazol-4-yl)methanamine hydrochloride | ESD-847291-250MG |
Cas.: 786684-21-7 | Purity: 95% | (S)-2-(2-Hydroxyethyl)piperidine hydrochloride | ESD-847292-25MG |
Cas.: 786684-21-7 | Purity: 95% | (S)-2-(2-Hydroxyethyl)piperidine hydrochloride | ESD-847292-100MG |
Cas.: 680596-79-6 | Purity: 98% | 4,4,5,5-Tetramethyl-2-(1,4-dioxaspiro[4.5]dec-7-en-8-yl)-1,3,2-dioxaborolane | ESD-847293-250MG |
Cas.: 680596-79-6 | Purity: 98% | 4,4,5,5-Tetramethyl-2-(1,4-dioxaspiro[4.5]dec-7-en-8-yl)-1,3,2-dioxaborolane | ESD-847293-1G |
Cas.: 135631-90-2 | Purity: 97% | 6-Bromo-4,4-dimethyl-3,4-dihydroquinolin-2(1H)-one | ESD-847294-250MG |
Cas.: 135631-90-2 | Purity: 97% | 6-Bromo-4,4-dimethyl-3,4-dihydroquinolin-2(1H)-one | ESD-847294-1G |
Cas.: 867279-13-8 | Purity: 98% | 4-Bromo-2-chloro-5-methylpyridine | ESD-847295-25MG |
Cas.: 867279-13-8 | Purity: 98% | 4-Bromo-2-chloro-5-methylpyridine | ESD-847295-100MG |
Cas.: 1150618-22-6 | Purity: 98% | 4-Hydroxyquinoline-7-carboxylic acid | ESD-847296-25MG |
Cas.: 1150618-22-6 | Purity: 98% | 4-Hydroxyquinoline-7-carboxylic acid | ESD-847296-100MG |
Cas.: 1268521-85-2 | Purity: 97% | trans-3-Hydroxycyclobutanecarboxylic acid | ESD-847297-25MG |
Cas.: 1268521-85-2 | Purity: 97% | trans-3-Hydroxycyclobutanecarboxylic acid | ESD-847297-100MG |
Cas.: 441800-93-7 | Purity: 97% | 2-(Ethoxycarbonyl)-1H-indole-3-carboxylic acid | ESD-847298-25MG |
Cas.: 441800-93-7 | Purity: 97% | 2-(Ethoxycarbonyl)-1H-indole-3-carboxylic acid | ESD-847298-100MG |
Cas.: 14088-99-4 | Purity: 98% | 1-(4-Chlorophenyl)imidazolidin-2-one | ESD-847299-25MG |
Cas.: 14088-99-4 | Purity: 98% | 1-(4-Chlorophenyl)imidazolidin-2-one | ESD-847299-100MG |
Cas.: 112581-95-0 | Purity: 98% | 2-Bromoimidazo[1,2-a]pyridine | ESD-847300-250MG |
Cas.: 112581-95-0 | Purity: 98% | 2-Bromoimidazo[1,2-a]pyridine | ESD-847300-1G |
Cas.: 112758-89-1 | Purity: 97% | 1-Phenyl-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine | ESD-847301-250MG |
Cas.: 112758-89-1 | Purity: 97% | 1-Phenyl-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine | ESD-847301-1G |
Cas.: 89895-06-7 | Purity: 97% | 1-(Piperidin-4-yl)ethanone hydrochloride | ESD-847302-250MG |
Cas.: 89895-06-7 | Purity: 97% | 1-(Piperidin-4-yl)ethanone hydrochloride | ESD-847302-1G |
Cas.: 23876-18-8 | Purity: 98% | 2-(2-Methyl-6-nitrophenyl)acetic acid | ESD-847303-250MG |
Cas.: 23876-18-8 | Purity: 98% | 2-(2-Methyl-6-nitrophenyl)acetic acid | ESD-847303-1G |
Cas.: 60857-16-1 | Purity: 97% | Ethyl 2-((4-methoxybenzyl)amino)acetate | ESD-847304-250MG |
Cas.: 60857-16-1 | Purity: 97% | Ethyl 2-((4-methoxybenzyl)amino)acetate | ESD-847304-1G |
Cas.: 240401-25-6 | Purity: 97% | 4-(Hydroxymethyl)piperidin-4-ol hydrochloride | ESD-847305-25MG |
Cas.: 240401-25-6 | Purity: 97% | 4-(Hydroxymethyl)piperidin-4-ol hydrochloride | ESD-847305-100MG |
Cas.: 1033772-22-3 | Purity: 98% | 1H-Pyrazolo[4,3-b]pyridine-5-carbonitrile | ESD-847306-25MG |
Cas.: 1033772-22-3 | Purity: 98% | 1H-Pyrazolo[4,3-b]pyridine-5-carbonitrile | ESD-847306-100MG |
Cas.: 717847-03-5 | Purity: 97% | 6-Morpholinopyrazin-2-amine | ESD-847307-250MG |
Cas.: 717847-03-5 | Purity: 97% | 6-Morpholinopyrazin-2-amine | ESD-847307-1G |
Cas.: 91469-55-5 | Purity: 97% | Cyclopent-3-enamine hydrochloride | ESD-847308-250MG |
Cas.: 91469-55-5 | Purity: 97% | Cyclopent-3-enamine hydrochloride | ESD-847308-1G |
Cas.: 502653-18-1 | Purity: 95% | 2-Phenyl-1-(piperazin-1-yl)ethanone hydrochloride | ESD-847309-50MG |
Cas.: 502653-18-1 | Purity: 95% | 2-Phenyl-1-(piperazin-1-yl)ethanone hydrochloride | ESD-847309-250MG |
Cas.: 1130165-74-0 | Purity: 96% | Ethyl 4-bromo-3-fluorobenzoate | ESD-847310-250MG |
Cas.: 1130165-74-0 | Purity: 96% | Ethyl 4-bromo-3-fluorobenzoate | ESD-847310-1G |
Cas.: 60031-08-5 | Purity: 97% | 3-Oxo-2,3-dihydro-1H-indene-5-carboxylic acid | ESD-847311-25MG |
Cas.: 60031-08-5 | Purity: 97% | 3-Oxo-2,3-dihydro-1H-indene-5-carboxylic acid | ESD-847311-100MG |
Cas.: 852362-25-5 | Purity: 98% | Quinoxalin-6-ylboronic acid hydrochloride | ESD-847312-25MG |
Cas.: 852362-25-5 | Purity: 98% | Quinoxalin-6-ylboronic acid hydrochloride | ESD-847312-100MG |
Cas.: 18088-10-3 | Purity: 95% | 4,6-Dimethylpicolinic acid | ESD-847313-25MG |
Cas.: 18088-10-3 | Purity: 95% | 4,6-Dimethylpicolinic acid | ESD-847313-100MG |
Cas.: 888473-50-5 | Purity: 96% | (1H-Pyrrol-3-yl)methanamine | ESD-847314-25MG |
Cas.: 888473-50-5 | Purity: 96% | (1H-Pyrrol-3-yl)methanamine | ESD-847314-100MG |
Cas.: 1370411-43-0 | Purity: 97% | 5-(4-Fluorophenethylsulfonyl)-1-phenyl-1H-tetrazole | ESD-847315-25MG |
Cas.: 1370411-43-0 | Purity: 97% | 5-(4-Fluorophenethylsulfonyl)-1-phenyl-1H-tetrazole | ESD-847315-100MG |
Cas.: 29086-41-7 | Purity: 97% | 1,1-Bis(bromomethyl)cyclopropane | ESD-847316-25MG |
Cas.: 29086-41-7 | Purity: 97% | 1,1-Bis(bromomethyl)cyclopropane | ESD-847316-100MG |
Cas.: 24206-39-1 | Purity: 98% | 1,2,3,4-Tetrahydroquinolin-4-ol | ESD-847317-25MG |
Cas.: 24206-39-1 | Purity: 98% | 1,2,3,4-Tetrahydroquinolin-4-ol | ESD-847317-100MG |
Cas.: 14088-98-3 | Purity: 98% | 1-(3-Chlorophenyl)imidazolidin-2-one | ESD-847318-25MG |
Cas.: 14088-98-3 | Purity: 98% | 1-(3-Chlorophenyl)imidazolidin-2-one | ESD-847318-100MG |
Cas.: 1236791-61-9 | Purity: 97% | 3-(Azetidin-3-yl)pyridine dihydrochloride | ESD-847319-25MG |
Cas.: 1236791-61-9 | Purity: 97% | 3-(Azetidin-3-yl)pyridine dihydrochloride | ESD-847319-100MG |
Cas.: 1214325-21-9 | Purity: 97% | Methyl 3-bromo-5-fluoroisonicotinate | ESD-847320-25MG |
Cas.: 1214325-21-9 | Purity: 97% | Methyl 3-bromo-5-fluoroisonicotinate | ESD-847320-100MG |
Cas.: 17286-47-4 | Purity: 97% | 2-(1H-Imidazol-2-yl)ethanamine dihydrochloride | ESD-847321-25MG |
Cas.: 17286-47-4 | Purity: 97% | 2-(1H-Imidazol-2-yl)ethanamine dihydrochloride | ESD-847321-100MG |
Cas.: 1082041-56-2 | Purity: 97% | 5-Nitro-1H-indazol-6-ol | ESD-847322-25MG |
Cas.: 1082041-56-2 | Purity: 97% | 5-Nitro-1H-indazol-6-ol | ESD-847322-100MG |
Cas.: 17289-30-4 | Purity: 95% | 4-(Chloromethyl)-1-methyl-1H-imidazole hydrochloride | ESD-847323-25MG |
Cas.: 17289-30-4 | Purity: 95% | 4-(Chloromethyl)-1-methyl-1H-imidazole hydrochloride | ESD-847323-100MG |
Cas.: 43029-20-5 | Purity: 95% | 3-Amino-6-methylpyrazin-2(1H)-one | ESD-847324-25MG |
Cas.: 43029-20-5 | Purity: 95% | 3-Amino-6-methylpyrazin-2(1H)-one | ESD-847324-100MG |
Cas.: 1196151-53-7 | Purity: 98% | 6-Bromopyrazine-2-carboxylic acid | ESD-847325-25MG |
Cas.: 1196151-53-7 | Purity: 98% | 6-Bromopyrazine-2-carboxylic acid | ESD-847325-100MG |
Cas.: 1353977-72-6 | Purity: 97% | 4-((4-Aminopipidin-1-yl)methyl)benzonitrile hydrochloride | ESD-847326-25MG |
Cas.: 1353977-72-6 | Purity: 97% | 4-((4-Aminopipidin-1-yl)methyl)benzonitrile hydrochloride | ESD-847326-100MG |
Cas.: 648449-01-8 | Purity: 97% | Methyl 4-chloroquinoline-6-carboxylate | ESD-847327-25MG |
Cas.: 648449-01-8 | Purity: 97% | Methyl 4-chloroquinoline-6-carboxylate | ESD-847327-100MG |
Cas.: 1260860-26-1 | Purity: 95% | 2,4-Dichloro-5-(1H-pyrazol-1-yl)pyrimidine | ESD-847328-25MG |
Cas.: 1260860-26-1 | Purity: 95% | 2,4-Dichloro-5-(1H-pyrazol-1-yl)pyrimidine | ESD-847328-100MG |
Cas.: 632352-56-8 | Purity: 98% | tert-Butyl 4-oxo-3-phenylpiperidine-1-carboxylate | ESD-847329-25MG |
Cas.: 632352-56-8 | Purity: 98% | tert-Butyl 4-oxo-3-phenylpiperidine-1-carboxylate | ESD-847329-100MG |
Cas.: 1214362-62-5 | Purity: 98% | Ethyl 2-bromo-6-fluorobenzoate | ESD-847330-250MG |
Cas.: 1214362-62-5 | Purity: 98% | Ethyl 2-bromo-6-fluorobenzoate | ESD-847330-1G |
Cas.: 172611-72-2 | Purity: ≥99% | 5,5-Dimethyl-2-(3-methylbutanoyl)cyclohexane-1,3-dione | ESD-847331-250MG |
Cas.: 172611-72-2 | Purity: ≥99% | 5,5-Dimethyl-2-(3-methylbutanoyl)cyclohexane-1,3-dione | ESD-847331-1G |
Cas.: 874774-41-1 | Purity: 98% | 2-Amino-3-bromo-5-(trifluoromethoxy)benzoic acid | ESD-847332-250MG |
Cas.: 874774-41-1 | Purity: 98% | 2-Amino-3-bromo-5-(trifluoromethoxy)benzoic acid | ESD-847332-1G |
Cas.: 956034-04-1 | Purity: 98% | Methyl 3-aminofuran-2-carboxylate | ESD-847333-50MG |
Cas.: 956034-04-1 | Purity: 98% | Methyl 3-aminofuran-2-carboxylate | ESD-847333-250MG |
Cas.: 26293-93-6 | Purity: 98% | 2,6-Dichloropyrimidine-4-carbonitrile | ESD-847334-50MG |
Cas.: 26293-93-6 | Purity: 98% | 2,6-Dichloropyrimidine-4-carbonitrile | ESD-847334-250MG |
Cas.: 442129-37-5 | Purity: 97% | 6-Chloro-5-methylpyridin-2-amine | ESD-847335-50MG |
Cas.: 442129-37-5 | Purity: 97% | 6-Chloro-5-methylpyridin-2-amine | ESD-847335-250MG |
Cas.: 99-67-2 | Purity: 95% | 2-Allylpent-4-enoic acid | ESD-847336-25MG |
Cas.: 99-67-2 | Purity: 95% | 2-Allylpent-4-enoic acid | ESD-847336-100MG |
Cas.: 1031927-02-2 | Purity: 97% | 4-(Imidazo[1,2-a]pyrazin-2-yl)-1,2,5-oxadiazol-3-amine | ESD-847337-25MG |
Cas.: 1031927-02-2 | Purity: 97% | 4-(Imidazo[1,2-a]pyrazin-2-yl)-1,2,5-oxadiazol-3-amine | ESD-847337-100MG |
Cas.: 222159-87-7 | Purity: 95% | 1-(5-Aminopentyl)-1H-pyrrole-2,5-dione 2,2,2-trifluoroacetate | ESD-847338-25MG |
Cas.: 222159-87-7 | Purity: 95% | 1-(5-Aminopentyl)-1H-pyrrole-2,5-dione 2,2,2-trifluoroacetate | ESD-847338-100MG |
Cas.: 288251-82-1 | Purity: 98% | 5-Amino-2-(4-methylpiperazin-1-yl)benzonitrile | ESD-847339-25MG |
Cas.: 288251-82-1 | Purity: 98% | 5-Amino-2-(4-methylpiperazin-1-yl)benzonitrile | ESD-847339-100MG |
Cas.: 173943-98-1 | Purity: 95% | Spiro[isochroman-1,4′-piperidine] hydrochloride | ESD-847340-25MG |
Cas.: 173943-98-1 | Purity: 95% | Spiro[isochroman-1,4′-piperidine] hydrochloride | ESD-847340-100MG |
Cas.: 945376-95-4 | Purity: 98% | 4-(3-Bromopyrazolo[1,5-a]pyrimidin-6-yl)phenol | ESD-847341-25MG |
Cas.: 945376-95-4 | Purity: 98% | 4-(3-Bromopyrazolo[1,5-a]pyrimidin-6-yl)phenol | ESD-847341-100MG |
Cas.: 1261504-50-0 | Purity: 97% | Methyl 2-hydroxy-6-nitrobenzoate | ESD-847342-25MG |
Cas.: 1261504-50-0 | Purity: 97% | Methyl 2-hydroxy-6-nitrobenzoate | ESD-847342-100MG |
Cas.: 865624-17-5 | Purity: 98% | 1-(Bromomethyl)-3-chloro-5-nitrobenzene | ESD-847343-25MG |
Cas.: 865624-17-5 | Purity: 98% | 1-(Bromomethyl)-3-chloro-5-nitrobenzene | ESD-847343-100MG |
Cas.: 1246549-62-1 | Purity: 98% | 7-Bromo-3-chloroquinoline | ESD-847344-25MG |
Cas.: 1246549-62-1 | Purity: 98% | 7-Bromo-3-chloroquinoline | ESD-847344-100MG |
Cas.: 4404-11-9 | Purity: 98% | 4-Chloro-1H-indole-2-carbonitrile | ESD-847345-25MG |
Cas.: 4404-11-9 | Purity: 98% | 4-Chloro-1H-indole-2-carbonitrile | ESD-847345-100MG |
Cas.: 181355-92-0 | Purity: 98% | 6-Chloro-4-iodo-3-methoxypyridazine | ESD-847346-25MG |
Cas.: 181355-92-0 | Purity: 98% | 6-Chloro-4-iodo-3-methoxypyridazine | ESD-847346-100MG |
Cas.: 122225-33-6 | Purity: 97% | (R)-2-Benzyl-4-(tert-butoxy)-4-oxobutanoic acid | ESD-847347-25MG |
Cas.: 122225-33-6 | Purity: 97% | (R)-2-Benzyl-4-(tert-butoxy)-4-oxobutanoic acid | ESD-847347-100MG |
Cas.: 1211516-25-4 | Purity: 97% | 6-Bromo-5-methylpicolinic acid | ESD-847348-25MG |
Cas.: 1211516-25-4 | Purity: 97% | 6-Bromo-5-methylpicolinic acid | ESD-847348-100MG |
Cas.: 99548-72-8 | Purity: 98% | 3-Bromo-2-ethylbenzoic acid | ESD-847349-25MG |
Cas.: 99548-72-8 | Purity: 98% | 3-Bromo-2-ethylbenzoic acid | ESD-847349-100MG |
Cas.: 445303-12-8 | Purity: 95% | 2-(2,3-Dihydrobenzofuran-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-847350-25MG |
Cas.: 445303-12-8 | Purity: 95% | 2-(2,3-Dihydrobenzofuran-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-847350-100MG |
Cas.: 182964-49-4 | Purity: 96% | 2-(1-Hydroxyethyl)benzonitrile | ESD-847351-25MG |
Cas.: 182964-49-4 | Purity: 96% | 2-(1-Hydroxyethyl)benzonitrile | ESD-847351-100MG |
Cas.: 1632285-93-8 | Purity: 97% | 2-(Bromomethyl)-3,5-dimethylpyridine hydrobromide | ESD-847352-25MG |
Cas.: 1632285-93-8 | Purity: 97% | 2-(Bromomethyl)-3,5-dimethylpyridine hydrobromide | ESD-847352-100MG |
Cas.: 69327-75-9 | Purity: 98% | 3-Isopropyl-2-(isopropylimino)-5-phenyl-1,3,5-thiadiazinan-4-one | ESD-847353-25MG |
Cas.: 69327-75-9 | Purity: 98% | 3-Isopropyl-2-(isopropylimino)-5-phenyl-1,3,5-thiadiazinan-4-one | ESD-847353-100MG |
Cas.: 1646152-53-5 | Purity: 95% | 4-(Indolin-5-yl)morpholine hydrochloride | ESD-847354-25MG |
Cas.: 1646152-53-5 | Purity: 95% | 4-(Indolin-5-yl)morpholine hydrochloride | ESD-847354-100MG |
Cas.: 1646152-48-8 | Purity: 97% | tert-Butylbis(oxazol-4-ylmethyl)carbamate | ESD-847355-25MG |
Cas.: 1646152-48-8 | Purity: 97% | tert-Butylbis(oxazol-4-ylmethyl)carbamate | ESD-847355-100MG |
Cas.: 1688656-70-3 | Purity: 95% | Bis((2-bromopyridin-4-yl)methyl)amine | ESD-847356-25MG |
Cas.: 1688656-70-3 | Purity: 95% | Bis((2-bromopyridin-4-yl)methyl)amine | ESD-847356-100MG |
Cas.: 1356114-40-3 | Purity: 98% | Azetidin-3-yl acetate 2,2,2-trifluoroacetate | ESD-847357-25MG |
Cas.: 1356114-40-3 | Purity: 98% | Azetidin-3-yl acetate 2,2,2-trifluoroacetate | ESD-847357-100MG |
Cas.: 137830-77-4 | Purity: 97% | 2-Methyl-1,2,6-thiadiazinane 1,1-dioxide | ESD-847358-25MG |
Cas.: 137830-77-4 | Purity: 97% | 2-Methyl-1,2,6-thiadiazinane 1,1-dioxide | ESD-847358-100MG |
Cas.: 1017782-45-4 | Purity: 98% | Methyl 3-(tert-butyl)-1H-pyrazole-4-carboxylate | ESD-847359-250MG |
Cas.: 1017782-45-4 | Purity: 98% | Methyl 3-(tert-butyl)-1H-pyrazole-4-carboxylate | ESD-847359-1G |
Cas.: 799293-83-7 | Purity: 97% | 3-Bromothieno[3,2-c]pyridin-4(5H)-one | ESD-847360-250MG |
Cas.: 799293-83-7 | Purity: 97% | 3-Bromothieno[3,2-c]pyridin-4(5H)-one | ESD-847360-1G |
Cas.: 86620-70-4 | Purity: 95% | 4-(Piperazin-1-ylmethyl)benzoic acid dihydrochloride | ESD-847361-250MG |
Cas.: 86620-70-4 | Purity: 95% | 4-(Piperazin-1-ylmethyl)benzoic acid dihydrochloride | ESD-847361-1G |
Cas.: 934481-43-3 | Purity: 95% | tert-Butyl 4-amino-3-methylbenzoate | ESD-847362-250MG |
Cas.: 934481-43-3 | Purity: 95% | tert-Butyl 4-amino-3-methylbenzoate | ESD-847362-1G |
Cas.: 112160-33-5 | Purity: 95% | Cyclohexanamine (S)-2-(((benzyloxy)carbonyl)amino)-5-(3-((2,2,5,7,8-pentamethylchroman-6-yl)sulfonyl)guanidino)pentanoate | ESD-847363-250MG |
Cas.: 112160-33-5 | Purity: 95% | Cyclohexanamine (S)-2-(((benzyloxy)carbonyl)amino)-5-(3-((2,2,5,7,8-pentamethylchroman-6-yl)sulfonyl)guanidino)pentanoate | ESD-847363-1G |
Cas.: 134419-43-5 | Purity: 95% | Methyl 5-bromo-2-hydroxy-3-methoxybenzoate | ESD-847364-250MG |
Cas.: 134419-43-5 | Purity: 95% | Methyl 5-bromo-2-hydroxy-3-methoxybenzoate | ESD-847364-1G |
Cas.: 904316-92-3 | Purity: 97% | 3-Oxa-8-azabicyclo[3.2.1]octane hydrochloride | ESD-847365-250MG |
Cas.: 904316-92-3 | Purity: 97% | 3-Oxa-8-azabicyclo[3.2.1]octane hydrochloride | ESD-847365-1G |
Cas.: 175791-53-4 | Purity: 98% | 5-Iodo-7H-pyrrolo[2,3-d]pyrimidine | ESD-847366-250MG |
Cas.: 175791-53-4 | Purity: 98% | 5-Iodo-7H-pyrrolo[2,3-d]pyrimidine | ESD-847366-1G |
Cas.: 62455-70-3 | Purity: 97% | 3-Cyclohexyl-3-oxopropanenitrile | ESD-847367-250MG |
Cas.: 62455-70-3 | Purity: 97% | 3-Cyclohexyl-3-oxopropanenitrile | ESD-847367-1G |
Cas.: 153898-63-6 | Purity: 97% | 2-Iodo-5-methoxyaniline | ESD-847368-250MG |
Cas.: 153898-63-6 | Purity: 97% | 2-Iodo-5-methoxyaniline | ESD-847368-1G |
Cas.: 856645-99-3 | Purity: 95% | (R)-1-(4-(Trifluoromethyl)phenyl)ethanamine hydrochloride | ESD-847369-50MG |
Cas.: 856645-99-3 | Purity: 95% | (R)-1-(4-(Trifluoromethyl)phenyl)ethanamine hydrochloride | ESD-847369-250MG |
Cas.: 60186-15-4 | Purity: 95% | 2,4-Difluoro-5-nitropyridine | ESD-847370-50MG |
Cas.: 60186-15-4 | Purity: 95% | 2,4-Difluoro-5-nitropyridine | ESD-847370-250MG |
Cas.: 1107694-84-7 | Purity: 97% | 2,8-Dichloroquinazolin-4-amine | ESD-847371-50MG |
Cas.: 1107694-84-7 | Purity: 97% | 2,8-Dichloroquinazolin-4-amine | ESD-847371-250MG |
Cas.: 78502-79-1 | Purity: 98% | 2-(Bromomethyl)-4-phenylthiazole | ESD-847372-50MG |
Cas.: 78502-79-1 | Purity: 98% | 2-(Bromomethyl)-4-phenylthiazole | ESD-847372-250MG |
Cas.: 67074-63-9 | Purity: 97% | 4-Methyl-3,4-dihydroquinoxalin-2(1H)-one | ESD-847374-25MG |
Cas.: 67074-63-9 | Purity: 97% | 4-Methyl-3,4-dihydroquinoxalin-2(1H)-one | ESD-847374-100MG |
Cas.: 910649-59-1 | Purity: 98% | 2-Chloro-5-methylpyridin-3-ol | ESD-847375-25MG |
Cas.: 910649-59-1 | Purity: 98% | 2-Chloro-5-methylpyridin-3-ol | ESD-847375-100MG |
Cas.: 1152475-42-7 | Purity: 95% | 7-Bromo-2-chlorothieno[3,2-d]pyrimidine | ESD-847376-25MG |
Cas.: 1152475-42-7 | Purity: 95% | 7-Bromo-2-chlorothieno[3,2-d]pyrimidine | ESD-847376-100MG |
Cas.: 1060816-22-9 | Purity: 97% | Ethyl 2-bromooxazole-5-carboxylate | ESD-847377-25MG |
Cas.: 1060816-22-9 | Purity: 97% | Ethyl 2-bromooxazole-5-carboxylate | ESD-847377-100MG |
Cas.: 1053655-76-7 | Purity: 97% | 3-Bromo-5-methoxy-1H-pyrrolo[2,3-b]pyridine | ESD-847378-25MG |
Cas.: 1053655-76-7 | Purity: 97% | 3-Bromo-5-methoxy-1H-pyrrolo[2,3-b]pyridine | ESD-847378-100MG |
Cas.: 69957-96-6 | Purity: 98% | (2-Chloro-4-methylphenyl)methanamine | ESD-847379-25MG |
Cas.: 69957-96-6 | Purity: 98% | (2-Chloro-4-methylphenyl)methanamine | ESD-847379-100MG |
Cas.: 32890-93-0 | Purity: 98% | 2,6-Dichloro-3-methoxybenzoic acid | ESD-847380-25MG |
Cas.: 32890-93-0 | Purity: 98% | 2,6-Dichloro-3-methoxybenzoic acid | ESD-847380-100MG |
Cas.: 201166-22-5 | Purity: 95% | 4-Isopropyl-2,2-dimethylbenzo[d][1,3]dioxole | ESD-847381-25MG |
Cas.: 201166-22-5 | Purity: 95% | 4-Isopropyl-2,2-dimethylbenzo[d][1,3]dioxole | ESD-847381-100MG |
Cas.: 893620-44-5 | Purity: 96% | 6-Bromo-5-fluoroindolin-2-one | ESD-847382-25MG |
Cas.: 893620-44-5 | Purity: 96% | 6-Bromo-5-fluoroindolin-2-one | ESD-847382-100MG |
Cas.: 686747-19-3 | Purity: 97% | Methyl 5-amino-1H-indole-3-carboxylate | ESD-847383-25MG |
Cas.: 686747-19-3 | Purity: 97% | Methyl 5-amino-1H-indole-3-carboxylate | ESD-847383-100MG |
Cas.: 885519-07-3 | Purity: 95% | 5-Bromo-1-methoxy-2-methyl-3-nitrobenzene | ESD-847384-25MG |
Cas.: 885519-07-3 | Purity: 95% | 5-Bromo-1-methoxy-2-methyl-3-nitrobenzene | ESD-847384-100MG |
Cas.: 64234-61-3 | Purity: 97% | (S)-3-Aminohexanoic acid hydrochloride | ESD-847385-25MG |
Cas.: 64234-61-3 | Purity: 97% | (S)-3-Aminohexanoic acid hydrochloride | ESD-847385-100MG |
Cas.: 166196-11-8 | Purity: 98% | 1-(2,6-Difluorobenzyl)-1H-1,2,3-triazole-4-carboxylic acid | ESD-847386-25MG |
Cas.: 166196-11-8 | Purity: 98% | 1-(2,6-Difluorobenzyl)-1H-1,2,3-triazole-4-carboxylic acid | ESD-847386-100MG |
Cas.: 24472-88-6 | Purity: 97% | N,N,N-Trimethyl-3-oxo-3-phenylpropan-1-aminium chloride | ESD-847387-25MG |
Cas.: 24472-88-6 | Purity: 97% | N,N,N-Trimethyl-3-oxo-3-phenylpropan-1-aminium chloride | ESD-847387-100MG |
Cas.: 183990-64-9 | Purity: 97% | Boc-β-HoVal-OH | ESD-847388-250MG |
Cas.: 183990-64-9 | Purity: 97% | Boc-β-HoVal-OH | ESD-847388-1G |
Cas.: 349480-74-6 | Purity: 98% | Imidazo[2,1-b]thiazol-6-ylmethanol | ESD-847389-250MG |
Cas.: 349480-74-6 | Purity: 98% | Imidazo[2,1-b]thiazol-6-ylmethanol | ESD-847389-1G |
Cas.: 113237-20-0 | Purity: 98% | 2,6-Dichloro-5-fluoronicotinamide | ESD-847390-250MG |
Cas.: 113237-20-0 | Purity: 98% | 2,6-Dichloro-5-fluoronicotinamide | ESD-847390-1G |
Cas.: 59194-26-2 | Purity: 97% | 5-Methoxy-2-(1H-pyrrol-1-yl)aniline | ESD-847391-250MG |
Cas.: 59194-26-2 | Purity: 97% | 5-Methoxy-2-(1H-pyrrol-1-yl)aniline | ESD-847391-1G |
Cas.: 942206-07-7 | Purity: 97% | 2-Bromo-5-iodo-4-methylpyridine | ESD-847392-250MG |
Cas.: 942206-07-7 | Purity: 97% | 2-Bromo-5-iodo-4-methylpyridine | ESD-847392-1G |
Cas.: 933-95-9 | Purity: 95% | 2-Amino-2-cyclopentylacetic acid | ESD-847393-250MG |
Cas.: 933-95-9 | Purity: 95% | 2-Amino-2-cyclopentylacetic acid | ESD-847393-1G |
Cas.: 695187-29-2 | Purity: 97% | 5-Chloro-2,4-difluorobenzaldehyde | ESD-847394-250MG |
Cas.: 695187-29-2 | Purity: 97% | 5-Chloro-2,4-difluorobenzaldehyde | ESD-847394-1G |
Cas.: 113770-21-1 | Purity: 97% | 7-Chloro-3,4-dihydro-2H-benzo[b][1,4]oxazine | ESD-847395-250MG |
Cas.: 113770-21-1 | Purity: 97% | 7-Chloro-3,4-dihydro-2H-benzo[b][1,4]oxazine | ESD-847395-1G |
Cas.: 877593-11-8 | Purity: 98% | tert-Butyl (3-(hydroxymethyl)pyridin-2-yl)carbamate | ESD-847396-250MG |
Cas.: 877593-11-8 | Purity: 98% | tert-Butyl (3-(hydroxymethyl)pyridin-2-yl)carbamate | ESD-847396-1G |
Cas.: 1979-96-0 | Purity: 98% | 4,6-Dichloro-2-(methylthio)-5-nitropyrimidine | ESD-847397-250MG |
Cas.: 1979-96-0 | Purity: 98% | 4,6-Dichloro-2-(methylthio)-5-nitropyrimidine | ESD-847397-1G |
Cas.: 5661-01-8 | Purity: 98% | 6,7-Dihydro-3H-cyclopenta[d]pyrimidin-4(5H)-one | ESD-847398-250MG |
Cas.: 5661-01-8 | Purity: 98% | 6,7-Dihydro-3H-cyclopenta[d]pyrimidin-4(5H)-one | ESD-847398-1G |
Cas.: 104992-55-4 | Purity: 97% | Bz-rA Phosphoramidite | ESD-847399-250MG |
Cas.: 104992-55-4 | Purity: 97% | Bz-rA Phosphoramidite | ESD-847399-1G |
Cas.: 3931-68-8 | Purity: 95% | 5-Chloroimidazo[1,2-a]pyridine hydrochloride | ESD-847400-250MG |
Cas.: 3931-68-8 | Purity: 95% | 5-Chloroimidazo[1,2-a]pyridine hydrochloride | ESD-847400-1G |
Cas.: 436095-30-6 | Purity: 95% | 1-[(2-Aminophenyl)sulfonyl]piperidine | ESD-847401-250MG |
Cas.: 436095-30-6 | Purity: 95% | 1-[(2-Aminophenyl)sulfonyl]piperidine | ESD-847401-1G |
Cas.: 105580-41-4 | Purity: 98% | tert-Butyl 4-acetylbenzoate | ESD-847402-250MG |
Cas.: 105580-41-4 | Purity: 98% | tert-Butyl 4-acetylbenzoate | ESD-847402-1G |
Cas.: 245124-17-8 | Purity: 95% | (4-Chloropyridin-3-yl)methanol hydrochloride | ESD-847403-250MG |
Cas.: 245124-17-8 | Purity: 95% | (4-Chloropyridin-3-yl)methanol hydrochloride | ESD-847403-1G |
Cas.: 155906-13-1 | Purity: 98% | 2,5-Difluoro-4-iodoaniline | ESD-847404-250MG |
Cas.: 155906-13-1 | Purity: 98% | 2,5-Difluoro-4-iodoaniline | ESD-847404-1G |
Cas.: 27883-60-9 | Purity: 97% | Methyl 4-hydroxy-5-methoxy-2-nitrobenzoate | ESD-847405-250MG |
Cas.: 27883-60-9 | Purity: 97% | Methyl 4-hydroxy-5-methoxy-2-nitrobenzoate | ESD-847405-1G |
Cas.: 623586-00-5 | Purity: 95% | (R)-Benzyl 3-methylpiperazine-1-carboxylate | ESD-847406-250MG |
Cas.: 623586-00-5 | Purity: 95% | (R)-Benzyl 3-methylpiperazine-1-carboxylate | ESD-847406-1G |
Cas.: 23814-14-4 | Purity: 98% | 2-Oxo-2,3-dihydro-1H-benzo[d]imidazole-5-carboxylic acid | ESD-847407-250MG |
Cas.: 23814-14-4 | Purity: 98% | 2-Oxo-2,3-dihydro-1H-benzo[d]imidazole-5-carboxylic acid | ESD-847407-1G |
Cas.: 1486-53-9 | Purity: 98% | 4-Benzyloxy-3-methoxybenzoicacid | ESD-847408-250MG |
Cas.: 1486-53-9 | Purity: 98% | 4-Benzyloxy-3-methoxybenzoicacid | ESD-847408-1G |
Cas.: 220141-70-8 | Purity: 95% | 5-Fluoro-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid hydrate | ESD-847409-1G |
Cas.: 220141-70-8 | Purity: 95% | 5-Fluoro-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid hydrate | ESD-847409-5G |
Cas.: 145821-59-6 | Purity: 98% | Tiagabine hydrochloride | ESD-847410-50MG |
Cas.: 145821-59-6 | Purity: 98% | Tiagabine hydrochloride | ESD-847410-250MG |
Cas.: 889944-76-7 | Purity: 95% | 6-Chloro-4-methylpyridine-3-sulfonyl chloride | ESD-847411-50MG |
Cas.: 889944-76-7 | Purity: 95% | 6-Chloro-4-methylpyridine-3-sulfonyl chloride | ESD-847411-250MG |
Cas.: 96600-76-9 | Purity: 95% | 4-Chloro-1-methyl-2-oxo-1,2-dihydroquinoline-3-carbaldehyde | ESD-847412-50MG |
Cas.: 96600-76-9 | Purity: 95% | 4-Chloro-1-methyl-2-oxo-1,2-dihydroquinoline-3-carbaldehyde | ESD-847412-250MG |
Cas.: 89284-39-9 | Purity: 97% | 4,5-Dichloropyridin-3-amine | ESD-847413-50MG |
Cas.: 89284-39-9 | Purity: 97% | 4,5-Dichloropyridin-3-amine | ESD-847413-250MG |
Cas.: 63894-67-7 | Purity: 98% | 4-(2-Chlorothieno[2,3-d]pyrimidin-4-yl)morpholine | ESD-847414-250MG |
Cas.: 63894-67-7 | Purity: 98% | 4-(2-Chlorothieno[2,3-d]pyrimidin-4-yl)morpholine | ESD-847414-1G |
Cas.: 215800-05-8 | Purity: 98% | 2-(4-Bromo-2-methylphenyl)acetonitrile | ESD-847415-250MG |
Cas.: 215800-05-8 | Purity: 98% | 2-(4-Bromo-2-methylphenyl)acetonitrile | ESD-847415-1G |
Cas.: 785777-98-2 | Purity: 97% | 2,5-Dichloro-4-(trifluoromethyl)pyrimidine | ESD-847416-50MG |
Cas.: 785777-98-2 | Purity: 97% | 2,5-Dichloro-4-(trifluoromethyl)pyrimidine | ESD-847416-250MG |
Cas.: 4018-65-9 | Purity: 95% | 3-Chlorobenzene-1,2-diol | ESD-847417-25MG |
Cas.: 4018-65-9 | Purity: 95% | 3-Chlorobenzene-1,2-diol | ESD-847417-100MG |
Cas.: 1201645-46-6 | Purity: 95% | N-(5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)acetamide | ESD-847418-25MG |
Cas.: 1201645-46-6 | Purity: 95% | N-(5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)acetamide | ESD-847418-100MG |
Cas.: 92406-53-6 | Purity: 95% | Methyl 5-amino-1-methyl-1H-pyrazole-3-carboxylate | ESD-847419-25MG |
Cas.: 92406-53-6 | Purity: 95% | Methyl 5-amino-1-methyl-1H-pyrazole-3-carboxylate | ESD-847419-100MG |
Cas.: 1234616-28-4 | Purity: 98% | 7-Bromo-1H-indazol-3-amine | ESD-847420-250MG |
Cas.: 1234616-28-4 | Purity: 98% | 7-Bromo-1H-indazol-3-amine | ESD-847420-1G |
Cas.: 40047-23-2 | Purity: 98% | 6-Hydroxyindole-2-carboxylic acid | ESD-847421-250MG |
Cas.: 40047-23-2 | Purity: 98% | 6-Hydroxyindole-2-carboxylic acid | ESD-847421-1G |
Cas.: 33471-40-8 | Purity: 97% | 4-Methylpyridazin-3(2H)-one | ESD-847422-250MG |
Cas.: 33471-40-8 | Purity: 97% | 4-Methylpyridazin-3(2H)-one | ESD-847422-1G |
Cas.: 901310-02-9 | Purity: 98% | 2-(2,6-Dibromophenyl)acetic acid | ESD-847423-250MG |
Cas.: 901310-02-9 | Purity: 98% | 2-(2,6-Dibromophenyl)acetic acid | ESD-847423-1G |
Cas.: 863785-96-0 | Purity: 97% | Methyl 4-oxo-1,4-dihydroquinoline-7-carboxylate | ESD-847424-50MG |
Cas.: 863785-96-0 | Purity: 97% | Methyl 4-oxo-1,4-dihydroquinoline-7-carboxylate | ESD-847424-250MG |
Cas.: 87199-83-5 | Purity: 97% | 7-Methoxyquinolin-3-amine | ESD-847425-25MG |
Cas.: 87199-83-5 | Purity: 97% | 7-Methoxyquinolin-3-amine | ESD-847425-100MG |
Cas.: 939986-65-9 | Purity: 97% | 6-Chloropyrimidine-4-carbonitrile | ESD-847426-25MG |
Cas.: 939986-65-9 | Purity: 97% | 6-Chloropyrimidine-4-carbonitrile | ESD-847426-100MG |
Cas.: 6652-06-8 | Purity: 97% | 4-(4-Chlorophenyl)piperidine hydrochloride | ESD-847427-250MG |
Cas.: 6652-06-8 | Purity: 97% | 4-(4-Chlorophenyl)piperidine hydrochloride | ESD-847427-1G |
Cas.: 124676-19-3 | Purity: 95% | 2-(1H-Benzo[d][1,2,3]triazol-1-yl)-2-(((benzyloxy)carbonyl)amino)acetic acid | ESD-847428-25MG |
Cas.: 124676-19-3 | Purity: 95% | 2-(1H-Benzo[d][1,2,3]triazol-1-yl)-2-(((benzyloxy)carbonyl)amino)acetic acid | ESD-847428-100MG |
Cas.: 103030-73-5 | Purity: 95% | 2-Amino-1,2,3,4-tetrahydronaphthalen-1-ol hydrochloride | ESD-847429-25MG |
Cas.: 103030-73-5 | Purity: 95% | 2-Amino-1,2,3,4-tetrahydronaphthalen-1-ol hydrochloride | ESD-847429-100MG |
Cas.: 773841-78-4 | Purity: 97% | Imidazo[2,1-b]thiazole-2-carboxylic acid | ESD-847430-25MG |
Cas.: 773841-78-4 | Purity: 97% | Imidazo[2,1-b]thiazole-2-carboxylic acid | ESD-847430-100MG |
Cas.: 947144-26-5 | Purity: 98% | 3-Nitro-6-(trifluoromethyl)pyridine-2,4-diol | ESD-847431-25MG |
Cas.: 947144-26-5 | Purity: 98% | 3-Nitro-6-(trifluoromethyl)pyridine-2,4-diol | ESD-847431-100MG |
Cas.: 139633-98-0 | Purity: 98% | (1-Ethynylcyclopropyl)benzene | ESD-847432-25MG |
Cas.: 139633-98-0 | Purity: 98% | (1-Ethynylcyclopropyl)benzene | ESD-847432-100MG |
Cas.: 1231930-33-8 | Purity: 95% | 6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole | ESD-847433-100MG |
Cas.: 1034737-23-9 | Purity: 95% | Methyl 2-amino-5-bromopyrimidine-4-carboxylate | ESD-847434-25MG |
Cas.: 1034737-23-9 | Purity: 95% | Methyl 2-amino-5-bromopyrimidine-4-carboxylate | ESD-847434-100MG |
Cas.: 950649-10-2 | Purity: 95% | N-(Piperidin-4-yl)pyrimidin-2-amine hydrochloride | ESD-847435-25MG |
Cas.: 950649-10-2 | Purity: 95% | N-(Piperidin-4-yl)pyrimidin-2-amine hydrochloride | ESD-847435-100MG |
Cas.: 269066-75-3 | Purity: 96% | 2-Bromo-1-naphthaldehyde | ESD-847436-25MG |
Cas.: 269066-75-3 | Purity: 96% | 2-Bromo-1-naphthaldehyde | ESD-847436-100MG |
Cas.: 2554-93-0 | Purity: 97% | 2-(Chloromethyl)piperidine hydrochloride | ESD-847437-25MG |
Cas.: 2554-93-0 | Purity: 97% | 2-(Chloromethyl)piperidine hydrochloride | ESD-847437-100MG |
Cas.: 34497-54-6 | Purity: 95% | 3-Hydroxy-2-methylquinolin-4(1H)-one | ESD-847438-25MG |
Cas.: 34497-54-6 | Purity: 95% | 3-Hydroxy-2-methylquinolin-4(1H)-one | ESD-847438-100MG |
Cas.: 917760-91-9 | Purity: 97% | 3-(5-Fluoropyridin-2-yl)acrylic acid hydrochloride | ESD-847439-25MG |
Cas.: 917760-91-9 | Purity: 97% | 3-(5-Fluoropyridin-2-yl)acrylic acid hydrochloride | ESD-847439-100MG |
Cas.: 1268444-68-3 | Purity: 97% | 1-(Pyridin-3-yl)cyclopropanecarboxylic acid hydrobromide | ESD-847440-25MG |
Cas.: 1268444-68-3 | Purity: 97% | 1-(Pyridin-3-yl)cyclopropanecarboxylic acid hydrobromide | ESD-847440-100MG |
Cas.: 267243-68-5 | Purity: 95% | N4-(3-Chloro-4-fluorophenyl)-7-(3-morpholinopropoxy)quinazoline-4,6-diamine | ESD-847441-25MG |
Cas.: 267243-68-5 | Purity: 95% | N4-(3-Chloro-4-fluorophenyl)-7-(3-morpholinopropoxy)quinazoline-4,6-diamine | ESD-847441-100MG |
Cas.: 868997-84-6 | Purity: 98% | 2-Butoxypyridin-4-amine | ESD-847442-25MG |
Cas.: 868997-84-6 | Purity: 98% | 2-Butoxypyridin-4-amine | ESD-847442-100MG |
Cas.: 1214377-45-3 | Purity: 96% | 2-Chloro-6-(difluoromethoxy)pyridine | ESD-847443-25MG |
Cas.: 1214377-45-3 | Purity: 96% | 2-Chloro-6-(difluoromethoxy)pyridine | ESD-847443-100MG |
Cas.: 1159813-33-8 | Purity: 98% | 1-(5-Hydroxypyrazin-2-yl)ethanone | ESD-847444-25MG |
Cas.: 1159813-33-8 | Purity: 98% | 1-(5-Hydroxypyrazin-2-yl)ethanone | ESD-847444-100MG |
Cas.: 205877-13-0 | Purity: 95% | (2-Amino-3-methoxyphenyl)methanol | ESD-847445-25MG |
Cas.: 205877-13-0 | Purity: 95% | (2-Amino-3-methoxyphenyl)methanol | ESD-847445-100MG |
Cas.: 811460-95-4 | Purity: 97% | 2-((tert-Butoxycarbonyl)amino)-2-cyclobutylacetic acid | ESD-847446-25MG |
Cas.: 811460-95-4 | Purity: 97% | 2-((tert-Butoxycarbonyl)amino)-2-cyclobutylacetic acid | ESD-847446-100MG |
Cas.: 1432678-91-5 | Purity: 97% | 2-Isopropylmorpholine hydrochloride | ESD-847447-25MG |
Cas.: 1432678-91-5 | Purity: 97% | 2-Isopropylmorpholine hydrochloride | ESD-847447-100MG |
Cas.: 1256820-00-4 | Purity: 98% | 2-Bromo-5-chloro-3-(trifluoromethyl)pyridine | ESD-847448-25MG |
Cas.: 1256820-00-4 | Purity: 98% | 2-Bromo-5-chloro-3-(trifluoromethyl)pyridine | ESD-847448-100MG |
Cas.: 1191908-38-9 | Purity: 97% | 6-Chloro-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-847449-25MG |
Cas.: 1191908-38-9 | Purity: 97% | 6-Chloro-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-847449-100MG |
Cas.: 1210734-76-1 | Purity: 97% | 4,6-Dichloroindoline hydrochloride | ESD-847450-25MG |
Cas.: 1210734-76-1 | Purity: 97% | 4,6-Dichloroindoline hydrochloride | ESD-847450-100MG |
Cas.: 134877-42-2 | Purity: 97% | ((2R,3R,5R)-3-(Benzoyloxy)-4,4-difluoro-5-((methylsulfonyl)oxy)tetrahydrofuran-2-yl)methyl benzoate | ESD-847451-25MG |
Cas.: 134877-42-2 | Purity: 97% | ((2R,3R,5R)-3-(Benzoyloxy)-4,4-difluoro-5-((methylsulfonyl)oxy)tetrahydrofuran-2-yl)methyl benzoate | ESD-847451-100MG |
Cas.: 173435-78-4 | Purity: 97% | 9-((tert-Butoxycarbonyl)amino)nonanoic acid | ESD-847452-250MG |
Cas.: 173435-78-4 | Purity: 97% | 9-((tert-Butoxycarbonyl)amino)nonanoic acid | ESD-847452-1G |
Cas.: 894769-77-8 | Purity: 97% | tert-Butyl 4-cyano-4-(4-fluorobenzyl)piperidine-1-carboxylate | ESD-847453-50MG |
Cas.: 894769-77-8 | Purity: 97% | tert-Butyl 4-cyano-4-(4-fluorobenzyl)piperidine-1-carboxylate | ESD-847453-250MG |
Cas.: 1078150-17-0 | Purity: 98% | 2-Bromo-6,7-dihydrothieno[3,2-c]pyridin-4(5H)-one | ESD-847454-50MG |
Cas.: 1078150-17-0 | Purity: 98% | 2-Bromo-6,7-dihydrothieno[3,2-c]pyridin-4(5H)-one | ESD-847454-250MG |
Cas.: 1192025-01-6 | Purity: 97% | 2-(3-Chloro-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-847455-50MG |
Cas.: 1192025-01-6 | Purity: 97% | 2-(3-Chloro-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-847455-250MG |
Cas.: 1227561-90-1 | Purity: 97% | 6-Bromo-5-chloropicolinaldehyde | ESD-847456-25MG |
Cas.: 1227561-90-1 | Purity: 97% | 6-Bromo-5-chloropicolinaldehyde | ESD-847456-100MG |
Cas.: 103347-14-4 | Purity: 98% | 4-(Bromomethyl)-1-chloro-2-methoxybenzene | ESD-847457-50MG |
Cas.: 103347-14-4 | Purity: 98% | 4-(Bromomethyl)-1-chloro-2-methoxybenzene | ESD-847457-250MG |
Cas.: 380-86-9 | Purity: 95% | 2,2-Difluoropentanedioic acid | ESD-847458-25MG |
Cas.: 380-86-9 | Purity: 95% | 2,2-Difluoropentanedioic acid | ESD-847458-100MG |
Cas.: 202282-59-5 | Purity: 95% | 2-((Bis(dimethylamino)methylene)amino)-1,3-dimethyl-4,5-dihydro-1H-imidazol-3-ium chloride | ESD-847459-25MG |
Cas.: 202282-59-5 | Purity: 95% | 2-((Bis(dimethylamino)methylene)amino)-1,3-dimethyl-4,5-dihydro-1H-imidazol-3-ium chloride | ESD-847459-100MG |
Cas.: 257892-43-6 | Purity: 95% | tert-Butyl (3-hydroxy-3-phenylpropyl)carbamate | ESD-847460-25MG |
Cas.: 257892-43-6 | Purity: 95% | tert-Butyl (3-hydroxy-3-phenylpropyl)carbamate | ESD-847460-100MG |
Cas.: 945655-38-9 | Purity: 95% | Ethyl 6-amino-2-phenyl-1H-indole-3-carboxylate | ESD-847461-25MG |
Cas.: 945655-38-9 | Purity: 95% | Ethyl 6-amino-2-phenyl-1H-indole-3-carboxylate | ESD-847461-100MG |
Cas.: 1201784-84-0 | Purity: 98% | 5-Bromopyridine-2,4-diamine | ESD-847462-25MG |
Cas.: 1201784-84-0 | Purity: 98% | 5-Bromopyridine-2,4-diamine | ESD-847462-100MG |
Cas.: 170235-18-4 | Purity: 95% | Methyl 6-bromo-5-methoxypicolinate | ESD-847463-25MG |
Cas.: 170235-18-4 | Purity: 95% | Methyl 6-bromo-5-methoxypicolinate | ESD-847463-100MG |
Cas.: 1355174-78-5 | Purity: 97% | Methyl 5-bromoquinoline-2-carboxylate | ESD-847464-25MG |
Cas.: 1355174-78-5 | Purity: 97% | Methyl 5-bromoquinoline-2-carboxylate | ESD-847464-100MG |
Cas.: 934-26-9 | Purity: 95% | 6-Chloro-3-hydrazinylpyridazin-4-amine | ESD-847465-25MG |
Cas.: 934-26-9 | Purity: 95% | 6-Chloro-3-hydrazinylpyridazin-4-amine | ESD-847465-100MG |
Cas.: 476622-89-6 | Purity: 98% | 5-Bromo-2-iodo-3-methoxypyrazine | ESD-847466-25MG |
Cas.: 476622-89-6 | Purity: 98% | 5-Bromo-2-iodo-3-methoxypyrazine | ESD-847466-100MG |
Cas.: 1211590-24-7 | Purity: 97% | 4-Bromo-5-fluoro-2-methylpyridine | ESD-847467-25MG |
Cas.: 1211590-24-7 | Purity: 97% | 4-Bromo-5-fluoro-2-methylpyridine | ESD-847467-100MG |
Cas.: 131666-74-5 | Purity: 97% | Methyl 2-(1H-indazol-3-yl)acetate | ESD-847468-25MG |
Cas.: 131666-74-5 | Purity: 97% | Methyl 2-(1H-indazol-3-yl)acetate | ESD-847468-100MG |
Cas.: 50371-68-1 | Purity: 98% | 4,5-Dichloro-1H-pyrrole-2-carboxamide | ESD-847469-25MG |
Cas.: 50371-68-1 | Purity: 98% | 4,5-Dichloro-1H-pyrrole-2-carboxamide | ESD-847469-100MG |
Cas.: 70384-83-7 | Purity: 98% | Ethyl 5-chloro-2-oxo-2H-chromene-3-carboxylate | ESD-847470-25MG |
Cas.: 70384-83-7 | Purity: 98% | Ethyl 5-chloro-2-oxo-2H-chromene-3-carboxylate | ESD-847470-100MG |
Cas.: 952138-13-5 | Purity: 97% | 4,7-Dichloro-1,6-naphthyridine | ESD-847471-25MG |
Cas.: 952138-13-5 | Purity: 97% | 4,7-Dichloro-1,6-naphthyridine | ESD-847471-100MG |
Cas.: 87864-14-0 | Purity: 98% | 2-Chloro-N-(2-(diethylamino)ethyl)quinoline-4-carboxamide | ESD-847472-250MG |
Cas.: 87864-14-0 | Purity: 98% | 2-Chloro-N-(2-(diethylamino)ethyl)quinoline-4-carboxamide | ESD-847472-1G |
Cas.: 211308-82-6 | Purity: 98% | 3-Iodo-5-(trifluoromethyl)pyridin-2-amine | ESD-847473-250MG |
Cas.: 211308-82-6 | Purity: 98% | 3-Iodo-5-(trifluoromethyl)pyridin-2-amine | ESD-847473-1G |
Cas.: 802325-29-7 | Purity: 98% | (5-Fluoropyridin-2-yl)methanol | ESD-847474-250MG |
Cas.: 802325-29-7 | Purity: 98% | (5-Fluoropyridin-2-yl)methanol | ESD-847474-1G |
Cas.: 1220630-83-0 | Purity: 98% | 3-Amino-4-(trifluoromethyl)benzonitrile | ESD-847475-250MG |
Cas.: 1220630-83-0 | Purity: 98% | 3-Amino-4-(trifluoromethyl)benzonitrile | ESD-847475-1G |
Cas.: 343-69-1 | Purity: 98% | 6-Trifluoromethylisatin | ESD-847476-250MG |
Cas.: 343-69-1 | Purity: 98% | 6-Trifluoromethylisatin | ESD-847476-1G |
Cas.: 3929-30-4 | Purity: 95% | 4-(4-Fluorophenyl)piperidin-4-ol hydrochloride | ESD-847477-250MG |
Cas.: 3929-30-4 | Purity: 95% | 4-(4-Fluorophenyl)piperidin-4-ol hydrochloride | ESD-847477-1G |
Cas.: 1217603-41-2 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-hydroxy-3-methylbutanoic acid | ESD-847478-50MG |
Cas.: 1217603-41-2 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-hydroxy-3-methylbutanoic acid | ESD-847478-250MG |
Cas.: 912361-56-9 | Purity: 98% | 2-(Adamantan-1-yl)-1H-pyrrole | ESD-847479-25MG |
Cas.: 912361-56-9 | Purity: 98% | 2-(Adamantan-1-yl)-1H-pyrrole | ESD-847479-100MG |
Cas.: 875515-76-7 | Purity: 96% | 4-Chlorothieno[3,2-d]pyrimidine-6-carboxylic acid | ESD-847480-25MG |
Cas.: 875515-76-7 | Purity: 96% | 4-Chlorothieno[3,2-d]pyrimidine-6-carboxylic acid | ESD-847480-100MG |
Cas.: 878650-31-8 | Purity: 98% | Methyl 2,6-dichloro-5-methoxypyrimidine-4-carboxylate | ESD-847481-25MG |
Cas.: 878650-31-8 | Purity: 98% | Methyl 2,6-dichloro-5-methoxypyrimidine-4-carboxylate | ESD-847481-100MG |
Cas.: 120758-03-4 | Purity: 98% | 2-Chloro-3,5-dimethoxyaniline | ESD-847482-25MG |
Cas.: 120758-03-4 | Purity: 98% | 2-Chloro-3,5-dimethoxyaniline | ESD-847482-100MG |
Cas.: 35715-72-1 | Purity: 97% | 4-(Chloromethyl)-1-(2-fluorophenyl)-1H-pyrazole | ESD-847483-25MG |
Cas.: 35715-72-1 | Purity: 97% | 4-(Chloromethyl)-1-(2-fluorophenyl)-1H-pyrazole | ESD-847483-100MG |
Cas.: 313340-08-8 | Purity: 98% | 3,5-Dichloro-6-ethylpyrazine-2-carboxamide | ESD-847484-25MG |
Cas.: 313340-08-8 | Purity: 98% | 3,5-Dichloro-6-ethylpyrazine-2-carboxamide | ESD-847484-100MG |
Cas.: 1303968-37-7 | Purity: 97% | 2,2-Dimethylpiperidin-4-one hydrochloride | ESD-847485-25MG |
Cas.: 1303968-37-7 | Purity: 97% | 2,2-Dimethylpiperidin-4-one hydrochloride | ESD-847485-100MG |
Cas.: 1624261-87-5 | Purity: 95% | tert-Butyl 1-(aminomethyl)-6-azaspiro[2.5]octane-6-carboxylate hydrochloride | ESD-847486-25MG |
Cas.: 1624261-87-5 | Purity: 95% | tert-Butyl 1-(aminomethyl)-6-azaspiro[2.5]octane-6-carboxylate hydrochloride | ESD-847486-100MG |
Cas.: 1207625-23-7 | Purity: 95% | 5-Bromo-6-chloro-3-iodopyridin-2-amine | ESD-847487-25MG |
Cas.: 1207625-23-7 | Purity: 95% | 5-Bromo-6-chloro-3-iodopyridin-2-amine | ESD-847487-100MG |
Cas.: 1229784-79-5 | Purity: 98% | 5,7-Difluoro-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-847488-25MG |
Cas.: 1229784-79-5 | Purity: 98% | 5,7-Difluoro-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-847488-100MG |
Cas.: 124289-22-1 | Purity: 95% | 3-Methyl-5-nitrobenzonitrile | ESD-847489-250MG |
Cas.: 124289-22-1 | Purity: 95% | 3-Methyl-5-nitrobenzonitrile | ESD-847489-1G |
Cas.: 1458-16-8 | Purity: 95% | Methyl 3-amino-6-iodopyrazine-2-carboxylate | ESD-847490-250MG |
Cas.: 1458-16-8 | Purity: 95% | Methyl 3-amino-6-iodopyrazine-2-carboxylate | ESD-847490-1G |
Cas.: 127918-92-7 | Purity: 95% | Methyl 2-amino-5-(4-chlorophenyl)thiazole-4-carboxylate | ESD-847491-250MG |
Cas.: 127918-92-7 | Purity: 95% | Methyl 2-amino-5-(4-chlorophenyl)thiazole-4-carboxylate | ESD-847491-1G |
Cas.: 5802-17-5 | Purity: 98% | 6-Methoxychroman-4-one | ESD-847492-250MG |
Cas.: 5802-17-5 | Purity: 98% | 6-Methoxychroman-4-one | ESD-847492-1G |
Cas.: 3438-61-7 | Purity: 97% | 5-Amino-4-methylpyrimidine | ESD-847493-250MG |
Cas.: 3438-61-7 | Purity: 97% | 5-Amino-4-methylpyrimidine | ESD-847493-1G |
Cas.: 7469-77-4 | Purity: 98% | 2-Methyl-1-naphthol | ESD-847494-250MG |
Cas.: 7469-77-4 | Purity: 98% | 2-Methyl-1-naphthol | ESD-847494-1G |
Cas.: 5043-81-2 | Purity: 98% | Methyl 3-amino-5-chloro-2-hydroxybenzoate | ESD-847495-250MG |
Cas.: 5043-81-2 | Purity: 98% | Methyl 3-amino-5-chloro-2-hydroxybenzoate | ESD-847495-1G |
Cas.: 63131-30-6 | Purity: 97% | Ethyl 3-(4-iodophenyl)-3-oxopropanoate | ESD-847496-250MG |
Cas.: 63131-30-6 | Purity: 97% | Ethyl 3-(4-iodophenyl)-3-oxopropanoate | ESD-847496-1G |
Cas.: 20721-17-9 | Purity: 98% | 5-Methylpyrazin-2(1H)-one | ESD-847497-250MG |
Cas.: 20721-17-9 | Purity: 98% | 5-Methylpyrazin-2(1H)-one | ESD-847497-1G |
Cas.: 1044767-99-8 | Purity: 98% | 5-Bromo-4-chloropyrimidin-2-amine | ESD-847498-250MG |
Cas.: 1044767-99-8 | Purity: 98% | 5-Bromo-4-chloropyrimidin-2-amine | ESD-847498-1G |
Cas.: 1245645-77-5 | Purity: 95% | Ethyl 5-ethyl-1,2,4-oxadiazole-3-carboxylate | ESD-847499-250MG |
Cas.: 1245645-77-5 | Purity: 95% | Ethyl 5-ethyl-1,2,4-oxadiazole-3-carboxylate | ESD-847499-1G |
Cas.: 800402-06-6 | Purity: 98% | 6-Chloro-3-iodopyridin-2-amine | ESD-847500-250MG |
Cas.: 800402-06-6 | Purity: 98% | 6-Chloro-3-iodopyridin-2-amine | ESD-847500-1G |
Cas.: 791846-40-7 | Purity: 95% | tert-Butyl 4-(4-bromo-2-cyanophenyl)piperazine-1-carboxylate | ESD-847501-250MG |
Cas.: 791846-40-7 | Purity: 95% | tert-Butyl 4-(4-bromo-2-cyanophenyl)piperazine-1-carboxylate | ESD-847501-1G |
Cas.: 27116-93-4 | Purity: 95% | Methyl 4-amino-1H-pyrazole-5-carboxylate hydrochloride | ESD-847502-250MG |
Cas.: 27116-93-4 | Purity: 95% | Methyl 4-amino-1H-pyrazole-5-carboxylate hydrochloride | ESD-847502-1G |
Cas.: 1105187-42-5 | Purity: 98% | tert-Butyl 2-amino-5H-pyrrolo[3,4-d]pyrimidine-6(7H)-carboxylate | ESD-847503-250MG |
Cas.: 1105187-42-5 | Purity: 98% | tert-Butyl 2-amino-5H-pyrrolo[3,4-d]pyrimidine-6(7H)-carboxylate | ESD-847503-1G |
Cas.: 38275-61-5 | Purity: 95% | 5-Chloropyrimidine-2-carboxylic acid | ESD-847504-250MG |
Cas.: 38275-61-5 | Purity: 95% | 5-Chloropyrimidine-2-carboxylic acid | ESD-847504-1G |
Cas.: 954238-81-4 | Purity: 97% | tert-Butyl (2-amino-3-chlorophenyl)carbamate | ESD-847505-250MG |
Cas.: 954238-81-4 | Purity: 97% | tert-Butyl (2-amino-3-chlorophenyl)carbamate | ESD-847505-1G |
Cas.: 22918-03-2 | Purity: 98% | 4-Chloro-2-iodopyridine | ESD-847506-250MG |
Cas.: 22918-03-2 | Purity: 98% | 4-Chloro-2-iodopyridine | ESD-847506-1G |
Cas.: 504414-32-8 | Purity: 98% | 4-(Benzyloxy)-2-fluorobenzaldehyde | ESD-847507-250MG |
Cas.: 504414-32-8 | Purity: 98% | 4-(Benzyloxy)-2-fluorobenzaldehyde | ESD-847507-1G |
Cas.: 31686-94-9 | Purity: 98% | Ethyl 4-(4-fluorophenyl)-2,4-dioxobutanoate | ESD-847508-250MG |
Cas.: 31686-94-9 | Purity: 98% | Ethyl 4-(4-fluorophenyl)-2,4-dioxobutanoate | ESD-847508-1G |
Cas.: 37631-92-8 | Purity: 95% | 2-(1-Aminocyclohexyl)acetic acid | ESD-847509-250MG |
Cas.: 37631-92-8 | Purity: 95% | 2-(1-Aminocyclohexyl)acetic acid | ESD-847509-1G |
Cas.: 261951-88-6 | Purity: 98% | (4-Methoxy-3-(trifluoromethyl)phenyl)methanol | ESD-847510-250MG |
Cas.: 261951-88-6 | Purity: 98% | (4-Methoxy-3-(trifluoromethyl)phenyl)methanol | ESD-847510-1G |
Cas.: 1220039-56-4 | Purity: 95% | N-Methylpiperidin-4-amine dihydrochloride | ESD-847511-250MG |
Cas.: 1220039-56-4 | Purity: 95% | N-Methylpiperidin-4-amine dihydrochloride | ESD-847511-1G |
Cas.: 55928-86-4 | Purity: 98% | 3,4,6-Tribromopyridazine | ESD-847512-250MG |
Cas.: 55928-86-4 | Purity: 98% | 3,4,6-Tribromopyridazine | ESD-847512-1G |
Cas.: 129798-91-0 | Purity: 97% | Ethyl piperazine-2-carboxylate dihydrochloride | ESD-847513-250MG |
Cas.: 129798-91-0 | Purity: 97% | Ethyl piperazine-2-carboxylate dihydrochloride | ESD-847513-1G |
Cas.: 1677-79-8 | Purity: 95% | 4-Chloropyridazin-3-ol | ESD-847514-250MG |
Cas.: 1677-79-8 | Purity: 95% | 4-Chloropyridazin-3-ol | ESD-847514-1G |
Cas.: 828243-30-7 | Purity: 98% | 3-(1-(tert-Butoxycarbonyl)piperidin-4-yl)benzoic acid | ESD-847515-250MG |
Cas.: 828243-30-7 | Purity: 98% | 3-(1-(tert-Butoxycarbonyl)piperidin-4-yl)benzoic acid | ESD-847515-1G |
Cas.: 124668-49-1 | Purity: 97% | N,N-Dimethylazetidin-3-amine dihydrochloride | ESD-847516-250MG |
Cas.: 124668-49-1 | Purity: 97% | N,N-Dimethylazetidin-3-amine dihydrochloride | ESD-847516-1G |
Cas.: 428871-64-1 | Purity: 97% | 4-Chloro-5-fluoro-2-nitroaniline | ESD-847517-250MG |
Cas.: 428871-64-1 | Purity: 97% | 4-Chloro-5-fluoro-2-nitroaniline | ESD-847517-1G |
Cas.: 259231-26-0 | Purity: 98% | 2-Bromo-4-(bromomethyl)-1-methylbenzene | ESD-847518-250MG |
Cas.: 259231-26-0 | Purity: 98% | 2-Bromo-4-(bromomethyl)-1-methylbenzene | ESD-847518-1G |
Cas.: 53631-13-3 | Purity: 97% | 2-Bromo-1-(3,5-dichlorophenyl)ethanone | ESD-847519-250MG |
Cas.: 53631-13-3 | Purity: 97% | 2-Bromo-1-(3,5-dichlorophenyl)ethanone | ESD-847519-1G |
Cas.: 627463-25-6 | Purity: 98% | 4-Bromo-2-ethyl-1-fluorobenzene | ESD-847520-250MG |
Cas.: 627463-25-6 | Purity: 98% | 4-Bromo-2-ethyl-1-fluorobenzene | ESD-847520-1G |
Cas.: 887268-25-9 | Purity: 95% | 2-Bromo-4-methyl-1-(trifluoromethoxy)benzene | ESD-847521-250MG |
Cas.: 887268-25-9 | Purity: 95% | 2-Bromo-4-methyl-1-(trifluoromethoxy)benzene | ESD-847521-1G |
Cas.: 52950-37-5 | Purity: 97% | (S)-4-Amino-3-phenylbutanoic acid hydrochloride | ESD-847522-250MG |
Cas.: 52950-37-5 | Purity: 97% | (S)-4-Amino-3-phenylbutanoic acid hydrochloride | ESD-847522-1G |
Cas.: 529512-79-6 | Purity: 98% | (2-Chloro-6-fluorophenyl)hydrazine hydrochloride | ESD-847523-250MG |
Cas.: 529512-79-6 | Purity: 98% | (2-Chloro-6-fluorophenyl)hydrazine hydrochloride | ESD-847523-1G |
Cas.: 99186-63-7 | Purity: 97% | Ethyl 2-(2-hydroxyphenoxy)acetate | ESD-847524-250MG |
Cas.: 99186-63-7 | Purity: 97% | Ethyl 2-(2-hydroxyphenoxy)acetate | ESD-847524-1G |
Cas.: 5211-02-9 | Purity: 98% | 3-Chloro-4-ethoxyaniline | ESD-847525-250MG |
Cas.: 5211-02-9 | Purity: 98% | 3-Chloro-4-ethoxyaniline | ESD-847525-1G |
Cas.: 32996-27-3 | Purity: 95% | 5-Methyl-6-nitrobenzo[d][1,3]dioxole | ESD-847526-250MG |
Cas.: 32996-27-3 | Purity: 95% | 5-Methyl-6-nitrobenzo[d][1,3]dioxole | ESD-847526-1G |
Cas.: 71042-72-3 | Purity: 97% | Ethyl 7-methyl-2,3-dihydro-1H-indene-4-carboxylate | ESD-847527-250MG |
Cas.: 71042-72-3 | Purity: 97% | Ethyl 7-methyl-2,3-dihydro-1H-indene-4-carboxylate | ESD-847527-1G |
Cas.: 1205744-55-3 | Purity: 97% | 6-Iodoimidazo[1,2-a]pyridine hydrochloride | ESD-847528-250MG |
Cas.: 1205744-55-3 | Purity: 97% | 6-Iodoimidazo[1,2-a]pyridine hydrochloride | ESD-847528-1G |
Cas.: 19985-09-2 | Purity: 95% | 1-Isopropyl-pyrrolidin-3-ylamine dihydrochloride | ESD-847529-250MG |
Cas.: 19985-09-2 | Purity: 95% | 1-Isopropyl-pyrrolidin-3-ylamine dihydrochloride | ESD-847529-1G |
Cas.: 186046-78-6 | Purity: 98% | 2-(4-(((Benzhydryloxy)carbonyl)amino)-2-oxopyrimdin-1(2H)-yl)acetic acid | ESD-847530-250MG |
Cas.: 186046-78-6 | Purity: 98% | 2-(4-(((Benzhydryloxy)carbonyl)amino)-2-oxopyrimdin-1(2H)-yl)acetic acid | ESD-847530-1G |
Cas.: 1885-32-1 | Purity: 96% | 2-Amino-3-methylbenzamide | ESD-847531-250MG |
Cas.: 1885-32-1 | Purity: 96% | 2-Amino-3-methylbenzamide | ESD-847531-1G |
Cas.: 70484-01-4 | Purity: 98% | 4-Bromophthalonitrile | ESD-847532-250MG |
Cas.: 70484-01-4 | Purity: 98% | 4-Bromophthalonitrile | ESD-847532-1G |
Cas.: 757978-33-9 | Purity: 97% | 5-Bromo-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde | ESD-847533-250MG |
Cas.: 757978-33-9 | Purity: 97% | 5-Bromo-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde | ESD-847533-1G |
Cas.: 232600-78-1 | Purity: 95% | Pyrazolo[1,5-a]pyrimidin-3-amine hydrochloride | ESD-847534-50MG |
Cas.: 232600-78-1 | Purity: 95% | Pyrazolo[1,5-a]pyrimidin-3-amine hydrochloride | ESD-847534-250MG |
Cas.: 1114830-16-8 | Purity: 98% | tert-Butyl 2-(5-bromopyrimidin-2-yl)acetate | ESD-847535-50MG |
Cas.: 1114830-16-8 | Purity: 98% | tert-Butyl 2-(5-bromopyrimidin-2-yl)acetate | ESD-847535-250MG |
Cas.: 38275-50-2 | Purity: 95% | 2-(Methylsulfonyl)pyrimidine-5-carbonitrile | ESD-847536-50MG |
Cas.: 38275-50-2 | Purity: 95% | 2-(Methylsulfonyl)pyrimidine-5-carbonitrile | ESD-847536-250MG |
Cas.: 71082-51-4 | Purity: 97% | 7-(Trifluoromethyl)quinoline-3-carboxylic acid | ESD-847537-25MG |
Cas.: 71082-51-4 | Purity: 97% | 7-(Trifluoromethyl)quinoline-3-carboxylic acid | ESD-847537-100MG |
Cas.: 1243389-57-2 | Purity: 97% | 6-Bromo-3-chlorobenzo[d]isoxazole | ESD-847538-25MG |
Cas.: 1243389-57-2 | Purity: 97% | 6-Bromo-3-chlorobenzo[d]isoxazole | ESD-847538-100MG |
Cas.: 853029-93-3 | Purity: 95% | 2-Bromo-6-methoxyisonicotinic acid | ESD-847539-25MG |
Cas.: 853029-93-3 | Purity: 95% | 2-Bromo-6-methoxyisonicotinic acid | ESD-847539-100MG |
Cas.: 1187933-30-7 | Purity: 95% | 6-Bromoindoline hydrochloride | ESD-847540-250MG |
Cas.: 1187933-30-7 | Purity: 95% | 6-Bromoindoline hydrochloride | ESD-847540-1G |
Cas.: 1243288-53-0 | Purity: 98% | 5-Bromo-1-methyl-1H-pyrazin-2-one | ESD-847541-250MG |
Cas.: 1243288-53-0 | Purity: 98% | 5-Bromo-1-methyl-1H-pyrazin-2-one | ESD-847541-1G |
Cas.: 773140-43-5 | Purity: 97% | Ethyl 4-aminopicolinate | ESD-847542-250MG |
Cas.: 773140-43-5 | Purity: 97% | Ethyl 4-aminopicolinate | ESD-847542-1G |
Cas.: 28165-45-9 | Purity: 98% | Methyl 3-bromo-2-hydroxybenzoate | ESD-847543-250MG |
Cas.: 28165-45-9 | Purity: 98% | Methyl 3-bromo-2-hydroxybenzoate | ESD-847543-1G |
Cas.: 13238-99-8 | Purity: 95% | 4-(1-Aminopropan-2-yl)phenol hydrochloride | ESD-847544-25MG |
Cas.: 13238-99-8 | Purity: 95% | 4-(1-Aminopropan-2-yl)phenol hydrochloride | ESD-847544-100MG |
Cas.: 39513-54-7 | Purity: 97% | Pyrimidine-4-carbohydrazide | ESD-847545-250MG |
Cas.: 39513-54-7 | Purity: 97% | Pyrimidine-4-carbohydrazide | ESD-847545-1G |
Cas.: 1167055-73-3 | Purity: 97% | 2-Bromooxazole-4-carboxylic acid | ESD-847546-50MG |
Cas.: 1167055-73-3 | Purity: 97% | 2-Bromooxazole-4-carboxylic acid | ESD-847546-250MG |
Cas.: 1260860-32-9 | Purity: 95% | 7-Bromobenzo[d]isoxazol-3-amine | ESD-847547-25MG |
Cas.: 1260860-32-9 | Purity: 95% | 7-Bromobenzo[d]isoxazol-3-amine | ESD-847547-100MG |
Cas.: 58481-17-7 | Purity: 97% | Methyl 2-(hydroxymethyl)isonicotinate | ESD-847548-25MG |
Cas.: 58481-17-7 | Purity: 97% | Methyl 2-(hydroxymethyl)isonicotinate | ESD-847548-100MG |
Cas.: 164738-44-7 | Purity: 98% | 2-Methoxypyrimidine-4-carbaldehyde | ESD-847549-25MG |
Cas.: 164738-44-7 | Purity: 98% | 2-Methoxypyrimidine-4-carbaldehyde | ESD-847549-100MG |
Cas.: 15366-32-2 | Purity: 95% | Ethyl 2-(1-methylguanidino)acetate hydrochloride | ESD-847550-100MG |
Cas.: 783335-58-0 | Purity: 97% | 6-Bromo-2,3-dihydro-1H-indene-1-carbonitrile | ESD-847552-25MG |
Cas.: 783335-58-0 | Purity: 97% | 6-Bromo-2,3-dihydro-1H-indene-1-carbonitrile | ESD-847552-100MG |
Cas.: 147071-00-9 | Purity: 97% | Methyl 1H-pyrrolo[2,3-c]pyridine-5-carboxylate | ESD-847553-25MG |
Cas.: 147071-00-9 | Purity: 97% | Methyl 1H-pyrrolo[2,3-c]pyridine-5-carboxylate | ESD-847553-100MG |
Cas.: 769916-07-6 | Purity: 97% | 6-Bromoquinazoline-4-carboxylic acid | ESD-847554-25MG |
Cas.: 769916-07-6 | Purity: 97% | 6-Bromoquinazoline-4-carboxylic acid | ESD-847554-100MG |
Cas.: 17322-91-7 | Purity: 95% | 1H-Pyrrolo[3,2-b]pyridin-5(4H)-one | ESD-847555-25MG |
Cas.: 17322-91-7 | Purity: 95% | 1H-Pyrrolo[3,2-b]pyridin-5(4H)-one | ESD-847555-100MG |
Cas.: 27582-24-7 | Purity: 96% | 5-Methyl-1H-imidazo[4,5-b]pyridine | ESD-847556-25MG |
Cas.: 27582-24-7 | Purity: 96% | 5-Methyl-1H-imidazo[4,5-b]pyridine | ESD-847556-100MG |
Cas.: 54376-50-0 | Purity: 98% | 5-Fluoro-2-methylpyrimidine | ESD-847557-25MG |
Cas.: 54376-50-0 | Purity: 98% | 5-Fluoro-2-methylpyrimidine | ESD-847557-100MG |
Cas.: 80304-42-3 | Purity: 97% | 1,5-Dimethyl-1H-imidazole-4-carboxylic acid | ESD-847558-25MG |
Cas.: 80304-42-3 | Purity: 97% | 1,5-Dimethyl-1H-imidazole-4-carboxylic acid | ESD-847558-100MG |
Cas.: 87597-21-5 | Purity: 95% | Ethyl 6,8-dibromoimidazo[1,2-a]pyrazine-2-carboxylate | ESD-847559-25MG |
Cas.: 87597-21-5 | Purity: 95% | Ethyl 6,8-dibromoimidazo[1,2-a]pyrazine-2-carboxylate | ESD-847559-100MG |
Cas.: 89202-89-1 | Purity: 95% | 1,4-Dimethyl-1H-pyrazole-3-carboxylic acid | ESD-847560-25MG |
Cas.: 89202-89-1 | Purity: 95% | 1,4-Dimethyl-1H-pyrazole-3-carboxylic acid | ESD-847560-100MG |
Cas.: 1016641-53-4 | Purity: 98% | 3-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazol-2(3H)-one | ESD-847561-25MG |
Cas.: 1016641-53-4 | Purity: 98% | 3-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazol-2(3H)-one | ESD-847561-100MG |
Cas.: 85979-59-5 | Purity: 97% | 2-Chloro-4-(4-fluoro-phenyl)-pyrimidine | ESD-847562-25MG |
Cas.: 85979-59-5 | Purity: 97% | 2-Chloro-4-(4-fluoro-phenyl)-pyrimidine | ESD-847562-100MG |
Cas.: 53090-46-3 | Purity: 97% | Ethyl 3-oxo-3-(thiophen-3-yl)propanoate | ESD-847563-25MG |
Cas.: 53090-46-3 | Purity: 97% | Ethyl 3-oxo-3-(thiophen-3-yl)propanoate | ESD-847563-100MG |
Cas.: 5949-24-6 | Purity: 97% | Cinnoline hydrochloride | ESD-847564-25MG |
Cas.: 5949-24-6 | Purity: 97% | Cinnoline hydrochloride | ESD-847564-100MG |
Cas.: 916737-77-4 | Purity: 98% | 6-Bromo-3-methoxypyridin-2-amine | ESD-847565-25MG |
Cas.: 916737-77-4 | Purity: 98% | 6-Bromo-3-methoxypyridin-2-amine | ESD-847565-100MG |
Cas.: 37760-98-8 | Purity: 97% | (S)-Methyl 2-amino-2-phenylacetate | ESD-847566-25MG |
Cas.: 37760-98-8 | Purity: 97% | (S)-Methyl 2-amino-2-phenylacetate | ESD-847566-100MG |
Cas.: 916210-93-0 | Purity: 97% | (S)-5-Bromo-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-847567-25MG |
Cas.: 916210-93-0 | Purity: 97% | (S)-5-Bromo-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-847567-100MG |
Cas.: 137778-18-8 | Purity: 98% | 5-Bromo-6-methylpicolinaldehyde | ESD-847568-25MG |
Cas.: 137778-18-8 | Purity: 98% | 5-Bromo-6-methylpicolinaldehyde | ESD-847568-100MG |
Cas.: 431-23-2 | Purity: 98% | 3,3,3-Trifluoro-2-methylpropan-1-ol | ESD-847569-25MG |
Cas.: 431-23-2 | Purity: 98% | 3,3,3-Trifluoro-2-methylpropan-1-ol | ESD-847569-100MG |
Cas.: 1033203-44-9 | Purity: 95% | 2-Bromo-4-chloro-5-fluoropyridine | ESD-847570-25MG |
Cas.: 1033203-44-9 | Purity: 95% | 2-Bromo-4-chloro-5-fluoropyridine | ESD-847570-100MG |
Cas.: 77513-58-7 | Purity: 98% | Ethyl 2-oxotetrahydrofuran-3-carboxylate | ESD-847571-25MG |
Cas.: 77513-58-7 | Purity: 98% | Ethyl 2-oxotetrahydrofuran-3-carboxylate | ESD-847571-100MG |
Cas.: 948573-55-5 | Purity: 98% | 4-Oxo-1,4-dihydroquinoline-7-carboxylic acid | ESD-847572-25MG |
Cas.: 948573-55-5 | Purity: 98% | 4-Oxo-1,4-dihydroquinoline-7-carboxylic acid | ESD-847572-100MG |
Cas.: 944401-58-5 | Purity: 98% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)pyrimidin-2-amine | ESD-847573-25MG |
Cas.: 944401-58-5 | Purity: 98% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)pyrimidin-2-amine | ESD-847573-100MG |
Cas.: 1328882-30-9 | Purity: 98% | (2-Cyano-4-methylphenyl)boronic acid | ESD-847574-25MG |
Cas.: 1328882-30-9 | Purity: 98% | (2-Cyano-4-methylphenyl)boronic acid | ESD-847574-100MG |
Cas.: 90086-41-2 | Purity: 97% | 1-(4-Iodophenyl)ethanamine | ESD-847575-25MG |
Cas.: 90086-41-2 | Purity: 97% | 1-(4-Iodophenyl)ethanamine | ESD-847575-100MG |
Cas.: 113210-35-8 | Purity: 95% | Methyl 2-((4-hydroxyphenyl)amino)acetate hydrochloride | ESD-847576-100MG |
Cas.: 1357945-24-4 | Purity: 95% | (6-Chloropyrazin-2-yl)methanamine hydrochloride | ESD-847577-25MG |
Cas.: 1357945-24-4 | Purity: 95% | (6-Chloropyrazin-2-yl)methanamine hydrochloride | ESD-847577-100MG |
Cas.: 784193-37-9 | Purity: 97% | 3-Bromo-4-nitro-1H-pyrazole | ESD-847578-25MG |
Cas.: 784193-37-9 | Purity: 97% | 3-Bromo-4-nitro-1H-pyrazole | ESD-847578-100MG |
Cas.: 339531-77-0 | Purity: 98% | 2-Amino-6-methoxyphenol hydrochloride | ESD-847579-25MG |
Cas.: 339531-77-0 | Purity: 98% | 2-Amino-6-methoxyphenol hydrochloride | ESD-847579-100MG |
Cas.: 34260-72-5 | Purity: 97% | (S)-Methyl 2-amino-3-(3-hydroxyphenyl)propanoate hydrochloride | ESD-847580-25MG |
Cas.: 34260-72-5 | Purity: 97% | (S)-Methyl 2-amino-3-(3-hydroxyphenyl)propanoate hydrochloride | ESD-847580-100MG |
Cas.: 1314977-20-2 | Purity: 98% | (2-Amino-4-(trifluoromethyl)thiazol-5-yl)methanol | ESD-847582-25MG |
Cas.: 1314977-20-2 | Purity: 98% | (2-Amino-4-(trifluoromethyl)thiazol-5-yl)methanol | ESD-847582-100MG |
Cas.: 1479085-67-0 | Purity: 97% | (4-Nitro-1H-pyrazol-5-yl)methanol | ESD-847583-25MG |
Cas.: 1479085-67-0 | Purity: 97% | (4-Nitro-1H-pyrazol-5-yl)methanol | ESD-847583-100MG |
Cas.: 1588441-22-8 | Purity: 95% | 2,2,2-Trifluoro-1-(pyridin-3-yl)ethanone hydrochloride | ESD-847584-25MG |
Cas.: 1588441-22-8 | Purity: 95% | 2,2,2-Trifluoro-1-(pyridin-3-yl)ethanone hydrochloride | ESD-847584-100MG |
Cas.: 896155-81-0 | Purity: 98% | 2-(Benzyloxy)-4-iodopyridine | ESD-847585-25MG |
Cas.: 896155-81-0 | Purity: 98% | 2-(Benzyloxy)-4-iodopyridine | ESD-847585-100MG |
Cas.: 1352625-33-2 | Purity: 98% | 4-Fluoropyrazolo[1,5-a]pyridine-3-carboxylic acid | ESD-847586-25MG |
Cas.: 1352625-33-2 | Purity: 98% | 4-Fluoropyrazolo[1,5-a]pyridine-3-carboxylic acid | ESD-847586-100MG |
Cas.: 18133-18-1 | Purity: 97% | 5-Oxo-1-phenylpyrrolidine-2-carboxylic acid | ESD-847587-25MG |
Cas.: 18133-18-1 | Purity: 97% | 5-Oxo-1-phenylpyrrolidine-2-carboxylic acid | ESD-847587-100MG |
Cas.: 27957-91-1 | Purity: 97% | (S)-Methyl 1-methylpyrrolidine-2-carboxylate | ESD-847588-25MG |
Cas.: 27957-91-1 | Purity: 97% | (S)-Methyl 1-methylpyrrolidine-2-carboxylate | ESD-847588-100MG |
Cas.: 1609396-24-8 | Purity: 95% | 2-(Chloromethyl)isonicotinonitrile hydrochloride | ESD-847589-25MG |
Cas.: 1609396-24-8 | Purity: 95% | 2-(Chloromethyl)isonicotinonitrile hydrochloride | ESD-847589-100MG |
Cas.: 113602-62-3 | Purity: 95% | Methyl 3-hydroxy-1-methyl-1H-pyrrole-2-carboxylate | ESD-847590-25MG |
Cas.: 113602-62-3 | Purity: 95% | Methyl 3-hydroxy-1-methyl-1H-pyrrole-2-carboxylate | ESD-847590-100MG |
Cas.: 1807542-78-4 | Purity: 97% | 2-Chloro-4-methoxythieno[3,2-d]pyrimidine | ESD-847591-25MG |
Cas.: 1807542-78-4 | Purity: 97% | 2-Chloro-4-methoxythieno[3,2-d]pyrimidine | ESD-847591-100MG |
Cas.: 151509-01-2 | Purity: 97% | Methyl 2-(aminomethyl)nicotinate hydrochloride | ESD-847592-25MG |
Cas.: 151509-01-2 | Purity: 97% | Methyl 2-(aminomethyl)nicotinate hydrochloride | ESD-847592-100MG |
Cas.: 3970-51-2 | Purity: 97% | 5-Chloro-1H-indene | ESD-847593-25MG |
Cas.: 3970-51-2 | Purity: 97% | 5-Chloro-1H-indene | ESD-847593-100MG |
Cas.: 1616370-88-7 | Purity: 97% | 2-(Piperidin-4-yl)phenol hydrochloride | ESD-847594-25MG |
Cas.: 1616370-88-7 | Purity: 97% | 2-(Piperidin-4-yl)phenol hydrochloride | ESD-847594-100MG |
Cas.: 619-22-7 | Purity: 97% | 3-(Dimethylamino)benzaldehyde | ESD-847595-25MG |
Cas.: 619-22-7 | Purity: 97% | 3-(Dimethylamino)benzaldehyde | ESD-847595-100MG |
Cas.: 135481-57-1 | Purity: 97% | 6-Benzyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine-2,4(1H,3H)-dione | ESD-847596-250MG |
Cas.: 135481-57-1 | Purity: 97% | 6-Benzyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine-2,4(1H,3H)-dione | ESD-847596-1G |
Cas.: 144744-41-2 | Purity: 97% | (R)-2-Amino-2-(4-fluorophenyl)acetic acid hydrochloride | ESD-847597-250MG |
Cas.: 144744-41-2 | Purity: 97% | (R)-2-Amino-2-(4-fluorophenyl)acetic acid hydrochloride | ESD-847597-1G |
Cas.: 1185155-89-8 | Purity: 97% | Ethyl 2-(2,4-dichlorophenyl)thiazole-4-carboxylate | ESD-847598-250MG |
Cas.: 1185155-89-8 | Purity: 97% | Ethyl 2-(2,4-dichlorophenyl)thiazole-4-carboxylate | ESD-847598-1G |
Cas.: 158429-38-0 | Purity: 98% | (4-(Methoxycarbonyl)-2-methylphenyl)boronic acid | ESD-847599-250MG |
Cas.: 158429-38-0 | Purity: 98% | (4-(Methoxycarbonyl)-2-methylphenyl)boronic acid | ESD-847599-1G |
Cas.: 84000-12-4 | Purity: 95% | Fmoc-N-Me-L-Met-OH | ESD-847600-250MG |
Cas.: 84000-12-4 | Purity: 95% | Fmoc-N-Me-L-Met-OH | ESD-847600-1G |
Cas.: 177420-64-3 | Purity: 97% | 2-Bromo-6-(trifluoromethyl)benzoic acid | ESD-847601-250MG |
Cas.: 177420-64-3 | Purity: 97% | 2-Bromo-6-(trifluoromethyl)benzoic acid | ESD-847601-1G |
Cas.: 887268-22-6 | Purity: 95% | 2-Bromo-1-fluoro-4-(methoxymethyl)benzene | ESD-847602-250MG |
Cas.: 887268-22-6 | Purity: 95% | 2-Bromo-1-fluoro-4-(methoxymethyl)benzene | ESD-847602-1G |
Cas.: 340771-31-5 | Purity: 98% | 1-Ethynyl-4-(methylsulfonyl)benzene | ESD-847603-25MG |
Cas.: 340771-31-5 | Purity: 98% | 1-Ethynyl-4-(methylsulfonyl)benzene | ESD-847603-100MG |
Cas.: 65515-33-5 | Purity: 95% | 6-Chloro-2-methoxynicotinic acid | ESD-847604-25MG |
Cas.: 65515-33-5 | Purity: 95% | 6-Chloro-2-methoxynicotinic acid | ESD-847604-100MG |
Cas.: 617689-07-3 | Purity: 97% | (5-Methoxy-2-methylphenyl)boronic acid | ESD-847605-25MG |
Cas.: 617689-07-3 | Purity: 97% | (5-Methoxy-2-methylphenyl)boronic acid | ESD-847605-100MG |
Cas.: 98203-04-4 | Purity: 95% | 6-Bromo-5-nitroquinoline | ESD-847606-250MG |
Cas.: 98203-04-4 | Purity: 95% | 6-Bromo-5-nitroquinoline | ESD-847606-1G |
Cas.: 96166-00-6 | Purity: 95% | 5-(Benzyloxy)pyridin-2-amine | ESD-847607-250MG |
Cas.: 96166-00-6 | Purity: 95% | 5-(Benzyloxy)pyridin-2-amine | ESD-847607-1G |
Cas.: 117499-16-8 | Purity: 97% | Di-tert-butyl (azanediylbis(ethane-2,1-diyl))dicarbamate | ESD-847608-250MG |
Cas.: 117499-16-8 | Purity: 97% | Di-tert-butyl (azanediylbis(ethane-2,1-diyl))dicarbamate | ESD-847608-1G |
Cas.: 16328-62-4 | Purity: 97% | 1H-Imidazo[4,5-b]pyridin-2(3H)-one | ESD-847609-250MG |
Cas.: 16328-62-4 | Purity: 97% | 1H-Imidazo[4,5-b]pyridin-2(3H)-one | ESD-847609-1G |
Cas.: 872602-74-9 | Purity: 98% | 6-Cyanopicolinic acid | ESD-847610-50MG |
Cas.: 872602-74-9 | Purity: 98% | 6-Cyanopicolinic acid | ESD-847610-250MG |
Cas.: 192799-05-6 | Purity: 97% | 6-Bromo-5-chloroindoline-2,3-dione | ESD-847611-25MG |
Cas.: 192799-05-6 | Purity: 97% | 6-Bromo-5-chloroindoline-2,3-dione | ESD-847611-100MG |
Cas.: 122833-58-3 | Purity: 95% | N,N’-((1R,2R)-cyclohexane-1,2-diyl)dimethanesulfonamide | ESD-847612-25MG |
Cas.: 122833-58-3 | Purity: 95% | N,N’-((1R,2R)-cyclohexane-1,2-diyl)dimethanesulfonamide | ESD-847612-100MG |
Cas.: 375857-62-8 | Purity: 98% | 3-Bromo-7-methylimidazo[1,2-a]pyrimidine | ESD-847613-25MG |
Cas.: 375857-62-8 | Purity: 98% | 3-Bromo-7-methylimidazo[1,2-a]pyrimidine | ESD-847613-100MG |
Cas.: 280110-69-2 | Purity: 97% | 1-Boc-4-(5-Methyl-1,3,4-oxadiazol-2-yl)piperidine | ESD-847614-25MG |
Cas.: 280110-69-2 | Purity: 97% | 1-Boc-4-(5-Methyl-1,3,4-oxadiazol-2-yl)piperidine | ESD-847614-100MG |
Cas.: 1245646-55-2 | Purity: 95% | (4,6-Dichloropyrimidin-5-yl)(4-methoxyphenyl)methanone | ESD-847615-25MG |
Cas.: 1245646-55-2 | Purity: 95% | (4,6-Dichloropyrimidin-5-yl)(4-methoxyphenyl)methanone | ESD-847615-100MG |
Cas.: 173471-71-1 | Purity: 97% | 6-(Dimethylamino)-2-naphthaldehyde | ESD-847616-25MG |
Cas.: 173471-71-1 | Purity: 97% | 6-(Dimethylamino)-2-naphthaldehyde | ESD-847616-100MG |
Cas.: 744219-32-7 | Purity: 95% | 1-Boc-4-(3-Iodo-1H-indazol-4-yl)piperazine | ESD-847617-25MG |
Cas.: 744219-32-7 | Purity: 95% | 1-Boc-4-(3-Iodo-1H-indazol-4-yl)piperazine | ESD-847617-100MG |
Cas.: 1251033-27-8 | Purity: 97% | 3-Bromo-1H-pyrazolo[3,4-d]pyrimidine | ESD-847618-25MG |
Cas.: 1251033-27-8 | Purity: 97% | 3-Bromo-1H-pyrazolo[3,4-d]pyrimidine | ESD-847618-100MG |
Cas.: 149765-15-1 | Purity: 95% | N-(4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-2-yl)-2,2-dimethylpropionamide | ESD-847619-25MG |
Cas.: 149765-15-1 | Purity: 95% | N-(4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-2-yl)-2,2-dimethylpropionamide | ESD-847619-100MG |
Cas.: 913179-36-9 | Purity: 95% | 5′-Fluorospiro[cyclopropane-1,3′-indoline] | ESD-847620-25MG |
Cas.: 913179-36-9 | Purity: 95% | 5′-Fluorospiro[cyclopropane-1,3′-indoline] | ESD-847620-100MG |
Cas.: 1000342-68-6 | Purity: 98% | 4-Bromo-1H-pyrrolo[3,2-c]pyridine | ESD-847621-25MG |
Cas.: 1000342-68-6 | Purity: 98% | 4-Bromo-1H-pyrrolo[3,2-c]pyridine | ESD-847621-100MG |
Cas.: 1017273-59-4 | Purity: 98% | 3-Methylimidazo[2,1-b]thiazole-2-carboxylic acid | ESD-847622-25MG |
Cas.: 1017273-59-4 | Purity: 98% | 3-Methylimidazo[2,1-b]thiazole-2-carboxylic acid | ESD-847622-100MG |
Cas.: 474538-99-3 | Purity: 95% | 1′-Benzylspiro[indoline-3,4′-piperidine] | ESD-847623-25MG |
Cas.: 474538-99-3 | Purity: 95% | 1′-Benzylspiro[indoline-3,4′-piperidine] | ESD-847623-100MG |
Cas.: 868594-48-3 | Purity: 98% | 1-Phenyl-2,5,8,11,14,17,20,23,26-nonaoxaoctacosan-28-ol | ESD-847624-25MG |
Cas.: 868594-48-3 | Purity: 98% | 1-Phenyl-2,5,8,11,14,17,20,23,26-nonaoxaoctacosan-28-ol | ESD-847624-100MG |
Cas.: 681249-57-0 | Purity: 95% | 2-(Trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4]triazolo[1,5-a]pyrazine | ESD-847625-25MG |
Cas.: 681249-57-0 | Purity: 95% | 2-(Trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4]triazolo[1,5-a]pyrazine | ESD-847625-100MG |
Cas.: 550364-01-7 | Purity: 95% | 3-(2H-1,2,3-Triazol-4-yl)benzonitrile | ESD-847626-25MG |
Cas.: 550364-01-7 | Purity: 95% | 3-(2H-1,2,3-Triazol-4-yl)benzonitrile | ESD-847626-100MG |
Cas.: 89717-64-6 | Purity: 98% | 4-Bromo-3-nitro-1H-pyrazole | ESD-847627-250MG |
Cas.: 89717-64-6 | Purity: 98% | 4-Bromo-3-nitro-1H-pyrazole | ESD-847627-1G |
Cas.: 887267-38-1 | Purity: 98% | 3-Chloro-2,4-difluorobenzonitrile | ESD-847628-250MG |
Cas.: 887267-38-1 | Purity: 98% | 3-Chloro-2,4-difluorobenzonitrile | ESD-847628-1G |
Cas.: 260057-49-6 | Purity: 95% | (3-Chlorobenzyl)hydrazine hydrochloride | ESD-847629-250MG |
Cas.: 260057-49-6 | Purity: 95% | (3-Chlorobenzyl)hydrazine hydrochloride | ESD-847629-1G |
Cas.: 1273-82-1 | Purity: 97% | Aminoferrocene | ESD-847630-25MG |
Cas.: 1273-82-1 | Purity: 97% | Aminoferrocene | ESD-847630-100MG |
Cas.: 32493-79-1 | Purity: 97% | 2,3-Dichloro-5,6-dimethylpyrazine | ESD-847631-25MG |
Cas.: 32493-79-1 | Purity: 97% | 2,3-Dichloro-5,6-dimethylpyrazine | ESD-847631-100MG |
Cas.: 1260790-53-1 | Purity: 98% | 2-Amino-4,6-difluorobenzaldehyde | ESD-847632-25MG |
Cas.: 1260790-53-1 | Purity: 98% | 2-Amino-4,6-difluorobenzaldehyde | ESD-847632-100MG |
Cas.: 956605-97-3 | Purity: 95% | (S)-1,3′-Bipyrrolidine dihydrochloride | ESD-847633-25MG |
Cas.: 956605-97-3 | Purity: 95% | (S)-1,3′-Bipyrrolidine dihydrochloride | ESD-847633-100MG |
Cas.: 175277-48-2 | Purity: 95% | 5-(Trifluoromethyl)picolinimidamide hydrochloride | ESD-847634-250MG |
Cas.: 175277-48-2 | Purity: 95% | 5-(Trifluoromethyl)picolinimidamide hydrochloride | ESD-847634-1G |
Cas.: 41110-29-6 | Purity: 97% | Methyl 3-methylpyrazine-2-carboxylate | ESD-847635-250MG |
Cas.: 41110-29-6 | Purity: 97% | Methyl 3-methylpyrazine-2-carboxylate | ESD-847635-1G |
Cas.: 1620-55-9 | Purity: 95% | 1-Phenyl-2-(pyridin-4-yl)ethanone | ESD-847636-250MG |
Cas.: 1620-55-9 | Purity: 95% | 1-Phenyl-2-(pyridin-4-yl)ethanone | ESD-847636-1G |
Cas.: 112257-20-2 | Purity: 98% | 1-Cbz-3-Aminoazetidine | ESD-847637-250MG |
Cas.: 112257-20-2 | Purity: 98% | 1-Cbz-3-Aminoazetidine | ESD-847637-1G |
Cas.: 675-11-6 | Purity: 96% | 4,6-Difluoropyrimidin-2-amine | ESD-847638-250MG |
Cas.: 675-11-6 | Purity: 96% | 4,6-Difluoropyrimidin-2-amine | ESD-847638-1G |
Cas.: 201937-23-7 | Purity: 95% | 6-Chloronicotimidamide hydrochloride | ESD-847639-25MG |
Cas.: 201937-23-7 | Purity: 95% | 6-Chloronicotimidamide hydrochloride | ESD-847639-100MG |
Cas.: 884660-48-4 | Purity: 95% | 6-Fluoro-5-iodopyridin-2-ol | ESD-847640-25MG |
Cas.: 884660-48-4 | Purity: 95% | 6-Fluoro-5-iodopyridin-2-ol | ESD-847640-100MG |
Cas.: 205393-21-1 | Purity: 97% | Bortezomib intermediates II | ESD-847641-25MG |
Cas.: 205393-21-1 | Purity: 97% | Bortezomib intermediates II | ESD-847641-100MG |
Cas.: 81246-34-6 | Purity: 97% | 5-Nitro-1H-imidazole-4-carbaldehyde | ESD-847642-25MG |
Cas.: 81246-34-6 | Purity: 97% | 5-Nitro-1H-imidazole-4-carbaldehyde | ESD-847642-100MG |
Cas.: 108605-62-5 | Purity: 97% | 2-Cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)but-2-enamide | ESD-847643-25MG |
Cas.: 108605-62-5 | Purity: 97% | 2-Cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)but-2-enamide | ESD-847643-100MG |
Cas.: 200204-85-9 | Purity: 97% | Ethyl 2-(5-bromobenzofuran-3-yl)acetate | ESD-847644-25MG |
Cas.: 200204-85-9 | Purity: 97% | Ethyl 2-(5-bromobenzofuran-3-yl)acetate | ESD-847644-100MG |
Cas.: 401567-43-9 | Purity: 97% | 5-Bromo-3-chlorobenzo[d]isoxazole | ESD-847645-25MG |
Cas.: 401567-43-9 | Purity: 97% | 5-Bromo-3-chlorobenzo[d]isoxazole | ESD-847645-100MG |
Cas.: 886047-45-6 | Purity: 97% | 2,5-Dichloro-6-methoxy-4-methylnicotinonitrile | ESD-847646-25MG |
Cas.: 886047-45-6 | Purity: 97% | 2,5-Dichloro-6-methoxy-4-methylnicotinonitrile | ESD-847646-100MG |
Cas.: 1245645-37-7 | Purity: 97% | cis-tert-Butyl 6-acetyl-3-azabicyclo[3.1.0]hexane-3-carboxylate | ESD-847647-25MG |
Cas.: 1245645-37-7 | Purity: 97% | cis-tert-Butyl 6-acetyl-3-azabicyclo[3.1.0]hexane-3-carboxylate | ESD-847647-100MG |
Cas.: 1211584-06-3 | Purity: 98% | 3-Chloro-2-methoxyisonicotinic acid | ESD-847648-25MG |
Cas.: 1211584-06-3 | Purity: 98% | 3-Chloro-2-methoxyisonicotinic acid | ESD-847648-100MG |
Cas.: 93035-02-0 | Purity: 98% | 3-Ethylpyrazin-2-amine | ESD-847649-25MG |
Cas.: 93035-02-0 | Purity: 98% | 3-Ethylpyrazin-2-amine | ESD-847649-100MG |
Cas.: 39860-12-3 | Purity: 97% | 1,5-Dimethyl-1H-benzo[d]imidazol-2-amine | ESD-847650-25MG |
Cas.: 39860-12-3 | Purity: 97% | 1,5-Dimethyl-1H-benzo[d]imidazol-2-amine | ESD-847650-100MG |
Cas.: 1263284-26-9 | Purity: 98% | 1,2,3,4-Tetrahydrocyclopenta[b]indol-2-amine | ESD-847651-25MG |
Cas.: 1263284-26-9 | Purity: 98% | 1,2,3,4-Tetrahydrocyclopenta[b]indol-2-amine | ESD-847651-100MG |
Cas.: 1173206-71-7 | Purity: 97% | tert-Butyl 3-(aminomethyl)azetidine-1-carboxylate hydrochloride | ESD-847652-25MG |
Cas.: 1173206-71-7 | Purity: 97% | tert-Butyl 3-(aminomethyl)azetidine-1-carboxylate hydrochloride | ESD-847652-100MG |
Cas.: 57631-11-5 | Purity: 98% | 5-Bromo-3-(trifluoromethyl)-1H-indazole | ESD-847653-25MG |
Cas.: 57631-11-5 | Purity: 98% | 5-Bromo-3-(trifluoromethyl)-1H-indazole | ESD-847653-100MG |
Cas.: 666841-74-3 | Purity: 95% | 3-(2-Methoxyphenyl)thiophene-2-carboxylic acid | ESD-847654-25MG |
Cas.: 666841-74-3 | Purity: 95% | 3-(2-Methoxyphenyl)thiophene-2-carboxylic acid | ESD-847654-100MG |
Cas.: 885520-03-6 | Purity: 97% | 5-Cyano-1H-indazole-3-carboxylic acid | ESD-847655-25MG |
Cas.: 885520-03-6 | Purity: 97% | 5-Cyano-1H-indazole-3-carboxylic acid | ESD-847655-100MG |
Cas.: 165947-52-4 | Purity: 98% | tert-Butyl 4,5-dihydrothieno[2,3-c]pyridine-6(7H)-carboxylate | ESD-847656-25MG |
Cas.: 165947-52-4 | Purity: 98% | tert-Butyl 4,5-dihydrothieno[2,3-c]pyridine-6(7H)-carboxylate | ESD-847656-100MG |
Cas.: 1242156-59-7 | Purity: 98% | 6-(tert-Butyl)-8-fluorophthalazin-1(2H)-one | ESD-847657-25MG |
Cas.: 1242156-59-7 | Purity: 98% | 6-(tert-Butyl)-8-fluorophthalazin-1(2H)-one | ESD-847657-100MG |
Cas.: 346593-03-1 | Purity: 98% | tert-Butyl 2,2-dimethyl-4-oxopiperidine-1-carboxylate | ESD-847658-25MG |
Cas.: 346593-03-1 | Purity: 98% | tert-Butyl 2,2-dimethyl-4-oxopiperidine-1-carboxylate | ESD-847658-100MG |
Cas.: 53975-70-5 | Purity: 98% | 1H-Pyrazolo[3,4-c]pyridin-3(2H)-one | ESD-847659-25MG |
Cas.: 53975-70-5 | Purity: 98% | 1H-Pyrazolo[3,4-c]pyridin-3(2H)-one | ESD-847659-100MG |
Cas.: 956460-98-3 | Purity: 95% | Ethyl 4-((tert-butoxycarbonyl)amino)piperidine-4-carboxylate | ESD-847660-25MG |
Cas.: 956460-98-3 | Purity: 95% | Ethyl 4-((tert-butoxycarbonyl)amino)piperidine-4-carboxylate | ESD-847660-100MG |
Cas.: 123320-44-5 | Purity: 98% | (3-(Benzyloxy)isoxazol-5-yl)methanol | ESD-847661-25MG |
Cas.: 123320-44-5 | Purity: 98% | (3-(Benzyloxy)isoxazol-5-yl)methanol | ESD-847661-100MG |
Cas.: 139183-91-8 | Purity: 95% | Methyl 5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-6-carboxylate | ESD-847662-25MG |
Cas.: 139183-91-8 | Purity: 95% | Methyl 5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-6-carboxylate | ESD-847662-100MG |
Cas.: 36650-75-6 | Purity: 97% | 4-Chloro-1H-pyrazole-5-carbonitrile | ESD-847663-25MG |
Cas.: 36650-75-6 | Purity: 97% | 4-Chloro-1H-pyrazole-5-carbonitrile | ESD-847663-100MG |
Cas.: 1159011-01-4 | Purity: 95% | 2-Methyl-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridine hydrochloride | ESD-847664-25MG |
Cas.: 1159011-01-4 | Purity: 95% | 2-Methyl-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridine hydrochloride | ESD-847664-100MG |
Cas.: 1355066-78-2 | Purity: 98% | 6-Chloro-8-methoxyquinoline | ESD-847665-25MG |
Cas.: 1355066-78-2 | Purity: 98% | 6-Chloro-8-methoxyquinoline | ESD-847665-100MG |
Cas.: 1196146-35-6 | Purity: 97% | Ethyl 4-chloro-6-(trifluoromethyl)nicotinate | ESD-847666-25MG |
Cas.: 1196146-35-6 | Purity: 97% | Ethyl 4-chloro-6-(trifluoromethyl)nicotinate | ESD-847666-100MG |
Cas.: 72695-20-6 | Purity: 95% | Isoindolin-4-ol hydrochloride | ESD-847667-25MG |
Cas.: 72695-20-6 | Purity: 95% | Isoindolin-4-ol hydrochloride | ESD-847667-100MG |
Cas.: 1227593-86-3 | Purity: 98% | 3-Chloro-2-methoxy-5-methylpyridine | ESD-847668-25MG |
Cas.: 1227593-86-3 | Purity: 98% | 3-Chloro-2-methoxy-5-methylpyridine | ESD-847668-100MG |
Cas.: 1588480-39-0 | Purity: 95% | (R)-1-Benzyl-2-methylpiperazine hydrochloride | ESD-847669-25MG |
Cas.: 1588480-39-0 | Purity: 95% | (R)-1-Benzyl-2-methylpiperazine hydrochloride | ESD-847669-100MG |
Cas.: 112822-82-9 | Purity: 95% | 1-Bromo-2,4,5-trifluoro-3-methylbenzene | ESD-847670-25MG |
Cas.: 112822-82-9 | Purity: 95% | 1-Bromo-2,4,5-trifluoro-3-methylbenzene | ESD-847670-100MG |
Cas.: 460053-60-5 | Purity: 98% | 1-(1H-Pyrrolo[3,2-c]pyridin-3-yl)ethanone | ESD-847671-25MG |
Cas.: 460053-60-5 | Purity: 98% | 1-(1H-Pyrrolo[3,2-c]pyridin-3-yl)ethanone | ESD-847671-100MG |
Cas.: 371770-32-0 | Purity: 95% | Fmoc-Cpa-OH | ESD-847672-25MG |
Cas.: 371770-32-0 | Purity: 95% | Fmoc-Cpa-OH | ESD-847672-100MG |
Cas.: 1638487-41-8 | Purity: 98% | 3-Bromo-2,5-difluorobenzonitrile | ESD-847673-25MG |
Cas.: 1638487-41-8 | Purity: 98% | 3-Bromo-2,5-difluorobenzonitrile | ESD-847673-100MG |
Cas.: 1536473-72-9 | Purity: 95% | tBuBrettPhos Pd G3 | ESD-847674-25MG |
Cas.: 1536473-72-9 | Purity: 95% | tBuBrettPhos Pd G3 | ESD-847674-100MG |
Cas.: 1171892-42-4 | Purity: 97% | 3-Isopropoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-847675-25MG |
Cas.: 1171892-42-4 | Purity: 97% | 3-Isopropoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-847675-100MG |
Cas.: 88069-49-2 | Purity: 97% | N-(2,6-Dimethylphenyl)-2-(hexahydro-1H-pyrrolizin-7a-yl)acetamide hydrochloride | ESD-847676-25MG |
Cas.: 88069-49-2 | Purity: 97% | N-(2,6-Dimethylphenyl)-2-(hexahydro-1H-pyrrolizin-7a-yl)acetamide hydrochloride | ESD-847676-100MG |
Cas.: 881658-92-0 | Purity: 98% | 8-Bromo-2-methoxy-1,5-naphthyridine | ESD-847677-25MG |
Cas.: 881658-92-0 | Purity: 98% | 8-Bromo-2-methoxy-1,5-naphthyridine | ESD-847677-100MG |
Cas.: 620616-08-2 | Purity: 97% | (S)-2-Amino-2-(3-chlorophenyl)ethanol hydrochloride | ESD-847678-25MG |
Cas.: 620616-08-2 | Purity: 97% | (S)-2-Amino-2-(3-chlorophenyl)ethanol hydrochloride | ESD-847678-100MG |
Cas.: 89747-69-3 | Purity: 97% | 2-Hydroxyethanesulfonic acid dimethylamide | ESD-847679-25MG |
Cas.: 89747-69-3 | Purity: 97% | 2-Hydroxyethanesulfonic acid dimethylamide | ESD-847679-100MG |
Cas.: 685109-10-8 | Purity: 96% | 7-Bromo-5-nitro-1H-indazole | ESD-847680-250MG |
Cas.: 685109-10-8 | Purity: 96% | 7-Bromo-5-nitro-1H-indazole | ESD-847680-1G |
Cas.: 407640-40-8 | Purity: 97% | 2-(4-Fluoro-2-methylphenyl)acetic acid | ESD-847681-250MG |
Cas.: 407640-40-8 | Purity: 97% | 2-(4-Fluoro-2-methylphenyl)acetic acid | ESD-847681-1G |
Cas.: 1048358-33-3 | Purity: 95% | N-Boc-2-Amino-5-bromo[1,3,4]thiadiazole | ESD-847682-250MG |
Cas.: 1048358-33-3 | Purity: 95% | N-Boc-2-Amino-5-bromo[1,3,4]thiadiazole | ESD-847682-1G |
Cas.: 169750-17-8 | Purity: 97% | 3-Fluoropyrrolidine hydrochloride | ESD-847683-250MG |
Cas.: 169750-17-8 | Purity: 97% | 3-Fluoropyrrolidine hydrochloride | ESD-847683-1G |
Cas.: 210538-68-4 | Purity: 95% | 5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidine hydrochloride | ESD-847684-250MG |
Cas.: 210538-68-4 | Purity: 95% | 5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidine hydrochloride | ESD-847684-1G |
Cas.: 1150617-61-0 | Purity: 98% | 5-Chloro-2-iodo-1-methyl-3-nitrobenzene | ESD-847685-250MG |
Cas.: 1150617-61-0 | Purity: 98% | 5-Chloro-2-iodo-1-methyl-3-nitrobenzene | ESD-847685-1G |
Cas.: 333954-86-2 | Purity: 97% | tert-Butyl 4-(4-cyanophenoxy)piperidine-1-carboxylate | ESD-847686-250MG |
Cas.: 333954-86-2 | Purity: 97% | tert-Butyl 4-(4-cyanophenoxy)piperidine-1-carboxylate | ESD-847686-1G |
Cas.: 4532-33-6 | Purity: 97% | 1-Methoxy-3-methyl-9H-carbazole | ESD-847687-50MG |
Cas.: 4532-33-6 | Purity: 97% | 1-Methoxy-3-methyl-9H-carbazole | ESD-847687-250MG |
Cas.: 909720-21-4 | Purity: 98% | 2,3-Dibromo-6-methoxypyridine | ESD-847688-25MG |
Cas.: 909720-21-4 | Purity: 98% | 2,3-Dibromo-6-methoxypyridine | ESD-847688-100MG |
Cas.: 124702-80-3 | Purity: 98% | 5,6-Dihydroxy-2,3-dihydro-1H-inden-1-one | ESD-847689-25MG |
Cas.: 124702-80-3 | Purity: 98% | 5,6-Dihydroxy-2,3-dihydro-1H-inden-1-one | ESD-847689-100MG |
Cas.: 14036-96-5 | Purity: 96% | 3-Bromo-6-methoxyquinoline | ESD-847690-25MG |
Cas.: 14036-96-5 | Purity: 96% | 3-Bromo-6-methoxyquinoline | ESD-847690-100MG |
Cas.: 226410-00-0 | Purity: 95% | Methyl 3-chloro-1H-pyrrole-2-carboxylate | ESD-847691-250MG |
Cas.: 226410-00-0 | Purity: 95% | Methyl 3-chloro-1H-pyrrole-2-carboxylate | ESD-847691-1G |
Cas.: 92926-32-4 | Purity: 97% | 6-Fluorospiro[4H-3,1-benzoxazine-4,4′-piperidin]-2(1H)-one | ESD-847692-25MG |
Cas.: 92926-32-4 | Purity: 97% | 6-Fluorospiro[4H-3,1-benzoxazine-4,4′-piperidin]-2(1H)-one | ESD-847692-100MG |
Cas.: 73576-33-7 | Purity: 98% | 4-Chloro-6-isopropylpyrimidin-2-amine | ESD-847693-250MG |
Cas.: 73576-33-7 | Purity: 98% | 4-Chloro-6-isopropylpyrimidin-2-amine | ESD-847693-1G |
Cas.: 1235406-42-4 | Purity: 98% | tert-Butyl thiazol-4-ylcarbamate | ESD-847694-250MG |
Cas.: 1235406-42-4 | Purity: 98% | tert-Butyl thiazol-4-ylcarbamate | ESD-847694-1G |
Cas.: 33581-96-3 | Purity: 95% | 4-Methylpiperazine-1-sulfonyl chloride hydrochloride | ESD-847695-250MG |
Cas.: 33581-96-3 | Purity: 95% | 4-Methylpiperazine-1-sulfonyl chloride hydrochloride | ESD-847695-1G |
Cas.: 1158749-94-0 | Purity: 98% | tert-Butyl 2-oxo-1,8-diazaspiro[4.5]decane-8-carboxylate | ESD-847696-25MG |
Cas.: 1158749-94-0 | Purity: 98% | tert-Butyl 2-oxo-1,8-diazaspiro[4.5]decane-8-carboxylate | ESD-847696-100MG |
Cas.: 189281-48-9 | Purity: 98% | 2,4-Dichloro-5-fluoropyridine | ESD-847697-25MG |
Cas.: 189281-48-9 | Purity: 98% | 2,4-Dichloro-5-fluoropyridine | ESD-847697-100MG |
Cas.: 17724-36-6 | Purity: 97% | 2,3,4,5-Tetrahydro-1H-benzo[c]azepine hydrochloride | ESD-847698-250MG |
Cas.: 17724-36-6 | Purity: 97% | 2,3,4,5-Tetrahydro-1H-benzo[c]azepine hydrochloride | ESD-847698-1G |
Cas.: 174496-99-2 | Purity: 97% | Ethyl 4-chloronicotinate hydrochloride | ESD-847699-250MG |
Cas.: 174496-99-2 | Purity: 97% | Ethyl 4-chloronicotinate hydrochloride | ESD-847699-1G |
Cas.: 518048-02-7 | Purity: 95% | Benzyl [1-[4-[[(4-fluorobenzyl)amino]carbonyl]-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]-1-methylethyl]carbamate | ESD-847700-250MG |
Cas.: 99337-81-2 | Purity: 95% | 4-Bromocyclohexanamine hydrochloride | ESD-847701-25MG |
Cas.: 99337-81-2 | Purity: 95% | 4-Bromocyclohexanamine hydrochloride | ESD-847701-100MG |
Cas.: 1135283-10-1 | Purity: 97% | 1-Ethynyl-2-methoxy-4-nitrobenzene | ESD-847702-25MG |
Cas.: 1135283-10-1 | Purity: 97% | 1-Ethynyl-2-methoxy-4-nitrobenzene | ESD-847702-100MG |
Cas.: 1017777-58-0 | Purity: 98% | 2-Chloro-6-fluoro-3-methoxyaniline | ESD-847705-25MG |
Cas.: 1017777-58-0 | Purity: 98% | 2-Chloro-6-fluoro-3-methoxyaniline | ESD-847705-100MG |
Cas.: 259868-83-2 | Purity: 95% | (S)-Methyl 2-(pyrrolidin-2-yl)acetate hydrochloride | ESD-847706-25MG |
Cas.: 259868-83-2 | Purity: 95% | (S)-Methyl 2-(pyrrolidin-2-yl)acetate hydrochloride | ESD-847706-100MG |
Cas.: 171-77-7 | Purity: 97% | 2H-Spiro[benzofuran-3,4′-piperidine] | ESD-847707-25MG |
Cas.: 171-77-7 | Purity: 97% | 2H-Spiro[benzofuran-3,4′-piperidine] | ESD-847707-100MG |
Cas.: 26287-69-4 | Purity: 97% | 1-((2S,3S,4R,5S)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione | ESD-847708-25MG |
Cas.: 26287-69-4 | Purity: 97% | 1-((2S,3S,4R,5S)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione | ESD-847708-100MG |
Cas.: 1126824-72-3 | Purity: 97% | 7-Bromothieno[2,3-b]pyrazine | ESD-847709-25MG |
Cas.: 1126824-72-3 | Purity: 97% | 7-Bromothieno[2,3-b]pyrazine | ESD-847709-100MG |
Cas.: 116308-38-4 | Purity: 98% | 2-Formylisonicotinonitrile | ESD-847710-25MG |
Cas.: 116308-38-4 | Purity: 98% | 2-Formylisonicotinonitrile | ESD-847710-100MG |
Cas.: 59942-87-9 | Purity: 97% | Pyrazolo[1,5-a]pyridin-2(1H)-one | ESD-847711-25MG |
Cas.: 59942-87-9 | Purity: 97% | Pyrazolo[1,5-a]pyridin-2(1H)-one | ESD-847711-100MG |
Cas.: 15936-81-9 | Purity: 98% | 5-Bromo-7-methyl-1H-indole | ESD-847712-25MG |
Cas.: 15936-81-9 | Purity: 98% | 5-Bromo-7-methyl-1H-indole | ESD-847712-100MG |
Cas.: 1168139-43-2 | Purity: 97% | (R)-1-(2-Fluorophenyl)ethanamine hydrochloride | ESD-847713-25MG |
Cas.: 1168139-43-2 | Purity: 97% | (R)-1-(2-Fluorophenyl)ethanamine hydrochloride | ESD-847713-100MG |
Cas.: 261723-28-8 | Purity: 97% | (3-Bromo-2-fluorophenyl)methanamine | ESD-847714-25MG |
Cas.: 261723-28-8 | Purity: 97% | (3-Bromo-2-fluorophenyl)methanamine | ESD-847714-100MG |
Cas.: 145122-56-1 | Purity: 95% | 4,7-Diazaspiro[2.5]octane dihydrochloride | ESD-847716-25MG |
Cas.: 145122-56-1 | Purity: 95% | 4,7-Diazaspiro[2.5]octane dihydrochloride | ESD-847716-100MG |
Cas.: 697739-12-1 | Purity: 97% | Ethyl imidazo[1,5-a]pyridine-8-carboxylate | ESD-847717-25MG |
Cas.: 697739-12-1 | Purity: 97% | Ethyl imidazo[1,5-a]pyridine-8-carboxylate | ESD-847717-100MG |
Cas.: 1190317-45-3 | Purity: 97% | 5-Bromo-1H-pyrrolo[2,3-b]pyridine-6-carbonitrile | ESD-847718-25MG |
Cas.: 1190317-45-3 | Purity: 97% | 5-Bromo-1H-pyrrolo[2,3-b]pyridine-6-carbonitrile | ESD-847718-100MG |
Cas.: 1190322-26-9 | Purity: 96% | 5-Bromo-1H-pyrrolo[2,3-b]pyridine-6-carboxylic acid | ESD-847719-25MG |
Cas.: 1190322-26-9 | Purity: 96% | 5-Bromo-1H-pyrrolo[2,3-b]pyridine-6-carboxylic acid | ESD-847719-100MG |
Cas.: 99429-80-8 | Purity: 97% | 4,6-Dichlorothieno[2,3-b]pyridine | ESD-847720-25MG |
Cas.: 99429-80-8 | Purity: 97% | 4,6-Dichlorothieno[2,3-b]pyridine | ESD-847720-100MG |
Cas.: 819867-21-5 | Purity: 95% | Di-tert-butyl(2′,6′-dimethoxy-[1,1′-biphenyl]-2-yl)phosphine | ESD-847721-25MG |
Cas.: 819867-21-5 | Purity: 95% | Di-tert-butyl(2′,6′-dimethoxy-[1,1′-biphenyl]-2-yl)phosphine | ESD-847721-100MG |
Cas.: 319442-18-7 | Purity: 97% | Ethyl 4-chlorothieno[3,2-d]pyrimidine-2-carboxylate | ESD-847722-25MG |
Cas.: 319442-18-7 | Purity: 97% | Ethyl 4-chlorothieno[3,2-d]pyrimidine-2-carboxylate | ESD-847722-100MG |
Cas.: 950514-14-4 | Purity: 97% | Methyl 2-oxo-1,2-dihydropyrimidine-4-carboxylate | ESD-847723-25MG |
Cas.: 950514-14-4 | Purity: 97% | Methyl 2-oxo-1,2-dihydropyrimidine-4-carboxylate | ESD-847723-100MG |
Cas.: 905281-60-9 | Purity: 98% | 4-(1-Methyl-1H-pyrazol-5-yl)pyridine | ESD-847724-25MG |
Cas.: 905281-60-9 | Purity: 98% | 4-(1-Methyl-1H-pyrazol-5-yl)pyridine | ESD-847724-100MG |
Cas.: 1209459-16-4 | Purity: 98% | 2-Bromopyrimidine-4-carbonitrile | ESD-847725-25MG |
Cas.: 1209459-16-4 | Purity: 98% | 2-Bromopyrimidine-4-carbonitrile | ESD-847725-100MG |
Cas.: 121591-81-9 | Purity: 97% | Methyl 3,4-dihydro-2H-benzo[b][1,4]oxazine-5-carboxylate | ESD-847726-25MG |
Cas.: 121591-81-9 | Purity: 97% | Methyl 3,4-dihydro-2H-benzo[b][1,4]oxazine-5-carboxylate | ESD-847726-100MG |
Cas.: 77185-71-8 | Purity: 96% | 6-Bromo-2-phenyl-1H-indole | ESD-847727-25MG |
Cas.: 77185-71-8 | Purity: 96% | 6-Bromo-2-phenyl-1H-indole | ESD-847727-100MG |
Cas.: 2435-47-4 | Purity: 98% | 3,6-Dimethylpyrazine-2-carbonitrile | ESD-847728-25MG |
Cas.: 2435-47-4 | Purity: 98% | 3,6-Dimethylpyrazine-2-carbonitrile | ESD-847728-100MG |
Cas.: 2849-92-5 | Purity: 98% | Methyl 1-methyl-1H-benzo[d]imidazole-2-carboxylate | ESD-847729-25MG |
Cas.: 2849-92-5 | Purity: 98% | Methyl 1-methyl-1H-benzo[d]imidazole-2-carboxylate | ESD-847729-100MG |
Cas.: 938062-38-5 | Purity: 98% | 6-Bromo-3-methoxy-1H-indazole | ESD-847730-25MG |
Cas.: 938062-38-5 | Purity: 98% | 6-Bromo-3-methoxy-1H-indazole | ESD-847730-100MG |
Cas.: 142031-88-7 | Purity: 98% | Methyl 3-(bromomethyl)-4-methoxybenzoate | ESD-847731-25MG |
Cas.: 142031-88-7 | Purity: 98% | Methyl 3-(bromomethyl)-4-methoxybenzoate | ESD-847731-100MG |
Cas.: 6214-47-7 | Purity: 97% | Ethyl 2-(4-chloropyrimidin-5-yl)acetate | ESD-847732-25MG |
Cas.: 6214-47-7 | Purity: 97% | Ethyl 2-(4-chloropyrimidin-5-yl)acetate | ESD-847732-100MG |
Cas.: 538372-37-1 | Purity: 98% | Methyl 3,4-diamino-2-methoxybenzoate | ESD-847733-25MG |
Cas.: 538372-37-1 | Purity: 98% | Methyl 3,4-diamino-2-methoxybenzoate | ESD-847733-100MG |
Cas.: 155797-02-7 | Purity: 98% | (S)-3-Methylpiperidine hydrochloride | ESD-847734-25MG |
Cas.: 155797-02-7 | Purity: 98% | (S)-3-Methylpiperidine hydrochloride | ESD-847734-100MG |
Cas.: 886372-61-8 | Purity: 97% | 5-Bromo-4-methoxy-2-methylpyridine | ESD-847735-25MG |
Cas.: 886372-61-8 | Purity: 97% | 5-Bromo-4-methoxy-2-methylpyridine | ESD-847735-100MG |
Cas.: 1240595-43-0 | Purity: 98% | Ethyl 4-amino-5-bromonicotinate | ESD-847736-25MG |
Cas.: 1240595-43-0 | Purity: 98% | Ethyl 4-amino-5-bromonicotinate | ESD-847736-100MG |
Cas.: 116855-03-9 | Purity: 95% | 3-Bromo-1-methyl-1H-pyrazolo[3,4-b]pyridine | ESD-847737-25MG |
Cas.: 116855-03-9 | Purity: 95% | 3-Bromo-1-methyl-1H-pyrazolo[3,4-b]pyridine | ESD-847737-100MG |
Cas.: 734522-82-8 | Purity: 95% | 4-(Bromomethyl)-1H-indazole | ESD-847738-25MG |
Cas.: 734522-82-8 | Purity: 95% | 4-(Bromomethyl)-1H-indazole | ESD-847738-100MG |
Cas.: 20668-20-6 | Purity: 98% | 3-Methyl-1,2,3,4-tetrahydroquinoline | ESD-847739-25MG |
Cas.: 20668-20-6 | Purity: 98% | 3-Methyl-1,2,3,4-tetrahydroquinoline | ESD-847739-100MG |
Cas.: 211940-25-9 | Purity: 97% | 2-Ethynyl-4-methylthiazole | ESD-847740-25MG |
Cas.: 211940-25-9 | Purity: 97% | 2-Ethynyl-4-methylthiazole | ESD-847740-100MG |
Cas.: 1472104-49-6 | Purity: 97% | 4-Bromo-2-fluoro-6-methoxybenzoic acid | ESD-847741-25MG |
Cas.: 1472104-49-6 | Purity: 97% | 4-Bromo-2-fluoro-6-methoxybenzoic acid | ESD-847741-100MG |
Cas.: 4253-81-0 | Purity: 96% | 2-(2-Nitrophenyl)pyridine | ESD-847742-25MG |
Cas.: 4253-81-0 | Purity: 96% | 2-(2-Nitrophenyl)pyridine | ESD-847742-100MG |
Cas.: 116278-69-4 | Purity: 98% | 6-Amino-2,3-dichlorophenol | ESD-847743-25MG |
Cas.: 116278-69-4 | Purity: 98% | 6-Amino-2,3-dichlorophenol | ESD-847743-100MG |
Cas.: 1520003-18-2 | Purity: 97% | 1-(6-Bromopyridin-2-yl)cyclobutanol | ESD-847744-25MG |
Cas.: 1520003-18-2 | Purity: 97% | 1-(6-Bromopyridin-2-yl)cyclobutanol | ESD-847744-100MG |
Cas.: 13061-28-4 | Purity: 97% | 1-(2,4,5-Trichlorophenyl)ethanone | ESD-847745-25MG |
Cas.: 13061-28-4 | Purity: 97% | 1-(2,4,5-Trichlorophenyl)ethanone | ESD-847745-100MG |
Cas.: 20028-34-6 | Purity: 97% | (1-Benzyl-1H-benzo[d]imidazol-2-yl)methanamine dihydrochloride | ESD-847746-25MG |
Cas.: 20028-34-6 | Purity: 97% | (1-Benzyl-1H-benzo[d]imidazol-2-yl)methanamine dihydrochloride | ESD-847746-100MG |
Cas.: 818-81-5 | Purity: 95% | 2-Methyloctan-1-ol | ESD-847747-25MG |
Cas.: 818-81-5 | Purity: 95% | 2-Methyloctan-1-ol | ESD-847747-100MG |
Cas.: 1621961-57-6 | Purity: 97% | (S)-5-Oxopiperazine-2-carboxylic acid hydrochloride | ESD-847748-25MG |
Cas.: 1621961-57-6 | Purity: 97% | (S)-5-Oxopiperazine-2-carboxylic acid hydrochloride | ESD-847748-100MG |
Cas.: 1243174-57-3 | Purity: 95% | (R)-3-Methyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butan-1-amine hydrochloride | ESD-847749-25MG |
Cas.: 1243174-57-3 | Purity: 95% | (R)-3-Methyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butan-1-amine hydrochloride | ESD-847749-100MG |
Cas.: 32938-48-0 | Purity: 95% | 4-(Bromomethyl)-2-chloropyridine hydrobromide | ESD-847750-25MG |
Cas.: 32938-48-0 | Purity: 95% | 4-(Bromomethyl)-2-chloropyridine hydrobromide | ESD-847750-100MG |
Cas.: 1216497-60-7 | Purity: 90% | 2-(2,4-dichlorophenyl)propan-2-amine hydrochloride | ESD-847751-100MG |
Cas.: 89282-38-2 | Purity: 98% | 5-Bromo-3-methoxypyrazin-2(1H)-one | ESD-847752-25MG |
Cas.: 89282-38-2 | Purity: 98% | 5-Bromo-3-methoxypyrazin-2(1H)-one | ESD-847752-100MG |
Cas.: 1254058-34-8 | Purity: 97% | 3-Methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)aniline | ESD-847753-25MG |
Cas.: 1254058-34-8 | Purity: 97% | 3-Methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)aniline | ESD-847753-100MG |
Cas.: 848135-96-6 | Purity: 97% | 7-Bromo-3-methyl-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-847754-25MG |
Cas.: 848135-96-6 | Purity: 97% | 7-Bromo-3-methyl-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-847754-100MG |
Cas.: 942190-60-5 | Purity: 95% | tert-Butyl 3-cyano-3-((trimethylsilyl)oxy)pyrrolidine-1-carboxylate | ESD-847755-25MG |
Cas.: 942190-60-5 | Purity: 95% | tert-Butyl 3-cyano-3-((trimethylsilyl)oxy)pyrrolidine-1-carboxylate | ESD-847755-100MG |
Cas.: 908571-75-5 | Purity: 97% | (S)-2-Amino-3-(3-aminophenyl)propanoic acid dihydrochloride | ESD-847756-25MG |
Cas.: 908571-75-5 | Purity: 97% | (S)-2-Amino-3-(3-aminophenyl)propanoic acid dihydrochloride | ESD-847756-100MG |
Cas.: 193290-27-6 | Purity: 97% | 3-(2-Hydroxyethyl)benzonitrile | ESD-847757-25MG |
Cas.: 193290-27-6 | Purity: 97% | 3-(2-Hydroxyethyl)benzonitrile | ESD-847757-100MG |
Cas.: 112257-24-6 | Purity: 98% | 1-Boc-3-Carbamoylpiperazine | ESD-847758-25MG |
Cas.: 112257-24-6 | Purity: 98% | 1-Boc-3-Carbamoylpiperazine | ESD-847758-100MG |
Cas.: 6149-92-4 | Purity: 98% | 2-(Aminomethyl)pyrrolidine dihydrochloride | ESD-847759-250MG |
Cas.: 6149-92-4 | Purity: 98% | 2-(Aminomethyl)pyrrolidine dihydrochloride | ESD-847759-1G |
Cas.: 18710-86-6 | Purity: 98% | 2-(3-Methyl-2-nitrophenyl)acetic acid | ESD-847760-250MG |
Cas.: 18710-86-6 | Purity: 98% | 2-(3-Methyl-2-nitrophenyl)acetic acid | ESD-847760-1G |
Cas.: 50340-79-9 | Purity: 98% | 5-(Methoxycarbonyl)thiophene-2-carboxylic acid | ESD-847761-250MG |
Cas.: 50340-79-9 | Purity: 98% | 5-(Methoxycarbonyl)thiophene-2-carboxylic acid | ESD-847761-1G |
Cas.: 858513-10-7 | Purity: 95% | 2-(2-Methyl-1H-imidazol-1-yl)ethanamine dihydrochloride | ESD-847762-250MG |
Cas.: 858513-10-7 | Purity: 95% | 2-(2-Methyl-1H-imidazol-1-yl)ethanamine dihydrochloride | ESD-847762-1G |
Cas.: 137-44-0 | Purity: 95% | 1H-Pyrazol-5(4H)-one | ESD-847763-250MG |
Cas.: 137-44-0 | Purity: 95% | 1H-Pyrazol-5(4H)-one | ESD-847763-1G |
Cas.: 30250-67-0 | Purity: 97% | 2-(2-Aminoethyl)isoindoline-1,3-dione hydrochloride | ESD-847764-250MG |
Cas.: 30250-67-0 | Purity: 97% | 2-(2-Aminoethyl)isoindoline-1,3-dione hydrochloride | ESD-847764-1G |
Cas.: 148625-35-8 | Purity: 98% | Methyl 3-formyl-4-nitrobenzoate | ESD-847765-250MG |
Cas.: 148625-35-8 | Purity: 98% | Methyl 3-formyl-4-nitrobenzoate | ESD-847765-1G |
Cas.: 89499-44-5 | Purity: 97% | Methyl 4-amino-5-chlorothiophene-2-carboxylate | ESD-847766-250MG |
Cas.: 89499-44-5 | Purity: 97% | Methyl 4-amino-5-chlorothiophene-2-carboxylate | ESD-847766-1G |
Cas.: 999-82-6 | Purity: 95% | (2-Bromoethyl)phosphonic acid | ESD-847767-250MG |
Cas.: 999-82-6 | Purity: 95% | (2-Bromoethyl)phosphonic acid | ESD-847767-1G |
Cas.: 675580-49-1 | Purity: 96% | (6-Chloroimidazo[1,2-b]pyridazin-3-yl)methanol | ESD-847768-250MG |
Cas.: 675580-49-1 | Purity: 96% | (6-Chloroimidazo[1,2-b]pyridazin-3-yl)methanol | ESD-847768-1G |
Cas.: 871583-23-2 | Purity: 98% | Methyl 4-chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate | ESD-847769-250MG |
Cas.: 871583-23-2 | Purity: 98% | Methyl 4-chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate | ESD-847769-1G |
Cas.: 850349-24-5 | Purity: 95% | 3-((4-Bromo-1H-pyrazol-1-yl)methyl)pyridine | ESD-847770-250MG |
Cas.: 850349-24-5 | Purity: 95% | 3-((4-Bromo-1H-pyrazol-1-yl)methyl)pyridine | ESD-847770-1G |
Cas.: 156635-89-1 | Purity: 95% | (4-(Benzyloxy)-2,6-difluorophenyl)boronic acid | ESD-847771-250MG |
Cas.: 156635-89-1 | Purity: 95% | (4-(Benzyloxy)-2,6-difluorophenyl)boronic acid | ESD-847771-1G |
Cas.: 348640-07-3 | Purity: 96% | 4-Bromo-1-tosyl-1H-pyrrolo[2,3-b]pyridine | ESD-847772-250MG |
Cas.: 348640-07-3 | Purity: 96% | 4-Bromo-1-tosyl-1H-pyrrolo[2,3-b]pyridine | ESD-847772-1G |
Cas.: 352673-16-6 | Purity: 98% | 1-(2-Chlorobenzoyl)piperidine-4-carboxylic acid | ESD-847773-250MG |
Cas.: 352673-16-6 | Purity: 98% | 1-(2-Chlorobenzoyl)piperidine-4-carboxylic acid | ESD-847773-1G |
Cas.: 262862-71-5 | Purity: 95% | (4-(4-Chlorophenoxy)phenyl)methanamine hydrochloride | ESD-847774-250MG |
Cas.: 262862-71-5 | Purity: 95% | (4-(4-Chlorophenoxy)phenyl)methanamine hydrochloride | ESD-847774-1G |
Cas.: 147201-04-5 | Purity: 98% | I-bu-rG Phosphoramidite | ESD-847775-250MG |
Cas.: 147201-04-5 | Purity: 98% | I-bu-rG Phosphoramidite | ESD-847775-1G |
Cas.: 181514-35-2 | Purity: 97% | 1-(7-Bromo-3,4-dihydroisoquinolin-2(1H)-yl)-2,2,2-trifluoroethanone | ESD-847776-250MG |
Cas.: 181514-35-2 | Purity: 97% | 1-(7-Bromo-3,4-dihydroisoquinolin-2(1H)-yl)-2,2,2-trifluoroethanone | ESD-847776-1G |
Cas.: 1002309-52-5 | Purity: 98% | 1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one | ESD-847777-250MG |
Cas.: 1002309-52-5 | Purity: 98% | 1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one | ESD-847777-1G |
Cas.: 139229-57-5 | Purity: 97% | Ethyl 1-(trifluoromethyl)cyclopropanecarboxylate | ESD-847778-250MG |
Cas.: 139229-57-5 | Purity: 97% | Ethyl 1-(trifluoromethyl)cyclopropanecarboxylate | ESD-847778-1G |
Cas.: 1161426-63-6 | Purity: 95% | 4-Fluoro-3-methylbenzene-1,2-diamine hydrochloride | ESD-847779-250MG |
Cas.: 1161426-63-6 | Purity: 95% | 4-Fluoro-3-methylbenzene-1,2-diamine hydrochloride | ESD-847779-1G |
Cas.: 360773-84-8 | Purity: 97% | tert-Butyl (1-(4-bromophenyl)cyclopropyl)carbamate | ESD-847780-250MG |
Cas.: 360773-84-8 | Purity: 97% | tert-Butyl (1-(4-bromophenyl)cyclopropyl)carbamate | ESD-847780-1G |
Cas.: 145285-36-5 | Purity: 95% | 1-(3-Chloropropyl)piperidin-4-ol | ESD-847781-250MG |
Cas.: 145285-36-5 | Purity: 95% | 1-(3-Chloropropyl)piperidin-4-ol | ESD-847781-1G |
Cas.: 1239450-42-0 | Purity: 95% | 2-Benzamido-3-methoxy-3-oxopropyl benzoate | ESD-847782-250MG |
Cas.: 1239450-42-0 | Purity: 95% | 2-Benzamido-3-methoxy-3-oxopropyl benzoate | ESD-847782-1G |
Cas.: 1015845-71-2 | Purity: 90% | 4-Chloro-6-(4-methyl-1H-pyrazol-1-yl)pyrimidine | ESD-847783-250MG |
Cas.: 1015845-71-2 | Purity: 90% | 4-Chloro-6-(4-methyl-1H-pyrazol-1-yl)pyrimidine | ESD-847783-1G |
Cas.: 23667-06-3 | Purity: 98% | 2-Bromo-N,N,4-trimethylaniline | ESD-847784-250MG |
Cas.: 23667-06-3 | Purity: 98% | 2-Bromo-N,N,4-trimethylaniline | ESD-847784-1G |
Cas.: 100241-11-0 | Purity: 95% | 3-Chloro-6-(piperazin-1-yl)pyridazine hydrochloride | ESD-847785-250MG |
Cas.: 100241-11-0 | Purity: 95% | 3-Chloro-6-(piperazin-1-yl)pyridazine hydrochloride | ESD-847785-1G |
Cas.: 5694-68-8 | Purity: 95% | (1,3-Dioxolan-2-yl)methanol | ESD-847786-250MG |
Cas.: 5694-68-8 | Purity: 95% | (1,3-Dioxolan-2-yl)methanol | ESD-847786-1G |
Cas.: 242452-35-3 | Purity: 95% | 1-(4-(Aminomethyl)phenyl)-N,N-dimethylmethanamine hydrochloride | ESD-847787-250MG |
Cas.: 242452-35-3 | Purity: 95% | 1-(4-(Aminomethyl)phenyl)-N,N-dimethylmethanamine hydrochloride | ESD-847787-1G |
Cas.: 946713-86-6 | Purity: 97% | 4-Fluoro-3-methoxyphenylacetic acid | ESD-847788-250MG |
Cas.: 946713-86-6 | Purity: 97% | 4-Fluoro-3-methoxyphenylacetic acid | ESD-847788-1G |
Cas.: 52833-93-9 | Purity: 97% | 2-Amino-5-chloropyridine-3-carboxylic acid | ESD-847789-250MG |
Cas.: 52833-93-9 | Purity: 97% | 2-Amino-5-chloropyridine-3-carboxylic acid | ESD-847789-1G |
Cas.: 719268-92-5 | Purity: 96% | 3-Fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-847790-250MG |
Cas.: 719268-92-5 | Purity: 96% | 3-Fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-847790-1G |
Cas.: 740806-67-1 | Purity: 98% | 4-Bromo-5-phenyloxazole | ESD-847791-25MG |
Cas.: 740806-67-1 | Purity: 98% | 4-Bromo-5-phenyloxazole | ESD-847791-100MG |
Cas.: 148038-83-9 | Purity: 95% | 6-Bromo-1H-imidazo[4,5-b]pyridin-2(3H)-one | ESD-847792-250MG |
Cas.: 148038-83-9 | Purity: 95% | 6-Bromo-1H-imidazo[4,5-b]pyridin-2(3H)-one | ESD-847792-1G |
Cas.: 1003709-67-8 | Purity: 95% | 4-Methoxy-2,3,5-trifluorobenzoic acid | ESD-847793-250MG |
Cas.: 1003709-67-8 | Purity: 95% | 4-Methoxy-2,3,5-trifluorobenzoic acid | ESD-847793-1G |
Cas.: 1190927-74-2 | Purity: 97% | 2,4-Dichloro-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidine hydrochloride | ESD-847794-25MG |
Cas.: 1190927-74-2 | Purity: 97% | 2,4-Dichloro-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidine hydrochloride | ESD-847794-100MG |
Cas.: 959058-59-4 | Purity: 97% | 7-Bromo-4-methoxy-2,3-dihydro-1H-inden-1-one | ESD-847795-25MG |
Cas.: 959058-59-4 | Purity: 97% | 7-Bromo-4-methoxy-2,3-dihydro-1H-inden-1-one | ESD-847795-100MG |
Cas.: 31493-66-0 | Purity: 95% | 1-Methyl-4-nitro-1H-benzo[d]imidazole | ESD-847796-25MG |
Cas.: 31493-66-0 | Purity: 95% | 1-Methyl-4-nitro-1H-benzo[d]imidazole | ESD-847796-100MG |
Cas.: 199851-22-4 | Purity: 98% | 4-Chloro-2-(tert-butylamino)-5-thiazolecarboxaldehyde | ESD-847797-250MG |
Cas.: 199851-22-4 | Purity: 98% | 4-Chloro-2-(tert-butylamino)-5-thiazolecarboxaldehyde | ESD-847797-1G |
Cas.: 89898-96-4 | Purity: 97% | 7-Nitro-2(1H)-quinoxalinone | ESD-847798-250MG |
Cas.: 89898-96-4 | Purity: 97% | 7-Nitro-2(1H)-quinoxalinone | ESD-847798-1G |
Cas.: 68208-26-4 | Purity: 95% | 3-Amino-3-(4-chlorophenyl)-1-propanol | ESD-847799-250MG |
Cas.: 68208-26-4 | Purity: 95% | 3-Amino-3-(4-chlorophenyl)-1-propanol | ESD-847799-1G |
Cas.: 554448-63-4 | Purity: 95% | 2-Fluoro-4-morpholinobenzaldehyde | ESD-847800-250MG |
Cas.: 554448-63-4 | Purity: 95% | 2-Fluoro-4-morpholinobenzaldehyde | ESD-847800-1G |
Cas.: 914348-90-6 | Purity: 95% | 2-(6-Methoxynaphthalen-2-yl)piperazine | ESD-847801-250MG |
Cas.: 914348-90-6 | Purity: 95% | 2-(6-Methoxynaphthalen-2-yl)piperazine | ESD-847801-1G |
Cas.: 914348-91-7 | Purity: 95% | 2-(2,5-Dichlorophenyl)piperazine | ESD-847802-250MG |
Cas.: 914348-91-7 | Purity: 95% | 2-(2,5-Dichlorophenyl)piperazine | ESD-847802-1G |
Cas.: 887344-27-6 | Purity: 97% | 3-(4-Methoxyphenyl)thiomorpholine | ESD-847803-250MG |
Cas.: 887344-27-6 | Purity: 97% | 3-(4-Methoxyphenyl)thiomorpholine | ESD-847803-1G |
Cas.: 910444-68-7 | Purity: 95% | 2-(2,5-Dimethoxyphenyl)piperazine | ESD-847804-250MG |
Cas.: 910444-68-7 | Purity: 95% | 2-(2,5-Dimethoxyphenyl)piperazine | ESD-847804-1G |
Cas.: 1361110-63-5 | Purity: 97% | 4-(2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine | ESD-847805-250MG |
Cas.: 1361110-63-5 | Purity: 97% | 4-(2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine | ESD-847805-1G |
Cas.: 1123169-43-6 | Purity: 98% | 7-Bromoquinazolin-4-amine | ESD-847807-250MG |
Cas.: 1123169-43-6 | Purity: 98% | 7-Bromoquinazolin-4-amine | ESD-847807-1G |
Cas.: 195877-46-4 | Purity: 95% | Methyl 2-(cyclopentylamino)acetate hydrochloride | ESD-847808-250MG |
Cas.: 195877-46-4 | Purity: 95% | Methyl 2-(cyclopentylamino)acetate hydrochloride | ESD-847808-1G |
Cas.: 61404-41-9 | Purity: 98% | Ethyl 6-chloro-3-hydroxypyridazine-4-carboxylate | ESD-847809-250MG |
Cas.: 61404-41-9 | Purity: 98% | Ethyl 6-chloro-3-hydroxypyridazine-4-carboxylate | ESD-847809-1G |
Cas.: 262433-55-6 | Purity: 95% | Allyl 4-amino-3-fluorobenzoate | ESD-847810-250MG |
Cas.: 262433-55-6 | Purity: 95% | Allyl 4-amino-3-fluorobenzoate | ESD-847810-1G |
Cas.: 89088-69-7 | Purity: 95% | 1-Methyl-1H-imidazol-4-amine hydrochloride | ESD-847811-250MG |
Cas.: 89088-69-7 | Purity: 95% | 1-Methyl-1H-imidazol-4-amine hydrochloride | ESD-847811-1G |
Cas.: 89292-91-1 | Purity: 95% | 5-(4-Methylpiperazin-1-yl)-1H-1,2,4-triazol-3-amine | ESD-847812-250MG |
Cas.: 89292-91-1 | Purity: 95% | 5-(4-Methylpiperazin-1-yl)-1H-1,2,4-triazol-3-amine | ESD-847812-1G |
Cas.: 1208-75-9 | Purity: 95% | 1-Benzylazepan-4-one | ESD-847813-250MG |
Cas.: 1208-75-9 | Purity: 95% | 1-Benzylazepan-4-one | ESD-847813-1G |
Cas.: 910444-80-3 | Purity: 95% | 2-Naphthalen-1-yl-piperazine | ESD-847814-250MG |
Cas.: 910444-80-3 | Purity: 95% | 2-Naphthalen-1-yl-piperazine | ESD-847814-1G |
Cas.: 61404-50-0 | Purity: 97% | 5-Ethylpyridazin-3(2H)-one | ESD-847815-25MG |
Cas.: 61404-50-0 | Purity: 97% | 5-Ethylpyridazin-3(2H)-one | ESD-847815-100MG |
Cas.: 5654-95-5 | Purity: 96% | 1H-Pyrrolo[2,3-b]pyridine-2,3-dione | ESD-847816-25MG |
Cas.: 5654-95-5 | Purity: 96% | 1H-Pyrrolo[2,3-b]pyridine-2,3-dione | ESD-847816-100MG |
Cas.: 1544-75-8 | Purity: 98% | 5-Fluoro-1H-benzo[d]imidazol-2(3H)-one | ESD-847817-250MG |
Cas.: 1544-75-8 | Purity: 98% | 5-Fluoro-1H-benzo[d]imidazol-2(3H)-one | ESD-847817-1G |
Cas.: 103505-54-0 | Purity: 98% | [2,2′-Bipyridine]-6,6′(1H,1’H)-dione | ESD-847818-250MG |
Cas.: 103505-54-0 | Purity: 98% | [2,2′-Bipyridine]-6,6′(1H,1’H)-dione | ESD-847818-1G |
Cas.: 157590-59-5 | Purity: 95% | 4-Chloro-5-(trifluoromethyl)benzene-1,2-diamine | ESD-847819-250MG |
Cas.: 157590-59-5 | Purity: 95% | 4-Chloro-5-(trifluoromethyl)benzene-1,2-diamine | ESD-847819-1G |
Cas.: 673487-36-0 | Purity: 98% | 4-Chloro-3-methylbenzene-1,2-diamine | ESD-847820-250MG |
Cas.: 673487-36-0 | Purity: 98% | 4-Chloro-3-methylbenzene-1,2-diamine | ESD-847820-1G |
Cas.: 1246349-97-2 | Purity: 95% | 4-Chloro-3-iodo-1-(4-methoxybenzyl)-1H-pyrazolo[4,3-c]pyridine | ESD-847821-250MG |
Cas.: 1246349-97-2 | Purity: 95% | 4-Chloro-3-iodo-1-(4-methoxybenzyl)-1H-pyrazolo[4,3-c]pyridine | ESD-847821-1G |
Cas.: 74733-26-9 | Purity: 98% | Methyl 3-chloro-4-formylbenzoate | ESD-847822-250MG |
Cas.: 74733-26-9 | Purity: 98% | Methyl 3-chloro-4-formylbenzoate | ESD-847822-1G |
Cas.: 223726-10-1 | Purity: 96% | 5-Acetyl-2-nitrobenzonitrile | ESD-847823-250MG |
Cas.: 223726-10-1 | Purity: 96% | 5-Acetyl-2-nitrobenzonitrile | ESD-847823-1G |
Cas.: 216002-19-6 | Purity: 97% | (S)-1-(3,5-Bis(trifluoromethyl)phenyl)ethanamine hydrochloride | ESD-847824-250MG |
Cas.: 216002-19-6 | Purity: 97% | (S)-1-(3,5-Bis(trifluoromethyl)phenyl)ethanamine hydrochloride | ESD-847824-1G |
Cas.: 85817-34-1 | Purity: 95% | (4-Benzylpiperazin-2-yl)methanol | ESD-847825-250MG |
Cas.: 85817-34-1 | Purity: 95% | (4-Benzylpiperazin-2-yl)methanol | ESD-847825-1G |
Cas.: 1335055-45-2 | Purity: 97% | 2-(5-Bromopyridin-2-yl)acetamide | ESD-847826-50MG |
Cas.: 1335055-45-2 | Purity: 97% | 2-(5-Bromopyridin-2-yl)acetamide | ESD-847826-250MG |
Cas.: 54915-41-2 | Purity: 97% | (2-Methyl-6-nitrophenyl)methanol | ESD-847827-50MG |
Cas.: 54915-41-2 | Purity: 97% | (2-Methyl-6-nitrophenyl)methanol | ESD-847827-250MG |
Cas.: 922163-35-7 | Purity: 97% | Methyl 3-((methylamino)methyl)benzoate | ESD-847828-50MG |
Cas.: 922163-35-7 | Purity: 97% | Methyl 3-((methylamino)methyl)benzoate | ESD-847828-250MG |
Cas.: 35657-41-1 | Purity: 95% | tert-Butyl (4-nitrobenzoyl)oxycarbamate | ESD-847829-50MG |
Cas.: 35657-41-1 | Purity: 95% | tert-Butyl (4-nitrobenzoyl)oxycarbamate | ESD-847829-250MG |
Cas.: 1217366-74-9 | Purity: 95% | 4-(4-Bromo-3-(1,3-dioxolan-2-yl)phenoxy)benzonitrile | ESD-847830-50MG |
Cas.: 1217366-74-9 | Purity: 95% | 4-(4-Bromo-3-(1,3-dioxolan-2-yl)phenoxy)benzonitrile | ESD-847830-250MG |
Cas.: 655225-01-7 | Purity: 97% | tert-Butyl 4-(2-bromoethyl)piperazine-1-carboxylate | ESD-847831-50MG |
Cas.: 655225-01-7 | Purity: 97% | tert-Butyl 4-(2-bromoethyl)piperazine-1-carboxylate | ESD-847831-250MG |
Cas.: 65685-51-0 | Purity: 97% | 6-Bromobenzo[d]isoxazol-3(2H)-one | ESD-847832-25MG |
Cas.: 65685-51-0 | Purity: 97% | 6-Bromobenzo[d]isoxazol-3(2H)-one | ESD-847832-100MG |
Cas.: 476014-92-3 | Purity: 95% | (S)-4-Hydroxypiperidin-2-one | ESD-847833-25MG |
Cas.: 476014-92-3 | Purity: 95% | (S)-4-Hydroxypiperidin-2-one | ESD-847833-100MG |
Cas.: 57078-99-6 | Purity: 97% | 5-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)pentanoic acid | ESD-847834-25MG |
Cas.: 57078-99-6 | Purity: 97% | 5-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)pentanoic acid | ESD-847834-100MG |
Cas.: 161807-18-7 | Purity: 97% | Methyl 2-(6-chloropyridin-2-yl)acetate | ESD-847835-25MG |
Cas.: 161807-18-7 | Purity: 97% | Methyl 2-(6-chloropyridin-2-yl)acetate | ESD-847835-100MG |
Cas.: 31698-88-1 | Purity: 95% | Methyl oxazole-2-carboxylate | ESD-847836-25MG |
Cas.: 31698-88-1 | Purity: 95% | Methyl oxazole-2-carboxylate | ESD-847836-100MG |
Cas.: 1311992-98-9 | Purity: 97% | 2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-(but-3-en-1-yl)hex-5-enoic acid | ESD-847837-25MG |
Cas.: 1311992-98-9 | Purity: 97% | 2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-(but-3-en-1-yl)hex-5-enoic acid | ESD-847837-100MG |
Cas.: 206347-30-0 | Purity: 98% | 7-Bromo-2,3-dihydrobenzofuran | ESD-847838-250MG |
Cas.: 206347-30-0 | Purity: 98% | 7-Bromo-2,3-dihydrobenzofuran | ESD-847838-1G |
Cas.: 89694-45-1 | Purity: 98% | 5-Bromo-2-methoxyphenylboronic acid | ESD-847839-5G |
Cas.: 89694-45-1 | Purity: 98% | 5-Bromo-2-methoxyphenylboronic acid | ESD-847839-25G |
Cas.: 949922-52-5 | Purity: 97% | 2-Bromo-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine hydrochloride | ESD-847840-50MG |
Cas.: 949922-52-5 | Purity: 97% | 2-Bromo-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine hydrochloride | ESD-847840-250MG |
Cas.: 109613-90-3 | Purity: 98% | 2-Chloro-3-fluoro-4-nitropyridine | ESD-847841-50MG |
Cas.: 109613-90-3 | Purity: 98% | 2-Chloro-3-fluoro-4-nitropyridine | ESD-847841-250MG |
Cas.: 32089-46-6 | Purity: 98% | 2-(4-Chloro-1H-pyrazol-1-yl)acetic acid | ESD-847842-250MG |
Cas.: 32089-46-6 | Purity: 98% | 2-(4-Chloro-1H-pyrazol-1-yl)acetic acid | ESD-847842-1G |
Cas.: 1588441-32-0 | Purity: 97% | Pyrazine-2,5-diamine dihydrochloride | ESD-847843-50MG |
Cas.: 1588441-32-0 | Purity: 97% | Pyrazine-2,5-diamine dihydrochloride | ESD-847843-250MG |
Cas.: 1206248-68-1 | Purity: 97% | 2-Bromo-7-chlorothiazolo[5,4-c]pyridine | ESD-847844-25MG |
Cas.: 1206248-68-1 | Purity: 97% | 2-Bromo-7-chlorothiazolo[5,4-c]pyridine | ESD-847844-100MG |
Cas.: 137281-08-4 | Purity: 97% | N-(4-Oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-2-yl)pivalamide | ESD-847845-25MG |
Cas.: 137281-08-4 | Purity: 97% | N-(4-Oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-2-yl)pivalamide | ESD-847845-100MG |
Cas.: 380177-22-0 | Purity: 97% | (5-Chloro-1-methyl-1H-benzo[d]imidazol-2-yl)methanol | ESD-847846-25MG |
Cas.: 380177-22-0 | Purity: 97% | (5-Chloro-1-methyl-1H-benzo[d]imidazol-2-yl)methanol | ESD-847846-100MG |
Cas.: 1092579-75-3 | Purity: 96% | 5-Bromo-4-chloro-3-iodo-1H-pyrrolo[2,3-b]pyridine | ESD-847847-50MG |
Cas.: 1092579-75-3 | Purity: 96% | 5-Bromo-4-chloro-3-iodo-1H-pyrrolo[2,3-b]pyridine | ESD-847847-250MG |
Cas.: 104632-25-9 | Purity: 98% | Pramipexole dihydrochloride | ESD-847848-50MG |
Cas.: 104632-25-9 | Purity: 98% | Pramipexole dihydrochloride | ESD-847848-250MG |
Cas.: 43038-36-4 | Purity: 95% | 4-Cyanobenzohydrazide | ESD-847849-250MG |
Cas.: 43038-36-4 | Purity: 95% | 4-Cyanobenzohydrazide | ESD-847849-1G |
Cas.: 95306-64-2 | Purity: 95% | 4-Amino-5-methylpyridin-2-ol | ESD-847850-250MG |
Cas.: 95306-64-2 | Purity: 95% | 4-Amino-5-methylpyridin-2-ol | ESD-847850-1G |
Cas.: 1314394-77-8 | Purity: 95% | (5-Fluoropyrimdin-2-yl)methanamine hydrochloride | ESD-847851-25MG |
Cas.: 1314394-77-8 | Purity: 95% | (5-Fluoropyrimdin-2-yl)methanamine hydrochloride | ESD-847851-100MG |
Cas.: 130200-58-7 | Purity: 98% | 7-Hydroxy-2-naphthonitrile | ESD-847852-25MG |
Cas.: 130200-58-7 | Purity: 98% | 7-Hydroxy-2-naphthonitrile | ESD-847852-100MG |
Cas.: 579475-29-9 | Purity: 98% | 5-Bromo-2-cyclopropylpyridine | ESD-847853-25MG |
Cas.: 579475-29-9 | Purity: 98% | 5-Bromo-2-cyclopropylpyridine | ESD-847853-100MG |
Cas.: 731862-92-3 | Purity: 97% | 1-(6-Aminohexyl)-1H-pyrrole-2,5-dione 2,2,2-trifluoroacetate | ESD-847854-25MG |
Cas.: 731862-92-3 | Purity: 97% | 1-(6-Aminohexyl)-1H-pyrrole-2,5-dione 2,2,2-trifluoroacetate | ESD-847854-100MG |
Cas.: 172314-56-6 | Purity: 95% | 4-Methyl-1,4-diazepan-5-one | ESD-847855-25MG |
Cas.: 172314-56-6 | Purity: 95% | 4-Methyl-1,4-diazepan-5-one | ESD-847855-100MG |
Cas.: 1353101-01-5 | Purity: 97% | 5,6,7,8-Tetrahydro-1,6-naphthyridin-3-amine hydrochloride | ESD-847856-25MG |
Cas.: 1353101-01-5 | Purity: 97% | 5,6,7,8-Tetrahydro-1,6-naphthyridin-3-amine hydrochloride | ESD-847856-100MG |
Cas.: 351210-07-6 | Purity: 98% | 3-Iodo-7-methoxy-1H-indazole | ESD-847857-25MG |
Cas.: 351210-07-6 | Purity: 98% | 3-Iodo-7-methoxy-1H-indazole | ESD-847857-100MG |
Cas.: 888721-83-3 | Purity: 95% | 6-Bromopyrrolo[2,1-f][1,2,4]triazin-4(3H)-one | ESD-847858-25MG |
Cas.: 888721-83-3 | Purity: 95% | 6-Bromopyrrolo[2,1-f][1,2,4]triazin-4(3H)-one | ESD-847858-100MG |
Cas.: 1346808-41-0 | Purity: 97% | 5-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoxazole | ESD-847859-25MG |
Cas.: 1346808-41-0 | Purity: 97% | 5-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoxazole | ESD-847859-100MG |
Cas.: 851768-35-9 | Purity: 95% | 5-Amino-3-methylbenzo[d]isoxazole | ESD-847860-25MG |
Cas.: 851768-35-9 | Purity: 95% | 5-Amino-3-methylbenzo[d]isoxazole | ESD-847860-100MG |
Cas.: 76240-19-2 | Purity: 95% | Ethyl 4-ethoxy-2-oxobut-3-enoate | ESD-847861-25MG |
Cas.: 76240-19-2 | Purity: 95% | Ethyl 4-ethoxy-2-oxobut-3-enoate | ESD-847861-100MG |
Cas.: 1439-08-3 | Purity: 97% | 5-Bromo-4-(tert-butyl)pyrimidine | ESD-847863-25MG |
Cas.: 1439-08-3 | Purity: 97% | 5-Bromo-4-(tert-butyl)pyrimidine | ESD-847863-100MG |
Cas.: 60729-38-6 | Purity: 98% | 3-Bromo-5-chlorothiophene-2-carboxylic acid | ESD-847864-25MG |
Cas.: 60729-38-6 | Purity: 98% | 3-Bromo-5-chlorothiophene-2-carboxylic acid | ESD-847864-100MG |
Cas.: 904745-62-6 | Purity: 98% | 5-(Bromomethyl)-2-chloro-3-iodopyridine | ESD-847865-25MG |
Cas.: 904745-62-6 | Purity: 98% | 5-(Bromomethyl)-2-chloro-3-iodopyridine | ESD-847865-100MG |
Cas.: 221135-63-3 | Purity: 98% | 5-Bromo-3,6-dimethylpyridin-2-amine | ESD-847866-25MG |
Cas.: 221135-63-3 | Purity: 98% | 5-Bromo-3,6-dimethylpyridin-2-amine | ESD-847866-100MG |
Cas.: 1799412-29-5 | Purity: 98% | tert-Butyl (3-acetylpyrazin-2-yl)carbamate | ESD-847867-25MG |
Cas.: 1799412-29-5 | Purity: 98% | tert-Butyl (3-acetylpyrazin-2-yl)carbamate | ESD-847867-100MG |
Cas.: 41566-80-7 | Purity: 97% | 4-Methoxy-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-847868-25MG |
Cas.: 41566-80-7 | Purity: 97% | 4-Methoxy-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-847868-100MG |
Cas.: 771583-12-1 | Purity: 97% | 2-(Aminomethyl)-4-bromoaniline | ESD-847869-25MG |
Cas.: 771583-12-1 | Purity: 97% | 2-(Aminomethyl)-4-bromoaniline | ESD-847869-100MG |
Cas.: 439814-87-6 | Purity: 97% | 4-Bromo-1-(dimethoxymethyl)-2-fluorobenzene | ESD-847870-25MG |
Cas.: 439814-87-6 | Purity: 97% | 4-Bromo-1-(dimethoxymethyl)-2-fluorobenzene | ESD-847870-100MG |
Cas.: 1057217-63-6 | Purity: 97% | 7-Bromoquinoline-2-carboxylic acid | ESD-847871-250MG |
Cas.: 1057217-63-6 | Purity: 97% | 7-Bromoquinoline-2-carboxylic acid | ESD-847871-1G |
Cas.: 302964-08-5 | Purity: 95% | 2-((6-Chloro-2-methylpyrimidin-4-yl)amino)-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide | ESD-847872-1G |
Cas.: 503821-94-1 | Purity: 95% | 3-Bromo-2-iodobenzoic acid | ESD-847873-250MG |
Cas.: 503821-94-1 | Purity: 95% | 3-Bromo-2-iodobenzoic acid | ESD-847873-1G |
Cas.: 166272-81-7 | Purity: 98% | Methyl 4-chloro-3-hydroxybenzoate | ESD-847874-250MG |
Cas.: 166272-81-7 | Purity: 98% | Methyl 4-chloro-3-hydroxybenzoate | ESD-847874-1G |
Cas.: 790667-43-5 | Purity: 97% | (R)-tert-Butyl 2-methyl-4-oxopiperidine-1-carboxylate | ESD-847875-100MG |
Cas.: 361456-68-0 | Purity: 97% | Benzo[d][1,3]dioxol-4-ylboronic acid | ESD-847876-25MG |
Cas.: 361456-68-0 | Purity: 97% | Benzo[d][1,3]dioxol-4-ylboronic acid | ESD-847876-100MG |
Cas.: 175290-73-0 | Purity: 95% | 6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanehydrazide hydrochloride | ESD-847877-25MG |
Cas.: 175290-73-0 | Purity: 95% | 6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanehydrazide hydrochloride | ESD-847877-100MG |
Cas.: 1060802-25-6 | Purity: 97% | 5-Bromo-4-chloropicolinic acid | ESD-847878-25MG |
Cas.: 1060802-25-6 | Purity: 97% | 5-Bromo-4-chloropicolinic acid | ESD-847878-100MG |
Cas.: 1180112-41-7 | Purity: 97% | tert-Butyl 1,7-diazaspiro[3.5]nonane-7-carboxylate | ESD-847880-25MG |
Cas.: 1180112-41-7 | Purity: 97% | tert-Butyl 1,7-diazaspiro[3.5]nonane-7-carboxylate | ESD-847880-100MG |
Cas.: 941710-30-1 | Purity: 97% | 7-Bromochroman | ESD-847881-25MG |
Cas.: 941710-30-1 | Purity: 97% | 7-Bromochroman | ESD-847881-100MG |
Cas.: 106976-23-2 | Purity: 97% | 5-Bromo-6-methylindoline-2,3-dione | ESD-847882-25MG |
Cas.: 106976-23-2 | Purity: 97% | 5-Bromo-6-methylindoline-2,3-dione | ESD-847882-100MG |
Cas.: 1646152-51-3 | Purity: 95% | Bis(oxazol-4-ylmethyl)amine hydrochloride | ESD-847883-25MG |
Cas.: 1646152-51-3 | Purity: 95% | Bis(oxazol-4-ylmethyl)amine hydrochloride | ESD-847883-100MG |
Cas.: 1416721-24-8 | Purity: 97% | 2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)benzaldehyde | ESD-847884-25MG |
Cas.: 1416721-24-8 | Purity: 97% | 2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)benzaldehyde | ESD-847884-100MG |
Cas.: 123853-39-4 | Purity: 95% | 4-(2,3-Dichlorophenyl)-5-(methoxycarbonyl)-2,6-dimethyl-1,4-dihydropyridine-3-carboxylic acid | ESD-847885-25MG |
Cas.: 123853-39-4 | Purity: 95% | 4-(2,3-Dichlorophenyl)-5-(methoxycarbonyl)-2,6-dimethyl-1,4-dihydropyridine-3-carboxylic acid | ESD-847885-100MG |
Cas.: 1313584-92-7 | Purity: 97% | (S)-Morpholin-2-ylmethanol hydrochloride | ESD-847886-250MG |
Cas.: 1313584-92-7 | Purity: 97% | (S)-Morpholin-2-ylmethanol hydrochloride | ESD-847886-1G |
Cas.: 90555-65-0 | Purity: 97% | 3-Ethylphenylboronic acid | ESD-847887-250MG |
Cas.: 90555-65-0 | Purity: 97% | 3-Ethylphenylboronic acid | ESD-847887-1G |
Cas.: 29840-57-1 | Purity: 95% | Ethyl 5-aminovalerate hydrochloride | ESD-847889-250MG |
Cas.: 29840-57-1 | Purity: 95% | Ethyl 5-aminovalerate hydrochloride | ESD-847889-1G |
Cas.: 63878-68-2 | Purity: 98% | 1-Fluoro-2-(fluoromethyl)-4-nitrobenzene | ESD-847890-25MG |
Cas.: 63878-68-2 | Purity: 98% | 1-Fluoro-2-(fluoromethyl)-4-nitrobenzene | ESD-847890-100MG |
Cas.: 887582-58-3 | Purity: 97% | (6-Methoxy-1H-indol-3-yl)methanamine | ESD-847891-25MG |
Cas.: 887582-58-3 | Purity: 97% | (6-Methoxy-1H-indol-3-yl)methanamine | ESD-847891-100MG |
Cas.: 5423-53-0 | Purity: 97% | 3-Amino-7-chloro-1,2,4-benzotriazine | ESD-847892-25MG |
Cas.: 5423-53-0 | Purity: 97% | 3-Amino-7-chloro-1,2,4-benzotriazine | ESD-847892-100MG |
Cas.: 859721-53-2 | Purity: 96% | 4-(4-(Trifluoromethyl)phenyl)oxazol-2-amine | ESD-847893-25MG |
Cas.: 859721-53-2 | Purity: 96% | 4-(4-(Trifluoromethyl)phenyl)oxazol-2-amine | ESD-847893-100MG |
Cas.: 953092-76-7 | Purity: 98% | Methyl 5-chloro-3-hydroxythiophene-2-carboxylate | ESD-847894-25MG |
Cas.: 953092-76-7 | Purity: 98% | Methyl 5-chloro-3-hydroxythiophene-2-carboxylate | ESD-847894-100MG |
Cas.: 955929-54-1 | Purity: 95% | Methyl 2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate | ESD-847895-25MG |
Cas.: 955929-54-1 | Purity: 95% | Methyl 2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate | ESD-847895-100MG |
Cas.: 1153769-18-6 | Purity: 96% | 1-(4-Chloropicolinoyl)piperidine-4-carboxylic acid | ESD-847896-25MG |
Cas.: 1153769-18-6 | Purity: 96% | 1-(4-Chloropicolinoyl)piperidine-4-carboxylic acid | ESD-847896-100MG |
Cas.: 139957-82-7 | Purity: 98% | 2-Chloro-5-ethynylthiophene | ESD-847897-25MG |
Cas.: 139957-82-7 | Purity: 98% | 2-Chloro-5-ethynylthiophene | ESD-847897-100MG |
Cas.: 932035-01-3 | Purity: 95% | 1-tert-Butyl 3-ethyl 4-aminopiperidine-1,3-dicarboxylate | ESD-847898-25MG |
Cas.: 932035-01-3 | Purity: 95% | 1-tert-Butyl 3-ethyl 4-aminopiperidine-1,3-dicarboxylate | ESD-847898-100MG |
Cas.: 959237-30-0 | Purity: 98% | 2,4-Dichloro-5-iodoquinazoline | ESD-847899-25MG |
Cas.: 959237-30-0 | Purity: 98% | 2,4-Dichloro-5-iodoquinazoline | ESD-847899-100MG |
Cas.: 1016258-66-4 | Purity: 95% | 1-tert-Butyl 4-ethyl 4-cyanopiperidine-1,4-dicarboxylate | ESD-847900-25MG |
Cas.: 1016258-66-4 | Purity: 95% | 1-tert-Butyl 4-ethyl 4-cyanopiperidine-1,4-dicarboxylate | ESD-847900-100MG |
Cas.: 960299-06-3 | Purity: 95% | 4-Chloro-6-methoxy-5-methylpyrimidine | ESD-847901-25MG |
Cas.: 960299-06-3 | Purity: 95% | 4-Chloro-6-methoxy-5-methylpyrimidine | ESD-847901-100MG |
Cas.: 54994-35-3 | Purity: 95% | 2-Chloro-6-phenylpyrimidin-4-amine | ESD-847902-25MG |
Cas.: 54994-35-3 | Purity: 95% | 2-Chloro-6-phenylpyrimidin-4-amine | ESD-847902-100MG |
Cas.: 852110-51-1 | Purity: 97% | (7-Bromo-2,3-dihydrobenzofuran-2-yl)methanol | ESD-847903-25MG |
Cas.: 852110-51-1 | Purity: 97% | (7-Bromo-2,3-dihydrobenzofuran-2-yl)methanol | ESD-847903-100MG |
Cas.: 144542-46-1 | Purity: 95% | (R)-4-(Iodomethyl)oxazolidin-2-one | ESD-847904-25MG |
Cas.: 144542-46-1 | Purity: 95% | (R)-4-(Iodomethyl)oxazolidin-2-one | ESD-847904-100MG |
Cas.: 1159821-42-7 | Purity: 97% | 5-Cyclopropylpyridin-2-ol | ESD-847905-25MG |
Cas.: 1159821-42-7 | Purity: 97% | 5-Cyclopropylpyridin-2-ol | ESD-847905-100MG |
Cas.: 1631962-79-2 | Purity: 98% | 1-Fluoro-3-methoxy-5-methyl-2-nitrobenzene | ESD-847906-25MG |
Cas.: 1631962-79-2 | Purity: 98% | 1-Fluoro-3-methoxy-5-methyl-2-nitrobenzene | ESD-847906-100MG |
Cas.: 1211596-30-3 | Purity: 98% | 2-Iodo-6-methylpyridin-3-amine | ESD-847907-25MG |
Cas.: 1211596-30-3 | Purity: 98% | 2-Iodo-6-methylpyridin-3-amine | ESD-847907-100MG |
Cas.: 52423-70-8 | Purity: 95% | 2-(3-(4-Chlorophenyl)pyrrolidin-3-yl)ethanol | ESD-847908-25MG |
Cas.: 52423-70-8 | Purity: 95% | 2-(3-(4-Chlorophenyl)pyrrolidin-3-yl)ethanol | ESD-847908-100MG |
Cas.: 81303-52-8 | Purity: 98% | Ethyl 5-carbamoyl-1-methyl-1H-pyrazole-4-carboxylate | ESD-847909-25MG |
Cas.: 81303-52-8 | Purity: 98% | Ethyl 5-carbamoyl-1-methyl-1H-pyrazole-4-carboxylate | ESD-847909-100MG |
Cas.: 677304-89-1 | Purity: 98% | Ethyl 2-aminobenzo[d]thiazole-7-carboxylate | ESD-847910-25MG |
Cas.: 677304-89-1 | Purity: 98% | Ethyl 2-aminobenzo[d]thiazole-7-carboxylate | ESD-847910-100MG |
Cas.: 56857-47-7 | Purity: 95% | (S)-2-((Carboxymethyl)amino)propanoic acid | ESD-847911-25MG |
Cas.: 56857-47-7 | Purity: 95% | (S)-2-((Carboxymethyl)amino)propanoic acid | ESD-847911-100MG |
Cas.: 1123172-38-2 | Purity: 95% | 1-Bromo-3-(tert-butyl)-5-fluorobenzene | ESD-847912-25MG |
Cas.: 1123172-38-2 | Purity: 95% | 1-Bromo-3-(tert-butyl)-5-fluorobenzene | ESD-847912-100MG |
Cas.: 957760-15-5 | Purity: 98% | 7-Chloro-1-methyl-1H-pyrazolo[3,4-c]pyridine | ESD-847913-25MG |
Cas.: 957760-15-5 | Purity: 98% | 7-Chloro-1-methyl-1H-pyrazolo[3,4-c]pyridine | ESD-847913-100MG |
Cas.: 56881-21-1 | Purity: 97% | Ethyl 7-aminothieno[2,3-b]pyrazine-6-carboxylate | ESD-847914-250MG |
Cas.: 56881-21-1 | Purity: 97% | Ethyl 7-aminothieno[2,3-b]pyrazine-6-carboxylate | ESD-847914-1G |
Cas.: 86718-01-6 | Purity: 95% | Methyl imidazo[1,2-a]pyridine-7-carboxylate | ESD-847915-250MG |
Cas.: 86718-01-6 | Purity: 95% | Methyl imidazo[1,2-a]pyridine-7-carboxylate | ESD-847915-1G |
Cas.: 115932-00-8 | Purity: 95% | Ethyl pyrazolo[1,5-a]pyrimidine-3-carboxylate | ESD-847916-250MG |
Cas.: 115932-00-8 | Purity: 95% | Ethyl pyrazolo[1,5-a]pyrimidine-3-carboxylate | ESD-847916-1G |
Cas.: 532440-88-3 | Purity: 98% | 2-Bromo-5-methoxy-4-methylaniline | ESD-847917-250MG |
Cas.: 532440-88-3 | Purity: 98% | 2-Bromo-5-methoxy-4-methylaniline | ESD-847917-1G |
Cas.: 380431-78-7 | Purity: 98% | 7-Bromo-5-fluoroindoline-2,3-dione | ESD-847918-250MG |
Cas.: 380431-78-7 | Purity: 98% | 7-Bromo-5-fluoroindoline-2,3-dione | ESD-847918-1G |
Cas.: 19030-75-2 | Purity: 98% | 5-N-Propyluracil | ESD-847919-250MG |
Cas.: 19030-75-2 | Purity: 98% | 5-N-Propyluracil | ESD-847919-1G |
Cas.: 400071-95-6 | Purity: 98% | 5-Bromo-1-methyl-1H-indole-3-carboxylic acid | ESD-847920-250MG |
Cas.: 400071-95-6 | Purity: 98% | 5-Bromo-1-methyl-1H-indole-3-carboxylic acid | ESD-847920-1G |
Cas.: 49674-28-4 | Purity: 98% | 3-Amino-5-(trifluoromethyl)benzonitrile | ESD-847921-250MG |
Cas.: 49674-28-4 | Purity: 98% | 3-Amino-5-(trifluoromethyl)benzonitrile | ESD-847921-1G |
Cas.: 137640-84-7 | Purity: 98% | 6-(3-(Trifluoromethyl)phenoxy)picolinic acid | ESD-847922-250MG |
Cas.: 137640-84-7 | Purity: 98% | 6-(3-(Trifluoromethyl)phenoxy)picolinic acid | ESD-847922-1G |
Cas.: 3920-38-5 | Purity: 97% | 1,3-Dimethyl-4-nitro-1H-pyrazole | ESD-847923-250MG |
Cas.: 3920-38-5 | Purity: 97% | 1,3-Dimethyl-4-nitro-1H-pyrazole | ESD-847923-1G |
Cas.: 1203898-21-8 | Purity: 98% | 2-Bromo-4-chloro-5-(trifluoromethyl)phenol | ESD-847924-250MG |
Cas.: 1203898-21-8 | Purity: 98% | 2-Bromo-4-chloro-5-(trifluoromethyl)phenol | ESD-847924-1G |
Cas.: 864754-16-5 | Purity: 97% | Ethyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)acetate | ESD-847925-250MG |
Cas.: 864754-16-5 | Purity: 97% | Ethyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)acetate | ESD-847925-1G |
Cas.: 396092-82-3 | Purity: 95% | 2-Bromo-N,N-dimethylpyridin-4-amine | ESD-847926-250MG |
Cas.: 1046079-35-9 | Purity: 97% | 5-(Piperidin-4-yl)-1,3,4-oxadiazol-2(3H)-one hydrochloride | ESD-847927-250MG |
Cas.: 1046079-35-9 | Purity: 97% | 5-(Piperidin-4-yl)-1,3,4-oxadiazol-2(3H)-one hydrochloride | ESD-847927-1G |
Cas.: 13808-65-6 | Purity: 98% | 4-Bromo-3-phenyl-1H-pyrazole | ESD-847928-250MG |
Cas.: 13808-65-6 | Purity: 98% | 4-Bromo-3-phenyl-1H-pyrazole | ESD-847928-1G |
Cas.: 61367-16-6 | Purity: 97% | cis-Methyl 4-aminocyclohexanecarboxylate hydrochloride | ESD-847929-250MG |
Cas.: 61367-16-6 | Purity: 97% | cis-Methyl 4-aminocyclohexanecarboxylate hydrochloride | ESD-847929-1G |
Cas.: 88211-50-1 | Purity: 97% | But-3-yn-1-amine hydrochloride | ESD-847930-250MG |
Cas.: 88211-50-1 | Purity: 97% | But-3-yn-1-amine hydrochloride | ESD-847930-1G |
Cas.: 408502-23-8 | Purity: 97% | 2-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-847931-250MG |
Cas.: 408502-23-8 | Purity: 97% | 2-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-847931-1G |
Cas.: 1389313-40-9 | Purity: 95% | 2-(5-(Trifluoromethoxy)-1H-indol-3-yl)ethanamine hydrochloride | ESD-847932-50MG |
Cas.: 1389313-40-9 | Purity: 95% | 2-(5-(Trifluoromethoxy)-1H-indol-3-yl)ethanamine hydrochloride | ESD-847932-250MG |
Cas.: 89792-07-4 | Purity: 95% | 2-Methyl-7H-pyrrolo[2,3-d]pyrimidine | ESD-847933-50MG |
Cas.: 89792-07-4 | Purity: 95% | 2-Methyl-7H-pyrrolo[2,3-d]pyrimidine | ESD-847933-250MG |
Cas.: 76305-83-4 | Purity: 95% | 2,2′-(Propane-1,3-diyldisulfinyl)diethanol | ESD-847934-25MG |
Cas.: 76305-83-4 | Purity: 95% | 2,2′-(Propane-1,3-diyldisulfinyl)diethanol | ESD-847934-100MG |
Cas.: 1251732-64-5 | Purity: 95% | tert-Butyl (4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl)carbamate | ESD-847935-250MG |
Cas.: 1251732-64-5 | Purity: 95% | tert-Butyl (4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl)carbamate | ESD-847935-1G |
Cas.: 64574-21-6 | Purity: 95% | 1H-Benzo[d]imidazole-4-carbonitrile | ESD-847936-25MG |
Cas.: 64574-21-6 | Purity: 95% | 1H-Benzo[d]imidazole-4-carbonitrile | ESD-847936-100MG |
Cas.: 903513-62-2 | Purity: 97% | (2-Aminopyridin-4-yl)boronic acid | ESD-847937-25MG |
Cas.: 903513-62-2 | Purity: 97% | (2-Aminopyridin-4-yl)boronic acid | ESD-847937-100MG |
Cas.: 14293-44-8 | Purity: 95% | 4-Chloro-N-(2,6-dimethylphenyl)-2-hydroxy-5-sulfamoylbenzamide | ESD-847938-25MG |
Cas.: 14293-44-8 | Purity: 95% | 4-Chloro-N-(2,6-dimethylphenyl)-2-hydroxy-5-sulfamoylbenzamide | ESD-847938-100MG |
Cas.: 904814-72-8 | Purity: 95% | 3-Bromo-2-phenylimidazo[1,2-a]pyrimidine | ESD-847939-25MG |
Cas.: 904814-72-8 | Purity: 95% | 3-Bromo-2-phenylimidazo[1,2-a]pyrimidine | ESD-847939-100MG |
Cas.: 1073372-04-9 | Purity: 97% | 1-(Phenylsulfonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-847940-250MG |
Cas.: 1073372-04-9 | Purity: 97% | 1-(Phenylsulfonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-847940-1G |
Cas.: 149506-79-6 | Purity: 98% | 4-(Dibenzylamino)cyclohexanone | ESD-847941-250MG |
Cas.: 149506-79-6 | Purity: 98% | 4-(Dibenzylamino)cyclohexanone | ESD-847941-1G |
Cas.: 6924-72-7 | Purity: 97% | Ethyl quinoxaline-6-carboxylate | ESD-847942-250MG |
Cas.: 6924-72-7 | Purity: 97% | Ethyl quinoxaline-6-carboxylate | ESD-847942-1G |
Cas.: 3273-44-7 | Purity: 97% | 5-Methyl-1H-pyrazole-3-carbaldehyde | ESD-847943-250MG |
Cas.: 3273-44-7 | Purity: 97% | 5-Methyl-1H-pyrazole-3-carbaldehyde | ESD-847943-1G |
Cas.: 1159599-99-1 | Purity: 97% | 2-Oxa-6-azaspiro[3.3]heptane oxalate | ESD-847944-250MG |
Cas.: 1159599-99-1 | Purity: 97% | 2-Oxa-6-azaspiro[3.3]heptane oxalate | ESD-847944-1G |
Cas.: 46112-46-3 | Purity: 95% | 4-(2-Hydroxyethyl)benzoic acid | ESD-847945-50MG |
Cas.: 46112-46-3 | Purity: 95% | 4-(2-Hydroxyethyl)benzoic acid | ESD-847945-250MG |
Cas.: 479195-19-2 | Purity: 98% | 2-Oxa-8-azaspiro[4.5]decane hydrochloride | ESD-847946-50MG |
Cas.: 479195-19-2 | Purity: 98% | 2-Oxa-8-azaspiro[4.5]decane hydrochloride | ESD-847946-250MG |
Cas.: 5028-17-1 | Purity: 97% | 2-(4-Methylpiperazin-1-yl)pyridin-3-amine | ESD-847947-250MG |
Cas.: 5028-17-1 | Purity: 97% | 2-(4-Methylpiperazin-1-yl)pyridin-3-amine | ESD-847947-1G |
Cas.: 730980-49-1 | Purity: 95% | (R)-8-Fluorochroman-4-amine hydrochloride | ESD-847948-25MG |
Cas.: 730980-49-1 | Purity: 95% | (R)-8-Fluorochroman-4-amine hydrochloride | ESD-847948-100MG |
Cas.: 149498-96-4 | Purity: 98% | Ethyl 3-amino-3-(pyridin-3-yl)propanoate dihydrochloride | ESD-847949-250MG |
Cas.: 149498-96-4 | Purity: 98% | Ethyl 3-amino-3-(pyridin-3-yl)propanoate dihydrochloride | ESD-847949-1G |
Cas.: 1263378-01-3 | Purity: 97% | N-Methyl-4-(methylsulfonyl)aniline hydrochloride | ESD-847950-250MG |
Cas.: 1263378-01-3 | Purity: 97% | N-Methyl-4-(methylsulfonyl)aniline hydrochloride | ESD-847950-1G |
Cas.: 541508-27-4 | Purity: 95% | 1-(5-Chloro-2-fluorophenyl)ethanone | ESD-847951-250MG |
Cas.: 541508-27-4 | Purity: 95% | 1-(5-Chloro-2-fluorophenyl)ethanone | ESD-847951-1G |
Cas.: 1083057-14-0 | Purity: 98% | tert-Butyl 3-(6-amino-3-methylpyridin-2-yl)benzoate | ESD-847952-50MG |
Cas.: 1083057-14-0 | Purity: 98% | tert-Butyl 3-(6-amino-3-methylpyridin-2-yl)benzoate | ESD-847952-250MG |
Cas.: 403850-84-0 | Purity: 97% | 7-Bromo-4-chloro-2-methylquinazoline | ESD-847953-100MG |
Cas.: 80827-67-4 | Purity: 97% | 1-(3-Methoxypyridin-2-yl)piperazine | ESD-847954-25MG |
Cas.: 80827-67-4 | Purity: 97% | 1-(3-Methoxypyridin-2-yl)piperazine | ESD-847954-100MG |
Cas.: 1217482-26-2 | Purity: 97% | (R)-Piperazin-2-ylmethanol dihydrochloride | ESD-847956-25MG |
Cas.: 1217482-26-2 | Purity: 97% | (R)-Piperazin-2-ylmethanol dihydrochloride | ESD-847956-100MG |
Cas.: 765914-78-1 | Purity: 97% | 4-Boc-2-(bromomethyl)morpholine | ESD-847957-25MG |
Cas.: 765914-78-1 | Purity: 97% | 4-Boc-2-(bromomethyl)morpholine | ESD-847957-100MG |
Cas.: 6775-40-2 | Purity: 98% | 5-Phenyl-1H-imidazol-2-amine | ESD-847958-25MG |
Cas.: 6775-40-2 | Purity: 98% | 5-Phenyl-1H-imidazol-2-amine | ESD-847958-100MG |
Cas.: 501009-05-8 | Purity: 98% | 1-(6-Fluoropyridin-2-yl)ethanone | ESD-847959-25MG |
Cas.: 501009-05-8 | Purity: 98% | 1-(6-Fluoropyridin-2-yl)ethanone | ESD-847959-100MG |
Cas.: 76053-45-7 | Purity: 98% | 5-Phenylpyridin-2-ol | ESD-847960-25MG |
Cas.: 76053-45-7 | Purity: 98% | 5-Phenylpyridin-2-ol | ESD-847960-100MG |
Cas.: 863032-29-5 | Purity: 95% | Methyl 2-(pyrimidin-4-yl)acetate | ESD-847961-25MG |
Cas.: 863032-29-5 | Purity: 95% | Methyl 2-(pyrimidin-4-yl)acetate | ESD-847961-100MG |
Cas.: 1256806-83-3 | Purity: 98% | 6-Chloro-5-fluoropyridin-3-amine | ESD-847962-25MG |
Cas.: 1256806-83-3 | Purity: 98% | 6-Chloro-5-fluoropyridin-3-amine | ESD-847962-100MG |
Cas.: 16257-84-4 | Purity: 97% | (2S,4S)-4-Aminopyrrolidine-2-carboxylic acid dihydrochloride | ESD-847963-25MG |
Cas.: 16257-84-4 | Purity: 97% | (2S,4S)-4-Aminopyrrolidine-2-carboxylic acid dihydrochloride | ESD-847963-100MG |
Cas.: 1807149-82-1 | Purity: 98% | Ethyl 6-bromo-5-methylpicolinate | ESD-847964-25MG |
Cas.: 1807149-82-1 | Purity: 98% | Ethyl 6-bromo-5-methylpicolinate | ESD-847964-100MG |
Cas.: 885523-35-3 | Purity: 96% | Methyl 7-bromo-1H-indole-5-carboxylate | ESD-847965-25MG |
Cas.: 885523-35-3 | Purity: 96% | Methyl 7-bromo-1H-indole-5-carboxylate | ESD-847965-100MG |
Cas.: 333998-11-1 | Purity: 98% | 6-Chloro-2-fluoro-3-nitropyridine | ESD-847966-25MG |
Cas.: 333998-11-1 | Purity: 98% | 6-Chloro-2-fluoro-3-nitropyridine | ESD-847966-100MG |
Cas.: 1268683-45-9 | Purity: 98% | (5-(Hydroxymethyl)thiophen-3-yl)boronic acid | ESD-847967-25MG |
Cas.: 1268683-45-9 | Purity: 98% | (5-(Hydroxymethyl)thiophen-3-yl)boronic acid | ESD-847967-100MG |
Cas.: 30482-66-7 | Purity: 97% | Ethyl 6-bromo-4-oxo-3,4-dihydro-2H-benzo[e][1,3]oxazine-2-carboxylate | ESD-847968-25MG |
Cas.: 30482-66-7 | Purity: 97% | Ethyl 6-bromo-4-oxo-3,4-dihydro-2H-benzo[e][1,3]oxazine-2-carboxylate | ESD-847968-100MG |
Cas.: 148983-03-3 | Purity: 98% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-cyclohexylpropanoic acid | ESD-847969-100MG |
Cas.: 68755-29-3 | Purity: 97% | 4-Chloro-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-847970-25MG |
Cas.: 68755-29-3 | Purity: 97% | 4-Chloro-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-847970-100MG |
Cas.: 933759-45-6 | Purity: 95% | 2-(Dimethylamino)pyrimidine-4-carboxylic acid | ESD-847971-25MG |
Cas.: 933759-45-6 | Purity: 95% | 2-(Dimethylamino)pyrimidine-4-carboxylic acid | ESD-847971-100MG |
Cas.: 1217599-13-7 | Purity: 95% | (R)-1-Boc-2-Isobutylpiperazine | ESD-847972-250MG |
Cas.: 1217599-13-7 | Purity: 95% | (R)-1-Boc-2-Isobutylpiperazine | ESD-847972-1G |
Cas.: 439117-38-1 | Purity: 98% | Methyl 5-chloro-2-cyanobenzoate | ESD-847973-250MG |
Cas.: 439117-38-1 | Purity: 98% | Methyl 5-chloro-2-cyanobenzoate | ESD-847973-1G |
Cas.: 1351479-09-8 | Purity: 95% | (1H-Pyrrol-2-yl)methanamine hydrochloride | ESD-847974-250MG |
Cas.: 1351479-09-8 | Purity: 95% | (1H-Pyrrol-2-yl)methanamine hydrochloride | ESD-847974-1G |
Cas.: 1350738-87-2 | Purity: 97% | 7-Bromo-3,4-dihydro-2H-benzo[b][1,4]oxazine hydrochloride | ESD-847975-250MG |
Cas.: 1350738-87-2 | Purity: 97% | 7-Bromo-3,4-dihydro-2H-benzo[b][1,4]oxazine hydrochloride | ESD-847975-1G |
Cas.: 1019108-05-4 | Purity: 98% | 3H-Imidazo[4,5-b]pyridine-5-carboxylic acid | ESD-847976-250MG |
Cas.: 1019108-05-4 | Purity: 98% | 3H-Imidazo[4,5-b]pyridine-5-carboxylic acid | ESD-847976-1G |
Cas.: 45695-03-2 | Purity: 95% | (R)-1-(Pyridin-2-yl)ethanamine | ESD-847977-250MG |
Cas.: 45695-03-2 | Purity: 95% | (R)-1-(Pyridin-2-yl)ethanamine | ESD-847977-1G |
Cas.: 141238-23-5 | Purity: 98% | 3-Chloro-5-nitropicolinic acid | ESD-847978-25MG |
Cas.: 141238-23-5 | Purity: 98% | 3-Chloro-5-nitropicolinic acid | ESD-847978-100MG |
Cas.: 93224-07-8 | Purity: 95% | 5-(Bromomethyl)pyrimidine hydrobromide | ESD-847979-25MG |
Cas.: 93224-07-8 | Purity: 95% | 5-(Bromomethyl)pyrimidine hydrobromide | ESD-847979-100MG |
Cas.: 220364-34-1 | Purity: 98% | tert-Butyl 3-(bromomethyl)benzylcarbamate | ESD-847980-50MG |
Cas.: 220364-34-1 | Purity: 98% | tert-Butyl 3-(bromomethyl)benzylcarbamate | ESD-847980-250MG |
Cas.: 221241-11-8 | Purity: 98% | 2,5-Dibromopyridine-3,4-diamine | ESD-847982-250MG |
Cas.: 221241-11-8 | Purity: 98% | 2,5-Dibromopyridine-3,4-diamine | ESD-847982-1G |
Cas.: 86967-55-7 | Purity: 95% | 2-(Morpholin-3-yl)acetic acid hydrochloride | ESD-847983-25MG |
Cas.: 86967-55-7 | Purity: 95% | 2-(Morpholin-3-yl)acetic acid hydrochloride | ESD-847983-100MG |
Cas.: 1027513-14-9 | Purity: 95% | 1-Fluoro-3-iodo-5-(trifluoromethyl)benzene | ESD-847984-25MG |
Cas.: 1027513-14-9 | Purity: 95% | 1-Fluoro-3-iodo-5-(trifluoromethyl)benzene | ESD-847984-100MG |
Cas.: 1215074-47-7 | Purity: 98% | 8-Bromo-2,3,4,5-tetrahydrobenzo[f][1,4]oxazepine | ESD-847985-25MG |
Cas.: 1215074-47-7 | Purity: 98% | 8-Bromo-2,3,4,5-tetrahydrobenzo[f][1,4]oxazepine | ESD-847985-100MG |
Cas.: 1198103-43-3 | Purity: 97% | (6-(Difluoromethoxy)pyridin-3-yl)methanamine | ESD-847986-25MG |
Cas.: 1198103-43-3 | Purity: 97% | (6-(Difluoromethoxy)pyridin-3-yl)methanamine | ESD-847986-100MG |
Cas.: 386267-31-8 | Purity: 97% | Ethyl 3-bromo-4-iodobenzoate | ESD-847987-50MG |
Cas.: 386267-31-8 | Purity: 97% | Ethyl 3-bromo-4-iodobenzoate | ESD-847987-250MG |
Cas.: 1394041-16-7 | Purity: 95% | 1-(3-Aminopyrrolidin-1-yl)ethanone hydrochloride | ESD-847988-50MG |
Cas.: 1394041-16-7 | Purity: 95% | 1-(3-Aminopyrrolidin-1-yl)ethanone hydrochloride | ESD-847988-250MG |
Cas.: 204378-42-7 | Purity: 98% | 2-Chloro-3-methoxy-6-methylpyridine | ESD-847989-50MG |
Cas.: 204378-42-7 | Purity: 98% | 2-Chloro-3-methoxy-6-methylpyridine | ESD-847989-250MG |
Cas.: 40590-77-0 | Purity: 95% | 1-(Bicyclo[2.2.2]oct-5-en-2-yl)ethanone | ESD-847990-50MG |
Cas.: 40590-77-0 | Purity: 95% | 1-(Bicyclo[2.2.2]oct-5-en-2-yl)ethanone | ESD-847990-250MG |
Cas.: 23699-65-2 | Purity: 97% | 1-(3-(Phenylamino)phenyl)ethanone | ESD-847991-50MG |
Cas.: 23699-65-2 | Purity: 97% | 1-(3-(Phenylamino)phenyl)ethanone | ESD-847991-250MG |
Cas.: 1398534-59-2 | Purity: 95% | Methyl 3-aminocyclopentanecarboxylate hydrochloride | ESD-847992-250MG |
Cas.: 1398534-59-2 | Purity: 95% | Methyl 3-aminocyclopentanecarboxylate hydrochloride | ESD-847992-1G |
Cas.: 797762-23-3 | Purity: 95% | 2-(3-Methoxybenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-847993-25MG |
Cas.: 797762-23-3 | Purity: 95% | 2-(3-Methoxybenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-847993-100MG |
Cas.: 261767-10-6 | Purity: 97% | Ethyl 2,3-dihydrobenzo[b][1,4]dioxine-5-carboxylate | ESD-847994-25MG |
Cas.: 261767-10-6 | Purity: 97% | Ethyl 2,3-dihydrobenzo[b][1,4]dioxine-5-carboxylate | ESD-847994-100MG |
Cas.: 766513-53-5 | Purity: 97% | (5-(Trifluoromethyl)pyridin-3-yl)methanamine | ESD-847995-25MG |
Cas.: 766513-53-5 | Purity: 97% | (5-(Trifluoromethyl)pyridin-3-yl)methanamine | ESD-847995-100MG |
Cas.: 942920-55-0 | Purity: 96% | Ethyl 4-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate | ESD-847996-25MG |
Cas.: 942920-55-0 | Purity: 96% | Ethyl 4-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate | ESD-847996-100MG |
Cas.: 91749-26-7 | Purity: 98% | 5-Iodo-4-methylpyrimidine | ESD-847997-25MG |
Cas.: 91749-26-7 | Purity: 98% | 5-Iodo-4-methylpyrimidine | ESD-847997-100MG |
Cas.: 33626-08-3 | Purity: 98% | (E)-5-(4-Methoxystylyl)benzene-1,3-diol | ESD-847998-25MG |
Cas.: 33626-08-3 | Purity: 98% | (E)-5-(4-Methoxystylyl)benzene-1,3-diol | ESD-847998-100MG |
Cas.: 53180-92-0 | Purity: 95% | 5-Chloropyridazin-4-amine | ESD-847999-25MG |
Cas.: 53180-92-0 | Purity: 95% | 5-Chloropyridazin-4-amine | ESD-847999-100MG |
Cas.: 1245648-32-1 | Purity: 98% | tert-Butyl 4-oxo-2-(trifluoromethyl)piperidine-1-carboxylate | ESD-848000-25MG |
Cas.: 1245648-32-1 | Purity: 98% | tert-Butyl 4-oxo-2-(trifluoromethyl)piperidine-1-carboxylate | ESD-848000-100MG |
Cas.: 1094070-46-8 | Purity: 95% | 6-Methyl-8-methylsulfanyl-imidazo[1,2-a]pyrazine | ESD-848001-25MG |
Cas.: 1094070-46-8 | Purity: 95% | 6-Methyl-8-methylsulfanyl-imidazo[1,2-a]pyrazine | ESD-848001-100MG |
Cas.: 1002334-06-6 | Purity: 98% | 1-Methyl-3-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-848002-25MG |
Cas.: 1002334-06-6 | Purity: 98% | 1-Methyl-3-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-848002-100MG |
Cas.: 1257106-65-2 | Purity: 95% | (R)-1-(3-Chloro-4-fluorophenyl)ethanamine hydrochloride | ESD-848003-25MG |
Cas.: 1257106-65-2 | Purity: 95% | (R)-1-(3-Chloro-4-fluorophenyl)ethanamine hydrochloride | ESD-848003-100MG |
Cas.: 1253792-97-0 | Purity: 95% | (R)-1-(3-Chloro-2-fluorophenyl)ethanamine hydrochloride | ESD-848004-25MG |
Cas.: 1253792-97-0 | Purity: 95% | (R)-1-(3-Chloro-2-fluorophenyl)ethanamine hydrochloride | ESD-848004-100MG |
Cas.: 1092351-96-6 | Purity: 97% | Methyl 2-bromooxazole-5-carboxylate | ESD-848005-25MG |
Cas.: 1092351-96-6 | Purity: 97% | Methyl 2-bromooxazole-5-carboxylate | ESD-848005-100MG |
Cas.: 1257861-04-3 | Purity: 95% | Ethyl 3-bromo-4-methyl-1H-pyrazole-5-carboxylate | ESD-848006-25MG |
Cas.: 1257861-04-3 | Purity: 95% | Ethyl 3-bromo-4-methyl-1H-pyrazole-5-carboxylate | ESD-848006-100MG |
Cas.: 858851-27-1 | Purity: 95% | 2,2,5,5-Tetramethylpiperazine dihydrochloride | ESD-848007-25MG |
Cas.: 858851-27-1 | Purity: 95% | 2,2,5,5-Tetramethylpiperazine dihydrochloride | ESD-848007-100MG |
Cas.: 6219-58-5 | Purity: 97% | 2-(1H-1,2,4-triazol-5-yl)aniline | ESD-848008-25MG |
Cas.: 6219-58-5 | Purity: 97% | 2-(1H-1,2,4-triazol-5-yl)aniline | ESD-848008-100MG |
Cas.: 1146699-64-0 | Purity: 97% | 3-(4-(Bromomethyl)-3-fluorophenyl)-1,2,4-oxadiazole | ESD-848009-25MG |
Cas.: 1146699-64-0 | Purity: 97% | 3-(4-(Bromomethyl)-3-fluorophenyl)-1,2,4-oxadiazole | ESD-848009-100MG |
Cas.: 139138-08-2 | Purity: 98% | 2-Amino-4-bromo-6-nitrophenol | ESD-848010-25MG |
Cas.: 139138-08-2 | Purity: 98% | 2-Amino-4-bromo-6-nitrophenol | ESD-848010-100MG |
Cas.: 1452518-88-5 | Purity: 97% | Methyl 4,5-diaminothiophene-2-carboxylate dihydrochloride | ESD-848011-25MG |
Cas.: 1452518-88-5 | Purity: 97% | Methyl 4,5-diaminothiophene-2-carboxylate dihydrochloride | ESD-848011-100MG |
Cas.: 566943-99-5 | Purity: 98% | 5-Chloroisoquinolin-6-amine | ESD-848012-25MG |
Cas.: 566943-99-5 | Purity: 98% | 5-Chloroisoquinolin-6-amine | ESD-848012-100MG |
Cas.: 133382-42-0 | Purity: 95% | 1-Oxa-8-azaspiro[4.5]decan-3-one hydrochloride | ESD-848013-25MG |
Cas.: 133382-42-0 | Purity: 95% | 1-Oxa-8-azaspiro[4.5]decan-3-one hydrochloride | ESD-848013-100MG |
Cas.: 871583-21-0 | Purity: 95% | Methyl 6-chloro-4-methoxy-1H-pyrrolo[3,2-c]pyridine-2-carboxylate | ESD-848014-25MG |
Cas.: 871583-21-0 | Purity: 95% | Methyl 6-chloro-4-methoxy-1H-pyrrolo[3,2-c]pyridine-2-carboxylate | ESD-848014-100MG |
Cas.: 1802489-60-6 | Purity: 98% | (6-Bromo-2-methoxypyridin-3-yl)methanol | ESD-848015-25MG |
Cas.: 1802489-60-6 | Purity: 98% | (6-Bromo-2-methoxypyridin-3-yl)methanol | ESD-848015-100MG |
Cas.: 1513412-80-0 | Purity: 98% | 6-Methyl-1H-indole-2-carbonitrile | ESD-848016-25MG |
Cas.: 1513412-80-0 | Purity: 98% | 6-Methyl-1H-indole-2-carbonitrile | ESD-848016-100MG |
Cas.: 237435-19-7 | Purity: 98% | 7-Chloro-2-phenyl-1H-pyrrolo[3,2-b]pyridine | ESD-848017-25MG |
Cas.: 237435-19-7 | Purity: 98% | 7-Chloro-2-phenyl-1H-pyrrolo[3,2-b]pyridine | ESD-848017-100MG |
Cas.: 1806995-45-8 | Purity: 98% | (4-Amino-5-bromopyridin-3-yl)methanol | ESD-848018-25MG |
Cas.: 1806995-45-8 | Purity: 98% | (4-Amino-5-bromopyridin-3-yl)methanol | ESD-848018-100MG |
Cas.: 1436686-17-7 | Purity: 97% | Ethyl 5-bromopyrazolo[1,5-a]pyrimidine-3-carboxylate | ESD-848019-25MG |
Cas.: 1436686-17-7 | Purity: 97% | Ethyl 5-bromopyrazolo[1,5-a]pyrimidine-3-carboxylate | ESD-848019-100MG |
Cas.: 20055-01-0 | Purity: 97% | 1-Methyl-1H-pyrazole-4,5-diamine sulfate | ESD-848020-25MG |
Cas.: 20055-01-0 | Purity: 97% | 1-Methyl-1H-pyrazole-4,5-diamine sulfate | ESD-848020-100MG |
Cas.: 61948-86-5 | Purity: 98% | 5-Methoxyquinazoline-2,4(1H,3H)-dione | ESD-848021-25MG |
Cas.: 61948-86-5 | Purity: 98% | 5-Methoxyquinazoline-2,4(1H,3H)-dione | ESD-848021-100MG |
Cas.: 1620569-21-2 | Purity: 95% | 5-Bromo-3-(piperazin-1-yl)pyrazin-2-amine 2,2,2-trifluoroacetate | ESD-848022-25MG |
Cas.: 1620569-21-2 | Purity: 95% | 5-Bromo-3-(piperazin-1-yl)pyrazin-2-amine 2,2,2-trifluoroacetate | ESD-848022-100MG |
Cas.: 1408074-64-5 | Purity: 97% | Methyl 5-bromo-7-azindole-6-carboxylate | ESD-848023-25MG |
Cas.: 1408074-64-5 | Purity: 97% | Methyl 5-bromo-7-azindole-6-carboxylate | ESD-848023-100MG |
Cas.: 119205-38-8 | Purity: 98% | Methyl 3-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-2-carboxylate | ESD-848024-25MG |
Cas.: 119205-38-8 | Purity: 98% | Methyl 3-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-2-carboxylate | ESD-848024-100MG |
Cas.: 109305-98-8 | Purity: 98% | 2-Bromo-4,5-dimethoxybenzonitrile | ESD-848025-250MG |
Cas.: 109305-98-8 | Purity: 98% | 2-Bromo-4,5-dimethoxybenzonitrile | ESD-848025-1G |
Cas.: 36127-17-0 | Purity: 95% | Methyl 8-methyl-3-oxo-8-azabicyclo[3.2.1]octane-2-carboxylate | ESD-848026-250MG |
Cas.: 36127-17-0 | Purity: 95% | Methyl 8-methyl-3-oxo-8-azabicyclo[3.2.1]octane-2-carboxylate | ESD-848026-1G |
Cas.: 220656-93-9 | Purity: 98% | Methyl 5-chloro-6-methoxynicotinate | ESD-848027-250MG |
Cas.: 220656-93-9 | Purity: 98% | Methyl 5-chloro-6-methoxynicotinate | ESD-848027-1G |
Cas.: 1031876-62-6 | Purity: 97% | 3-Amino-1-methyl-1H-indazol-6-ol | ESD-848028-250MG |
Cas.: 1031876-62-6 | Purity: 97% | 3-Amino-1-methyl-1H-indazol-6-ol | ESD-848028-1G |
Cas.: 6339-19-1 | Purity: 97% | 5-Amino-4-chloropyridazin-3(2H)-one | ESD-848029-250MG |
Cas.: 6339-19-1 | Purity: 97% | 5-Amino-4-chloropyridazin-3(2H)-one | ESD-848029-1G |
Cas.: 1860-99-7 | Purity: 97% | 2-Bromothiophene-3-carbaldehyde | ESD-848030-250MG |
Cas.: 1860-99-7 | Purity: 97% | 2-Bromothiophene-3-carbaldehyde | ESD-848030-1G |
Cas.: 6336-32-9 | Purity: 95% | 5,11-Dihydroindolo[3,2-b]carbazole | ESD-848031-250MG |
Cas.: 6336-32-9 | Purity: 95% | 5,11-Dihydroindolo[3,2-b]carbazole | ESD-848031-1G |
Cas.: 84060-08-2 | Purity: 95% | 1′-Boc-1,2-dihydro-2-oxo-spiro[4H-3,1-benzoxazine-4,4′-piperidine] | ESD-848032-250MG |
Cas.: 84060-08-2 | Purity: 95% | 1′-Boc-1,2-dihydro-2-oxo-spiro[4H-3,1-benzoxazine-4,4′-piperidine] | ESD-848032-1G |
Cas.: 927800-41-7 | Purity: 98% | 5-Bromo-8-chloroquinoline | ESD-848033-250MG |
Cas.: 927800-41-7 | Purity: 98% | 5-Bromo-8-chloroquinoline | ESD-848033-1G |
Cas.: 2818-70-4 | Purity: 98% | 5-Iodo-2-methyl-1H-benzo[d]imidazole | ESD-848034-250MG |
Cas.: 2818-70-4 | Purity: 98% | 5-Iodo-2-methyl-1H-benzo[d]imidazole | ESD-848034-1G |
Cas.: 6232-91-3 | Purity: 97% | 5-Methoxy-1H-benzimidazole-2-ylamine | ESD-848035-250MG |
Cas.: 6232-91-3 | Purity: 97% | 5-Methoxy-1H-benzimidazole-2-ylamine | ESD-848035-1G |
Cas.: 137384-48-6 | Purity: 98% | 6-Chloro-3-methylimidazo[1,2-b]pyridazine | ESD-848036-250MG |
Cas.: 137384-48-6 | Purity: 98% | 6-Chloro-3-methylimidazo[1,2-b]pyridazine | ESD-848036-1G |
Cas.: 14714-22-8 | Purity: 98% | 6-Chloro-2-methylimidazo[1,2-b]pyridazine-3-carboxylic acid | ESD-848037-250MG |
Cas.: 14714-22-8 | Purity: 98% | 6-Chloro-2-methylimidazo[1,2-b]pyridazine-3-carboxylic acid | ESD-848037-1G |
Cas.: 50610-32-7 | Purity: 98% | N,N’-(2-Chloro-1,4-phenylene)diacetamide | ESD-848038-250MG |
Cas.: 50610-32-7 | Purity: 98% | N,N’-(2-Chloro-1,4-phenylene)diacetamide | ESD-848038-1G |
Cas.: 24638-29-7 | Purity: 97% | 2,3-Diamino-5-methylpyridine | ESD-848039-250MG |
Cas.: 24638-29-7 | Purity: 97% | 2,3-Diamino-5-methylpyridine | ESD-848039-1G |
Cas.: 945762-00-5 | Purity: 95% | 3-Bromo-1H-indazole-7-carbonitrile | ESD-848040-250MG |
Cas.: 945762-00-5 | Purity: 95% | 3-Bromo-1H-indazole-7-carbonitrile | ESD-848040-1G |
Cas.: 769-20-0 | Purity: 98% | 6-Amino-7-bromobenzothiazole | ESD-848041-250MG |
Cas.: 769-20-0 | Purity: 98% | 6-Amino-7-bromobenzothiazole | ESD-848041-1G |
Cas.: 882521-63-3 | Purity: 98% | 7-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine | ESD-848042-250MG |
Cas.: 882521-63-3 | Purity: 98% | 7-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine | ESD-848042-1G |
Cas.: 100189-16-0 | Purity: 97% | 5-(1-Hydroxyethyl)-2-methylpyridine | ESD-848043-250MG |
Cas.: 100189-16-0 | Purity: 97% | 5-(1-Hydroxyethyl)-2-methylpyridine | ESD-848043-1G |
Cas.: 1121057-75-7 | Purity: 97% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine hydrochloride | ESD-848044-250MG |
Cas.: 1121057-75-7 | Purity: 97% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine hydrochloride | ESD-848044-1G |
Cas.: 214623-57-1 | Purity: 95% | 5-Amino-2-methoxybenzonitrile | ESD-848046-250MG |
Cas.: 214623-57-1 | Purity: 95% | 5-Amino-2-methoxybenzonitrile | ESD-848046-1G |
Cas.: 16935-34-5 | Purity: 97% | 5-Isopropylimidazolidine-2,4-dione | ESD-848047-250MG |
Cas.: 16935-34-5 | Purity: 97% | 5-Isopropylimidazolidine-2,4-dione | ESD-848047-1G |
Cas.: 279261-82-4 | Purity: 98% | (4-Ethoxy-2-fluorophenyl)boronic acid | ESD-848048-250MG |
Cas.: 279261-82-4 | Purity: 98% | (4-Ethoxy-2-fluorophenyl)boronic acid | ESD-848048-1G |
Cas.: 1150617-54-1 | Purity: 98% | 6-Bromo-1H-pyrazolo[4,3-b]pyridine | ESD-848049-250MG |
Cas.: 1150617-54-1 | Purity: 98% | 6-Bromo-1H-pyrazolo[4,3-b]pyridine | ESD-848049-1G |
Cas.: 1092287-30-3 | Purity: 98% | 2-Chloroquinoline-5-carboxylic acid | ESD-848050-250MG |
Cas.: 1092287-30-3 | Purity: 98% | 2-Chloroquinoline-5-carboxylic acid | ESD-848050-1G |
Cas.: 1040377-03-4 | Purity: 97% | 1-(Tetrahydro-2H-pyran-4-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-848051-250MG |
Cas.: 1040377-03-4 | Purity: 97% | 1-(Tetrahydro-2H-pyran-4-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-848051-1G |
Cas.: 99419-31-5 | Purity: 95% | 3-Methyl-oxetane-3-carbaldehyde | ESD-848052-250MG |
Cas.: 99419-31-5 | Purity: 95% | 3-Methyl-oxetane-3-carbaldehyde | ESD-848052-1G |
Cas.: 81279-39-2 | Purity: 95% | 5′-O-DMT-2′-O-iBu-N-Bz-Guanosine | ESD-848053-250MG |
Cas.: 81279-39-2 | Purity: 95% | 5′-O-DMT-2′-O-iBu-N-Bz-Guanosine | ESD-848053-1G |
Cas.: 88887-87-0 | Purity: 97% | 1-Methylcyclopropanamine hydrochloride | ESD-848054-250MG |
Cas.: 88887-87-0 | Purity: 97% | 1-Methylcyclopropanamine hydrochloride | ESD-848054-1G |
Cas.: 1465327-51-8 | Purity: 98% | Ethyl 3-chloro-4-formylbenzoate | ESD-848055-250MG |
Cas.: 1465327-51-8 | Purity: 98% | Ethyl 3-chloro-4-formylbenzoate | ESD-848055-1G |
Cas.: 144053-98-5 | Purity: 97% | Morpholin-2-ylmethanol hydrochloride | ESD-848056-250MG |
Cas.: 144053-98-5 | Purity: 97% | Morpholin-2-ylmethanol hydrochloride | ESD-848056-1G |
Cas.: 35998-96-0 | Purity: 97% | Methyl 5-amino-2-nitrobenzoate | ESD-848057-250MG |
Cas.: 35998-96-0 | Purity: 97% | Methyl 5-amino-2-nitrobenzoate | ESD-848057-1G |
Cas.: 1224944-77-7 | Purity: 97% | Ethyl 5-chloropyrazolo[1,5-a]pyrimidine-3-carboxylate | ESD-848058-250MG |
Cas.: 1224944-77-7 | Purity: 97% | Ethyl 5-chloropyrazolo[1,5-a]pyrimidine-3-carboxylate | ESD-848058-1G |
Cas.: 1174020-52-0 | Purity: 95% | tert-Butyl 2-(hydroxymethyl)-1,4-oxazepane-4-carboxylate | ESD-848059-250MG |
Cas.: 1174020-52-0 | Purity: 95% | tert-Butyl 2-(hydroxymethyl)-1,4-oxazepane-4-carboxylate | ESD-848059-1G |
Cas.: 1214352-00-7 | Purity: 97% | 2-(3-Methyl-5-(trifluoromethyl)phenyl)acetic acid | ESD-848060-250MG |
Cas.: 1214352-00-7 | Purity: 97% | 2-(3-Methyl-5-(trifluoromethyl)phenyl)acetic acid | ESD-848060-1G |
Cas.: 85070-58-2 | Purity: 97% | Methyl 2-fluoro-4-formylbenzoate | ESD-848061-250MG |
Cas.: 85070-58-2 | Purity: 97% | Methyl 2-fluoro-4-formylbenzoate | ESD-848061-1G |
Cas.: 75115-28-5 | Purity: 95% | N3-Benzylpyridine-3,4-diamine | ESD-848062-250MG |
Cas.: 75115-28-5 | Purity: 95% | N3-Benzylpyridine-3,4-diamine | ESD-848062-1G |
Cas.: 34371-14-7 | Purity: 97% | (4S,5R)-4-Hydroxy-5-(hydroxymethyl)dihydrofuran-2(3H)-one | ESD-848063-250MG |
Cas.: 34371-14-7 | Purity: 97% | (4S,5R)-4-Hydroxy-5-(hydroxymethyl)dihydrofuran-2(3H)-one | ESD-848063-1G |
Cas.: 1256781-64-2 | Purity: 97% | 2-(2,5-Dibromophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-848064-250MG |
Cas.: 1256781-64-2 | Purity: 97% | 2-(2,5-Dibromophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-848064-1G |
Cas.: 893615-28-6 | Purity: 98% | 5-Amino-4-bromo-2-fluorobenzonitrile | ESD-848065-250MG |
Cas.: 893615-28-6 | Purity: 98% | 5-Amino-4-bromo-2-fluorobenzonitrile | ESD-848065-1G |
Cas.: 97042-18-7 | Purity: 96% | 4-((4-(Allyloxy)phenyl)sulfonyl)phenol | ESD-848066-250MG |
Cas.: 97042-18-7 | Purity: 96% | 4-((4-(Allyloxy)phenyl)sulfonyl)phenol | ESD-848066-1G |
Cas.: 127828-22-2 | Purity: 97% | tert-Butyl (2-(2-aminoethoxy)ethyl)carbamate | ESD-848067-250MG |
Cas.: 127828-22-2 | Purity: 97% | tert-Butyl (2-(2-aminoethoxy)ethyl)carbamate | ESD-848067-1G |
Cas.: 856629-37-3 | Purity: 95% | 1-(2-Chlorophenyl)ethanamine hydrochloride | ESD-848068-250MG |
Cas.: 856629-37-3 | Purity: 95% | 1-(2-Chlorophenyl)ethanamine hydrochloride | ESD-848068-1G |
Cas.: 138624-99-4 | Purity: 97% | 2,2,2-Trifluoro-1-(pyridin-3-yl)ethanol | ESD-848069-250MG |
Cas.: 138624-99-4 | Purity: 97% | 2,2,2-Trifluoro-1-(pyridin-3-yl)ethanol | ESD-848069-1G |
Cas.: 535936-86-8 | Purity: 97% | Methyl 2-amino-2-cyclopropylacetate hydrochloride | ESD-848070-250MG |
Cas.: 535936-86-8 | Purity: 97% | Methyl 2-amino-2-cyclopropylacetate hydrochloride | ESD-848070-1G |
Cas.: 55805-95-3 | Purity: 98% | 1-(2-Hydroxy-5-nitrophenyl)propan-1-one | ESD-848071-250MG |
Cas.: 55805-95-3 | Purity: 98% | 1-(2-Hydroxy-5-nitrophenyl)propan-1-one | ESD-848071-1G |
Cas.: 860555-85-7 | Purity: 98% | N-(2,5-Dibromophenyl)benzamide | ESD-848072-250MG |
Cas.: 860555-85-7 | Purity: 98% | N-(2,5-Dibromophenyl)benzamide | ESD-848072-1G |
Cas.: 1195-07-9 | Purity: 95% | 5-(Aminomethyl)-2-methylpyrimidin-4-amine hydrochloride | ESD-848073-250MG |
Cas.: 1195-07-9 | Purity: 95% | 5-(Aminomethyl)-2-methylpyrimidin-4-amine hydrochloride | ESD-848073-1G |
Cas.: 630120-99-9 | Purity: 98% | 5-(Benzyloxy)-2-bromopyridine | ESD-848074-250MG |
Cas.: 630120-99-9 | Purity: 98% | 5-(Benzyloxy)-2-bromopyridine | ESD-848074-1G |
Cas.: 1188263-64-0 | Purity: 97% | Ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate acetate | ESD-848075-250MG |
Cas.: 1188263-64-0 | Purity: 97% | Ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate acetate | ESD-848075-1G |
Cas.: 1131580-60-3 | Purity: 95% | 3,5-Difluoro-4-nitrobenzoic acid | ESD-848076-250MG |
Cas.: 1131580-60-3 | Purity: 95% | 3,5-Difluoro-4-nitrobenzoic acid | ESD-848076-1G |
Cas.: 18228-46-1 | Purity: 95% | 1-(4-Methoxyphenyl)-2-methylpropan-1-ol | ESD-848077-250MG |
Cas.: 18228-46-1 | Purity: 95% | 1-(4-Methoxyphenyl)-2-methylpropan-1-ol | ESD-848077-1G |
Cas.: 57371-44-5 | Purity: 97% | 3-(4-(Benzyloxy)-3-methoxyphenyl)propan-1-ol | ESD-848078-250MG |
Cas.: 57371-44-5 | Purity: 97% | 3-(4-(Benzyloxy)-3-methoxyphenyl)propan-1-ol | ESD-848078-1G |
Cas.: 919354-20-4 | Purity: 97% | 4-Methylpiperidine-4-carboxylic acid hydrochloride | ESD-848079-250MG |
Cas.: 919354-20-4 | Purity: 97% | 4-Methylpiperidine-4-carboxylic acid hydrochloride | ESD-848079-1G |
Cas.: 219320-28-2 | Purity: 95% | (S)-(1-Methylpyrrolidin-2-yl)methanamine dihydrochloride | ESD-848080-250MG |
Cas.: 219320-28-2 | Purity: 95% | (S)-(1-Methylpyrrolidin-2-yl)methanamine dihydrochloride | ESD-848080-1G |
Cas.: 1112213-20-3 | Purity: 98% | 3-Amino-6-chloropicolinic acid hydrochloride | ESD-848081-250MG |
Cas.: 1112213-20-3 | Purity: 98% | 3-Amino-6-chloropicolinic acid hydrochloride | ESD-848081-1G |
Cas.: 932016-10-9 | Purity: 95% | 4-((4-Bromo-2-fluorophenyl)amino)-6-methoxyquinazolin-7-ol hydrochloride | ESD-848082-250MG |
Cas.: 932016-10-9 | Purity: 95% | 4-((4-Bromo-2-fluorophenyl)amino)-6-methoxyquinazolin-7-ol hydrochloride | ESD-848082-1G |
Cas.: 106272-17-7 | Purity: 98% | 2-(4-Phenoxyphenyl)ethanamine hydrochloride | ESD-848083-250MG |
Cas.: 106272-17-7 | Purity: 98% | 2-(4-Phenoxyphenyl)ethanamine hydrochloride | ESD-848083-1G |
Cas.: 1049695-95-5 | Purity: 97% | N-Benzyl-1-(4-methoxyphenyl)propan-2-amine hydrochloride | ESD-848084-250MG |
Cas.: 1049695-95-5 | Purity: 97% | N-Benzyl-1-(4-methoxyphenyl)propan-2-amine hydrochloride | ESD-848084-1G |
Cas.: 86732-22-1 | Purity: 95% | 2-Benzyloctahydropyrrolo[3,4-c]pyrrole | ESD-848085-250MG |
Cas.: 86732-22-1 | Purity: 95% | 2-Benzyloctahydropyrrolo[3,4-c]pyrrole | ESD-848085-1G |
Cas.: 126728-20-9 | Purity: 98% | 2,4-Dichloropyrido[2,3-d]pyrimidine | ESD-848086-250MG |
Cas.: 126728-20-9 | Purity: 98% | 2,4-Dichloropyrido[2,3-d]pyrimidine | ESD-848086-1G |
Cas.: 67127-91-7 | Purity: 98% | 2,5-Bis(benzyloxy)benzoic acid | ESD-848087-250MG |
Cas.: 67127-91-7 | Purity: 98% | 2,5-Bis(benzyloxy)benzoic acid | ESD-848087-1G |
Cas.: 761390-58-3 | Purity: 95% | (R)-1-(3-Fluorophenyl)ethanamine | ESD-848088-250MG |
Cas.: 761390-58-3 | Purity: 95% | (R)-1-(3-Fluorophenyl)ethanamine | ESD-848088-1G |
Cas.: 31897-80-0 | Purity: 95% | N-Methyl-1-(2-phenyladamantan-1-yl)propan-2-amine hydrochloride | ESD-848089-250MG |
Cas.: 31897-80-0 | Purity: 95% | N-Methyl-1-(2-phenyladamantan-1-yl)propan-2-amine hydrochloride | ESD-848089-1G |
Cas.: 660406-84-8 | Purity: 97% | tert-Butyl 4-(2-cyanoacetyl)piperidine-1-carboxylate | ESD-848090-250MG |
Cas.: 660406-84-8 | Purity: 97% | tert-Butyl 4-(2-cyanoacetyl)piperidine-1-carboxylate | ESD-848090-1G |
Cas.: 648418-25-1 | Purity: 98% | Benzyl 4-hydroxyazepane-1-carboxylate | ESD-848091-250MG |
Cas.: 648418-25-1 | Purity: 98% | Benzyl 4-hydroxyazepane-1-carboxylate | ESD-848091-1G |
Cas.: 57944-44-2 | Purity: 98% | 7-Ethoxy-2-naphthalenol | ESD-848092-250MG |
Cas.: 57944-44-2 | Purity: 98% | 7-Ethoxy-2-naphthalenol | ESD-848092-1G |
Cas.: 6761-52-0 | Purity: 97% | 3-Aminopyrazine-2-carbohydrazide | ESD-848093-250MG |
Cas.: 6761-52-0 | Purity: 97% | 3-Aminopyrazine-2-carbohydrazide | ESD-848093-1G |
Cas.: 7398-42-7 | Purity: 98% | Methyl 2-(4-(bromomethyl)phenyl)acetate | ESD-848094-250MG |
Cas.: 7398-42-7 | Purity: 98% | Methyl 2-(4-(bromomethyl)phenyl)acetate | ESD-848094-1G |
Cas.: 590417-93-9 | Purity: 97% | 4-Bromo-2-methyl-2H-indazole | ESD-848095-250MG |
Cas.: 590417-93-9 | Purity: 97% | 4-Bromo-2-methyl-2H-indazole | ESD-848095-1G |
Cas.: 503176-43-0 | Purity: 95% | 1-(Pyrazin-2-yl)-1H-pyrazole-4-carbaldehyde | ESD-848096-50MG |
Cas.: 503176-43-0 | Purity: 95% | 1-(Pyrazin-2-yl)-1H-pyrazole-4-carbaldehyde | ESD-848096-250MG |
Cas.: 1214342-53-6 | Purity: 97% | (4-Bromo-3-fluorophenyl)methanamine hydrochloride | ESD-848097-250MG |
Cas.: 1214342-53-6 | Purity: 97% | (4-Bromo-3-fluorophenyl)methanamine hydrochloride | ESD-848097-1G |
Cas.: 953409-03-5 | Purity: 95% | 1-(Furan-2-ylmethyl)pyrrolidine-2-carboxylic acid hydrochloride | ESD-848098-50MG |
Cas.: 953409-03-5 | Purity: 95% | 1-(Furan-2-ylmethyl)pyrrolidine-2-carboxylic acid hydrochloride | ESD-848098-250MG |
Cas.: 24851-69-2 | Purity: 95% | 2-Methylbenzo[d]thiazole-5-carboxylic acid | ESD-848099-250MG |
Cas.: 24851-69-2 | Purity: 95% | 2-Methylbenzo[d]thiazole-5-carboxylic acid | ESD-848099-1G |
Cas.: 22353-53-3 | Purity: 97% | 3-Chloro-2-methoxy-5-nitropyridine | ESD-848100-250MG |
Cas.: 22353-53-3 | Purity: 97% | 3-Chloro-2-methoxy-5-nitropyridine | ESD-848100-1G |
Cas.: 886886-04-0 | Purity: 97% | 3-Methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine | ESD-848101-250MG |
Cas.: 886886-04-0 | Purity: 97% | 3-Methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine | ESD-848101-1G |
Cas.: 1260807-99-5 | Purity: 97% | Ethyl 3-amino-7-bromoquinoline-2-carboxylate | ESD-848102-50MG |
Cas.: 1260807-99-5 | Purity: 97% | Ethyl 3-amino-7-bromoquinoline-2-carboxylate | ESD-848102-250MG |
Cas.: 103997-21-3 | Purity: 97% | 5-Chloro-6-oxo-1,6-dihydropyridine-2-carboxylic acid | ESD-848103-50MG |
Cas.: 103997-21-3 | Purity: 97% | 5-Chloro-6-oxo-1,6-dihydropyridine-2-carboxylic acid | ESD-848103-250MG |
Cas.: 19460-86-7 | Purity: 97% | N-Me-Phe-OMe HCl | ESD-848104-250MG |
Cas.: 19460-86-7 | Purity: 97% | N-Me-Phe-OMe HCl | ESD-848104-1G |
Cas.: 737007-45-3 | Purity: 98% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(1H-pyrrolo[2,3-b]pyridin-3-yl)propanoic acid | ESD-848105-25MG |
Cas.: 737007-45-3 | Purity: 98% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(1H-pyrrolo[2,3-b]pyridin-3-yl)propanoic acid | ESD-848105-100MG |
Cas.: 1010446-31-7 | Purity: 97% | (S)-tert-Butyl 3-(piperazin-1-yl)pyrrolidine-1-carboxylate | ESD-848106-25MG |
Cas.: 1010446-31-7 | Purity: 97% | (S)-tert-Butyl 3-(piperazin-1-yl)pyrrolidine-1-carboxylate | ESD-848106-100MG |
Cas.: 838892-95-8 | Purity: 97% | 5-(Bromomethyl)-2-methylthiazole | ESD-848107-25MG |
Cas.: 838892-95-8 | Purity: 97% | 5-(Bromomethyl)-2-methylthiazole | ESD-848107-100MG |
Cas.: 1337880-58-6 | Purity: 98% | tert-Butyl 6-hydroxy-1H-indazole-1-carboxylate | ESD-848108-25MG |
Cas.: 1337880-58-6 | Purity: 98% | tert-Butyl 6-hydroxy-1H-indazole-1-carboxylate | ESD-848108-100MG |
Cas.: 51984-63-5 | Purity: 98% | 5-Chloro-6-methylpyridin-3-ol | ESD-848109-25MG |
Cas.: 51984-63-5 | Purity: 98% | 5-Chloro-6-methylpyridin-3-ol | ESD-848109-100MG |
Cas.: 327021-84-1 | Purity: 95% | 7-Fluoro-1,2,3,4-tetrahydrocyclopenta[b]indole | ESD-848110-250MG |
Cas.: 327021-84-1 | Purity: 95% | 7-Fluoro-1,2,3,4-tetrahydrocyclopenta[b]indole | ESD-848110-1G |
Cas.: 1119280-68-0 | Purity: 97% | 2-Chlorothieno[3,2-d]pyrimidine | ESD-848111-250MG |
Cas.: 1119280-68-0 | Purity: 97% | 2-Chlorothieno[3,2-d]pyrimidine | ESD-848111-1G |
Cas.: 35613-44-6 | Purity: 96% | Methyl 2-(2-aminophenyl)acetate | ESD-848112-250MG |
Cas.: 35613-44-6 | Purity: 96% | Methyl 2-(2-aminophenyl)acetate | ESD-848112-1G |
Cas.: 125802-37-1 | Purity: 95% | 1-Phenylcycloheptanamine hydrochloride | ESD-848113-250MG |
Cas.: 125802-37-1 | Purity: 95% | 1-Phenylcycloheptanamine hydrochloride | ESD-848113-1G |
Cas.: 1159813-53-2 | Purity: 95% | 8-Bromo-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-848114-250MG |
Cas.: 1159813-53-2 | Purity: 95% | 8-Bromo-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-848114-1G |
Cas.: 1094355-53-9 | Purity: 95% | 2-(2,4-Dichlorophenyl)thiazole-4-carboxylic acid | ESD-848115-250MG |
Cas.: 1094355-53-9 | Purity: 95% | 2-(2,4-Dichlorophenyl)thiazole-4-carboxylic acid | ESD-848115-1G |
Cas.: 1214899-85-0 | Purity: 98% | 6-Bromo-1-methyl-1H-indazol-3-amine | ESD-848116-250MG |
Cas.: 1214899-85-0 | Purity: 98% | 6-Bromo-1-methyl-1H-indazol-3-amine | ESD-848116-1G |
Cas.: 1203260-55-2 | Purity: 95% | Benzyl piperidin-3-ylcarbamate hydrochloride | ESD-848117-250MG |
Cas.: 1203260-55-2 | Purity: 95% | Benzyl piperidin-3-ylcarbamate hydrochloride | ESD-848117-1G |
Cas.: 276872-89-0 | Purity: 90% | tert-butyl 3-methylenepiperidine-1-carboxylate | ESD-848118-250MG |
Cas.: 276872-89-0 | Purity: 90% | tert-butyl 3-methylenepiperidine-1-carboxylate | ESD-848118-1G |
Cas.: 65568-55-0 | Purity: 95% | Ethyl 2-amino-4-trifluoromethylbenzoate | ESD-848119-250MG |
Cas.: 65568-55-0 | Purity: 95% | Ethyl 2-amino-4-trifluoromethylbenzoate | ESD-848119-1G |
Cas.: 4910-04-7 | Purity: 98% | 3-(tert-Butyl)-4-hydroxybenzonitrile | ESD-848120-250MG |
Cas.: 4910-04-7 | Purity: 98% | 3-(tert-Butyl)-4-hydroxybenzonitrile | ESD-848120-1G |
Cas.: 2683-35-4 | Purity: 97% | 3,5-Dibromo-1-methylpyridin-4(1H)-one | ESD-848121-250MG |
Cas.: 2683-35-4 | Purity: 97% | 3,5-Dibromo-1-methylpyridin-4(1H)-one | ESD-848121-1G |
Cas.: 50712-69-1 | Purity: 98% | 2-(Bromomethyl)-5-chlorobenzonitrile | ESD-848122-250MG |
Cas.: 50712-69-1 | Purity: 98% | 2-(Bromomethyl)-5-chlorobenzonitrile | ESD-848122-1G |
Cas.: 1167055-65-3 | Purity: 97% | 5-Fluoro-1-methoxy-2-methyl-3-nitrobenzene | ESD-848123-50MG |
Cas.: 1167055-65-3 | Purity: 97% | 5-Fluoro-1-methoxy-2-methyl-3-nitrobenzene | ESD-848123-250MG |
Cas.: 903557-48-2 | Purity: 95% | 5-Bromo-4-methyl-2,3-dihydro-1H-inden-1-one | ESD-848124-25MG |
Cas.: 903557-48-2 | Purity: 95% | 5-Bromo-4-methyl-2,3-dihydro-1H-inden-1-one | ESD-848124-100MG |
Cas.: 4922-68-3 | Purity: 98% | 3-Bromo[1,2,4]triazolo[4,3-a]pyridine | ESD-848125-250MG |
Cas.: 4922-68-3 | Purity: 98% | 3-Bromo[1,2,4]triazolo[4,3-a]pyridine | ESD-848125-1G |
Cas.: 915087-33-1 | Purity: 98% | Enzalutamide | ESD-848126-250MG |
Cas.: 915087-33-1 | Purity: 98% | Enzalutamide | ESD-848126-1G |
Cas.: 110178-35-3 | Purity: 98% | 3-(2-Methoxyethoxy)aniline | ESD-848127-250MG |
Cas.: 110178-35-3 | Purity: 98% | 3-(2-Methoxyethoxy)aniline | ESD-848127-1G |
Cas.: 24537-50-6 | Purity: 97% | 2-Oxopiperidine-4-carboxylic acid | ESD-848128-250MG |
Cas.: 24537-50-6 | Purity: 97% | 2-Oxopiperidine-4-carboxylic acid | ESD-848128-1G |
Cas.: 33204-85-2 | Purity: 98% | 2-Bromo-3,4-dimethylpyridine | ESD-848129-25MG |
Cas.: 33204-85-2 | Purity: 98% | 2-Bromo-3,4-dimethylpyridine | ESD-848129-100MG |
Cas.: 139163-56-7 | Purity: 95% | 1-(6-Bromopyridin-2-yl)ethanol | ESD-848130-250MG |
Cas.: 139163-56-7 | Purity: 95% | 1-(6-Bromopyridin-2-yl)ethanol | ESD-848130-1G |
Cas.: 1134307-94-0 | Purity: 97% | 1H-Pyrrolo[2,3-b]pyridin-4-amine hydrochloride | ESD-848131-250MG |
Cas.: 1134307-94-0 | Purity: 97% | 1H-Pyrrolo[2,3-b]pyridin-4-amine hydrochloride | ESD-848131-1G |
Cas.: 1220040-26-5 | Purity: 95% | 2-Methylpiperidine-3-carboxylic acid hydrochloride | ESD-848132-25MG |
Cas.: 1220040-26-5 | Purity: 95% | 2-Methylpiperidine-3-carboxylic acid hydrochloride | ESD-848132-100MG |
Cas.: 1332832-16-2 | Purity: 95% | (S)-1-(o-Tolyl)ethanamine hydrochloride | ESD-848133-25MG |
Cas.: 1332832-16-2 | Purity: 95% | (S)-1-(o-Tolyl)ethanamine hydrochloride | ESD-848133-100MG |
Cas.: 53912-85-9 | Purity: 97% | (S)-2-(Pyrrolidin-2-yl)acetic acid hydrochloride | ESD-848134-250MG |
Cas.: 53912-85-9 | Purity: 97% | (S)-2-(Pyrrolidin-2-yl)acetic acid hydrochloride | ESD-848134-1G |
Cas.: 81256-88-4 | Purity: 95% | 5′-DMT-3′-TBDMS-Bz-rA | ESD-848135-25MG |
Cas.: 81256-88-4 | Purity: 95% | 5′-DMT-3′-TBDMS-Bz-rA | ESD-848135-100MG |
Cas.: 188187-03-3 | Purity: 97% | Methyl 2-(bromomethyl)-3-chlorobenzoate | ESD-848136-250MG |
Cas.: 188187-03-3 | Purity: 97% | Methyl 2-(bromomethyl)-3-chlorobenzoate | ESD-848136-1G |
Cas.: 40274-67-7 | Purity: 98% | 9-Oxo-9H-xanthene-2-carboxylic acid | ESD-848137-25MG |
Cas.: 40274-67-7 | Purity: 98% | 9-Oxo-9H-xanthene-2-carboxylic acid | ESD-848137-100MG |
Cas.: 1010814-94-4 | Purity: 97% | tert-Butyl 3-(2-(tert-butoxy)-2-oxoethyl)-4-oxopiperidine-1-carboxylate | ESD-848138-25MG |
Cas.: 1010814-94-4 | Purity: 97% | tert-Butyl 3-(2-(tert-butoxy)-2-oxoethyl)-4-oxopiperidine-1-carboxylate | ESD-848138-100MG |
Cas.: 672883-95-3 | Purity: 95% | (S)-5-Aminopipidin-2-one hydrochloride | ESD-848139-25MG |
Cas.: 672883-95-3 | Purity: 95% | (S)-5-Aminopipidin-2-one hydrochloride | ESD-848139-100MG |
Cas.: 1163248-54-1 | Purity: 97% | (5-Methyl-1H-pyrazol-3-yl)boronic acid | ESD-848140-25MG |
Cas.: 1163248-54-1 | Purity: 97% | (5-Methyl-1H-pyrazol-3-yl)boronic acid | ESD-848140-100MG |
Cas.: 1075-12-3 | Purity: 98% | 7-Fluoroisoquinoline | ESD-848141-25MG |
Cas.: 1075-12-3 | Purity: 98% | 7-Fluoroisoquinoline | ESD-848141-100MG |
Cas.: 1308298-23-8 | Purity: 98% | (2-(Trifluoromethyl)pyrimidin-5-yl)boronic acid | ESD-848142-25MG |
Cas.: 1308298-23-8 | Purity: 98% | (2-(Trifluoromethyl)pyrimidin-5-yl)boronic acid | ESD-848142-100MG |
Cas.: 13575-16-1 | Purity: 98% | Ethyl 5-phenyloxazole-2-carboxylate | ESD-848143-25MG |
Cas.: 13575-16-1 | Purity: 98% | Ethyl 5-phenyloxazole-2-carboxylate | ESD-848143-100MG |
Cas.: 31053-30-2 | Purity: 97% | 2,3-Dihydroisoquinoline-1,4-dione | ESD-848144-25MG |
Cas.: 31053-30-2 | Purity: 97% | 2,3-Dihydroisoquinoline-1,4-dione | ESD-848144-100MG |
Cas.: 139986-03-1 | Purity: 95% | (R)-tert-Butyl 3-(tosyloxy)pyrrolidine-1-carboxylate | ESD-848145-25MG |
Cas.: 139986-03-1 | Purity: 95% | (R)-tert-Butyl 3-(tosyloxy)pyrrolidine-1-carboxylate | ESD-848145-100MG |
Cas.: 1197239-37-4 | Purity: 97% | tert-Butyl (3-aminocyclopentyl)carbamate hydrochloride | ESD-848146-50MG |
Cas.: 1197239-37-4 | Purity: 97% | tert-Butyl (3-aminocyclopentyl)carbamate hydrochloride | ESD-848146-250MG |
Cas.: 134135-41-4 | Purity: 98% | 5-(Bromomethyl)thiophene-2-carbonitrile | ESD-848147-25MG |
Cas.: 134135-41-4 | Purity: 98% | 5-(Bromomethyl)thiophene-2-carbonitrile | ESD-848147-100MG |
Cas.: 660830-62-6 | Purity: 98% | Ethyl 7-bromoisoquinoline-3-carboxylate | ESD-848148-25MG |
Cas.: 660830-62-6 | Purity: 98% | Ethyl 7-bromoisoquinoline-3-carboxylate | ESD-848148-100MG |
Cas.: 138588-22-4 | Purity: 97% | 3-(Pyridin-2-yl)-1,2,4-thiadiazol-5-amine | ESD-848149-25MG |
Cas.: 138588-22-4 | Purity: 97% | 3-(Pyridin-2-yl)-1,2,4-thiadiazol-5-amine | ESD-848149-100MG |
Cas.: 1211595-72-0 | Purity: 98% | 5-Fluoro-6-methoxy-1H-indole | ESD-848150-25MG |
Cas.: 1211595-72-0 | Purity: 98% | 5-Fluoro-6-methoxy-1H-indole | ESD-848150-100MG |
Cas.: 1235406-28-6 | Purity: 97% | 3-Cyano-4-fluoro-N-(thiazol-2-yl)benzenesulfonamide | ESD-848151-25MG |
Cas.: 1235406-28-6 | Purity: 97% | 3-Cyano-4-fluoro-N-(thiazol-2-yl)benzenesulfonamide | ESD-848151-100MG |
Cas.: 136725-55-8 | Purity: 97% | (R)-3-Fluoropyrrolidine hydrochloride | ESD-848152-250MG |
Cas.: 136725-55-8 | Purity: 97% | (R)-3-Fluoropyrrolidine hydrochloride | ESD-848152-1G |
Cas.: 81190-68-3 | Purity: 98% | 2-Amino-4,6-dibromobenzoic acid | ESD-848153-250MG |
Cas.: 81190-68-3 | Purity: 98% | 2-Amino-4,6-dibromobenzoic acid | ESD-848153-1G |
Cas.: 1484-04-4 | Purity: 98% | 1-(9-Ethyl-9H-carbazol-3-yl)ethanone | ESD-848154-250MG |
Cas.: 1484-04-4 | Purity: 98% | 1-(9-Ethyl-9H-carbazol-3-yl)ethanone | ESD-848154-1G |
Cas.: 152840-65-8 | Purity: 98% | 2,6-Dichloro-5-fluoropyridin-3-amine | ESD-848155-250MG |
Cas.: 152840-65-8 | Purity: 98% | 2,6-Dichloro-5-fluoropyridin-3-amine | ESD-848155-1G |
Cas.: 128577-47-9 | Purity: 98% | Methyl 4-(bromomethyl)-3-fluorobenzoate | ESD-848157-250MG |
Cas.: 128577-47-9 | Purity: 98% | Methyl 4-(bromomethyl)-3-fluorobenzoate | ESD-848157-1G |
Cas.: 327044-56-4 | Purity: 98% | tert-Butyl 6-hydroxy-3,4-dihydroquinoline-1(2H)-carboxylate | ESD-848158-50MG |
Cas.: 327044-56-4 | Purity: 98% | tert-Butyl 6-hydroxy-3,4-dihydroquinoline-1(2H)-carboxylate | ESD-848158-250MG |
Cas.: 1071974-01-0 | Purity: 97% | Benzyl 2-cyano-2-(4-fluoro-5-methyl-2-nitrophenyl)acetate | ESD-848159-50MG |
Cas.: 1071974-01-0 | Purity: 97% | Benzyl 2-cyano-2-(4-fluoro-5-methyl-2-nitrophenyl)acetate | ESD-848159-250MG |
Cas.: 5423-54-1 | Purity: 97% | 1,5-Naphthyridin-4-ol | ESD-848160-250MG |
Cas.: 5423-54-1 | Purity: 97% | 1,5-Naphthyridin-4-ol | ESD-848160-1G |
Cas.: 1187173-43-8 | Purity: 97% | 2,7-Diazaspiro[4.5]decan-1-one hydrochloride | ESD-848161-250MG |
Cas.: 1187173-43-8 | Purity: 97% | 2,7-Diazaspiro[4.5]decan-1-one hydrochloride | ESD-848161-1G |
Cas.: 161489-05-0 | Purity: 97% | 4-Iodo-6-methoxypyrimidine | ESD-848162-250MG |
Cas.: 161489-05-0 | Purity: 97% | 4-Iodo-6-methoxypyrimidine | ESD-848162-1G |
Cas.: 1195710-15-6 | Purity: 97% | 7-Chloroquinolin-3-amine | ESD-848163-25MG |
Cas.: 1195710-15-6 | Purity: 97% | 7-Chloroquinolin-3-amine | ESD-848163-100MG |
Cas.: 885654-56-8 | Purity: 95% | 4-(Morpholinomethyl)piperidin-4-ol | ESD-848165-25MG |
Cas.: 885654-56-8 | Purity: 95% | 4-(Morpholinomethyl)piperidin-4-ol | ESD-848165-100MG |
Cas.: 82070-49-3 | Purity: 97% | 7-Methoxy-2,3-dihydro-1,8-naphthyridin-4(1H)-one | ESD-848166-25MG |
Cas.: 82070-49-3 | Purity: 97% | 7-Methoxy-2,3-dihydro-1,8-naphthyridin-4(1H)-one | ESD-848166-100MG |
Cas.: 1259436-59-3 | Purity: 97% | (1S,3R)-3-Aminocyclopentanol hydrochloride | ESD-848167-25MG |
Cas.: 1259436-59-3 | Purity: 97% | (1S,3R)-3-Aminocyclopentanol hydrochloride | ESD-848167-100MG |
Cas.: 95037-20-0 | Purity: 95% | (3-Amino-5,6-dichloropyrazin-2-yl)methanol | ESD-848168-25MG |
Cas.: 95037-20-0 | Purity: 95% | (3-Amino-5,6-dichloropyrazin-2-yl)methanol | ESD-848168-100MG |
Cas.: 1033203-31-4 | Purity: 97% | 4-Chloro-5-methylpyridin-2-amine | ESD-848169-25MG |
Cas.: 1033203-31-4 | Purity: 97% | 4-Chloro-5-methylpyridin-2-amine | ESD-848169-100MG |
Cas.: 682342-65-0 | Purity: 95% | 5-Iodo-4-(trifluoromethyl)thiazol-2-amine | ESD-848170-25MG |
Cas.: 682342-65-0 | Purity: 95% | 5-Iodo-4-(trifluoromethyl)thiazol-2-amine | ESD-848170-100MG |
Cas.: 943845-78-1 | Purity: 95% | (1H-Indazol-5-yl)methanamine hydrochloride | ESD-848171-25MG |
Cas.: 943845-78-1 | Purity: 95% | (1H-Indazol-5-yl)methanamine hydrochloride | ESD-848171-100MG |
Cas.: 56946-65-7 | Purity: 98% | 2,4-Dichloro-6,7-dihydro-5H-cyclopenta[b]pyridine | ESD-848172-25MG |
Cas.: 56946-65-7 | Purity: 98% | 2,4-Dichloro-6,7-dihydro-5H-cyclopenta[b]pyridine | ESD-848172-100MG |
Cas.: 263845-82-5 | Purity: 95% | 2-Bromo-4-hydrazinylbenzonitrile | ESD-848173-25MG |
Cas.: 263845-82-5 | Purity: 95% | 2-Bromo-4-hydrazinylbenzonitrile | ESD-848173-100MG |
Cas.: 1142197-14-5 | Purity: 98% | 2-Bromo-5-cyclopropylpyridine | ESD-848174-25MG |
Cas.: 1142197-14-5 | Purity: 98% | 2-Bromo-5-cyclopropylpyridine | ESD-848174-100MG |
Cas.: 1427438-90-1 | Purity: 98% | 4-Bromo-2-fluoro-6-hydroxybenzaldehyde | ESD-848175-25MG |
Cas.: 1427438-90-1 | Purity: 98% | 4-Bromo-2-fluoro-6-hydroxybenzaldehyde | ESD-848175-100MG |
Cas.: 1241725-84-7 | Purity: 97% | 4,5,6,7-Tetrahydrothiazolo[5,4-c]pyridine hydrochloride | ESD-848176-25MG |
Cas.: 1241725-84-7 | Purity: 97% | 4,5,6,7-Tetrahydrothiazolo[5,4-c]pyridine hydrochloride | ESD-848176-100MG |
Cas.: 1190897-26-7 | Purity: 95% | Ethyl 3-hydroxy-8,9-dihydro-5H-pyridazino[3,4-d]azepine-7(6H)-carboxylate | ESD-848177-50MG |
Cas.: 1190897-26-7 | Purity: 95% | Ethyl 3-hydroxy-8,9-dihydro-5H-pyridazino[3,4-d]azepine-7(6H)-carboxylate | ESD-848177-250MG |
Cas.: 167484-91-5 | Purity: 96% | tert-Butyl 5-fluorospiro[indoline-3,4′-piperidine]-1′-carboxylate | ESD-848178-50MG |
Cas.: 167484-91-5 | Purity: 96% | tert-Butyl 5-fluorospiro[indoline-3,4′-piperidine]-1′-carboxylate | ESD-848178-250MG |
Cas.: 53090-43-0 | Purity: 97% | Ethyl 3-(3,4-dichlorophenyl)-3-oxopropanoate | ESD-848179-50MG |
Cas.: 53090-43-0 | Purity: 97% | Ethyl 3-(3,4-dichlorophenyl)-3-oxopropanoate | ESD-848179-250MG |
Cas.: 1187928-41-1 | Purity: 96% | Methyl 6-bromobenzo[d]thiazole-2-carboxylate | ESD-848180-25MG |
Cas.: 1187928-41-1 | Purity: 96% | Methyl 6-bromobenzo[d]thiazole-2-carboxylate | ESD-848180-100MG |
Cas.: 924869-17-0 | Purity: 95% | Methyl benzo[d]oxazole-5-carboxylate | ESD-848181-250MG |
Cas.: 924869-17-0 | Purity: 95% | Methyl benzo[d]oxazole-5-carboxylate | ESD-848181-1G |
Cas.: 181585-93-3 | Purity: 95% | Methyl 5-nitro-1H-pyrazole-3-carboxylate | ESD-848182-250MG |
Cas.: 181585-93-3 | Purity: 95% | Methyl 5-nitro-1H-pyrazole-3-carboxylate | ESD-848182-1G |
Cas.: 177269-37-3 | Purity: 97% | Methyl 3-amino-2,2-dimethylpropanoate hydrochloride | ESD-848183-250MG |
Cas.: 177269-37-3 | Purity: 97% | Methyl 3-amino-2,2-dimethylpropanoate hydrochloride | ESD-848183-1G |
Cas.: 142337-95-9 | Purity: 95% | 3-Bromo-5-ethylpyridine | ESD-848184-250MG |
Cas.: 142337-95-9 | Purity: 95% | 3-Bromo-5-ethylpyridine | ESD-848184-1G |
Cas.: 52090-89-8 | Purity: 97% | 5-Chloro-3H-imidazo[4,5-b]pyridine | ESD-848185-250MG |
Cas.: 52090-89-8 | Purity: 97% | 5-Chloro-3H-imidazo[4,5-b]pyridine | ESD-848185-1G |
Cas.: 37972-24-0 | Purity: 98% | 2-Ethynylpyrimidine | ESD-848186-250MG |
Cas.: 37972-24-0 | Purity: 98% | 2-Ethynylpyrimidine | ESD-848186-1G |
Cas.: 81228-25-3 | Purity: 98% | 4-(Benzyloxy)-3-fluorophenol | ESD-848187-250MG |
Cas.: 81228-25-3 | Purity: 98% | 4-(Benzyloxy)-3-fluorophenol | ESD-848187-1G |
Cas.: 37785-48-1 | Purity: 95% | 2-(3,4,5-Trimethoxyphenyl)ethanol | ESD-848189-250MG |
Cas.: 37785-48-1 | Purity: 95% | 2-(3,4,5-Trimethoxyphenyl)ethanol | ESD-848189-1G |
Cas.: 18368-59-7 | Purity: 98% | 3-Bromo-4-methylpyridin-2-ol | ESD-848190-250MG |
Cas.: 18368-59-7 | Purity: 98% | 3-Bromo-4-methylpyridin-2-ol | ESD-848190-1G |
Cas.: 952182-19-3 | Purity: 98% | Methyl 5-chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate | ESD-848191-250MG |
Cas.: 952182-19-3 | Purity: 98% | Methyl 5-chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate | ESD-848191-1G |
Cas.: 43201-13-4 | Purity: 98% | 5-Bromo-1,2,4-thiadiazole | ESD-848192-250MG |
Cas.: 43201-13-4 | Purity: 98% | 5-Bromo-1,2,4-thiadiazole | ESD-848192-1G |
Cas.: 1213128-98-3 | Purity: 95% | (S)-1-(3,5-Difluorophenyl)ethanamine hydrochloride | ESD-848193-25MG |
Cas.: 1213128-98-3 | Purity: 95% | (S)-1-(3,5-Difluorophenyl)ethanamine hydrochloride | ESD-848193-100MG |
Cas.: 73177-33-0 | Purity: 98% | 2-Methyl-1H-indole-6-carboxylic acid | ESD-848194-25MG |
Cas.: 73177-33-0 | Purity: 98% | 2-Methyl-1H-indole-6-carboxylic acid | ESD-848194-100MG |
Cas.: 1032350-06-3 | Purity: 97% | tert-Butyl (1-(4-bromophenyl)cyclobutyl)carbamate | ESD-848195-250MG |
Cas.: 1032350-06-3 | Purity: 97% | tert-Butyl (1-(4-bromophenyl)cyclobutyl)carbamate | ESD-848195-1G |
Cas.: 1207625-18-0 | Purity: 97% | 3-Chloro-7H-pyrrolo[2,3-c]pyridazine | ESD-848196-50MG |
Cas.: 1207625-18-0 | Purity: 97% | 3-Chloro-7H-pyrrolo[2,3-c]pyridazine | ESD-848196-250MG |
Cas.: 156094-63-2 | Purity: 98% | 2-(Bromomethyl)-6-methoxypyridine | ESD-848197-50MG |
Cas.: 156094-63-2 | Purity: 98% | 2-(Bromomethyl)-6-methoxypyridine | ESD-848197-250MG |
Cas.: 57672-33-0 | Purity: 97% | 7-Nitro-2,3-dihydro-1,4-benzodioxine-6-carboxylic acid | ESD-848198-250MG |
Cas.: 57672-33-0 | Purity: 97% | 7-Nitro-2,3-dihydro-1,4-benzodioxine-6-carboxylic acid | ESD-848198-1G |
Cas.: 123730-64-3 | Purity: 98% | Ethyl 4-cyanopiperidine-4-carboxylate hydrochloride | ESD-848199-25MG |
Cas.: 123730-64-3 | Purity: 98% | Ethyl 4-cyanopiperidine-4-carboxylate hydrochloride | ESD-848199-100MG |
Cas.: 674792-08-6 | Purity: 97% | 4-Boc-4,7-diazaspiro[2.5]octane | ESD-848200-25MG |
Cas.: 674792-08-6 | Purity: 97% | 4-Boc-4,7-diazaspiro[2.5]octane | ESD-848200-100MG |
Cas.: 1260763-03-8 | Purity: 97% | 5′-Bromospiro[cyclopropane-1,3′-indoline] | ESD-848201-25MG |
Cas.: 1260763-03-8 | Purity: 97% | 5′-Bromospiro[cyclopropane-1,3′-indoline] | ESD-848201-100MG |
Cas.: 374795-37-6 | Purity: 95% | 2-Oxa-7-azaspiro[4.5]decane hydrochloride | ESD-848202-25MG |
Cas.: 374795-37-6 | Purity: 95% | 2-Oxa-7-azaspiro[4.5]decane hydrochloride | ESD-848202-100MG |
Cas.: 25063-68-7 | Purity: 97% | 2,2-Dimethyl-5-((pyridin-3-ylamino)methylene)-1,3-dioxane-4,6-dione | ESD-848203-250MG |
Cas.: 25063-68-7 | Purity: 97% | 2,2-Dimethyl-5-((pyridin-3-ylamino)methylene)-1,3-dioxane-4,6-dione | ESD-848203-1G |
Cas.: 16948-10-0 | Purity: 98% | 3-((tert-Butoxycarbonyl)amino)-2-methylpropanoic acid | ESD-848204-250MG |
Cas.: 16948-10-0 | Purity: 98% | 3-((tert-Butoxycarbonyl)amino)-2-methylpropanoic acid | ESD-848204-1G |
Cas.: 6639-06-1 | Purity: 98% | 3-(1H-Indol-1-yl)propanoic acid | ESD-848205-250MG |
Cas.: 6639-06-1 | Purity: 98% | 3-(1H-Indol-1-yl)propanoic acid | ESD-848205-1G |
Cas.: 76155-78-7 | Purity: 98% | (R)-1-(4-Bromophenyl)ethanol | ESD-848206-250MG |
Cas.: 76155-78-7 | Purity: 98% | (R)-1-(4-Bromophenyl)ethanol | ESD-848206-1G |
Cas.: 1262988-77-1 | Purity: 97% | 1-Benzyl-4-hydroxypiperidine-4-carboxylic acid hydrochloride | ESD-848207-250MG |
Cas.: 1262988-77-1 | Purity: 97% | 1-Benzyl-4-hydroxypiperidine-4-carboxylic acid hydrochloride | ESD-848207-1G |
Cas.: 494769-34-5 | Purity: 98% | N-Boc-2-Amino-4-formylthiazole | ESD-848208-250MG |
Cas.: 494769-34-5 | Purity: 98% | N-Boc-2-Amino-4-formylthiazole | ESD-848208-1G |
Cas.: 6653-80-1 | Purity: 95% | 1-(Chloromethyl)-4-ethoxybenzene | ESD-848209-250MG |
Cas.: 6653-80-1 | Purity: 95% | 1-(Chloromethyl)-4-ethoxybenzene | ESD-848209-1G |
Cas.: 1157849-51-8 | Purity: 97% | (S)-1-Methylpiperidin-3-amine dihydrochloride | ESD-848210-25MG |
Cas.: 1157849-51-8 | Purity: 97% | (S)-1-Methylpiperidin-3-amine dihydrochloride | ESD-848210-100MG |
Cas.: 37465-61-5 | Purity: 96% | 2-((2-(1H-Indol-3-yl)ethyl)amino)ethanol | ESD-848211-50MG |
Cas.: 37465-61-5 | Purity: 96% | 2-((2-(1H-Indol-3-yl)ethyl)amino)ethanol | ESD-848211-250MG |
Cas.: 425380-37-6 | Purity: 98% | 4-Bromo-7-methoxy-1H-pyrrolo[2,3-c]pyridine | ESD-848212-50MG |
Cas.: 425380-37-6 | Purity: 98% | 4-Bromo-7-methoxy-1H-pyrrolo[2,3-c]pyridine | ESD-848212-250MG |
Cas.: 425380-38-7 | Purity: 98% | 4-Bromo-7-chloro-1H-pyrrolo[2,3-c]pyridine | ESD-848213-50MG |
Cas.: 425380-38-7 | Purity: 98% | 4-Bromo-7-chloro-1H-pyrrolo[2,3-c]pyridine | ESD-848213-250MG |
Cas.: 69584-91-4 | Purity: 95% | 1′-Methylspiro[indoline-3,4′-piperidine] | ESD-848214-25MG |
Cas.: 69584-91-4 | Purity: 95% | 1′-Methylspiro[indoline-3,4′-piperidine] | ESD-848214-100MG |
Cas.: 884860-61-1 | Purity: 95% | 2,7-Dichlorothiazolo[5,4-c]pyridine | ESD-848215-25MG |
Cas.: 884860-61-1 | Purity: 95% | 2,7-Dichlorothiazolo[5,4-c]pyridine | ESD-848215-100MG |
Cas.: 1209458-06-9 | Purity: 98% | (6-Bromopyrazin-2-yl)methanol | ESD-848216-25MG |
Cas.: 1209458-06-9 | Purity: 98% | (6-Bromopyrazin-2-yl)methanol | ESD-848216-100MG |
Cas.: 871940-31-7 | Purity: 95% | (3-Cyano-2,4-difluorophenyl)boronic acid | ESD-848217-250MG |
Cas.: 871940-31-7 | Purity: 95% | (3-Cyano-2,4-difluorophenyl)boronic acid | ESD-848217-1G |
Cas.: 21544-81-0 | Purity: 98% | 4,6-Dimethoxyindoline-2,3-dione | ESD-848218-250MG |
Cas.: 1189042-70-3 | Purity: 95% | 2-(2-Fluoro-3-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-848219-250MG |
Cas.: 1189042-70-3 | Purity: 95% | 2-(2-Fluoro-3-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-848219-1G |
Cas.: 870774-29-1 | Purity: 98% | (3-(Naphthalen-2-yl)phenyl)boronic acid | ESD-848220-250MG |
Cas.: 870774-29-1 | Purity: 98% | (3-(Naphthalen-2-yl)phenyl)boronic acid | ESD-848220-1G |
Cas.: 218594-79-7 | Purity: 97% | (S)-Morpholin-3-ylmethanol hydrochloride | ESD-848221-250MG |
Cas.: 218594-79-7 | Purity: 97% | (S)-Morpholin-3-ylmethanol hydrochloride | ESD-848221-1G |
Cas.: 1227048-78-3 | Purity: 98% | Methyl 2-amino-5-iodonicotinate | ESD-848222-250MG |
Cas.: 1227048-78-3 | Purity: 98% | Methyl 2-amino-5-iodonicotinate | ESD-848222-1G |
Cas.: 210963-04-5 | Purity: 95% | 4-(((tert-Butoxycarbonyl)(methyl)amino)methyl)benzoic acid | ESD-848223-250MG |
Cas.: 210963-04-5 | Purity: 95% | 4-(((tert-Butoxycarbonyl)(methyl)amino)methyl)benzoic acid | ESD-848223-1G |
Cas.: 259808-67-8 | Purity: 98% | 1-Boc-3,3-Dimethylpiperazine | ESD-848224-250MG |
Cas.: 259808-67-8 | Purity: 98% | 1-Boc-3,3-Dimethylpiperazine | ESD-848224-1G |
Cas.: 157014-41-0 | Purity: 95% | Benzyl (4-(2-bromoacetyl)phenyl)carbamate | ESD-848225-250MG |
Cas.: 157014-41-0 | Purity: 95% | Benzyl (4-(2-bromoacetyl)phenyl)carbamate | ESD-848225-1G |
Cas.: 52559-11-2 | Purity: 98% | Pyridine-2,3,4-triamine | ESD-848226-250MG |
Cas.: 52559-11-2 | Purity: 98% | Pyridine-2,3,4-triamine | ESD-848226-1G |
Cas.: 885049-08-1 | Purity: 95% | tert-Butyl 4-guanidinopiperidine-1-carboxylate hydrochloride | ESD-848227-50MG |
Cas.: 885049-08-1 | Purity: 95% | tert-Butyl 4-guanidinopiperidine-1-carboxylate hydrochloride | ESD-848227-250MG |
Cas.: 1446332-69-9 | Purity: 98% | tert-Butyl 4-(4-formyl-3-hydroxyphenyl)piperazine-1-carboxylate | ESD-848229-50MG |
Cas.: 1446332-69-9 | Purity: 98% | tert-Butyl 4-(4-formyl-3-hydroxyphenyl)piperazine-1-carboxylate | ESD-848229-250MG |
Cas.: 1190310-51-0 | Purity: 97% | 5-Chloro-3-iodo-1H-pyrrolo[2,3-c]pyridine | ESD-848230-50MG |
Cas.: 1190310-51-0 | Purity: 97% | 5-Chloro-3-iodo-1H-pyrrolo[2,3-c]pyridine | ESD-848230-250MG |
Cas.: 21599-35-9 | Purity: 98% | 2-(Methylthio)-7,8-dihydroquinazolin-5(6H)-one | ESD-848231-25MG |
Cas.: 21599-35-9 | Purity: 98% | 2-(Methylthio)-7,8-dihydroquinazolin-5(6H)-one | ESD-848231-100MG |
Cas.: 1018656-53-5 | Purity: 95% | 2-(Pyridin-2-yl)morpholine | ESD-848232-25MG |
Cas.: 1018656-53-5 | Purity: 95% | 2-(Pyridin-2-yl)morpholine | ESD-848232-100MG |
Cas.: 49827-15-8 | Purity: 97% | tert-Butyl 2-iodoacetate | ESD-848234-250MG |
Cas.: 49827-15-8 | Purity: 97% | tert-Butyl 2-iodoacetate | ESD-848234-1G |
Cas.: 5799-76-8 | Purity: 97% | 4-(Prop-2-yn-1-yl)morpholine | ESD-848235-250MG |
Cas.: 5799-76-8 | Purity: 97% | 4-(Prop-2-yn-1-yl)morpholine | ESD-848235-1G |
Cas.: 30152-05-7 | Purity: 98% | 1-(3-Hydroxypyridin-4-yl)ethanone | ESD-848236-50MG |
Cas.: 30152-05-7 | Purity: 98% | 1-(3-Hydroxypyridin-4-yl)ethanone | ESD-848236-250MG |
Cas.: 131395-17-0 | Purity: 95% | 4-(2,2,2-Trifluoroethyl)aniline | ESD-848237-25MG |
Cas.: 131395-17-0 | Purity: 95% | 4-(2,2,2-Trifluoroethyl)aniline | ESD-848237-100MG |
Cas.: 796729-10-7 | Purity: 98% | 5,6-Dihydro-4H-pyrrolo[1,2-b]pyrazole-3-carboxylic acid | ESD-848238-25MG |
Cas.: 796729-10-7 | Purity: 98% | 5,6-Dihydro-4H-pyrrolo[1,2-b]pyrazole-3-carboxylic acid | ESD-848238-100MG |
Cas.: 1780480-20-7 | Purity: 98% | 3-Chloro-4-methoxy-1-methyl-1H-indazole | ESD-848239-25MG |
Cas.: 1780480-20-7 | Purity: 98% | 3-Chloro-4-methoxy-1-methyl-1H-indazole | ESD-848239-100MG |
Cas.: 43189-20-4 | Purity: 97% | Methyl 2-amino-2-(4-chlorophenyl)acetate | ESD-848240-250MG |
Cas.: 43189-20-4 | Purity: 97% | Methyl 2-amino-2-(4-chlorophenyl)acetate | ESD-848240-1G |
Cas.: 1210129-64-8 | Purity: 95% | 6-Chloro-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine | ESD-848241-50MG |
Cas.: 1210129-64-8 | Purity: 95% | 6-Chloro-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine | ESD-848241-250MG |
Cas.: 215798-14-4 | Purity: 95% | 6-(Trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-848242-50MG |
Cas.: 215798-14-4 | Purity: 95% | 6-(Trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-848242-250MG |
Cas.: 1262802-59-4 | Purity: 97% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-cyclopentylpropanoic acid | ESD-848243-50MG |
Cas.: 1262802-59-4 | Purity: 97% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-cyclopentylpropanoic acid | ESD-848243-250MG |
Cas.: 1187830-48-3 | Purity: 95% | 5-Iodo-2-(pyridin-3-yl)thiazole | ESD-848244-50MG |
Cas.: 1187830-48-3 | Purity: 95% | 5-Iodo-2-(pyridin-3-yl)thiazole | ESD-848244-250MG |
Cas.: 356072-46-3 | Purity: 98% | Spiro[indoline-3,4′-piperidin]-2-one hydrochloride | ESD-848245-25MG |
Cas.: 356072-46-3 | Purity: 98% | Spiro[indoline-3,4′-piperidin]-2-one hydrochloride | ESD-848245-100MG |
Cas.: 1588441-24-0 | Purity: 95% | 2-Amino-5-chloropyrimidine-4-carboxylic acid hydrochloride | ESD-848246-25MG |
Cas.: 1588441-24-0 | Purity: 95% | 2-Amino-5-chloropyrimidine-4-carboxylic acid hydrochloride | ESD-848246-100MG |
Cas.: 6604-06-4 | Purity: 98% | 2-Phenylcyclopentanamine | ESD-848247-25MG |
Cas.: 6604-06-4 | Purity: 98% | 2-Phenylcyclopentanamine | ESD-848247-100MG |
Cas.: 7557-02-0 | Purity: 97% | Quinazolin-8-ol | ESD-848248-50MG |
Cas.: 7557-02-0 | Purity: 97% | Quinazolin-8-ol | ESD-848248-250MG |
Cas.: 73087-83-9 | Purity: 95% | 3,6-Dibromo-9-(4-bromophenyl)-9H-carbazole | ESD-848249-250MG |
Cas.: 73087-83-9 | Purity: 95% | 3,6-Dibromo-9-(4-bromophenyl)-9H-carbazole | ESD-848249-1G |
Cas.: 112960-16-4 | Purity: 97% | (4aR,10bR)-rel-4-Propyl-2,3,4,4a,5,10b-hexahydrochromeno[4,3-b][1,4]oxazin-9-ol hydrochloride | ESD-848250-25MG |
Cas.: 112960-16-4 | Purity: 97% | (4aR,10bR)-rel-4-Propyl-2,3,4,4a,5,10b-hexahydrochromeno[4,3-b][1,4]oxazin-9-ol hydrochloride | ESD-848250-100MG |
Cas.: 69214-34-2 | Purity: 97% | 8-Bromoimidazo[1,2-a]pyrazine | ESD-848251-25MG |
Cas.: 69214-34-2 | Purity: 97% | 8-Bromoimidazo[1,2-a]pyrazine | ESD-848251-100MG |
Cas.: 1190319-56-2 | Purity: 98% | 6-Bromo-1H-pyrrolo[3,2-b]pyridine-3-carboxylic acid | ESD-848252-25MG |
Cas.: 1190319-56-2 | Purity: 98% | 6-Bromo-1H-pyrrolo[3,2-b]pyridine-3-carboxylic acid | ESD-848252-100MG |
Cas.: 734531-00-1 | Purity: 98% | 3-Methyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine | ESD-848253-25MG |
Cas.: 734531-00-1 | Purity: 98% | 3-Methyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine | ESD-848253-100MG |
Cas.: 823221-95-0 | Purity: 98% | 5-Chloro-4-iodo-2-(trifluoromethyl)pyridine | ESD-848254-25MG |
Cas.: 823221-95-0 | Purity: 98% | 5-Chloro-4-iodo-2-(trifluoromethyl)pyridine | ESD-848254-100MG |
Cas.: 173998-63-5 | Purity: 97% | 7-Fluoro-1,2,3,4-tetrahydronaphthalen-2-amine | ESD-848255-25MG |
Cas.: 173998-63-5 | Purity: 97% | 7-Fluoro-1,2,3,4-tetrahydronaphthalen-2-amine | ESD-848255-100MG |
Cas.: 86027-00-1 | Purity: 97% | 4,5-Dimethyl-1H-imidazole formate | ESD-848256-250MG |
Cas.: 86027-00-1 | Purity: 97% | 4,5-Dimethyl-1H-imidazole formate | ESD-848256-1G |
Cas.: 119022-51-4 | Purity: 97% | 1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3(2H)-one | ESD-848257-250MG |
Cas.: 119022-51-4 | Purity: 97% | 1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3(2H)-one | ESD-848257-1G |
Cas.: 875160-43-3 | Purity: 97% | 4-Bromo-1-methyl-1H-pyrrole-2-carboxylic acid | ESD-848258-250MG |
Cas.: 875160-43-3 | Purity: 97% | 4-Bromo-1-methyl-1H-pyrrole-2-carboxylic acid | ESD-848258-1G |
Cas.: 874289-11-9 | Purity: 97% | (4-(Cyclohexylcarbamoyl)-3-fluorophenyl)boronic acid | ESD-848259-250MG |
Cas.: 874289-11-9 | Purity: 97% | (4-(Cyclohexylcarbamoyl)-3-fluorophenyl)boronic acid | ESD-848259-1G |
Cas.: 138505-25-6 | Purity: 97% | 5-Bromo-2-isopropoxybenzaldehyde | ESD-848260-250MG |
Cas.: 138505-25-6 | Purity: 97% | 5-Bromo-2-isopropoxybenzaldehyde | ESD-848260-1G |
Cas.: 39885-08-0 | Purity: 97% | (2-Amino-6-chlorophenyl)methanol | ESD-848261-250MG |
Cas.: 39885-08-0 | Purity: 97% | (2-Amino-6-chlorophenyl)methanol | ESD-848261-1G |
Cas.: 621-06-7 | Purity: 98% | N,2-Diphenylacetamide | ESD-848262-250MG |
Cas.: 621-06-7 | Purity: 98% | N,2-Diphenylacetamide | ESD-848262-1G |
Cas.: 62022-04-2 | Purity: 98% | Ethyl 2,4-dichloronicotinate | ESD-848263-250MG |
Cas.: 62022-04-2 | Purity: 98% | Ethyl 2,4-dichloronicotinate | ESD-848263-1G |
Cas.: 160233-76-1 | Purity: 98% | 6-Bromoquinoline-4-carboxylic acid | ESD-848264-250MG |
Cas.: 160233-76-1 | Purity: 98% | 6-Bromoquinoline-4-carboxylic acid | ESD-848264-1G |
Cas.: 31577-25-0 | Purity: 98% | (2-Bromomethyl)-4-chloro-1-nitrobenzene | ESD-848265-250MG |
Cas.: 31577-25-0 | Purity: 98% | (2-Bromomethyl)-4-chloro-1-nitrobenzene | ESD-848265-1G |
Cas.: 79944-63-1 | Purity: 95% | (3-Amino-5-chlorophenyl)methanol | ESD-848266-250MG |
Cas.: 79944-63-1 | Purity: 95% | (3-Amino-5-chlorophenyl)methanol | ESD-848266-1G |
Cas.: 26595-78-8 | Purity: 95% | 2-Amino-N-ethylacetamide hydrochloride | ESD-848267-250MG |
Cas.: 26595-78-8 | Purity: 95% | 2-Amino-N-ethylacetamide hydrochloride | ESD-848267-1G |
Cas.: 91420-25-6 | Purity: 95% | 5-Bromo-2-methylpyridin-3-ol | ESD-848268-250MG |
Cas.: 91420-25-6 | Purity: 95% | 5-Bromo-2-methylpyridin-3-ol | ESD-848268-1G |
Cas.: 1436436-17-7 | Purity: 97% | (R)-Morpholin-2-ylmethanol hydrochloride | ESD-848269-250MG |
Cas.: 1436436-17-7 | Purity: 97% | (R)-Morpholin-2-ylmethanol hydrochloride | ESD-848269-1G |
Cas.: 938465-64-6 | Purity: 98% | (4-((Dimethylamino)methyl)phenyl)boronic acid hydrochloride | ESD-848270-250MG |
Cas.: 938465-64-6 | Purity: 98% | (4-((Dimethylamino)methyl)phenyl)boronic acid hydrochloride | ESD-848270-1G |
Cas.: 192927-69-8 | Purity: 95% | 2,4-Difluoro-3-hydroxybenzaldehyde | ESD-848271-250MG |
Cas.: 192927-69-8 | Purity: 95% | 2,4-Difluoro-3-hydroxybenzaldehyde | ESD-848271-1G |
Cas.: 879132-48-6 | Purity: 98% | 1-((2-(Trimethylsilyl)ethoxy)methyl)-1H-pyrrolo[2,3-b]pyridin-2(3H)-one | ESD-848272-250MG |
Cas.: 879132-48-6 | Purity: 98% | 1-((2-(Trimethylsilyl)ethoxy)methyl)-1H-pyrrolo[2,3-b]pyridin-2(3H)-one | ESD-848272-1G |
Cas.: 33781-38-3 | Purity: 95% | 5-Chloro-2,3-dihydro-1H-inden-1-ol | ESD-848273-250MG |
Cas.: 33781-38-3 | Purity: 95% | 5-Chloro-2,3-dihydro-1H-inden-1-ol | ESD-848273-1G |
Cas.: 2632-14-6 | Purity: 95% | 2-Bromo-1-(4-ethylphenyl)ethanone | ESD-848274-250MG |
Cas.: 2632-14-6 | Purity: 95% | 2-Bromo-1-(4-ethylphenyl)ethanone | ESD-848274-1G |
Cas.: 350683-40-8 | Purity: 97% | Ethyl indoline-6-carboxylate | ESD-848275-250MG |
Cas.: 350683-40-8 | Purity: 97% | Ethyl indoline-6-carboxylate | ESD-848275-1G |
Cas.: 59412-12-3 | Purity: 98% | 2,5-Dichloroquinoline | ESD-848276-250MG |
Cas.: 59412-12-3 | Purity: 98% | 2,5-Dichloroquinoline | ESD-848276-1G |
Cas.: 857048-73-8 | Purity: 95% | 4-(Piperidin-4-yloxy)benzamide hydrochloride | ESD-848277-250MG |
Cas.: 857048-73-8 | Purity: 95% | 4-(Piperidin-4-yloxy)benzamide hydrochloride | ESD-848277-1G |
Cas.: 1131587-78-4 | Purity: 96% | Methyl 5-bromo-2-(difluoromethoxy)benzoate | ESD-848278-250MG |
Cas.: 1131587-78-4 | Purity: 96% | Methyl 5-bromo-2-(difluoromethoxy)benzoate | ESD-848278-1G |
Cas.: 159184-14-2 | Purity: 97% | tert-Butyl (2-(4-nitrophenoxy)ethyl)carbamate | ESD-848279-250MG |
Cas.: 159184-14-2 | Purity: 97% | tert-Butyl (2-(4-nitrophenoxy)ethyl)carbamate | ESD-848279-1G |
Cas.: 115289-55-9 | Purity: 95% | Methyl 2-aminopent-4-enoate hydrochloride | ESD-848280-250MG |
Cas.: 115289-55-9 | Purity: 95% | Methyl 2-aminopent-4-enoate hydrochloride | ESD-848280-1G |
Cas.: 947684-78-8 | Purity: 97% | (R)-tert-Butyl 2-benzylpiperazine-1-carboxylate | ESD-848281-250MG |
Cas.: 947684-78-8 | Purity: 97% | (R)-tert-Butyl 2-benzylpiperazine-1-carboxylate | ESD-848281-1G |
Cas.: 76496-63-4 | Purity: 98% | (S)-2-(4-Chlorophenyl)-2-hydroxyacetic acid | ESD-848282-250MG |
Cas.: 76496-63-4 | Purity: 98% | (S)-2-(4-Chlorophenyl)-2-hydroxyacetic acid | ESD-848282-1G |
Cas.: 746671-32-9 | Purity: 98% | 4,6-Dichloro-2-(trifluoromethyl)quinazoline | ESD-848283-250MG |
Cas.: 746671-32-9 | Purity: 98% | 4,6-Dichloro-2-(trifluoromethyl)quinazoline | ESD-848283-1G |
Cas.: 128276-50-6 | Purity: 96% | 4,6-Dimethoxypyrimidine-2-carboxylic acid | ESD-848284-250MG |
Cas.: 128276-50-6 | Purity: 96% | 4,6-Dimethoxypyrimidine-2-carboxylic acid | ESD-848284-1G |
Cas.: 23938-73-0 | Purity: 97% | 2-Amino-4-(benzyloxy)-3-methoxybenzoic acid | ESD-848285-25MG |
Cas.: 23938-73-0 | Purity: 97% | 2-Amino-4-(benzyloxy)-3-methoxybenzoic acid | ESD-848285-100MG |
Cas.: 120277-15-8 | Purity: 97% | 4-(Bromomethyl)-2-methoxypyridine | ESD-848286-50MG |
Cas.: 120277-15-8 | Purity: 97% | 4-(Bromomethyl)-2-methoxypyridine | ESD-848286-250MG |
Cas.: 1082040-57-0 | Purity: 97% | Methyl 6-chloro-1H-indole-4-carboxylate | ESD-848287-25MG |
Cas.: 1082040-57-0 | Purity: 97% | Methyl 6-chloro-1H-indole-4-carboxylate | ESD-848287-100MG |
Cas.: 1588440-97-4 | Purity: 95% | 2,6-Diazaspiro[3.4]octan-7-one oxalate | ESD-848288-25MG |
Cas.: 1588440-97-4 | Purity: 95% | 2,6-Diazaspiro[3.4]octan-7-one oxalate | ESD-848288-100MG |
Cas.: 24005-61-6 | Purity: 95% | 6-Methoxy-2-pyrazinecarboxylic acid | ESD-848289-250MG |
Cas.: 24005-61-6 | Purity: 95% | 6-Methoxy-2-pyrazinecarboxylic acid | ESD-848289-1G |
Cas.: 137401-45-7 | Purity: 97% | 2-((tert-Butoxycarbonyl)amino)-3-ethoxy-3-oxopropanoic acid | ESD-848290-250MG |
Cas.: 137401-45-7 | Purity: 97% | 2-((tert-Butoxycarbonyl)amino)-3-ethoxy-3-oxopropanoic acid | ESD-848290-1G |
Cas.: 14925-09-8 | Purity: 98% | N-Methylbiphenyl-2-amine | ESD-848291-250MG |
Cas.: 14925-09-8 | Purity: 98% | N-Methylbiphenyl-2-amine | ESD-848291-1G |
Cas.: 66909-27-1 | Purity: 97% | 5-Methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid | ESD-848292-50MG |
Cas.: 66909-27-1 | Purity: 97% | 5-Methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid | ESD-848292-250MG |
Cas.: 716361-91-0 | Purity: 97% | 1-Methyl-1H-1,2,3-triazole-5-carboxylic acid | ESD-848293-50MG |
Cas.: 716361-91-0 | Purity: 97% | 1-Methyl-1H-1,2,3-triazole-5-carboxylic acid | ESD-848293-250MG |
Cas.: 1375325-68-0 | Purity: 98% | (2′-Amino-[1,1′-biphenyl]-2-yl)(dicyclohexyl(2′,6′-diisopropoxy-[1,1′-biphenyl]-2-yl)phosphoranyl)palladium(III) chloride | ESD-848294-250MG |
Cas.: 1375325-68-0 | Purity: 98% | (2′-Amino-[1,1′-biphenyl]-2-yl)(dicyclohexyl(2′,6′-diisopropoxy-[1,1′-biphenyl]-2-yl)phosphoranyl)palladium(III) chloride | ESD-848294-1G |
Cas.: 1201935-36-5 | Purity: 98% | 1-(1-Methylpiperidin-4-yl)-1H-pyrazol-4-amine | ESD-848295-25MG |
Cas.: 1201935-36-5 | Purity: 98% | 1-(1-Methylpiperidin-4-yl)-1H-pyrazol-4-amine | ESD-848295-100MG |
Cas.: 375854-77-6 | Purity: 95% | 2-(Trimethylsilyl)ethyl 4-(((trifluoromethyl)sulfonyl)oxy)-5,6-dihydropyridine-1(2H)-carboxylate | ESD-848296-25MG |
Cas.: 375854-77-6 | Purity: 95% | 2-(Trimethylsilyl)ethyl 4-(((trifluoromethyl)sulfonyl)oxy)-5,6-dihydropyridine-1(2H)-carboxylate | ESD-848296-100MG |
Cas.: 1610028-39-1 | Purity: 95% | 2,3-Dihydro-1H-pyrrolo[2,3-c]pyridine hydrochloride | ESD-848297-25MG |
Cas.: 1610028-39-1 | Purity: 95% | 2,3-Dihydro-1H-pyrrolo[2,3-c]pyridine hydrochloride | ESD-848297-100MG |
Cas.: 1646152-47-7 | Purity: 97% | Methyl 5-methoxy-4-((4-methoxybenzyl)oxy)-2-nitrobenzoate | ESD-848298-25MG |
Cas.: 1646152-47-7 | Purity: 97% | Methyl 5-methoxy-4-((4-methoxybenzyl)oxy)-2-nitrobenzoate | ESD-848298-100MG |
Cas.: 556775-77-0 | Purity: 97% | 2-(4-Bromo-1H-imidazol-1-yl)pyridine | ESD-848299-250MG |
Cas.: 556775-77-0 | Purity: 97% | 2-(4-Bromo-1H-imidazol-1-yl)pyridine | ESD-848299-1G |
Cas.: 50765-11-2 | Purity: 97% | 5-Hydroxy-2-iodobenzaldehyde | ESD-848300-250MG |
Cas.: 50765-11-2 | Purity: 97% | 5-Hydroxy-2-iodobenzaldehyde | ESD-848300-1G |
Cas.: 918538-04-2 | Purity: 97% | Pyrrolo[2,1-f][1,2,4]triazine-2,4(1H,3H)-dione | ESD-848301-250MG |
Cas.: 918538-04-2 | Purity: 97% | Pyrrolo[2,1-f][1,2,4]triazine-2,4(1H,3H)-dione | ESD-848301-1G |
Cas.: 399-67-7 | Purity: 95% | 7-Fluoro-1H-indole-2-carboxylic acid | ESD-848302-250MG |
Cas.: 399-67-7 | Purity: 95% | 7-Fluoro-1H-indole-2-carboxylic acid | ESD-848302-1G |
Cas.: 1049729-31-8 | Purity: 97% | (2-Bromo-6-fluorophenyl)hydrazine hydrochloride | ESD-848303-250MG |
Cas.: 1049729-31-8 | Purity: 97% | (2-Bromo-6-fluorophenyl)hydrazine hydrochloride | ESD-848303-1G |
Cas.: 142166-01-6 | Purity: 98% | Methyl 3,4-dihydro-2H-benzo[b][1,4]oxazine-7-carboxylate | ESD-848304-250MG |
Cas.: 142166-01-6 | Purity: 98% | Methyl 3,4-dihydro-2H-benzo[b][1,4]oxazine-7-carboxylate | ESD-848304-1G |
Cas.: 16433-96-8 | Purity: 97% | 1-Ethynyl-2-nitrobenzene | ESD-848305-250MG |
Cas.: 16433-96-8 | Purity: 97% | 1-Ethynyl-2-nitrobenzene | ESD-848305-1G |
Cas.: 1187930-42-2 | Purity: 98% | 6,7-Dihydro-5H-cyclopenta[b]pyridin-7-amine hydrochloride | ESD-848306-50MG |
Cas.: 1187930-42-2 | Purity: 98% | 6,7-Dihydro-5H-cyclopenta[b]pyridin-7-amine hydrochloride | ESD-848306-250MG |
Cas.: 1029720-23-7 | Purity: 95% | Methyl 3-(dibromomethyl)picolinate | ESD-848307-50MG |
Cas.: 1029720-23-7 | Purity: 95% | Methyl 3-(dibromomethyl)picolinate | ESD-848307-250MG |
Cas.: 255864-58-5 | Purity: 97% | 1-Boc-2-Ethynylpiperidine | ESD-848308-250MG |
Cas.: 255864-58-5 | Purity: 97% | 1-Boc-2-Ethynylpiperidine | ESD-848308-1G |
Cas.: 96929-05-4 | Purity: 98% | Ethyl 2-(((tert-butoxycarbonyl)amino)methyl)thiazole-4-carboxylate | ESD-848309-250MG |
Cas.: 96929-05-4 | Purity: 98% | Ethyl 2-(((tert-butoxycarbonyl)amino)methyl)thiazole-4-carboxylate | ESD-848309-1G |
Cas.: 1190320-33-2 | Purity: 97% | 6-Fluoro-1H-pyrrolo[3,2-b]pyridine | ESD-848310-25MG |
Cas.: 1190320-33-2 | Purity: 97% | 6-Fluoro-1H-pyrrolo[3,2-b]pyridine | ESD-848310-100MG |
Cas.: 80845-58-5 | Purity: 98% | Methyl 1-benzyl-1,2,3,6-tetrahydropyridine-4-carboxylate | ESD-848311-250MG |
Cas.: 80845-58-5 | Purity: 98% | Methyl 1-benzyl-1,2,3,6-tetrahydropyridine-4-carboxylate | ESD-848311-1G |
Cas.: 943830-58-8 | Purity: 97% | 1-Bromo-4-chloro-2-fluoro-3-methylbenzene | ESD-848312-250MG |
Cas.: 943830-58-8 | Purity: 97% | 1-Bromo-4-chloro-2-fluoro-3-methylbenzene | ESD-848312-1G |
Cas.: 837392-65-1 | Purity: 98% | 5-Bromobenzo[d]isoxazole | ESD-848313-250MG |
Cas.: 837392-65-1 | Purity: 98% | 5-Bromobenzo[d]isoxazole | ESD-848313-1G |
Cas.: 22433-12-1 | Purity: 98% | (5-Bromopyrimidin-2-yl)methanol | ESD-848314-25MG |
Cas.: 22433-12-1 | Purity: 98% | (5-Bromopyrimidin-2-yl)methanol | ESD-848314-100MG |
Cas.: 64460-41-9 | Purity: 98% | Pyridin-4-ylmethanamine hydrochloride | ESD-848315-250MG |
Cas.: 64460-41-9 | Purity: 98% | Pyridin-4-ylmethanamine hydrochloride | ESD-848315-1G |
Cas.: 61044-96-0 | Purity: 97% | 4-Chloro-5-methyl-2-(methylthio)pyrimidine | ESD-848316-250MG |
Cas.: 61044-96-0 | Purity: 97% | 4-Chloro-5-methyl-2-(methylthio)pyrimidine | ESD-848316-1G |
Cas.: 63788-62-5 | Purity: 97% | 2-Acetylamino-4-methylthiazole-5-carboxylic acid | ESD-848317-250MG |
Cas.: 231958-04-6 | Purity: 98% | 3-((tert-Butoxycarbonyl)amino)-4-methylbenzoic acid | ESD-848318-250MG |
Cas.: 231958-04-6 | Purity: 98% | 3-((tert-Butoxycarbonyl)amino)-4-methylbenzoic acid | ESD-848318-1G |
Cas.: 24195-10-6 | Purity: 97% | 2-(Methoxycarbonyl)isonicotinic acid | ESD-848319-250MG |
Cas.: 24195-10-6 | Purity: 97% | 2-(Methoxycarbonyl)isonicotinic acid | ESD-848319-1G |
Cas.: 67279-23-6 | Purity: 97% | 2,3,5,6,7,8-Hexahydrophthalazine-1,4-dione | ESD-848320-50MG |
Cas.: 67279-23-6 | Purity: 97% | 2,3,5,6,7,8-Hexahydrophthalazine-1,4-dione | ESD-848320-250MG |
Cas.: 885278-05-7 | Purity: 95% | 2-(2,4-Difluorophenyl)-1H-imidazole | ESD-848321-50MG |
Cas.: 885278-05-7 | Purity: 95% | 2-(2,4-Difluorophenyl)-1H-imidazole | ESD-848321-250MG |
Cas.: 1992-09-2 | Purity: 98% | 2-(4-Amino-3-methylphenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol | ESD-848322-50MG |
Cas.: 1992-09-2 | Purity: 98% | 2-(4-Amino-3-methylphenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol | ESD-848322-250MG |
Cas.: 57356-66-8 | Purity: 98% | 4-(Pyrimidin-2-yl)morpholine | ESD-848323-50MG |
Cas.: 57356-66-8 | Purity: 98% | 4-(Pyrimidin-2-yl)morpholine | ESD-848323-250MG |
Cas.: 955027-77-7 | Purity: 95% | 3-(Hydroxymethyl)piperidin-4-ol hydrochloride | ESD-848324-50MG |
Cas.: 955027-77-7 | Purity: 95% | 3-(Hydroxymethyl)piperidin-4-ol hydrochloride | ESD-848324-250MG |
Cas.: 85157-21-7 | Purity: 97% | 2-(7-Amino-2-oxo-2H-chromen-4-yl)acetic acid | ESD-848325-250MG |
Cas.: 85157-21-7 | Purity: 97% | 2-(7-Amino-2-oxo-2H-chromen-4-yl)acetic acid | ESD-848325-1G |
Cas.: 408359-52-4 | Purity: 95% | 1-(3-Cyclopropylphenyl)ethanone | ESD-848326-25MG |
Cas.: 408359-52-4 | Purity: 95% | 1-(3-Cyclopropylphenyl)ethanone | ESD-848326-100MG |
Cas.: 1311254-85-9 | Purity: 95% | (S)-1-(4-Bromo-2-fluorophenyl)ethanamine hydrochloride | ESD-848327-25MG |
Cas.: 1311254-85-9 | Purity: 95% | (S)-1-(4-Bromo-2-fluorophenyl)ethanamine hydrochloride | ESD-848327-100MG |
Cas.: 475057-86-4 | Purity: 96% | 4-Hydroxypicolinonitrile | ESD-848328-25MG |
Cas.: 475057-86-4 | Purity: 96% | 4-Hydroxypicolinonitrile | ESD-848328-100MG |
Cas.: 14384-34-0 | Purity: 98% | 2,3,4,9-Tetrahydro-1H-carbazol-3-ol | ESD-848329-25MG |
Cas.: 14384-34-0 | Purity: 98% | 2,3,4,9-Tetrahydro-1H-carbazol-3-ol | ESD-848329-100MG |
Cas.: 80354-00-3 | Purity: 98% | 2-Bromoimidazo[2,1-b]thiazole-6-carboxylic acid | ESD-848330-25MG |
Cas.: 80354-00-3 | Purity: 98% | 2-Bromoimidazo[2,1-b]thiazole-6-carboxylic acid | ESD-848330-100MG |
Cas.: 215115-09-6 | Purity: 97% | 8-Bromo-6-methylquinazolin-4(3H)-one | ESD-848331-25MG |
Cas.: 215115-09-6 | Purity: 97% | 8-Bromo-6-methylquinazolin-4(3H)-one | ESD-848331-100MG |
Cas.: 911372-78-6 | Purity: 97% | (R)-4-(1-Aminoethyl)benzonitrile hydrochloride | ESD-848332-25MG |
Cas.: 911372-78-6 | Purity: 97% | (R)-4-(1-Aminoethyl)benzonitrile hydrochloride | ESD-848332-100MG |
Cas.: 892152-26-0 | Purity: 97% | 7-Bromo-6-methoxy-2,3-dihydro-1H-inden-1-one | ESD-848333-25MG |
Cas.: 892152-26-0 | Purity: 97% | 7-Bromo-6-methoxy-2,3-dihydro-1H-inden-1-one | ESD-848333-100MG |
Cas.: 51934-39-5 | Purity: 98% | 7-Bromo-1-naphthoic acid | ESD-848334-25MG |
Cas.: 51934-39-5 | Purity: 98% | 7-Bromo-1-naphthoic acid | ESD-848334-100MG |
Cas.: 1001050-21-0 | Purity: 98% | 2-Bromo-5-(pyrrolidin-1-yl)pyrazine | ESD-848335-25MG |
Cas.: 1001050-21-0 | Purity: 98% | 2-Bromo-5-(pyrrolidin-1-yl)pyrazine | ESD-848335-100MG |
Cas.: 873551-20-3 | Purity: 97% | tert-Butyl 4-cyano-5,6-dihydropyridine-1(2H)-carboxylate | ESD-848336-25MG |
Cas.: 873551-20-3 | Purity: 97% | tert-Butyl 4-cyano-5,6-dihydropyridine-1(2H)-carboxylate | ESD-848336-100MG |
Cas.: 887308-14-7 | Purity: 97% | 5-Bromo-2-chloro-3-(methylsulfonyl)pyridine | ESD-848337-25MG |
Cas.: 887308-14-7 | Purity: 97% | 5-Bromo-2-chloro-3-(methylsulfonyl)pyridine | ESD-848337-100MG |
Cas.: 247092-10-0 | Purity: 98% | Methyl 2-chloro-5-hydroxybenzoate | ESD-848338-250MG |
Cas.: 247092-10-0 | Purity: 98% | Methyl 2-chloro-5-hydroxybenzoate | ESD-848338-1G |
Cas.: 78008-36-3 | Purity: 98% | (R)-1,4-Dioxaspiro[4.5]decane-2-carbaldehyde | ESD-848339-250MG |
Cas.: 78008-36-3 | Purity: 98% | (R)-1,4-Dioxaspiro[4.5]decane-2-carbaldehyde | ESD-848339-1G |
Cas.: 1214328-84-3 | Purity: 98% | Methyl 5-bromo-3-(trifluoromethyl)picolinate | ESD-848340-50MG |
Cas.: 1214328-84-3 | Purity: 98% | Methyl 5-bromo-3-(trifluoromethyl)picolinate | ESD-848340-250MG |
Cas.: 362052-00-4 | Purity: 95% | 2-(4-Cyanophenyl)propanoic acid | ESD-848341-50MG |
Cas.: 362052-00-4 | Purity: 95% | 2-(4-Cyanophenyl)propanoic acid | ESD-848341-250MG |
Cas.: 1257850-83-1 | Purity: 95% | (R)-tert-Butyl (morpholin-3-ylmethyl)carbamate | ESD-848342-25MG |
Cas.: 1257850-83-1 | Purity: 95% | (R)-tert-Butyl (morpholin-3-ylmethyl)carbamate | ESD-848342-100MG |
Cas.: 660830-63-7 | Purity: 95% | 7-Bromoisoquinoline-3-carboxylic acid | ESD-848343-25MG |
Cas.: 660830-63-7 | Purity: 95% | 7-Bromoisoquinoline-3-carboxylic acid | ESD-848343-100MG |
Cas.: 511231-70-2 | Purity: 98% | 5-Chloroquinoline-2-carboxylic acid | ESD-848344-25MG |
Cas.: 511231-70-2 | Purity: 98% | 5-Chloroquinoline-2-carboxylic acid | ESD-848344-100MG |
Cas.: 1206680-27-4 | Purity: 97% | Methyl 4-bromo-2-fluoro-3-methylbenzoate | ESD-848345-25MG |
Cas.: 1206680-27-4 | Purity: 97% | Methyl 4-bromo-2-fluoro-3-methylbenzoate | ESD-848345-100MG |
Cas.: 787580-93-2 | Purity: 95% | 3-Oxo-2,3-dihydro-1H-indazole-5-carboxylic acid | ESD-848346-25MG |
Cas.: 787580-93-2 | Purity: 95% | 3-Oxo-2,3-dihydro-1H-indazole-5-carboxylic acid | ESD-848346-100MG |
Cas.: 10408-85-2 | Purity: 98% | N-Methyl-2,3-dihydro-1H-inden-2-amine hydrochloride | ESD-848347-250MG |
Cas.: 10408-85-2 | Purity: 98% | N-Methyl-2,3-dihydro-1H-inden-2-amine hydrochloride | ESD-848347-1G |
Cas.: 5753-26-4 | Purity: 97% | 1-(2-Chloroethyl)-4-methylpiperazine dihydrochloride | ESD-848348-250MG |
Cas.: 5753-26-4 | Purity: 97% | 1-(2-Chloroethyl)-4-methylpiperazine dihydrochloride | ESD-848348-1G |
Cas.: 60298-18-2 | Purity: 95% | Ethyl 5-oxopyrrolidine-3-carboxylate | ESD-848349-250MG |
Cas.: 60298-18-2 | Purity: 95% | Ethyl 5-oxopyrrolidine-3-carboxylate | ESD-848349-1G |
Cas.: 880468-89-3 | Purity: 95% | (R)-tert-Butyl 1-(benzylamino)-3-methoxy-1-oxopropan-2-ylcarbamate | ESD-848350-250MG |
Cas.: 880468-89-3 | Purity: 95% | (R)-tert-Butyl 1-(benzylamino)-3-methoxy-1-oxopropan-2-ylcarbamate | ESD-848350-1G |
Cas.: 106556-66-5 | Purity: 95% | Ethyl 2,2-dimethyl-3-oxopyrrolidine-1-carboxylate | ESD-848351-250MG |
Cas.: 106556-66-5 | Purity: 95% | Ethyl 2,2-dimethyl-3-oxopyrrolidine-1-carboxylate | ESD-848351-1G |
Cas.: 859169-20-3 | Purity: 97% | Ethyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate | ESD-848352-250MG |
Cas.: 859169-20-3 | Purity: 97% | Ethyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate | ESD-848352-1G |
Cas.: 77533-18-7 | Purity: 98% | 2-(Bromomethyl)-3-chlorobenzonitrile | ESD-848353-250MG |
Cas.: 77533-18-7 | Purity: 98% | 2-(Bromomethyl)-3-chlorobenzonitrile | ESD-848353-1G |
Cas.: 69206-89-9 | Purity: 98% | 6-(Piperidin-1-yl)pyrimidin-4-amine | ESD-848354-250MG |
Cas.: 69206-89-9 | Purity: 98% | 6-(Piperidin-1-yl)pyrimidin-4-amine | ESD-848354-1G |
Cas.: 346599-62-0 | Purity: 98% | 4-Chloro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one | ESD-848355-250MG |
Cas.: 346599-62-0 | Purity: 98% | 4-Chloro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one | ESD-848355-1G |
Cas.: 1181816-12-5 | Purity: 98% | tert-Butyl 6-oxo-2-azaspiro[3.3]heptane-2-carboxylate | ESD-848356-250MG |
Cas.: 1181816-12-5 | Purity: 98% | tert-Butyl 6-oxo-2-azaspiro[3.3]heptane-2-carboxylate | ESD-848356-1G |
Cas.: 845909-49-1 | Purity: 97% | Ethyl 4-fluoropiperidine-4-carboxylate hydrochloride | ESD-848357-250MG |
Cas.: 845909-49-1 | Purity: 97% | Ethyl 4-fluoropiperidine-4-carboxylate hydrochloride | ESD-848357-1G |
Cas.: 120711-81-1 | Purity: 97% | 7-Nitro-3,4-dihydro-2H-1,4-benzooxazine | ESD-848358-250MG |
Cas.: 120711-81-1 | Purity: 97% | 7-Nitro-3,4-dihydro-2H-1,4-benzooxazine | ESD-848358-1G |
Cas.: 853058-41-0 | Purity: 95% | Ethyl 4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidine-7-carboxylate | ESD-848359-250MG |
Cas.: 853058-41-0 | Purity: 95% | Ethyl 4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidine-7-carboxylate | ESD-848359-1G |
Cas.: 50920-64-4 | Purity: 95% | Ethyl 1-ethyl-3-methyl-1H-pyrazole-5-carboxylate | ESD-848360-250MG |
Cas.: 50920-64-4 | Purity: 95% | Ethyl 1-ethyl-3-methyl-1H-pyrazole-5-carboxylate | ESD-848360-1G |
Cas.: 1245816-10-7 | Purity: 98% | (5-Methyl-1H-indazol-4-yl)boronic acid | ESD-848361-250MG |
Cas.: 1245816-10-7 | Purity: 98% | (5-Methyl-1H-indazol-4-yl)boronic acid | ESD-848361-1G |
Cas.: 1009303-77-8 | Purity: 97% | 2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenemethanol | ESD-848362-250MG |
Cas.: 1009303-77-8 | Purity: 97% | 2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenemethanol | ESD-848362-1G |
Cas.: 1227382-01-5 | Purity: 95% | tert-Butyl 2,6-diazaspiro[3.3]heptane-2-carboxylate oxalate | ESD-848363-250MG |
Cas.: 1227382-01-5 | Purity: 95% | tert-Butyl 2,6-diazaspiro[3.3]heptane-2-carboxylate oxalate | ESD-848363-1G |
Cas.: 1056264-66-4 | Purity: 95% | 2-Bromo-3-chloro-6-fluorobenzaldehyde | ESD-848364-250MG |
Cas.: 1056264-66-4 | Purity: 95% | 2-Bromo-3-chloro-6-fluorobenzaldehyde | ESD-848364-1G |
Cas.: 1004294-58-9 | Purity: 98% | 6-Bromo-5-chloropyridin-2-amine | ESD-848365-250MG |
Cas.: 1004294-58-9 | Purity: 98% | 6-Bromo-5-chloropyridin-2-amine | ESD-848365-1G |
Cas.: 105919-34-4 | Purity: 97% | (1S,2S)-rel-2-Fluorocyclopropanecarboxylic acid | ESD-848366-250MG |
Cas.: 105919-34-4 | Purity: 97% | (1S,2S)-rel-2-Fluorocyclopropanecarboxylic acid | ESD-848366-1G |
Cas.: 58142-99-7 | Purity: 98% | 5-Iodoisoquinoline | ESD-848367-250MG |
Cas.: 58142-99-7 | Purity: 98% | 5-Iodoisoquinoline | ESD-848367-1G |
Cas.: 845895-95-6 | Purity: 97% | 5,7-Dichloropyrazolo[1,5-a]pyrimidine-3-carbonitrile | ESD-848368-250MG |
Cas.: 845895-95-6 | Purity: 97% | 5,7-Dichloropyrazolo[1,5-a]pyrimidine-3-carbonitrile | ESD-848368-1G |
Cas.: 1261644-21-6 | Purity: 98% | (2-Bromo-3-iodophenyl)methanol | ESD-848369-250MG |
Cas.: 1261644-21-6 | Purity: 98% | (2-Bromo-3-iodophenyl)methanol | ESD-848369-1G |
Cas.: 944401-69-8 | Purity: 98% | 5-Bromo-4-fluoropyridin-2-amine | ESD-848370-250MG |
Cas.: 944401-69-8 | Purity: 98% | 5-Bromo-4-fluoropyridin-2-amine | ESD-848370-1G |
Cas.: 1214345-40-0 | Purity: 98% | 2-Bromo-6-(difluoromethoxy)pyridine | ESD-848371-250MG |
Cas.: 1214345-40-0 | Purity: 98% | 2-Bromo-6-(difluoromethoxy)pyridine | ESD-848371-1G |
Cas.: 20020-27-3 | Purity: 98% | Phenethyl methanesulfonate | ESD-848372-250MG |
Cas.: 20020-27-3 | Purity: 98% | Phenethyl methanesulfonate | ESD-848372-1G |
Cas.: 104033-62-7 | Purity: 98% | (4-Isopropoxyphenyl)hydrazine hydrochloride | ESD-848373-250MG |
Cas.: 22246-02-2 | Purity: 98% | 6-Chloro-3,4-dihydroisoquinolin-1(2H)-one | ESD-848374-250MG |
Cas.: 22246-02-2 | Purity: 98% | 6-Chloro-3,4-dihydroisoquinolin-1(2H)-one | ESD-848374-1G |
Cas.: 89640-55-1 | Purity: 98% | 3-Iodo-4-methoxypyridine | ESD-848375-250MG |
Cas.: 89640-55-1 | Purity: 98% | 3-Iodo-4-methoxypyridine | ESD-848375-1G |
Cas.: 296261-32-0 | Purity: 96% | 2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)malonic acid | ESD-848376-250MG |
Cas.: 296261-32-0 | Purity: 96% | 2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)malonic acid | ESD-848376-1G |
Cas.: 767-80-6 | Purity: 96% | 5-Fluoropyrimidine-2,4,6-triol | ESD-848377-250MG |
Cas.: 767-80-6 | Purity: 96% | 5-Fluoropyrimidine-2,4,6-triol | ESD-848377-1G |
Cas.: 958635-15-9 | Purity: 97% | (S)-Tetrahydro-1H-oxazolo[3,4-a]pyrazin-3(5H)-one hydrochloride | ESD-848378-250MG |
Cas.: 958635-15-9 | Purity: 97% | (S)-Tetrahydro-1H-oxazolo[3,4-a]pyrazin-3(5H)-one hydrochloride | ESD-848378-1G |
Cas.: 90924-46-2 | Purity: 98% | Methyl 2-oxoindoline-4-carboxylate | ESD-848379-250MG |
Cas.: 90924-46-2 | Purity: 98% | Methyl 2-oxoindoline-4-carboxylate | ESD-848379-1G |
Cas.: 220000-86-2 | Purity: 98% | tert-Butyl 4-chloropicolinate | ESD-848380-250MG |
Cas.: 220000-86-2 | Purity: 98% | tert-Butyl 4-chloropicolinate | ESD-848380-1G |
Cas.: 888720-52-3 | Purity: 98% | 4-Chloro-5-isopropylpyrrolo[2,1-f][1,2,4]triazine | ESD-848381-50MG |
Cas.: 888720-52-3 | Purity: 98% | 4-Chloro-5-isopropylpyrrolo[2,1-f][1,2,4]triazine | ESD-848381-250MG |
Cas.: 1053656-45-3 | Purity: 95% | 1-Chloro-7-nitropyrrolo[1,2-a]pyrazine | ESD-848382-50MG |
Cas.: 1053656-45-3 | Purity: 95% | 1-Chloro-7-nitropyrrolo[1,2-a]pyrazine | ESD-848382-250MG |
Cas.: 1260812-97-2 | Purity: 95% | 2-Bromo-3-methyl-5H-pyrrolo[2,3-b]pyrazine | ESD-848383-50MG |
Cas.: 1260812-97-2 | Purity: 95% | 2-Bromo-3-methyl-5H-pyrrolo[2,3-b]pyrazine | ESD-848383-250MG |
Cas.: 945212-26-0 | Purity: 95% | (R)-N-Fmoc-2-(7-octenyl)Alanine | ESD-848384-50MG |
Cas.: 945212-26-0 | Purity: 95% | (R)-N-Fmoc-2-(7-octenyl)Alanine | ESD-848384-250MG |
Cas.: 1628557-04-9 | Purity: 97% | Isoquinolin-3-ylmethanamine hydrochloride | ESD-848385-50MG |
Cas.: 1628557-04-9 | Purity: 97% | Isoquinolin-3-ylmethanamine hydrochloride | ESD-848385-250MG |
Cas.: 1429056-38-1 | Purity: 97% | N2-Methylpyridine-2,4-diamine hydrochloride | ESD-848386-50MG |
Cas.: 1429056-38-1 | Purity: 97% | N2-Methylpyridine-2,4-diamine hydrochloride | ESD-848386-250MG |
Cas.: 1190861-43-8 | Purity: 97% | 6-Bromo-2′,3′,5′,6′-tetrahydrospiro[indoline-3,4′-pyran]-2-one | ESD-848387-25MG |
Cas.: 1190861-43-8 | Purity: 97% | 6-Bromo-2′,3′,5′,6′-tetrahydrospiro[indoline-3,4′-pyran]-2-one | ESD-848387-100MG |
Cas.: 855945-03-8 | Purity: 97% | 2-(4-Acetamidophenoxy)-N,N,N-trimethylethanaminium bromide | ESD-848388-25MG |
Cas.: 855945-03-8 | Purity: 97% | 2-(4-Acetamidophenoxy)-N,N,N-trimethylethanaminium bromide | ESD-848388-100MG |
Cas.: 1310923-28-4 | Purity: 98% | (S)-1-(2-Fluorophenyl)propan-1-amine hydrochloride | ESD-848389-25MG |
Cas.: 1310923-28-4 | Purity: 98% | (S)-1-(2-Fluorophenyl)propan-1-amine hydrochloride | ESD-848389-100MG |
Cas.: 1610028-43-7 | Purity: 95% | 6-(Aminomethyl)picolinic acid hydrochloride | ESD-848390-25MG |
Cas.: 1610028-43-7 | Purity: 95% | 6-(Aminomethyl)picolinic acid hydrochloride | ESD-848390-100MG |
Cas.: 937681-12-4 | Purity: 97% | 2,2-Dimethylpiperidin-4-ol | ESD-848391-25MG |
Cas.: 937681-12-4 | Purity: 97% | 2,2-Dimethylpiperidin-4-ol | ESD-848391-100MG |
Cas.: 38157-08-3 | Purity: 95% | (E)-Ethyl 3-(4-(benzyloxy)-3-methoxyphenyl)acrylate | ESD-848392-25MG |
Cas.: 38157-08-3 | Purity: 95% | (E)-Ethyl 3-(4-(benzyloxy)-3-methoxyphenyl)acrylate | ESD-848392-100MG |
Cas.: 957793-35-0 | Purity: 97% | cis-Ethyl 3-aminocyclobutanecarboxylate hydrochloride | ESD-848394-25MG |
Cas.: 957793-35-0 | Purity: 97% | cis-Ethyl 3-aminocyclobutanecarboxylate hydrochloride | ESD-848394-100MG |
Cas.: 77474-33-0 | Purity: 97% | 7-Methoxy-4-oxo-1,4-dihydroquinoline-2-carboxylic acid | ESD-848395-250MG |
Cas.: 77474-33-0 | Purity: 97% | 7-Methoxy-4-oxo-1,4-dihydroquinoline-2-carboxylic acid | ESD-848395-1G |
Cas.: 1002309-48-9 | Purity: 97% | 1-Cyclobutyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-848396-250MG |
Cas.: 1002309-48-9 | Purity: 97% | 1-Cyclobutyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-848396-1G |
Cas.: 1187930-34-2 | Purity: 97% | 3-Amino-6-bromopyridin-2(1H)-one hydrobromide | ESD-848397-250MG |
Cas.: 1187930-34-2 | Purity: 97% | 3-Amino-6-bromopyridin-2(1H)-one hydrobromide | ESD-848397-1G |
Cas.: 723286-79-1 | Purity: 95% | tert-Butyl 5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-carboxylate | ESD-848398-250MG |
Cas.: 723286-79-1 | Purity: 95% | tert-Butyl 5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-carboxylate | ESD-848398-1G |
Cas.: 1416352-02-7 | Purity: 95% | 4-(Dibenzylamino)cyclohexanone hydrochloride | ESD-848399-250MG |
Cas.: 1416352-02-7 | Purity: 95% | 4-(Dibenzylamino)cyclohexanone hydrochloride | ESD-848399-1G |
Cas.: 1041861-94-2 | Purity: 97% | 4-(4-Aminophenoxy)pyridin-2(1H)-one | ESD-848400-50MG |
Cas.: 1041861-94-2 | Purity: 97% | 4-(4-Aminophenoxy)pyridin-2(1H)-one | ESD-848400-250MG |
Cas.: 1820574-01-3 | Purity: 95% | (R)-1-(3-Chloro-5-fluorophenyl)ethanamine hydrochloride | ESD-848401-25MG |
Cas.: 1820574-01-3 | Purity: 95% | (R)-1-(3-Chloro-5-fluorophenyl)ethanamine hydrochloride | ESD-848401-100MG |
Cas.: 1420271-08-4 | Purity: 97% | 2-Azaspiro[3.3]heptane hydrochloride | ESD-848402-25MG |
Cas.: 1420271-08-4 | Purity: 97% | 2-Azaspiro[3.3]heptane hydrochloride | ESD-848402-100MG |
Cas.: 135311-97-6 | Purity: 97% | 6,7-Dihydroisoquinolin-8(5H)-one hydrochloride | ESD-848403-250MG |
Cas.: 135311-97-6 | Purity: 97% | 6,7-Dihydroisoquinolin-8(5H)-one hydrochloride | ESD-848403-1G |
Cas.: 92664-05-6 | Purity: 95% | Potassium 1-cyano-3-ethoxy-2,3-dioxopropan-1-ide | ESD-848404-250MG |
Cas.: 92664-05-6 | Purity: 95% | Potassium 1-cyano-3-ethoxy-2,3-dioxopropan-1-ide | ESD-848404-1G |
Cas.: 30216-52-5 | Purity: 98% | 2-Hydrazinylthiazole hydrochloride | ESD-848405-25MG |
Cas.: 30216-52-5 | Purity: 98% | 2-Hydrazinylthiazole hydrochloride | ESD-848405-100MG |
Cas.: 676994-64-2 | Purity: 95% | 5,6,7,8-Tetrahydro-1,6-naphthyridin-2(1H)-one | ESD-848406-25MG |
Cas.: 676994-64-2 | Purity: 95% | 5,6,7,8-Tetrahydro-1,6-naphthyridin-2(1H)-one | ESD-848406-100MG |
Cas.: 898044-50-3 | Purity: 96% | 4-Chloro-5-fluoro-2-methylpyrimidine | ESD-848407-1G |
Cas.: 898044-50-3 | Purity: 96% | 4-Chloro-5-fluoro-2-methylpyrimidine | ESD-848407-5G |
Cas.: 210962-09-7 | Purity: 97% | 1-(Pyridin-4-yl)piperidine-4-carboxylic acid hydrochloride | ESD-848408-250MG |
Cas.: 210962-09-7 | Purity: 97% | 1-(Pyridin-4-yl)piperidine-4-carboxylic acid hydrochloride | ESD-848408-1G |
Cas.: 398495-65-3 | Purity: 95% | 5-tert-Butyl 1-ethyl 3-aminopyrrolo[3,4-c]pyrazole-1,5(4H,6H)-dicarboxylate | ESD-848409-250MG |
Cas.: 398495-65-3 | Purity: 95% | 5-tert-Butyl 1-ethyl 3-aminopyrrolo[3,4-c]pyrazole-1,5(4H,6H)-dicarboxylate | ESD-848409-1G |
Cas.: 4014-77-1 | Purity: 98% | 10,11-Dihydro-5H-dibenzo[b,f]azepin-10-ol | ESD-848410-25MG |
Cas.: 4014-77-1 | Purity: 98% | 10,11-Dihydro-5H-dibenzo[b,f]azepin-10-ol | ESD-848410-100MG |
Cas.: 1018680-09-5 | Purity: 98% | (5-(Dimethylamino)pyridin-3-yl)boronic acid | ESD-848411-25MG |
Cas.: 1018680-09-5 | Purity: 98% | (5-(Dimethylamino)pyridin-3-yl)boronic acid | ESD-848411-100MG |
Cas.: 5562-20-9 | Purity: 98% | 2-(1-Benzylpiperidin-3-yl)acetonitrile | ESD-848412-25MG |
Cas.: 5562-20-9 | Purity: 98% | 2-(1-Benzylpiperidin-3-yl)acetonitrile | ESD-848412-100MG |
Cas.: 1190965-20-8 | Purity: 97% | 5-Chloro-3H-spiro[isobenzofuran-1,4′-piperidine] hydrochloride | ESD-848413-25MG |
Cas.: 1190965-20-8 | Purity: 97% | 5-Chloro-3H-spiro[isobenzofuran-1,4′-piperidine] hydrochloride | ESD-848413-100MG |
Cas.: 1175275-00-9 | Purity: 95% | 1-Cyclohexyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-848414-25MG |
Cas.: 1175275-00-9 | Purity: 95% | 1-Cyclohexyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-848414-100MG |
Cas.: 811442-84-9 | Purity: 98% | tert-Butyl (14-amino-3,6,9,12-tetraoxatetradecyl)carbamate | ESD-848415-25MG |
Cas.: 811442-84-9 | Purity: 98% | tert-Butyl (14-amino-3,6,9,12-tetraoxatetradecyl)carbamate | ESD-848415-100MG |
Cas.: 4104-35-2 | Purity: 98% | 5-Chloro-3-methylbenzo[c]isoxazole | ESD-848416-25MG |
Cas.: 4104-35-2 | Purity: 98% | 5-Chloro-3-methylbenzo[c]isoxazole | ESD-848416-100MG |
Cas.: 776-79-4 | Purity: 98% | 2-(2-Carboxyethyl)benzoic acid | ESD-848417-250MG |
Cas.: 776-79-4 | Purity: 98% | 2-(2-Carboxyethyl)benzoic acid | ESD-848417-1G |
Cas.: 73458-39-6 | Purity: 95% | 5-Nitrobenzo[d]thiazol-2-amine | ESD-848418-250MG |
Cas.: 73458-39-6 | Purity: 95% | 5-Nitrobenzo[d]thiazol-2-amine | ESD-848418-1G |
Cas.: 158257-40-0 | Purity: 95% | (3S,4S)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-hydroxy-6-methylheptanoic acid | ESD-848419-250MG |
Cas.: 158257-40-0 | Purity: 95% | (3S,4S)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-hydroxy-6-methylheptanoic acid | ESD-848419-1G |
Cas.: 1210494-26-0 | Purity: 95% | Methyl 4-amino-1-(4-chlorobenzyl)piperidine-4-carboxylate dihydrochloride | ESD-848420-250MG |
Cas.: 1210494-26-0 | Purity: 95% | Methyl 4-amino-1-(4-chlorobenzyl)piperidine-4-carboxylate dihydrochloride | ESD-848420-1G |
Cas.: 221681-84-1 | Purity: 98% | 4-Chloro-1H-indazol-6-amine | ESD-848421-50MG |
Cas.: 221681-84-1 | Purity: 98% | 4-Chloro-1H-indazol-6-amine | ESD-848421-250MG |
Cas.: 206201-64-1 | Purity: 97% | 6-Formylnicotinotrile | ESD-848422-50MG |
Cas.: 206201-64-1 | Purity: 97% | 6-Formylnicotinotrile | ESD-848422-250MG |
Cas.: 132907-72-3 | Purity: 98% | Ramosetron Hydrochloride | ESD-848423-50MG |
Cas.: 132907-72-3 | Purity: 98% | Ramosetron Hydrochloride | ESD-848423-250MG |
Cas.: 64463-46-3 | Purity: 98% | Methyl 4-formylpicolinate | ESD-848424-25MG |
Cas.: 64463-46-3 | Purity: 98% | Methyl 4-formylpicolinate | ESD-848424-100MG |
Cas.: 1190309-92-2 | Purity: 98% | 6-Chloro-3-nitro-1H-pyrrolo[2,3-b]pyridine | ESD-848425-50MG |
Cas.: 1190309-92-2 | Purity: 98% | 6-Chloro-3-nitro-1H-pyrrolo[2,3-b]pyridine | ESD-848425-250MG |
Cas.: 940298-93-1 | Purity: 95% | (2-Fluoro-4-methoxyphenyl)hydrazine hydrochloride | ESD-848426-25MG |
Cas.: 940298-93-1 | Purity: 95% | (2-Fluoro-4-methoxyphenyl)hydrazine hydrochloride | ESD-848426-100MG |
Cas.: 782495-18-5 | Purity: 95% | (S)-1,1,1-Trifluoro-N-(pyrrolidin-2-ylmethyl)methanesulfonamide | ESD-848427-25MG |
Cas.: 782495-18-5 | Purity: 95% | (S)-1,1,1-Trifluoro-N-(pyrrolidin-2-ylmethyl)methanesulfonamide | ESD-848427-100MG |
Cas.: 952582-08-0 | Purity: 98% | 4-(6-Bromopyridin-3-yl)morpholine | ESD-848428-25MG |
Cas.: 952582-08-0 | Purity: 98% | 4-(6-Bromopyridin-3-yl)morpholine | ESD-848428-100MG |
Cas.: 61859-96-9 | Purity: 95% | Methyl 3-(trifluoromethyl)-1H-pyrazole-4-carboxylate | ESD-848429-25MG |
Cas.: 61859-96-9 | Purity: 95% | Methyl 3-(trifluoromethyl)-1H-pyrazole-4-carboxylate | ESD-848429-100MG |
Cas.: 1263279-50-0 | Purity: 97% | 5-Bromo-3-phenyl-1,2,4-oxadiazole | ESD-848430-25MG |
Cas.: 1263279-50-0 | Purity: 97% | 5-Bromo-3-phenyl-1,2,4-oxadiazole | ESD-848430-100MG |
Cas.: 956460-93-8 | Purity: 97% | 4-Fluoro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one | ESD-848431-25MG |
Cas.: 956460-93-8 | Purity: 97% | 4-Fluoro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one | ESD-848431-100MG |
Cas.: 114306-17-1 | Purity: 98% | 6-Bromo-1H-indol-3-yl acetate | ESD-848432-25MG |
Cas.: 114306-17-1 | Purity: 98% | 6-Bromo-1H-indol-3-yl acetate | ESD-848432-100MG |
Cas.: 1190319-92-6 | Purity: 97% | 6-Fluoro-3-iodo-1H-pyrrolo[2,3-b]pyridine | ESD-848433-25MG |
Cas.: 1190319-92-6 | Purity: 97% | 6-Fluoro-3-iodo-1H-pyrrolo[2,3-b]pyridine | ESD-848433-100MG |
Cas.: 1260848-49-4 | Purity: 95% | 5-Chloro-2-iodo-1H-pyrrolo[2,3-b]pyridine | ESD-848434-25MG |
Cas.: 1260848-49-4 | Purity: 95% | 5-Chloro-2-iodo-1H-pyrrolo[2,3-b]pyridine | ESD-848434-100MG |
Cas.: 1416351-95-5 | Purity: 95% | 1-(2-Chloro-5-methylpyrimidin-4-yl)ethanone | ESD-848435-25MG |
Cas.: 1416351-95-5 | Purity: 95% | 1-(2-Chloro-5-methylpyrimidin-4-yl)ethanone | ESD-848435-100MG |
Cas.: 19655-46-0 | Purity: 98% | 8-Chloro-6-methylquinoline | ESD-848436-25MG |
Cas.: 19655-46-0 | Purity: 98% | 8-Chloro-6-methylquinoline | ESD-848436-100MG |
Cas.: 1053656-76-0 | Purity: 98% | tert-Butyl 2-cyanopiperazine-1-carboxylate | ESD-848437-25MG |
Cas.: 1053656-76-0 | Purity: 98% | tert-Butyl 2-cyanopiperazine-1-carboxylate | ESD-848437-100MG |
Cas.: 885520-59-2 | Purity: 98% | 6-Bromo-4-fluoro-1H-indole | ESD-848438-25MG |
Cas.: 885520-59-2 | Purity: 98% | 6-Bromo-4-fluoro-1H-indole | ESD-848438-100MG |
Cas.: 33842-18-1 | Purity: 97% | Methyl 6-bromobenzo[d][1,3]dioxole-4-carboxylate | ESD-848439-25MG |
Cas.: 33842-18-1 | Purity: 97% | Methyl 6-bromobenzo[d][1,3]dioxole-4-carboxylate | ESD-848439-100MG |
Cas.: 912556-91-3 | Purity: 97% | N-(3-Chloro-4-fluorophenyl)-6-(3-chloropropoxy)-7-methoxyquinazolin-4-amine | ESD-848440-25MG |
Cas.: 912556-91-3 | Purity: 97% | N-(3-Chloro-4-fluorophenyl)-6-(3-chloropropoxy)-7-methoxyquinazolin-4-amine | ESD-848440-100MG |
Cas.: 1134776-39-8 | Purity: 97% | (R)-4-(1-Aminoethyl)benzoic acid hydrochloride | ESD-848441-25MG |
Cas.: 1134776-39-8 | Purity: 97% | (R)-4-(1-Aminoethyl)benzoic acid hydrochloride | ESD-848441-100MG |
Cas.: 371240-66-3 | Purity: 97% | tert-Butyl 3-mercaptopyrrolidine-1-carboxylate | ESD-848442-25MG |
Cas.: 371240-66-3 | Purity: 97% | tert-Butyl 3-mercaptopyrrolidine-1-carboxylate | ESD-848442-100MG |
Cas.: 1381928-30-8 | Purity: 95% | (R)-2-(4-Fluorophenyl)pyrrolidine hydrochloride | ESD-848443-25MG |
Cas.: 1381928-30-8 | Purity: 95% | (R)-2-(4-Fluorophenyl)pyrrolidine hydrochloride | ESD-848443-100MG |
Cas.: 77862-95-4 | Purity: 98% | Methyl 1H-imidazo[4,5-b]pyridine-6-carboxylate | ESD-848444-50MG |
Cas.: 77862-95-4 | Purity: 98% | Methyl 1H-imidazo[4,5-b]pyridine-6-carboxylate | ESD-848444-250MG |
Cas.: 13134-38-8 | Purity: 97% | 3,6-Dimethylpyrazin-2-amine | ESD-848445-250MG |
Cas.: 13134-38-8 | Purity: 97% | 3,6-Dimethylpyrazin-2-amine | ESD-848445-1G |
Cas.: 75266-40-9 | Purity: 96% | (S)-Methyl 2-(((benzyloxy)carbonyl)amino)but-3-enoate | ESD-848446-50MG |
Cas.: 75266-40-9 | Purity: 96% | (S)-Methyl 2-(((benzyloxy)carbonyl)amino)but-3-enoate | ESD-848446-250MG |
Cas.: 1176723-57-1 | Purity: 97% | 2-Nitro-5-(trifluoromethyl)benzaldehyde | ESD-848447-50MG |
Cas.: 1176723-57-1 | Purity: 97% | 2-Nitro-5-(trifluoromethyl)benzaldehyde | ESD-848447-250MG |
Cas.: 943831-11-6 | Purity: 98% | (2-Chloro-4-fluoro-3-methoxyphenyl)boronic acid | ESD-848448-50MG |
Cas.: 943831-11-6 | Purity: 98% | (2-Chloro-4-fluoro-3-methoxyphenyl)boronic acid | ESD-848448-250MG |
Cas.: 6161-64-4 | Purity: 98% | 1-(2-Methoxy-6-methylphenyl)ethanone | ESD-848449-50MG |
Cas.: 6161-64-4 | Purity: 98% | 1-(2-Methoxy-6-methylphenyl)ethanone | ESD-848449-250MG |
Cas.: 1536398-19-2 | Purity: 95% | (2-(4-(Methoxycarbonyl)piperidin-1-yl)pyrimidin-5-yl)boronic acid | ESD-848450-50MG |
Cas.: 1536398-19-2 | Purity: 95% | (2-(4-(Methoxycarbonyl)piperidin-1-yl)pyrimidin-5-yl)boronic acid | ESD-848450-250MG |
Cas.: 1149388-51-1 | Purity: 95% | Methyl 4-cyano-2-fluoro-5-nitrobenzoate | ESD-848451-50MG |
Cas.: 1149388-51-1 | Purity: 95% | Methyl 4-cyano-2-fluoro-5-nitrobenzoate | ESD-848451-250MG |
Cas.: 113304-84-0 | Purity: 97% | (R)-Methyl 1-benzylpyrrolidine-2-carboxylate | ESD-848452-50MG |
Cas.: 113304-84-0 | Purity: 97% | (R)-Methyl 1-benzylpyrrolidine-2-carboxylate | ESD-848452-250MG |
Cas.: 1285229-48-2 | Purity: 95% | 2-Amino-N-(2-methoxyethyl)thiazole-5-carboxamide | ESD-848453-50MG |
Cas.: 1285229-48-2 | Purity: 95% | 2-Amino-N-(2-methoxyethyl)thiazole-5-carboxamide | ESD-848453-250MG |
Cas.: 1538218-73-3 | Purity: 95% | 2-Amino-N-(3-hydroxypropyl)thiazole-5-carboxamide | ESD-848454-50MG |
Cas.: 1538218-73-3 | Purity: 95% | 2-Amino-N-(3-hydroxypropyl)thiazole-5-carboxamide | ESD-848454-250MG |
Cas.: 315180-16-6 | Purity: 97% | 2-(Chloromethyl)-6-fluoropyridine | ESD-848455-50MG |
Cas.: 315180-16-6 | Purity: 97% | 2-(Chloromethyl)-6-fluoropyridine | ESD-848455-250MG |
Cas.: 30563-98-5 | Purity: 97% | Ethyl 5-nitropicolinate | ESD-848456-50MG |
Cas.: 30563-98-5 | Purity: 97% | Ethyl 5-nitropicolinate | ESD-848456-250MG |
Cas.: 1212972-48-9 | Purity: 95% | (S)-1-(3,4-Difluorophenyl)ethanamine hydrochloride | ESD-848457-25MG |
Cas.: 1212972-48-9 | Purity: 95% | (S)-1-(3,4-Difluorophenyl)ethanamine hydrochloride | ESD-848457-100MG |
Cas.: 1235451-62-3 | Purity: 95% | tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indoline-1-carboxylate | ESD-848458-50MG |
Cas.: 1235451-62-3 | Purity: 95% | tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indoline-1-carboxylate | ESD-848458-250MG |
Cas.: 933746-10-2 | Purity: 98% | 2-Chloro-5-methylpyrimidine-4-carboxylic acid | ESD-848459-25MG |
Cas.: 933746-10-2 | Purity: 98% | 2-Chloro-5-methylpyrimidine-4-carboxylic acid | ESD-848459-100MG |
Cas.: 877624-38-9 | Purity: 95% | Methyl 5-(bromomethyl)nicotinate | ESD-848460-25MG |
Cas.: 877624-38-9 | Purity: 95% | Methyl 5-(bromomethyl)nicotinate | ESD-848460-100MG |
Cas.: 1257553-87-9 | Purity: 97% | 3-(Cyclopropylmethoxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-848461-25MG |
Cas.: 1257553-87-9 | Purity: 97% | 3-(Cyclopropylmethoxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-848461-100MG |
Cas.: 400715-69-7 | Purity: 98% | Ethyl 5-(3-chlorophenyl)oxazole-2-carboxylate | ESD-848462-25MG |
Cas.: 400715-69-7 | Purity: 98% | Ethyl 5-(3-chlorophenyl)oxazole-2-carboxylate | ESD-848462-100MG |
Cas.: 130408-16-1 | Purity: 95% | 4,7-Difluoroindan-1-one | ESD-848463-250MG |
Cas.: 130408-16-1 | Purity: 95% | 4,7-Difluoroindan-1-one | ESD-848463-1G |
Cas.: 104711-65-1 | Purity: 98% | 4-Chloro-6-methylpicolinonitrile | ESD-848464-50MG |
Cas.: 104711-65-1 | Purity: 98% | 4-Chloro-6-methylpicolinonitrile | ESD-848464-250MG |
Cas.: 5261-23-4 | Purity: 97% | 3,3′,3”,3”’-(Ethane-1,2-diylbis(azanetriyl))tetrakis(propan-1-ol) | ESD-848465-50MG |
Cas.: 5261-23-4 | Purity: 97% | 3,3′,3”,3”’-(Ethane-1,2-diylbis(azanetriyl))tetrakis(propan-1-ol) | ESD-848465-250MG |
Cas.: 1391356-26-5 | Purity: 97% | (R)-1-(m-Tolyl)propan-1-amine hydrochloride | ESD-848466-50MG |
Cas.: 1391356-26-5 | Purity: 97% | (R)-1-(m-Tolyl)propan-1-amine hydrochloride | ESD-848466-250MG |
Cas.: 1619264-47-9 | Purity: 95% | (1-(Pyridin-3-yl)piperidin-4-yl)methanol | ESD-848467-50MG |
Cas.: 1619264-47-9 | Purity: 95% | (1-(Pyridin-3-yl)piperidin-4-yl)methanol | ESD-848467-250MG |
Cas.: 55690-62-5 | Purity: 97% | 6-Chloroimidazo[1,2-b]pyridazin-2-ol | ESD-848468-50MG |
Cas.: 55690-62-5 | Purity: 97% | 6-Chloroimidazo[1,2-b]pyridazin-2-ol | ESD-848468-250MG |
Cas.: 1598381-36-2 | Purity: 95% | 1-Oxa-3,9-diazaspiro[5.5]undecan-2-one hydrochloride | ESD-848469-50MG |
Cas.: 1598381-36-2 | Purity: 95% | 1-Oxa-3,9-diazaspiro[5.5]undecan-2-one hydrochloride | ESD-848469-250MG |
Cas.: 36070-84-5 | Purity: 95% | 5-Bromopyrazine-2-carboxamide | ESD-848470-50MG |
Cas.: 36070-84-5 | Purity: 95% | 5-Bromopyrazine-2-carboxamide | ESD-848470-250MG |
Cas.: 84665-66-7 | Purity: 80% | Magnesium monoperoxyphthalate hexahydrate | ESD-848471-1G |
Cas.: 84665-66-7 | Purity: 80% | Magnesium monoperoxyphthalate hexahydrate | ESD-848471-5G |
Cas.: 17671-50-0 | Purity: 95% | 2-(Trimethylammonio)acetate compound with 2-hydroxypropane-1,2,3-tricarboxylic acid (1:1) | ESD-848472-1G |
Cas.: 17671-50-0 | Purity: 95% | 2-(Trimethylammonio)acetate compound with 2-hydroxypropane-1,2,3-tricarboxylic acid (1:1) | ESD-848472-10G |
Cas.: 67383-32-8 | Purity: 97% | Ethyl 4-hydroxy-2-methylpyrimidine-5-carboxylate | ESD-848473-250MG |
Cas.: 67383-32-8 | Purity: 97% | Ethyl 4-hydroxy-2-methylpyrimidine-5-carboxylate | ESD-848473-1G |
Cas.: 62830-55-1 | Purity: 97% | (4-Iodophenyl)hydrazine hydrochloride | ESD-848474-250MG |
Cas.: 62830-55-1 | Purity: 97% | (4-Iodophenyl)hydrazine hydrochloride | ESD-848474-1G |
Cas.: 7147-77-5 | Purity: 98% | 5-(4-Nitrophenyl)furan-2-carbaldehyde | ESD-848475-1G |
Cas.: 7147-77-5 | Purity: 98% | 5-(4-Nitrophenyl)furan-2-carbaldehyde | ESD-848475-5G |
Cas.: 34404-32-5 | Purity: 97% | HD-Lys(Z)-OH | ESD-848476-250MG |
Cas.: 34404-32-5 | Purity: 97% | HD-Lys(Z)-OH | ESD-848476-1G |
Cas.: 249561-98-6 | Purity: 97% | N-(2-Chloro-3-(dimethylamino)allylidene)-N-methylmethanaminium hexafluorophosphate(V) | ESD-848477-1G |
Cas.: 249561-98-6 | Purity: 97% | N-(2-Chloro-3-(dimethylamino)allylidene)-N-methylmethanaminium hexafluorophosphate(V) | ESD-848477-5G |
Cas.: 2164-83-2 | Purity: 98% | 4,6-Dihydroxy-5-nitropyrimdine | ESD-848478-1G |
Cas.: 2164-83-2 | Purity: 98% | 4,6-Dihydroxy-5-nitropyrimdine | ESD-848478-5G |
Cas.: 32703-87-0 | Purity: 95% | Boc-β-Ala-Osu | ESD-848479-250MG |
Cas.: 32703-87-0 | Purity: 95% | Boc-β-Ala-Osu | ESD-848479-1G |
Cas.: 7749-47-5 | Purity: 97% | 2-Amino-4-methyl-6-methoxypyrimidine | ESD-848481-1G |
Cas.: 7749-47-5 | Purity: 97% | 2-Amino-4-methyl-6-methoxypyrimidine | ESD-848481-5G |
Cas.: 16533-45-2 | Purity: 97% | 2-(Ethoxycarbonyl)-6-nitrobenzoic acid | ESD-848482-250MG |
Cas.: 16533-45-2 | Purity: 97% | 2-(Ethoxycarbonyl)-6-nitrobenzoic acid | ESD-848482-1G |
Cas.: 85-81-4 | Purity: 98% | 6-Methoxy-8-nitroquinoline | ESD-848483-250MG |
Cas.: 85-81-4 | Purity: 98% | 6-Methoxy-8-nitroquinoline | ESD-848483-1G |
Cas.: 6358-08-3 | Purity: 97% | 2-Amino-4-chloro-6-nitrophenol | ESD-848484-250MG |
Cas.: 6358-08-3 | Purity: 97% | 2-Amino-4-chloro-6-nitrophenol | ESD-848484-1G |
Cas.: 86978-24-7 | Purity: 95% | (Z)-2-(2-((tert-Butoxycarbonyl)amino)thiazol-4-yl)pent-2-enoic acid | ESD-848485-250MG |
Cas.: 86978-24-7 | Purity: 95% | (Z)-2-(2-((tert-Butoxycarbonyl)amino)thiazol-4-yl)pent-2-enoic acid | ESD-848485-1G |
Cas.: 15260-11-4 | Purity: 95% | H-Thr(Bzl)-OBzl.oxalate | ESD-848486-250MG |
Cas.: 15260-11-4 | Purity: 95% | H-Thr(Bzl)-OBzl.oxalate | ESD-848486-1G |
Cas.: 352195-40-5 | Purity: 97% | Inosine 5′-monophosphate disodium salt hydrate | ESD-848487-1G |
Cas.: 352195-40-5 | Purity: 97% | Inosine 5′-monophosphate disodium salt hydrate | ESD-848487-5G |
Cas.: 3273-68-5 | Purity: 98% | 4-(2-Oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)butanoic acid | ESD-848488-250MG |
Cas.: 3273-68-5 | Purity: 98% | 4-(2-Oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)butanoic acid | ESD-848488-1G |
Cas.: 3768-18-1 | Purity: 95% | N-Acetylcytidine | ESD-848489-250MG |
Cas.: 3768-18-1 | Purity: 95% | N-Acetylcytidine | ESD-848489-1G |
Cas.: 681435-27-8 | Purity: 97% | 5′-Uridylic acid disodium salt xhydrate | ESD-848490-1G |
Cas.: 681435-27-8 | Purity: 97% | 5′-Uridylic acid disodium salt xhydrate | ESD-848490-10G |
Cas.: 61535-49-7 | Purity: 98% | HD-Trp-OEt.HCl | ESD-848491-250MG |
Cas.: 61535-49-7 | Purity: 98% | HD-Trp-OEt.HCl | ESD-848491-1G |
Cas.: 74918-21-1 | Purity: 95% | 4,4′-(Propane-1,3-diylbis(oxy))bis(benzene-1,3-diamine) tetrahydrochloride | ESD-848492-250MG |
Cas.: 74918-21-1 | Purity: 95% | 4,4′-(Propane-1,3-diylbis(oxy))bis(benzene-1,3-diamine) tetrahydrochloride | ESD-848492-1G |
Cas.: 117-57-7 | Purity: 98% | 3-Hydroxy-2-methylquinoline-4-carboxylic acid | ESD-848493-1G |
Cas.: 117-57-7 | Purity: 98% | 3-Hydroxy-2-methylquinoline-4-carboxylic acid | ESD-848493-5G |
Cas.: 5100-98-1 | Purity: 97% | 3-Chloro-2-iodotoluene | ESD-848494-250MG |
Cas.: 5100-98-1 | Purity: 97% | 3-Chloro-2-iodotoluene | ESD-848494-1G |
Cas.: 97509-75-6 | Purity: 98% | 3-Fluoropicolinonitrile | ESD-848495-250MG |
Cas.: 97509-75-6 | Purity: 98% | 3-Fluoropicolinonitrile | ESD-848495-1G |
Cas.: 6530-09-2 | Purity: 97% | 3-Aminoquinuclidine dihydrochloride | ESD-848496-250MG |
Cas.: 6530-09-2 | Purity: 97% | 3-Aminoquinuclidine dihydrochloride | ESD-848496-1G |
Cas.: 1065010-87-8 | Purity: 97% | Potassium cyclopropyltrifluoroborate | ESD-848497-250MG |
Cas.: 1065010-87-8 | Purity: 97% | Potassium cyclopropyltrifluoroborate | ESD-848497-1G |
Cas.: 77987-49-6 | Purity: 97% | Z-Glycinol | ESD-848498-5G |
Cas.: 36157-41-2 | Purity: 97% | 2,5-Dichlorothiophene-3-carboxylic acid | ESD-848499-250MG |
Cas.: 36157-41-2 | Purity: 97% | 2,5-Dichlorothiophene-3-carboxylic acid | ESD-848499-1G |
Cas.: 3601-66-9 | Purity: 98% | Boc-DL-Phg-OH | ESD-848500-1G |
Cas.: 3601-66-9 | Purity: 98% | Boc-DL-Phg-OH | ESD-848500-5G |
Cas.: 16467-50-8 | Purity: 95% | 2-Chloro-N-(cyclohexylcarbamoyl)acetamide | ESD-848501-250MG |
Cas.: 16467-50-8 | Purity: 95% | 2-Chloro-N-(cyclohexylcarbamoyl)acetamide | ESD-848501-1G |
Cas.: 89634-75-3 | Purity: 97% | 2-Chloro-5-fluorobenzotrifluoride | ESD-848502-250MG |
Cas.: 89634-75-3 | Purity: 97% | 2-Chloro-5-fluorobenzotrifluoride | ESD-848502-1G |
Cas.: 52615-97-1 | Purity: 97% | H-Asp(Obzl)-OtBu.HCl | ESD-848503-250MG |
Cas.: 52615-97-1 | Purity: 97% | H-Asp(Obzl)-OtBu.HCl | ESD-848503-1G |
Cas.: 1104-22-9 | Purity: 98% | Meclizine dihydrochloride | ESD-848504-250MG |
Cas.: 1104-22-9 | Purity: 98% | Meclizine dihydrochloride | ESD-848504-1G |
Cas.: 134-47-4 | Purity: 95% | 7,7′-(Carbonylbis(azanediyl))bis(4-hydroxynaphthalene-2-sulfonic acid) | ESD-848505-250MG |
Cas.: 134-47-4 | Purity: 95% | 7,7′-(Carbonylbis(azanediyl))bis(4-hydroxynaphthalene-2-sulfonic acid) | ESD-848505-1G |
Cas.: 162758-35-2 | Purity: 95% | 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxylic acid | ESD-848506-250MG |
Cas.: 162758-35-2 | Purity: 95% | 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxylic acid | ESD-848506-1G |
Cas.: 3850-40-6 | Purity: 95% | 2-((tert-Butoxycarbonyl)amino)-3-hydroxypropanoic acid | ESD-848507-250MG |
Cas.: 3850-40-6 | Purity: 95% | 2-((tert-Butoxycarbonyl)amino)-3-hydroxypropanoic acid | ESD-848507-1G |
Cas.: 1291487-29-0 | Purity: 95% | 4-Aminopicolinic acid hydrochloride | ESD-848508-250MG |
Cas.: 1291487-29-0 | Purity: 95% | 4-Aminopicolinic acid hydrochloride | ESD-848508-1G |
Cas.: 35657-36-4 | Purity: 97% | O-(4-Nitrobenzoyl)hydroxylamine | ESD-848509-250MG |
Cas.: 35657-36-4 | Purity: 97% | O-(4-Nitrobenzoyl)hydroxylamine | ESD-848509-1G |
Cas.: 84758-81-6 | Purity: 95% | tert-Butyl 2-amino-2-methylpropanoate hydrochloride | ESD-848510-250MG |
Cas.: 84758-81-6 | Purity: 95% | tert-Butyl 2-amino-2-methylpropanoate hydrochloride | ESD-848510-1G |
Cas.: 181256-18-8 | Purity: 97% | 3-Bromo-4-chloropyridine hydrochloride | ESD-848512-250MG |
Cas.: 181256-18-8 | Purity: 97% | 3-Bromo-4-chloropyridine hydrochloride | ESD-848512-1G |
Cas.: 141699-58-3 | Purity: 98% | 1-Boc-3-Methanesulfonyloxyazetidine | ESD-848513-250MG |
Cas.: 141699-58-3 | Purity: 98% | 1-Boc-3-Methanesulfonyloxyazetidine | ESD-848513-1G |
Cas.: 2673-22-5 | Purity: 65% in EtOH | Sodium 1,4-dioxo-1,4-bis(tridecyloxy)butane-2-sulfonate | ESD-848514-1G |
Cas.: 2673-22-5 | Purity: 65% in EtOH | Sodium 1,4-dioxo-1,4-bis(tridecyloxy)butane-2-sulfonate | ESD-848514-5G |
Cas.: 1260243-04-6 | Purity: 98% | Ethyl 5-amino-1H-pyrazole-4-carboxylate | ESD-848515-1G |
Cas.: 1260243-04-6 | Purity: 98% | Ethyl 5-amino-1H-pyrazole-4-carboxylate | ESD-848515-5G |
Cas.: 100643-27-4 | Purity: 97% | 2,6-Diaminopyrimidin-4-ol | ESD-848517-5G |
Cas.: 100643-27-4 | Purity: 97% | 2,6-Diaminopyrimidin-4-ol | ESD-848517-25G |
Cas.: 55368-42-8 | Purity: 98% | 4-Bromobenzimidamide hydrochloride | ESD-848518-250MG |
Cas.: 55368-42-8 | Purity: 98% | 4-Bromobenzimidamide hydrochloride | ESD-848518-1G |
Cas.: 1019852-03-9 | Purity: 95% | (4-Methylpiperazin-1-yl)piperidin-4-yl-methanone dihydrochloride | ESD-848519-250MG |
Cas.: 1019852-03-9 | Purity: 95% | (4-Methylpiperazin-1-yl)piperidin-4-yl-methanone dihydrochloride | ESD-848519-1G |
Cas.: 3829-80-9 | Purity: 97% | Methyl 2-amino-4-methylthiazole-5-carboxylate | ESD-848520-250MG |
Cas.: 3829-80-9 | Purity: 97% | Methyl 2-amino-4-methylthiazole-5-carboxylate | ESD-848520-1G |
Cas.: 892-48-8 | Purity: 97% | 5′-Chloro-5′-deoxyadenosine | ESD-848521-250MG |
Cas.: 892-48-8 | Purity: 97% | 5′-Chloro-5′-deoxyadenosine | ESD-848521-1G |
Cas.: 6280-87-1 | Purity: 98% | 5-Chloropentanenitrile | ESD-848522-5G |
Cas.: 6280-87-1 | Purity: 98% | 5-Chloropentanenitrile | ESD-848522-25G |
Cas.: 719-64-2 | Purity: 95% | 5-Chloro-3-phenylbenzo[c]isoxazole | ESD-848523-1G |
Cas.: 719-64-2 | Purity: 95% | 5-Chloro-3-phenylbenzo[c]isoxazole | ESD-848523-10G |
Cas.: 20388-87-8 | Purity: 97% | 2-Phenylpropan-1-amine hydrochloride | ESD-848524-1G |
Cas.: 20388-87-8 | Purity: 97% | 2-Phenylpropan-1-amine hydrochloride | ESD-848524-5G |
Cas.: 14294-11-2 | Purity: 98% | 1-(Pyridin-2-yl)thiourea | ESD-848525-250MG |
Cas.: 14294-11-2 | Purity: 98% | 1-(Pyridin-2-yl)thiourea | ESD-848525-1G |
Cas.: 89-56-5 | Purity: 98% | 5-Methylsalicylic acid | ESD-848526-1G |
Cas.: 89-56-5 | Purity: 98% | 5-Methylsalicylic acid | ESD-848526-5G |
Cas.: 10272-49-8 | Purity: 97% | 4-Phenylpiperidine hydrochloride | ESD-848527-250MG |
Cas.: 10272-49-8 | Purity: 97% | 4-Phenylpiperidine hydrochloride | ESD-848527-1G |
Cas.: 6629-60-3 | Purity: 95% | Ethylhydrazine oxalate | ESD-848528-250MG |
Cas.: 6629-60-3 | Purity: 95% | Ethylhydrazine oxalate | ESD-848528-1G |
Cas.: 40966-87-8 | Purity: 98% | 2-Amino-5-chloropyridin-3-ol | ESD-848529-250MG |
Cas.: 40966-87-8 | Purity: 98% | 2-Amino-5-chloropyridin-3-ol | ESD-848529-1G |
Cas.: 60832-72-6 | Purity: 97% | Oxazolo[4,5-b]pyridin-2(3H)-one | ESD-848530-1G |
Cas.: 60832-72-6 | Purity: 97% | Oxazolo[4,5-b]pyridin-2(3H)-one | ESD-848530-5G |
Cas.: 672-45-7 | Purity: 95% | 2,4-Dihydroxy-6-trifluoromethylpyrimidine | ESD-848531-250MG |
Cas.: 672-45-7 | Purity: 95% | 2,4-Dihydroxy-6-trifluoromethylpyrimidine | ESD-848531-1G |
Cas.: 33494-80-3 | Purity: 98% | Potassium di-tert-butyl phosphate | ESD-848532-250MG |
Cas.: 33494-80-3 | Purity: 98% | Potassium di-tert-butyl phosphate | ESD-848532-1G |
Cas.: 615-87-2 | Purity: 97% | 1,5-Dibromo-2,4-dimethylbenzene | ESD-848533-250MG |
Cas.: 615-87-2 | Purity: 97% | 1,5-Dibromo-2,4-dimethylbenzene | ESD-848533-1G |
Cas.: 6188-23-4 | Purity: 97% | 6-Bromoimidazo[1,2-a]pyridine | ESD-848534-1G |
Cas.: 129832-03-7 | Purity: 98% | Potassium (1R,2S,3R,4R,5S,6S)-2,3,4,5,6-pentakis(phosphonooxy)cyclohexyl phosphate | ESD-848535-250MG |
Cas.: 129832-03-7 | Purity: 98% | Potassium (1R,2S,3R,4R,5S,6S)-2,3,4,5,6-pentakis(phosphonooxy)cyclohexyl phosphate | ESD-848535-1G |
Cas.: 14296-92-5 | Purity: 98% | Boc-Gly-Pro-OH | ESD-848537-250MG |
Cas.: 14296-92-5 | Purity: 98% | Boc-Gly-Pro-OH | ESD-848537-1G |
Cas.: 93224-85-2 | Purity: 95% | 2-Bromo-6-chlorobenzoic acid | ESD-848538-1G |
Cas.: 93224-85-2 | Purity: 95% | 2-Bromo-6-chlorobenzoic acid | ESD-848538-5G |
Cas.: 2899-43-6 | Purity: 95% | Ethyl 2-amino-4-methylpentanoate | ESD-848539-1G |
Cas.: 2899-43-6 | Purity: 95% | Ethyl 2-amino-4-methylpentanoate | ESD-848539-5G |
Cas.: 78339-57-8 | Purity: 97% | ZD-Pyr-OH | ESD-848540-250MG |
Cas.: 78339-57-8 | Purity: 97% | ZD-Pyr-OH | ESD-848540-1G |
Cas.: 615-16-7 | Purity: 98% | 2-Hydroxybenzimidazole | ESD-848541-1G |
Cas.: 615-16-7 | Purity: 98% | 2-Hydroxybenzimidazole | ESD-848541-5G |
Cas.: 193902-78-2 | Purity: 97% | tert-Butyl 4-(5-nitropyridin-2-yl)piperazine-1-carboxylate | ESD-848542-250MG |
Cas.: 193902-78-2 | Purity: 97% | tert-Butyl 4-(5-nitropyridin-2-yl)piperazine-1-carboxylate | ESD-848542-1G |
Cas.: 4876-59-9 | Purity: 97% | 4-(Dimethylamino)piperidine dihydrochloride | ESD-848543-250MG |
Cas.: 4876-59-9 | Purity: 97% | 4-(Dimethylamino)piperidine dihydrochloride | ESD-848543-1G |
Cas.: 158152-94-4 | Purity: 97% | 6-Methylpyridine-2,4-diol | ESD-848544-250MG |
Cas.: 158152-94-4 | Purity: 97% | 6-Methylpyridine-2,4-diol | ESD-848544-1G |
Cas.: 20759-14-2 | Purity: 98% | Ruthenium(III) chloride hydrate | ESD-848545-250MG |
Cas.: 20759-14-2 | Purity: 98% | Ruthenium(III) chloride hydrate | ESD-848545-1G |
Cas.: 100189-84-2 | Purity: 98% | 2,5-Dibromo-1,3-dimethylbenzene | ESD-848546-250MG |
Cas.: 100189-84-2 | Purity: 98% | 2,5-Dibromo-1,3-dimethylbenzene | ESD-848546-1G |
Cas.: 56976-06-8 | Purity: 97% | Boc-Cys(tBu)-OH | ESD-848547-1G |
Cas.: 56976-06-8 | Purity: 97% | Boc-Cys(tBu)-OH | ESD-848547-5G |
Cas.: 93076-03-0 | Purity: 98% | 3-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one hydrochloride | ESD-848548-250MG |
Cas.: 93076-03-0 | Purity: 98% | 3-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one hydrochloride | ESD-848548-1G |
Cas.: 39977-41-8 | Purity: 95% | 5-(Hydroxymethyl)picolinic acid | ESD-848549-25MG |
Cas.: 39977-41-8 | Purity: 95% | 5-(Hydroxymethyl)picolinic acid | ESD-848549-100MG |
Cas.: 1179361-48-8 | Purity: 97% | Methyl 6-carbamimidoylnicotinate hydrochloride | ESD-848550-25MG |
Cas.: 1179361-48-8 | Purity: 97% | Methyl 6-carbamimidoylnicotinate hydrochloride | ESD-848550-100MG |
Cas.: 205584-61-8 | Purity: 96% | 8-Bromo-2,3,4,5-tetrahydro-1H-benzo[b]azepine | ESD-848551-25MG |
Cas.: 205584-61-8 | Purity: 96% | 8-Bromo-2,3,4,5-tetrahydro-1H-benzo[b]azepine | ESD-848551-100MG |
Cas.: 400652-57-5 | Purity: 95% | (R)-tert-Butyl (2-amino-3-phenylpropyl)carbamate | ESD-848552-50MG |
Cas.: 400652-57-5 | Purity: 95% | (R)-tert-Butyl (2-amino-3-phenylpropyl)carbamate | ESD-848552-250MG |
Cas.: 871709-92-1 | Purity: 96% | 3-Amino-1H-indazole-6-carboxylic acid | ESD-848553-50MG |
Cas.: 871709-92-1 | Purity: 96% | 3-Amino-1H-indazole-6-carboxylic acid | ESD-848553-250MG |
Cas.: 52407-92-8 | Purity: 95% | 3-Methyl-3,8-diaza-bicyclo[3.2.1]octane dihydrochloride | ESD-848554-50MG |
Cas.: 52407-92-8 | Purity: 95% | 3-Methyl-3,8-diaza-bicyclo[3.2.1]octane dihydrochloride | ESD-848554-250MG |
Cas.: 211053-50-8 | Purity: 95% | (S)-Morpholin-3-ylmethanol | ESD-848555-25MG |
Cas.: 211053-50-8 | Purity: 95% | (S)-Morpholin-3-ylmethanol | ESD-848555-100MG |
Cas.: 1245645-10-6 | Purity: 98% | 6-Chloro-3-iodoimidazo[1,2-a]pyrazine | ESD-848556-50MG |
Cas.: 1245645-10-6 | Purity: 98% | 6-Chloro-3-iodoimidazo[1,2-a]pyrazine | ESD-848556-250MG |
Cas.: 1171920-15-2 | Purity: 98% | 5-(Trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid | ESD-848557-50MG |
Cas.: 1171920-15-2 | Purity: 98% | 5-(Trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid | ESD-848557-250MG |
Cas.: 1253790-80-5 | Purity: 98% | (R)-1-(4-Chloro-3-fluorophenyl)ethanamine hydrochloride | ESD-848558-50MG |
Cas.: 1253790-80-5 | Purity: 98% | (R)-1-(4-Chloro-3-fluorophenyl)ethanamine hydrochloride | ESD-848558-250MG |
Cas.: 75893-75-3 | Purity: 95% | 6-Cyclopropylnicotinic acid | ESD-848559-50MG |
Cas.: 75893-75-3 | Purity: 95% | 6-Cyclopropylnicotinic acid | ESD-848559-250MG |
Cas.: 73027-77-7 | Purity: 98% | 4,6-Dibromonicotinic acid | ESD-848560-50MG |
Cas.: 73027-77-7 | Purity: 98% | 4,6-Dibromonicotinic acid | ESD-848560-250MG |
Cas.: 69543-97-1 | Purity: 98% | 4-Bromo-6-methoxypyrimidine | ESD-848561-50MG |
Cas.: 69543-97-1 | Purity: 98% | 4-Bromo-6-methoxypyrimidine | ESD-848561-250MG |
Cas.: 372118-00-8 | Purity: 98% | Methyl 4,6-dihydroxypyridazine-3-carboxylate | ESD-848562-50MG |
Cas.: 372118-00-8 | Purity: 98% | Methyl 4,6-dihydroxypyridazine-3-carboxylate | ESD-848562-250MG |
Cas.: 1354940-72-9 | Purity: 97% | 1,2,3,4-Tetrahydro-2,7-naphthyridine hydrochloride | ESD-848563-50MG |
Cas.: 1354940-72-9 | Purity: 97% | 1,2,3,4-Tetrahydro-2,7-naphthyridine hydrochloride | ESD-848563-250MG |
Cas.: 76325-96-7 | Purity: 95% | trans-2-(4-Aminocyclohexyl)acetic acid hydrochloride | ESD-848564-50MG |
Cas.: 76325-96-7 | Purity: 95% | trans-2-(4-Aminocyclohexyl)acetic acid hydrochloride | ESD-848564-250MG |
Cas.: 651030-56-7 | Purity: 97% | 2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethanol | ESD-848565-50MG |
Cas.: 651030-56-7 | Purity: 97% | 2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethanol | ESD-848565-250MG |
Cas.: 16718-42-6 | Purity: 98% | 4,5,6-Trimethoxy-2,3-dihydro-1H-inden-1-one | ESD-848566-50MG |
Cas.: 16718-42-6 | Purity: 98% | 4,5,6-Trimethoxy-2,3-dihydro-1H-inden-1-one | ESD-848566-250MG |
Cas.: 885520-14-9 | Purity: 97% | 6-Fluoro-4-nitro-1H-indazole | ESD-848567-50MG |
Cas.: 885520-14-9 | Purity: 97% | 6-Fluoro-4-nitro-1H-indazole | ESD-848567-250MG |
Cas.: 267413-32-1 | Purity: 97% | 3-Amino-1H-indazole-6-carbonitrile | ESD-848568-50MG |
Cas.: 267413-32-1 | Purity: 97% | 3-Amino-1H-indazole-6-carbonitrile | ESD-848568-250MG |
Cas.: 1257553-74-4 | Purity: 97% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)picolinamide | ESD-848569-50MG |
Cas.: 1257553-74-4 | Purity: 97% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)picolinamide | ESD-848569-250MG |
Cas.: 151859-37-9 | Purity: 98% | Methyl 3-bromo-2,4-dimethylbenzoate | ESD-848570-50MG |
Cas.: 151859-37-9 | Purity: 98% | Methyl 3-bromo-2,4-dimethylbenzoate | ESD-848570-250MG |
Cas.: 42182-25-2 | Purity: 97% | 1-(2-Aminopyridin-4-yl)ethanone | ESD-848571-50MG |
Cas.: 42182-25-2 | Purity: 97% | 1-(2-Aminopyridin-4-yl)ethanone | ESD-848571-250MG |
Cas.: 3230-35-1 | Purity: 96% | 6-Nitronaphthalen-2-amine | ESD-848572-50MG |
Cas.: 3230-35-1 | Purity: 96% | 6-Nitronaphthalen-2-amine | ESD-848572-250MG |
Cas.: 1159982-14-5 | Purity: 97% | 4-Bromo-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile | ESD-848573-50MG |
Cas.: 1159982-14-5 | Purity: 97% | 4-Bromo-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile | ESD-848573-250MG |
Cas.: 1227578-74-6 | Purity: 97% | 2-Bromo-4-methylpyridin-3-ol | ESD-848574-50MG |
Cas.: 1227578-74-6 | Purity: 97% | 2-Bromo-4-methylpyridin-3-ol | ESD-848574-250MG |
Cas.: 495414-81-8 | Purity: 97% | 1-tert-Butyl 4-ethyl 4-(cyanomethyl)piperidine-1,4-dicarboxylate | ESD-848575-50MG |
Cas.: 495414-81-8 | Purity: 97% | 1-tert-Butyl 4-ethyl 4-(cyanomethyl)piperidine-1,4-dicarboxylate | ESD-848575-250MG |
Cas.: 162318-34-5 | Purity: 95% | 5-Ethynyl-2,2′-bipyridine | ESD-848576-50MG |
Cas.: 162318-34-5 | Purity: 95% | 5-Ethynyl-2,2′-bipyridine | ESD-848576-250MG |
Cas.: 105675-84-1 | Purity: 98% | 4-Chloro-1-methyl-1H-pyrazol-5-amine | ESD-848577-50MG |
Cas.: 105675-84-1 | Purity: 98% | 4-Chloro-1-methyl-1H-pyrazol-5-amine | ESD-848577-250MG |
Cas.: 25297-52-3 | Purity: 97% | 2-Chloro-6-methoxy-4-methylpyridine | ESD-848578-50MG |
Cas.: 25297-52-3 | Purity: 97% | 2-Chloro-6-methoxy-4-methylpyridine | ESD-848578-250MG |
Cas.: 33259-24-4 | Purity: 98% | 3-Bromo-2,6-dimethylpyridin-4-amine | ESD-848579-50MG |
Cas.: 33259-24-4 | Purity: 98% | 3-Bromo-2,6-dimethylpyridin-4-amine | ESD-848579-250MG |
Cas.: 141305-40-0 | Purity: 98% | 4-Bromo-2-phenylthiazole | ESD-848580-50MG |
Cas.: 141305-40-0 | Purity: 98% | 4-Bromo-2-phenylthiazole | ESD-848580-250MG |
Cas.: 194665-89-9 | Purity: 97% | 2-(Aminomethyl)pyridin-3-ol | ESD-848581-50MG |
Cas.: 194665-89-9 | Purity: 97% | 2-(Aminomethyl)pyridin-3-ol | ESD-848581-250MG |
Cas.: 1245913-20-5 | Purity: 98% | 6-Chloro-2-(trifluoromethyl)nicotinonitrile | ESD-848582-50MG |
Cas.: 1245913-20-5 | Purity: 98% | 6-Chloro-2-(trifluoromethyl)nicotinonitrile | ESD-848582-250MG |
Cas.: 68050-37-3 | Purity: 97% | 5-Chloroquinolin-2-amine | ESD-848583-50MG |
Cas.: 68050-37-3 | Purity: 97% | 5-Chloroquinolin-2-amine | ESD-848583-250MG |
Cas.: 16082-13-6 | Purity: 98% | Diethyl pyridazine-3,4-dicarboxylate | ESD-848584-50MG |
Cas.: 16082-13-6 | Purity: 98% | Diethyl pyridazine-3,4-dicarboxylate | ESD-848584-250MG |
Cas.: 35106-82-2 | Purity: 95% | (2-Vinylphenyl)methanol | ESD-848585-50MG |
Cas.: 35106-82-2 | Purity: 95% | (2-Vinylphenyl)methanol | ESD-848585-250MG |
Cas.: 74803-32-0 | Purity: 97% | 8-Chloro[1,2,4]triazolo[1,5-a]pyrazine | ESD-848586-50MG |
Cas.: 74803-32-0 | Purity: 97% | 8-Chloro[1,2,4]triazolo[1,5-a]pyrazine | ESD-848586-250MG |
Cas.: 959240-54-1 | Purity: 98% | 4-Bromo-N,N-dimethylpyrimidin-2-amine | ESD-848587-50MG |
Cas.: 959240-54-1 | Purity: 98% | 4-Bromo-N,N-dimethylpyrimidin-2-amine | ESD-848587-250MG |
Cas.: 1067193-36-5 | Purity: 98% | 5-Chloro-1H-pyrrolo[2,3-c]pyridine-3-carboxylic acid | ESD-848588-25MG |
Cas.: 1067193-36-5 | Purity: 98% | 5-Chloro-1H-pyrrolo[2,3-c]pyridine-3-carboxylic acid | ESD-848588-100MG |
Cas.: 55329-22-1 | Purity: 98% | 4-Chloro-6-methyl-2-(methylsulfonyl)pyrimidine | ESD-848589-50MG |
Cas.: 55329-22-1 | Purity: 98% | 4-Chloro-6-methyl-2-(methylsulfonyl)pyrimidine | ESD-848589-250MG |
Cas.: 916420-30-9 | Purity: 98% | 6-Bromo-4-chloropyrrolo[2,1-f][1,2,4]triazine | ESD-848590-50MG |
Cas.: 916420-30-9 | Purity: 98% | 6-Bromo-4-chloropyrrolo[2,1-f][1,2,4]triazine | ESD-848590-250MG |
Cas.: 1211522-68-7 | Purity: 98% | 4,6-Dichloro-3-methyl-1H-pyrazolo[3,4-d]pyrimidine | ESD-848591-25MG |
Cas.: 1211522-68-7 | Purity: 98% | 4,6-Dichloro-3-methyl-1H-pyrazolo[3,4-d]pyrimidine | ESD-848591-100MG |
Cas.: 108130-10-5 | Purity: 98% | Ethyl 2,6-dichloro-4-methylnicotinate | ESD-848592-250MG |
Cas.: 108130-10-5 | Purity: 98% | Ethyl 2,6-dichloro-4-methylnicotinate | ESD-848592-1G |
Cas.: 188416-20-8 | Purity: 95% | 3-(6-Chloro-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol hydrochloride | ESD-848593-50MG |
Cas.: 188416-20-8 | Purity: 95% | 3-(6-Chloro-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol hydrochloride | ESD-848593-250MG |
Cas.: 959918-19-5 | Purity: 95% | 3-Ethynylpiperidine hydrochloride | ESD-848594-50MG |
Cas.: 959918-19-5 | Purity: 95% | 3-Ethynylpiperidine hydrochloride | ESD-848594-250MG |
Cas.: 59663-72-8 | Purity: 97% | 2-Propylpiperidin-4-one hydrochloride | ESD-848595-50MG |
Cas.: 59663-72-8 | Purity: 97% | 2-Propylpiperidin-4-one hydrochloride | ESD-848595-250MG |
Cas.: 66073-33-4 | Purity: 98% | Ethyl 4-(2-nitrophenyl)-3-oxobutanoate | ESD-848596-250MG |
Cas.: 66073-33-4 | Purity: 98% | Ethyl 4-(2-nitrophenyl)-3-oxobutanoate | ESD-848596-1G |
Cas.: 1082041-33-5 | Purity: 98% | 4-Chloro-1H-indazol-5-amine | ESD-848597-25MG |
Cas.: 1082041-33-5 | Purity: 98% | 4-Chloro-1H-indazol-5-amine | ESD-848597-100MG |
Cas.: 267875-55-8 | Purity: 98% | 3-Methyl-1H-indazole-5-carbonitrile | ESD-848598-25MG |
Cas.: 267875-55-8 | Purity: 98% | 3-Methyl-1H-indazole-5-carbonitrile | ESD-848598-100MG |
Cas.: 1799412-42-2 | Purity: 98% | 4-(1-(o-Tolyl)vinyl)benzoic acid | ESD-848599-25MG |
Cas.: 1799412-42-2 | Purity: 98% | 4-(1-(o-Tolyl)vinyl)benzoic acid | ESD-848599-100MG |
Cas.: 1641-41-4 | Purity: 97% | 4-Indanol | ESD-848600-250MG |
Cas.: 1641-41-4 | Purity: 97% | 4-Indanol | ESD-848600-1G |
Cas.: 312753-53-0 | Purity: 98% | 5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochloride | ESD-848601-50MG |
Cas.: 312753-53-0 | Purity: 98% | 5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochloride | ESD-848601-250MG |
Cas.: 168960-18-7 | Purity: 97% | tert-Butyl ((1R,4S)-4-(hydroxymethyl)cyclopent-2-en-1-yl)carbamate | ESD-848602-25MG |
Cas.: 168960-18-7 | Purity: 97% | tert-Butyl ((1R,4S)-4-(hydroxymethyl)cyclopent-2-en-1-yl)carbamate | ESD-848602-100MG |
Cas.: 439944-71-5 | Purity: 98% | Methyl 4-(3-hydroxyisoxazol-5-yl)piperidine-1-carboxylate | ESD-848603-25MG |
Cas.: 439944-71-5 | Purity: 98% | Methyl 4-(3-hydroxyisoxazol-5-yl)piperidine-1-carboxylate | ESD-848603-100MG |
Cas.: 1588441-27-3 | Purity: 97% | 4-Methyl-6-nitroindoline | ESD-848604-25MG |
Cas.: 1588441-27-3 | Purity: 97% | 4-Methyl-6-nitroindoline | ESD-848604-100MG |
Cas.: 1799434-48-2 | Purity: 97% | tert-Butyl ((2-(methylsulfonyl)pyrimidin-4-yl)methyl)carbamate | ESD-848605-25MG |
Cas.: 1799434-48-2 | Purity: 97% | tert-Butyl ((2-(methylsulfonyl)pyrimidin-4-yl)methyl)carbamate | ESD-848605-100MG |
Cas.: 1430219-76-3 | Purity: 95% | Potassium trifluoro(oxetan-3-yl)borate | ESD-848606-25MG |
Cas.: 1430219-76-3 | Purity: 95% | Potassium trifluoro(oxetan-3-yl)borate | ESD-848606-100MG |
Cas.: 1543874-84-5 | Purity: 98% | tert-Butyl 2-amino-5-methylhexanoate | ESD-848607-25MG |
Cas.: 1543874-84-5 | Purity: 98% | tert-Butyl 2-amino-5-methylhexanoate | ESD-848607-100MG |
Cas.: 1257850-82-0 | Purity: 95% | (S)-2-(4-(tert-Butoxycarbonyl)morpholin-2-yl)acetic acid | ESD-848608-25MG |
Cas.: 1257850-82-0 | Purity: 95% | (S)-2-(4-(tert-Butoxycarbonyl)morpholin-2-yl)acetic acid | ESD-848608-100MG |
Cas.: 55304-72-8 | Purity: 97% | 2,3,6-Trichloro-5-nitropyridine | ESD-848609-50MG |
Cas.: 55304-72-8 | Purity: 97% | 2,3,6-Trichloro-5-nitropyridine | ESD-848609-250MG |
Cas.: 1000802-52-7 | Purity: 95% | 1-(2-(Pyrrolidin-1-yl)ethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-848610-50MG |
Cas.: 1000802-52-7 | Purity: 95% | 1-(2-(Pyrrolidin-1-yl)ethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-848610-250MG |
Cas.: 1018656-57-9 | Purity: 95% | 2-(Pyridin-4-yl)morpholine | ESD-848611-25MG |
Cas.: 1018656-57-9 | Purity: 95% | 2-(Pyridin-4-yl)morpholine | ESD-848611-100MG |
Cas.: 38696-23-0 | Purity: 98% | 5-Bromo-2-methoxy-4-methylpyrimidine | ESD-848612-25MG |
Cas.: 38696-23-0 | Purity: 98% | 5-Bromo-2-methoxy-4-methylpyrimidine | ESD-848612-100MG |
Cas.: 89033-30-7 | Purity: 98% | 5-Aminopyridazin-3(2H)-one | ESD-848613-50MG |
Cas.: 89033-30-7 | Purity: 98% | 5-Aminopyridazin-3(2H)-one | ESD-848613-250MG |
Cas.: 862895-48-5 | Purity: 97% | 2-Bromo-5-iodo-4-nitro-1H-imidazole | ESD-848614-50MG |
Cas.: 862895-48-5 | Purity: 97% | 2-Bromo-5-iodo-4-nitro-1H-imidazole | ESD-848614-250MG |
Cas.: 321429-48-5 | Purity: 95% | (S)-1-(3-Fluorophenyl)ethylamine hydrochloride | ESD-848615-25MG |
Cas.: 321429-48-5 | Purity: 95% | (S)-1-(3-Fluorophenyl)ethylamine hydrochloride | ESD-848615-100MG |
Cas.: 1060810-03-8 | Purity: 97% | 5-Chloro-2-methylisonicotinic acid | ESD-848616-25MG |
Cas.: 1060810-03-8 | Purity: 97% | 5-Chloro-2-methylisonicotinic acid | ESD-848616-100MG |
Cas.: 1023812-90-9 | Purity: 96% | 2-(tert-Butyl)isonicotinaldehyde | ESD-848617-25MG |
Cas.: 1023812-90-9 | Purity: 96% | 2-(tert-Butyl)isonicotinaldehyde | ESD-848617-100MG |
Cas.: 1416354-38-5 | Purity: 95% | 4-(2-Phenylpropan-2-yl)aniline hydrochloride | ESD-848618-250MG |
Cas.: 1416354-38-5 | Purity: 95% | 4-(2-Phenylpropan-2-yl)aniline hydrochloride | ESD-848618-1G |
Cas.: 1588441-16-0 | Purity: 97% | 8-Bromoquinoline-3-carboxylic acid hydrate | ESD-848619-250MG |
Cas.: 1588441-16-0 | Purity: 97% | 8-Bromoquinoline-3-carboxylic acid hydrate | ESD-848619-1G |
Cas.: 1313593-59-7 | Purity: 95% | (S)-1-(3-Chloro-2-fluorophenyl)ethanamine hydrochloride | ESD-848620-50MG |
Cas.: 1313593-59-7 | Purity: 95% | (S)-1-(3-Chloro-2-fluorophenyl)ethanamine hydrochloride | ESD-848620-250MG |
Cas.: 325152-98-5 | Purity: 98% | (S)-2-Amino-2-(3-fluorophenyl)ethanol | ESD-848621-50MG |
Cas.: 325152-98-5 | Purity: 98% | (S)-2-Amino-2-(3-fluorophenyl)ethanol | ESD-848621-250MG |
Cas.: 376646-56-9 | Purity: 98% | 5-Chloro-4-fluoro-1H-indole | ESD-848622-50MG |
Cas.: 376646-56-9 | Purity: 98% | 5-Chloro-4-fluoro-1H-indole | ESD-848622-250MG |
Cas.: 5823-51-8 | Purity: 98% | 1,2,5-Thiadiazolidine 1,1-dioxide | ESD-848623-50MG |
Cas.: 5823-51-8 | Purity: 98% | 1,2,5-Thiadiazolidine 1,1-dioxide | ESD-848623-250MG |
Cas.: 229623-53-4 | Purity: 95% | 3-Aminobenzo[d]isoxazole-6-carbonitrile | ESD-848624-50MG |
Cas.: 229623-53-4 | Purity: 95% | 3-Aminobenzo[d]isoxazole-6-carbonitrile | ESD-848624-250MG |
Cas.: 258506-74-0 | Purity: 98% | 4-Chloro-6-iodopyrimidine | ESD-848625-50MG |
Cas.: 258506-74-0 | Purity: 98% | 4-Chloro-6-iodopyrimidine | ESD-848625-250MG |
Cas.: 329217-74-5 | Purity: 97% | 6-Bromo-5-methoxypicolinaldehyde | ESD-848626-50MG |
Cas.: 329217-74-5 | Purity: 97% | 6-Bromo-5-methoxypicolinaldehyde | ESD-848626-250MG |
Cas.: 669070-64-8 | Purity: 95% | 2-(Pyridin-2-yl)-1H-benzo[d]imidazole-6-carboxylic acid | ESD-848627-50MG |
Cas.: 669070-64-8 | Purity: 95% | 2-(Pyridin-2-yl)-1H-benzo[d]imidazole-6-carboxylic acid | ESD-848627-250MG |
Cas.: 185030-22-2 | Purity: 97% | Ethyl 2-(5-bromopyrimidin-4-yl)acetate | ESD-848628-50MG |
Cas.: 185030-22-2 | Purity: 97% | Ethyl 2-(5-bromopyrimidin-4-yl)acetate | ESD-848628-250MG |
Cas.: 724788-64-1 | Purity: 98% | Ethyl 4-bromo-6-methoxy-1,5-naphthyridine-3-carboxylate | ESD-848629-50MG |
Cas.: 724788-64-1 | Purity: 98% | Ethyl 4-bromo-6-methoxy-1,5-naphthyridine-3-carboxylate | ESD-848629-250MG |
Cas.: 1228879-24-0 | Purity: 95% | 1-(2-(Trifluoromethyl)phenyl)cyclopropanamine hydrochloride | ESD-848630-50MG |
Cas.: 1228879-24-0 | Purity: 95% | 1-(2-(Trifluoromethyl)phenyl)cyclopropanamine hydrochloride | ESD-848630-250MG |
Cas.: 956523-98-1 | Purity: 98% | tert-Butyl (6-formylpyridin-2-yl)carbamate | ESD-848631-50MG |
Cas.: 956523-98-1 | Purity: 98% | tert-Butyl (6-formylpyridin-2-yl)carbamate | ESD-848631-250MG |
Cas.: 1346264-25-2 | Purity: 95% | 1-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanecarbonitrile | ESD-848632-50MG |
Cas.: 1346264-25-2 | Purity: 95% | 1-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanecarbonitrile | ESD-848632-250MG |
Cas.: 76780-96-6 | Purity: 98% | 2,4-Dichloro-6,7,8,9-tetrahydro-5H-cyclohepta[d]pyrimidine | ESD-848633-50MG |
Cas.: 76780-96-6 | Purity: 98% | 2,4-Dichloro-6,7,8,9-tetrahydro-5H-cyclohepta[d]pyrimidine | ESD-848633-250MG |
Cas.: 3622-03-5 | Purity: 95% | 6-Chlorobenzo[d]thiazole-2-carboxylic acid | ESD-848634-50MG |
Cas.: 3622-03-5 | Purity: 95% | 6-Chlorobenzo[d]thiazole-2-carboxylic acid | ESD-848634-250MG |
Cas.: 1251014-35-3 | Purity: 97% | Ethyl 6-bromoindolizine-2-carboxylate | ESD-848635-50MG |
Cas.: 1251014-35-3 | Purity: 97% | Ethyl 6-bromoindolizine-2-carboxylate | ESD-848635-250MG |
Cas.: 409127-32-8 | Purity: 98% | Methyl 2,6-dichloro-4-cyanobenzoate | ESD-848636-50MG |
Cas.: 409127-32-8 | Purity: 98% | Methyl 2,6-dichloro-4-cyanobenzoate | ESD-848636-250MG |
Cas.: 83431-02-1 | Purity: 98% | 1-(3-Methoxypyridin-4-yl)ethanone | ESD-848637-50MG |
Cas.: 83431-02-1 | Purity: 98% | 1-(3-Methoxypyridin-4-yl)ethanone | ESD-848637-250MG |
Cas.: 1227159-85-4 | Purity: 95% | (1-(4-Bromophenyl)cyclobutyl)methanol | ESD-848638-50MG |
Cas.: 1227159-85-4 | Purity: 95% | (1-(4-Bromophenyl)cyclobutyl)methanol | ESD-848638-250MG |
Cas.: 858515-66-9 | Purity: 98% | 7-Fluoro-1H-indole-3-carboxylic acid | ESD-848639-50MG |
Cas.: 858515-66-9 | Purity: 98% | 7-Fluoro-1H-indole-3-carboxylic acid | ESD-848639-250MG |
Cas.: 10447-29-7 | Purity: 98% | Ethyl quinoline-4-carboxylate | ESD-848640-50MG |
Cas.: 10447-29-7 | Purity: 98% | Ethyl quinoline-4-carboxylate | ESD-848640-250MG |
Cas.: 1214337-57-1 | Purity: 97% | Ethyl 5-bromo-6-chloropicolinate | ESD-848641-50MG |
Cas.: 1214337-57-1 | Purity: 97% | Ethyl 5-bromo-6-chloropicolinate | ESD-848641-250MG |
Cas.: 60390-47-8 | Purity: 98% | Ethyl 5-hydroxy-2-methylnicotinate | ESD-848642-50MG |
Cas.: 60390-47-8 | Purity: 98% | Ethyl 5-hydroxy-2-methylnicotinate | ESD-848642-250MG |
Cas.: 170438-69-4 | Purity: 95% | 1-(Piperidin-4-yl)-1H-indazole | ESD-848643-50MG |
Cas.: 170438-69-4 | Purity: 95% | 1-(Piperidin-4-yl)-1H-indazole | ESD-848643-250MG |
Cas.: 116986-08-4 | Purity: 97% | Methyl 2-(bromomethyl)nicotinate | ESD-848644-50MG |
Cas.: 116986-08-4 | Purity: 97% | Methyl 2-(bromomethyl)nicotinate | ESD-848644-250MG |
Cas.: 223141-46-6 | Purity: 98% | Ethyl 7-chloro-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxylate | ESD-848645-50MG |
Cas.: 223141-46-6 | Purity: 98% | Ethyl 7-chloro-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxylate | ESD-848645-250MG |
Cas.: 1346148-32-0 | Purity: 98% | Methyl 5-fluoro-3-methylpicolinate | ESD-848646-50MG |
Cas.: 1346148-32-0 | Purity: 98% | Methyl 5-fluoro-3-methylpicolinate | ESD-848646-250MG |
Cas.: 1211532-85-2 | Purity: 98% | 5-Chloro-3-methyl-2-nitropyridine | ESD-848647-50MG |
Cas.: 1211532-85-2 | Purity: 98% | 5-Chloro-3-methyl-2-nitropyridine | ESD-848647-250MG |
Cas.: 1598386-14-1 | Purity: 95% | [1,2,4]Triazolo[4,3-a]pyridin-7-amine hydrochloride | ESD-848649-50MG |
Cas.: 1598386-14-1 | Purity: 95% | [1,2,4]Triazolo[4,3-a]pyridin-7-amine hydrochloride | ESD-848649-250MG |
Cas.: 1598381-37-3 | Purity: 98% | Methyl 2,5-dibromo-1H-pyrrole-3-carboxylate | ESD-848650-50MG |
Cas.: 1598381-37-3 | Purity: 98% | Methyl 2,5-dibromo-1H-pyrrole-3-carboxylate | ESD-848650-250MG |
Cas.: 3999-42-6 | Purity: 98% | (2,6-Dimethylpyridin-1-ium-1-yl)trihydroborate | ESD-848651-50MG |
Cas.: 3999-42-6 | Purity: 98% | (2,6-Dimethylpyridin-1-ium-1-yl)trihydroborate | ESD-848651-250MG |
Cas.: 1114546-30-3 | Purity: 97% | 4-Bromo-2-fluoro-3-methylbenzonitrile | ESD-848652-50MG |
Cas.: 1114546-30-3 | Purity: 97% | 4-Bromo-2-fluoro-3-methylbenzonitrile | ESD-848652-250MG |
Cas.: 1314936-02-1 | Purity: 97% | 3,5-Dichloro-2-ethylpyrazine | ESD-848653-50MG |
Cas.: 1314936-02-1 | Purity: 97% | 3,5-Dichloro-2-ethylpyrazine | ESD-848653-250MG |
Cas.: 267876-25-5 | Purity: 98% | (1H-Pyrrolo[2,3-b]pyridin-5-yl)methanamine | ESD-848654-50MG |
Cas.: 267876-25-5 | Purity: 98% | (1H-Pyrrolo[2,3-b]pyridin-5-yl)methanamine | ESD-848654-250MG |
Cas.: 1076196-38-7 | Purity: 97% | 2-(4-Aminophenoxy)-N,N,N-trimethylethanaminium bromide hydrobromide | ESD-848655-50MG |
Cas.: 1076196-38-7 | Purity: 97% | 2-(4-Aminophenoxy)-N,N,N-trimethylethanaminium bromide hydrobromide | ESD-848655-250MG |
Cas.: 182287-50-9 | Purity: 97% | 2-Amino-3-(tetrahydro-2H-pyran-4-yl)propanoic acid hydrochloride | ESD-848656-50MG |
Cas.: 182287-50-9 | Purity: 97% | 2-Amino-3-(tetrahydro-2H-pyran-4-yl)propanoic acid hydrochloride | ESD-848656-250MG |
Cas.: 870837-70-0 | Purity: 97% | 4-(1H-Imidazol-1-yl)-3-methoxybenzaldehyde | ESD-848657-50MG |
Cas.: 870837-70-0 | Purity: 97% | 4-(1H-Imidazol-1-yl)-3-methoxybenzaldehyde | ESD-848657-250MG |
Cas.: 642444-30-2 | Purity: 96% | 2-(3-(Trifluoromethoxy)phenyl)ethanol | ESD-848658-50MG |
Cas.: 642444-30-2 | Purity: 96% | 2-(3-(Trifluoromethoxy)phenyl)ethanol | ESD-848658-250MG |
Cas.: 6343-68-6 | Purity: 97% | 4,6-Dichloro-5-ethylpyrimidin-2-amine | ESD-848659-50MG |
Cas.: 6343-68-6 | Purity: 97% | 4,6-Dichloro-5-ethylpyrimidin-2-amine | ESD-848659-250MG |
Cas.: 904813-39-4 | Purity: 98% | 3-Methylquinoxaline-5-carboxylic acid | ESD-848660-50MG |
Cas.: 904813-39-4 | Purity: 98% | 3-Methylquinoxaline-5-carboxylic acid | ESD-848660-250MG |
Cas.: 387827-19-2 | Purity: 97% | tert-Butyl 4-(3-aminophenyl)piperidine-1-carboxylate | ESD-848661-50MG |
Cas.: 387827-19-2 | Purity: 97% | tert-Butyl 4-(3-aminophenyl)piperidine-1-carboxylate | ESD-848661-250MG |
Cas.: 86604-77-5 | Purity: 95% | (4-Methoxy-3-methylpyridin-2-yl)methanol | ESD-848662-50MG |
Cas.: 86604-77-5 | Purity: 95% | (4-Methoxy-3-methylpyridin-2-yl)methanol | ESD-848662-250MG |
Cas.: 1624260-45-2 | Purity: 97% | 6-Chloro-3-methoxybenzo[b]thiophene-2-carboxylic acid | ESD-848663-25MG |
Cas.: 1624260-45-2 | Purity: 97% | 6-Chloro-3-methoxybenzo[b]thiophene-2-carboxylic acid | ESD-848663-100MG |
Cas.: 501331-02-8 | Purity: 98% | (R)-2-(((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoic acid | ESD-848664-25MG |
Cas.: 501331-02-8 | Purity: 98% | (R)-2-(((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoic acid | ESD-848664-100MG |
Cas.: 55457-11-9 | Purity: 98% | 7-Methylpyrazolo[1,5-a][1,3,5]triazin-4(3H)-one | ESD-848665-25MG |
Cas.: 55457-11-9 | Purity: 98% | 7-Methylpyrazolo[1,5-a][1,3,5]triazin-4(3H)-one | ESD-848665-100MG |
Cas.: 49716-18-9 | Purity: 95% | 6-Chloro-1,2,3,4-tetrahydroquinoline | ESD-848666-250MG |
Cas.: 49716-18-9 | Purity: 95% | 6-Chloro-1,2,3,4-tetrahydroquinoline | ESD-848666-1G |
Cas.: 32822-84-7 | Purity: 98% | Methyl 3-hydroxy-4,5-dimethylthiophene-2-carboxylate | ESD-848667-50MG |
Cas.: 32822-84-7 | Purity: 98% | Methyl 3-hydroxy-4,5-dimethylthiophene-2-carboxylate | ESD-848667-250MG |
Cas.: 130148-53-7 | Purity: 95% | 2-Amino-6-bromoquinazolin-4-ol | ESD-848668-25MG |
Cas.: 130148-53-7 | Purity: 95% | 2-Amino-6-bromoquinazolin-4-ol | ESD-848668-100MG |
Cas.: 22490-86-4 | Purity: 95% | 3-Amino-3-(3-methoxyphenyl)propan-1-ol | ESD-848669-250MG |
Cas.: 22490-86-4 | Purity: 95% | 3-Amino-3-(3-methoxyphenyl)propan-1-ol | ESD-848669-1G |
Cas.: 1353958-73-2 | Purity: 96% | 1-(Pyridin-2-ylsulfonyl)piperidin-4-amine hydrochloride | ESD-848670-50MG |
Cas.: 1353958-73-2 | Purity: 96% | 1-(Pyridin-2-ylsulfonyl)piperidin-4-amine hydrochloride | ESD-848670-250MG |
Cas.: 958026-66-9 | Purity: 97% | tert-Butyl 3-(2-bromoethyl)pyrrolidine-1-carboxylate | ESD-848671-50MG |
Cas.: 958026-66-9 | Purity: 97% | tert-Butyl 3-(2-bromoethyl)pyrrolidine-1-carboxylate | ESD-848671-250MG |
Cas.: 908240-50-6 | Purity: 98% | 2,4-Dichloropyrido[3,4-d]pyrimidine | ESD-848672-25MG |
Cas.: 908240-50-6 | Purity: 98% | 2,4-Dichloropyrido[3,4-d]pyrimidine | ESD-848672-100MG |
Cas.: 136888-26-1 | Purity: 97% | 5,6-Dichloro-1H-pyrrolo[3,2-b]pyridin-2(3H)-one | ESD-848673-25MG |
Cas.: 136888-26-1 | Purity: 97% | 5,6-Dichloro-1H-pyrrolo[3,2-b]pyridin-2(3H)-one | ESD-848673-100MG |
Cas.: 1261739-13-2 | Purity: 97% | Ethyl 4-chloro-5-methylpicolinate | ESD-848674-25MG |
Cas.: 1261739-13-2 | Purity: 97% | Ethyl 4-chloro-5-methylpicolinate | ESD-848674-100MG |
Cas.: 1588441-00-2 | Purity: 95% | (3-Methoxypyridin-2-yl)methanamine hydrochloride | ESD-848675-25MG |
Cas.: 1588441-00-2 | Purity: 95% | (3-Methoxypyridin-2-yl)methanamine hydrochloride | ESD-848675-100MG |
Cas.: 790692-90-9 | Purity: 98% | 6-Chloro-5-iodo-3-nitropyridin-2-amine | ESD-848676-25MG |
Cas.: 790692-90-9 | Purity: 98% | 6-Chloro-5-iodo-3-nitropyridin-2-amine | ESD-848676-100MG |
Cas.: 1632285-87-0 | Purity: 95% | (2-Methoxypyrimidin-4-yl)methanamine hydrochloride | ESD-848677-25MG |
Cas.: 1632285-87-0 | Purity: 95% | (2-Methoxypyrimidin-4-yl)methanamine hydrochloride | ESD-848677-100MG |
Cas.: 1799439-04-5 | Purity: 95% | (5-Bromo-6-chloropyridin-2-yl)methanamine hydrochloride | ESD-848678-25MG |
Cas.: 1799439-04-5 | Purity: 95% | (5-Bromo-6-chloropyridin-2-yl)methanamine hydrochloride | ESD-848678-100MG |
Cas.: 1314390-34-5 | Purity: 98% | tert-Butyl (2-bromopyrimidin-5-yl)carbamate | ESD-848679-25MG |
Cas.: 1314390-34-5 | Purity: 98% | tert-Butyl (2-bromopyrimidin-5-yl)carbamate | ESD-848679-100MG |
Cas.: 1799412-36-4 | Purity: 97% | N-(3-Acetyl-5-(benzyloxy)-2-hydroxyphenyl)-2-chloroacetamide | ESD-848680-25MG |
Cas.: 1799412-36-4 | Purity: 97% | N-(3-Acetyl-5-(benzyloxy)-2-hydroxyphenyl)-2-chloroacetamide | ESD-848680-100MG |
Cas.: 1627722-90-0 | Purity: 97% | Methyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline-8-carboxylate | ESD-848681-25MG |